,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
1245,GO:0007409,0.00122838792719789,0.999764266657344,13,20,axonogenesis,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
3079,GO:0032990,0.00163780651829722,0.999633886264854,14,23,cell part morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
4686,GO:0048812,0.00163780651829722,0.999633886264854,14,23,neuron projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
4703,GO:0048858,0.00163780651829722,0.999633886264854,14,23,cell projection morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
27,GO:0000165,0.00319580100518907,0.998878035995505,22,44,MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;PSMB10;BMP7;SPTBN4;FGF18
3313,GO:0035116,0.00362195808160637,1,5,5,embryonic hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
3315,GO:0035137,0.00362195808160637,1,5,5,hindlimb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;NOTCH1
2338,GO:0021953,0.00379372434107233,0.999788063965604,6,7,central nervous system neuron differentiation,BP,WNT7A;WNT3;AXIN1;WNT2;FGF8;SPTBN4
4530,GO:0048193,0.0039099393809276,0.999626737501734,7,9,Golgi vesicle transport,BP,RABIF;SPTBN5;SPTB;CNIH4;USE1;TBC1D14;SPTBN4
2950,GO:0032526,0.00416067807331185,0.999464335549099,8,11,response to retinoic acid,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;RBP4;WNT5B
5359,GO:0060561,0.00475508355703071,1,4,4,apoptotic process involved in morphogenesis,BP,JAG2;VDR;BMP7;NOTCH1
6717,GO:1902742,0.00475508355703071,1,4,4,apoptotic process involved in development,BP,JAG2;VDR;BMP7;NOTCH1
4644,GO:0048667,0.00612919957116395,0.998361372620379,13,23,cell morphogenesis involved in neuron differentiation,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
5579,GO:0061564,0.00617277690189062,0.998348015046696,13,23,axon development,BP,WNT7A;WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
3362,GO:0035556,0.00706454344664442,0.99660708737121,38,93,intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;RABIF;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;RAB40B;RRAS2;SPTBN5;FZD7;SPTB;FGF8;AMOT;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1;RND3;GUCY1B3
1246,GO:0007411,0.00724714827533378,0.998470931328058,10,16,axon guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA
6334,GO:0097485,0.00724714827533378,0.998470931328058,10,16,neuron projection guidance,BP,WNT3;SPTBN5;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA
122,GO:0001570,0.00809308011902683,0.999518206000103,5,6,vasculogenesis,BP,WNT7A;HEY1;WNT7B;AMOT;NOTCH1
5562,GO:0061383,0.00813452700602549,1,4,4,trabecula morphogenesis,BP,HEY1;RBP4;BMP7;NOTCH1
5563,GO:0061384,0.00813452700602549,1,4,4,heart trabecula morphogenesis,BP,HEY1;RBP4;BMP7;NOTCH1
2391,GO:0023014,0.00826230875384951,0.996721843743733,22,47,signal transduction by protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;PSMB10;BMP7;SPTBN4;FGF18
485,GO:0003206,0.00978734358397314,0.998604516419751,7,10,cardiac chamber morphogenesis,BP,HEY1;WNT2;RBP4;FGF8;BMP4;BMP7;NOTCH1
1218,GO:0007267,0.0104030118247658,0.995501142177768,25,56,cell-cell signaling,BP,TLE1;WNT7A;GJB2;SYT5;BMP6;GJA3;WNT3;WNT7B;KCNG2;AXIN1;WNT2;PXK;FZD7;RBP4;FGF8;WNT5B;CCL20;INHBB;FGF17;HRAS;BMP4;GDNF;PSMB10;FGF18;NOTCH1
2510,GO:0030326,0.0116796172756264,0.998694719997675,6,8,embryonic limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
3311,GO:0035113,0.0116796172756264,0.998694719997675,6,8,embryonic appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
3768,GO:0043087,0.0133151588465901,0.995640686440652,14,27,regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;AMOT;ARTN;CCL20;FGF17;HRAS;GDNF;TBC1D14;SPTBN4;FGF18
1249,GO:0007420,0.0143091405449621,0.995679449237505,12,23,brain development,BP,WNT7A;WNT3;ACAT1;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
790,GO:0005654,0.0152467798183966,0.994191664841446,17,36,nucleoplasm,CC,TLE1;HEY1;MSRA;POU3F1;MAPK12;ARL6IP4;VDR;DUSP5;PKP1;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FSTL3;NOTCH1;PM20D2
1251,GO:0007423,0.0157355424074302,0.994638971714437,14,28,sensory organ development,BP,WNT7A;GJB2;BMP6;GJB6;WNT7B;JAG2;AXIN1;WNT2;RBP4;FGF8;WNT5B;BMP4;BMP7;NOTCH1
1543,GO:0009887,0.0161867085779927,0.99310385974941,21,47,animal organ morphogenesis,BP,TLE1;WNT7A;BMP6;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;RBP4;FGF8;VDR;WNK4;HRAS;BMP4;GDNF;PSMB10;BMP7;FGF18;NOTCH1
3988,GO:0044260,0.0163885460592596,0.990948226744087,56,153,cellular macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;HEY1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;SPTB;FGF8;VDR;PUS1;ARTN;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;BMP4;RNF144A;RAB3D;KRT10;GDNF;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;LAGE3;FGF18;FSTL3;NOTCH1;ETFB;DPM3;PM20D2
67,GO:0000904,0.0164829391726879,0.994345142128917,14,28,cell morphogenesis involved in differentiation,BP,WNT7A;WNT3;SPTBN5;FZD7;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
2672,GO:0031175,0.0169037400723705,0.993896244612849,15,31,neuron projection development,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
1248,GO:0007417,0.0169468463393621,0.993878427369016,15,31,central nervous system development,BP,WNT7A;WNT3;ACAT1;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;SPTBN4;DRP2;PTS;NOTCH1
1556,GO:0009913,0.0170489104655376,0.996198861424746,8,14,epidermal cell differentiation,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;KRT10;NOTCH1
1117,GO:0006935,0.0170997808262724,0.993622561512121,16,33,chemotaxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;AMOT;ARTN;CCL20;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1
3616,GO:0042330,0.0170997808262724,0.993622561512121,16,33,taxis,BP,PIK3CG;WNT3;SPTBN5;SPTB;FGF8;AMOT;ARTN;CCL20;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1
3788,GO:0043170,0.0173771884317572,0.990322645583773,61,169,macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;RHBDL3;BMP6;WNT3;HEY1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;SPTB;FGF8;VDR;PUS1;ARTN;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;GDNF;USE1;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;LAGE3;FGF18;FSTL3;NOTCH1;ETFB;DPM3;PM20D2;PEPD
4618,GO:0048598,0.0178832725299475,0.99322268364643,16,34,embryonic morphogenesis,BP,WNT7A;WNT3;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;RBP4;FGF8;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
823,GO:0005794,0.0181006776549975,0.992885306965694,17,37,Golgi apparatus,CC,WNT7A;WNT3;WNT7B;CDH1;RAB39A;SPTB;WNT5B;ABCG1;PKN3;HRAS;RNF144A;TBC1D14;RAB38;FSTL3;NOTCH1;RND3;RAB20
3906,GO:0043547,0.0182378003669446,0.993992946313517,13,25,positive regulation of GTPase activity,BP,RABIF;AXIN1;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;TBC1D14;SPTBN4;FGF18
1319,GO:0008091,0.0182866239646303,1,3,3,spectrin,CC,SPTBN5;SPTB;SPTBN4
2532,GO:0030506,0.0182948784306089,1,3,3,ankyrin binding,MF,CDH1;SPTB;SPTBN4
5198,GO:0060070,0.0185235370530613,0.994963804945192,10,18,canonical Wnt signaling pathway,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;PSMB10;NOTCH1
3947,GO:0043902,0.0191666279670797,1,3,3,positive regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
2484,GO:0030258,0.0199298850015471,0.992714300980735,15,30,lipid modification,BP,PIK3CG;HACL1;ACAT1;ACADVL;FGF8;ABCG1;FGF17;ECI1;ETFDH;PIK3CA;DECR1;FGF18;CPT1C;ZFYVE21;ETFB
6167,GO:0090100,0.0199541771269226,0.997706556321574,5,7,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;INHBB;BMP4;BMP7;NOTCH1
2455,GO:0030182,0.0209414747912592,0.990524164386758,22,52,neuron differentiation,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;CDH1;FZD7;SPTB;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
4139,GO:0045165,0.0210536812049767,0.993575502831903,11,21,cell fate commitment,BP,WNT7A;WNT3;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;NOTCH1
4034,GO:0044431,0.0214084858502149,0.993447876000739,11,21,Golgi apparatus part,CC,WNT7A;WNT3;WNT7B;CDH1;RAB39A;WNT5B;ABCG1;HRAS;RAB38;NOTCH1;RND3
1238,GO:0007369,0.0218982153665962,0.994851034079157,8,14,gastrulation,BP,WNT3;AXIN1;FZD7;FGF8;AMOT;DUSP5;BMP4;BMP7
2806,GO:0031981,0.0222239858005113,0.990322423711663,20,45,nuclear lumen,CC,MAGEC2;TLE1;HEY1;MSRA;POU3F1;MAPK12;ACADVL;ARL6IP4;VDR;DUSP5;PKP1;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;PM20D2
1950,GO:0016055,0.0222595905186988,0.993140054510122,11,21,Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;PSMB10;NOTCH1
6464,GO:0198738,0.0222595905186988,0.993140054510122,11,21,cell-cell signaling by wnt,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;PSMB10;NOTCH1
5407,GO:0060711,0.0225176981451777,0.998444304523828,4,5,labyrinthine layer development,BP,HEY1;WNT7B;WNT2;BMP7
1318,GO:0008083,0.0228338264303403,0.993103021564034,11,20,growth factor activity,MF,BMP6;JAG2;FGF8;ARTN;INHBB;FGF17;BMP4;GDNF;BMP7;NUDT6;FGF18
4641,GO:0048663,0.0229994551210132,0.998399274709522,4,5,neuron fate commitment,BP,JAG2;AXIN1;BMP4;NOTCH1
4206,GO:0045606,0.0232185746484679,1,3,3,positive regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
5944,GO:0072044,0.0232263412046087,1,3,3,collecting duct development,BP,WNT7B;BMP4;NOTCH1
1534,GO:0009755,0.0232309702506995,1,3,3,hormone-mediated signaling pathway,BP,VDR;BMP4;BMP7
3857,GO:0043401,0.0232309702506995,1,3,3,steroid hormone mediated signaling pathway,BP,VDR;BMP4;BMP7
4764,GO:0050768,0.0234276740754643,0.997176485849654,5,7,negative regulation of neurogenesis,BP,WNT7A;WNT3;BMP7;NOTCH1;LINGO1
4655,GO:0048704,0.0234327176373844,1,3,3,embryonic skeletal system morphogenesis,BP,AXIN1;BMP4;BMP7
5246,GO:0060272,0.0234327176373844,1,3,3,embryonic skeletal joint morphogenesis,BP,AXIN1;BMP4;BMP7
6072,GO:0072498,0.0234327176373844,1,3,3,embryonic skeletal joint development,BP,AXIN1;BMP4;BMP7
2144,GO:0017145,0.0235627046431923,1,3,3,stem cell division,BP,WNT7A;FZD7;NOTCH1
4515,GO:0048103,0.0235627046431923,1,3,3,somatic stem cell division,BP,WNT7A;FZD7;NOTCH1
5289,GO:0060395,0.023773667778649,0.998326165865893,4,5,SMAD protein signal transduction,BP,BMP6;INHBB;BMP4;BMP7
1682,GO:0010721,0.0239874110406263,0.996103250611936,6,9,negative regulation of cell development,BP,WNT7A;CLDN18;WNT3;BMP7;NOTCH1;LINGO1
5574,GO:0061448,0.024350111582124,0.992374282386406,11,21,connective tissue development,BP,WNT7A;BMP6;ACAT1;WNT7B;WNT5B;BMP4;BMP7;PIK3CA;PLA2G16;FGF18;NOTCH1
4628,GO:0048638,0.0250787347436673,0.99331976416235,9,16,regulation of developmental growth,BP,ACTN3;WNT3;WNT2;RBP4;FGF8;BMP4;SPTBN4;PIK3CA;NOTCH1
1987,GO:0016307,0.0251951643234394,1,3,3,phosphatidylinositol phosphate kinase activity,MF,PIK3CG;PIK3CA;ZFYVE21
3861,GO:0043407,0.0253819697989862,1,3,3,negative regulation of MAP kinase activity,BP,DUSP5;BMP4;BMP7
5825,GO:0071383,0.0254510350036204,0.996855557684956,5,7,cellular response to steroid hormone stimulus,BP,GJB2;HEY1;VDR;BMP4;BMP7
5792,GO:0071300,0.0255679695040666,0.996836748620468,5,7,cellular response to retinoic acid,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
5136,GO:0055024,0.0257413297312075,0.99573907547616,6,9,regulation of cardiac muscle tissue development,BP,WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
481,GO:0003197,0.0266561772509465,0.996660367498002,5,7,endocardial cushion development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
272,GO:0002088,0.0267516481253633,0.996644778609348,5,7,lens development in camera-type eye,BP,WNT7A;WNT7B;WNT2;WNT5B;BMP4
5665,GO:0070306,0.0270785839333686,1,3,3,lens fiber cell differentiation,BP,WNT7A;WNT7B;WNT5B
5666,GO:0070307,0.0270785839333686,1,3,3,lens fiber cell development,BP,WNT7A;WNT7B;WNT5B
3725,GO:0042787,0.0274013930564464,1,3,3,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A;PSMB10
4614,GO:0048589,0.0276964030738727,0.990487905254484,12,24,developmental growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;RBP4;FGF8;BMP4;SPTBN4;PIK3CA;NOTCH1
2609,GO:0030858,0.0282008753288734,0.99640591176415,5,7,positive regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
2470,GO:0030216,0.0283573972161786,0.994632283534649,6,10,keratinocyte differentiation,BP,POU3F1;VDR;DSG3;PKP1;KRT10;NOTCH1
504,GO:0003272,0.0285825583553823,0.997852347446213,4,5,endocardial cushion formation,BP,HEY1;FGF8;BMP7;NOTCH1
3978,GO:0044238,0.0285929209326792,0.983718948928303,76,220,primary metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;RHBDL3;ACTN3;HACL1;MBOAT2;BMP6;HEY1;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;SPTB;FGF8;VDR;PUS1;ARTN;NUDT7;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;ECI1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;CPT1C;ZFYVE21;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
1831,GO:0014855,0.0286013726794137,1,3,3,striated muscle cell proliferation,BP,WNT2;RBP4;NOTCH1
5178,GO:0060038,0.0286013726794137,1,3,3,cardiac muscle cell proliferation,BP,WNT2;RBP4;NOTCH1
5182,GO:0060043,0.0286013726794137,1,3,3,regulation of cardiac muscle cell proliferation,BP,WNT2;RBP4;NOTCH1
1099,GO:0006888,0.0288903151928095,0.9978209091669,4,5,ER to Golgi vesicle-mediated transport,BP,SPTBN5;SPTB;CNIH4;SPTBN4
4656,GO:0048705,0.0290833850770746,0.995025136977614,6,9,skeletal system morphogenesis,BP,WNT7A;BMP6;AXIN1;BMP4;BMP7;FGF18
5379,GO:0060612,0.0299013439471607,1,3,3,adipose tissue development,BP,ACAT1;PIK3CA;PLA2G16
4657,GO:0048706,0.0305312976304422,0.997651098486552,4,5,embryonic skeletal system development,BP,AXIN1;RBP4;BMP4;BMP7
3308,GO:0035107,0.0308177415900964,0.994644766191303,6,9,appendage morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
3309,GO:0035108,0.0308177415900964,0.994644766191303,6,9,limb morphogenesis,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
1106,GO:0006906,0.0309955456413919,0.997602399807432,4,5,vesicle fusion,BP,SYT5;RAB39A;TBC1D14;RAB20
4546,GO:0048284,0.0309955456413919,0.997602399807432,4,5,organelle fusion,BP,SYT5;RAB39A;TBC1D14;RAB20
6181,GO:0090174,0.0309955456413919,0.997602399807432,4,5,organelle membrane fusion,BP,SYT5;RAB39A;TBC1D14;RAB20
683,GO:0005085,0.0316187648281009,0.991163462507636,9,16,guanyl-nucleotide exchange factor activity,MF,RABIF;SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4;FGF18
5001,GO:0051438,0.0322918117432839,1,3,3,regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1;PSMB10
5003,GO:0051443,0.0322918117432839,1,3,3,positive regulation of ubiquitin-protein transferase activity,BP,MAGEC2;AXIN1;PSMB10
2606,GO:0030855,0.0326680620579952,0.98548838704445,18,42,epithelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;JAG2;POU3F1;ACADVL;FZD7;FGF8;VDR;WNT5B;DSG3;PKP1;BMP4;KRT10;GDNF;BMP7;NOTCH1
3139,GO:0033539,0.0331844304346913,1,3,3,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFDH;ETFB
5830,GO:0071396,0.0332103226965646,0.988045652768734,12,25,cellular response to lipid,BP,GJB2;BMP6;WNT3;HEY1;WNT7B;WNT2;FZD7;VDR;WNT5B;CCL20;BMP4;BMP7
484,GO:0003205,0.0336507673994352,0.992245132670512,7,12,cardiac chamber development,BP,HEY1;WNT2;RBP4;FGF8;BMP4;BMP7;NOTCH1
2544,GO:0030534,0.0345589193269233,1,3,3,adult behavior,BP,GDNF;FADD;SPTBN4
1428,GO:0009062,0.0346283099385709,0.990989261868743,8,14,fatty acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
103,GO:0001501,0.0347785212856033,0.986877996882453,13,27,skeletal system development,BP,WNT7A;CLDN18;BMP6;WNT7B;JAG2;AXIN1;RBP4;FGF8;VDR;WNT5B;BMP4;BMP7;FGF18
4196,GO:0045595,0.0349357571155338,0.983097868829513,22,53,regulation of cell differentiation,BP,WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;FGF8;VDR;WNT5B;ABCG1;BMP4;GDNF;FADD;BMP7;FGF18;FSTL3;NOTCH1;LINGO1
2400,GO:0030004,0.0350828301866272,1,3,3,cellular monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
2557,GO:0030641,0.0350828301866272,1,3,3,regulation of cellular pH,BP,RAB39A;RAB38;RAB20
4283,GO:0045851,0.0350828301866272,1,3,3,pH reduction,BP,RAB39A;RAB38;RAB20
5008,GO:0051452,0.0350828301866272,1,3,3,intracellular pH reduction,BP,RAB39A;RAB38;RAB20
5009,GO:0051453,0.0350828301866272,1,3,3,regulation of intracellular pH,BP,RAB39A;RAB38;RAB20
6230,GO:0090383,0.0350828301866272,1,3,3,phagosome acidification,BP,RAB39A;RAB38;RAB20
66,GO:0000902,0.0352881290029822,0.985000325613121,16,36,cell morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;FZD7;SPTB;FGF8;VDR;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
6954,GO:1905114,0.0360436084024416,0.986837311499165,12,25,cell surface receptor signaling pathway involved in cell-cell signaling,BP,TLE1;WNT7A;WNT3;WNT7B;AXIN1;WNT2;FZD7;FGF8;WNT5B;BMP4;PSMB10;NOTCH1
1241,GO:0007389,0.0391495946347412,0.986344344019602,11,22,pattern specification process,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;ALG5;BMP4;GDNF;BMP7;NOTCH1
1969,GO:0016202,0.0392966197349077,0.990589671604077,7,12,regulation of striated muscle tissue development,BP,ACTN3;WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
4625,GO:0048634,0.0392966197349077,0.990589671604077,7,12,regulation of muscle organ development,BP,ACTN3;WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
6610,GO:1901861,0.0392966197349077,0.990589671604077,7,12,regulation of muscle tissue development,BP,ACTN3;WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
1011,GO:0006635,0.0404852268175654,0.990232406823861,7,12,fatty acid beta-oxidation,BP,ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
800,GO:0005759,0.0413214360199587,0.986495355611047,10,19,mitochondrial matrix,CC,GLDC;ACAT1;MRPL14;ACADVL;PUS1;TSFM;ECI1;ETFDH;DECR1;ETFB
4600,GO:0048545,0.041364076198909,0.988318839002897,8,15,response to steroid hormone,BP,GJB2;BMP6;HEY1;WNT7B;VDR;BMP4;BMP7;NOTCH1
2622,GO:0030900,0.0417366488161563,0.988189367961616,8,15,forebrain development,BP,WNT7A;WNT7B;AXIN1;POU3F1;CDH1;FGF8;BMP4;NOTCH1
6441,GO:0099531,0.0418998041641019,1,3,3,presynaptic process involved in chemical synaptic transmission,BP,WNT7A;SYT5;GDNF
690,GO:0005109,0.0429010447738843,0.990917955846463,6,10,frizzled binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B
5263,GO:0060322,0.0430500141959374,0.983557974714774,12,26,head development,BP,WNT7A;WNT3;ACAT1;WNT7B;AXIN1;POU3F1;WNT2;CDH1;FGF8;BMP4;BMP7;NOTCH1
4379,GO:0046488,0.0434982780963298,0.988069186659229,8,14,phosphatidylinositol metabolic process,BP,PIK3CG;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;ZFYVE21;DPM3
3812,GO:0043231,0.044367326409086,0.973381073389646,71,204,intracellular membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;PIK3CG;HACL1;MBOAT2;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;ACADVL;PXMP2;RAB40B;RRAS2;CDH1;ARL6IP4;TMEM160;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;CNIH4;TSFM;DUSP5;ABCG1;PKN3;ALG5;PKP1;HRAS;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;RND3;CPT1C;RAB20;ETFB;DPM3;PM20D2
4667,GO:0048732,0.0452186621253601,0.981752757722899,13,29,gland development,BP,WNT3;ACAT1;WNT7B;WNT2;CDH1;FGF8;VDR;BMP4;FADD;BMP7;PIK3CA;FSTL3;NOTCH1
1544,GO:0009888,0.045744141857138,0.974418744752691,32,85,tissue development,BP,WNT7A;GJB2;ACTN3;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;WNT2;ACADVL;FZD7;RBP4;FGF8;VDR;ARTN;WNT5B;DSG3;WNK4;DUSP5;PKP1;BMP4;KRT10;GDNF;PSMB10;BMP7;PIK3CA;PLA2G16;FGF18;NOTCH1
4031,GO:0044428,0.0459955263651699,0.976937918655852,22,53,nuclear part,CC,MAGEC2;TLE1;HEY1;MSRA;POU3F1;MAPK12;ACADVL;RAB40B;ARL6IP4;VDR;AMOT;DUSP5;PKP1;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;PM20D2
5104,GO:0051961,0.0461274373701624,0.991847351928028,5,8,negative regulation of nervous system development,BP,WNT7A;WNT3;BMP7;NOTCH1;LINGO1
2236,GO:0019538,0.0462695256638301,0.972359971058663,47,129,protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;RHBDL3;BMP6;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;MAPK12;MRPL14;RAB40B;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;GDNF;USE1;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;ETFB;DPM3;PM20D2;PEPD
3977,GO:0044237,0.0475808559526086,0.971608244355376,76,224,cellular metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;ACTN3;HACL1;MBOAT2;BMP6;HEY1;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;ARTN;NUDT7;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;BMP4;RNF144A;RAB3D;KRT10;ECI1;GDNF;ETFDH;DEPTOR;LYPLAL1;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;PNMT;CPT1C;ZFYVE21;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
3746,GO:0043009,0.0484972732915173,0.981822018202735,11,24,chordate embryonic development,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;RBP4;FGF8;AMOT;BMP4;BMP7;NOTCH1
4197,GO:0045596,0.0486972428604334,0.981992198487908,11,23,negative regulation of cell differentiation,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;ABCG1;BMP4;BMP7;FSTL3;NOTCH1;LINGO1
5879,GO:0071704,0.0489176500595255,0.970911303431581,78,230,organic substance metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;RHBDL3;ACTN3;HACL1;MBOAT2;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;SPTB;FGF8;VDR;PUS1;ARTN;NUDT7;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;ECI1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;PNMT;CPT1C;ZFYVE21;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
5294,GO:0060411,0.0512001305881939,0.99064771348181,5,8,cardiac septum morphogenesis,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
3170,GO:0033993,0.0516441971582264,0.976077262522514,17,39,response to lipid,BP,WNT7A;GJB2;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;FZD7;RBP4;VDR;WNT5B;CCL20;ABCG1;BMP4;BMP7;NOTCH1
4653,GO:0048699,0.0527510697353435,0.972812362044284,22,56,generation of neurons,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;CDH1;FZD7;SPTB;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
4668,GO:0048736,0.0532717209035386,0.988013713995642,6,10,appendage development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
5224,GO:0060173,0.0532717209035386,0.988013713995642,6,10,limb development,BP,WNT7A;WNT3;FGF8;BMP4;BMP7;NOTCH1
965,GO:0006464,0.0539607013717685,0.968521450930497,36,97,cellular protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;MSRA;AXIN1;MAPK12;RAB40B;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;ALG5;HRAS;BMP4;RNF144A;RAB3D;KRT10;GDNF;DEPTOR;LYPLAL1;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18;ETFB;DPM3
3479,GO:0036211,0.0539607013717685,0.968521450930497,36,97,protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;MSRA;AXIN1;MAPK12;RAB40B;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;ALG5;HRAS;BMP4;RNF144A;RAB3D;KRT10;GDNF;DEPTOR;LYPLAL1;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18;ETFB;DPM3
2607,GO:0030856,0.0541330663476111,0.989934571552784,5,8,regulation of epithelial cell differentiation,BP,BMP6;VDR;BMP4;GDNF;NOTCH1
6055,GO:0072329,0.0550301437989968,0.983387188731844,8,15,monocarboxylic acid catabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
697,GO:0005125,0.0550616712155651,0.984873333018446,7,13,cytokine activity,MF,WNT7A;BMP6;WNT2;CCL20;INHBB;BMP4;BMP7
1720,GO:0010862,0.055089120886642,0.992375209669046,4,6,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
5285,GO:0060389,0.055089120886642,0.992375209669046,4,6,pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
5288,GO:0060393,0.055089120886642,0.992375209669046,4,6,regulation of pathway-restricted SMAD protein phosphorylation,BP,BMP6;INHBB;BMP4;BMP7
4227,GO:0045665,0.0554091969962759,0.992314409950448,4,6,negative regulation of neuron differentiation,BP,WNT3;BMP7;NOTCH1;LINGO1
132,GO:0001654,0.0559575195606737,0.981224231935109,9,18,eye development,BP,WNT7A;BMP6;WNT7B;AXIN1;WNT2;RBP4;WNT5B;BMP4;BMP7
426,GO:0003007,0.056350760811321,0.984426605010147,7,13,heart morphogenesis,BP,HEY1;WNT2;RBP4;FGF8;BMP4;BMP7;NOTCH1
3865,GO:0043412,0.05637902322506,0.966788922892725,37,100,macromolecule modification,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;MSRA;AXIN1;MAPK12;RAB40B;SPTBN5;FZD7;SPTB;FGF8;PUS1;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;ALG5;HRAS;BMP4;RNF144A;RAB3D;KRT10;GDNF;DEPTOR;LYPLAL1;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18;ETFB;DPM3
5480,GO:0061025,0.0564267629866168,0.989367193611097,5,8,membrane fusion,BP,SYT5;RABIF;RAB39A;TBC1D14;RAB20
785,GO:0005634,0.0580118870165646,0.966101833637191,35,93,nucleus,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;HEY1;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;ACADVL;RAB40B;ARL6IP4;VDR;PUS1;AMOT;TSFM;DUSP5;PKN3;PKP1;HRAS;KRT10;TBC1D14;PSMB10;FADD;SPTBN4;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;NOTCH1;PM20D2
5556,GO:0061351,0.0581336160199259,0.988939579873265,5,8,neural precursor cell proliferation,BP,WNT7A;WNT2;FGF8;ARTN;NOTCH1
945,GO:0006357,0.0594003001924649,0.970947667191114,18,44,regulation of transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
3098,GO:0033077,0.0595061116978508,0.991523626661752,4,6,T cell differentiation in thymus,BP,JAG2;FZD7;BMP4;FADD
705,GO:0005160,0.0603203675305567,0.991363718695603,4,6,transforming growth factor beta receptor binding,MF,BMP6;INHBB;BMP4;BMP7
201,GO:0001890,0.0605010696066192,0.98488217677826,6,11,placenta development,BP,GJB2;HEY1;WNT7B;WNT2;VDR;BMP7
2804,GO:0031974,0.0605445473664711,0.964651137711142,34,90,membrane-enclosed lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;HACL1;WNT3;HEY1;ACAT1;WNT7B;MSRA;POU3F1;MAPK12;MRPL14;ACADVL;ARL6IP4;VDR;PUS1;WNT5B;NUDT7;TSFM;DUSP5;PKP1;ECI1;ETFDH;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;ETFB;PM20D2
3814,GO:0043233,0.0605445473664711,0.964651137711142,34,90,organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;HACL1;WNT3;HEY1;ACAT1;WNT7B;MSRA;POU3F1;MAPK12;MRPL14;ACADVL;ARL6IP4;VDR;PUS1;WNT5B;NUDT7;TSFM;DUSP5;PKP1;ECI1;ETFDH;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;ETFB;PM20D2
5605,GO:0070013,0.0605445473664711,0.964651137711142,34,90,intracellular organelle lumen,CC,MAGEC2;GLDC;TLE1;WNT7A;HACL1;WNT3;HEY1;ACAT1;WNT7B;MSRA;POU3F1;MAPK12;MRPL14;ACADVL;ARL6IP4;VDR;PUS1;WNT5B;NUDT7;TSFM;DUSP5;PKP1;ECI1;ETFDH;TBC1D14;PSMB10;SPTBN4;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;ETFB;PM20D2
424,GO:0003002,0.0608615740660504,0.9791930989402,9,18,regionalization,BP,WNT7A;WNT3;WNT7B;AXIN1;WNT2;FGF8;BMP4;GDNF;NOTCH1
4983,GO:0051345,0.0610212786482174,0.971743725659664,16,36,positive regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;ARTN;CCL20;FGF17;HRAS;GDNF;TBC1D14;FADD;SPTBN4;FGF18
1019,GO:0006650,0.0611211953706446,0.979615623595489,9,17,glycerophospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;ZFYVE21;DPM3
1936,GO:0015980,0.0613078079339697,0.988132335465356,5,8,energy derivation by oxidation of organic compounds,BP,ACTN3;ACADVL;ETFDH;PIK3CA;ETFB
100,GO:0001191,0.0613610762499189,0.994957712963343,3,4,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
684,GO:0005088,0.0621349953344554,0.980685764500114,8,15,Ras guanyl-nucleotide exchange factor activity,MF,SPTBN5;SPTB;FGF8;ARTN;FGF17;GDNF;SPTBN4;FGF18
2564,GO:0030666,0.0621815604302402,0.98236953271623,7,13,endocytic vesicle membrane,CC,WNT7A;WNT3;WNT7B;RAB39A;WNT5B;RAB38;RAB20
1023,GO:0006661,0.0628431315275985,0.985167579730929,6,10,phosphatidylinositol biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18;DPM3
4881,GO:0051093,0.0628993050463382,0.972080701969043,14,32,negative regulation of developmental process,BP,WNT7A;CLDN18;WNT3;AXIN1;FZD7;RBP4;FGF8;AMOT;ABCG1;BMP4;BMP7;FSTL3;NOTCH1;LINGO1
483,GO:0003203,0.0630617119852631,0.990818792592677,4,6,endocardial cushion morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
2534,GO:0030509,0.0642094793520402,0.983679875242206,6,11,BMP signaling pathway,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
5887,GO:0071772,0.0642094793520402,0.983679875242206,6,11,response to BMP,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
5888,GO:0071773,0.0642094793520402,0.983679875242206,6,11,cellular response to BMP stimulus,BP,BMP6;FGF8;BMP4;BMP7;FSTL3;NOTCH1
1404,GO:0008593,0.0644666995230774,0.990535625527778,4,6,regulation of Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
1537,GO:0009792,0.0645649834218803,0.974096505585931,11,25,embryo development ending in birth or egg hatching,BP,HEY1;WNT7B;JAG2;AXIN1;WNT2;RBP4;FGF8;AMOT;BMP4;BMP7;NOTCH1
5260,GO:0060317,0.0646416390336686,0.990500184921096,4,6,cardiac epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;NOTCH1
942,GO:0006352,0.065233895931986,0.994486537901826,3,4,DNA-templated transcription, initiation,BP,VDR;HNF1A;NOTCH1
949,GO:0006367,0.065233895931986,0.994486537901826,3,4,transcription initiation from RNA polymerase II promoter,BP,VDR;HNF1A;NOTCH1
4736,GO:0050679,0.0653992899558517,0.981209533344904,7,13,positive regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;HRAS;BMP4;NOTCH1
3992,GO:0044267,0.0660770765493282,0.959582698650548,42,116,cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;MAPK12;MRPL14;RAB40B;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;TSFM;DUSP5;INHBB;PKN3;FGF17;ALG5;HRAS;BMP4;RNF144A;RAB3D;KRT10;GDNF;DEPTOR;LYPLAL1;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;ETFB;DPM3;PM20D2
4643,GO:0048666,0.0661760315764335,0.969228079541276,15,36,neuron development,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
2446,GO:0030163,0.0663013886554452,0.980881243446222,7,13,protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A;USE1;LYPLAL1;PSMB10
4629,GO:0048639,0.0663627757934681,0.982971373792999,6,11,positive regulation of developmental growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
2433,GO:0030111,0.0672359015238045,0.978030329628941,8,16,regulation of Wnt signaling pathway,BP,TLE1;WNT7A;WNT3;AXIN1;WNT2;WNT5B;PSMB10;NOTCH1
3915,GO:0043565,0.0673559877071155,0.985166539362418,5,9,sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;HNF1A;NOTCH1
4320,GO:0045995,0.0677005895451087,0.979613116037253,7,14,regulation of embryonic development,BP,WNT2;FZD7;AMOT;BMP4;GDNF;BMP7;NOTCH1
1851,GO:0015031,0.0679169326328366,0.965572987220689,19,46,protein transport,BP,RABIF;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;NOTCH1;RAB20
1256,GO:0007492,0.0680849800979528,0.989794458418832,4,6,endoderm development,BP,FGF8;DUSP5;BMP4;NOTCH1
5307,GO:0060429,0.068811204104415,0.962650560813159,23,60,epithelium development,BP,WNT7A;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;POU3F1;WNT2;ACADVL;FZD7;FGF8;VDR;WNT5B;DSG3;WNK4;PKP1;BMP4;KRT10;GDNF;PSMB10;BMP7;NOTCH1
2360,GO:0022411,0.0691268687625825,0.982050957496574,6,11,cellular component disassembly,BP,AXIN1;MRPL14;SPTBN5;CDH1;SPTB;SPTBN4
4664,GO:0048729,0.0691360663972625,0.965966927372868,17,42,tissue morphogenesis,BP,WNT7A;WNT3;HEY1;WNT7B;JAG2;AXIN1;WNT2;FZD7;FGF8;VDR;ARTN;WNK4;BMP4;GDNF;PSMB10;BMP7;NOTCH1
1613,GO:0010498,0.0693133540534286,0.989538980267053,4,6,proteasomal protein catabolic process,BP,PMAIP1;AXIN1;RNF144A;PSMB10
1555,GO:0009912,0.0699106602485991,1,2,2,auditory receptor cell fate commitment,BP,JAG2;NOTCH1
5211,GO:0060120,0.0699106602485991,1,2,2,inner ear receptor cell fate commitment,BP,JAG2;NOTCH1
4209,GO:0045616,0.0699147469337941,1,2,2,regulation of keratinocyte differentiation,BP,VDR;NOTCH1
4210,GO:0045618,0.0699147469337941,1,2,2,positive regulation of keratinocyte differentiation,BP,VDR;NOTCH1
5936,GO:0072017,0.069922315280172,1,2,2,distal tubule development,BP,WNK4;NOTCH1
3128,GO:0033280,0.0699562562487601,1,2,2,response to vitamin D,BP,VDR;BMP7
6670,GO:1902337,0.0699562562487601,1,2,2,regulation of apoptotic process involved in morphogenesis,BP,VDR;BMP7
6920,GO:1904748,0.0699562562487601,1,2,2,regulation of apoptotic process involved in development,BP,VDR;BMP7
5389,GO:0060669,0.0699822696683374,1,2,2,embryonic placenta morphogenesis,BP,WNT7B;BMP7
5406,GO:0060710,0.0699822696683374,1,2,2,chorio-allantoic fusion,BP,WNT7B;BMP7
5409,GO:0060713,0.0699822696683374,1,2,2,labyrinthine layer morphogenesis,BP,WNT7B;BMP7
3294,GO:0035005,0.0700575031048245,1,2,2,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,PIK3CG;PIK3CA
1564,GO:0009952,0.0700695230643034,0.981734288017545,6,11,anterior/posterior pattern specification,BP,WNT3;AXIN1;WNT2;FGF8;BMP4;NOTCH1
4204,GO:0045604,0.0701479325322559,0.993868047768717,3,4,regulation of epidermal cell differentiation,BP,VDR;BMP4;NOTCH1
1986,GO:0016303,0.0701736700757996,0.985797484219086,5,8,1-phosphatidylinositol-3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
3470,GO:0036092,0.0701736700757996,0.985797484219086,5,8,phosphatidylinositol-3-phosphate biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
5119,GO:0052742,0.0701736700757996,0.985797484219086,5,8,phosphatidylinositol kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
2324,GO:0021871,0.070594808014617,0.989270401707646,4,6,forebrain regionalization,BP,WNT7B;AXIN1;FGF8;BMP4
4695,GO:0048844,0.0708633743096379,0.989213847784632,4,6,artery morphogenesis,BP,HEY1;FGF8;BMP4;NOTCH1
5435,GO:0060840,0.0708633743096379,0.989213847784632,4,6,artery development,BP,HEY1;FGF8;BMP4;NOTCH1
4090,GO:0044801,0.0710202530325331,0.989180770287673,4,6,single-organism membrane fusion,BP,SYT5;RAB39A;TBC1D14;RAB20
4044,GO:0044446,0.0715980492884877,0.954595534287399,62,180,intracellular organelle part,CC,MAGEC2;GLDC;TLE1;WNT7A;SYT5;ACTN3;HACL1;MBOAT2;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;POU3F1;MAPK12;MRPL14;ACADVL;PXK;PXMP2;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;TSFM;DUSP5;ABCG1;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;ETFDH;USE1;TBC1D14;PSMB10;RAB38;SPTBN4;PLA2G16;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;DPM3;PM20D2
105,GO:0001503,0.0730076785324651,0.9734389558404,9,19,ossification,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;FGF18;FSTL3;NOTCH1
99,GO:0001190,0.0730128355248917,1,2,2,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,POU3F1;NOTCH1
6408,GO:0098811,0.0730128355248917,1,2,2,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,POU3F1;NOTCH1
5184,GO:0060045,0.0734368680376105,1,2,2,positive regulation of cardiac muscle cell proliferation,BP,WNT2;NOTCH1
3872,GO:0043457,0.0735815370557977,1,2,2,regulation of cellular respiration,BP,ACTN3;PIK3CA
1332,GO:0008152,0.0741101372051632,0.95437646085797,80,240,metabolic process,BP,MAGEC2;GLDC;TLE1;WNT7A;PIK3CG;RHBDL3;ACTN3;HACL1;MBOAT2;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;ARTN;NUDT7;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;ECI1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;PNMT;CPT1C;ZFYVE21;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
5056,GO:0051693,0.0741516586250466,0.993347389724023,3,4,actin filament capping,BP,SPTBN5;SPTB;SPTBN4
289,GO:0002244,0.0742531203268486,0.993334002431668,3,4,hematopoietic progenitor cell differentiation,BP,BMP4;FSTL3;NOTCH1
3152,GO:0033612,0.0751481353070981,0.988299261450532,4,6,receptor serine/threonine kinase binding,MF,BMP6;BMP4;FADD;BMP7
1803,GO:0014070,0.0760823495825108,0.963771993529113,15,36,response to organic cyclic compound,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;ACAT1;WNT7B;PMAIP1;CDH1;FGF8;VDR;BMP4;FADD;BMP7;NOTCH1
4994,GO:0051402,0.0772819815188876,0.98384370782456,5,8,neuron apoptotic process,BP,FGF8;HRAS;GDNF;FADD;PIK3CA
4311,GO:0045944,0.0776407668206351,0.96373384344116,14,34,positive regulation of transcription from RNA polymerase II promoter,BP,WNT7A;BMP6;HEY1;POU3F1;WNT2;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
4620,GO:0048608,0.0782381203325569,0.963642194902764,14,33,reproductive structure development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
5575,GO:0061458,0.0782381203325569,0.963642194902764,14,33,reproductive system development,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
470,GO:0003177,0.0783451343305086,0.992786221690048,3,4,pulmonary valve development,BP,HEY1;BMP4;NOTCH1
475,GO:0003184,0.0783451343305086,0.992786221690048,3,4,pulmonary valve morphogenesis,BP,HEY1;BMP4;NOTCH1
6963,GO:1905314,0.0783451343305086,0.992786221690048,3,4,semi-lunar valve development,BP,HEY1;BMP4;NOTCH1
4165,GO:0045333,0.0786050252780462,0.987544715818395,4,6,cellular respiration,BP,ACTN3;ETFDH;PIK3CA;ETFB
187,GO:0001837,0.0789607874027982,0.981683979898223,5,9,epithelial to mesenchymal transition,BP,HEY1;WNT2;FGF8;BMP7;NOTCH1
4202,GO:0045601,0.0799343907272655,0.992569366206861,3,4,regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
4203,GO:0045603,0.0799343907272655,0.992569366206861,3,4,positive regulation of endothelial cell differentiation,BP,BMP6;BMP4;NOTCH1
487,GO:0003208,0.0800578701582991,1,2,2,cardiac ventricle morphogenesis,BP,HEY1;NOTCH1
5541,GO:0061314,0.0800578701582991,1,2,2,Notch signaling involved in heart development,BP,HEY1;NOTCH1
4254,GO:0045746,0.0801011880648471,1,2,2,negative regulation of Notch signaling pathway,BP,HEY1;BMP7
3862,GO:0043408,0.080285223723451,0.96251699965294,14,33,regulation of MAPK cascade,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;BMP7;FGF18
1172,GO:0007154,0.0802874436604992,0.948452745562315,59,175,cell communication,BP,RHPN1;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
2347,GO:0022008,0.0805082338985746,0.955243205078134,23,61,neurogenesis,BP,WNT7A;BMP6;WNT3;WNT7B;JAG2;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;FZD7;SPTB;FGF8;ARTN;WNT5B;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
6366,GO:0098588,0.0813314229069781,0.954925261855997,23,59,bounding membrane of organelle,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;PXMP2;SPTBN5;FZD7;RAB39A;WNT5B;ABCG1;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;RAB38;PLA2G16;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20
3710,GO:0042733,0.0816970728360371,0.992326181244433,3,4,embryonic digit morphogenesis,BP,WNT7A;BMP4;NOTCH1
4183,GO:0045445,0.0818302568949407,0.992307693300274,3,4,myoblast differentiation,BP,MAPK12;BMP4;NOTCH1
841,GO:0005882,0.0823723027030456,1,2,2,intermediate filament,CC,PKP1;KRT10
2491,GO:0030280,0.0823723027030456,1,2,2,structural constituent of epidermis,MF,PKP1;KRT10
4129,GO:0045111,0.0823723027030456,1,2,2,intermediate filament cytoskeleton,CC,PKP1;KRT10
129,GO:0001649,0.0834246513347722,0.973444430728894,7,14,osteoblast differentiation,BP,BMP6;WNT3;WNT7B;RRAS2;BMP4;BMP7;NOTCH1
2226,GO:0019395,0.0836298172363272,0.971160704598092,8,16,fatty acid oxidation,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
3242,GO:0034440,0.0836298172363272,0.971160704598092,8,16,lipid oxidation,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
3431,GO:0035904,0.0837321647649289,0.992041947695543,3,4,aorta development,BP,HEY1;FGF8;NOTCH1
3433,GO:0035909,0.0837321647649289,0.992041947695543,3,4,aorta morphogenesis,BP,HEY1;FGF8;NOTCH1
4570,GO:0048471,0.0838417430865255,0.966366671566286,10,22,perinuclear region of cytoplasm,CC,GJB2;SYT5;AXIN1;RAB40B;CDH1;INHBB;PKN3;HRAS;PLA2G16;TPD52
1321,GO:0008104,0.0840847100837987,0.951589788136705,26,69,protein localization,BP,WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;AMOT;CNIH4;WNK4;INHBB;ABCG1;TSPAN15;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
4290,GO:0045893,0.0841640806991001,0.957056107988785,17,43,positive regulation of transcription, DNA-templated,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
6712,GO:1902680,0.0841640806991001,0.957056107988785,17,43,positive regulation of RNA biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
6804,GO:1903508,0.0841640806991001,0.957056107988785,17,43,positive regulation of nucleic acid-templated transcription,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
1911,GO:0015833,0.0843432175373487,0.955637272848275,19,47,peptide transport,BP,RABIF;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;NOTCH1;RAB20
3731,GO:0042886,0.0843432175373487,0.955637272848275,19,47,amide transport,BP,RABIF;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;NOTCH1;RAB20
943,GO:0006354,0.0853845639516186,1,2,2,DNA-templated transcription, elongation,BP,AXIN1;TSFM
3023,GO:0032784,0.0853845639516186,1,2,2,regulation of DNA-templated transcription, elongation,BP,AXIN1;TSFM
482,GO:0003198,0.0856477238674466,0.99177103528537,3,4,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,HEY1;FGF8;NOTCH1
3971,GO:0044093,0.0861633414555012,0.950893202532989,25,64,positive regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;ARTN;CCL20;DUSP5;FGF17;HRAS;BMP4;GDNF;TBC1D14;PSMB10;FADD;SPTBN4;PIK3CA;FGF18
6435,GO:0099106,0.0862089337076271,1,2,2,ion channel regulator activity,MF,WNK4;TSPAN13
1359,GO:0008238,0.086299582348743,1,2,2,exopeptidase activity,MF,PM20D2;PEPD
2093,GO:0016805,0.086299582348743,1,2,2,dipeptidase activity,MF,PM20D2;PEPD
4229,GO:0045667,0.0863917137980167,0.979350633240124,5,9,regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
856,GO:0005921,0.0863997135608019,0.991663793406885,3,4,gap junction,CC,GJB2;GJA3;GJB6
857,GO:0005922,0.0863997135608019,0.991663793406885,3,4,connexin complex,CC,GJB2;GJA3;GJB6
6964,GO:1905330,0.0865282168968196,0.975987314269049,6,11,regulation of morphogenesis of an epithelium,BP,WNT2;FZD7;BMP4;GDNF;PSMB10;BMP7
4766,GO:0050770,0.0869043831767017,0.991591541553122,3,4,regulation of axonogenesis,BP,WNT7A;WNT3;LINGO1
4132,GO:0045123,0.0870349481031445,1,2,2,cellular extravasation,BP,PIK3CG;FADD
146,GO:0001704,0.0870679769594948,0.97462643272309,6,12,formation of primary germ layer,BP,WNT3;AXIN1;FZD7;DUSP5;BMP4;BMP7
134,GO:0001656,0.08768596670746,0.975568082941237,6,11,metanephros development,BP,ACAT1;WNT7B;FGF8;BMP4;GDNF;BMP7
457,GO:0003156,0.0877313788441919,0.975551599946654,6,11,regulation of animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
1244,GO:0007405,0.0879634759585073,1,2,2,neuroblast proliferation,BP,ARTN;NOTCH1
314,GO:0002320,0.0881317573404111,1,2,2,lymphoid progenitor cell differentiation,BP,BMP4;NOTCH1
469,GO:0003176,0.0881317573404111,1,2,2,aortic valve development,BP,BMP4;NOTCH1
472,GO:0003180,0.0881317573404111,1,2,2,aortic valve morphogenesis,BP,BMP4;NOTCH1
2537,GO:0030513,0.0881317573404111,1,2,2,positive regulation of BMP signaling pathway,BP,BMP4;NOTCH1
5464,GO:0060976,0.0881317573404111,1,2,2,coronary vasculature development,BP,BMP4;NOTCH1
7075,GO:2000136,0.0881317573404111,1,2,2,regulation of cell proliferation involved in heart morphogenesis,BP,BMP4;NOTCH1
4279,GO:0045839,0.0881763392063475,1,2,2,negative regulation of mitotic nuclear division,BP,BMP4;BMP7
5319,GO:0060442,0.0881763392063475,1,2,2,branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
5398,GO:0060687,0.0881763392063475,1,2,2,regulation of branching involved in prostate gland morphogenesis,BP,BMP4;BMP7
5311,GO:0060433,0.0881927294877178,1,2,2,bronchus development,BP,WNT7B;BMP4
5315,GO:0060438,0.0881927294877178,1,2,2,trachea development,BP,WNT7B;BMP4
5316,GO:0060439,0.0881927294877178,1,2,2,trachea morphogenesis,BP,WNT7B;BMP4
6024,GO:0072205,0.0881927294877178,1,2,2,metanephric collecting duct development,BP,WNT7B;BMP4
1602,GO:0010453,0.0882138728625982,1,2,2,regulation of cell fate commitment,BP,FZD7;BMP4
5427,GO:0060795,0.0882138728625982,1,2,2,cell fate commitment involved in formation of primary germ layer,BP,FZD7;BMP4
4777,GO:0050793,0.0882237909915329,0.947547843166127,29,79,regulation of developmental process,BP,WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;AXIN1;MAPK12;WNT2;FZD7;RBP4;FGF8;VDR;AMOT;WNT5B;ABCG1;BMP4;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;FGF18;FSTL3;NOTCH1;LINGO1
233,GO:0001958,0.0885950434356583,0.991347858434708,3,4,endochondral ossification,BP,BMP6;BMP4;FGF18
3467,GO:0036075,0.0885950434356583,0.991347858434708,3,4,replacement ossification,BP,BMP6;BMP4;FGF18
4789,GO:0050808,0.0891082943423238,0.978478223422307,5,9,synapse organization,BP,WNT7A;WNT7B;CDH1;GDNF;DRP2
4454,GO:0046887,0.0892271528766092,0.991256103560391,3,4,positive regulation of hormone secretion,BP,BMP6;RBP4;INHBB
5130,GO:0055017,0.0893611864091385,0.991236602635889,3,4,cardiac muscle tissue growth,BP,WNT2;RBP4;NOTCH1
5133,GO:0055021,0.0893611864091385,0.991236602635889,3,4,regulation of cardiac muscle tissue growth,BP,WNT2;RBP4;NOTCH1
1791,GO:0014045,0.089379102652816,1,2,2,establishment of endothelial blood-brain barrier,BP,WNT7A;WNT7B
2348,GO:0022009,0.089379102652816,1,2,2,central nervous system vasculogenesis,BP,WNT7A;WNT7B
2952,GO:0032536,0.089379102652816,1,2,2,regulation of cell projection size,BP,WNT7A;WNT7B
5443,GO:0060856,0.089379102652816,1,2,2,establishment of blood-brain barrier,BP,WNT7A;WNT7B
1829,GO:0014834,0.0894003285200205,1,2,2,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A;FZD7
3858,GO:0043403,0.0894003285200205,1,2,2,skeletal muscle tissue regeneration,BP,WNT7A;FZD7
2394,GO:0023052,0.0896297880179277,0.941780156459501,59,176,signaling,BP,RHPN1;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;KCNK6;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
4062,GO:0044700,0.0896297880179277,0.941780156459501,59,176,single organism signaling,BP,RHPN1;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;GJA3;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;KCNK6;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
931,GO:0006261,0.0901835376263288,1,2,2,DNA-dependent DNA replication,BP,BMP6;BMP4
1191,GO:0007184,0.0901835376263288,1,2,2,SMAD protein import into nucleus,BP,BMP6;BMP4
5286,GO:0060390,0.0901835376263288,1,2,2,regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
5287,GO:0060391,0.0901835376263288,1,2,2,positive regulation of SMAD protein import into nucleus,BP,BMP6;BMP4
6228,GO:0090329,0.0901835376263288,1,2,2,regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
7065,GO:2000105,0.0901835376263288,1,2,2,positive regulation of DNA-dependent DNA replication,BP,BMP6;BMP4
1258,GO:0007498,0.0904394072932871,0.978047024092236,5,9,mesoderm development,BP,WNT3;AXIN1;FGF8;BMP4;BMP7
20,GO:0000139,0.0909838555868418,0.977869955435387,5,9,Golgi membrane,CC,RAB39A;ABCG1;HRAS;NOTCH1;RND3
5177,GO:0060037,0.0909904601511654,0.990998296728448,3,4,pharyngeal system development,BP,FGF8;BMP4;BMP7
6633,GO:1901998,0.0914063978180812,1,2,2,toxin transport,BP,RAB40B;ABCG1
2879,GO:0032330,0.0916696844858316,0.9908982646882,3,4,regulation of chondrocyte differentiation,BP,BMP6;BMP4;FGF18
5338,GO:0060502,0.0919412217284296,1,2,2,epithelial cell proliferation involved in lung morphogenesis,BP,WNT2;BMP4
3401,GO:0035767,0.0927461463570717,1,2,2,endothelial cell chemotaxis,BP,FGF18;NOTCH1
7197,GO:2001026,0.0927461463570717,1,2,2,regulation of endothelial cell chemotaxis,BP,FGF18;NOTCH1
5602,GO:0065009,0.0930348239411971,0.94303385465116,33,89,regulation of molecular function,BP,MAGEC2;PIK3CG;RABIF;HEY1;WNT7B;PMAIP1;AXIN1;MAPK12;WNT2;SPTBN5;SPTB;FGF8;VDR;AMOT;ARTN;WNK4;CCL20;DUSP5;FGF17;HRAS;BMP4;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;TSPAN13;PTS;NOTCH1
6229,GO:0090382,0.0933360755726455,0.990651146436596,3,4,phagosome maturation,BP,RAB39A;RAB38;RAB20
2567,GO:0030670,0.0933380977541952,0.990650845089798,3,4,phagocytic vesicle membrane,CC,RAB39A;RAB38;RAB20
4184,GO:0045446,0.0935570886381916,0.972143866261627,6,12,endothelial cell differentiation,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
948,GO:0006366,0.0940478393004002,0.950195655272486,18,46,transcription from RNA polymerase II promoter,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;FGF8;VDR;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
4929,GO:0051216,0.0944198163662676,0.968910167236197,7,14,cartilage development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;BMP7;FGF18
3595,GO:0042246,0.0944893854558561,0.990478703674279,3,4,tissue regeneration,BP,WNT7A;FZD7;NOTCH1
827,GO:0005802,0.0946562872245925,1,2,2,trans-Golgi network,CC,CDH1;RAB38
6398,GO:0098791,0.0946562872245925,1,2,2,Golgi subcompartment,CC,CDH1;RAB38
5855,GO:0071542,0.0947046814902469,0.990446385003715,3,4,dopaminergic neuron differentiation,BP,WNT3;WNT2;FGF8
2881,GO:0032332,0.0948279547511802,1,2,2,positive regulation of chondrocyte differentiation,BP,BMP6;FGF18
4281,GO:0045843,0.0951746637069703,0.983728513003444,4,6,negative regulation of striated muscle tissue development,BP,FZD7;RBP4;FGF8;BMP4
4626,GO:0048635,0.0951746637069703,0.983728513003444,4,6,negative regulation of muscle organ development,BP,FZD7;RBP4;FGF8;BMP4
6611,GO:1901862,0.0951746637069703,0.983728513003444,4,6,negative regulation of muscle tissue development,BP,FZD7;RBP4;FGF8;BMP4
2944,GO:0032501,0.0953131407316453,0.937773082408708,64,194,multicellular organismal process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;DSG3;WNK4;CCL20;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;BMP4;RAB3D;KRT10;KCNK6;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;HNF1A;FGF18;FSTL3;PTS;NOTCH1;LINGO1;GUCY1B3;PEPD
4603,GO:0048562,0.0954575593298975,0.968473304190888,7,14,embryonic organ morphogenesis,BP,GJB6;AXIN1;RBP4;FGF8;BMP4;BMP7;NOTCH1
202,GO:0001892,0.0955581037601516,0.980844858196806,4,7,embryonic placenta development,BP,HEY1;WNT7B;WNT2;BMP7
1945,GO:0016050,0.0963336796911665,0.976108639513832,5,9,vesicle organization,BP,SYT5;RAB39A;TBC1D14;RAB38;RAB20
6687,GO:1902531,0.0967816784671173,0.944767764173554,23,61,regulation of intracellular signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;AMOT;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;DEPTOR;FADD;BMP7;PIK3CA;FGF18;NOTCH1
1415,GO:0008654,0.0968883049029273,0.965311686444742,8,16,phospholipid biosynthetic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;DPM3
6945,GO:1904954,0.0969268353049456,1,2,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
7036,GO:1990909,0.0969268353049456,1,2,2,Wnt signalosome,CC,WNT3;WNT2
3077,GO:0032984,0.0970086822788524,0.975883672350321,5,9,macromolecular complex disassembly,BP,AXIN1;MRPL14;SPTBN5;SPTB;SPTBN4
3818,GO:0043241,0.0970086822788524,0.975883672350321,5,9,protein complex disassembly,BP,AXIN1;MRPL14;SPTBN5;SPTB;SPTBN4
5764,GO:0070997,0.0971073441814511,0.972086668411852,6,11,neuron death,BP,RRAS2;FGF8;HRAS;GDNF;FADD;PIK3CA
1949,GO:0016054,0.0972408620420278,0.962170417232557,9,19,organic acid catabolic process,BP,GLDC;HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
4356,GO:0046395,0.0972408620420278,0.962170417232557,9,19,carboxylic acid catabolic process,BP,GLDC;HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
3476,GO:0036151,0.0975816945547228,1,2,2,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;PLA2G16
3477,GO:0036152,0.0975816945547228,1,2,2,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;PLA2G16
1178,GO:0007162,0.0984063395231807,0.980045642651446,4,7,negative regulation of cell adhesion,BP,CDH1;FZD7;BMP4;NOTCH1
4198,GO:0045597,0.0986730609013091,0.951851531071045,14,34,positive regulation of cell differentiation,BP,BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;WNT5B;BMP4;GDNF;FADD;BMP7;FGF18;NOTCH1
897,GO:0006091,0.0989590631142817,0.975230233184657,5,9,generation of precursor metabolites and energy,BP,ACTN3;ACADVL;ETFDH;PIK3CA;ETFB
6249,GO:0090596,0.0998447804906896,0.966609858939717,7,14,sensory organ morphogenesis,BP,GJB6;AXIN1;WNT2;RBP4;FGF8;BMP4;BMP7
4775,GO:0050790,0.0998571401414862,0.939825179206241,29,77,regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;AMOT;ARTN;CCL20;DUSP5;FGF17;HRAS;BMP4;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;PTS;NOTCH1
5138,GO:0055026,0.0999252298464412,0.989650485288677,3,4,negative regulation of cardiac muscle tissue development,BP,FZD7;RBP4;FGF8
4581,GO:0048513,0.100101497013431,0.936070334666313,40,115,animal organ development,BP,TLE1;WNT7A;GJB2;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;RBP4;FGF8;VDR;ARTN;WNT5B;DSG3;WNK4;INHBB;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;FADD;BMP7;PIK3CA;PLA2G16;TPD52;FGF18;FSTL3;NOTCH1
4607,GO:0048568,0.100341076784006,0.957572266181674,10,23,embryonic organ development,BP,HEY1;GJB6;WNT7B;AXIN1;WNT2;RBP4;FGF8;BMP4;BMP7;NOTCH1
4950,GO:0051254,0.101152446417021,0.946587156531765,17,44,positive regulation of RNA metabolic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
6231,GO:0090385,0.101173796634081,1,2,2,phagosome-lysosome fusion,BP,RAB39A;RAB20
5565,GO:0061418,0.102063077894171,1,2,2,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB10;NOTCH1
4461,GO:0046907,0.102173336428043,0.948219462530558,15,38,intracellular transport,BP,WNT7A;SYT5;PIK3CG;BMP6;SPTBN5;CDH1;FZD7;SPTB;CNIH4;ABCG1;BMP4;TBC1D14;BMP7;SPTBN4;ZFYVE21
4300,GO:0045927,0.102582598287568,0.968592506408275,6,12,positive regulation of growth,BP,ACTN3;WNT3;WNT2;FGF8;SPTBN4;NOTCH1
7059,GO:2000058,0.102852576592041,1,2,2,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;PSMB10
7060,GO:2000060,0.102852576592041,1,2,2,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,AXIN1;PSMB10
1272,GO:0007586,0.103564178904778,0.989081908212538,3,4,digestion,BP,RBP4;VDR;WNK4
2363,GO:0022600,0.103564178904778,0.989081908212538,3,4,digestive system process,BP,RBP4;VDR;WNK4
6640,GO:1902043,0.103756669926859,1,2,2,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD
4731,GO:0050673,0.103981110829861,0.961186125092851,8,17,epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
4735,GO:0050678,0.103981110829861,0.961186125092851,8,17,regulation of epithelial cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;VDR;HRAS;BMP4;NOTCH1
5351,GO:0060541,0.104137749251554,0.958120354239261,9,20,respiratory system development,BP,WNT7B;AXIN1;WNT2;RBP4;FGF8;BMP4;FGF18;FSTL3;NOTCH1
2856,GO:0032259,0.104273286686127,0.981497565096039,4,6,methylation,BP,RAB3D;PIK3CA;PNMT;ETFB
4144,GO:0045184,0.104429894792933,0.94041797193858,22,58,establishment of protein localization,BP,RABIF;BMP6;PMAIP1;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;TSPAN15;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
3766,GO:0043085,0.105124000592546,0.938882654485228,24,62,positive regulation of catalytic activity,BP,MAGEC2;PIK3CG;RABIF;WNT7B;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;VDR;ARTN;CCL20;DUSP5;FGF17;HRAS;BMP4;GDNF;TBC1D14;PSMB10;FADD;SPTBN4;PIK3CA;FGF18
4282,GO:0045844,0.106315273700792,0.977772875231536,4,7,positive regulation of striated muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
4627,GO:0048636,0.106315273700792,0.977772875231536,4,7,positive regulation of muscle organ development,BP,ACTN3;WNT2;BMP4;NOTCH1
6612,GO:1901863,0.106315273700792,0.977772875231536,4,7,positive regulation of muscle tissue development,BP,ACTN3;WNT2;BMP4;NOTCH1
107,GO:0001505,0.106361486716178,0.98863719029391,3,4,regulation of neurotransmitter levels,BP,WNT7A;SYT5;GDNF
1084,GO:0006836,0.106361486716178,0.98863719029391,3,4,neurotransmitter transport,BP,WNT7A;SYT5;GDNF
4630,GO:0048640,0.10637011424558,0.988635808446105,3,4,negative regulation of developmental growth,BP,WNT3;RBP4;BMP4
5636,GO:0070229,0.106379555764591,1,2,2,negative regulation of lymphocyte apoptotic process,BP,BMP4;FADD
5640,GO:0070233,0.106379555764591,1,2,2,negative regulation of T cell apoptotic process,BP,BMP4;FADD
2425,GO:0030073,0.106648964762313,0.988591111885863,3,4,insulin secretion,BP,KCNG2;RBP4;INHBB
4780,GO:0050796,0.106648964762313,0.988591111885863,3,4,regulation of insulin secretion,BP,KCNG2;RBP4;INHBB
6213,GO:0090276,0.106648964762313,0.988591111885863,3,4,regulation of peptide hormone secretion,BP,KCNG2;RBP4;INHBB
536,GO:0003674,0.106880207765279,0.961301263450839,108,345,molecular_function,MF,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;RHBDL3;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;BOLA1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;MB21D2;RAB20;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
7166,GO:2000736,0.107465507531415,1,2,2,regulation of stem cell differentiation,BP,GDNF;NOTCH1
1373,GO:0008344,0.107489016630013,1,2,2,adult locomotory behavior,BP,GDNF;SPTBN4
1220,GO:0007269,0.107999820627094,1,2,2,neurotransmitter secretion,BP,WNT7A;SYT5
3495,GO:0036465,0.107999820627094,1,2,2,synaptic vesicle recycling,BP,WNT7A;SYT5
6452,GO:0099643,0.107999820627094,1,2,2,signal release from synapse,BP,WNT7A;SYT5
4371,GO:0046474,0.108014949028789,0.967905454524873,6,11,glycerophospholipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18;DPM3
758,GO:0005515,0.108845442225251,0.931005147458239,83,255,protein binding,MF,MAGEC2;TJP3;RHPN1;GLDC;TLE1;WNT7A;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;RABIF;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;PXK;PXMP2;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;CLDN15;BOLA1;GDNF;USE1;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;LINGO1;RND3;CPT1C;ZFYVE21;MB21D2;ETFB;GUCY1B3;DPM3;PEPD
3078,GO:0032989,0.109034436499699,0.942830292363596,16,41,cellular component morphogenesis,BP,WNT7A;WNT3;WNT7B;SPTBN5;FZD7;SPTB;FGF8;VDR;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
1586,GO:0010092,0.109164960242102,0.980259731655944,4,6,specification of animal organ identity,BP,WNT2;FGF8;BMP4;GDNF
4081,GO:0044767,0.109311711719987,0.927460461646004,57,172,single-organism developmental process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;WNK4;DUSP5;INHBB;ABCG1;FGF17;ALG5;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1
1657,GO:0010646,0.109471481428278,0.930987980156142,34,96,regulation of cell communication,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;PXK;FZD7;RBP4;FGF8;AMOT;WNT5B;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
3867,GO:0043414,0.109749094315545,0.988089783980273,3,4,macromolecule methylation,BP,RAB3D;PIK3CA;ETFB
1658,GO:0010647,0.110084312980359,0.935977647361978,23,61,positive regulation of cell communication,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;RBP4;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;NOTCH1
2395,GO:0023056,0.110084312980359,0.935977647361978,23,61,positive regulation of signaling,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;RBP4;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;NOTCH1
2389,GO:0022900,0.110221773735967,1,2,2,electron transport chain,BP,ETFDH;ETFB
2390,GO:0022904,0.110221773735967,1,2,2,respiratory electron transport chain,BP,ETFDH;ETFB
5105,GO:0051962,0.110579431771002,0.960865539746805,7,15,positive regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
2575,GO:0030742,0.112706336236814,1,2,2,GTP-dependent protein binding,MF,RAB3D;RAB38
1223,GO:0007275,0.113049841174563,0.924931052418578,52,156,multicellular organism development,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;DSG3;WNK4;DUSP5;INHBB;FGF17;ALG5;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1
2651,GO:0031090,0.113630420395493,0.930630437446689,28,76,organelle membrane,CC,WNT7A;SYT5;WNT3;ACAT1;WNT7B;PMAIP1;MRPL14;ACADVL;PXMP2;SPTBN5;FZD7;RAB39A;WNT5B;ABCG1;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;ECI1;ETFDH;RAB38;PLA2G16;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20
5963,GO:0072089,0.11386083407543,0.975532553792346,4,7,stem cell proliferation,BP,WNT3;WNT7B;ARTN;NOTCH1
3312,GO:0035115,0.114029669538027,1,2,2,embryonic forelimb morphogenesis,BP,WNT7A;WNT3
3314,GO:0035136,0.114029669538027,1,2,2,forelimb morphogenesis,BP,WNT7A;WNT3
5273,GO:0060343,0.114325192346329,1,2,2,trabecula formation,BP,HEY1;RBP4
5274,GO:0060347,0.114325192346329,1,2,2,heart trabecula formation,BP,HEY1;RBP4
6573,GO:1901575,0.114338531083842,0.934819886666149,21,54,organic substance catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;HACL1;ACAT1;PMAIP1;AXIN1;ACADVL;NUDT7;PKP1;RNF144A;ECI1;ETFDH;USE1;LYPLAL1;PSMB10;PLA2G16;DECR1;CPT1C;ETFB
1444,GO:0009109,0.115403715728477,1,2,2,coenzyme catabolic process,BP,ACAT1;NUDT7
1932,GO:0015936,0.115403715728477,1,2,2,coenzyme A metabolic process,BP,ACAT1;NUDT7
3166,GO:0033865,0.115403715728477,1,2,2,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
3169,GO:0033875,0.115403715728477,1,2,2,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
3173,GO:0034032,0.115403715728477,1,2,2,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
4350,GO:0046356,0.115403715728477,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
4916,GO:0051187,0.115403715728477,1,2,2,cofactor catabolic process,BP,ACAT1;NUDT7
7052,GO:2000027,0.116330319859236,0.951941282381917,9,20,regulation of organ morphogenesis,BP,WNT2;FZD7;FGF8;VDR;BMP4;GDNF;PSMB10;BMP7;NOTCH1
1646,GO:0010628,0.116450905082241,0.932953047749978,21,57,positive regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;FGF8;VDR;PKP1;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
5049,GO:0051649,0.11691852660958,0.936715392009607,17,44,establishment of localization in cell,BP,WNT7A;SYT5;PIK3CG;BMP6;PMAIP1;SPTBN5;CDH1;FZD7;SPTB;CNIH4;ABCG1;BMP4;GDNF;TBC1D14;BMP7;SPTBN4;ZFYVE21
1988,GO:0016310,0.117444048569514,0.92779191938412,28,78,phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18;ZFYVE21
973,GO:0006479,0.118164002982642,1,2,2,protein methylation,BP,RAB3D;ETFB
1350,GO:0008213,0.118164002982642,1,2,2,protein alkylation,BP,RAB3D;ETFB
144,GO:0001701,0.119265649690331,0.955913119926894,7,16,in utero embryonic development,BP,HEY1;WNT7B;JAG2;WNT2;AMOT;BMP7;NOTCH1
822,GO:0005793,0.119536106275532,1,2,2,endoplasmic reticulum-Golgi intermediate compartment,CC,GJB2;CNIH4
2439,GO:0030145,0.119642943104723,1,2,2,manganese ion binding,MF,NUDT7;PEPD
7092,GO:2000209,0.120188166551285,0.980860973710456,3,5,regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
7177,GO:2000811,0.120188166551285,0.980860973710456,3,5,negative regulation of anoikis,BP,TLE1;PIK3CA;NOTCH1
6697,GO:1902582,0.120196041999142,0.949243986491371,9,21,single-organism intracellular transport,BP,WNT7A;SYT5;PIK3CG;BMP6;CDH1;FZD7;ABCG1;BMP4;BMP7
2099,GO:0016829,0.120409151368624,0.957531501154733,7,14,lyase activity,MF,GLDC;HACL1;ACAT1;PUS1;ECI1;PTS;GUCY1B3
1423,GO:0009056,0.120514678736462,0.927570534262469,25,67,catabolic process,BP,MAGEC2;GLDC;PIK3CG;ACTN3;HACL1;ACAT1;PMAIP1;AXIN1;ACADVL;RAB39A;NUDT7;PKP1;RNF144A;ECI1;ETFDH;USE1;LYPLAL1;TBC1D14;PSMB10;PIK3CA;PLA2G16;DECR1;CPT1C;ETFB;PEPD
2397,GO:0023061,0.120749084559229,0.96111280499459,6,12,signal release,BP,WNT7A;SYT5;BMP6;KCNG2;RBP4;INHBB
5953,GO:0072073,0.120846898321959,0.95218669167003,8,18,kidney epithelium development,BP,ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
257,GO:0002062,0.121051331759869,0.967485086567606,5,9,chondrocyte differentiation,BP,WNT7A;BMP6;WNT5B;BMP4;FGF18
454,GO:0003148,0.121058540800274,1,2,2,outflow tract septum morphogenesis,BP,FGF8;BMP4
2454,GO:0030178,0.121088949842098,0.965428694221817,5,10,negative regulation of Wnt signaling pathway,BP,TLE1;AXIN1;WNT5B;PSMB10;NOTCH1
5545,GO:0061326,0.121183713467928,0.955986535646313,7,15,renal tubule development,BP,ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5931,GO:0072009,0.121183713467928,0.955986535646313,7,15,nephron epithelium development,BP,ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
5960,GO:0072080,0.121183713467928,0.955986535646313,7,15,nephron tubule development,BP,ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;NOTCH1
4635,GO:0048645,0.122051398969534,0.967119940602488,5,9,animal organ formation,BP,WNT2;FGF8;BMP4;GDNF;BMP7
2323,GO:0021846,0.122348536287168,1,2,2,cell proliferation in forebrain,BP,WNT7A;FGF8
88,GO:0001076,0.122638679243393,0.980277359954791,3,5,transcription factor activity, RNA polymerase II transcription factor binding,MF,TLE1;POU3F1;NOTCH1
689,GO:0005105,0.122800766701451,1,2,2,type 1 fibroblast growth factor receptor binding,MF,FGF17;FGF18
806,GO:0005768,0.122824638909049,0.943065152700883,11,26,endosome,CC,SYT5;RAB40B;CDH1;FZD7;ABCG1;TSPAN15;RNF144A;TBC1D14;RAB38;ZFYVE21;RAB20
6695,GO:1902580,0.122943752154644,0.938471147955899,13,33,single-organism cellular localization,BP,WNT7A;SYT5;PIK3CG;BMP6;PMAIP1;RAB40B;CDH1;FZD7;ABCG1;TSPAN15;BMP4;BMP7;SPTBN4
1522,GO:0009653,0.123235097441707,0.921747915080105,32,92,anatomical structure morphogenesis,BP,TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;SPTBN5;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNK4;DUSP5;HRAS;BMP4;GDNF;PSMB10;BMP7;SPTBN4;PIK3CA;TPD52;FGF18;NOTCH1;LINGO1
2945,GO:0032502,0.123822604143886,0.916664043556887,57,173,developmental process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;WNK4;DUSP5;INHBB;ABCG1;FGF17;ALG5;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1
1627,GO:0010557,0.125830127641876,0.929617754376678,18,48,positive regulation of macromolecule biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
967,GO:0006468,0.125974231637464,0.922926281353368,26,72,protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18
1568,GO:0009967,0.127978642232754,0.924512677076686,22,59,positive regulation of signal transduction,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;NOTCH1
3605,GO:0042306,0.128203332389556,0.962656069932879,5,10,regulation of protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
6816,GO:1903533,0.128203332389556,0.962656069932879,5,10,regulation of protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
6903,GO:1904589,0.128203332389556,0.962656069932879,5,10,regulation of protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
1640,GO:0010604,0.12831671202969,0.917754360128309,33,94,positive regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;DUSP5;INHBB;PKP1;HRAS;BMP4;RNF144A;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1
5040,GO:0051603,0.12855203198251,0.97097444662549,4,7,proteolysis involved in cellular protein catabolic process,BP,PMAIP1;AXIN1;RNF144A;PSMB10
944,GO:0006355,0.128765628950734,0.923032004778975,23,63,regulation of transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
2441,GO:0030154,0.129209737610215,0.914292445334635,42,125,cell differentiation,BP,SLC2A14;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;INHBB;ABCG1;PKP1;HRAS;BMP4;KRT10;GDNF;RAB38;FADD;BMP7;SPTBN4;PIK3CA;TPD52;FGF18;FSTL3;NOTCH1;LINGO1
2489,GO:0030278,0.129223778173798,0.962253181590759,5,10,regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7;NOTCH1
507,GO:0003279,0.129933596234435,0.961972170727066,5,10,cardiac septum development,BP,HEY1;FGF8;BMP4;BMP7;NOTCH1
5358,GO:0060560,0.130654257905391,0.970301410626881,4,7,developmental growth involved in morphogenesis,BP,WNT3;WNT7B;BMP4;NOTCH1
6395,GO:0098772,0.131281678302883,0.92648315227909,18,46,molecular function regulator,MF,WNT7A;RABIF;WNT3;AXIN1;WNT2;SPTBN5;SPTB;FGF8;ARTN;WNK4;FGF17;GDNF;TBC1D14;SPTBN4;PIK3CA;FGF18;TSPAN13;NOTCH1
4027,GO:0044422,0.131692390323733,0.910777429940764,62,185,organelle part,CC,MAGEC2;GLDC;TLE1;WNT7A;SYT5;ACTN3;HACL1;MBOAT2;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;POU3F1;MAPK12;MRPL14;ACADVL;PXK;PXMP2;RAB40B;SPTBN5;CDH1;FZD7;ARL6IP4;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;TSFM;DUSP5;ABCG1;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;ETFDH;USE1;TBC1D14;PSMB10;RAB38;SPTBN4;PLA2G16;DECR1;LAGE3;FGF18;FSTL3;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;DPM3;PM20D2
4615,GO:0048592,0.131822202716788,0.96122144689333,5,10,eye morphogenesis,BP,AXIN1;WNT2;RBP4;BMP4;BMP7
2259,GO:0019842,0.132200282795709,0.969803165149085,4,7,vitamin binding,MF,GLDC;HACL1;RBP4;VDR
4066,GO:0044707,0.132526094910852,0.910113711084018,61,187,single-multicellular organism process,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;DSG3;WNK4;CCL20;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;BMP4;RAB3D;KRT10;KCNK6;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;HNF1A;FGF18;FSTL3;PTS;NOTCH1;LINGO1;PEPD
6174,GO:0090132,0.132599901161505,0.946227957669854,8,18,epithelium migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;FGF18;NOTCH1
4433,GO:0046834,0.132624313569287,0.955994653155699,6,12,lipid phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18;ZFYVE21
4439,GO:0046854,0.132624313569287,0.955994653155699,6,12,phosphatidylinositol phosphorylation,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18;ZFYVE21
2667,GO:0031128,0.133943354178594,0.962684506274447,5,9,developmental induction,BP,WNT3;WNT2;FGF8;BMP4;GDNF
3998,GO:0044282,0.134355140912676,0.939229615205393,10,23,small molecule catabolic process,BP,GLDC;ACTN3;HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
4319,GO:0045992,0.134549514355698,0.977349580823153,3,5,negative regulation of embryonic development,BP,FZD7;BMP4;BMP7
4398,GO:0046620,0.135495932078074,0.968731823272308,4,7,regulation of organ growth,BP,WNT2;RBP4;FGF8;NOTCH1
2437,GO:0030139,0.135868309124196,0.944540837702309,8,18,endocytic vesicle,CC,WNT7A;WNT3;WNT7B;RAB39A;AMOT;WNT5B;RAB38;RAB20
459,GO:0003158,0.136013567464652,0.952959382433168,6,13,endothelium development,BP,WNT7A;BMP6;HEY1;WNT7B;BMP4;NOTCH1
3606,GO:0042307,0.136198446726733,0.976932448726772,3,5,positive regulation of protein import into nucleus,BP,BMP6;CDH1;BMP4
6905,GO:1904591,0.136198446726733,0.976932448726772,3,5,positive regulation of protein import,BP,BMP6;CDH1;BMP4
783,GO:0005622,0.136209791774536,0.920648729578223,97,303,intracellular,CC,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;PNMT;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2
1535,GO:0009790,0.136375547585189,0.923669184386605,17,46,embryo development,BP,WNT7A;WNT3;HEY1;GJB6;WNT7B;JAG2;AXIN1;WNT2;FZD7;RBP4;FGF8;AMOT;DUSP5;BMP4;GDNF;BMP7;NOTCH1
2507,GO:0030323,0.138022764353511,0.943421704664688,8,18,respiratory tube development,BP,WNT7B;WNT2;RBP4;FGF8;BMP4;FGF18;FSTL3;NOTCH1
2508,GO:0030324,0.138022764353511,0.943421704664688,8,18,lung development,BP,WNT7B;WNT2;RBP4;FGF8;BMP4;FGF18;FSTL3;NOTCH1
1606,GO:0010463,0.139154806548247,0.976177437707663,3,5,mesenchymal cell proliferation,BP,WNT2;BMP4;BMP7
18,GO:0000122,0.139998227370923,0.945823421042937,7,16,negative regulation of transcription from RNA polymerase II promoter,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;NOTCH1
1609,GO:0010467,0.140045366038071,0.909616439339617,32,91,gene expression,BP,TLE1;WNT7A;RHBDL3;BMP6;WNT3;HEY1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;TSFM;ABCG1;PKP1;HRAS;TSPAN15;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;NOTCH1
688,GO:0005104,0.140225139059092,0.982737466254675,3,4,fibroblast growth factor receptor binding,MF,FGF8;FGF17;FGF18
3747,GO:0043010,0.140287554501142,0.946838865960188,7,15,camera-type eye development,BP,WNT7A;WNT7B;WNT2;RBP4;WNT5B;BMP4;BMP7
3483,GO:0036294,0.140366580199001,0.96712559994395,4,7,cellular response to decreased oxygen levels,BP,PMAIP1;PSMB10;BMP7;NOTCH1
5842,GO:0071453,0.140366580199001,0.96712559994395,4,7,cellular response to oxygen levels,BP,PMAIP1;PSMB10;BMP7;NOTCH1
5843,GO:0071456,0.140366580199001,0.96712559994395,4,7,cellular response to hypoxia,BP,PMAIP1;PSMB10;BMP7;NOTCH1
2535,GO:0030510,0.140984982413422,0.975705457302151,3,5,regulation of BMP signaling pathway,BP,BMP4;FSTL3;NOTCH1
2599,GO:0030835,0.140993076614331,0.975703362140134,3,5,negative regulation of actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
3819,GO:0043242,0.140993076614331,0.975703362140134,3,5,negative regulation of protein complex disassembly,BP,SPTBN5;SPTB;SPTBN4
6614,GO:1901880,0.140993076614331,0.975703362140134,3,5,negative regulation of protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
2601,GO:0030837,0.141009982717168,0.975698985820731,3,5,negative regulation of actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
2707,GO:0031333,0.141009982717168,0.975698985820731,3,5,negative regulation of protein complex assembly,BP,SPTBN5;SPTB;SPTBN4
2862,GO:0032272,0.141009982717168,0.975698985820731,3,5,negative regulation of protein polymerization,BP,SPTBN5;SPTB;SPTBN4
6096,GO:0072594,0.142153305807865,0.950138194172481,6,13,establishment of protein localization to organelle,BP,BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
6166,GO:0090092,0.142620885930842,0.949921459048697,6,13,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;INHBB;BMP4;BMP7;FSTL3;NOTCH1
3903,GO:0043542,0.142674638362969,0.949896526453803,6,13,endothelial cell migration,BP,WNT7A;AMOT;BMP4;PIK3CA;FGF18;NOTCH1
3979,GO:0044242,0.142961823455925,0.937802511150074,9,20,cellular lipid catabolic process,BP,PIK3CG;HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
4666,GO:0048731,0.143561918738036,0.902276615656809,49,148,system development,BP,TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;DSG3;WNK4;INHBB;FGF17;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1
1399,GO:0008544,0.143875165115264,0.939433621978639,8,19,epidermis development,BP,JAG2;POU3F1;VDR;DSG3;PKP1;BMP4;KRT10;NOTCH1
975,GO:0006487,0.143904306264319,1,2,2,protein N-linked glycosylation,BP,ALG5;DPM3
2161,GO:0018196,0.143904306264319,1,2,2,peptidyl-asparagine modification,BP,ALG5;DPM3
2169,GO:0018279,0.143904306264319,1,2,2,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
3863,GO:0043409,0.144163730650449,0.974877397541557,3,5,negative regulation of MAPK cascade,BP,DUSP5;BMP4;BMP7
4226,GO:0045664,0.145247504652883,0.943185171576466,7,16,regulation of neuron differentiation,BP,WNT7A;BMP6;WNT3;BMP4;BMP7;NOTCH1;LINGO1
4882,GO:0051094,0.145505971271046,0.916537529993847,18,48,positive regulation of developmental process,BP,WNT7A;ACTN3;BMP6;WNT3;WNT7B;MAPK12;WNT2;FGF8;VDR;AMOT;WNT5B;BMP4;GDNF;FADD;BMP7;SPTBN4;FGF18;NOTCH1
5304,GO:0060425,0.145513854377151,0.965398713075487,4,7,lung morphogenesis,BP,WNT7B;WNT2;FGF8;BMP4
986,GO:0006520,0.14576918897202,0.950127109033498,6,12,cellular amino acid metabolic process,BP,GLDC;ACAT1;MSRA;PSMB10;PTS;PEPD
3626,GO:0042379,0.146942543902637,1,2,2,chemokine receptor binding,MF,CNIH4;CCL20
4503,GO:0048020,0.146942543902637,1,2,2,CCR chemokine receptor binding,MF,CNIH4;CCL20
3080,GO:0032991,0.147218377422342,0.905232511149521,30,86,macromolecular complex,CC,GLDC;GJB2;PIK3CG;GJA3;WNT3;GJB6;KCNG2;AXIN1;POU3F1;MRPL14;WNT2;PXK;PXMP2;CDH1;RBP4;SPTB;VDR;AMOT;PKP1;RNF144A;KCNK6;ETFDH;PSMB10;FADD;PIK3CA;HNF1A;NOTCH1;CPT1C;GUCY1B3;DPM3
5137,GO:0055025,0.14935112024657,0.973503554412611,3,5,positive regulation of cardiac muscle tissue development,BP,WNT2;BMP4;NOTCH1
5399,GO:0060688,0.149607595164708,0.964003848404904,4,7,regulation of morphogenesis of a branching structure,BP,WNT2;BMP4;GDNF;BMP7
1565,GO:0009953,0.149952593233846,0.963885433447437,4,7,dorsal/ventral pattern formation,BP,WNT7A;WNT3;FGF8;BMP4
87,GO:0001071,0.150062535825217,0.951761528886346,5,11,nucleic acid binding transcription factor activity,MF,HEY1;POU3F1;VDR;HNF1A;NOTCH1
542,GO:0003700,0.150062535825217,0.951761528886346,5,11,transcription factor activity, sequence-specific DNA binding,MF,HEY1;POU3F1;VDR;HNF1A;NOTCH1
3986,GO:0044257,0.150530774045413,0.953549889955704,5,10,cellular protein catabolic process,BP,MAGEC2;PMAIP1;AXIN1;RNF144A;PSMB10
1567,GO:0009966,0.150657560378401,0.902189594394757,31,89,regulation of signal transduction,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;AMOT;WNT5B;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
784,GO:0005623,0.150835442263567,0.935446309023413,107,342,cell,CC,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;BOLA1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;TMEM206;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2
4055,GO:0044464,0.150835442263567,0.935446309023413,107,342,cell part,CC,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;BOLA1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;TMEM206;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2
3991,GO:0044265,0.15090213605205,0.946039236299674,6,13,cellular macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A;PSMB10
1018,GO:0006644,0.153243396157704,0.932120760503041,9,20,phospholipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;ZFYVE21;DPM3
1941,GO:0016042,0.154359931585623,0.927799961784097,10,23,lipid catabolic process,BP,PIK3CG;HACL1;ACAT1;ACADVL;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;ETFB
4702,GO:0048856,0.1544866860757,0.893470469583157,53,162,anatomical structure development,BP,SLC2A14;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;DSG3;WNK4;DUSP5;INHBB;FGF17;ALG5;PKP1;HRAS;BMP4;KRT10;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1
4236,GO:0045684,0.15501729129971,0.971971126329081,3,5,positive regulation of epidermis development,BP,VDR;BMP4;NOTCH1
244,GO:0002009,0.155188161892405,0.918108089525609,13,34,morphogenesis of an epithelium,BP,WNT7A;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;WNK4;BMP4;GDNF;PSMB10;BMP7;NOTCH1
2951,GO:0032535,0.155352597605739,0.938014317501773,7,16,regulation of cellular component size,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;DEPTOR;SPTBN4
4301,GO:0045930,0.156470349780594,0.961623231295901,4,7,negative regulation of mitotic cell cycle,BP,HRAS;BMP4;PSMB10;BMP7
984,GO:0006511,0.156996594580958,0.971428029338296,3,5,ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A;PSMB10
2285,GO:0019941,0.156996594580958,0.971428029338296,3,5,modification-dependent protein catabolic process,BP,AXIN1;RNF144A;PSMB10
3784,GO:0043161,0.156996594580958,0.971428029338296,3,5,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,AXIN1;RNF144A;PSMB10
3934,GO:0043632,0.156996594580958,0.971428029338296,3,5,modification-dependent macromolecule catabolic process,BP,AXIN1;RNF144A;PSMB10
138,GO:0001664,0.157193604500481,0.933223106353713,8,18,G-protein coupled receptor binding,MF,WNT7A;WNT3;WNT7B;WNT2;FZD7;WNT5B;CNIH4;CCL20
4692,GO:0048839,0.157197935811367,0.943033101171792,6,13,inner ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
3336,GO:0035295,0.157238822563945,0.912889208279057,15,40,tube development,BP,WNT7A;CLDN18;ACAT1;WNT7B;WNT2;RBP4;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;FGF18;FSTL3;NOTCH1
1953,GO:0016070,0.15732319279109,0.899702202386149,27,76,RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;LAGE3;FSTL3;NOTCH1
5487,GO:0061036,0.157892449678206,0.971180894699134,3,5,positive regulation of cartilage development,BP,BMP6;BMP4;FGF18
3945,GO:0043900,0.158025430815815,0.971144139714123,3,5,regulation of multi-organism process,BP,BMP6;INHBB;NOTCH1
4287,GO:0045862,0.158217508397129,0.944380462374404,6,12,positive regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;RNF144A;PSMB10;FADD
6777,GO:1903305,0.158270476523471,0.971076363406606,3,5,regulation of regulated secretory pathway,BP,SYT5;RAB3D;NOTCH1
3895,GO:0043523,0.158391378839941,0.960947417854702,4,7,regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
3896,GO:0043524,0.158391378839941,0.960947417854702,4,7,negative regulation of neuron apoptotic process,BP,FGF8;HRAS;GDNF;PIK3CA
2858,GO:0032268,0.15862869610343,0.900339281592997,25,69,regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CCL20;TSFM;DUSP5;INHBB;HRAS;BMP4;RNF144A;DEPTOR;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;PM20D2
1694,GO:0010769,0.158740878564673,0.970946083999834,3,5,regulation of cell morphogenesis involved in differentiation,BP,WNT7A;WNT3;LINGO1
5431,GO:0060828,0.158807486027399,0.94225707302158,6,13,regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2;WNT5B;PSMB10;NOTCH1
1539,GO:0009799,0.160212772898715,0.949415678934276,5,10,specification of symmetry,BP,AXIN1;FGF8;ALG5;BMP4;NOTCH1
1243,GO:0007399,0.161999937245294,0.896034311046103,27,78,nervous system development,BP,WNT7A;BMP6;WNT3;ACAT1;WNT7B;JAG2;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;FZD7;SPTB;FGF8;ARTN;WNT5B;FGF17;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;DRP2;PTS;NOTCH1;LINGO1
4377,GO:0046486,0.162055163786048,0.927156426160387,9,20,glycerolipid metabolic process,BP,PIK3CG;MBOAT2;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;ZFYVE21;DPM3
3363,GO:0035567,0.163688301975167,0.969562150818437,3,5,non-canonical Wnt signaling pathway,BP,WNT7A;FZD7;PSMB10
5928,GO:0072006,0.163874213915684,0.928510904961404,8,19,nephron development,BP,ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;NOTCH1
3545,GO:0040019,0.163946924524546,0.969489118199398,3,5,positive regulation of embryonic development,BP,WNT2;AMOT;GDNF
2153,GO:0018105,0.164169819020496,0.945481515438851,5,11,peptidyl-serine phosphorylation,BP,AXIN1;MAPK12;PKN3;SPTBN4;PIK3CA
2165,GO:0018209,0.164169819020496,0.945481515438851,5,11,peptidyl-serine modification,BP,AXIN1;MAPK12;PKN3;SPTBN4;PIK3CA
6758,GO:1903052,0.164465235361627,0.969342546311828,3,5,positive regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A;PSMB10
5299,GO:0060419,0.16450082118955,0.96933247301378,3,5,heart growth,BP,WNT2;RBP4;NOTCH1
5300,GO:0060420,0.16450082118955,0.96933247301378,3,5,regulation of heart growth,BP,WNT2;RBP4;NOTCH1
2453,GO:0030177,0.166067912926757,0.946862370927262,5,10,positive regulation of Wnt signaling pathway,BP,WNT7A;WNT3;AXIN1;WNT2;PSMB10
149,GO:0001707,0.166392197447798,0.954360198460712,4,8,mesoderm formation,BP,WNT3;AXIN1;BMP4;BMP7
4557,GO:0048332,0.166392197447798,0.954360198460712,4,8,mesoderm morphogenesis,BP,WNT3;AXIN1;BMP4;BMP7
5727,GO:0070696,0.167300067709307,0.968536039118529,3,5,transmembrane receptor protein serine/threonine kinase binding,MF,BMP6;BMP4;BMP7
5728,GO:0070700,0.167300067709307,0.968536039118529,3,5,BMP receptor binding,MF,BMP6;BMP4;BMP7
2604,GO:0030850,0.167948834586338,0.968350312955705,3,5,prostate gland development,BP,BMP4;BMP7;NOTCH1
5341,GO:0060512,0.167948834586338,0.968350312955705,3,5,prostate gland morphogenesis,BP,BMP4;BMP7;NOTCH1
5411,GO:0060740,0.167948834586338,0.968350312955705,3,5,prostate gland epithelium morphogenesis,BP,BMP4;BMP7;NOTCH1
2471,GO:0030217,0.16803306485344,0.953717612935372,4,8,T cell differentiation,BP,JAG2;FZD7;BMP4;FADD
4167,GO:0045335,0.168206011032124,0.968276570869567,3,5,phagocytic vesicle,CC,RAB39A;RAB38;RAB20
3950,GO:0043933,0.170580055054344,0.904710893164317,15,38,macromolecular complex subunit organization,BP,TLE1;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;MRPL14;SPTBN5;SPTB;ABCG1;HRAS;FADD;SPTBN4;DECR1;HNF1A
4091,GO:0044802,0.171619724420787,0.916024395730369,10,25,single-organism membrane organization,BP,SYT5;PMAIP1;RAB40B;CDH1;RAB39A;TSPAN15;GDNF;TBC1D14;SPTBN4;RAB20
5880,GO:0071705,0.172044398986462,0.895624009192052,20,54,nitrogen compound transport,BP,RABIF;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;BMP4;RAB3D;GDNF;USE1;TBC1D14;RAB38;BMP7;NOTCH1;RAB20
2393,GO:0023051,0.172354640702907,0.884357604534142,34,99,regulation of signaling,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;WNT2;PXK;FZD7;RBP4;FGF8;AMOT;WNT5B;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
3519,GO:0038093,0.172362246846341,0.967075484116373,3,5,Fc receptor signaling pathway,BP,HRAS;PSMB10;PIK3CA
3521,GO:0038095,0.172362246846341,0.967075484116373,3,5,Fc-epsilon receptor signaling pathway,BP,HRAS;PSMB10;PIK3CA
165,GO:0001759,0.172427325025457,0.955885606885107,4,7,organ induction,BP,WNT2;FGF8;BMP4;GDNF
262,GO:0002067,0.172801798758275,0.951832562768435,4,8,glandular epithelial cell differentiation,BP,BMP6;FGF8;BMP4;NOTCH1
5275,GO:0060348,0.173143847833928,0.943723859471352,5,10,bone development,BP,CLDN18;BMP6;FGF8;BMP4;FGF18
524,GO:0003344,0.173181845451404,0.981703229275204,2,3,pericardium morphogenesis,BP,BMP7;NOTCH1
716,GO:0005200,0.173195436632661,0.98170081275454,2,3,structural constituent of cytoskeleton,MF,SPTB;SPTBN4
1703,GO:0010812,0.17323377070672,0.981693996149567,2,3,negative regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
6345,GO:0097651,0.173376919009424,0.98166853115968,2,3,phosphatidylinositol 3-kinase complex, class I,CC,PIK3CG;PIK3CA
6802,GO:1903506,0.173653049472851,0.890828273947247,23,65,regulation of nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
1697,GO:0010799,0.174221847052545,0.981517896784922,2,3,regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1698,GO:0010800,0.174221847052545,0.981517896784922,2,3,positive regulation of peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
1211,GO:0007257,0.174244378017725,0.981513872265791,2,3,activation of JUN kinase activity,BP,WNT7B;AXIN1
2336,GO:0021915,0.174426675208423,0.951184312709712,4,8,neural tube development,BP,FGF8;BMP4;BMP7;NOTCH1
1994,GO:0016331,0.174432019417347,0.927929193447656,7,16,morphogenesis of embryonic epithelium,BP,WNT7B;JAG2;WNT2;FGF8;BMP4;GDNF;BMP7
693,GO:0005112,0.17456847140972,0.981455937992439,2,3,Notch binding,MF,JAG2;NOTCH1
3181,GO:0034103,0.174628746504664,0.981445154231217,2,3,regulation of tissue remodeling,BP,CLDN18;VDR
150,GO:0001708,0.174641998547039,0.981442782937543,2,3,cell fate specification,BP,FZD7;NOTCH1
5306,GO:0060428,0.174987063484151,0.966307902898699,3,5,lung epithelium development,BP,WNT7B;WNT2;BMP4
3248,GO:0034504,0.175075240096052,0.932586854046396,6,14,protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
6483,GO:1900180,0.175075240096052,0.932586854046396,6,14,regulation of protein localization to nucleus,BP,CLDN18;BMP6;CDH1;FZD7;BMP4;BMP7
5832,GO:0071407,0.175635895658318,0.926030644737969,7,17,cellular response to organic cyclic compound,BP,GJB2;PIK3CG;HEY1;CDH1;VDR;BMP4;BMP7
4900,GO:0051154,0.175688816389926,0.98125503112866,2,3,negative regulation of striated muscle cell differentiation,BP,FZD7;NOTCH1
3815,GO:0043234,0.176195955882203,0.89221837253459,20,56,protein complex,CC,GJB2;GJA3;WNT3;GJB6;AXIN1;POU3F1;WNT2;PXK;PXMP2;CDH1;RBP4;SPTB;VDR;AMOT;ETFDH;PSMB10;FADD;HNF1A;NOTCH1;GUCY1B3
6846,GO:1903707,0.177359347568473,0.950006688296248,4,8,negative regulation of hemopoiesis,BP,CLDN18;BMP4;FSTL3;NOTCH1
1181,GO:0007165,0.17761518562932,0.87548251695975,52,159,signal transduction,BP,RHPN1;TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;ACADVL;RAB40B;RRAS2;SPTBN5;FZD7;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
3960,GO:0044060,0.178036681342649,0.980830795141504,2,3,regulation of endocrine process,BP,BMP6;INHBB
5468,GO:0060986,0.178036681342649,0.980830795141504,2,3,endocrine hormone secretion,BP,BMP6;INHBB
6541,GO:1901214,0.17861029304519,0.941259983599882,5,10,regulation of neuron death,BP,RRAS2;FGF8;HRAS;GDNF;PIK3CA
4270,GO:0045822,0.17877516110664,0.980696462188991,2,3,negative regulation of heart contraction,BP,PIK3CG;SPTBN4
6811,GO:1903523,0.17877516110664,0.980696462188991,2,3,negative regulation of blood circulation,BP,PIK3CG;SPTBN4
6172,GO:0090130,0.179038400214088,0.919928867746909,8,19,tissue migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;PIK3CA;FGF18;NOTCH1
94,GO:0001104,0.179338184322188,0.980593757106207,2,3,RNA polymerase II transcription cofactor activity,MF,TLE1;POU3F1
791,GO:0005667,0.179562724985172,0.980552727403821,2,3,transcription factor complex,CC,POU3F1;VDR
1096,GO:0006885,0.18009095648225,0.964795339638219,3,5,regulation of pH,BP,RAB39A;RAB38;RAB20
1005,GO:0006606,0.18068886140717,0.937830543179619,5,11,protein import into nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
2128,GO:0017038,0.18068886140717,0.937830543179619,5,11,protein import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4075,GO:0044744,0.18068886140717,0.937830543179619,5,11,protein targeting to nucleus,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4905,GO:0051170,0.18068886140717,0.937830543179619,5,11,nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
6700,GO:1902593,0.18068886140717,0.937830543179619,5,11,single-organism nuclear import,BP,BMP6;CDH1;FZD7;BMP4;BMP7
2367,GO:0022607,0.182277557183313,0.883532296122375,24,68,cellular component assembly,BP,TLE1;WNT7A;GJB2;ACTN3;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;RAB39A;SPTB;PKP1;HRAS;TBC1D14;RAB38;FADD;BMP7;SPTBN4;DECR1;HNF1A;NOTCH1;RAB20
4707,GO:0048869,0.182570847499661,0.873333239081971,42,128,cellular developmental process,BP,SLC2A14;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;RRAS2;SPTBN5;CDH1;FZD7;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;INHBB;ABCG1;PKP1;HRAS;BMP4;KRT10;GDNF;RAB38;FADD;BMP7;SPTBN4;PIK3CA;TPD52;FGF18;FSTL3;NOTCH1;LINGO1
1378,GO:0008374,0.182618870637731,0.979990336060035,2,3,O-acyltransferase activity,MF,MBOAT2;CPT1C
4231,GO:0045669,0.182753135597606,0.94781526201156,4,8,positive regulation of osteoblast differentiation,BP,BMP6;WNT7B;BMP4;BMP7
1551,GO:0009895,0.182904343427569,0.936780430348876,5,11,negative regulation of catabolic process,BP,PIK3CG;ACTN3;PKP1;TBC1D14;PIK3CA
5986,GO:0072132,0.183269359866195,0.947603797317082,4,8,mesenchyme morphogenesis,BP,HEY1;FGF8;BMP7;NOTCH1
2538,GO:0030514,0.183834086103004,0.979764666071908,2,3,negative regulation of BMP signaling pathway,BP,FSTL3;NOTCH1
3875,GO:0043467,0.183840943558657,0.979763389311438,2,3,regulation of generation of precursor metabolites and energy,BP,ACTN3;PIK3CA
6878,GO:1904019,0.183952181561079,0.979742673198499,2,3,epithelial cell apoptotic process,BP,PIK3CG;JAG2
3125,GO:0033273,0.183986171607682,0.979736341205158,2,3,response to vitamin,BP,VDR;BMP7
4014,GO:0044346,0.184136865681237,0.979708257480383,2,3,fibroblast apoptotic process,BP,PIK3CG;PIK3CA
7101,GO:2000269,0.184136865681237,0.979708257480383,2,3,regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
7102,GO:2000270,0.184136865681237,0.979708257480383,2,3,negative regulation of fibroblast apoptotic process,BP,PIK3CG;PIK3CA
964,GO:0006461,0.184454367357188,0.899489489776591,13,33,protein complex assembly,BP,TLE1;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;FADD;SPTBN4;DECR1;HNF1A
5655,GO:0070271,0.184454367357188,0.899489489776591,13,33,protein complex biogenesis,BP,TLE1;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;FADD;SPTBN4;DECR1;HNF1A
1422,GO:0009055,0.184477445614131,0.963474289493966,3,5,electron carrier activity,MF,GLDC;ETFDH;ETFB
3048,GO:0032879,0.184653318268723,0.875825027903724,32,94,regulation of localization,BP,WNT7A;SYT5;PIK3CG;CLDN18;BMP6;WNT3;JAG2;PMAIP1;KCNG2;RRAS2;CDH1;FZD7;RBP4;AMOT;WNT5B;WNK4;CCL20;INHBB;ABCG1;HRAS;BMP4;RAB3D;KCNK6;GDNF;TBC1D14;FADD;BMP7;SPTBN4;FGF18;TSPAN13;NOTCH1;RAB20
4677,GO:0048762,0.184975485606529,0.922180125978414,7,16,mesenchymal cell differentiation,BP,HEY1;WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
2504,GO:0030316,0.185082518847339,0.979531614053527,2,3,osteoclast differentiation,BP,CLDN18;FSTL3
4232,GO:0045670,0.185082518847339,0.979531614053527,2,3,regulation of osteoclast differentiation,BP,CLDN18;FSTL3
4233,GO:0045671,0.185082518847339,0.979531614053527,2,3,negative regulation of osteoclast differentiation,BP,CLDN18;FSTL3
750,GO:0005496,0.185132419589364,0.979522273228848,2,3,steroid binding,MF,VDR;ABCG1
6484,GO:1900181,0.185188529819516,0.979511767713803,2,3,negative regulation of protein localization to nucleus,BP,CLDN18;BMP7
6738,GO:1902930,0.185369200606724,0.979477923844886,2,3,regulation of alcohol biosynthetic process,BP,VDR;ABCG1
4616,GO:0048593,0.18578608953885,0.94656853542216,4,8,camera-type eye morphogenesis,BP,WNT2;RBP4;BMP4;BMP7
5658,GO:0070293,0.185799604025486,0.979397195367066,2,3,renal absorption,BP,WNK4;HNF1A
4765,GO:0050769,0.186532386203121,0.926638386580123,6,14,positive regulation of neurogenesis,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
2719,GO:0031396,0.186856764048262,0.962749580506081,3,5,regulation of protein ubiquitination,BP,MAGEC2;AXIN1;PSMB10
2721,GO:0031398,0.186856764048262,0.962749580506081,3,5,positive regulation of protein ubiquitination,BP,MAGEC2;AXIN1;PSMB10
6785,GO:1903320,0.186856764048262,0.962749580506081,3,5,regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1;PSMB10
6787,GO:1903322,0.186856764048262,0.962749580506081,3,5,positive regulation of protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1;PSMB10
4941,GO:0051241,0.186922268932836,0.890868368604739,16,43,negative regulation of multicellular organismal process,BP,WNT7A;PIK3CG;CLDN18;WNT3;FZD7;RBP4;FGF8;AMOT;WNK4;INHBB;BMP4;BMP7;SPTBN4;FSTL3;NOTCH1;LINGO1
4669,GO:0048738,0.186989418694026,0.919730854717822,7,17,cardiac muscle tissue development,BP,WNT2;FZD7;RBP4;FGF8;BMP4;BMP7;NOTCH1
4418,GO:0046697,0.187417105130842,0.979092501029484,2,3,decidualization,BP,GJB2;VDR
4948,GO:0051252,0.189265038428372,0.878163118188163,24,69,regulation of RNA metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
5433,GO:0060837,0.189323559536879,0.978730720508395,2,3,blood vessel endothelial cell differentiation,BP,HEY1;NOTCH1
5437,GO:0060842,0.189323559536879,0.978730720508395,2,3,arterial endothelial cell differentiation,BP,HEY1;NOTCH1
477,GO:0003188,0.189715643735849,0.978655959810287,2,3,heart valve formation,BP,HEY1;NOTCH1
478,GO:0003190,0.189715643735849,0.978655959810287,2,3,atrioventricular valve formation,BP,HEY1;NOTCH1
2356,GO:0022407,0.189999765728795,0.924808954864254,6,14,regulation of cell-cell adhesion,BP,CDH1;BMP4;FADD;BMP7;PIK3CA;FSTL3
2230,GO:0019438,0.191347769062317,0.87416491999155,27,77,aromatic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3
6034,GO:0072234,0.191371612982822,0.978338865623528,2,3,metanephric nephron tubule development,BP,ACAT1;WNT7B
6038,GO:0072243,0.191371612982822,0.978338865623528,2,3,metanephric nephron epithelium development,BP,ACAT1;WNT7B
7031,GO:1990837,0.191587471862384,0.978297371815906,2,3,sequence-specific double-stranded DNA binding,MF,HEY1;HNF1A
2618,GO:0030879,0.192691585494455,0.932074338448118,5,11,mammary gland development,BP,WNT3;WNT7B;WNT2;VDR;BMP4
687,GO:0005102,0.19307108706237,0.872990645799264,27,76,receptor binding,MF,WNT7A;PIK3CG;ACTN3;HACL1;BMP6;WNT3;WNT7B;JAG2;WNT2;FZD7;FGF8;VDR;ARTN;WNT5B;NUDT7;CNIH4;CCL20;INHBB;FGF17;BMP4;GDNF;FADD;BMP7;NUDT6;FGF18;NOTCH1;LINGO1
5047,GO:0051641,0.193616763769029,0.876956610517573,22,63,cellular localization,BP,WNT7A;SYT5;PIK3CG;CLDN18;BMP6;PMAIP1;RAB40B;SPTBN5;CDH1;FZD7;SPTB;AMOT;CNIH4;ABCG1;TSPAN15;BMP4;GDNF;TBC1D14;RAB38;BMP7;SPTBN4;ZFYVE21
2442,GO:0030155,0.195406405483595,0.89978938856781,10,27,regulation of cell adhesion,BP,PIK3CG;JAG2;CDH1;FZD7;BMP4;FADD;BMP7;PIK3CA;FSTL3;NOTCH1
5897,GO:0071822,0.195555005907424,0.889499834596197,14,36,protein complex subunit organization,BP,TLE1;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;MRPL14;SPTBN5;SPTB;HRAS;FADD;SPTBN4;DECR1;HNF1A
4063,GO:0044702,0.195653656010031,0.880957005682616,18,50,single organism reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;SPTBN4;FSTL3;NOTCH1
6688,GO:1902532,0.196419984932222,0.921386113309678,6,14,negative regulation of intracellular signal transduction,BP,TLE1;ACTN3;DUSP5;BMP4;DEPTOR;BMP7
2798,GO:0031960,0.196898789085664,0.930017952541692,5,11,response to corticosteroid,BP,GJB2;BMP6;HEY1;WNT7B;NOTCH1
5135,GO:0055023,0.197396386760685,0.977166870581491,2,3,positive regulation of cardiac muscle tissue growth,BP,WNT2;NOTCH1
2424,GO:0030072,0.198026837962575,0.959270865009446,3,5,peptide hormone secretion,BP,KCNG2;RBP4;INHBB
3833,GO:0043276,0.198252123724104,0.953115528190594,3,6,anoikis,BP,TLE1;PIK3CA;NOTCH1
1993,GO:0016328,0.198512670393058,0.941224233030259,4,8,lateral plasma membrane,CC,GJB2;AXIN1;CDH1;CLDN15
5410,GO:0060716,0.19852483512938,0.976944150216193,2,3,labyrinthine layer blood vessel development,BP,HEY1;WNT2
4185,GO:0045453,0.198591767279277,0.976930908102584,2,3,bone resorption,BP,CLDN18;RAB3D
4436,GO:0046849,0.198591767279277,0.976930908102584,2,3,bone remodeling,BP,CLDN18;RAB3D
2902,GO:0032370,0.198952020230356,0.976859573083082,2,3,positive regulation of lipid transport,BP,BMP6;ABCG1
6999,GO:1905954,0.198952020230356,0.976859573083082,2,3,positive regulation of lipid localization,BP,BMP6;ABCG1
5396,GO:0060685,0.199389441303768,0.976772818955472,2,3,regulation of prostatic bud formation,BP,BMP4;BMP7
5397,GO:0060686,0.199389441303768,0.976772818955472,2,3,negative regulation of prostatic bud formation,BP,BMP4;BMP7
6965,GO:1905331,0.199389441303768,0.976772818955472,2,3,negative regulation of morphogenesis of an epithelium,BP,BMP4;BMP7
5071,GO:0051784,0.199445637902249,0.976761662398134,2,3,negative regulation of nuclear division,BP,BMP4;BMP7
5276,GO:0060349,0.200171850359709,0.958588425868923,3,5,bone morphogenesis,BP,BMP6;BMP4;FGF18
5277,GO:0060350,0.200171850359709,0.958588425868923,3,5,endochondral bone morphogenesis,BP,BMP6;BMP4;FGF18
7210,GO:2001141,0.200268390085597,0.870892771286699,23,66,regulation of RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
3932,GO:0043624,0.200525010413347,0.940362565335934,4,8,cellular protein complex disassembly,BP,MRPL14;SPTBN5;SPTB;SPTBN4
5795,GO:0071310,0.200732685587294,0.866724282304677,27,79,cellular response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;WNT5B;CCL20;INHBB;FGF17;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
4224,GO:0045661,0.200763139982609,0.976499382144596,2,3,regulation of myoblast differentiation,BP,BMP4;NOTCH1
4225,GO:0045662,0.200763139982609,0.976499382144596,2,3,negative regulation of myoblast differentiation,BP,BMP4;NOTCH1
6186,GO:0090181,0.200842246856576,0.976483590056933,2,3,regulation of cholesterol metabolic process,BP,ACADVL;ABCG1
4942,GO:0051246,0.202465856128298,0.867407387582908,25,71,regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CCL20;TSFM;DUSP5;INHBB;HRAS;BMP4;RNF144A;DEPTOR;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;PM20D2
2624,GO:0030902,0.202486150418571,0.976154289815998,2,3,hindbrain development,BP,WNT7A;BMP7
5983,GO:0072125,0.203176700276237,0.976015319210223,2,3,negative regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
6189,GO:0090185,0.203176700276237,0.976015319210223,2,3,negative regulation of kidney development,BP,BMP4;BMP7
6197,GO:0090194,0.203176700276237,0.976015319210223,2,3,negative regulation of glomerulus development,BP,BMP4;BMP7
6604,GO:1901723,0.203176700276237,0.976015319210223,2,3,negative regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
4428,GO:0046822,0.203219993553741,0.92689081232475,5,11,regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
6540,GO:1901213,0.203568108959707,0.975936380801604,2,3,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,BMP4;NOTCH1
6235,GO:0090407,0.20452551641663,0.896254985537639,10,24,organophosphate biosynthetic process,BP,PIK3CG;MBOAT2;ACAT1;FGF8;FGF17;PIK3CA;PLA2G16;FGF18;GUCY1B3;DPM3
1607,GO:0010464,0.204638397888685,0.975719903288479,2,3,regulation of mesenchymal cell proliferation,BP,WNT2;BMP4
1648,GO:0010631,0.205008433713689,0.909442783018038,7,17,epithelial cell migration,BP,WNT7A;AMOT;PKN3;BMP4;PIK3CA;FGF18;NOTCH1
1573,GO:0009987,0.205618356638335,0.881193853981748,101,323,cellular process,BP,MAGEC2;SLC2A14;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KRT10;KCNK6;ECI1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DECR1;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
3822,GO:0043254,0.206169389808705,0.925416396280726,5,11,regulation of protein complex assembly,BP,PMAIP1;SPTBN5;SPTB;SPTBN4;HNF1A
4834,GO:0050922,0.206187199798663,0.97540502204998,2,3,negative regulation of chemotaxis,BP,WNT3;NOTCH1
2407,GO:0030030,0.206899104237577,0.878055418855348,15,42,cell projection organization,BP,WNT7A;WNT3;WNT7B;SPTBN5;CDH1;SPTB;FGF8;ARTN;HRAS;GDNF;BMP7;SPTBN4;PIK3CA;NOTCH1;LINGO1
3017,GO:0032768,0.207228096689621,0.956310727501172,3,5,regulation of monooxygenase activity,BP,VDR;GDNF;PTS
941,GO:0006351,0.207747995112582,0.865233361099693,23,66,transcription, DNA-templated,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
2147,GO:0017156,0.207764161870837,0.975082446091304,2,3,calcium ion regulated exocytosis,BP,SYT5;NOTCH1
2149,GO:0017158,0.207764161870837,0.975082446091304,2,3,regulation of calcium ion-dependent exocytosis,BP,SYT5;NOTCH1
2357,GO:0022408,0.208523170845511,0.974926477686001,2,3,negative regulation of cell-cell adhesion,BP,CDH1;BMP4
2809,GO:0031984,0.208554665514681,0.974919995898329,2,3,organelle subcompartment,CC,CDH1;RAB38
78,GO:0000981,0.210185472083312,0.948737239340236,3,6,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HEY1;VDR;HNF1A
114,GO:0001533,0.210256917931066,0.948710555979073,3,6,cornified envelope,CC,DSG3;PKP1;KRT10
2728,GO:0031424,0.210256917931066,0.948710555979073,3,6,keratinization,BP,DSG3;PKP1;KRT10
5654,GO:0070268,0.210256917931066,0.948710555979073,3,6,cornification,BP,DSG3;PKP1;KRT10
851,GO:0005911,0.210723273160227,0.886183979126416,11,30,cell-cell junction,CC,TJP3;GJB2;CLDN18;GJA3;GJB6;CDH1;AMOT;DSG3;WNK4;PKP1;CLDN15
1696,GO:0010771,0.210826825413842,0.974450275990365,2,3,negative regulation of cell morphogenesis involved in differentiation,BP,WNT3;LINGO1
1769,GO:0010977,0.210826825413842,0.974450275990365,2,3,negative regulation of neuron projection development,BP,WNT3;LINGO1
4767,GO:0050771,0.210826825413842,0.974450275990365,2,3,negative regulation of axonogenesis,BP,WNT3;LINGO1
2623,GO:0030901,0.211517491917052,0.974306675581197,2,3,midbrain development,BP,WNT3;WNT2
6940,GO:1904948,0.211517491917052,0.974306675581197,2,3,midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
6944,GO:1904953,0.211517491917052,0.974306675581197,2,3,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,WNT3;WNT2
2611,GO:0030863,0.211958824491335,0.931830357734939,4,9,cortical cytoskeleton,CC,SPTBN5;CDH1;SPTB;SPTBN4
2612,GO:0030864,0.211958824491335,0.931830357734939,4,9,cortical actin cytoskeleton,CC,SPTBN5;CDH1;SPTB;SPTBN4
3580,GO:0042147,0.212061757397543,0.974193244659111,2,3,retrograde transport, endosome to Golgi,BP,TBC1D14;ZFYVE21
181,GO:0001822,0.212171231670628,0.889613899087392,10,26,kidney development,BP,BMP6;ACAT1;WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
6212,GO:0090263,0.212481533676359,0.935149830761755,4,8,positive regulation of canonical Wnt signaling pathway,BP,WNT7A;AXIN1;WNT2;PSMB10
4910,GO:0051179,0.212498415429513,0.847279847676164,55,170,localization,BP,SLC2A14;WNT7A;GJB2;SYT5;PIK3CG;CLDN18;RABIF;BMP6;GJA3;WNT3;JAG2;PMAIP1;KCNG2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;CNIH4;WNK4;CCL20;INHBB;ABCG1;PKN3;PKP1;HRAS;TSPAN15;BMP4;RAB3D;CLDN15;KCNK6;GDNF;USE1;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;TPD52;HNF1A;FGF18;TSPAN13;NOTCH1;ZFYVE21;RAB20
133,GO:0001655,0.212758671195352,0.885442776509289,11,29,urogenital system development,BP,BMP6;ACAT1;WNT7B;RBP4;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
5927,GO:0072001,0.212758671195352,0.885442776509289,11,29,renal system development,BP,BMP6;ACAT1;WNT7B;RBP4;FGF8;WNK4;BMP4;GDNF;BMP7;FSTL3;NOTCH1
7051,GO:2000026,0.212761446637889,0.862565306262803,22,63,regulation of multicellular organismal development,BP,WNT7A;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT2;FZD7;RBP4;FGF8;VDR;AMOT;BMP4;GDNF;PSMB10;FADD;BMP7;PLA2G16;FGF18;FSTL3;NOTCH1;LINGO1
4306,GO:0045935,0.213281571447614,0.867794001868955,18,51,positive regulation of nucleobase-containing compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
4977,GO:0051336,0.213327094797104,0.870491189417527,17,45,regulation of hydrolase activity,BP,RABIF;PMAIP1;AXIN1;MAPK12;SPTBN5;SPTB;FGF8;AMOT;ARTN;CCL20;FGF17;HRAS;GDNF;TBC1D14;FADD;SPTBN4;FGF18
2365,GO:0022603,0.213964806181126,0.875741526996368,14,38,regulation of anatomical structure morphogenesis,BP,WNT7A;WNT3;HEY1;WNT2;FZD7;FGF8;VDR;AMOT;BMP4;GDNF;PSMB10;BMP7;NOTCH1;LINGO1
6406,GO:0098805,0.214342588429276,0.864201255690863,20,56,whole membrane,CC,WNT7A;SYT5;WNT3;WNT7B;PMAIP1;PXMP2;CDH1;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;RNF144A;RAB3D;RAB38;FADD;PLA2G16;CPT1C;ZFYVE21;RAB20
6551,GO:1901343,0.21466816705237,0.930571114593756,4,9,negative regulation of vasculature development,BP,AMOT;BMP4;BMP7;NOTCH1
92,GO:0001101,0.215138531221235,0.897284092574727,8,20,response to acid chemical,BP,GJB2;BMP6;WNT3;WNT7B;WNT2;FZD7;RBP4;WNT5B
5242,GO:0060255,0.216719864838848,0.847547981675877,38,115,regulation of macromolecule metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;RNF144A;GDNF;DEPTOR;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1;PM20D2
3561,GO:0042074,0.217041876499477,0.973144280825972,2,3,cell migration involved in gastrulation,BP,FGF8;AMOT
2339,GO:0021954,0.217057054212144,0.973141053439438,2,3,central nervous system neuron development,BP,FGF8;SPTBN4
6109,GO:0072676,0.217253094273859,0.933025237471522,4,8,lymphocyte migration,BP,PIK3CG;ARTN;CCL20;FADD
195,GO:0001845,0.217299484834412,0.973089477869729,2,3,phagolysosome assembly,BP,RAB39A;RAB20
725,GO:0005243,0.217557058874905,0.973034628745105,2,3,gap junction channel activity,MF,GJB2;GJA3
2377,GO:0022829,0.217557058874905,0.973034628745105,2,3,wide pore channel activity,MF,GJB2;GJA3
4679,GO:0048771,0.217966814718794,0.932705277522735,4,8,tissue remodeling,BP,CLDN18;FGF8;VDR;RAB3D
2325,GO:0021872,0.218095143927183,0.972919873636756,2,3,forebrain generation of neurons,BP,AXIN1;FGF8
2327,GO:0021879,0.218095143927183,0.972919873636756,2,3,forebrain neuron differentiation,BP,AXIN1;FGF8
156,GO:0001736,0.218640303695937,0.972803371650471,2,3,establishment of planar polarity,BP,FZD7;PSMB10
1180,GO:0007164,0.218640303695937,0.972803371650471,2,3,establishment of tissue polarity,BP,FZD7;PSMB10
5199,GO:0060071,0.218640303695937,0.972803371650471,2,3,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7;PSMB10
6182,GO:0090175,0.218640303695937,0.972803371650471,2,3,regulation of establishment of planar polarity,BP,FZD7;PSMB10
2492,GO:0030282,0.218788595558403,0.94548398672209,3,6,bone mineralization,BP,BMP6;BMP4;BMP7
2530,GO:0030500,0.218788595558403,0.94548398672209,3,6,regulation of bone mineralization,BP,BMP6;BMP4;BMP7
2531,GO:0030501,0.218788595558403,0.94548398672209,3,6,positive regulation of bone mineralization,BP,BMP6;BMP4;BMP7
3927,GO:0043618,0.219234101394908,0.972676202832875,2,3,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMB10;NOTCH1
3929,GO:0043620,0.219234101394908,0.972676202832875,2,3,regulation of DNA-templated transcription in response to stress,BP,PSMB10;NOTCH1
6733,GO:1902904,0.219651435864623,0.945153235538916,3,6,negative regulation of supramolecular fiber organization,BP,SPTBN5;SPTB;SPTBN4
2414,GO:0030042,0.219657423503475,0.945150937460808,3,6,actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
2598,GO:0030834,0.219657423503475,0.945150937460808,3,6,regulation of actin filament depolymerization,BP,SPTBN5;SPTB;SPTBN4
3821,GO:0043244,0.219657423503475,0.945150937460808,3,6,regulation of protein complex disassembly,BP,SPTBN5;SPTB;SPTBN4
4954,GO:0051261,0.219657423503475,0.945150937460808,3,6,protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
6613,GO:1901879,0.219657423503475,0.945150937460808,3,6,regulation of protein depolymerization,BP,SPTBN5;SPTB;SPTBN4
1424,GO:0009057,0.220414192220527,0.894007696589679,8,20,macromolecule catabolic process,BP,MAGEC2;PMAIP1;AXIN1;PKP1;RNF144A;USE1;LYPLAL1;PSMB10
5492,GO:0061046,0.220841557981976,0.972330518673177,2,3,regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
5493,GO:0061047,0.220841557981976,0.972330518673177,2,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2;BMP4
638,GO:0004674,0.220902877898631,0.915462893255004,5,12,protein serine/threonine kinase activity,MF,PIK3CG;MAPK12;WNK4;PKN3;PIK3CA
776,GO:0005578,0.221276248039124,0.899855548778397,7,17,proteinaceous extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4;LINGO1
2043,GO:0016579,0.221326369958527,0.972225849924859,2,3,protein deubiquitination,BP,AXIN1;PSMB10
5715,GO:0070646,0.221326369958527,0.972225849924859,2,3,protein modification by small protein removal,BP,AXIN1;PSMB10
4952,GO:0051259,0.221579001758858,0.901282445937495,7,16,protein oligomerization,BP,HACL1;ACAT1;PMAIP1;KCNG2;SPTBN5;HRAS;DECR1
4430,GO:0046824,0.221796933038601,0.944327274517665,3,6,positive regulation of nucleocytoplasmic transport,BP,BMP6;CDH1;BMP4
3779,GO:0043124,0.222324107506029,0.972009844798156,2,3,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;BMP7
2160,GO:0018193,0.222461694605552,0.875443532367809,12,32,peptidyl-amino acid modification,BP,AXIN1;MAPK12;FGF8;PKN3;FGF17;ALG5;RAB3D;BMP7;SPTBN4;PIK3CA;FGF18;DPM3
3982,GO:0044248,0.22302517312144,0.857658443077696,20,56,cellular catabolic process,BP,MAGEC2;GLDC;PIK3CG;HACL1;ACAT1;PMAIP1;AXIN1;ACADVL;RAB39A;NUDT7;PKP1;RNF144A;ECI1;ETFDH;TBC1D14;PSMB10;PIK3CA;DECR1;CPT1C;ETFB
4305,GO:0045934,0.223154642059922,0.881589269696098,10,27,negative regulation of nucleobase-containing compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
1454,GO:0009132,0.223198684406035,0.971819840863124,2,3,nucleoside diphosphate metabolic process,BP,ACTN3;NUDT7
3134,GO:0033365,0.223407824723256,0.897200968523179,7,18,protein localization to organelle,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
4939,GO:0051239,0.223936047429605,0.844919346978402,32,95,regulation of multicellular organismal process,BP,WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;WNT7B;KCNG2;WNT2;FZD7;RBP4;FGF8;VDR;AMOT;WNK4;CCL20;INHBB;HRAS;BMP4;KCNK6;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;FGF18;FSTL3;NOTCH1;LINGO1
1777,GO:0012506,0.224034754860631,0.877812018426931,11,29,vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RNF144A;RAB3D;RAB38;RAB20
2560,GO:0030659,0.224034754860631,0.877812018426931,11,29,cytoplasmic vesicle membrane,CC,WNT7A;SYT5;WNT3;WNT7B;RAB39A;WNT5B;PKP1;RNF144A;RAB3D;RAB38;RAB20
1626,GO:0010556,0.224118787351188,0.85038446199047,25,73,regulation of macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
3293,GO:0035004,0.22425074037597,0.916165887041348,5,11,phosphatidylinositol 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
4466,GO:0046934,0.22425074037597,0.916165887041348,5,11,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
5120,GO:0052813,0.22425074037597,0.916165887041348,5,11,phosphatidylinositol bisphosphate kinase activity,MF,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
5635,GO:0070228,0.224353603041328,0.971567982938847,2,3,regulation of lymphocyte apoptotic process,BP,BMP4;FADD
5639,GO:0070232,0.224353603041328,0.971567982938847,2,3,regulation of T cell apoptotic process,BP,BMP4;FADD
4346,GO:0046330,0.224574828057542,0.915996781264072,5,11,positive regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
425,GO:0003006,0.224876336629219,0.867969221765887,14,38,developmental process involved in reproduction,BP,WNT7A;GJB2;BMP6;HEY1;WNT7B;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;FSTL3;NOTCH1
5604,GO:0070011,0.225735625891263,0.929186108109549,4,8,peptidase activity, acting on L-amino acid peptides,MF,RHBDL3;PSMB10;PM20D2;PEPD
294,GO:0002260,0.226241373269352,0.971153980612481,2,3,lymphocyte homeostasis,BP,PMAIP1;FADD
3754,GO:0043029,0.226241373269352,0.971153980612481,2,3,T cell homeostasis,BP,PMAIP1;FADD
6438,GO:0099504,0.226554979097474,0.971084924349965,2,3,synaptic vesicle cycle,BP,WNT7A;SYT5
5295,GO:0060412,0.227008956913306,0.942299803487014,3,6,ventricular septum morphogenesis,BP,HEY1;BMP4;NOTCH1
5539,GO:0061311,0.227498295594189,0.94210792532495,3,6,cell surface receptor signaling pathway involved in heart development,BP,HEY1;BMP4;NOTCH1
4899,GO:0051153,0.227601674476474,0.942067355161285,3,6,regulation of striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
4103,GO:0045017,0.227868740648874,0.906201131210003,6,13,glycerolipid biosynthetic process,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18;DPM3
5470,GO:0060993,0.229148293745274,0.903233686640369,6,14,kidney morphogenesis,BP,WNT7B;FGF8;WNK4;BMP4;GDNF;BMP7
4763,GO:0050767,0.231200935438547,0.886076454264719,8,21,regulation of neurogenesis,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1;LINGO1
6346,GO:0097659,0.231841771074275,0.846514768689565,23,67,nucleic acid-templated transcription,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
5598,GO:0065003,0.231890955535228,0.866283332346589,13,34,macromolecular complex assembly,BP,TLE1;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;SPTBN5;SPTB;HRAS;FADD;SPTBN4;DECR1;HNF1A
3790,GO:0043178,0.232078029576326,0.969855633573717,2,3,alcohol binding,MF,RBP4;ABCG1
356,GO:0002573,0.232369885540342,0.922139904098193,4,9,myeloid leukocyte differentiation,BP,CLDN18;BMP4;FADD;FSTL3
4577,GO:0048489,0.232798805707395,0.969693373132846,2,3,synaptic vesicle transport,BP,WNT7A;SYT5
6333,GO:0097480,0.232798805707395,0.969693373132846,2,3,establishment of synaptic vesicle localization,BP,WNT7A;SYT5
6426,GO:0099003,0.232798805707395,0.969693373132846,2,3,vesicle-mediated transport in synapse,BP,WNT7A;SYT5
4636,GO:0048646,0.233465239809693,0.854244661326989,17,49,anatomical structure formation involved in morphogenesis,BP,WNT7A;PIK3CG;WNT3;HEY1;AXIN1;WNT2;FZD7;RBP4;FGF8;AMOT;DUSP5;BMP4;GDNF;BMP7;PIK3CA;FGF18;NOTCH1
6602,GO:1901701,0.234362625283019,0.855242754955126,16,47,cellular response to oxygen-containing compound,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;VDR;WNT5B;CCL20;INHBB;BMP7;PIK3CA;GUCY1B3
260,GO:0002065,0.234509804788576,0.908135846206186,5,12,columnar/cuboidal epithelial cell differentiation,BP,BMP6;JAG2;FGF8;BMP4;NOTCH1
6165,GO:0090090,0.235792842849528,0.920468922488694,4,9,negative regulation of canonical Wnt signaling pathway,BP,AXIN1;WNT5B;PSMB10;NOTCH1
3808,GO:0043227,0.236606812714233,0.834578526570015,84,262,membrane-bounded organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;MBOAT2;BMP6;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;ACADVL;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;DSG3;CNIH4;TSFM;DUSP5;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;BMP7;SPTBN4;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;DPM3;PM20D2;PEPD
4709,GO:0048871,0.237120685416964,0.896722717756027,6,15,multicellular organismal homeostasis,BP,CLDN18;BMP6;ACADVL;RBP4;RAB3D;PIK3CA
6222,GO:0090304,0.23838578739014,0.836381775720517,28,82,nucleic acid metabolic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;NOTCH1
1549,GO:0009893,0.238657557655966,0.831252120184345,35,105,positive regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;RNF144A;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1
3864,GO:0043410,0.239050309517008,0.867465656888813,11,29,positive regulation of MAPK cascade,BP,WNT7A;PIK3CG;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;HRAS;BMP4;FGF18
1653,GO:0010639,0.240429722426262,0.904884319452206,5,12,negative regulation of organelle organization,BP,SPTBN5;SPTB;BMP4;BMP7;SPTBN4
3037,GO:0032835,0.241097199984088,0.93667074384568,3,6,glomerulus development,BP,BMP4;BMP7;NOTCH1
5568,GO:0061437,0.241097199984088,0.93667074384568,3,6,renal system vasculature development,BP,BMP4;BMP7;NOTCH1
5571,GO:0061440,0.241097199984088,0.93667074384568,3,6,kidney vasculature development,BP,BMP4;BMP7;NOTCH1
5933,GO:0072012,0.241097199984088,0.93667074384568,3,6,glomerulus vasculature development,BP,BMP4;BMP7;NOTCH1
5978,GO:0072109,0.241097199984088,0.93667074384568,3,6,glomerular mesangium development,BP,BMP4;BMP7;NOTCH1
2157,GO:0018130,0.241164604493578,0.835977364946362,26,76,heterocycle biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;PTS;NOTCH1;GUCY1B3
2205,GO:0019219,0.241362470959517,0.835662370935655,26,77,regulation of nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FSTL3;NOTCH1
1808,GO:0014706,0.241536283671844,0.879410119452147,8,21,striated muscle tissue development,BP,ACTN3;WNT2;FZD7;RBP4;FGF8;BMP4;BMP7;NOTCH1
2090,GO:0016790,0.242027690673361,0.967578172154086,2,3,thiolester hydrolase activity,MF,NUDT7;LYPLAL1
632,GO:0004620,0.242232039143857,0.967530544772927,2,3,phospholipase activity,MF,LYPLAL1;PLA2G16
1984,GO:0016298,0.242232039143857,0.967530544772927,2,3,lipase activity,MF,LYPLAL1;PLA2G16
1202,GO:0007219,0.242452712221918,0.917180154964677,4,9,Notch signaling pathway,BP,HEY1;JAG2;BMP7;NOTCH1
2255,GO:0019827,0.242612528971233,0.917100624356959,4,9,stem cell population maintenance,BP,WNT7A;FZD7;BMP7;NOTCH1
6387,GO:0098727,0.242612528971233,0.917100624356959,4,9,maintenance of cell number,BP,WNT7A;FZD7;BMP7;NOTCH1
2292,GO:0021532,0.243835568754153,0.967155615512668,2,3,neural tube patterning,BP,FGF8;BMP4
6440,GO:0099513,0.243892800361395,0.902964367327025,5,12,polymeric cytoskeletal fiber,CC,ACTN3;AMOT;PKP1;RAB3D;KRT10
4228,GO:0045666,0.245556255587242,0.915630608998891,4,9,positive regulation of neuron differentiation,BP,BMP6;WNT3;BMP4;BMP7
3653,GO:0042487,0.246352807001124,0.966562763327142,2,3,regulation of odontogenesis of dentin-containing tooth,BP,FGF8;BMP4
4986,GO:0051348,0.246517117123128,0.904279357869812,5,11,negative regulation of transferase activity,BP,DUSP5;BMP4;DEPTOR;PSMB10;BMP7
6790,GO:1903364,0.247291295852683,0.934127069152309,3,6,positive regulation of cellular protein catabolic process,BP,AXIN1;RNF144A;PSMB10
2705,GO:0031330,0.247514635840752,0.914647280209691,4,9,negative regulation of cellular catabolic process,BP,PIK3CG;PKP1;TBC1D14;PIK3CA
3537,GO:0040007,0.248098701785824,0.856729965223921,12,33,growth,BP,WNT7A;ACTN3;WNT3;WNT7B;WNT2;FZD7;RBP4;FGF8;BMP4;SPTBN4;PIK3CA;NOTCH1
1767,GO:0010975,0.248687912297194,0.914056108760804,4,9,regulation of neuron projection development,BP,WNT7A;WNT3;BMP7;LINGO1
6361,GO:0098542,0.249164881551486,0.918170218187829,4,8,defense response to other organism,BP,PMAIP1;CCL20;HRAS;FADD
4502,GO:0048018,0.249210237214434,0.933330501321858,3,6,receptor agonist activity,MF,WNT7A;WNT3;WNT2
4400,GO:0046622,0.24924229843383,0.933317158150182,3,6,positive regulation of organ growth,BP,WNT2;FGF8;NOTCH1
4260,GO:0045778,0.249591103288467,0.913599975558312,4,9,positive regulation of ossification,BP,BMP6;WNT7B;BMP4;BMP7
2860,GO:0032270,0.249823565601493,0.835301743774,21,60,positive regulation of cellular protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;RNF144A;PSMB10;FADD;BMP7;PIK3CA;FGF18
5486,GO:0061035,0.250005227458021,0.932999311237148,3,6,regulation of cartilage development,BP,BMP6;BMP4;FGF18
5524,GO:0061180,0.250887537491728,0.912943651802546,4,9,mammary gland epithelium development,BP,WNT3;WNT7B;WNT2;VDR
521,GO:0003337,0.252708843702866,0.965042429751133,2,3,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,BMP4;GDNF
6045,GO:0072283,0.252708843702866,0.965042429751133,2,3,metanephric renal vesicle morphogenesis,BP,BMP4;GDNF
5236,GO:0060231,0.253319909023386,0.931610952023748,3,6,mesenchymal to epithelial transition,BP,FZD7;BMP4;GDNF
1976,GO:0016247,0.253393087837454,0.964876758022911,2,3,channel regulator activity,MF,WNK4;TSPAN13
1152,GO:0007033,0.253635291664519,0.931478225102555,3,6,vacuole organization,BP,RAB39A;TBC1D14;RAB20
3688,GO:0042592,0.253945610601541,0.834700437811534,19,56,homeostatic process,BP,PIK3CG;CLDN18;BMP6;GJB6;WNT7B;PMAIP1;ACADVL;RBP4;RAB39A;VDR;WNK4;ABCG1;BMP4;RAB3D;RAB38;FADD;PIK3CA;HNF1A;RAB20
5139,GO:0055037,0.254286760504883,0.911213869283073,4,9,recycling endosome,CC,SYT5;FZD7;ABCG1;TBC1D14
6644,GO:1902106,0.254310920448421,0.93119352304302,3,6,negative regulation of leukocyte differentiation,BP,CLDN18;BMP4;FSTL3
1511,GO:0009605,0.254530581761956,0.826154779447527,25,74,response to external stimulus,BP,GJB2;PIK3CG;BMP6;WNT3;GJB6;ACAT1;PMAIP1;SPTBN5;SPTB;FGF8;VDR;AMOT;ARTN;CCL20;INHBB;HRAS;BMP4;GDNF;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1
2597,GO:0030833,0.254632026772942,0.931058036820444,3,6,regulation of actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
6638,GO:1902041,0.254904270425928,0.96450948052367,2,3,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD
6757,GO:1903050,0.255605012216932,0.930646807874876,3,6,regulation of proteolysis involved in cellular protein catabolic process,BP,AXIN1;RNF144A;PSMB10
5187,GO:0060054,0.255704702711054,0.964314170700247,2,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A;FZD7
698,GO:0005126,0.256158183417515,0.878365064239997,7,17,cytokine receptor binding,MF,BMP6;CNIH4;CCL20;INHBB;BMP4;FADD;BMP7
4949,GO:0051253,0.256166841686016,0.863019575661,9,25,negative regulation of RNA metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
7069,GO:2000112,0.256200758886391,0.827127891148088,23,68,regulation of cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
3964,GO:0044085,0.258447569333947,0.824129277765224,24,71,cellular component biogenesis,BP,TLE1;WNT7A;GJB2;ACTN3;HACL1;ACAT1;PMAIP1;KCNG2;AXIN1;SPTBN5;CDH1;RAB39A;SPTB;PKP1;HRAS;TBC1D14;RAB38;FADD;BMP7;SPTBN4;DECR1;HNF1A;NOTCH1;RAB20
2369,GO:0022612,0.260022292324236,0.893849145529916,5,12,gland morphogenesis,BP,FGF8;VDR;BMP4;BMP7;NOTCH1
283,GO:0002220,0.260683276148085,0.963087319905766,2,3,innate immune response activating cell surface receptor signaling pathway,BP,HRAS;PSMB10
285,GO:0002223,0.260683276148085,0.963087319905766,2,3,stimulatory C-type lectin receptor signaling pathway,BP,HRAS;PSMB10
3113,GO:0033157,0.261909465586001,0.892764096205154,5,12,regulation of intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4477,GO:0046983,0.26246649733274,0.83717299135813,15,42,protein dimerization activity,MF,GLDC;SYT5;ACTN3;BMP6;HEY1;ACAT1;AXIN1;RBP4;INHBB;ABCG1;GDNF;TPD52;HNF1A;PTS;NOTCH1
3020,GO:0032774,0.262467635618107,0.822118970670113,23,68,RNA biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
4611,GO:0048584,0.262625006908675,0.821992827348614,23,68,positive regulation of response to stimulus,BP,WNT7A;PIK3CG;BMP6;WNT3;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;ARTN;CCL20;DUSP5;INHBB;HRAS;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;NOTCH1
3859,GO:0043405,0.26308666004317,0.865167778438149,8,21,regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7;FGF18
4289,GO:0045892,0.26335600187256,0.863839892780755,8,22,negative regulation of transcription, DNA-templated,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
6803,GO:1903507,0.26335600187256,0.863839892780755,8,22,negative regulation of nucleic acid-templated transcription,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
4568,GO:0048468,0.263645099607462,0.818471732457431,25,76,cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT7B;AXIN1;POU3F1;WNT2;SPTBN5;CDH1;FZD7;SPTB;FGF8;ARTN;WNT5B;INHBB;HRAS;BMP4;GDNF;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1;LINGO1
4992,GO:0051384,0.263825930368555,0.90629071201432,4,9,response to glucocorticoid,BP,GJB2;BMP6;HEY1;WNT7B
1250,GO:0007422,0.263931959544534,0.927084872007515,3,6,peripheral nervous system development,BP,POU3F1;ARTN;GDNF
6689,GO:1902533,0.264578643384622,0.835568217053784,15,42,positive regulation of intracellular signal transduction,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;FGF8;CCL20;DUSP5;HRAS;BMP4;FADD;PIK3CA;FGF18;NOTCH1
1111,GO:0006913,0.264663296285529,0.891173793689296,5,12,nucleocytoplasmic transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
4904,GO:0051169,0.264663296285529,0.891173793689296,5,12,nuclear transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
3094,GO:0033036,0.264717746307517,0.816880575640309,26,77,macromolecule localization,BP,WNT7A;CLDN18;RABIF;BMP6;PMAIP1;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;AMOT;CNIH4;WNK4;INHBB;ABCG1;TSPAN15;BMP4;RAB3D;USE1;TBC1D14;RAB38;BMP7;SPTBN4;NOTCH1;RAB20
1149,GO:0007030,0.265268190529195,1,1,1,Golgi organization,BP,SPTBN5
2270,GO:0019894,0.265268190529195,1,1,1,kinesin binding,MF,SPTBN5
2818,GO:0032029,0.265268190529195,1,1,1,myosin tail binding,MF,SPTBN5
2819,GO:0032036,0.265268190529195,1,1,1,myosin heavy chain binding,MF,SPTBN5
3245,GO:0034452,0.265268190529195,1,1,1,dynactin binding,MF,SPTBN5
3930,GO:0043621,0.265268190529195,1,1,1,protein self-association,MF,SPTBN5
4189,GO:0045505,0.265268190529195,1,1,1,dynein intermediate chain binding,MF,SPTBN5
5223,GO:0060170,0.265268190529195,1,1,1,ciliary membrane,CC,SPTBN5
6323,GO:0097381,0.265268190529195,1,1,1,photoreceptor disc membrane,CC,SPTBN5
253,GO:0002052,0.265276287191838,1,1,1,positive regulation of neuroblast proliferation,BP,NOTCH1
278,GO:0002193,0.265276287191838,1,1,1,MAML1-RBP-Jkappa- ICN1 complex,CC,NOTCH1
316,GO:0002328,0.265276287191838,1,1,1,pro-B cell differentiation,BP,NOTCH1
334,GO:0002437,0.265276287191838,1,1,1,inflammatory response to antigenic stimulus,BP,NOTCH1
461,GO:0003160,0.265276287191838,1,1,1,endocardium morphogenesis,BP,NOTCH1
462,GO:0003161,0.265276287191838,1,1,1,cardiac conduction system development,BP,NOTCH1
463,GO:0003162,0.265276287191838,1,1,1,atrioventricular node development,BP,NOTCH1
464,GO:0003169,0.265276287191838,1,1,1,coronary vein morphogenesis,BP,NOTCH1
486,GO:0003207,0.265276287191838,1,1,1,cardiac chamber formation,BP,NOTCH1
489,GO:0003211,0.265276287191838,1,1,1,cardiac ventricle formation,BP,NOTCH1
491,GO:0003214,0.265276287191838,1,1,1,cardiac left ventricle morphogenesis,BP,NOTCH1
492,GO:0003215,0.265276287191838,1,1,1,cardiac right ventricle morphogenesis,BP,NOTCH1
493,GO:0003219,0.265276287191838,1,1,1,cardiac right ventricle formation,BP,NOTCH1
494,GO:0003222,0.265276287191838,1,1,1,ventricular trabecula myocardium morphogenesis,BP,NOTCH1
496,GO:0003229,0.265276287191838,1,1,1,ventricular cardiac muscle tissue development,BP,NOTCH1
499,GO:0003241,0.265276287191838,1,1,1,growth involved in heart morphogenesis,BP,NOTCH1
500,GO:0003256,0.265276287191838,1,1,1,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,NOTCH1
501,GO:0003264,0.265276287191838,1,1,1,regulation of cardioblast proliferation,BP,NOTCH1
502,GO:0003266,0.265276287191838,1,1,1,regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
503,GO:0003270,0.265276287191838,1,1,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,NOTCH1
505,GO:0003273,0.265276287191838,1,1,1,cell migration involved in endocardial cushion formation,BP,NOTCH1
1204,GO:0007221,0.265276287191838,1,1,1,positive regulation of transcription of Notch receptor target,BP,NOTCH1
1254,GO:0007440,0.265276287191838,1,1,1,foregut morphogenesis,BP,NOTCH1
1579,GO:0010002,0.265276287191838,1,1,1,cardioblast differentiation,BP,NOTCH1
1639,GO:0010596,0.265276287191838,1,1,1,negative regulation of endothelial cell migration,BP,NOTCH1
1650,GO:0010633,0.265276287191838,1,1,1,negative regulation of epithelial cell migration,BP,NOTCH1
1714,GO:0010830,0.265276287191838,1,1,1,regulation of myotube differentiation,BP,NOTCH1
1715,GO:0010832,0.265276287191838,1,1,1,negative regulation of myotube differentiation,BP,NOTCH1
1781,GO:0014009,0.265276287191838,1,1,1,glial cell proliferation,BP,NOTCH1
1783,GO:0014014,0.265276287191838,1,1,1,negative regulation of gliogenesis,BP,NOTCH1
1845,GO:0014902,0.265276287191838,1,1,1,myotube differentiation,BP,NOTCH1
2291,GO:0021515,0.265276287191838,1,1,1,cell differentiation in spinal cord,BP,NOTCH1
2490,GO:0030279,0.265276287191838,1,1,1,negative regulation of ossification,BP,NOTCH1
2942,GO:0032495,0.265276287191838,1,1,1,response to muramyl dipeptide,BP,NOTCH1
3902,GO:0043537,0.265276287191838,1,1,1,negative regulation of blood vessel endothelial cell migration,BP,NOTCH1
4116,GO:0045070,0.265276287191838,1,1,1,positive regulation of viral genome replication,BP,NOTCH1
4230,GO:0045668,0.265276287191838,1,1,1,negative regulation of osteoblast differentiation,BP,NOTCH1
4238,GO:0045686,0.265276287191838,1,1,1,negative regulation of glial cell differentiation,BP,NOTCH1
4295,GO:0045920,0.265276287191838,1,1,1,negative regulation of exocytosis,BP,NOTCH1
4312,GO:0045955,0.265276287191838,1,1,1,negative regulation of calcium ion-dependent exocytosis,BP,NOTCH1
4387,GO:0046532,0.265276287191838,1,1,1,regulation of photoreceptor cell differentiation,BP,NOTCH1
4388,GO:0046533,0.265276287191838,1,1,1,negative regulation of photoreceptor cell differentiation,BP,NOTCH1
4590,GO:0048524,0.265276287191838,1,1,1,positive regulation of viral process,BP,NOTCH1
4662,GO:0048713,0.265276287191838,1,1,1,regulation of oligodendrocyte differentiation,BP,NOTCH1
4663,GO:0048715,0.265276287191838,1,1,1,negative regulation of oligodendrocyte differentiation,BP,NOTCH1
5128,GO:0055010,0.265276287191838,1,1,1,ventricular cardiac muscle tissue morphogenesis,BP,NOTCH1
5240,GO:0060251,0.265276287191838,1,1,1,regulation of glial cell proliferation,BP,NOTCH1
5241,GO:0060253,0.265276287191838,1,1,1,negative regulation of glial cell proliferation,BP,NOTCH1
5284,GO:0060379,0.265276287191838,1,1,1,cardiac muscle cell myoblast differentiation,BP,NOTCH1
5343,GO:0060525,0.265276287191838,1,1,1,prostate glandular acinus development,BP,NOTCH1
5344,GO:0060528,0.265276287191838,1,1,1,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,NOTCH1
5412,GO:0060742,0.265276287191838,1,1,1,epithelial cell differentiation involved in prostate gland development,BP,NOTCH1
5423,GO:0060767,0.265276287191838,1,1,1,epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
5424,GO:0060768,0.265276287191838,1,1,1,regulation of epithelial cell proliferation involved in prostate gland development,BP,NOTCH1
5438,GO:0060843,0.265276287191838,1,1,1,venous endothelial cell differentiation,BP,NOTCH1
5455,GO:0060947,0.265276287191838,1,1,1,cardiac vascular smooth muscle cell differentiation,BP,NOTCH1
5456,GO:0060948,0.265276287191838,1,1,1,cardiac vascular smooth muscle cell development,BP,NOTCH1
5463,GO:0060973,0.265276287191838,1,1,1,cell migration involved in heart development,BP,NOTCH1
5465,GO:0060977,0.265276287191838,1,1,1,coronary vasculature morphogenesis,BP,NOTCH1
5466,GO:0060979,0.265276287191838,1,1,1,vasculogenesis involved in coronary vascular morphogenesis,BP,NOTCH1
5467,GO:0060982,0.265276287191838,1,1,1,coronary artery morphogenesis,BP,NOTCH1
5566,GO:0061419,0.265276287191838,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,NOTCH1
6098,GO:0072602,0.265276287191838,1,1,1,interleukin-4 secretion,BP,NOTCH1
6158,GO:0090049,0.265276287191838,1,1,1,regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
6159,GO:0090051,0.265276287191838,1,1,1,negative regulation of cell migration involved in sprouting angiogenesis,BP,NOTCH1
6273,GO:0097084,0.265276287191838,1,1,1,vascular smooth muscle cell development,BP,NOTCH1
6539,GO:1901201,0.265276287191838,1,1,1,regulation of extracellular matrix assembly,BP,NOTCH1
6563,GO:1901532,0.265276287191838,1,1,1,regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
6564,GO:1901533,0.265276287191838,1,1,1,negative regulation of hematopoietic progenitor cell differentiation,BP,NOTCH1
6660,GO:1902263,0.265276287191838,1,1,1,apoptotic process involved in embryonic digit morphogenesis,BP,NOTCH1
6716,GO:1902692,0.265276287191838,1,1,1,regulation of neuroblast proliferation,BP,NOTCH1
6778,GO:1903306,0.265276287191838,1,1,1,negative regulation of regulated secretory pathway,BP,NOTCH1
6843,GO:1903671,0.265276287191838,1,1,1,negative regulation of sprouting angiogenesis,BP,NOTCH1
6874,GO:1903902,0.265276287191838,1,1,1,positive regulation of viral life cycle,BP,NOTCH1
6974,GO:1905456,0.265276287191838,1,1,1,regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
6975,GO:1905457,0.265276287191838,1,1,1,negative regulation of lymphoid progenitor cell differentiation,BP,NOTCH1
7085,GO:2000179,0.265276287191838,1,1,1,positive regulation of neural precursor cell proliferation,BP,NOTCH1
7167,GO:2000737,0.265276287191838,1,1,1,negative regulation of stem cell differentiation,BP,NOTCH1
7188,GO:2000973,0.265276287191838,1,1,1,regulation of pro-B cell differentiation,BP,NOTCH1
7189,GO:2000974,0.265276287191838,1,1,1,negative regulation of pro-B cell differentiation,BP,NOTCH1
7198,GO:2001027,0.265276287191838,1,1,1,negative regulation of endothelial cell chemotaxis,BP,NOTCH1
1811,GO:0014731,0.265285015193196,1,1,1,spectrin-associated cytoskeleton,CC,SPTB
2684,GO:0031235,0.265285015193196,1,1,1,intrinsic component of the cytoplasmic side of the plasma membrane,CC,SPTB
3801,GO:0043204,0.26531036783781,1,1,1,perikaryon,CC,DRP2
526,GO:0003365,0.265316864367337,1,1,1,establishment of cell polarity involved in ameboidal cell migration,BP,AMOT
1336,GO:0008180,0.265316864367337,1,1,1,COP9 signalosome,CC,AMOT
3346,GO:0035329,0.265316864367337,1,1,1,hippo signaling,BP,AMOT
3898,GO:0043532,0.265316864367337,1,1,1,angiostatin binding,MF,AMOT
2749,GO:0031624,0.265348212333391,1,1,1,ubiquitin conjugating enzyme binding,MF,RNF144A
4019,GO:0044390,0.265348212333391,1,1,1,ubiquitin-like protein conjugating enzyme binding,MF,RNF144A
5587,GO:0061630,0.265348212333391,1,1,1,ubiquitin protein ligase activity,MF,RNF144A
5591,GO:0061659,0.265348212333391,1,1,1,ubiquitin-like protein ligase activity,MF,RNF144A
1145,GO:0007016,0.265354731217039,1,1,1,cytoskeletal anchoring at plasma membrane,BP,SPTBN4
1296,GO:0007628,0.265354731217039,1,1,1,adult walking behavior,BP,SPTBN4
1604,GO:0010459,0.265354731217039,1,1,1,negative regulation of heart rate,BP,SPTBN4
2050,GO:0016605,0.265354731217039,1,1,1,PML body,CC,SPTBN4
2337,GO:0021952,0.265354731217039,1,1,1,central nervous system projection neuron axonogenesis,BP,SPTBN4
2340,GO:0021955,0.265354731217039,1,1,1,central nervous system neuron axonogenesis,BP,SPTBN4
3123,GO:0033268,0.265354731217039,1,1,1,node of Ranvier,CC,SPTBN4
3124,GO:0033270,0.265354731217039,1,1,1,paranode region of axon,CC,SPTBN4
3673,GO:0042551,0.265354731217039,1,1,1,neuron maturation,BP,SPTBN4
3793,GO:0043194,0.265354731217039,1,1,1,axon initial segment,CC,SPTBN4
3800,GO:0043203,0.265354731217039,1,1,1,axon hillock,CC,SPTBN4
4137,GO:0045161,0.265354731217039,1,1,1,neuronal ion channel clustering,BP,SPTBN4
4138,GO:0045162,0.265354731217039,1,1,1,clustering of voltage-gated sodium channels,BP,SPTBN4
5744,GO:0070852,0.265354731217039,1,1,1,cell body fiber,CC,SPTBN4
6253,GO:0090659,0.265354731217039,1,1,1,walking behavior,BP,SPTBN4
2201,GO:0019215,0.265360783364432,1,1,1,intermediate filament binding,MF,PKP1
4125,GO:0045103,0.265360783364432,1,1,1,intermediate filament-based process,BP,PKP1
4126,GO:0045104,0.265360783364432,1,1,1,intermediate filament cytoskeleton organization,BP,PKP1
4127,GO:0045109,0.265360783364432,1,1,1,intermediate filament organization,BP,PKP1
4128,GO:0045110,0.265360783364432,1,1,1,intermediate filament bundle assembly,BP,PKP1
6455,GO:0101003,0.265360783364432,1,1,1,ficolin-1-rich granule membrane,CC,PKP1
370,GO:0002675,0.265362475470478,1,1,1,positive regulation of acute inflammatory response,BP,PIK3CG
371,GO:0002679,0.265362475470478,1,1,1,respiratory burst involved in defense response,BP,PIK3CG
865,GO:0005944,0.265362475470478,1,1,1,phosphatidylinositol 3-kinase complex, class IB,CC,PIK3CG
1741,GO:0010896,0.265362475470478,1,1,1,regulation of triglyceride catabolic process,BP,PIK3CG
1742,GO:0010897,0.265362475470478,1,1,1,negative regulation of triglyceride catabolic process,BP,PIK3CG
2855,GO:0032252,0.265362475470478,1,1,1,secretory granule localization,BP,PIK3CG
3398,GO:0035747,0.265362475470478,1,1,1,natural killer cell chemotaxis,BP,PIK3CG
4244,GO:0045730,0.265362475470478,1,1,1,respiratory burst,BP,PIK3CG
6108,GO:0072672,0.265362475470478,1,1,1,neutrophil extravasation,BP,PIK3CG
6208,GO:0090209,0.265362475470478,1,1,1,negative regulation of triglyceride metabolic process,BP,PIK3CG
6310,GO:0097284,0.265362475470478,1,1,1,hepatocyte apoptotic process,BP,PIK3CG
3656,GO:0042492,0.265377264373811,1,1,1,gamma-delta T cell differentiation,BP,JAG2
4114,GO:0045061,0.265377264373811,1,1,1,thymic T cell selection,BP,JAG2
4402,GO:0046629,0.265377264373811,1,1,1,gamma-delta T cell activation,BP,JAG2
7005,GO:1990134,0.265377264373811,1,1,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,JAG2
2709,GO:0031338,0.265384034249964,1,1,1,regulation of vesicle fusion,BP,TBC1D14
5923,GO:0071955,0.265384034249964,1,1,1,recycling endosome to Golgi transport,BP,TBC1D14
847,GO:0005901,0.2653873659821,1,1,1,caveola,CC,CDH1
1593,GO:0010226,0.2653873659821,1,1,1,response to lithium ion,BP,CDH1
2048,GO:0016600,0.2653873659821,1,1,1,flotillin complex,CC,CDH1
3380,GO:0035635,0.2653873659821,1,1,1,entry of bacterium into host cell,BP,CDH1
5790,GO:0071285,0.2653873659821,1,1,1,cellular response to lithium ion,BP,CDH1
5870,GO:0071680,0.2653873659821,1,1,1,response to indole-3-methanol,BP,CDH1
5871,GO:0071681,0.2653873659821,1,1,1,cellular response to indole-3-methanol,BP,CDH1
543,GO:0003707,0.265392736532542,1,1,1,steroid hormone receptor activity,MF,VDR
669,GO:0004879,0.265392736532542,1,1,1,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,VDR
751,GO:0005499,0.265392736532542,1,1,1,vitamin D binding,MF,VDR
1387,GO:0008434,0.265392736532542,1,1,1,calcitriol receptor activity,MF,VDR
1770,GO:0010979,0.265392736532542,1,1,1,regulation of vitamin D 24-hydroxylase activity,BP,VDR
1771,GO:0010980,0.265392736532542,1,1,1,positive regulation of vitamin D 24-hydroxylase activity,BP,VDR
2542,GO:0030522,0.265392736532542,1,1,1,intracellular receptor signaling pathway,BP,VDR
2558,GO:0030656,0.265392736532542,1,1,1,regulation of vitamin metabolic process,BP,VDR
2821,GO:0032052,0.265392736532542,1,1,1,bile acid binding,MF,VDR
3183,GO:0034105,0.265392736532542,1,1,1,positive regulation of tissue remodeling,BP,VDR
3328,GO:0035257,0.265392736532542,1,1,1,nuclear hormone receptor binding,MF,VDR
3528,GO:0038181,0.265392736532542,1,1,1,bile acid receptor activity,MF,VDR
3529,GO:0038183,0.265392736532542,1,1,1,bile acid signaling pathway,BP,VDR
3530,GO:0038186,0.265392736532542,1,1,1,lithocholic acid receptor activity,MF,VDR
3623,GO:0042362,0.265392736532542,1,1,1,fat-soluble vitamin biosynthetic process,BP,VDR
3625,GO:0042368,0.265392736532542,1,1,1,vitamin D biosynthetic process,BP,VDR
3734,GO:0042974,0.265392736532542,1,1,1,retinoic acid receptor binding,MF,VDR
4088,GO:0044798,0.265392736532542,1,1,1,nuclear transcription factor complex,CC,VDR
4475,GO:0046965,0.265392736532542,1,1,1,retinoid X receptor binding,MF,VDR
4825,GO:0050892,0.265392736532542,1,1,1,intestinal absorption,BP,VDR
5188,GO:0060056,0.265392736532542,1,1,1,mammary gland involution,BP,VDR
5189,GO:0060057,0.265392736532542,1,1,1,apoptotic process involved in mammary gland involution,BP,VDR
5190,GO:0060058,0.265392736532542,1,1,1,positive regulation of apoptotic process involved in mammary gland involution,BP,VDR
5356,GO:0060556,0.265392736532542,1,1,1,regulation of vitamin D biosynthetic process,BP,VDR
5357,GO:0060558,0.265392736532542,1,1,1,regulation of calcidiol 1-monooxygenase activity,BP,VDR
5705,GO:0070561,0.265392736532542,1,1,1,vitamin D receptor signaling pathway,BP,VDR
5714,GO:0070644,0.265392736532542,1,1,1,vitamin D response element binding,MF,VDR
5793,GO:0071305,0.265392736532542,1,1,1,cellular response to vitamin D,BP,VDR
6247,GO:0090575,0.265392736532542,1,1,1,RNA polymerase II transcription factor complex,CC,VDR
6359,GO:0098531,0.265392736532542,1,1,1,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,VDR
6642,GO:1902098,0.265392736532542,1,1,1,calcitriol binding,MF,VDR
6651,GO:1902121,0.265392736532542,1,1,1,lithocholic acid binding,MF,VDR
6661,GO:1902271,0.265392736532542,1,1,1,D3 vitamins binding,MF,VDR
6672,GO:1902339,0.265392736532542,1,1,1,positive regulation of apoptotic process involved in morphogenesis,BP,VDR
6808,GO:1903519,0.265392736532542,1,1,1,regulation of mammary gland involution,BP,VDR
6809,GO:1903521,0.265392736532542,1,1,1,positive regulation of mammary gland involution,BP,VDR
6919,GO:1904747,0.265392736532542,1,1,1,positive regulation of apoptotic process involved in development,BP,VDR
444,GO:0003096,0.265421388606086,1,1,1,renal sodium ion transport,BP,WNK4
1340,GO:0008200,0.265421388606086,1,1,1,ion channel inhibitor activity,MF,WNK4
1693,GO:0010766,0.265421388606086,1,1,1,negative regulation of sodium ion transport,BP,WNK4
1977,GO:0016248,0.265421388606086,1,1,1,channel inhibitor activity,MF,WNK4
2135,GO:0017081,0.265421388606086,1,1,1,chloride channel regulator activity,MF,WNK4
2265,GO:0019869,0.265421388606086,1,1,1,chloride channel inhibitor activity,MF,WNK4
2443,GO:0030157,0.265421388606086,1,1,1,pancreatic juice secretion,BP,WNK4
5326,GO:0060457,0.265421388606086,1,1,1,negative regulation of digestive system process,BP,WNK4
5659,GO:0070294,0.265421388606086,1,1,1,renal sodium ion absorption,BP,WNK4
5995,GO:0072156,0.265421388606086,1,1,1,distal tubule morphogenesis,BP,WNK4
6190,GO:0090186,0.265421388606086,1,1,1,regulation of pancreatic juice secretion,BP,WNK4
6191,GO:0090188,0.265421388606086,1,1,1,negative regulation of pancreatic juice secretion,BP,WNK4
192,GO:0001842,0.265433430981873,1,1,1,neural fold formation,BP,BMP7
2289,GO:0021502,0.265433430981873,1,1,1,neural fold elevation formation,BP,BMP7
3186,GO:0034114,0.265433430981873,1,1,1,regulation of heterotypic cell-cell adhesion,BP,BMP7
3187,GO:0034116,0.265433430981873,1,1,1,positive regulation of heterotypic cell-cell adhesion,BP,BMP7
3473,GO:0036118,0.265433430981873,1,1,1,hyaluranon cable assembly,BP,BMP7
3620,GO:0042347,0.265433430981873,1,1,1,negative regulation of NF-kappaB import into nucleus,BP,BMP7
3742,GO:0042992,0.265433430981873,1,1,1,negative regulation of transcription factor import into nucleus,BP,BMP7
5693,GO:0070486,0.265433430981873,1,1,1,leukocyte aggregation,BP,BMP7
5694,GO:0070487,0.265433430981873,1,1,1,monocyte aggregation,BP,BMP7
5941,GO:0072038,0.265433430981873,1,1,1,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,BMP7
5942,GO:0072039,0.265433430981873,1,1,1,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5943,GO:0072040,0.265433430981873,1,1,1,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
5956,GO:0072076,0.265433430981873,1,1,1,nephrogenic mesenchyme development,BP,BMP7
5985,GO:0072131,0.265433430981873,1,1,1,kidney mesenchyme morphogenesis,BP,BMP7
5987,GO:0072133,0.265433430981873,1,1,1,metanephric mesenchyme morphogenesis,BP,BMP7
5988,GO:0072134,0.265433430981873,1,1,1,nephrogenic mesenchyme morphogenesis,BP,BMP7
5989,GO:0072135,0.265433430981873,1,1,1,kidney mesenchymal cell proliferation,BP,BMP7
5990,GO:0072136,0.265433430981873,1,1,1,metanephric mesenchymal cell proliferation involved in metanephros development,BP,BMP7
6285,GO:0097152,0.265433430981873,1,1,1,mesenchymal cell apoptotic process,BP,BMP7
6465,GO:1900006,0.265433430981873,1,1,1,positive regulation of dendrite development,BP,BMP7
6476,GO:1900104,0.265433430981873,1,1,1,regulation of hyaluranon cable assembly,BP,BMP7
6477,GO:1900106,0.265433430981873,1,1,1,positive regulation of hyaluranon cable assembly,BP,BMP7
6535,GO:1901145,0.265433430981873,1,1,1,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,BMP7
6671,GO:1902338,0.265433430981873,1,1,1,negative regulation of apoptotic process involved in morphogenesis,BP,BMP7
6679,GO:1902455,0.265433430981873,1,1,1,negative regulation of stem cell population maintenance,BP,BMP7
6871,GO:1903867,0.265433430981873,1,1,1,extraembryonic membrane development,BP,BMP7
6912,GO:1904672,0.265433430981873,1,1,1,regulation of somatic stem cell population maintenance,BP,BMP7
6913,GO:1904673,0.265433430981873,1,1,1,negative regulation of somatic stem cell population maintenance,BP,BMP7
6918,GO:1904746,0.265433430981873,1,1,1,negative regulation of apoptotic process involved in development,BP,BMP7
6953,GO:1905069,0.265433430981873,1,1,1,allantois development,BP,BMP7
7053,GO:2000036,0.265433430981873,1,1,1,regulation of stem cell population maintenance,BP,BMP7
7202,GO:2001053,0.265433430981873,1,1,1,regulation of mesenchymal cell apoptotic process,BP,BMP7
7203,GO:2001054,0.265433430981873,1,1,1,negative regulation of mesenchymal cell apoptotic process,BP,BMP7
1995,GO:0016332,0.265491189803234,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP,WNT7B
2896,GO:0032364,0.265491189803234,1,1,1,oxygen homeostasis,BP,WNT7B
3135,GO:0033483,0.265491189803234,1,1,1,gas homeostasis,BP,WNT7B
5330,GO:0060482,0.265491189803234,1,1,1,lobar bronchus development,BP,WNT7B
5345,GO:0060534,0.265491189803234,1,1,1,trachea cartilage development,BP,WNT7B
5346,GO:0060535,0.265491189803234,1,1,1,trachea cartilage morphogenesis,BP,WNT7B
5347,GO:0060536,0.265491189803234,1,1,1,cartilage morphogenesis,BP,WNT7B
5948,GO:0072053,0.265491189803234,1,1,1,renal inner medulla development,BP,WNT7B
5949,GO:0072054,0.265491189803234,1,1,1,renal outer medulla development,BP,WNT7B
5950,GO:0072060,0.265491189803234,1,1,1,outer medullary collecting duct development,BP,WNT7B
5951,GO:0072061,0.265491189803234,1,1,1,inner medullary collecting duct development,BP,WNT7B
6035,GO:0072236,0.265491189803234,1,1,1,metanephric loop of Henle development,BP,WNT7B
147,GO:0001705,0.265565687068566,1,1,1,ectoderm formation,BP,FZD7
153,GO:0001712,0.265565687068566,1,1,1,ectodermal cell fate commitment,BP,FZD7
154,GO:0001715,0.265565687068566,1,1,1,ectodermal cell fate specification,BP,FZD7
1242,GO:0007398,0.265565687068566,1,1,1,ectoderm development,BP,FZD7
1577,GO:0009996,0.265565687068566,1,1,1,negative regulation of cell fate specification,BP,FZD7
1603,GO:0010454,0.265565687068566,1,1,1,negative regulation of cell fate commitment,BP,FZD7
1612,GO:0010470,0.265565687068566,1,1,1,regulation of gastrulation,BP,FZD7
1670,GO:0010668,0.265565687068566,1,1,1,ectodermal cell differentiation,BP,FZD7
3353,GO:0035411,0.265565687068566,1,1,1,catenin import into nucleus,BP,FZD7
3354,GO:0035412,0.265565687068566,1,1,1,regulation of catenin import into nucleus,BP,FZD7
3701,GO:0042659,0.265565687068566,1,1,1,regulation of cell fate specification,BP,FZD7
3702,GO:0042665,0.265565687068566,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
3703,GO:0042666,0.265565687068566,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
7115,GO:2000383,0.265565687068566,1,1,1,regulation of ectoderm development,BP,FZD7
7116,GO:2000384,0.265565687068566,1,1,1,negative regulation of ectoderm development,BP,FZD7
7139,GO:2000542,0.265565687068566,1,1,1,negative regulation of gastrulation,BP,FZD7
602,GO:0004375,0.26559760642964,1,1,1,glycine dehydrogenase (decarboxylating) activity,MF,GLDC
867,GO:0005960,0.26559760642964,1,1,1,glycine cleavage complex,CC,GLDC
990,GO:0006544,0.26559760642964,1,1,1,glycine metabolic process,BP,GLDC
991,GO:0006546,0.26559760642964,1,1,1,glycine catabolic process,BP,GLDC
1433,GO:0009069,0.26559760642964,1,1,1,serine family amino acid metabolic process,BP,GLDC
1434,GO:0009071,0.26559760642964,1,1,1,serine family amino acid catabolic process,BP,GLDC
2045,GO:0016594,0.26559760642964,1,1,1,glycine binding,MF,GLDC
2058,GO:0016638,0.26559760642964,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,GLDC
2059,GO:0016642,0.26559760642964,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,GLDC
2232,GO:0019464,0.26559760642964,1,1,1,glycine decarboxylation via glycine cleavage system,BP,GLDC
7009,GO:1990204,0.26559760642964,1,1,1,oxidoreductase complex,CC,GLDC
556,GO:0003841,0.265624605984523,1,1,1,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
2009,GO:0016411,0.265624605984523,1,1,1,acylglycerol O-acyltransferase activity,MF,MBOAT2
3586,GO:0042171,0.265624605984523,1,1,1,lysophosphatidic acid acyltransferase activity,MF,MBOAT2
4483,GO:0047144,0.265624605984523,1,1,1,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2
5865,GO:0071617,0.265624605984523,1,1,1,lysophospholipid acyltransferase activity,MF,MBOAT2
935,GO:0006304,0.265846702101013,1,1,1,DNA modification,BP,PIK3CA
936,GO:0006305,0.265846702101013,1,1,1,DNA alkylation,BP,PIK3CA
937,GO:0006306,0.265846702101013,1,1,1,DNA methylation,BP,PIK3CA
3506,GO:0038028,0.265846702101013,1,1,1,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,PIK3CA
3954,GO:0044028,0.265846702101013,1,1,1,DNA hypomethylation,BP,PIK3CA
3955,GO:0044029,0.265846702101013,1,1,1,hypomethylation of CpG island,BP,PIK3CA
3956,GO:0044030,0.265846702101013,1,1,1,regulation of DNA methylation,BP,PIK3CA
4073,GO:0044728,0.265846702101013,1,1,1,DNA methylation or demethylation,BP,PIK3CA
5854,GO:0071514,0.265846702101013,1,1,1,genetic imprinting,BP,PIK3CA
7154,GO:2000653,0.265846702101013,1,1,1,regulation of genetic imprinting,BP,PIK3CA
6601,GO:1901700,0.266331472556874,0.821773539696735,21,62,response to oxygen-containing compound,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;GJB6;WNT7B;WNT2;CDH1;FZD7;RBP4;VDR;WNT5B;CCL20;INHBB;FADD;BMP7;PIK3CA;NOTCH1;GUCY1B3
6966,GO:1905332,0.266363034592763,0.926030555783703,3,6,positive regulation of morphogenesis of an epithelium,BP,WNT2;BMP4;GDNF
4032,GO:0044429,0.266507594392391,0.84401766626606,12,32,mitochondrial part,CC,GLDC;ACAT1;PMAIP1;MRPL14;ACADVL;PUS1;TSFM;ECI1;ETFDH;DECR1;CPT1C;ETFB
5362,GO:0060571,0.267240791569598,0.925648286107112,3,6,morphogenesis of an epithelial fold,BP,WNT2;BMP4;BMP7
5363,GO:0060572,0.267240791569598,0.925648286107112,3,6,morphogenesis of an epithelial bud,BP,WNT2;BMP4;BMP7
159,GO:0001743,0.267939530267314,1,1,1,optic placode formation,BP,AXIN1
950,GO:0006368,0.267939530267314,1,1,1,transcription elongation from RNA polymerase II promoter,BP,AXIN1
2321,GO:0021797,0.267939530267314,1,1,1,forebrain anterior/posterior pattern specification,BP,AXIN1
2326,GO:0021877,0.267939530267314,1,1,1,forebrain neuron fate commitment,BP,AXIN1
2328,GO:0021881,0.267939530267314,1,1,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,AXIN1
2333,GO:0021898,0.267939530267314,1,1,1,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,AXIN1
2346,GO:0021999,0.267939530267314,1,1,1,neural plate anterior/posterior regionalization,BP,AXIN1
2444,GO:0030159,0.267939530267314,1,1,1,receptor signaling complex scaffold activity,MF,AXIN1
2616,GO:0030877,0.267939530267314,1,1,1,beta-catenin destruction complex,CC,AXIN1
2626,GO:0030910,0.267939530267314,1,1,1,olfactory placode formation,BP,AXIN1
3024,GO:0032785,0.267939530267314,1,1,1,negative regulation of DNA-templated transcription, elongation,BP,AXIN1
3069,GO:0032947,0.267939530267314,1,1,1,protein complex scaffold,MF,AXIN1
3197,GO:0034243,0.267939530267314,1,1,1,regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
3198,GO:0034244,0.267939530267314,1,1,1,negative regulation of transcription elongation from RNA polymerase II promoter,BP,AXIN1
4554,GO:0048318,0.267939530267314,1,1,1,axial mesoderm development,BP,AXIN1
4555,GO:0048319,0.267939530267314,1,1,1,axial mesoderm morphogenesis,BP,AXIN1
4556,GO:0048320,0.267939530267314,1,1,1,axial mesoderm formation,BP,AXIN1
5426,GO:0060788,0.267939530267314,1,1,1,ectodermal placode formation,BP,AXIN1
5430,GO:0060823,0.267939530267314,1,1,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,AXIN1
5447,GO:0060896,0.267939530267314,1,1,1,neural plate pattern specification,BP,AXIN1
5448,GO:0060897,0.267939530267314,1,1,1,neural plate regionalization,BP,AXIN1
5606,GO:0070016,0.267939530267314,1,1,1,armadillo repeat domain binding,MF,AXIN1
5686,GO:0070411,0.267939530267314,1,1,1,I-SMAD binding,MF,AXIN1
5874,GO:0071696,0.267939530267314,1,1,1,ectodermal placode development,BP,AXIN1
5875,GO:0071697,0.267939530267314,1,1,1,ectodermal placode morphogenesis,BP,AXIN1
5876,GO:0071698,0.267939530267314,1,1,1,olfactory placode development,BP,AXIN1
5877,GO:0071699,0.267939530267314,1,1,1,olfactory placode morphogenesis,BP,AXIN1
6930,GO:1904885,0.267939530267314,1,1,1,beta-catenin destruction complex assembly,BP,AXIN1
6931,GO:1904886,0.267939530267314,1,1,1,beta-catenin destruction complex disassembly,BP,AXIN1
795,GO:0005739,0.267987485337696,0.819989038887727,22,61,mitochondrion,CC,GLDC;ACAT1;MSRA;PMAIP1;MAPK12;MRPL14;ACADVL;TMEM160;PUS1;TSFM;ABCG1;RAB3D;ECI1;BOLA1;ETFDH;RAB38;CCDC51;NUDT6;DECR1;PTS;CPT1C;ETFB
642,GO:0004697,0.268008394136455,1,1,1,protein kinase C activity,MF,PKN3
3182,GO:0034104,0.268442257388568,1,1,1,negative regulation of tissue remodeling,BP,CLDN18
3463,GO:0036035,0.268442257388568,1,1,1,osteoclast development,BP,CLDN18
4261,GO:0045779,0.268442257388568,1,1,1,negative regulation of bone resorption,BP,CLDN18
4438,GO:0046851,0.268442257388568,1,1,1,negative regulation of bone remodeling,BP,CLDN18
5903,GO:0071847,0.268442257388568,1,1,1,TNFSF11-mediated signaling pathway,BP,CLDN18
7215,GO:2001204,0.268442257388568,1,1,1,regulation of osteoclast development,BP,CLDN18
7216,GO:2001205,0.268442257388568,1,1,1,negative regulation of osteoclast development,BP,CLDN18
6192,GO:0090189,0.269023535340755,0.960985275397019,2,3,regulation of branching involved in ureteric bud morphogenesis,BP,BMP4;GDNF
6925,GO:1904837,0.269386242486388,1,1,1,beta-catenin-TCF complex assembly,BP,TLE1
1214,GO:0007263,0.269752409129913,1,1,1,nitric oxide mediated signal transduction,BP,GUCY1B3
2283,GO:0019934,0.269752409129913,1,1,1,cGMP-mediated signaling,BP,GUCY1B3
2284,GO:0019935,0.269752409129913,1,1,1,cyclic-nucleotide-mediated signaling,BP,GUCY1B3
3510,GO:0038060,0.269752409129913,1,1,1,nitric oxide-cGMP-mediated signaling pathway,BP,GUCY1B3
5884,GO:0071731,0.269752409129913,1,1,1,response to nitric oxide,BP,GUCY1B3
5885,GO:0071732,0.269752409129913,1,1,1,cellular response to nitric oxide,BP,GUCY1B3
6652,GO:1902170,0.269752409129913,1,1,1,cellular response to reactive nitrogen species,BP,GUCY1B3
3376,GO:0035623,0.269998186928678,1,1,1,renal glucose absorption,BP,HNF1A
5243,GO:0060260,0.269998186928678,1,1,1,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
5244,GO:0060261,0.269998186928678,1,1,1,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
7078,GO:2000142,0.269998186928678,1,1,1,regulation of DNA-templated transcription, initiation,BP,HNF1A
7079,GO:2000144,0.269998186928678,1,1,1,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
2282,GO:0019932,0.270228882320122,0.924340576329755,3,6,second-messenger-mediated signaling,BP,ACTN3;CCL20;GUCY1B3
2574,GO:0030728,0.270669966674301,1,1,1,ovulation,BP,INHBB
2864,GO:0032274,0.270669966674301,1,1,1,gonadotropin secretion,BP,INHBB
2865,GO:0032276,0.270669966674301,1,1,1,regulation of gonadotropin secretion,BP,INHBB
2866,GO:0032277,0.270669966674301,1,1,1,negative regulation of gonadotropin secretion,BP,INHBB
2867,GO:0032278,0.270669966674301,1,1,1,positive regulation of gonadotropin secretion,BP,INHBB
2968,GO:0032605,0.270669966674301,1,1,1,hepatocyte growth factor production,BP,INHBB
2983,GO:0032646,0.270669966674301,1,1,1,regulation of hepatocyte growth factor production,BP,INHBB
2996,GO:0032686,0.270669966674301,1,1,1,negative regulation of hepatocyte growth factor production,BP,INHBB
4006,GO:0044320,0.270669966674301,1,1,1,cellular response to leptin stimulus,BP,INHBB
4413,GO:0046676,0.270669966674301,1,1,1,negative regulation of insulin secretion,BP,INHBB
4424,GO:0046789,0.270669966674301,1,1,1,host cell surface receptor binding,MF,INHBB
4426,GO:0046812,0.270669966674301,1,1,1,host cell surface binding,MF,INHBB
4447,GO:0046880,0.270669966674301,1,1,1,regulation of follicle-stimulating hormone secretion,BP,INHBB
4448,GO:0046881,0.270669966674301,1,1,1,positive regulation of follicle-stimulating hormone secretion,BP,INHBB
4449,GO:0046882,0.270669966674301,1,1,1,negative regulation of follicle-stimulating hormone secretion,BP,INHBB
4451,GO:0046884,0.270669966674301,1,1,1,follicle-stimulating hormone secretion,BP,INHBB
4525,GO:0048175,0.270669966674301,1,1,1,hepatocyte growth factor biosynthetic process,BP,INHBB
4526,GO:0048176,0.270669966674301,1,1,1,regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
4527,GO:0048178,0.270669966674301,1,1,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,INHBB
5247,GO:0060278,0.270669966674301,1,1,1,regulation of ovulation,BP,INHBB
5248,GO:0060279,0.270669966674301,1,1,1,positive regulation of ovulation,BP,INHBB
6215,GO:0090278,0.270669966674301,1,1,1,negative regulation of peptide hormone secretion,BP,INHBB
2722,GO:0031399,0.271280411030201,0.821377446707238,19,55,regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;DEPTOR;PSMB10;BMP7;SPTBN4;PIK3CA;FGF18
2418,GO:0030054,0.271421441731927,0.818777059694099,20,61,cell junction,CC,TJP3;GJB2;SYT5;ACTN3;CLDN18;GJA3;GJB6;RRAS2;CDH1;AMOT;DSG3;WNK4;PKP1;CLDN15;SPTBN4;DRP2;NOTCH1;RND3;CPT1C;ZFYVE21
46,GO:0000287,0.271553982878355,0.92375750256631,3,6,magnesium ion binding,MF,HACL1;MAPK12;NUDT7
417,GO:0002831,0.27245044255971,1,1,1,regulation of response to biotic stimulus,BP,BMP6
418,GO:0002833,0.27245044255971,1,1,1,positive regulation of response to biotic stimulus,BP,BMP6
2761,GO:0031664,0.27245044255971,1,1,1,regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2762,GO:0031666,0.27245044255971,1,1,1,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,BMP6
2817,GO:0032026,0.27245044255971,1,1,1,response to magnesium ion,BP,BMP6
3437,GO:0035929,0.27245044255971,1,1,1,steroid hormone secretion,BP,BMP6
3438,GO:0035930,0.27245044255971,1,1,1,corticosteroid hormone secretion,BP,BMP6
3439,GO:0035931,0.27245044255971,1,1,1,mineralocorticoid secretion,BP,BMP6
3440,GO:0035932,0.27245044255971,1,1,1,aldosterone secretion,BP,BMP6
5369,GO:0060586,0.27245044255971,1,1,1,multicellular organismal iron ion homeostasis,BP,BMP6
7180,GO:2000831,0.27245044255971,1,1,1,regulation of steroid hormone secretion,BP,BMP6
7181,GO:2000833,0.27245044255971,1,1,1,positive regulation of steroid hormone secretion,BP,BMP6
7182,GO:2000846,0.27245044255971,1,1,1,regulation of corticosteroid hormone secretion,BP,BMP6
7183,GO:2000848,0.27245044255971,1,1,1,positive regulation of corticosteroid hormone secretion,BP,BMP6
7184,GO:2000855,0.27245044255971,1,1,1,regulation of mineralocorticoid secretion,BP,BMP6
7185,GO:2000857,0.27245044255971,1,1,1,positive regulation of mineralocorticoid secretion,BP,BMP6
7186,GO:2000858,0.27245044255971,1,1,1,regulation of aldosterone secretion,BP,BMP6
7187,GO:2000860,0.27245044255971,1,1,1,positive regulation of aldosterone secretion,BP,BMP6
3539,GO:0040011,0.272622994762396,0.815070821744878,22,66,locomotion,BP,WNT7A;PIK3CG;WNT3;JAG2;RRAS2;SPTBN5;SPTB;FGF8;AMOT;ARTN;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;FADD;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1
4908,GO:0051173,0.273407676669599,0.821259025971255,18,53,positive regulation of nitrogen compound metabolic process,BP,WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
1067,GO:0006796,0.273836999621953,0.802817134446786,34,102,phosphate-containing compound metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;ACAT1;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;NUDT7;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;BMP7;SPTBN4;PIK3CA;PLA2G16;FGF18;ZFYVE21;GUCY1B3;DPM3
6114,GO:0080090,0.274929963359721,0.799062945874583,39,120,regulation of primary metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;RNF144A;GDNF;DEPTOR;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1;PM20D2
955,GO:0006399,0.275008714235345,0.959440403070999,2,3,tRNA metabolic process,BP,PUS1;LAGE3
1306,GO:0008033,0.275008714235345,0.959440403070999,2,3,tRNA processing,BP,PUS1;LAGE3
5920,GO:0071901,0.275235568416013,0.92212733306251,3,6,negative regulation of protein serine/threonine kinase activity,BP,DUSP5;BMP4;BMP7
773,GO:0005548,0.275264182539826,1,1,1,phospholipid transporter activity,MF,ABCG1
1400,GO:0008565,0.275264182539826,1,1,1,protein transporter activity,MF,ABCG1
1526,GO:0009720,0.275264182539826,1,1,1,detection of hormone stimulus,BP,ABCG1
1528,GO:0009726,0.275264182539826,1,1,1,detection of endogenous stimulus,BP,ABCG1
1684,GO:0010742,0.275264182539826,1,1,1,macrophage derived foam cell differentiation,BP,ABCG1
1685,GO:0010743,0.275264182539826,1,1,1,regulation of macrophage derived foam cell differentiation,BP,ABCG1
1686,GO:0010745,0.275264182539826,1,1,1,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
1728,GO:0010874,0.275264182539826,1,1,1,regulation of cholesterol efflux,BP,ABCG1
1729,GO:0010875,0.275264182539826,1,1,1,positive regulation of cholesterol efflux,BP,ABCG1
1731,GO:0010878,0.275264182539826,1,1,1,cholesterol storage,BP,ABCG1
1735,GO:0010883,0.275264182539826,1,1,1,regulation of lipid storage,BP,ABCG1
1736,GO:0010885,0.275264182539826,1,1,1,regulation of cholesterol storage,BP,ABCG1
1737,GO:0010887,0.275264182539826,1,1,1,negative regulation of cholesterol storage,BP,ABCG1
1738,GO:0010888,0.275264182539826,1,1,1,negative regulation of lipid storage,BP,ABCG1
1871,GO:0015197,0.275264182539826,1,1,1,peptide transporter activity,MF,ABCG1
1884,GO:0015399,0.275264182539826,1,1,1,primary active transmembrane transporter activity,MF,ABCG1
1885,GO:0015405,0.275264182539826,1,1,1,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
2098,GO:0016820,0.275264182539826,1,1,1,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
2235,GO:0019534,0.275264182539826,1,1,1,toxin transporter activity,MF,ABCG1
2905,GO:0032373,0.275264182539826,1,1,1,positive regulation of sterol transport,BP,ABCG1
2908,GO:0032376,0.275264182539826,1,1,1,positive regulation of cholesterol transport,BP,ABCG1
3176,GO:0034040,0.275264182539826,1,1,1,lipid-transporting ATPase activity,MF,ABCG1
3177,GO:0034041,0.275264182539826,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
3223,GO:0034374,0.275264182539826,1,1,1,low-density lipoprotein particle remodeling,BP,ABCG1
3240,GO:0034436,0.275264182539826,1,1,1,glycoprotein transport,BP,ABCG1
3241,GO:0034437,0.275264182539826,1,1,1,glycoprotein transporter activity,MF,ABCG1
3692,GO:0042626,0.275264182539826,1,1,1,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
3738,GO:0042982,0.275264182539826,1,1,1,amyloid precursor protein metabolic process,BP,ABCG1
3739,GO:0042987,0.275264182539826,1,1,1,amyloid precursor protein catabolic process,BP,ABCG1
3886,GO:0043492,0.275264182539826,1,1,1,ATPase activity, coupled to movement of substances,MF,ABCG1
3941,GO:0043691,0.275264182539826,1,1,1,reverse cholesterol transport,BP,ABCG1
4191,GO:0045542,0.275264182539826,1,1,1,positive regulation of cholesterol biosynthetic process,BP,ABCG1
5160,GO:0055094,0.275264182539826,1,1,1,response to lipoprotein particle,BP,ABCG1
5161,GO:0055099,0.275264182539826,1,1,1,response to high density lipoprotein particle,BP,ABCG1
6163,GO:0090077,0.275264182539826,1,1,1,foam cell differentiation,BP,ABCG1
6205,GO:0090205,0.275264182539826,1,1,1,positive regulation of cholesterol metabolic process,BP,ABCG1
6561,GO:1901505,0.275264182539826,1,1,1,carbohydrate derivative transporter activity,MF,ABCG1
6580,GO:1901618,0.275264182539826,1,1,1,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
6739,GO:1902932,0.275264182539826,1,1,1,positive regulation of alcohol biosynthetic process,BP,ABCG1
166,GO:0001763,0.275543094057656,0.864162466209532,7,18,morphogenesis of a branching structure,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
4675,GO:0048754,0.275543094057656,0.864162466209532,7,18,branching morphogenesis of an epithelial tube,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
5513,GO:0061138,0.275543094057656,0.864162466209532,7,18,morphogenesis of a branching epithelium,BP,WNT2;FGF8;VDR;BMP4;GDNF;BMP7;NOTCH1
5103,GO:0051960,0.275580042961776,0.855501294186332,8,22,regulation of nervous system development,BP,WNT7A;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1;LINGO1
5938,GO:0072028,0.276388233860691,0.88431046167215,5,12,nephron morphogenesis,BP,FGF8;WNK4;BMP4;GDNF;BMP7
95,GO:0001105,0.276948552387976,1,1,1,RNA polymerase II transcription coactivator activity,MF,POU3F1
4943,GO:0051247,0.277681193918452,0.812934386630467,21,61,positive regulation of protein metabolic process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;PMAIP1;AXIN1;MAPK12;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;RNF144A;PSMB10;FADD;BMP7;PIK3CA;FGF18
268,GO:0002082,0.278472871309985,1,1,1,regulation of oxidative phosphorylation,BP,ACTN3
428,GO:0003009,0.278472871309985,1,1,1,skeletal muscle contraction,BP,ACTN3
895,GO:0006089,0.278472871309985,1,1,1,lactate metabolic process,BP,ACTN3
910,GO:0006110,0.278472871309985,1,1,1,regulation of glycolytic process,BP,ACTN3
913,GO:0006113,0.278472871309985,1,1,1,fermentation,BP,ACTN3
914,GO:0006119,0.278472871309985,1,1,1,oxidative phosphorylation,BP,ACTN3
1674,GO:0010677,0.278472871309985,1,1,1,negative regulation of cellular carbohydrate metabolic process,BP,ACTN3
1810,GO:0014728,0.278472871309985,1,1,1,regulation of the force of skeletal muscle contraction,BP,ACTN3
1812,GO:0014732,0.278472871309985,1,1,1,skeletal muscle atrophy,BP,ACTN3
1813,GO:0014733,0.278472871309985,1,1,1,regulation of skeletal muscle adaptation,BP,ACTN3
1822,GO:0014819,0.278472871309985,1,1,1,regulation of skeletal muscle contraction,BP,ACTN3
1830,GO:0014854,0.278472871309985,1,1,1,response to inactivity,BP,ACTN3
1832,GO:0014862,0.278472871309985,1,1,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,ACTN3
1834,GO:0014870,0.278472871309985,1,1,1,response to muscle inactivity,BP,ACTN3
1837,GO:0014877,0.278472871309985,1,1,1,response to muscle inactivity involved in regulation of muscle adaptation,BP,ACTN3
1838,GO:0014883,0.278472871309985,1,1,1,transition between fast and slow fiber,BP,ACTN3
1839,GO:0014888,0.278472871309985,1,1,1,striated muscle adaptation,BP,ACTN3
1841,GO:0014891,0.278472871309985,1,1,1,striated muscle atrophy,BP,ACTN3
1842,GO:0014894,0.278472871309985,1,1,1,response to denervation involved in regulation of muscle adaptation,BP,ACTN3
2238,GO:0019659,0.278472871309985,1,1,1,glucose catabolic process to lactate,BP,ACTN3
2239,GO:0019660,0.278472871309985,1,1,1,glycolytic fermentation,BP,ACTN3
2240,GO:0019661,0.278472871309985,1,1,1,glucose catabolic process to lactate via pyruvate,BP,ACTN3
3117,GO:0033173,0.278472871309985,1,1,1,calcineurin-NFAT signaling cascade,BP,ACTN3
3874,GO:0043465,0.278472871309985,1,1,1,regulation of fermentation,BP,ACTN3
3876,GO:0043470,0.278472871309985,1,1,1,regulation of carbohydrate catabolic process,BP,ACTN3
3889,GO:0043501,0.278472871309985,1,1,1,skeletal muscle adaptation,BP,ACTN3
4269,GO:0045820,0.278472871309985,1,1,1,negative regulation of glycolytic process,BP,ACTN3
4293,GO:0045912,0.278472871309985,1,1,1,negative regulation of carbohydrate metabolic process,BP,ACTN3
4818,GO:0050879,0.278472871309985,1,1,1,multicellular organismal movement,BP,ACTN3
4820,GO:0050881,0.278472871309985,1,1,1,musculoskeletal movement,BP,ACTN3
4919,GO:0051194,0.278472871309985,1,1,1,positive regulation of cofactor metabolic process,BP,ACTN3
4920,GO:0051195,0.278472871309985,1,1,1,negative regulation of cofactor metabolic process,BP,ACTN3
4922,GO:0051197,0.278472871309985,1,1,1,positive regulation of coenzyme metabolic process,BP,ACTN3
4923,GO:0051198,0.278472871309985,1,1,1,negative regulation of coenzyme metabolic process,BP,ACTN3
5749,GO:0070884,0.278472871309985,1,1,1,regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
5750,GO:0070885,0.278472871309985,1,1,1,negative regulation of calcineurin-NFAT signaling cascade,BP,ACTN3
6227,GO:0090324,0.278472871309985,1,1,1,negative regulation of oxidative phosphorylation,BP,ACTN3
6350,GO:0097720,0.278472871309985,1,1,1,calcineurin-mediated signaling,BP,ACTN3
6714,GO:1902688,0.278472871309985,1,1,1,regulation of NAD metabolic process,BP,ACTN3
6715,GO:1902690,0.278472871309985,1,1,1,positive regulation of NAD metabolic process,BP,ACTN3
6827,GO:1903578,0.278472871309985,1,1,1,regulation of ATP metabolic process,BP,ACTN3
6828,GO:1903579,0.278472871309985,1,1,1,negative regulation of ATP metabolic process,BP,ACTN3
6829,GO:1903580,0.278472871309985,1,1,1,positive regulation of ATP metabolic process,BP,ACTN3
6848,GO:1903715,0.278472871309985,1,1,1,regulation of aerobic respiration,BP,ACTN3
6879,GO:1904023,0.278472871309985,1,1,1,regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
6880,GO:1904025,0.278472871309985,1,1,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,ACTN3
495,GO:0003228,0.278503877287611,1,1,1,atrial cardiac muscle tissue development,BP,WNT2
5127,GO:0055009,0.278503877287611,1,1,1,atrial cardiac muscle tissue morphogenesis,BP,WNT2
5337,GO:0060501,0.278503877287611,1,1,1,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
7173,GO:2000794,0.278503877287611,1,1,1,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,WNT2
4070,GO:0044712,0.279693564173444,0.827374272144358,14,38,single-organism catabolic process,BP,GLDC;PIK3CG;ACTN3;HACL1;ACAT1;ACADVL;NUDT7;ECI1;ETFDH;PLA2G16;DECR1;CPT1C;ETFB;PEPD
1237,GO:0007368,0.280031603133611,0.897694129904548,4,9,determination of left/right symmetry,BP,AXIN1;FGF8;ALG5;NOTCH1
1540,GO:0009855,0.280031603133611,0.897694129904548,4,9,determination of bilateral symmetry,BP,AXIN1;FGF8;ALG5;NOTCH1
403,GO:0002758,0.280609468618124,0.919720878980593,3,6,innate immune response-activating signal transduction,BP,HRAS;PSMB10;FADD
3965,GO:0044087,0.281041934084818,0.840394345025114,10,28,regulation of cellular component biogenesis,BP,WNT7A;PMAIP1;SPTBN5;SPTB;HRAS;TBC1D14;BMP7;SPTBN4;HNF1A;NOTCH1
1426,GO:0009059,0.281181327638662,0.80126154873782,28,84,macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;ALG5;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1;DPM3
1547,GO:0009891,0.281246951580536,0.813158146046035,19,56,positive regulation of biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;ABCG1;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
1000,GO:0006577,0.281584239341682,1,1,1,amino-acid betaine metabolic process,BP,CPT1C
1501,GO:0009437,0.281584239341682,1,1,1,carnitine metabolic process,BP,CPT1C
6110,GO:0072678,0.281942186300647,0.919119125511831,3,6,T cell migration,BP,PIK3CG;CCL20;FADD
1166,GO:0007088,0.282582891394183,0.918829129945277,3,6,regulation of mitotic nuclear division,BP,FGF8;BMP4;BMP7
2836,GO:0032103,0.283398876237138,0.895871102641269,4,9,positive regulation of response to external stimulus,BP,PIK3CG;BMP6;ARTN;FGF18
2636,GO:0031012,0.28391928680511,0.850965540742995,8,21,extracellular matrix,CC,WNT7A;WNT3;WNT7B;WNT2;WNT5B;BMP4;BMP7;LINGO1
1352,GO:0008219,0.285102905212744,0.802305553430138,24,72,cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;RRAS2;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;KRT10;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
3649,GO:0042475,0.286000614772296,0.8944538544467,4,9,odontogenesis of dentin-containing tooth,BP,JAG2;FGF8;BMP4;BMP7
440,GO:0003085,0.286479080838686,1,1,1,negative regulation of systemic arterial blood pressure,BP,KCNK6
5200,GO:0060075,0.286479080838686,1,1,1,regulation of resting membrane potential,BP,KCNK6
3047,GO:0032874,0.286548027193301,0.878242548193882,5,12,positive regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
5664,GO:0070304,0.286548027193301,0.878242548193882,5,12,positive regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4726,GO:0050662,0.286840852183794,0.878065998172402,5,12,coenzyme binding,MF,HACL1;ACAT1;ACADVL;ETFDH;DECR1
960,GO:0006414,0.286874754188781,0.956286683989093,2,3,translational elongation,BP,MRPL14;TSFM
2954,GO:0032543,0.286874754188781,0.956286683989093,2,3,mitochondrial translation,BP,MRPL14;TSFM
5618,GO:0070125,0.286874754188781,0.956286683989093,2,3,mitochondrial translational elongation,BP,MRPL14;TSFM
3044,GO:0032870,0.287392628952661,0.846198129451678,8,23,cellular response to hormone stimulus,BP,GJB2;HEY1;VDR;INHBB;BMP4;BMP7;PIK3CA;NOTCH1
863,GO:0005942,0.287705879993336,0.940977734283318,2,4,phosphatidylinositol 3-kinase complex,CC,PIK3CG;PIK3CA
2698,GO:0031323,0.287806080538639,0.787673188669677,40,124,regulation of cellular metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;RNF144A;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1;PM20D2
1210,GO:0007254,0.288089902569191,0.877311875957042,5,12,JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4344,GO:0046328,0.288089902569191,0.877311875957042,5,12,regulation of JNK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
932,GO:0006275,0.288372251910757,0.916188053313933,3,6,regulation of DNA replication,BP,BMP6;HRAS;BMP4
4249,GO:0045740,0.288372251910757,0.916188053313933,3,6,positive regulation of DNA replication,BP,BMP6;HRAS;BMP4
686,GO:0005096,0.288711224857247,0.940618185785671,2,4,GTPase activator activity,MF,AXIN1;TBC1D14
5348,GO:0060537,0.288910965536858,0.846241908712921,8,22,muscle tissue development,BP,ACTN3;WNT2;FZD7;RBP4;FGF8;BMP4;BMP7;NOTCH1
3345,GO:0035315,0.28895218987207,0.940531846531067,2,4,hair cell differentiation,BP,JAG2;NOTCH1
3655,GO:0042491,0.28895218987207,0.940531846531067,2,4,auditory receptor cell differentiation,BP,JAG2;NOTCH1
2033,GO:0016525,0.289280036869062,0.940414276739781,2,4,negative regulation of angiogenesis,BP,AMOT;NOTCH1
4045,GO:0044448,0.289628641898913,0.888604244053215,4,10,cell cortex part,CC,SPTBN5;CDH1;SPTB;SPTBN4
4507,GO:0048037,0.290444529466696,0.863764212591035,6,15,cofactor binding,MF,GLDC;HACL1;ACAT1;ACADVL;ETFDH;DECR1
1300,GO:0008013,0.290454698849423,0.93999208038304,2,4,beta-catenin binding,MF,AXIN1;CDH1
4940,GO:0051240,0.290511624493126,0.805721376180805,19,56,positive regulation of multicellular organismal process,BP,WNT7A;ACTN3;BMP6;WNT3;WNT7B;WNT2;FGF8;VDR;AMOT;CCL20;INHBB;HRAS;BMP4;GDNF;FADD;BMP7;SPTBN4;FGF18;NOTCH1
32,GO:0000188,0.291537029006784,1,1,1,inactivation of MAPK activity,BP,DUSP5
1329,GO:0008138,0.291537029006784,1,1,1,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP5
2125,GO:0017017,0.291537029006784,1,1,1,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP5
3140,GO:0033549,0.291537029006784,1,1,1,MAP kinase phosphatase activity,MF,DUSP5
3446,GO:0035970,0.291537029006784,1,1,1,peptidyl-threonine dephosphorylation,BP,DUSP5
2703,GO:0031328,0.292374736013464,0.806167005825398,18,53,positive regulation of cellular biosynthetic process,BP,WNT7A;BMP6;HEY1;AXIN1;POU3F1;WNT2;CDH1;FZD7;VDR;CCL20;HRAS;BMP4;GDNF;FADD;BMP7;HNF1A;FSTL3;NOTCH1
579,GO:0004165,0.293113698760551,1,1,1,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
7218,GO:2001233,0.293302283778266,0.86432957543004,6,14,regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB;BMP4;GDNF;DEPTOR;FADD
2717,GO:0031349,0.293383376715172,0.890391010272065,4,9,positive regulation of defense response,BP,PIK3CG;HRAS;PSMB10;FADD
1615,GO:0010507,0.293481327526879,0.938897405239339,2,4,negative regulation of autophagy,BP,TBC1D14;PIK3CA
5994,GO:0072148,0.293559042324795,0.938869167168444,2,4,epithelial cell fate commitment,BP,JAG2;NOTCH1
5781,GO:0071241,0.294106700485806,0.886055673188405,4,10,cellular response to inorganic substance,BP,BMP6;CDH1;FSTL3;GUCY1B3
4511,GO:0048048,0.294634576605957,0.93847769652389,2,4,embryonic eye morphogenesis,BP,AXIN1;BMP7
5331,GO:0060485,0.294974543754067,0.851141255866228,7,18,mesenchyme development,BP,HEY1;WNT2;FGF8;BMP4;GDNF;BMP7;NOTCH1
5251,GO:0060284,0.295183802260647,0.835461758251802,9,25,regulation of cell development,BP,WNT7A;CLDN18;BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1;LINGO1
1102,GO:0006892,0.296048020251944,1,1,1,post-Golgi vesicle-mediated transport,BP,RABIF
4933,GO:0051223,0.296685799395912,0.842053382046229,8,21,regulation of protein transport,BP,BMP6;KCNG2;CDH1;FZD7;RBP4;INHBB;BMP4;BMP7
3267,GO:0034654,0.296823940028359,0.79141268600248,25,75,nucleobase-containing compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1;GUCY1B3
1538,GO:0009798,0.298429372410931,0.887579012923664,4,9,axis specification,BP,WNT7A;WNT3;BMP4;NOTCH1
3316,GO:0035148,0.298685095179152,0.870846880074395,5,12,tube formation,BP,FGF8;BMP4;GDNF;BMP7;NOTCH1
580,GO:0004174,0.299323623107117,1,1,1,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
2061,GO:0016649,0.299323623107117,1,1,1,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
2073,GO:0016722,0.299323623107117,1,1,1,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
2141,GO:0017133,0.299323623107117,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
2696,GO:0031304,0.299323623107117,1,1,1,intrinsic component of mitochondrial inner membrane,CC,ETFDH
2697,GO:0031305,0.299323623107117,1,1,1,integral component of mitochondrial inner membrane,CC,ETFDH
2966,GO:0032592,0.299323623107117,1,1,1,integral component of mitochondrial membrane,CC,ETFDH
3944,GO:0043783,0.299323623107117,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
4159,GO:0045251,0.299323623107117,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
4508,GO:0048038,0.299323623107117,1,1,1,quinone binding,MF,ETFDH
4509,GO:0048039,0.299323623107117,1,1,1,ubiquinone binding,MF,ETFDH
5022,GO:0051539,0.299323623107117,1,1,1,4 iron, 4 sulfur cluster binding,MF,ETFDH
6365,GO:0098573,0.299323623107117,1,1,1,intrinsic component of mitochondrial membrane,CC,ETFDH
6403,GO:0098798,0.299323623107117,1,1,1,mitochondrial protein complex,CC,ETFDH
2533,GO:0030507,0.299560726202878,0.936668689127369,2,4,spectrin binding,MF,SPTBN5;SPTBN4
2961,GO:0032570,0.300616370624094,1,1,1,response to progesterone,BP,GJB2
4076,GO:0044752,0.300616370624094,1,1,1,response to human chorionic gonadotropin,BP,GJB2
6324,GO:0097386,0.300616370624094,1,1,1,glial cell projection,CC,GJB2
6328,GO:0097449,0.300616370624094,1,1,1,astrocyte projection,CC,GJB2
692,GO:0005111,0.300939257351679,0.952389931976605,2,3,type 2 fibroblast growth factor receptor binding,MF,FGF17;FGF18
6362,GO:0098552,0.301365434938373,0.866407375384178,5,13,side of membrane,CC,CDH1;SPTB;FGF8;AMOT;ABCG1
4934,GO:0051224,0.30157426756152,0.935921682770979,2,4,negative regulation of protein transport,BP,INHBB;BMP7
5850,GO:0071495,0.301670440944972,0.800152014625833,17,52,cellular response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;WNT2;CDH1;FGF8;VDR;INHBB;FGF17;BMP4;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
80,GO:0000983,0.302021741821655,1,1,1,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,HEY1
541,GO:0003696,0.302021741821655,1,1,1,satellite DNA binding,MF,HEY1
3432,GO:0035907,0.302021741821655,1,1,1,dorsal aorta development,BP,HEY1
3434,GO:0035912,0.302021741821655,1,1,1,dorsal aorta morphogenesis,BP,HEY1
3441,GO:0035939,0.302021741821655,1,1,1,microsatellite binding,MF,HEY1
3485,GO:0036304,0.302021741821655,1,1,1,umbilical cord morphogenesis,BP,HEY1
3855,GO:0043392,0.302021741821655,1,1,1,negative regulation of DNA binding,BP,HEY1
5481,GO:0061027,0.302021741821655,1,1,1,umbilical cord development,BP,HEY1
7158,GO:2000678,0.302021741821655,1,1,1,negative regulation of transcription regulatory region DNA binding,BP,HEY1
7178,GO:2000820,0.302021741821655,1,1,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,HEY1
7217,GO:2001212,0.302021741821655,1,1,1,regulation of vasculogenesis,BP,HEY1
405,GO:0002762,0.302488036596669,0.935581226726866,2,4,negative regulation of myeloid leukocyte differentiation,BP,CLDN18;FSTL3
6684,GO:1902494,0.302570100790229,0.845948168898451,7,18,catalytic complex,CC,GLDC;PIK3CG;RNF144A;PSMB10;FADD;PIK3CA;DPM3
1004,GO:0006605,0.30334552826008,0.865159190405174,5,13,protein targeting,BP,BMP6;CDH1;FZD7;BMP4;BMP7
568,GO:0003995,0.303468331204941,1,1,1,acyl-CoA dehydrogenase activity,MF,ACADVL
613,GO:0004466,0.303468331204941,1,1,1,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
1485,GO:0009295,0.303468331204941,1,1,1,nucleoid,CC,ACADVL
1496,GO:0009409,0.303468331204941,1,1,1,response to cold,BP,ACADVL
3499,GO:0036498,0.303468331204941,1,1,1,IRE1-mediated unfolded protein response,BP,ACADVL
3700,GO:0042645,0.303468331204941,1,1,1,mitochondrial nucleoid,CC,ACADVL
1739,GO:0010893,0.303676002587499,0.935137248393076,2,4,positive regulation of steroid biosynthetic process,BP,BMP6;ABCG1
3654,GO:0042490,0.30387888344059,0.902044680767721,3,7,mechanoreceptor differentiation,BP,JAG2;BMP4;NOTCH1
5208,GO:0060113,0.30387888344059,0.902044680767721,3,7,inner ear receptor cell differentiation,BP,JAG2;BMP4;NOTCH1
4895,GO:0051148,0.304138859119632,0.901912653310088,3,7,negative regulation of muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
5016,GO:0051494,0.304541498352768,0.901708020216357,3,7,negative regulation of cytoskeleton organization,BP,SPTBN5;SPTB;SPTBN4
404,GO:0002761,0.30530998476632,0.90131693116154,3,7,regulation of myeloid leukocyte differentiation,BP,CLDN18;FADD;FSTL3
6224,GO:0090316,0.306543736190835,0.900687632425173,3,7,positive regulation of intracellular protein transport,BP,BMP6;CDH1;BMP4
744,GO:0005355,0.306837595649124,1,1,1,glucose transmembrane transporter activity,MF,SLC2A14
1864,GO:0015145,0.306837595649124,1,1,1,monosaccharide transmembrane transporter activity,MF,SLC2A14
1865,GO:0015149,0.306837595649124,1,1,1,hexose transmembrane transporter activity,MF,SLC2A14
3194,GO:0034219,0.306837595649124,1,1,1,carbohydrate transmembrane transport,BP,SLC2A14
3356,GO:0035428,0.306837595649124,1,1,1,hexose transmembrane transport,BP,SLC2A14
5141,GO:0055056,0.306837595649124,1,1,1,D-glucose transmembrane transporter activity,MF,SLC2A14
6908,GO:1904659,0.306837595649124,1,1,1,glucose transmembrane transport,BP,SLC2A14
6996,GO:1905950,0.306837595649124,1,1,1,monosaccharide transmembrane transport,BP,SLC2A14
6002,GO:0072170,0.307418533916843,0.933728474051149,2,4,metanephric tubule development,BP,ACAT1;WNT7B
245,GO:0002011,0.307764878309328,0.900063025871128,3,7,morphogenesis of an epithelial sheet,BP,WNT7A;BMP7;NOTCH1
4830,GO:0050918,0.307911826797386,0.906997610814033,3,6,positive chemotaxis,BP,FGF8;ARTN;BMP4
113,GO:0001525,0.308210043809831,0.825943900239846,9,25,angiogenesis,BP,WNT7A;PIK3CG;HEY1;FGF8;AMOT;BMP4;PIK3CA;FGF18;NOTCH1
4028,GO:0044424,0.308233921901699,0.784958428053417,92,294,intracellular part,CC,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;DSG3;CNIH4;WNK4;TSFM;DUSP5;INHBB;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;PNMT;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2
203,GO:0001893,0.308846439287577,0.933186935721301,2,4,maternal placenta development,BP,GJB2;VDR
1681,GO:0010720,0.309736516283987,0.848974210317323,6,16,positive regulation of cell development,BP,BMP6;WNT3;WNT2;BMP4;BMP7;NOTCH1
1525,GO:0009719,0.30983064999335,0.785916315359406,21,64,response to endogenous stimulus,BP,WNT7A;GJB2;PIK3CG;BMP6;HEY1;ACAT1;WNT7B;WNT2;CDH1;FGF8;VDR;INHBB;ABCG1;FGF17;BMP4;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
2159,GO:0018149,0.309842909232796,1,1,1,peptide cross-linking,BP,KRT10
564,GO:0003985,0.309997076835544,1,1,1,acetyl-CoA C-acetyltransferase activity,MF,ACAT1
566,GO:0003988,0.309997076835544,1,1,1,acetyl-CoA C-acyltransferase activity,MF,ACAT1
993,GO:0006550,0.309997076835544,1,1,1,isoleucine catabolic process,BP,ACAT1
1933,GO:0015937,0.309997076835544,1,1,1,coenzyme A biosynthetic process,BP,ACAT1
2019,GO:0016453,0.309997076835544,1,1,1,C-acetyltransferase activity,MF,ACAT1
2115,GO:0016885,0.309997076835544,1,1,1,ligase activity, forming carbon-carbon bonds,MF,ACAT1
3167,GO:0033866,0.309997076835544,1,1,1,nucleoside bisphosphate biosynthetic process,BP,ACAT1
3171,GO:0034030,0.309997076835544,1,1,1,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
3174,GO:0034033,0.309997076835544,1,1,1,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
4474,GO:0046952,0.309997076835544,1,1,1,ketone body catabolic process,BP,ACAT1
5937,GO:0072019,0.309997076835544,1,1,1,proximal convoluted tubule development,BP,ACAT1
6033,GO:0072229,0.309997076835544,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
6036,GO:0072237,0.309997076835544,1,1,1,metanephric proximal tubule development,BP,ACAT1
6723,GO:1902858,0.309997076835544,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
6724,GO:1902860,0.309997076835544,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
1188,GO:0007178,0.310181713787512,0.839019140044593,7,19,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,BMP6;FGF8;INHBB;BMP4;BMP7;FSTL3;NOTCH1
1354,GO:0008233,0.311605796936547,0.880101415155063,4,9,peptidase activity,MF,RHBDL3;PSMB10;PM20D2;PEPD
540,GO:0003690,0.311666398612999,0.932110877626925,2,4,double-stranded DNA binding,MF,HEY1;HNF1A
4068,GO:0044710,0.312257961396427,0.764448058613292,47,143,single-organism metabolic process,BP,GLDC;WNT7A;PIK3CG;ACTN3;HACL1;MBOAT2;BMP6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;MAPK12;ACADVL;SPTBN5;FZD7;RBP4;SPTB;FGF8;VDR;ARTN;NUDT7;CCL20;DUSP5;INHBB;ABCG1;FGF17;ALG5;HRAS;BMP4;ECI1;GDNF;ETFDH;PSMB10;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;FGF18;PTS;CPT1C;ZFYVE21;ETFB;GUCY1B3;DPM3;PEPD
6542,GO:1901215,0.312912231421851,0.879349376371093,4,9,negative regulation of neuron death,BP,FGF8;HRAS;GDNF;PIK3CA
4822,GO:0050886,0.313543863124884,0.931389608200662,2,4,endocrine process,BP,BMP6;INHBB
749,GO:0005488,0.314393421886595,0.783486863706934,94,302,binding,MF,MAGEC2;TJP3;RHPN1;GLDC;TLE1;WNT7A;SYT5;PIK3CG;RHBDL3;ACTN3;CLDN18;HACL1;RABIF;BMP6;WNT3;HEY1;ACAT1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;CLDN15;BOLA1;GDNF;ETFDH;USE1;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;DRP2;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;LINGO1;RND3;CPT1C;ZFYVE21;MB21D2;RAB20;ETFB;GUCY1B3;DPM3;PEPD
5039,GO:0051602,0.314701757036488,1,1,1,response to electrical stimulus,BP,GJB6
5390,GO:0060674,0.315056612700098,0.930805622273832,2,4,placenta blood vessel development,BP,HEY1;WNT2
2634,GO:0030976,0.315201135378587,1,1,1,thiamine pyrophosphate binding,MF,HACL1
4890,GO:0051129,0.316098703329076,0.834856397354642,7,19,negative regulation of cellular component organization,BP,WNT3;SPTBN5;SPTB;BMP4;BMP7;SPTBN4;LINGO1
953,GO:0006396,0.316225288323695,0.877433616334614,4,9,RNA processing,BP,ARL6IP4;PUS1;BMP4;LAGE3
6845,GO:1903706,0.316572996257263,0.856711854950465,5,13,regulation of hemopoiesis,BP,CLDN18;BMP4;FADD;FSTL3;NOTCH1
1642,GO:0010608,0.316753702423502,0.877126918583218,4,9,posttranscriptional regulation of gene expression,BP,TSFM;BMP4;GDNF;PSMB10
3306,GO:0035091,0.316948244666395,0.895310224774224,3,7,phosphatidylinositol binding,MF,SYT5;PXK;FZD7
552,GO:0003746,0.317499380649427,1,1,1,translation elongation factor activity,MF,TSFM
1328,GO:0008135,0.317499380649427,1,1,1,translation factor activity, RNA binding,MF,TSFM
5620,GO:0070129,0.317499380649427,1,1,1,regulation of mitochondrial translation,BP,TSFM
7095,GO:2000241,0.317816862005785,0.872184287772805,4,10,regulation of reproductive process,BP,INHBB;BMP4;BMP7;NOTCH1
2712,GO:0031344,0.317831450800416,0.855898280094151,5,13,regulation of cell projection organization,BP,WNT7A;WNT3;HRAS;BMP7;LINGO1
5301,GO:0060421,0.317939408198302,0.929685731126059,2,4,positive regulation of heart growth,BP,WNT2;NOTCH1
1487,GO:0009306,0.317986980104111,0.845573763481214,6,15,protein secretion,BP,BMP6;KCNG2;RAB40B;RBP4;INHBB;NOTCH1
465,GO:0003170,0.318385802104946,0.894557324250514,3,7,heart valve development,BP,HEY1;BMP4;NOTCH1
471,GO:0003179,0.318385802104946,0.894557324250514,3,7,heart valve morphogenesis,BP,HEY1;BMP4;NOTCH1
2078,GO:0016746,0.31891375750506,0.87152715873897,4,10,transferase activity, transferring acyl groups,MF,MBOAT2;ACAT1;PLA2G16;CPT1C
6711,GO:1902679,0.318972100080915,0.82350742222657,8,23,negative regulation of RNA biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
140,GO:0001667,0.31922592964855,0.817772040917297,9,25,ameboidal-type cell migration,BP,WNT7A;FGF8;AMOT;PKN3;BMP4;GDNF;PIK3CA;FGF18;NOTCH1
1226,GO:0007283,0.319948245435349,0.870906165547921,4,10,spermatogenesis,BP,SLC2A14;JAG2;FSTL3;NOTCH1
4531,GO:0048232,0.319948245435349,0.870906165547921,4,10,male gamete generation,BP,SLC2A14;JAG2;FSTL3;NOTCH1
259,GO:0002064,0.320047956406822,0.841974042571807,6,16,epithelial cell development,BP,WNT7A;BMP6;WNT7B;WNT5B;BMP4;NOTCH1
5954,GO:0072074,0.320149070364815,0.928821094270695,2,4,kidney mesenchyme development,BP,BMP4;BMP7
263,GO:0002068,0.32057190380579,0.928655021625911,2,4,glandular epithelial cell development,BP,BMP6;BMP4
518,GO:0003309,0.32057190380579,0.928655021625911,2,4,type B pancreatic cell differentiation,BP,BMP6;BMP4
519,GO:0003323,0.32057190380579,0.928655021625911,2,4,type B pancreatic cell development,BP,BMP6;BMP4
3427,GO:0035883,0.32057190380579,0.928655021625911,2,4,enteroendocrine cell differentiation,BP,BMP6;BMP4
194,GO:0001844,0.320830810822377,1,1,1,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
1749,GO:0010917,0.320830810822377,1,1,1,negative regulation of mitochondrial membrane potential,BP,PMAIP1
2937,GO:0032459,0.320830810822377,1,1,1,regulation of protein oligomerization,BP,PMAIP1
2938,GO:0032461,0.320830810822377,1,1,1,positive regulation of protein oligomerization,BP,PMAIP1
3409,GO:0035794,0.320830810822377,1,1,1,positive regulation of mitochondrial membrane permeability,BP,PMAIP1
3893,GO:0043516,0.320830810822377,1,1,1,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3894,GO:0043517,0.320830810822377,1,1,1,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
4278,GO:0045837,0.320830810822377,1,1,1,negative regulation of membrane potential,BP,PMAIP1
4924,GO:0051204,0.320830810822377,1,1,1,protein insertion into mitochondrial membrane,BP,PMAIP1
5078,GO:0051881,0.320830810822377,1,1,1,regulation of mitochondrial membrane potential,BP,PMAIP1
6321,GO:0097345,0.320830810822377,1,1,1,mitochondrial outer membrane permeabilization,BP,PMAIP1
6508,GO:1900739,0.320830810822377,1,1,1,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
6509,GO:1900740,0.320830810822377,1,1,1,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,PMAIP1
6521,GO:1901028,0.320830810822377,1,1,1,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
6522,GO:1901030,0.320830810822377,1,1,1,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,PMAIP1
6607,GO:1901798,0.320830810822377,1,1,1,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
6648,GO:1902110,0.320830810822377,1,1,1,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
6658,GO:1902235,0.320830810822377,1,1,1,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
6659,GO:1902237,0.320830810822377,1,1,1,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
6713,GO:1902686,0.320830810822377,1,1,1,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,PMAIP1
6855,GO:1903747,0.320830810822377,1,1,1,regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
6856,GO:1903749,0.320830810822377,1,1,1,positive regulation of establishment of protein localization to mitochondrion,BP,PMAIP1
6985,GO:1905710,0.320830810822377,1,1,1,positive regulation of membrane permeability,BP,PMAIP1
7228,GO:2001244,0.320830810822377,1,1,1,positive regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
2102,GO:0016835,0.320832054729233,0.900684239382246,3,6,carbon-oxygen lyase activity,MF,PUS1;ECI1;PTS
1775,GO:0012501,0.320894898856713,0.773639908458398,23,70,programmed cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;DSG3;INHBB;PKP1;HRAS;BMP4;KRT10;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
5479,GO:0061024,0.32133888108722,0.800316912105309,12,35,membrane organization,BP,SYT5;RABIF;PMAIP1;RAB40B;CDH1;RAB39A;TSPAN15;GDNF;TBC1D14;RAB38;SPTBN4;RAB20
3860,GO:0043406,0.321747405690872,0.840809716144108,6,16,positive regulation of MAP kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;FGF18
3613,GO:0042325,0.322195763856555,0.781551312059437,18,54,regulation of phosphorylation,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;DEPTOR;BMP7;SPTBN4;PIK3CA;FGF18
728,GO:0005246,0.322547724940313,1,1,1,calcium channel regulator activity,MF,TSPAN13
200,GO:0001889,0.322860799748307,0.892198133861012,3,7,liver development,BP,ACAT1;PIK3CA;NOTCH1
5476,GO:0061008,0.322860799748307,0.892198133861012,3,7,hepaticobiliary system development,BP,ACAT1;PIK3CA;NOTCH1
582,GO:0004177,0.322870374114816,1,1,1,aminopeptidase activity,MF,PEPD
583,GO:0004180,0.322870374114816,1,1,1,carboxypeptidase activity,MF,PEPD
584,GO:0004181,0.322870374114816,1,1,1,metallocarboxypeptidase activity,MF,PEPD
1356,GO:0008235,0.322870374114816,1,1,1,metalloexopeptidase activity,MF,PEPD
1358,GO:0008237,0.322870374114816,1,1,1,metallopeptidase activity,MF,PEPD
2553,GO:0030574,0.322870374114816,1,1,1,collagen catabolic process,BP,PEPD
3980,GO:0044243,0.322870374114816,1,1,1,multicellular organismal catabolic process,BP,PEPD
6457,GO:0102009,0.322870374114816,1,1,1,proline dipeptidase activity,MF,PEPD
269,GO:0002084,0.323085592634775,1,1,1,protein depalmitoylation,BP,LYPLAL1
633,GO:0004622,0.323085592634775,1,1,1,lysophospholipase activity,MF,LYPLAL1
1389,GO:0008474,0.323085592634775,1,1,1,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
3584,GO:0042159,0.323085592634775,1,1,1,lipoprotein catabolic process,BP,LYPLAL1
6372,GO:0098599,0.323085592634775,1,1,1,palmitoyl hydrolase activity,MF,LYPLAL1
6389,GO:0098734,0.323085592634775,1,1,1,macromolecule depalmitoylation,BP,LYPLAL1
7179,GO:2000826,0.323189467218896,0.927622511041894,2,4,regulation of heart morphogenesis,BP,BMP4;NOTCH1
3985,GO:0044255,0.32325062337421,0.777327776883775,20,58,cellular lipid metabolic process,BP,PIK3CG;HACL1;MBOAT2;ACAT1;ACADVL;RBP4;FGF8;NUDT7;ABCG1;FGF17;ECI1;ETFDH;PIK3CA;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;ETFB;DPM3
1768,GO:0010976,0.323389594109978,0.927543255519793,2,4,positive regulation of neuron projection development,BP,WNT3;BMP7
832,GO:0005829,0.323424419189802,0.757915164282586,38,118,cytosol,CC,MAGEC2;RHPN1;TLE1;GJB2;PIK3CG;ACTN3;RABIF;GJB6;MSRA;PMAIP1;AXIN1;MAPK12;ACADVL;PXK;SPTBN5;RBP4;RAB39A;SPTB;AMOT;DSG3;WNK4;HRAS;KRT10;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;SPTBN4;PIK3CA;PLA2G16;DECR1;PTS;NOTCH1;PNMT;ZFYVE21;ETFB;GUCY1B3
3919,GO:0043583,0.323561351966817,0.839563630883242,6,16,ear development,BP,GJB2;GJB6;JAG2;FGF8;BMP4;NOTCH1
2156,GO:0018125,0.323785684741571,1,1,1,peptidyl-cysteine methylation,BP,RAB3D
2162,GO:0018198,0.323785684741571,1,1,1,peptidyl-cysteine modification,BP,RAB3D
3686,GO:0042588,0.323785684741571,1,1,1,zymogen granule,CC,RAB3D
2358,GO:0022409,0.323789585304351,0.868589608697529,4,10,positive regulation of cell-cell adhesion,BP,FADD;BMP7;PIK3CA;FSTL3
7220,GO:2001235,0.324070785438925,0.899071909369405,3,6,positive regulation of apoptotic signaling pathway,BP,PMAIP1;INHBB;FADD
1915,GO:0015850,0.324525793205469,0.872579465640899,4,9,organic hydroxy compound transport,BP,BMP6;RBP4;ABCG1;GDNF
208,GO:0001910,0.325296595251949,1,1,1,regulation of leukocyte mediated cytotoxicity,BP,FADD
209,GO:0001912,0.325296595251949,1,1,1,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
211,GO:0001914,0.325296595251949,1,1,1,regulation of T cell mediated cytotoxicity,BP,FADD
212,GO:0001916,0.325296595251949,1,1,1,positive regulation of T cell mediated cytotoxicity,BP,FADD
380,GO:0002691,0.325296595251949,1,1,1,regulation of cellular extravasation,BP,FADD
381,GO:0002693,0.325296595251949,1,1,1,positive regulation of cellular extravasation,BP,FADD
393,GO:0002709,0.325296595251949,1,1,1,regulation of T cell mediated immunity,BP,FADD
394,GO:0002711,0.325296595251949,1,1,1,positive regulation of T cell mediated immunity,BP,FADD
1804,GO:0014072,0.325296595251949,1,1,1,response to isoquinoline alkaloid,BP,FADD
2690,GO:0031265,0.325296595251949,1,1,1,CD95 death-inducing signaling complex,CC,FADD
2710,GO:0031341,0.325296595251949,1,1,1,regulation of cell killing,BP,FADD
2711,GO:0031343,0.325296595251949,1,1,1,positive regulation of cell killing,BP,FADD
3391,GO:0035697,0.325296595251949,1,1,1,CD8-positive, alpha-beta T cell extravasation,BP,FADD
3392,GO:0035698,0.325296595251949,1,1,1,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
3493,GO:0036462,0.325296595251949,1,1,1,TRAIL-activated apoptotic signaling pathway,BP,FADD
3592,GO:0042220,0.325296595251949,1,1,1,response to cocaine,BP,FADD
3835,GO:0043278,0.325296595251949,1,1,1,response to morphine,BP,FADD
4520,GO:0048148,0.325296595251949,1,1,1,behavioral response to cocaine,BP,FADD
4595,GO:0048535,0.325296595251949,1,1,1,lymph node development,BP,FADD
5279,GO:0060359,0.325296595251949,1,1,1,response to ammonium ion,BP,FADD
5353,GO:0060546,0.325296595251949,1,1,1,negative regulation of necroptotic process,BP,FADD
5642,GO:0070235,0.325296595251949,1,1,1,regulation of activation-induced cell death of T cells,BP,FADD
5643,GO:0070236,0.325296595251949,1,1,1,negative regulation of activation-induced cell death of T cells,BP,FADD
6112,GO:0072683,0.325296595251949,1,1,1,T cell extravasation,BP,FADD
6266,GO:0097049,0.325296595251949,1,1,1,motor neuron apoptotic process,BP,FADD
6304,GO:0097202,0.325296595251949,1,1,1,activation of cysteine-type endopeptidase activity,BP,FADD
6336,GO:0097527,0.325296595251949,1,1,1,necroptotic signaling pathway,BP,FADD
7121,GO:2000407,0.325296595251949,1,1,1,regulation of T cell extravasation,BP,FADD
7122,GO:2000409,0.325296595251949,1,1,1,positive regulation of T cell extravasation,BP,FADD
7125,GO:2000449,0.325296595251949,1,1,1,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
7126,GO:2000451,0.325296595251949,1,1,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
7127,GO:2000452,0.325296595251949,1,1,1,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
7128,GO:2000454,0.325296595251949,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
5629,GO:0070169,0.325457686068929,0.890818311698971,3,7,positive regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
814,GO:0005777,0.325474679714951,0.87201959105983,4,9,peroxisome,CC,HACL1;PXMP2;NUDT7;PLA2G16
3681,GO:0042579,0.325474679714951,0.87201959105983,4,9,microbody,CC,HACL1;PXMP2;NUDT7;PLA2G16
4038,GO:0044438,0.325474679714951,0.87201959105983,4,9,microbody part,CC,HACL1;PXMP2;NUDT7;PLA2G16
4039,GO:0044439,0.325474679714951,0.87201959105983,4,9,peroxisomal part,CC,HACL1;PXMP2;NUDT7;PLA2G16
5979,GO:0072110,0.325660928201104,0.926640610030168,2,4,glomerular mesangial cell proliferation,BP,BMP4;BMP7
5982,GO:0072124,0.325660928201104,0.926640610030168,2,4,regulation of glomerular mesangial cell proliferation,BP,BMP4;BMP7
6195,GO:0090192,0.325660928201104,0.926640610030168,2,4,regulation of glomerulus development,BP,BMP4;BMP7
6603,GO:1901722,0.325660928201104,0.926640610030168,2,4,regulation of cell proliferation involved in kidney development,BP,BMP4;BMP7
6815,GO:1903532,0.326207616616135,0.853483468270246,5,12,positive regulation of secretion by cell,BP,BMP6;RBP4;INHBB;RAB3D;GDNF
1956,GO:0016079,0.326432162054524,1,1,1,synaptic vesicle exocytosis,BP,SYT5
2487,GO:0030276,0.326432162054524,1,1,1,clathrin binding,MF,SYT5
2643,GO:0031045,0.326432162054524,1,1,1,dense core granule,CC,SYT5
4576,GO:0048488,0.326432162054524,1,1,1,synaptic vesicle endocytosis,BP,SYT5
4681,GO:0048791,0.326432162054524,1,1,1,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT5
7025,GO:1990769,0.326432162054524,1,1,1,proximal neuron projection,CC,SYT5
2713,GO:0031345,0.328273946636358,0.925595028478034,2,4,negative regulation of cell projection organization,BP,WNT3;LINGO1
4597,GO:0048537,0.328382725668227,1,1,1,mucosal-associated lymphoid tissue development,BP,ARTN
4599,GO:0048541,0.328382725668227,1,1,1,Peyer's patch development,BP,ARTN
5516,GO:0061146,0.328382725668227,1,1,1,Peyer's patch morphogenesis,BP,ARTN
6262,GO:0097021,0.328382725668227,1,1,1,lymphocyte migration into lymphoid organs,BP,ARTN
152,GO:0001710,0.328925264426068,1,1,1,mesodermal cell fate commitment,BP,BMP4
252,GO:0002043,0.328925264426068,1,1,1,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,BMP4
273,GO:0002089,0.328925264426068,1,1,1,lens morphogenesis in camera-type eye,BP,BMP4
447,GO:0003128,0.328925264426068,1,1,1,heart field specification,BP,BMP4
452,GO:0003139,0.328925264426068,1,1,1,secondary heart field specification,BP,BMP4
455,GO:0003149,0.328925264426068,1,1,1,membranous septum morphogenesis,BP,BMP4
1190,GO:0007182,0.328925264426068,1,1,1,common-partner SMAD protein phosphorylation,BP,BMP4
1259,GO:0007500,0.328925264426068,1,1,1,mesodermal cell fate determination,BP,BMP4
1587,GO:0010159,0.328925264426068,1,1,1,specification of animal organ position,BP,BMP4
2015,GO:0016441,0.328925264426068,1,1,1,posttranscriptional gene silencing,BP,BMP4
2020,GO:0016458,0.328925264426068,1,1,1,gene silencing,BP,BMP4
2475,GO:0030224,0.328925264426068,1,1,1,monocyte differentiation,BP,BMP4
2644,GO:0031047,0.328925264426068,1,1,1,gene silencing by RNA,BP,BMP4
2645,GO:0031050,0.328925264426068,1,1,1,dsRNA fragmentation,BP,BMP4
2880,GO:0032331,0.328925264426068,1,1,1,negative regulation of chondrocyte differentiation,BP,BMP4
3101,GO:0033081,0.328925264426068,1,1,1,regulation of T cell differentiation in thymus,BP,BMP4
3102,GO:0033083,0.328925264426068,1,1,1,regulation of immature T cell proliferation,BP,BMP4
3103,GO:0033084,0.328925264426068,1,1,1,regulation of immature T cell proliferation in thymus,BP,BMP4
3104,GO:0033085,0.328925264426068,1,1,1,negative regulation of T cell differentiation in thymus,BP,BMP4
3105,GO:0033087,0.328925264426068,1,1,1,negative regulation of immature T cell proliferation,BP,BMP4
3106,GO:0033088,0.328925264426068,1,1,1,negative regulation of immature T cell proliferation in thymus,BP,BMP4
3319,GO:0035194,0.328925264426068,1,1,1,posttranscriptional gene silencing by RNA,BP,BMP4
3320,GO:0035195,0.328925264426068,1,1,1,gene silencing by miRNA,BP,BMP4
3321,GO:0035196,0.328925264426068,1,1,1,production of miRNAs involved in gene silencing by miRNA,BP,BMP4
3420,GO:0035844,0.328925264426068,1,1,1,cloaca development,BP,BMP4
3449,GO:0035989,0.328925264426068,1,1,1,tendon development,BP,BMP4
3450,GO:0035990,0.328925264426068,1,1,1,tendon cell differentiation,BP,BMP4
3451,GO:0035992,0.328925264426068,1,1,1,tendon formation,BP,BMP4
3452,GO:0035993,0.328925264426068,1,1,1,deltoid tuberosity development,BP,BMP4
3547,GO:0040029,0.328925264426068,1,1,1,regulation of gene expression, epigenetic,BP,BMP4
4194,GO:0045581,0.328925264426068,1,1,1,negative regulation of T cell differentiation,BP,BMP4
4212,GO:0045620,0.328925264426068,1,1,1,negative regulation of lymphocyte differentiation,BP,BMP4
4563,GO:0048389,0.328925264426068,1,1,1,intermediate mesoderm development,BP,BMP4
4564,GO:0048390,0.328925264426068,1,1,1,intermediate mesoderm morphogenesis,BP,BMP4
4565,GO:0048391,0.328925264426068,1,1,1,intermediate mesoderm formation,BP,BMP4
4566,GO:0048392,0.328925264426068,1,1,1,intermediate mesodermal cell differentiation,BP,BMP4
4654,GO:0048701,0.328925264426068,1,1,1,embryonic cranial skeleton morphogenesis,BP,BMP4
5131,GO:0055018,0.328925264426068,1,1,1,regulation of cardiac muscle fiber development,BP,BMP4
5132,GO:0055020,0.328925264426068,1,1,1,positive regulation of cardiac muscle fiber development,BP,BMP4
5219,GO:0060147,0.328925264426068,1,1,1,regulation of posttranscriptional gene silencing,BP,BMP4
5220,GO:0060148,0.328925264426068,1,1,1,positive regulation of posttranscriptional gene silencing,BP,BMP4
5231,GO:0060197,0.328925264426068,1,1,1,cloacal septation,BP,BMP4
5237,GO:0060235,0.328925264426068,1,1,1,lens induction in camera-type eye,BP,BMP4
5280,GO:0060363,0.328925264426068,1,1,1,cranial suture morphogenesis,BP,BMP4
5317,GO:0060440,0.328925264426068,1,1,1,trachea formation,BP,BMP4
5339,GO:0060503,0.328925264426068,1,1,1,bud dilation involved in lung branching,BP,BMP4
5393,GO:0060677,0.328925264426068,1,1,1,ureteric bud elongation,BP,BMP4
5394,GO:0060681,0.328925264426068,1,1,1,branch elongation involved in ureteric bud branching,BP,BMP4
5452,GO:0060914,0.328925264426068,1,1,1,heart formation,BP,BMP4
5459,GO:0060964,0.328925264426068,1,1,1,regulation of gene silencing by miRNA,BP,BMP4
5460,GO:0060966,0.328925264426068,1,1,1,regulation of gene silencing by RNA,BP,BMP4
5461,GO:0060968,0.328925264426068,1,1,1,regulation of gene silencing,BP,BMP4
5471,GO:0060994,0.328925264426068,1,1,1,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,BMP4
5474,GO:0061004,0.328925264426068,1,1,1,pattern specification involved in kidney development,BP,BMP4
5488,GO:0061037,0.328925264426068,1,1,1,negative regulation of cartilage development,BP,BMP4
5517,GO:0061149,0.328925264426068,1,1,1,BMP signaling pathway involved in ureter morphogenesis,BP,BMP4
5518,GO:0061150,0.328925264426068,1,1,1,renal system segmentation,BP,BMP4
5519,GO:0061151,0.328925264426068,1,1,1,BMP signaling pathway involved in renal system segmentation,BP,BMP4
5521,GO:0061155,0.328925264426068,1,1,1,pulmonary artery endothelial tube morphogenesis,BP,BMP4
5530,GO:0061216,0.328925264426068,1,1,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,BMP4
5532,GO:0061218,0.328925264426068,1,1,1,negative regulation of mesonephros development,BP,BMP4
5533,GO:0061227,0.328925264426068,1,1,1,pattern specification involved in mesonephros development,BP,BMP4
5543,GO:0061323,0.328925264426068,1,1,1,cell proliferation involved in heart morphogenesis,BP,BMP4
5544,GO:0061325,0.328925264426068,1,1,1,cell proliferation involved in outflow tract morphogenesis,BP,BMP4
5569,GO:0061438,0.328925264426068,1,1,1,renal system vasculature morphogenesis,BP,BMP4
5570,GO:0061439,0.328925264426068,1,1,1,kidney vasculature morphogenesis,BP,BMP4
5586,GO:0061626,0.328925264426068,1,1,1,pharyngeal arch artery morphogenesis,BP,BMP4
5646,GO:0070244,0.328925264426068,1,1,1,negative regulation of thymocyte apoptotic process,BP,BMP4
5756,GO:0070918,0.328925264426068,1,1,1,production of small RNA involved in gene silencing by RNA,BP,BMP4
5757,GO:0070920,0.328925264426068,1,1,1,regulation of production of small RNA involved in gene silencing by RNA,BP,BMP4
5917,GO:0071893,0.328925264426068,1,1,1,BMP signaling pathway involved in nephric duct formation,BP,BMP4
5935,GO:0072015,0.328925264426068,1,1,1,glomerular visceral epithelial cell development,BP,BMP4
5945,GO:0072048,0.328925264426068,1,1,1,renal system pattern specification,BP,BMP4
5946,GO:0072049,0.328925264426068,1,1,1,comma-shaped body morphogenesis,BP,BMP4
5965,GO:0072095,0.328925264426068,1,1,1,regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5966,GO:0072096,0.328925264426068,1,1,1,negative regulation of branch elongation involved in ureteric bud branching,BP,BMP4
5967,GO:0072097,0.328925264426068,1,1,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,BMP4
5968,GO:0072098,0.328925264426068,1,1,1,anterior/posterior pattern specification involved in kidney development,BP,BMP4
5969,GO:0072099,0.328925264426068,1,1,1,anterior/posterior pattern specification involved in ureteric bud development,BP,BMP4
5970,GO:0072100,0.328925264426068,1,1,1,specification of ureteric bud anterior/posterior symmetry,BP,BMP4
5971,GO:0072101,0.328925264426068,1,1,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,BMP4
5972,GO:0072102,0.328925264426068,1,1,1,glomerulus morphogenesis,BP,BMP4
5973,GO:0072103,0.328925264426068,1,1,1,glomerulus vasculature morphogenesis,BP,BMP4
5974,GO:0072104,0.328925264426068,1,1,1,glomerular capillary formation,BP,BMP4
6010,GO:0072179,0.328925264426068,1,1,1,nephric duct formation,BP,BMP4
6012,GO:0072189,0.328925264426068,1,1,1,ureter development,BP,BMP4
6013,GO:0072190,0.328925264426068,1,1,1,ureter urothelium development,BP,BMP4
6014,GO:0072191,0.328925264426068,1,1,1,ureter smooth muscle development,BP,BMP4
6015,GO:0072192,0.328925264426068,1,1,1,ureter epithelial cell differentiation,BP,BMP4
6016,GO:0072193,0.328925264426068,1,1,1,ureter smooth muscle cell differentiation,BP,BMP4
6017,GO:0072197,0.328925264426068,1,1,1,ureter morphogenesis,BP,BMP4
6018,GO:0072198,0.328925264426068,1,1,1,mesenchymal cell proliferation involved in ureter development,BP,BMP4
6019,GO:0072199,0.328925264426068,1,1,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
6020,GO:0072200,0.328925264426068,1,1,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,BMP4
6044,GO:0072278,0.328925264426068,1,1,1,metanephric comma-shaped body morphogenesis,BP,BMP4
6052,GO:0072310,0.328925264426068,1,1,1,glomerular epithelial cell development,BP,BMP4
6194,GO:0090191,0.328925264426068,1,1,1,negative regulation of branching involved in ureteric bud morphogenesis,BP,BMP4
6276,GO:0097094,0.328925264426068,1,1,1,craniofacial suture morphogenesis,BP,BMP4
6623,GO:1901963,0.328925264426068,1,1,1,regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
6624,GO:1901964,0.328925264426068,1,1,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,BMP4
6764,GO:1903131,0.328925264426068,1,1,1,mononuclear cell differentiation,BP,BMP4
6860,GO:1903798,0.328925264426068,1,1,1,regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
6861,GO:1903800,0.328925264426068,1,1,1,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,BMP4
6932,GO:1904888,0.328925264426068,1,1,1,cranial skeletal system development,BP,BMP4
7039,GO:2000004,0.328925264426068,1,1,1,regulation of metanephric S-shaped body morphogenesis,BP,BMP4
7040,GO:2000005,0.328925264426068,1,1,1,negative regulation of metanephric S-shaped body morphogenesis,BP,BMP4
7041,GO:2000006,0.328925264426068,1,1,1,regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
7042,GO:2000007,0.328925264426068,1,1,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,BMP4
7076,GO:2000137,0.328925264426068,1,1,1,negative regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
7077,GO:2000138,0.328925264426068,1,1,1,positive regulation of cell proliferation involved in heart morphogenesis,BP,BMP4
7149,GO:2000637,0.328925264426068,1,1,1,positive regulation of gene silencing by miRNA,BP,BMP4
4610,GO:0048583,0.32893134366756,0.75686895396079,32,100,regulation of response to stimulus,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;WNT2;FZD7;FGF8;AMOT;ARTN;WNT5B;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
4234,GO:0045682,0.328949544524044,0.888950470493774,3,7,regulation of epidermis development,BP,VDR;BMP4;NOTCH1
2027,GO:0016482,0.329617899727022,0.925054268609775,2,4,cytosolic transport,BP,TBC1D14;ZFYVE21
5799,GO:0071322,0.330087700945851,0.924864757609553,2,4,cellular response to carbohydrate stimulus,BP,GJB6;PIK3CA
5800,GO:0071326,0.330087700945851,0.924864757609553,2,4,cellular response to monosaccharide stimulus,BP,GJB6;PIK3CA
5801,GO:0071331,0.330087700945851,0.924864757609553,2,4,cellular response to hexose stimulus,BP,GJB6;PIK3CA
5802,GO:0071333,0.330087700945851,0.924864757609553,2,4,cellular response to glucose stimulus,BP,GJB6;PIK3CA
644,GO:0004707,0.330119707598727,1,1,1,MAP kinase activity,MF,MAPK12
1134,GO:0006975,0.330119707598727,1,1,1,DNA damage induced protein phosphorylation,BP,MAPK12
7038,GO:1990967,0.330228343793393,1,1,1,multi-organism toxin transport,BP,RAB40B
5633,GO:0070201,0.331328998995887,0.808664228998784,9,25,regulation of establishment of protein localization,BP,BMP6;PMAIP1;KCNG2;CDH1;FZD7;RBP4;INHBB;BMP4;BMP7
5062,GO:0051716,0.331885154246425,0.745846260750879,55,177,cellular response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;ACADVL;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
1047,GO:0006725,0.332245241808166,0.75277091353279,34,104,cellular aromatic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3
3269,GO:0034660,0.332502615080267,0.894818003796983,3,6,ncRNA metabolic process,BP,PUS1;HRAS;LAGE3
1322,GO:0008105,0.33272854015478,1,1,1,asymmetric protein localization,BP,WNT7A
1809,GO:0014719,0.33272854015478,1,1,1,skeletal muscle satellite cell activation,BP,WNT7A
2293,GO:0021533,0.33272854015478,1,1,1,cell differentiation in hindbrain,BP,WNT7A
2305,GO:0021681,0.33272854015478,1,1,1,cerebellar granular layer development,BP,WNT7A
2306,GO:0021683,0.33272854015478,1,1,1,cerebellar granular layer morphogenesis,BP,WNT7A
2307,GO:0021684,0.33272854015478,1,1,1,cerebellar granular layer formation,BP,WNT7A
2317,GO:0021707,0.33272854015478,1,1,1,cerebellar granule cell differentiation,BP,WNT7A
2668,GO:0031133,0.33272854015478,1,1,1,regulation of axon diameter,BP,WNT7A
3388,GO:0035659,0.33272854015478,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
5108,GO:0051965,0.33272854015478,1,1,1,positive regulation of synapse assembly,BP,WNT7A
5195,GO:0060066,0.33272854015478,1,1,1,oviduct development,BP,WNT7A
5473,GO:0060997,0.33272854015478,1,1,1,dendritic spine morphogenesis,BP,WNT7A
6410,GO:0098815,0.33272854015478,1,1,1,modulation of excitatory postsynaptic potential,BP,WNT7A
6933,GO:1904889,0.33272854015478,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
6934,GO:1904891,0.33272854015478,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
6970,GO:1905383,0.33272854015478,1,1,1,protein localization to presynapse,BP,WNT7A
6971,GO:1905384,0.33272854015478,1,1,1,regulation of protein localization to presynapse,BP,WNT7A
6972,GO:1905386,0.33272854015478,1,1,1,positive regulation of protein localization to presynapse,BP,WNT7A
7129,GO:2000463,0.33272854015478,1,1,1,positive regulation of excitatory postsynaptic potential,BP,WNT7A
6302,GO:0097197,0.33332667727649,1,1,1,tetraspanin-enriched microdomain,CC,TSPAN15
4245,GO:0045732,0.333706390139173,0.886382866389507,3,7,positive regulation of protein catabolic process,BP,AXIN1;RNF144A;PSMB10
2714,GO:0031346,0.334012349427968,0.88621680463568,3,7,positive regulation of cell projection organization,BP,WNT3;HRAS;BMP7
2699,GO:0031324,0.334209991972539,0.771577799286988,18,54,negative regulation of cellular metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;ACADVL;VDR;DUSP5;INHBB;PKP1;BMP4;DEPTOR;TBC1D14;PSMB10;BMP7;PIK3CA;NOTCH1
2,GO:0000003,0.334689772737759,0.771177324191394,18,54,reproduction,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;SPTBN4;FSTL3;NOTCH1
2362,GO:0022414,0.334689772737759,0.771177324191394,18,54,reproductive process,BP,SLC2A14;WNT7A;GJB2;BMP6;WNT3;HEY1;WNT7B;JAG2;WNT2;RBP4;FGF8;VDR;INHBB;BMP4;BMP7;SPTBN4;FSTL3;NOTCH1
111,GO:0001522,0.335229803494396,1,1,1,pseudouridine synthesis,BP,PUS1
652,GO:0004730,0.335229803494396,1,1,1,pseudouridylate synthase activity,MF,PUS1
1571,GO:0009982,0.335229803494396,1,1,1,pseudouridine synthase activity,MF,PUS1
2037,GO:0016556,0.335229803494396,1,1,1,mRNA modification,BP,PUS1
2111,GO:0016866,0.335229803494396,1,1,1,intramolecular transferase activity,MF,PUS1
2665,GO:0031119,0.335229803494396,1,1,1,tRNA pseudouridine synthesis,BP,PUS1
5754,GO:0070902,0.335229803494396,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
7020,GO:1990481,0.335229803494396,1,1,1,mRNA pseudouridine synthesis,BP,PUS1
5878,GO:0071702,0.335339699285608,0.763150424041907,22,66,organic substance transport,BP,SLC2A14;RABIF;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;CNIH4;INHBB;ABCG1;BMP4;RAB3D;GDNF;USE1;TBC1D14;RAB38;BMP7;HNF1A;NOTCH1;RAB20
349,GO:0002521,0.335485729888649,0.819408776185478,7,20,leukocyte differentiation,BP,CLDN18;JAG2;FZD7;BMP4;FADD;TPD52;FSTL3
2548,GO:0030545,0.33575772353627,0.885267373238391,3,7,receptor regulator activity,MF,WNT7A;WNT3;WNT2
2549,GO:0030546,0.33575772353627,0.885267373238391,3,7,receptor activator activity,MF,WNT7A;WNT3;WNT2
227,GO:0001947,0.336375633028719,0.922304309471833,2,4,heart looping,BP,FGF8;NOTCH1
5560,GO:0061371,0.336375633028719,0.922304309471833,2,4,determination of heart left/right asymmetry,BP,FGF8;NOTCH1
729,GO:0005249,0.33733833197979,0.921908344591546,2,4,voltage-gated potassium channel activity,MF,KCNG2;KCNK6
736,GO:0005267,0.33733833197979,0.921908344591546,2,4,potassium channel activity,MF,KCNG2;KCNK6
1315,GO:0008076,0.33733833197979,0.921908344591546,2,4,voltage-gated potassium channel complex,CC,KCNG2;KCNK6
1856,GO:0015079,0.33733833197979,0.921908344591546,2,4,potassium ion transmembrane transporter activity,MF,KCNG2;KCNK6
3281,GO:0034705,0.33733833197979,0.921908344591546,2,4,potassium channel complex,CC,KCNG2;KCNK6
1610,GO:0010468,0.33756163859507,0.755193387547677,26,81,regulation of gene expression,BP,TLE1;WNT7A;BMP6;WNT3;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FSTL3;NOTCH1
756,GO:0005509,0.338856762286659,0.808730254757342,8,23,calcium ion binding,MF,SYT5;RHBDL3;ACTN3;JAG2;CDH1;DSG3;TPD52;NOTCH1
4077,GO:0044763,0.339687769548233,0.752194218792066,87,280,single-organism cellular process,BP,SLC2A14;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;CCL20;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RAB3D;KRT10;KCNK6;ECI1;GDNF;ETFDH;USE1;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DECR1;DRP2;FGF18;FSTL3;PTS;NOTCH1;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PEPD
5048,GO:0051648,0.339787855220897,0.883061323092778,3,7,vesicle localization,BP,WNT7A;SYT5;PIK3CG
3922,GO:0043588,0.340124186641438,0.826040862691221,6,17,skin development,BP,POU3F1;VDR;DSG3;PKP1;KRT10;NOTCH1
5743,GO:0070851,0.340211270216327,0.863193262975816,4,9,growth factor receptor binding,MF,FGF8;FGF17;FGF18;LINGO1
5170,GO:0060021,0.34057200036764,0.920570592981163,2,4,palate development,BP,WNT7A;JAG2
217,GO:0001932,0.340583337192331,0.768569995086302,17,51,regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;DEPTOR;BMP7;SPTBN4;PIK3CA;FGF18
4724,GO:0050660,0.341165972681266,0.920323573423142,2,4,flavin adenine dinucleotide binding,MF,ACADVL;ETFDH
1569,GO:0009968,0.341982547590749,0.775889745154057,14,42,negative regulation of signal transduction,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;FSTL3;NOTCH1
6789,GO:1903362,0.342530270807766,0.881549135525981,3,7,regulation of cellular protein catabolic process,BP,AXIN1;RNF144A;PSMB10
824,GO:0005796,0.343460280656811,0.856463450630782,4,10,Golgi lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
232,GO:0001957,0.343521404421606,1,1,1,intramembranous ossification,BP,FGF18
258,GO:0002063,0.343521404421606,1,1,1,chondrocyte development,BP,FGF18
3400,GO:0035766,0.343521404421606,1,1,1,cell chemotaxis to fibroblast growth factor,BP,FGF18
3402,GO:0035768,0.343521404421606,1,1,1,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
3466,GO:0036072,0.343521404421606,1,1,1,direct ossification,BP,FGF18
6926,GO:1904847,0.343521404421606,1,1,1,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
6927,GO:1904849,0.343521404421606,1,1,1,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
7140,GO:2000544,0.343521404421606,1,1,1,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
7141,GO:2000546,0.343521404421606,1,1,1,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
7199,GO:2001028,0.343521404421606,1,1,1,positive regulation of endothelial cell chemotaxis,BP,FGF18
1637,GO:0010594,0.343717836855737,0.856301742625137,4,10,regulation of endothelial cell migration,BP,WNT7A;BMP4;FGF18;NOTCH1
3994,GO:0044271,0.344391511422928,0.748495920982032,27,82,cellular nitrogen compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;PTS;NOTCH1;GUCY1B3
1563,GO:0009950,0.34449096347587,1,1,1,dorsal/ventral axis specification,BP,WNT3
1695,GO:0010770,0.34449096347587,1,1,1,positive regulation of cell morphogenesis involved in differentiation,BP,WNT3
4010,GO:0044338,0.34449096347587,1,1,1,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,WNT3
4011,GO:0044339,0.34449096347587,1,1,1,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,WNT3
4012,GO:0044340,0.34449096347587,1,1,1,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,WNT3
4645,GO:0048668,0.34449096347587,1,1,1,collateral sprouting,BP,WNT3
4646,GO:0048669,0.34449096347587,1,1,1,collateral sprouting in absence of injury,BP,WNT3
4647,GO:0048670,0.34449096347587,1,1,1,regulation of collateral sprouting,BP,WNT3
4648,GO:0048672,0.34449096347587,1,1,1,positive regulation of collateral sprouting,BP,WNT3
4651,GO:0048696,0.34449096347587,1,1,1,regulation of collateral sprouting in absence of injury,BP,WNT3
4652,GO:0048697,0.34449096347587,1,1,1,positive regulation of collateral sprouting in absence of injury,BP,WNT3
4768,GO:0050772,0.34449096347587,1,1,1,positive regulation of axonogenesis,BP,WNT3
5192,GO:0060061,0.34449096347587,1,1,1,Spemann organizer formation,BP,WNT3
5193,GO:0060064,0.34449096347587,1,1,1,Spemann organizer formation at the anterior end of the primitive streak,BP,WNT3
6071,GO:0072497,0.34449096347587,1,1,1,mesenchymal stem cell differentiation,BP,WNT3
6976,GO:1905474,0.34449096347587,1,1,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,WNT3
1116,GO:0006928,0.344511860865101,0.753099529814916,23,72,movement of cell or subcellular component,BP,WNT7A;PIK3CG;ACTN3;WNT3;JAG2;RRAS2;SPTBN5;SPTB;FGF8;AMOT;ARTN;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;FADD;BMP7;SPTBN4;PIK3CA;FGF18;NOTCH1
4803,GO:0050851,0.34468387886311,0.880355350143537,3,7,antigen receptor-mediated signaling pathway,BP,HRAS;PSMB10;PIK3CA
4804,GO:0050852,0.34468387886311,0.880355350143537,3,7,T cell receptor signaling pathway,BP,HRAS;PSMB10;PIK3CA
2476,GO:0030225,0.344806072735964,0.918800921410892,2,4,macrophage differentiation,BP,BMP4;FADD
1325,GO:0008113,0.345190104706812,1,1,1,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
2064,GO:0016671,0.345190104706812,1,1,1,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
2426,GO:0030091,0.345190104706812,1,1,1,protein repair,BP,MSRA
2148,GO:0017157,0.345538084829895,0.879880317421201,3,7,regulation of exocytosis,BP,SYT5;RAB3D;NOTCH1
1557,GO:0009914,0.346372575171706,0.854630512949351,4,10,hormone transport,BP,BMP6;KCNG2;RBP4;INHBB
4446,GO:0046879,0.346372575171706,0.854630512949351,4,10,hormone secretion,BP,BMP6;KCNG2;RBP4;INHBB
4450,GO:0046883,0.346372575171706,0.854630512949351,4,10,regulation of hormone secretion,BP,BMP6;KCNG2;RBP4;INHBB
4255,GO:0045747,0.346989007647492,0.917880507803123,2,4,positive regulation of Notch signaling pathway,BP,JAG2;NOTCH1
3524,GO:0038128,0.347026967391681,0.917864453942533,2,4,ERBB2 signaling pathway,BP,HRAS;PIK3CA
6164,GO:0090087,0.347151125365266,0.803782052482993,8,22,regulation of peptide transport,BP,BMP6;KCNG2;CDH1;FZD7;RBP4;INHBB;BMP4;BMP7
204,GO:0001894,0.347626987111423,0.878714990473187,3,7,tissue homeostasis,BP,CLDN18;RBP4;RAB3D
1673,GO:0010676,0.348247807979229,0.91734725297382,2,4,positive regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1746,GO:0010907,0.348247807979229,0.91734725297382,2,4,positive regulation of glucose metabolic process,BP,ACTN3;PMAIP1
5634,GO:0070227,0.348282968022596,0.917332332196527,2,4,lymphocyte apoptotic process,BP,BMP4;FADD
5638,GO:0070231,0.348282968022596,0.917332332196527,2,4,T cell apoptotic process,BP,BMP4;FADD
5826,GO:0071384,0.348322283792026,0.917315646175354,2,4,cellular response to corticosteroid stimulus,BP,GJB2;HEY1
5827,GO:0071385,0.348322283792026,0.917315646175354,2,4,cellular response to glucocorticoid stimulus,BP,GJB2;HEY1
2038,GO:0016567,0.348366973030285,0.835628755147273,5,13,protein ubiquitination,BP,MAGEC2;AXIN1;RAB40B;RNF144A;PSMB10
2935,GO:0032446,0.348366973030285,0.835628755147273,5,13,protein modification by small protein conjugation,BP,MAGEC2;AXIN1;RAB40B;RNF144A;PSMB10
3573,GO:0042110,0.349251944362518,0.819506287612405,6,17,T cell activation,BP,PIK3CG;JAG2;FZD7;BMP4;FADD;PIK3CA
2934,GO:0032438,0.349312319146443,1,1,1,melanosome organization,BP,RAB38
3133,GO:0033363,0.349312319146443,1,1,1,secretory granule organization,BP,RAB38
3384,GO:0035646,0.349312319146443,1,1,1,endosome to melanosome transport,BP,RAB38
3385,GO:0035650,0.349312319146443,1,1,1,AP-1 adaptor complex binding,MF,RAB38
3386,GO:0035651,0.349312319146443,1,1,1,AP-3 adaptor complex binding,MF,RAB38
3492,GO:0036461,0.349312319146443,1,1,1,BLOC-2 complex binding,MF,RAB38
3878,GO:0043476,0.349312319146443,1,1,1,pigment accumulation,BP,RAB38
3879,GO:0043482,0.349312319146443,1,1,1,cellular pigment accumulation,BP,RAB38
3881,GO:0043485,0.349312319146443,1,1,1,endosome to pigment granule transport,BP,RAB38
4674,GO:0048753,0.349312319146443,1,1,1,pigment granule organization,BP,RAB38
4676,GO:0048757,0.349312319146443,1,1,1,pigment granule maturation,BP,RAB38
5221,GO:0060155,0.349312319146443,1,1,1,platelet dense granule organization,BP,RAB38
6772,GO:1903232,0.349312319146443,1,1,1,melanosome assembly,BP,RAB38
3614,GO:0042326,0.350158332166437,0.834408015844467,5,13,negative regulation of phosphorylation,BP,ACTN3;DUSP5;BMP4;DEPTOR;BMP7
45,GO:0000285,0.35048423428149,1,1,1,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
878,GO:0006006,0.350647122895978,0.851922543419565,4,10,glucose metabolic process,BP,ACTN3;PMAIP1;RBP4;PIK3CA
6332,GO:0097479,0.351466965336534,0.915975226175316,2,4,synaptic vesicle localization,BP,WNT7A;SYT5
4537,GO:0048247,0.35167981482456,0.915884085602264,2,4,lymphocyte chemotaxis,BP,PIK3CG;CCL20
3542,GO:0040014,0.351930373344987,0.915776731003847,2,4,regulation of multicellular organism growth,BP,SPTBN4;PIK3CA
2655,GO:0031098,0.352501679262544,0.832805805682553,5,13,stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
3045,GO:0032872,0.352501679262544,0.832805805682553,5,13,regulation of stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
4995,GO:0051403,0.352501679262544,0.832805805682553,5,13,stress-activated MAPK cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
5662,GO:0070302,0.352501679262544,0.832805805682553,5,13,regulation of stress-activated protein kinase signaling cascade,BP,WNT7A;WNT7B;AXIN1;FZD7;HRAS
249,GO:0002028,0.353542849784679,0.915084104602541,2,4,regulation of sodium ion transport,BP,WNK4;SPTBN4
1076,GO:0006814,0.353542849784679,0.915084104602541,2,4,sodium ion transport,BP,WNK4;SPTBN4
3264,GO:0034645,0.354121525464135,0.741007802145977,26,80,cellular macromolecule biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;ALG5;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1;DPM3
7067,GO:2000107,0.354178504075732,0.914810234334225,2,4,negative regulation of leukocyte apoptotic process,BP,BMP4;FADD
1137,GO:0006979,0.354204873501449,0.817995155912476,6,16,response to oxidative stress,BP,GJB2;MSRA;FGF8;ETFDH;BMP7;GUCY1B3
1363,GO:0008284,0.354904388365515,0.774194649488573,12,34,positive regulation of cell proliferation,BP,WNT7A;BMP6;WNT2;FZD7;FGF8;FGF17;HRAS;BMP4;GDNF;FADD;FGF18;NOTCH1
2208,GO:0019222,0.355056987319514,0.728051913440536,42,133,regulation of metabolic process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;RNF144A;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;FGF18;FSTL3;PTS;NOTCH1;PM20D2
892,GO:0006084,0.355394778829965,0.914284894563317,2,4,acetyl-CoA metabolic process,BP,ACAT1;NUDT7
766,GO:0005525,0.355461287136752,0.790100467722995,9,25,GTP binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2181,GO:0019001,0.355461287136752,0.790100467722995,9,25,guanyl nucleotide binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2955,GO:0032549,0.355461287136752,0.790100467722995,9,25,ribonucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2956,GO:0032550,0.355461287136752,0.790100467722995,9,25,purine ribonucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
2960,GO:0032561,0.355461287136752,0.790100467722995,9,25,guanyl ribonucleotide binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
1562,GO:0009948,0.355528867446223,0.914226872863715,2,4,anterior/posterior axis specification,BP,WNT3;BMP4
4778,GO:0050794,0.355682125678177,0.726484891762065,69,223,regulation of cellular process,BP,MAGEC2;RHPN1;TLE1;WNT7A;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;GDNF;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;RAB20;GUCY1B3;PM20D2
715,GO:0005198,0.356115435269568,0.788450114166721,9,26,structural molecule activity,MF,ACTN3;CLDN18;AXIN1;MRPL14;SPTB;PKP1;CLDN15;KRT10;SPTBN4
3071,GO:0032963,0.356471175748459,0.913818533835811,2,4,collagen metabolic process,BP,BMP4;PEPD
3987,GO:0044259,0.356471175748459,0.913818533835811,2,4,multicellular organismal macromolecule metabolic process,BP,BMP4;PEPD
3202,GO:0034260,0.356671823969547,0.913731451344469,2,4,negative regulation of GTPase activity,BP,AMOT;HRAS
6576,GO:1901606,0.356965272804417,0.913604008215,2,4,alpha-amino acid catabolic process,BP,GLDC;ACAT1
3538,GO:0040008,0.357183932252911,0.787612056496701,9,26,regulation of growth,BP,ACTN3;WNT3;WNT2;RBP4;FGF8;BMP4;SPTBN4;PIK3CA;NOTCH1
1417,GO:0008670,0.357252127531223,1,1,1,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
2062,GO:0016651,0.357252127531223,1,1,1,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
1942,GO:0016043,0.357956666232717,0.724064879359435,46,147,cellular component organization,BP,TLE1;WNT7A;GJB2;SYT5;ACTN3;HACL1;RABIF;WNT3;ACAT1;WNT7B;PMAIP1;KCNG2;AXIN1;MRPL14;RAB40B;SPTBN5;CDH1;FZD7;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;ABCG1;PKP1;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;TBC1D14;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;DRP2;HNF1A;NOTCH1;LINGO1;RND3;RAB20
634,GO:0004623,0.357960982700467,1,1,1,phospholipase A2 activity,MF,PLA2G16
1022,GO:0006658,0.357960982700467,1,1,1,phosphatidylserine metabolic process,BP,PLA2G16
1024,GO:0006662,0.357960982700467,1,1,1,glycerol ether metabolic process,BP,PLA2G16
1150,GO:0007031,0.357960982700467,1,1,1,peroxisome organization,BP,PLA2G16
1420,GO:0008970,0.357960982700467,1,1,1,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
2178,GO:0018904,0.357960982700467,1,1,1,ether metabolic process,BP,PLA2G16
3474,GO:0036149,0.357960982700467,1,1,1,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
3475,GO:0036150,0.357960982700467,1,1,1,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
4376,GO:0046485,0.357960982700467,1,1,1,ether lipid metabolic process,BP,PLA2G16
5117,GO:0052739,0.357960982700467,1,1,1,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
5118,GO:0052740,0.357960982700467,1,1,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
6889,GO:1904177,0.357960982700467,1,1,1,regulation of adipose tissue development,BP,PLA2G16
5140,GO:0055038,0.359141872243526,0.912655581470361,2,4,recycling endosome membrane,CC,SYT5;FZD7
1954,GO:0016071,0.35939376352228,0.872053058828554,3,7,mRNA metabolic process,BP,ARL6IP4;PUS1;PKP1
1154,GO:0007040,0.360080383411012,0.912244925152675,2,4,lysosome organization,BP,RAB39A;RAB20
6117,GO:0080171,0.360080383411012,0.912244925152675,2,4,lytic vacuole organization,BP,RAB39A;RAB20
1527,GO:0009725,0.361478981963391,0.766756556247176,12,37,response to hormone,BP,GJB2;BMP6;HEY1;ACAT1;WNT7B;VDR;INHBB;ABCG1;BMP4;BMP7;PIK3CA;NOTCH1
626,GO:0004576,0.361725938058051,1,1,1,oligosaccharyl transferase activity,MF,ALG5
627,GO:0004581,0.361725938058051,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
3327,GO:0035251,0.361725938058051,1,1,1,UDP-glucosyltransferase activity,MF,ALG5
4385,GO:0046527,0.361725938058051,1,1,1,glucosyltransferase activity,MF,ALG5
5783,GO:0071260,0.362116551642099,0.911350421805303,2,4,cellular response to mechanical stimulus,BP,BMP6;FADD
6116,GO:0080135,0.362163232608218,0.801254535974473,7,19,regulation of cellular response to stress,BP,WNT7A;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;BMP7
2724,GO:0031401,0.362198191807899,0.750353237655619,17,51,positive regulation of protein modification process,BP,MAGEC2;WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;PSMB10;BMP7;PIK3CA;FGF18
631,GO:0004603,0.362533045457544,1,1,1,phenylethanolamine N-methyltransferase activity,MF,PNMT
1524,GO:0009713,0.362533045457544,1,1,1,catechol-containing compound biosynthetic process,BP,PNMT
3631,GO:0042414,0.362533045457544,1,1,1,epinephrine metabolic process,BP,PNMT
3633,GO:0042418,0.362533045457544,1,1,1,epinephrine biosynthetic process,BP,PNMT
3634,GO:0042423,0.362533045457544,1,1,1,catecholamine biosynthetic process,BP,PNMT
119,GO:0001562,0.362741137253851,1,1,1,response to protozoan,BP,HRAS
1636,GO:0010586,0.362741137253851,1,1,1,miRNA metabolic process,BP,HRAS
2740,GO:0031529,0.362741137253851,1,1,1,ruffle organization,BP,HRAS
3429,GO:0035900,0.362741137253851,1,1,1,response to isolation stress,BP,HRAS
3562,GO:0042088,0.362741137253851,1,1,1,T-helper 1 type immune response,BP,HRAS
3730,GO:0042832,0.362741137253851,1,1,1,defense response to protozoan,BP,HRAS
4524,GO:0048169,0.362741137253851,1,1,1,regulation of long-term neuronal synaptic plasticity,BP,HRAS
6290,GO:0097178,0.362741137253851,1,1,1,ruffle assembly,BP,HRAS
6468,GO:1900027,0.362741137253851,1,1,1,regulation of ruffle assembly,BP,HRAS
6469,GO:1900029,0.362741137253851,1,1,1,positive regulation of ruffle assembly,BP,HRAS
7098,GO:2000249,0.362741137253851,1,1,1,regulation of actin cytoskeleton reorganization,BP,HRAS
7099,GO:2000251,0.362741137253851,1,1,1,positive regulation of actin cytoskeleton reorganization,BP,HRAS
7147,GO:2000628,0.362741137253851,1,1,1,regulation of miRNA metabolic process,BP,HRAS
7148,GO:2000630,0.362741137253851,1,1,1,positive regulation of miRNA metabolic process,BP,HRAS
2861,GO:0032271,0.362899277260957,0.870036131444448,3,7,regulation of protein polymerization,BP,SPTBN5;SPTB;SPTBN4
915,GO:0006139,0.362976426806632,0.727116739418399,32,99,nucleobase-containing compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;NOTCH1;GUCY1B3
1548,GO:0009892,0.363024425037037,0.744684908953376,19,58,negative regulation of metabolic process,BP,TLE1;PIK3CG;ACTN3;BMP6;HEY1;AXIN1;ACADVL;VDR;DUSP5;INHBB;PKP1;HRAS;BMP4;DEPTOR;TBC1D14;PSMB10;BMP7;PIK3CA;NOTCH1
2428,GO:0030098,0.363370724729827,0.822509848332588,5,14,lymphocyte differentiation,BP,JAG2;FZD7;BMP4;FADD;TPD52
3059,GO:0032924,0.363682663631104,0.910659099419922,2,4,activin receptor signaling pathway,BP,INHBB;FSTL3
1967,GO:0016192,0.364673043145273,0.741251064913038,20,61,vesicle-mediated transport,BP,WNT7A;SYT5;PIK3CG;RABIF;RAB40B;SPTBN5;RAB39A;SPTB;CNIH4;PKP1;HRAS;RAB3D;USE1;TBC1D14;RAB38;SPTBN4;PIK3CA;NOTCH1;ZFYVE21;RAB20
3850,GO:0043331,0.365380423712998,0.909906396594812,2,4,response to dsRNA,BP,PMAIP1;BMP4
1581,GO:0010033,0.365706602305431,0.725530392650727,31,96,response to organic substance,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;PMAIP1;WNT2;ACADVL;CDH1;FZD7;RBP4;FGF8;VDR;WNT5B;CCL20;INHBB;ABCG1;FGF17;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
5680,GO:0070374,0.366658697931829,0.826461807522334,5,12,positive regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4;FGF18
1130,GO:0006959,0.367202336911405,0.909094859639382,2,4,humoral immune response,BP,PSMB10;NOTCH1
189,GO:0001839,0.368252678173582,1,1,1,neural plate morphogenesis,BP,FGF8
190,GO:0001840,0.368252678173582,1,1,1,neural plate development,BP,FGF8
1308,GO:0008045,0.368252678173582,1,1,1,motor neuron axon guidance,BP,FGF8
1316,GO:0008078,0.368252678173582,1,1,1,mesodermal cell migration,BP,FGF8
2297,GO:0021544,0.368252678173582,1,1,1,subpallium development,BP,FGF8
2322,GO:0021798,0.368252678173582,1,1,1,forebrain dorsal/ventral pattern formation,BP,FGF8
2334,GO:0021903,0.368252678173582,1,1,1,rostrocaudal neural tube patterning,BP,FGF8
2392,GO:0023019,0.368252678173582,1,1,1,signal transduction involved in regulation of gene expression,BP,FGF8
2628,GO:0030917,0.368252678173582,1,1,1,midbrain-hindbrain boundary development,BP,FGF8
3145,GO:0033563,0.368252678173582,1,1,1,dorsal/ventral axon guidance,BP,FGF8
4562,GO:0048382,0.368252678173582,1,1,1,mesendoderm development,BP,FGF8
6175,GO:0090133,0.368252678173582,1,1,1,mesendoderm migration,BP,FGF8
6176,GO:0090134,0.368252678173582,1,1,1,cell migration involved in mesendoderm migration,BP,FGF8
1261,GO:0007517,0.368354744513626,0.786113961782606,8,23,muscle organ development,BP,ACTN3;MAPK12;WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
3421,GO:0035850,0.36844785518029,0.866813273575677,3,7,epithelial cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
5777,GO:0071229,0.368541113929737,0.818848683863144,5,14,cellular response to acid chemical,BP,WNT3;WNT7B;WNT2;FZD7;WNT5B
565,GO:0003986,0.369975000827331,1,1,1,acetyl-CoA hydrolase activity,MF,NUDT7
1934,GO:0015938,0.369975000827331,1,1,1,coenzyme A catabolic process,BP,NUDT7
1980,GO:0016289,0.369975000827331,1,1,1,CoA hydrolase activity,MF,NUDT7
2539,GO:0030515,0.369975000827331,1,1,1,snoRNA binding,MF,NUDT7
3168,GO:0033869,0.369975000827331,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
3172,GO:0034031,0.369975000827331,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
3175,GO:0034034,0.369975000827331,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
4042,GO:0044444,0.370079856736695,0.717513309682348,78,248,cytoplasmic part,CC,MAGEC2;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;RABIF;MBOAT2;WNT3;GJB6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;MAPK12;MRPL14;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;TMEM160;RBP4;RAB39A;SPTB;PUS1;AMOT;WNT5B;NUDT7;DSG3;CNIH4;WNK4;TSFM;INHBB;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;FSTL3;PTS;NOTCH1;PNMT;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3
5546,GO:0061333,0.370627044279353,0.838985016858717,4,10,renal tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
5958,GO:0072078,0.370627044279353,0.838985016858717,4,10,nephron tubule morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
3650,GO:0042476,0.370980896207901,0.838751708701678,4,10,odontogenesis,BP,JAG2;FGF8;BMP4;BMP7
57,GO:0000502,0.371461652312273,1,1,1,proteasome complex,CC,PSMB10
587,GO:0004298,0.371461652312273,1,1,1,threonine-type endopeptidase activity,MF,PSMB10
833,GO:0005839,0.371461652312273,1,1,1,proteasome core complex,CC,PSMB10
987,GO:0006521,0.371461652312273,1,1,1,regulation of cellular amino acid metabolic process,BP,PSMB10
2670,GO:0031145,0.371461652312273,1,1,1,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
2671,GO:0031146,0.371461652312273,1,1,1,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
2720,GO:0031397,0.371461652312273,1,1,1,negative regulation of protein ubiquitination,BP,PSMB10
3121,GO:0033238,0.371461652312273,1,1,1,regulation of cellular amine metabolic process,BP,PSMB10
4999,GO:0051436,0.371461652312273,1,1,1,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
5000,GO:0051437,0.371461652312273,1,1,1,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
5002,GO:0051439,0.371461652312273,1,1,1,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
5004,GO:0051444,0.371461652312273,1,1,1,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
5603,GO:0070003,0.371461652312273,1,1,1,threonine-type peptidase activity,MF,PSMB10
6786,GO:1903321,0.371461652312273,1,1,1,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
6909,GO:1904666,0.371461652312273,1,1,1,regulation of ubiquitin protein ligase activity,BP,PSMB10
6910,GO:1904667,0.371461652312273,1,1,1,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
6911,GO:1904668,0.371461652312273,1,1,1,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
6968,GO:1905368,0.371461652312273,1,1,1,peptidase complex,CC,PSMB10
6969,GO:1905369,0.371461652312273,1,1,1,endopeptidase complex,CC,PSMB10
7003,GO:1990111,0.371461652312273,1,1,1,spermatoproteasome complex,CC,PSMB10
5957,GO:0072077,0.372156873996799,0.90686802332771,2,4,renal vesicle morphogenesis,BP,BMP4;GDNF
5961,GO:0072087,0.372156873996799,0.90686802332771,2,4,renal vesicle development,BP,BMP4;GDNF
2723,GO:0031400,0.372853753068231,0.81863634997239,5,13,negative regulation of protein modification process,BP,DUSP5;BMP4;DEPTOR;PSMB10;BMP7
4953,GO:0051260,0.372939096188466,0.837457948986533,4,10,protein homooligomerization,BP,ACAT1;KCNG2;SPTBN5;DECR1
5194,GO:0060065,0.373381950416058,0.906312895703193,2,4,uterus development,BP,WNT7A;RBP4
5342,GO:0060513,0.373385169882056,0.906311434479287,2,4,prostatic bud formation,BP,BMP4;BMP7
5375,GO:0060601,0.373385169882056,0.906311434479287,2,4,lateral sprouting from an epithelium,BP,BMP4;BMP7
561,GO:0003874,0.373964584083338,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
2104,GO:0016838,0.373964584083338,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
1671,GO:0010669,0.374168410112802,1,1,1,epithelial structure maintenance,BP,RBP4
2119,GO:0016918,0.374168410112802,1,1,1,retinal binding,MF,RBP4
2258,GO:0019841,0.374168410112802,1,1,1,retinol binding,MF,RBP4
2488,GO:0030277,0.374168410112802,1,1,1,maintenance of gastrointestinal epithelium,BP,RBP4
2816,GO:0032024,0.374168410112802,1,1,1,positive regulation of insulin secretion,BP,RBP4
3258,GO:0034632,0.374168410112802,1,1,1,retinol transporter activity,MF,RBP4
3259,GO:0034633,0.374168410112802,1,1,1,retinol transport,BP,RBP4
3679,GO:0042572,0.374168410112802,1,1,1,retinol metabolic process,BP,RBP4
4399,GO:0046621,0.374168410112802,1,1,1,negative regulation of organ growth,BP,RBP4
4440,GO:0046864,0.374168410112802,1,1,1,isoprenoid transport,BP,RBP4
4441,GO:0046865,0.374168410112802,1,1,1,terpenoid transport,BP,RBP4
4552,GO:0048305,0.374168410112802,1,1,1,immunoglobulin secretion,BP,RBP4
4861,GO:0051023,0.374168410112802,1,1,1,regulation of immunoglobulin secretion,BP,RBP4
4862,GO:0051024,0.374168410112802,1,1,1,positive regulation of immunoglobulin secretion,BP,RBP4
5134,GO:0055022,0.374168410112802,1,1,1,negative regulation of cardiac muscle tissue growth,BP,RBP4
5183,GO:0060044,0.374168410112802,1,1,1,negative regulation of cardiac muscle cell proliferation,BP,RBP4
5191,GO:0060059,0.374168410112802,1,1,1,embryonic retina morphogenesis in camera-type eye,BP,RBP4
5509,GO:0061117,0.374168410112802,1,1,1,negative regulation of heart growth,BP,RBP4
6214,GO:0090277,0.374168410112802,1,1,1,positive regulation of peptide hormone secretion,BP,RBP4
3841,GO:0043296,0.374254475432116,0.801162291674091,6,17,apical junction complex,CC,TJP3;CLDN18;CDH1;AMOT;WNK4;CLDN15
1408,GO:0008625,0.374351790071015,0.905872151993808,2,4,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;FADD
2294,GO:0021536,0.37440971389753,0.863308589104323,3,7,diencephalon development,BP,CDH1;FGF8;BMP4
2342,GO:0021983,0.37440971389753,0.863308589104323,3,7,pituitary gland development,BP,CDH1;FGF8;BMP4
6402,GO:0098797,0.374849253739657,0.814341973667229,5,14,plasma membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1;FADD
4582,GO:0048514,0.375033990287884,0.766209348585672,10,30,blood vessel morphogenesis,BP,WNT7A;PIK3CG;HEY1;WNT7B;FGF8;AMOT;BMP4;PIK3CA;FGF18;NOTCH1
1260,GO:0007507,0.375067925344123,0.779582472821782,8,24,heart development,BP,HEY1;WNT2;FZD7;RBP4;FGF8;BMP4;BMP7;NOTCH1
3296,GO:0035019,0.375880775110461,0.905175014865088,2,4,somatic stem cell population maintenance,BP,WNT7A;BMP7
1887,GO:0015629,0.376314109855482,0.787229746039,7,21,actin cytoskeleton,CC,ACTN3;MSRA;SPTBN5;CDH1;SPTB;AMOT;SPTBN4
2429,GO:0030099,0.376359313646618,0.831144959916462,4,11,myeloid cell differentiation,BP,CLDN18;BMP4;FADD;FSTL3
562,GO:0003924,0.376695876970048,0.780998700916795,8,22,GTPase activity,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20
3543,GO:0040017,0.376781570226287,0.76571357844587,10,29,positive regulation of locomotion,BP,WNT7A;RRAS2;ARTN;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
2413,GO:0030041,0.377153016583789,0.861681330170013,3,7,actin filament polymerization,BP,SPTBN5;SPTB;SPTBN4
1299,GO:0008009,0.378709759039945,1,1,1,chemokine activity,MF,CCL20
2775,GO:0031731,0.378709759039945,1,1,1,CCR6 chemokine receptor binding,MF,CCL20
2973,GO:0032610,0.378709759039945,1,1,1,interleukin-1 alpha production,BP,CCL20
2987,GO:0032650,0.378709759039945,1,1,1,regulation of interleukin-1 alpha production,BP,CCL20
3008,GO:0032730,0.378709759039945,1,1,1,positive regulation of interleukin-1 alpha production,BP,CCL20
3368,GO:0035584,0.378709759039945,1,1,1,calcium-mediated signaling using intracellular calcium source,BP,CCL20
3594,GO:0042222,0.378709759039945,1,1,1,interleukin-1 biosynthetic process,BP,CCL20
4176,GO:0045360,0.378709759039945,1,1,1,regulation of interleukin-1 biosynthetic process,BP,CCL20
4177,GO:0045362,0.378709759039945,1,1,1,positive regulation of interleukin-1 biosynthetic process,BP,CCL20
4752,GO:0050719,0.378709759039945,1,1,1,interleukin-1 alpha biosynthetic process,BP,CCL20
4753,GO:0050721,0.378709759039945,1,1,1,regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
4754,GO:0050726,0.378709759039945,1,1,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,CCL20
5067,GO:0051770,0.378709759039945,1,1,1,positive regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
5683,GO:0070391,0.378709759039945,1,1,1,response to lipoteichoic acid,BP,CCL20
5776,GO:0071223,0.378709759039945,1,1,1,cellular response to lipoteichoic acid,BP,CCL20
6111,GO:0072679,0.378709759039945,1,1,1,thymocyte migration,BP,CCL20
3760,GO:0043065,0.379271335453522,0.788234587605518,7,19,positive regulation of apoptotic process,BP,PMAIP1;VDR;INHBB;BMP4;FADD;BMP7;NOTCH1
537,GO:0003676,0.379694433372158,0.763337534345323,10,29,nucleic acid binding,MF,HEY1;POU3F1;MRPL14;ARL6IP4;VDR;PUS1;NUDT7;TSFM;HNF1A;NOTCH1
968,GO:0006469,0.380170068851214,0.832641646322045,4,10,negative regulation of protein kinase activity,BP,DUSP5;BMP4;DEPTOR;BMP7
3157,GO:0033673,0.380170068851214,0.832641646322045,4,10,negative regulation of kinase activity,BP,DUSP5;BMP4;DEPTOR;BMP7
7221,GO:2001236,0.380951035957051,0.816482407440159,5,12,regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF;DEPTOR;FADD
1070,GO:0006807,0.381282495985016,0.705010198701888,41,128,nitrogen compound metabolic process,BP,GLDC;TLE1;WNT7A;ACTN3;MBOAT2;BMP6;HEY1;ACAT1;MSRA;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;PLA2G16;HNF1A;LAGE3;FSTL3;PTS;NOTCH1;PNMT;CPT1C;GUCY1B3;PEPD
5902,GO:0071840,0.381351883187786,0.70291736060523,46,148,cellular component organization or biogenesis,BP,TLE1;WNT7A;GJB2;SYT5;ACTN3;HACL1;RABIF;WNT3;ACAT1;WNT7B;PMAIP1;KCNG2;AXIN1;MRPL14;RAB40B;SPTBN5;CDH1;FZD7;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;ABCG1;PKP1;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;TBC1D14;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;DECR1;DRP2;HNF1A;NOTCH1;LINGO1;RND3;RAB20
522,GO:0003338,0.382248995083464,0.858633975138047,3,7,metanephros morphogenesis,BP,WNT7B;BMP4;GDNF
3109,GO:0033135,0.382662141931913,0.851999022929111,3,8,regulation of peptidyl-serine phosphorylation,BP,AXIN1;SPTBN4;PIK3CA
2700,GO:0031325,0.383159311957038,0.709806545395695,31,97,positive regulation of cellular metabolic process,BP,MAGEC2;WNT7A;PIK3CG;ACTN3;BMP6;HEY1;WNT7B;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;CCL20;DUSP5;INHBB;HRAS;BMP4;RNF144A;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1
4894,GO:0051147,0.383583305308111,0.826213755933593,4,11,regulation of muscle cell differentiation,BP,MAPK12;FZD7;BMP4;NOTCH1
2100,GO:0016830,0.384299405638267,0.901286087993114,2,4,carbon-carbon lyase activity,MF,HACL1;ACAT1
5751,GO:0070887,0.384895228033321,0.709985107120922,29,92,cellular response to chemical stimulus,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;WNT7B;PMAIP1;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;WNT5B;CCL20;INHBB;FGF17;BMP4;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1;GUCY1B3
3049,GO:0032880,0.384923943991338,0.752671968880253,11,33,regulation of protein localization,BP,WNT7A;CLDN18;BMP6;PMAIP1;KCNG2;CDH1;FZD7;RBP4;INHBB;BMP4;BMP7
120,GO:0001568,0.38533560554578,0.746895279000397,12,37,blood vessel development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;BMP7;PIK3CA;FGF18;NOTCH1
2286,GO:0019953,0.385874329140047,0.772287748310327,8,23,sexual reproduction,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;SPTBN4;FSTL3;NOTCH1
2909,GO:0032386,0.386518212711143,0.805889294000029,5,14,regulation of intracellular transport,BP,BMP6;CDH1;FZD7;BMP4;BMP7
237,GO:0001963,0.386813557035058,1,1,1,synaptic transmission, dopaminergic,BP,GDNF
1792,GO:0014046,0.386813557035058,1,1,1,dopamine secretion,BP,GDNF
1796,GO:0014059,0.386813557035058,1,1,1,regulation of dopamine secretion,BP,GDNF
1919,GO:0015872,0.386813557035058,1,1,1,dopamine transport,BP,GDNF
2320,GO:0021784,0.386813557035058,1,1,1,postganglionic parasympathetic fiber development,BP,GDNF
2524,GO:0030432,0.386813557035058,1,1,1,peristalsis,BP,GDNF
2846,GO:0032225,0.386813557035058,1,1,1,regulation of synaptic transmission, dopaminergic,BP,GDNF
3149,GO:0033603,0.386813557035058,1,1,1,positive regulation of dopamine secretion,BP,GDNF
3151,GO:0033605,0.386813557035058,1,1,1,positive regulation of catecholamine secretion,BP,GDNF
3884,GO:0043489,0.386813557035058,1,1,1,RNA stabilization,BP,GDNF
4539,GO:0048255,0.386813557035058,1,1,1,mRNA stabilization,BP,GDNF
4572,GO:0048483,0.386813557035058,1,1,1,autonomic nervous system development,BP,GDNF
4573,GO:0048484,0.386813557035058,1,1,1,enteric nervous system development,BP,GDNF
4574,GO:0048485,0.386813557035058,1,1,1,sympathetic nervous system development,BP,GDNF
4575,GO:0048486,0.386813557035058,1,1,1,parasympathetic nervous system development,BP,GDNF
5031,GO:0051580,0.386813557035058,1,1,1,regulation of neurotransmitter uptake,BP,GDNF
5032,GO:0051583,0.386813557035058,1,1,1,dopamine uptake involved in synaptic transmission,BP,GDNF
5033,GO:0051584,0.386813557035058,1,1,1,regulation of dopamine uptake involved in synaptic transmission,BP,GDNF
5034,GO:0051588,0.386813557035058,1,1,1,regulation of neurotransmitter transport,BP,GDNF
5094,GO:0051934,0.386813557035058,1,1,1,catecholamine uptake involved in synaptic transmission,BP,GDNF
5097,GO:0051940,0.386813557035058,1,1,1,regulation of catecholamine uptake involved in synaptic transmission,BP,GDNF
5100,GO:0051954,0.386813557035058,1,1,1,positive regulation of amine transport,BP,GDNF
5392,GO:0060676,0.386813557035058,1,1,1,ureteric bud formation,BP,GDNF
5975,GO:0072106,0.386813557035058,1,1,1,regulation of ureteric bud formation,BP,GDNF
5976,GO:0072107,0.386813557035058,1,1,1,positive regulation of ureteric bud formation,BP,GDNF
6004,GO:0072172,0.386813557035058,1,1,1,mesonephric tubule formation,BP,GDNF
6237,GO:0090493,0.386813557035058,1,1,1,catecholamine uptake,BP,GDNF
6238,GO:0090494,0.386813557035058,1,1,1,dopamine uptake,BP,GDNF
6407,GO:0098810,0.386813557035058,1,1,1,neurotransmitter reuptake,BP,GDNF
6962,GO:1905278,0.386813557035058,1,1,1,positive regulation of epithelial tube formation,BP,GDNF
2895,GO:0032355,0.387589302932153,0.855406109528398,3,7,response to estradiol,BP,WNT7A;GJB2;BMP7
3582,GO:0042157,0.387663190428062,0.855361201522705,3,7,lipoprotein metabolic process,BP,ABCG1;LYPLAL1;DPM3
6485,GO:1900182,0.387933086953594,0.848695091590779,3,8,positive regulation of protein localization to nucleus,BP,BMP6;CDH1;BMP4
290,GO:0002250,0.389551468153629,0.854211225410422,3,7,adaptive immune response,BP,PIK3CG;HRAS;FADD
2774,GO:0031730,0.389745800131113,1,1,1,CCR5 chemokine receptor binding,MF,CNIH4
6288,GO:0097164,0.390818270364278,0.853437246923879,3,7,ammonium ion metabolic process,BP,MBOAT2;PLA2G16;CPT1C
386,GO:0002699,0.391331289568512,0.897971695045154,2,4,positive regulation of immune effector process,BP,RBP4;FADD
1252,GO:0007431,0.391669594565104,0.897810710219147,2,4,salivary gland development,BP,FGF8;BMP7
1253,GO:0007435,0.391669594565104,0.897810710219147,2,4,salivary gland morphogenesis,BP,FGF8;BMP7
3334,GO:0035272,0.391669594565104,0.897810710219147,2,4,exocrine system development,BP,FGF8;BMP7
5322,GO:0060445,0.391669594565104,0.897810710219147,2,4,branching involved in salivary gland morphogenesis,BP,FGF8;BMP7
4218,GO:0045637,0.391757148417716,0.846276328251685,3,8,regulation of myeloid cell differentiation,BP,CLDN18;FADD;FSTL3
2911,GO:0032388,0.391900096471303,0.846185555953351,3,8,positive regulation of intracellular transport,BP,BMP6;CDH1;BMP4
342,GO:0002460,0.392274070201717,0.897522715264862,2,4,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,HRAS;FADD
5531,GO:0061217,0.392701391644773,0.89731885151812,2,4,regulation of mesonephros development,BP,BMP4;GDNF
2079,GO:0016747,0.393060402943274,0.845447808099799,3,8,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2;ACAT1;CPT1C
3247,GO:0034470,0.394901564118546,0.896265638563047,2,4,ncRNA processing,BP,PUS1;LAGE3
74,GO:0000975,0.395404316298773,0.84395232592376,3,8,regulatory region DNA binding,MF,VDR;HNF1A;NOTCH1
86,GO:0001067,0.395404316298773,0.84395232592376,3,8,regulatory region nucleic acid binding,MF,VDR;HNF1A;NOTCH1
3973,GO:0044212,0.395404316298773,0.84395232592376,3,8,transcription regulatory region DNA binding,MF,VDR;HNF1A;NOTCH1
740,GO:0005319,0.395459991878529,0.895997368946909,2,4,lipid transporter activity,MF,RBP4;ABCG1
3830,GO:0043269,0.395469331614744,0.773804913614918,7,20,regulation of ion transport,BP,PIK3CG;KCNG2;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13
5318,GO:0060441,0.395535630122013,0.895961002504107,2,4,epithelial tube branching involved in lung morphogenesis,BP,WNT2;BMP4
3333,GO:0035270,0.396129175163868,0.798813644601454,5,14,endocrine system development,BP,BMP6;CDH1;FGF8;BMP4;FSTL3
3882,GO:0043487,0.3974625291478,0.89503216684806,2,4,regulation of RNA stability,BP,GDNF;PSMB10
3883,GO:0043488,0.3974625291478,0.89503216684806,2,4,regulation of mRNA stability,BP,GDNF;PSMB10
2024,GO:0016462,0.39746411029141,0.755252240548204,9,26,pyrophosphatase activity,MF,RAB40B;RRAS2;RAB39A;ABCG1;HRAS;RAB3D;RAB38;RND3;RAB20
2096,GO:0016817,0.39746411029141,0.755252240548204,9,26,hydrolase activity, acting on acid anhydrides,MF,RAB40B;RRAS2;RAB39A;ABCG1;HRAS;RAB3D;RAB38;RND3;RAB20
2097,GO:0016818,0.39746411029141,0.755252240548204,9,26,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RAB40B;RRAS2;RAB39A;ABCG1;HRAS;RAB3D;RAB38;RND3;RAB20
2137,GO:0017111,0.39746411029141,0.755252240548204,9,26,nucleoside-triphosphatase activity,MF,RAB40B;RRAS2;RAB39A;ABCG1;HRAS;RAB3D;RAB38;RND3;RAB20
3996,GO:0044273,0.397564764713481,0.894982756750178,2,4,sulfur compound catabolic process,BP,ACAT1;NUDT7
5361,GO:0060563,0.39792288850195,0.842337679701527,3,8,neuroepithelial cell differentiation,BP,JAG2;FGF8;NOTCH1
4,GO:0000030,0.398284356075647,1,1,1,mannosyltransferase activity,MF,DPM3
628,GO:0004582,0.398284356075647,1,1,1,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
981,GO:0006505,0.398284356075647,1,1,1,GPI anchor metabolic process,BP,DPM3
982,GO:0006506,0.398284356075647,1,1,1,GPI anchor biosynthetic process,BP,DPM3
1476,GO:0009247,0.398284356075647,1,1,1,glycolipid biosynthetic process,BP,DPM3
2152,GO:0018103,0.398284356075647,1,1,1,protein C-linked glycosylation,BP,DPM3
2167,GO:0018211,0.398284356075647,1,1,1,peptidyl-tryptophan modification,BP,DPM3
2170,GO:0018317,0.398284356075647,1,1,1,protein C-linked glycosylation via tryptophan,BP,DPM3
2174,GO:0018406,0.398284356075647,1,1,1,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
2736,GO:0031501,0.398284356075647,1,1,1,mannosyltransferase complex,CC,DPM3
3118,GO:0033185,0.398284356075647,1,1,1,dolichol-phosphate-mannose synthase complex,CC,DPM3
3331,GO:0035268,0.398284356075647,1,1,1,protein mannosylation,BP,DPM3
3332,GO:0035269,0.398284356075647,1,1,1,protein O-linked mannosylation,BP,DPM3
4369,GO:0046467,0.398284356075647,1,1,1,membrane lipid biosynthetic process,BP,DPM3
6335,GO:0097502,0.398284356075647,1,1,1,mannosylation,BP,DPM3
1224,GO:0007276,0.398727742626625,0.771224444152044,7,20,gamete generation,BP,SLC2A14;WNT3;JAG2;INHBB;BMP4;FSTL3;NOTCH1
4785,GO:0050804,0.39904593715302,0.819778612837872,4,10,modulation of synaptic transmission,BP,WNT7A;PXK;HRAS;GDNF
974,GO:0006486,0.400222526601623,0.893693702510031,2,4,protein glycosylation,BP,ALG5;DPM3
3866,GO:0043413,0.400222526601623,0.893693702510031,2,4,macromolecule glycosylation,BP,ALG5;DPM3
5614,GO:0070085,0.400222526601623,0.893693702510031,2,4,glycosylation,BP,ALG5;DPM3
3983,GO:0044249,0.401353431404321,0.687680446431649,39,122,cellular biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;FGF17;ALG5;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3;DPM3
7086,GO:2000181,0.401591816272826,0.87996866650315,2,5,negative regulation of blood vessel morphogenesis,BP,AMOT;NOTCH1
2946,GO:0032504,0.401750979201154,0.750579591700549,9,27,multicellular organism reproduction,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
4621,GO:0048609,0.401750979201154,0.750579591700549,9,27,multicellular organismal reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;FSTL3;NOTCH1
769,GO:0005543,0.401938633086013,0.794486595900022,5,14,phospholipid binding,MF,SYT5;PXK;FZD7;ABCG1;SPTBN4
498,GO:0003231,0.402425112038661,0.839431314016192,3,8,cardiac ventricle development,BP,HEY1;BMP4;NOTCH1
508,GO:0003281,0.402425112038661,0.839431314016192,3,8,ventricular septum development,BP,HEY1;BMP4;NOTCH1
816,GO:0005782,0.402753361021994,0.892458010171224,2,4,peroxisomal matrix,CC,HACL1;NUDT7
2785,GO:0031907,0.402753361021994,0.892458010171224,2,4,microbody lumen,CC,HACL1;NUDT7
5121,GO:0055001,0.4028711574986,0.839141972965058,3,8,muscle cell development,BP,AXIN1;BMP4;NOTCH1
6550,GO:1901342,0.403009953914504,0.791110116147775,5,15,regulation of vasculature development,BP,HEY1;AMOT;BMP4;BMP7;NOTCH1
198,GO:0001883,0.404029378117779,0.749835848732382,9,26,purine nucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
636,GO:0004672,0.405082000643366,0.755432495784486,8,24,protein kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA;FGF18
282,GO:0002218,0.405565722245505,0.844279116439536,3,7,activation of innate immune response,BP,HRAS;PSMB10;FADD
842,GO:0005884,0.405928346421816,0.877616495882261,2,5,actin filament,CC,ACTN3;AMOT
5179,GO:0060039,0.406389841450559,0.877364705939061,2,5,pericardium development,BP,BMP7;NOTCH1
4865,GO:0051046,0.406969949470224,0.747396881332626,9,26,regulation of secretion,BP,SYT5;BMP6;KCNG2;RBP4;WNK4;INHBB;RAB3D;GDNF;NOTCH1
3279,GO:0034703,0.407806218699969,0.835923779684161,3,8,cation channel complex,CC,KCNG2;KCNK6;CPT1C
402,GO:0002757,0.408582429507694,0.808672845250029,4,11,immune response-activating signal transduction,BP,HRAS;PSMB10;FADD;PIK3CA
407,GO:0002764,0.408582429507694,0.808672845250029,4,11,immune response-regulating signaling pathway,BP,HRAS;PSMB10;FADD;PIK3CA
930,GO:0006260,0.408852299183377,0.84220077237061,3,7,DNA replication,BP,BMP6;HRAS;BMP4
5126,GO:0055008,0.409865176525914,0.875459448316974,2,5,cardiac muscle tissue morphogenesis,BP,WNT2;NOTCH1
5297,GO:0060415,0.409865176525914,0.875459448316974,2,5,muscle tissue morphogenesis,BP,WNT2;NOTCH1
5115,GO:0052689,0.41020348480011,0.88877368592227,2,4,carboxylic ester hydrolase activity,MF,LYPLAL1;PLA2G16
3899,GO:0043534,0.410886938214435,0.874896222065856,2,5,blood vessel endothelial cell migration,BP,AMOT;NOTCH1
2154,GO:0018107,0.411013349200971,0.874826443163967,2,5,peptidyl-threonine phosphorylation,BP,AXIN1;BMP7
2166,GO:0018210,0.411013349200971,0.874826443163967,2,5,peptidyl-threonine modification,BP,AXIN1;BMP7
1580,GO:0010008,0.411694353753765,0.787134876124543,5,14,endosome membrane,CC,SYT5;FZD7;TSPAN15;RNF144A;ZFYVE21
4040,GO:0044440,0.411694353753765,0.787134876124543,5,14,endosomal part,CC,SYT5;FZD7;TSPAN15;RNF144A;ZFYVE21
488,GO:0003209,0.411694785674424,0.874449920622843,2,5,cardiac atrium morphogenesis,BP,WNT2;NOTCH1
497,GO:0003230,0.411694785674424,0.874449920622843,2,5,cardiac atrium development,BP,WNT2;NOTCH1
6373,GO:0098602,0.412202695454493,0.73355204312505,10,32,single organism cell adhesion,BP,PIK3CG;WNT7B;CDH1;FZD7;PKP1;BMP4;FADD;BMP7;PIK3CA;FSTL3
6864,GO:1903828,0.412663018324429,0.873913858226942,2,5,negative regulation of cellular protein localization,BP,CLDN18;BMP7
5716,GO:0070647,0.412681438106261,0.786385042837685,5,14,protein modification by small protein conjugation or removal,BP,MAGEC2;AXIN1;RAB40B;RNF144A;PSMB10
3330,GO:0035265,0.412916865466964,0.810055477325734,4,10,organ growth,BP,WNT2;RBP4;FGF8;NOTCH1
6942,GO:1904950,0.413562880113723,0.873414518835901,2,5,negative regulation of establishment of protein localization,BP,INHBB;BMP7
2204,GO:0019218,0.413627015292835,0.805042777603463,4,11,regulation of steroid metabolic process,BP,BMP6;ACADVL;VDR;ABCG1
6813,GO:1903530,0.414363272662909,0.749173935929356,8,23,regulation of secretion by cell,BP,SYT5;BMP6;KCNG2;RBP4;INHBB;RAB3D;GDNF;NOTCH1
1554,GO:0009898,0.415245841220464,0.872477703605718,2,5,cytoplasmic side of plasma membrane,CC,CDH1;SPTB
6363,GO:0098562,0.415245841220464,0.872477703605718,2,5,cytoplasmic side of membrane,CC,CDH1;SPTB
7118,GO:2000403,0.415544727905602,0.886088924847938,2,4,positive regulation of lymphocyte migration,BP,CCL20;FADD
7119,GO:2000404,0.415544727905602,0.886088924847938,2,4,regulation of T cell migration,BP,CCL20;FADD
7120,GO:2000406,0.415544727905602,0.886088924847938,2,4,positive regulation of T cell migration,BP,CCL20;FADD
4219,GO:0045638,0.415936756842521,0.872092000548708,2,5,negative regulation of myeloid cell differentiation,BP,CLDN18;FSTL3
6643,GO:1902105,0.415990690804625,0.803331332936543,4,11,regulation of leukocyte differentiation,BP,CLDN18;BMP4;FADD;FSTL3
1182,GO:0007166,0.416272305287013,0.679447899363262,31,99,cell surface receptor signaling pathway,BP,TLE1;WNT7A;CLDN18;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;MAPK12;WNT2;FZD7;FGF8;WNT5B;CCL20;INHBB;FGF17;HRAS;TSPAN15;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1
4980,GO:0051341,0.416994070200461,0.836992823402818,3,7,regulation of oxidoreductase activity,BP,VDR;GDNF;PTS
1072,GO:0006810,0.417246050242209,0.671365161159927,42,135,transport,BP,SLC2A14;WNT7A;GJB2;SYT5;PIK3CG;RABIF;BMP6;GJA3;PMAIP1;KCNG2;RAB40B;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;VDR;CNIH4;WNK4;INHBB;ABCG1;PKP1;HRAS;BMP4;RAB3D;CLDN15;KCNK6;GDNF;USE1;TBC1D14;PSMB10;RAB38;BMP7;SPTBN4;PIK3CA;TPD52;HNF1A;TSPAN13;NOTCH1;ZFYVE21;RAB20
647,GO:0004713,0.418871916013949,0.835779585379559,3,7,protein tyrosine kinase activity,MF,FGF8;FGF17;FGF18
7010,GO:1990234,0.419009917256151,0.801135405289011,4,11,transferase complex,CC,PIK3CG;RNF144A;PIK3CA;DPM3
1398,GO:0008543,0.4190706161135,0.835650943704294,3,7,fibroblast growth factor receptor signaling pathway,BP,FGF8;FGF17;FGF18
2676,GO:0031214,0.419509243383255,0.828167332038568,3,8,biomineral tissue development,BP,BMP6;BMP4;BMP7
5627,GO:0070167,0.419509243383255,0.828167332038568,3,8,regulation of biomineral tissue development,BP,BMP6;BMP4;BMP7
4906,GO:0051171,0.419604162099635,0.682112159122759,26,82,regulation of nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FSTL3;NOTCH1
1270,GO:0007584,0.419901355519063,0.86986626843086,2,5,response to nutrient,BP,VDR;BMP7
3785,GO:0043167,0.421467218031734,0.667388671553373,42,136,ion binding,MF,GLDC;SYT5;PIK3CG;RHBDL3;ACTN3;HACL1;RABIF;ACAT1;JAG2;MAPK12;ACADVL;PXK;RAB40B;RRAS2;CDH1;FZD7;RAB39A;VDR;NUDT7;DSG3;WNK4;ABCG1;PKN3;HRAS;BMP4;RNF144A;RAB3D;ETFDH;RAB38;BMP7;SPTBN4;PIK3CA;TPD52;DECR1;DRP2;PTS;NOTCH1;RND3;ZFYVE21;RAB20;GUCY1B3;PEPD
6025,GO:0072207,0.423173627206844,0.868013107244041,2,5,metanephric epithelium development,BP,ACAT1;WNT7B
5623,GO:0070161,0.423301813150815,0.730453939746115,9,29,anchoring junction,CC,ACTN3;RRAS2;CDH1;DSG3;PKP1;SPTBN4;NOTCH1;RND3;ZFYVE21
3891,GO:0043506,0.423477122267625,0.867840490270249,2,5,regulation of JUN kinase activity,BP,WNT7B;AXIN1
3892,GO:0043507,0.423477122267625,0.867840490270249,2,5,positive regulation of JUN kinase activity,BP,WNT7B;AXIN1
4612,GO:0048585,0.423913774801335,0.701526822492265,15,47,negative regulation of response to stimulus,BP,TLE1;ACTN3;WNT3;HEY1;AXIN1;WNT5B;DUSP5;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;FSTL3;NOTCH1
4711,GO:0048878,0.423952172692688,0.708769326502034,13,41,chemical homeostasis,BP,PIK3CG;BMP6;GJB6;WNT7B;RBP4;RAB39A;VDR;WNK4;ABCG1;RAB38;PIK3CA;HNF1A;RAB20
466,GO:0003171,0.424454041206283,0.867283998203281,2,5,atrioventricular valve development,BP,HEY1;NOTCH1
473,GO:0003181,0.424454041206283,0.867283998203281,2,5,atrioventricular valve morphogenesis,BP,HEY1;NOTCH1
1091,GO:0006873,0.425145911227078,0.761789517124665,6,17,cellular ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20
2399,GO:0030003,0.425145911227078,0.761789517124665,6,17,cellular cation homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20
1628,GO:0010558,0.425353994759502,0.729688243859514,9,28,negative regulation of macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;INHBB;BMP4;BMP7;NOTCH1
4868,GO:0051049,0.425685793703029,0.68462503586216,21,66,regulation of transport,BP,SYT5;PIK3CG;BMP6;PMAIP1;KCNG2;CDH1;FZD7;RBP4;WNK4;INHBB;ABCG1;BMP4;RAB3D;KCNK6;GDNF;TBC1D14;BMP7;SPTBN4;TSPAN13;NOTCH1;RAB20
818,GO:0005788,0.426925371007756,0.795325840079887,4,11,endoplasmic reticulum lumen,CC,WNT7A;WNT3;WNT7B;WNT5B
1311,GO:0008064,0.426934646355575,0.823154090638639,3,8,regulation of actin polymerization or depolymerization,BP,SPTBN5;SPTB;SPTBN4
2596,GO:0030832,0.426934646355575,0.823154090638639,3,8,regulation of actin filament length,BP,SPTBN5;SPTB;SPTBN4
4584,GO:0048518,0.427349414135785,0.66116275513541,44,142,positive regulation of biological process,BP,MAGEC2;TLE1;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;RRAS2;CDH1;FZD7;RBP4;FGF8;VDR;AMOT;ARTN;WNT5B;CCL20;DUSP5;INHBB;ABCG1;FGF17;PKP1;HRAS;BMP4;RNF144A;RAB3D;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1
3276,GO:0034698,0.427355647060275,0.865623408500125,2,5,response to gonadotropin,BP,GJB2;NOTCH1
3588,GO:0042176,0.427980846006041,0.822441972287975,3,8,regulation of protein catabolic process,BP,AXIN1;RNF144A;PSMB10
6699,GO:1902589,0.428311989348883,0.701063763279919,14,44,single-organism organelle organization,BP,SYT5;PMAIP1;AXIN1;SPTBN5;RAB39A;SPTB;AMOT;PKP1;HRAS;TBC1D14;SPTBN4;NOTCH1;RND3;RAB20
5152,GO:0055082,0.428669739696117,0.735844718662075,8,24,cellular chemical homeostasis,BP,PIK3CG;BMP6;GJB6;RAB39A;VDR;RAB38;PIK3CA;RAB20
771,GO:0005546,0.428943268305207,0.864709909525335,2,5,phosphatidylinositol-4,5-bisphosphate binding,MF,SYT5;FZD7
250,GO:0002040,0.429024969880387,0.864662805323965,2,5,sprouting angiogenesis,BP,BMP4;NOTCH1
331,GO:0002429,0.430139844750593,0.820967871336051,3,8,immune response-activating cell surface receptor signaling pathway,BP,HRAS;PSMB10;PIK3CA
408,GO:0002768,0.430139844750593,0.820967871336051,3,8,immune response-regulating cell surface receptor signaling pathway,BP,HRAS;PSMB10;PIK3CA
2701,GO:0031326,0.431081069155806,0.67157122068825,26,82,regulation of cellular biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
5677,GO:0070371,0.431784526420579,0.774996366957427,5,13,ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4;FGF18
5678,GO:0070372,0.431784526420579,0.774996366957427,5,13,regulation of ERK1 and ERK2 cascade,BP,FGF8;CCL20;HRAS;BMP4;FGF18
1553,GO:0009897,0.432682005627039,0.819224313226683,3,8,external side of plasma membrane,CC,FGF8;AMOT;ABCG1
3335,GO:0035282,0.432886482045415,0.86242595763737,2,5,segmentation,BP,BMP4;NOTCH1
5239,GO:0060249,0.433077087205734,0.818952580482557,3,8,anatomical structure homeostasis,BP,CLDN18;RBP4;RAB3D
220,GO:0001935,0.433412552653554,0.818721689615147,3,8,endothelial cell proliferation,BP,BMP6;WNT2;BMP4
221,GO:0001936,0.433412552653554,0.818721689615147,3,8,regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
222,GO:0001938,0.433412552653554,0.818721689615147,3,8,positive regulation of endothelial cell proliferation,BP,BMP6;WNT2;BMP4
3786,GO:0043168,0.433780872371775,0.667465446682153,27,87,anion binding,MF,GLDC;SYT5;PIK3CG;HACL1;MAPK12;ACADVL;PXK;RAB40B;RRAS2;FZD7;RAB39A;VDR;WNK4;ABCG1;PKN3;HRAS;BMP4;RAB3D;ETFDH;RAB38;BMP7;SPTBN4;PIK3CA;DECR1;RND3;RAB20;GUCY1B3
4370,GO:0046470,0.434417932623132,0.876306965784406,2,4,phosphatidylcholine metabolic process,BP,MBOAT2;PLA2G16
6220,GO:0090288,0.434771943597204,0.8613262521238,2,5,negative regulation of cellular response to growth factor stimulus,BP,FSTL3;NOTCH1
1113,GO:0006915,0.435694211884212,0.677480140436567,20,63,apoptotic process,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;GJB6;JAG2;PMAIP1;AXIN1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
7223,GO:2001238,0.435714931861958,0.875617560894322,2,4,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;FADD
1514,GO:0009612,0.436280606053638,0.816741632383585,3,8,response to mechanical stimulus,BP,BMP6;INHBB;FADD
348,GO:0002520,0.436482480517838,0.720146298895266,9,28,immune system development,BP,CLDN18;JAG2;FZD7;ARTN;BMP4;FADD;TPD52;FSTL3;NOTCH1
4594,GO:0048534,0.436482480517838,0.720146298895266,9,28,hematopoietic or lymphoid organ development,BP,CLDN18;JAG2;FZD7;ARTN;BMP4;FADD;TPD52;FSTL3;NOTCH1
2638,GO:0031018,0.437474726902116,0.859741193430698,2,5,endocrine pancreas development,BP,BMP6;BMP4
3740,GO:0042990,0.437537238486074,0.859704412416433,2,5,regulation of transcription factor import into nucleus,BP,CDH1;BMP7
3741,GO:0042991,0.437537238486074,0.859704412416433,2,5,transcription factor import into nucleus,BP,CDH1;BMP7
798,GO:0005743,0.437993385130989,0.766777677680307,5,14,mitochondrial inner membrane,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH
1066,GO:0006793,0.438067922867219,0.656770457660463,34,108,phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;MBOAT2;BMP6;ACAT1;WNT7B;AXIN1;MAPK12;SPTBN5;FZD7;SPTB;FGF8;ARTN;NUDT7;WNK4;CCL20;DUSP5;INHBB;PKN3;FGF17;HRAS;BMP4;GDNF;DEPTOR;PSMB10;BMP7;SPTBN4;PIK3CA;PLA2G16;FGF18;ZFYVE21;GUCY1B3;DPM3
6168,GO:0090101,0.439073247435365,0.858798924018233,2,5,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,FSTL3;NOTCH1
4476,GO:0046982,0.439173824540179,0.748263764802988,6,18,protein heterodimerization activity,MF,SYT5;BMP6;RBP4;ABCG1;TPD52;NOTCH1
1546,GO:0009890,0.439196245766638,0.711129893374904,10,31,negative regulation of biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;ACADVL;VDR;INHBB;BMP4;BMP7;NOTCH1
2702,GO:0031327,0.439196245766638,0.711129893374904,10,31,negative regulation of cellular biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;ACADVL;VDR;INHBB;BMP4;BMP7;NOTCH1
538,GO:0003677,0.439382185459365,0.762868811299846,5,15,DNA binding,MF,HEY1;POU3F1;VDR;HNF1A;NOTCH1
5980,GO:0072111,0.439405846914556,0.858602418266036,2,5,cell proliferation involved in kidney development,BP,BMP4;BMP7
6575,GO:1901605,0.439873509145413,0.81424579167293,3,8,alpha-amino acid metabolic process,BP,GLDC;ACAT1;MSRA
6401,GO:0098796,0.441406804303016,0.761252471408312,5,15,membrane protein complex,CC,GJB2;GJA3;GJB6;CDH1;FADD
4907,GO:0051172,0.441599711518753,0.70902700646817,10,31,negative regulation of nitrogen compound metabolic process,BP,TLE1;ACTN3;BMP6;HEY1;AXIN1;VDR;PKP1;BMP4;BMP7;NOTCH1
4605,GO:0048565,0.441862151492688,0.81285699368482,3,8,digestive tract development,BP,CLDN18;BMP4;NOTCH1
5167,GO:0055123,0.441862151492688,0.81285699368482,3,8,digestive system development,BP,CLDN18;BMP4;NOTCH1
6187,GO:0090183,0.442048989904074,0.812726241716177,3,8,regulation of kidney development,BP,BMP4;GDNF;BMP7
5962,GO:0072088,0.442686251559978,0.783529588547664,4,11,nephron epithelium morphogenesis,BP,FGF8;WNK4;BMP4;GDNF
1659,GO:0010648,0.443240360442823,0.683695411990833,15,48,negative regulation of cell communication,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;FSTL3;NOTCH1
2396,GO:0023057,0.443240360442823,0.683695411990833,15,48,negative regulation of signaling,BP,TLE1;ACTN3;HEY1;AXIN1;WNT5B;DUSP5;INHBB;BMP4;GDNF;DEPTOR;PSMB10;FADD;BMP7;FSTL3;NOTCH1
4892,GO:0051145,0.443716564986104,0.811557188774912,3,8,smooth muscle cell differentiation,BP,HEY1;BMP4;NOTCH1
5143,GO:0055067,0.444111122329008,0.811280041407617,3,8,monovalent inorganic cation homeostasis,BP,RAB39A;RAB38;RAB20
219,GO:0001934,0.444997322195971,0.68258298133358,15,47,positive regulation of protein phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;BMP7;PIK3CA;FGF18
3615,GO:0042327,0.444997322195971,0.68258298133358,15,47,positive regulation of phosphorylation,BP,WNT7A;PIK3CG;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;BMP7;PIK3CA;FGF18
4182,GO:0045444,0.44535512209231,0.781501673907026,4,11,fat cell differentiation,BP,AXIN1;WNT5B;NUDT7;INHBB
3254,GO:0034614,0.445487376956312,0.854981855368582,2,5,cellular response to reactive oxygen species,BP,BMP7;GUCY1B3
409,GO:0002790,0.445803170169462,0.745015282647667,6,17,peptide secretion,BP,BMP6;KCNG2;RAB40B;RBP4;INHBB;NOTCH1
1876,GO:0015267,0.445919392549363,0.781071783596149,4,11,channel activity,MF,GJB2;GJA3;KCNG2;KCNK6
2374,GO:0022803,0.445919392549363,0.781071783596149,4,11,passive transmembrane transporter activity,MF,GJB2;GJA3;KCNG2;KCNK6
4375,GO:0046483,0.446915113124307,0.649265713674141,33,105,heterocycle metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;PTS;NOTCH1;GUCY1B3
3141,GO:0033554,0.447160085828178,0.684156427940977,14,44,cellular response to stress,BP,WNT7A;GJB2;WNT7B;PMAIP1;AXIN1;MAPK12;ACADVL;FZD7;INHBB;HRAS;PSMB10;BMP7;NOTCH1;GUCY1B3
157,GO:0001738,0.4472766676427,0.853906653626377,2,5,morphogenesis of a polarized epithelium,BP,FZD7;PSMB10
4832,GO:0050920,0.447697742985945,0.779714347927991,4,11,regulation of chemotaxis,BP,WNT3;ARTN;FGF18;NOTCH1
1762,GO:0010952,0.448247811031912,0.816201846541387,3,7,positive regulation of peptidase activity,BP,PMAIP1;MAPK12;FADD
135,GO:0001657,0.448531068461623,0.779076902723564,4,11,ureteric bud development,BP,FGF8;BMP4;GDNF;BMP7
5999,GO:0072163,0.448531068461623,0.779076902723564,4,11,mesonephric epithelium development,BP,FGF8;BMP4;GDNF;BMP7
6000,GO:0072164,0.448531068461623,0.779076902723564,4,11,mesonephric tubule development,BP,FGF8;BMP4;GDNF;BMP7
6957,GO:1905207,0.449950658773106,0.852291326556627,2,5,regulation of cardiocyte differentiation,BP,FZD7;BMP4
7163,GO:2000725,0.449950658773106,0.852291326556627,2,5,regulation of cardiac muscle cell differentiation,BP,FZD7;BMP4
4495,GO:0048010,0.450804069062067,0.806546955536576,3,8,vascular endothelial growth factor receptor signaling pathway,BP,MAPK12;PIK3CA;FGF18
453,GO:0003143,0.451408313073798,0.851406470193089,2,5,embryonic heart tube morphogenesis,BP,FGF8;NOTCH1
3299,GO:0035050,0.451408313073798,0.851406470193089,2,5,embryonic heart tube development,BP,FGF8;NOTCH1
199,GO:0001885,0.45216220751211,0.850947630122669,2,5,endothelial cell development,BP,WNT7A;WNT7B
5482,GO:0061028,0.45216220751211,0.850947630122669,2,5,establishment of endothelial barrier,BP,WNT7A;WNT7B
1247,GO:0007416,0.453010427464247,0.850430405283136,2,5,synapse assembly,BP,WNT7A;CDH1
2000,GO:0016358,0.453018692729665,0.850425360228276,2,5,dendrite development,BP,WNT7A;BMP7
5475,GO:0061005,0.453640169960411,0.804523145748999,3,8,cell differentiation involved in kidney development,BP,BMP4;GDNF;NOTCH1
5041,GO:0051604,0.453648602107688,0.804517112449772,3,8,protein maturation,BP,RHBDL3;TSPAN15;FADD
3567,GO:0042098,0.454658199218869,0.803794038010005,3,8,T cell proliferation,BP,PIK3CG;BMP4;FADD
3767,GO:0043086,0.45557117530106,0.714340774399895,8,23,negative regulation of catalytic activity,BP,AMOT;DUSP5;HRAS;BMP4;DEPTOR;PSMB10;BMP7;NOTCH1
197,GO:0001882,0.455580778320274,0.70464298894955,9,27,nucleoside binding,MF,RAB40B;RRAS2;RAB39A;HRAS;RAB3D;RAB38;RND3;RAB20;GUCY1B3
6767,GO:1903169,0.456153483515178,0.848504809758532,2,5,regulation of calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
4866,GO:0051047,0.457368306943062,0.751269503833611,5,14,positive regulation of secretion,BP,BMP6;RBP4;INHBB;RAB3D;GDNF
5360,GO:0060562,0.458289564455981,0.709131839780687,8,25,epithelial tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
726,GO:0005244,0.459081558412721,0.84669806967641,2,5,voltage-gated ion channel activity,MF,KCNG2;KCNK6
2378,GO:0022832,0.459081558412721,0.84669806967641,2,5,voltage-gated channel activity,MF,KCNG2;KCNK6
2383,GO:0022843,0.459081558412721,0.84669806967641,2,5,voltage-gated cation channel activity,MF,KCNG2;KCNK6
373,GO:0002683,0.460245645405046,0.745984839660958,5,15,negative regulation of immune system process,BP,CLDN18;BMP4;FADD;FSTL3;NOTCH1
2912,GO:0032391,0.460686813532361,0.930111404589636,1,2,photoreceptor connecting cilium,CC,SPTBN5
3424,GO:0035869,0.460686813532361,0.930111404589636,1,2,ciliary transition zone,CC,SPTBN5
4386,GO:0046530,0.460692770993389,0.930109266559775,1,2,photoreceptor cell differentiation,BP,NOTCH1
490,GO:0003213,0.46072433182707,0.930097939177208,1,2,cardiac right atrium morphogenesis,BP,NOTCH1
5964,GO:0072091,0.460736904718495,0.930093426338155,1,2,regulation of stem cell proliferation,BP,NOTCH1
7152,GO:2000648,0.460736904718495,0.930093426338155,1,2,positive regulation of stem cell proliferation,BP,NOTCH1
251,GO:0002042,0.460775313771995,0.930079638788991,1,2,cell migration involved in sprouting angiogenesis,BP,NOTCH1
4696,GO:0048845,0.460775313771995,0.930079638788991,1,2,venous blood vessel morphogenesis,BP,NOTCH1
5436,GO:0060841,0.460775313771995,0.930079638788991,1,2,venous blood vessel development,BP,NOTCH1
6869,GO:1903847,0.460775313771995,0.930079638788991,1,2,regulation of aorta morphogenesis,BP,NOTCH1
6870,GO:1903849,0.460775313771995,0.930079638788991,1,2,positive regulation of aorta morphogenesis,BP,NOTCH1
6980,GO:1905651,0.460775313771995,0.930079638788991,1,2,regulation of artery morphogenesis,BP,NOTCH1
6981,GO:1905653,0.460775313771995,0.930079638788991,1,2,positive regulation of artery morphogenesis,BP,NOTCH1
3948,GO:0043903,0.46078238285666,0.930077101024878,1,2,regulation of symbiosis, encompassing mutualism through parasitism,BP,NOTCH1
4115,GO:0045069,0.46078238285666,0.930077101024878,1,2,regulation of viral genome replication,BP,NOTCH1
4776,GO:0050792,0.46078238285666,0.930077101024878,1,2,regulation of viral process,BP,NOTCH1
6872,GO:1903900,0.46078238285666,0.930077101024878,1,2,regulation of viral life cycle,BP,NOTCH1
1705,GO:0010818,0.460787744789372,0.930075176077399,1,2,T cell chemotaxis,BP,PIK3CG
4757,GO:0050729,0.460787744789372,0.930075176077399,1,2,positive regulation of inflammatory response,BP,PIK3CG
6251,GO:0090630,0.460803606642669,0.930069481419983,1,2,activation of GTPase activity,BP,TBC1D14
3544,GO:0040018,0.460831100704453,0.93005960986515,1,2,positive regulation of multicellular organism growth,BP,SPTBN4
228,GO:0001948,0.460832192763882,0.930059217749044,1,2,glycoprotein binding,MF,CDH1
4444,GO:0046875,0.460838720775109,0.930056873762602,1,2,ephrin receptor binding,MF,PIK3CG
2002,GO:0016363,0.460840091815161,0.930056381462015,1,2,nuclear matrix,CC,SPTBN4
3234,GO:0034399,0.460840091815161,0.930056381462015,1,2,nuclear periphery,CC,SPTBN4
1999,GO:0016342,0.46085454138969,0.930051192896468,1,2,catenin complex,CC,CDH1
4099,GO:0044853,0.46085454138969,0.930051192896468,1,2,plasma membrane raft,CC,CDH1
4161,GO:0045295,0.46085454138969,0.930051192896468,1,2,gamma-catenin binding,MF,CDH1
1718,GO:0010839,0.460860983232639,0.930048879669353,1,2,negative regulation of keratinocyte proliferation,BP,VDR
6759,GO:1903053,0.460899439504175,0.930035069167075,1,2,regulation of extracellular matrix organization,BP,NOTCH1
5414,GO:0060745,0.460923108223248,0.930026568278677,1,2,mammary gland branching involved in pregnancy,BP,VDR
3508,GO:0038031,0.46093725750202,0.93002148606839,1,2,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
2372,GO:0022617,0.460981139259663,0.93000572279207,1,2,extracellular matrix disassembly,BP,CDH1
1275,GO:0007595,0.46098508936187,0.930004303711047,1,2,lactation,BP,VDR
864,GO:0005943,0.461144731083864,0.929946935711298,1,2,phosphatidylinositol 3-kinase complex, class IA,CC,PIK3CA
3914,GO:0043560,0.461144731083864,0.929946935711298,1,2,insulin receptor substrate binding,MF,PIK3CA
2209,GO:0019226,0.461294731650384,0.92989300306627,1,2,transmission of nerve impulse,BP,SPTBN4
3454,GO:0036003,0.462025021846631,0.929630022411409,1,2,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,NOTCH1
6574,GO:1901576,0.462846019955779,0.629567782153454,40,127,organic substance biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;CDH1;FZD7;RBP4;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;FGF17;ALG5;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3;DPM3
1219,GO:0007268,0.462915895098347,0.746748004064766,5,14,chemical synaptic transmission,BP,WNT7A;SYT5;PXK;HRAS;GDNF
6423,GO:0098916,0.462915895098347,0.746748004064766,5,14,anterograde trans-synaptic signaling,BP,WNT7A;SYT5;PXK;HRAS;GDNF
6442,GO:0099536,0.462915895098347,0.746748004064766,5,14,synaptic signaling,BP,WNT7A;SYT5;PXK;HRAS;GDNF
6443,GO:0099537,0.462915895098347,0.746748004064766,5,14,trans-synaptic signaling,BP,WNT7A;SYT5;PXK;HRAS;GDNF
270,GO:0002085,0.46337602146057,0.929141746047754,1,2,inhibition of neuroepithelial cell differentiation,BP,NOTCH1
1240,GO:0007386,0.46337602146057,0.929141746047754,1,2,compartment pattern specification,BP,NOTCH1
1819,GO:0014807,0.46337602146057,0.929141746047754,1,2,regulation of somitogenesis,BP,NOTCH1
2608,GO:0030857,0.46337602146057,0.929141746047754,1,2,negative regulation of epithelial cell differentiation,BP,NOTCH1
3548,GO:0040034,0.46337602146057,0.929141746047754,1,2,regulation of development, heterochronic,BP,NOTCH1
4205,GO:0045605,0.46337602146057,0.929141746047754,1,2,negative regulation of epidermal cell differentiation,BP,NOTCH1
4207,GO:0045607,0.46337602146057,0.929141746047754,1,2,regulation of auditory receptor cell differentiation,BP,NOTCH1
4208,GO:0045608,0.46337602146057,0.929141746047754,1,2,negative regulation of auditory receptor cell differentiation,BP,NOTCH1
4214,GO:0045631,0.46337602146057,0.929141746047754,1,2,regulation of mechanoreceptor differentiation,BP,NOTCH1
4215,GO:0045632,0.46337602146057,0.929141746047754,1,2,negative regulation of mechanoreceptor differentiation,BP,NOTCH1
4235,GO:0045683,0.46337602146057,0.929141746047754,1,2,negative regulation of epidermis development,BP,NOTCH1
4578,GO:0048505,0.46337602146057,0.929141746047754,1,2,regulation of timing of cell differentiation,BP,NOTCH1
5462,GO:0060972,0.46337602146057,0.929141746047754,1,2,left/right pattern formation,BP,NOTCH1
5762,GO:0070986,0.46337602146057,0.929141746047754,1,2,left/right axis specification,BP,NOTCH1
7190,GO:2000980,0.46337602146057,0.929141746047754,1,2,regulation of inner ear receptor cell differentiation,BP,NOTCH1
7191,GO:2000981,0.46337602146057,0.929141746047754,1,2,negative regulation of inner ear receptor cell differentiation,BP,NOTCH1
1203,GO:0007220,0.463449952205444,0.929114959445918,1,2,Notch receptor processing,BP,JAG2
4133,GO:0045124,0.463477803066549,0.929104866720437,1,2,regulation of bone resorption,BP,CLDN18
4437,GO:0046850,0.463477803066549,0.929104866720437,1,2,regulation of bone remodeling,BP,CLDN18
5952,GO:0072070,0.463533363018759,0.929084729707987,1,2,loop of Henle development,BP,WNT7B
4294,GO:0045913,0.463627905076641,0.843868064608161,2,5,positive regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
96,GO:0001106,0.463768576440479,0.928999436179855,1,2,RNA polymerase II transcription corepressor activity,MF,TLE1
6257,GO:0097009,0.46379365211406,0.928990339053928,1,2,energy homeostasis,BP,PIK3CA
7066,GO:2000106,0.464029353546994,0.843616719185442,2,5,regulation of leukocyte apoptotic process,BP,BMP4;FADD
604,GO:0004383,0.464073102837793,0.928888904004325,1,2,guanylate cyclase activity,MF,GUCY1B3
1314,GO:0008074,0.464073102837793,0.928888904004325,1,2,guanylate cyclase complex, soluble,CC,GUCY1B3
1570,GO:0009975,0.464073102837793,0.928888904004325,1,2,cyclase activity,MF,GUCY1B3
2106,GO:0016849,0.464073102837793,0.928888904004325,1,2,phosphorus-oxygen lyase activity,MF,GUCY1B3
479,GO:0003192,0.464102583948363,0.928878197168384,1,2,mitral valve formation,BP,NOTCH1
2978,GO:0032633,0.464102583948363,0.928878197168384,1,2,interleukin-4 production,BP,NOTCH1
4113,GO:0045058,0.464176415190985,0.928851378580432,1,2,T cell selection,BP,JAG2
858,GO:0005923,0.464402312738097,0.742560300991255,5,15,bicellular tight junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
5622,GO:0070160,0.464402312738097,0.742560300991255,5,15,occluding junction,CC,TJP3;CLDN18;AMOT;WNK4;CLDN15
2237,GO:0019637,0.464438831198093,0.67375054354965,13,39,organophosphate metabolic process,BP,PIK3CG;ACTN3;MBOAT2;ACAT1;FGF8;NUDT7;FGF17;PIK3CA;PLA2G16;FGF18;ZFYVE21;GUCY1B3;DPM3
4659,GO:0048709,0.464481102398247,0.928740630231189,1,2,oligodendrocyte differentiation,BP,NOTCH1
2145,GO:0017147,0.465085439595854,0.928520615268066,1,2,Wnt-protein binding,MF,FZD7
2447,GO:0030165,0.465085439595854,0.928520615268066,1,2,PDZ domain binding,MF,FZD7
3728,GO:0042813,0.465085439595854,0.928520615268066,1,2,Wnt-activated receptor activity,MF,FZD7
6958,GO:1905208,0.46554717057215,0.928352204219217,1,2,negative regulation of cardiocyte differentiation,BP,FZD7
7164,GO:2000726,0.46554717057215,0.928352204219217,1,2,negative regulation of cardiac muscle cell differentiation,BP,FZD7
176,GO:0001816,0.465954612513192,0.725894251767057,6,18,cytokine production,BP,PIK3CG;CCL20;INHBB;HRAS;FADD;NOTCH1
1262,GO:0007519,0.466048913698261,0.842348690029438,2,5,skeletal muscle tissue development,BP,ACTN3;NOTCH1
2886,GO:0032346,0.466114666389927,0.928144844335935,1,2,positive regulation of aldosterone metabolic process,BP,BMP6
2889,GO:0032349,0.466114666389927,0.928144844335935,1,2,positive regulation of aldosterone biosynthetic process,BP,BMP6
2892,GO:0032352,0.466114666389927,0.928144844335935,1,2,positive regulation of hormone metabolic process,BP,BMP6
4453,GO:0046886,0.466114666389927,0.928144844335935,1,2,positive regulation of hormone biosynthetic process,BP,BMP6
6154,GO:0090031,0.466114666389927,0.928144844335935,1,2,positive regulation of steroid hormone biosynthetic process,BP,BMP6
3976,GO:0044236,0.466225586884498,0.842237476196708,2,5,multicellular organism metabolic process,BP,BMP4;PEPD
6392,GO:0098751,0.46641742699648,0.928034049089602,1,2,bone cell development,BP,CLDN18
3138,GO:0033500,0.467283170828394,0.760441208210589,4,12,carbohydrate homeostasis,BP,GJB6;RBP4;PIK3CA;HNF1A
3689,GO:0042593,0.467283170828394,0.760441208210589,4,12,glucose homeostasis,BP,GJB6;RBP4;PIK3CA;HNF1A
75,GO:0000976,0.467555057561939,0.9276166853154,1,2,transcription regulatory region sequence-specific DNA binding,MF,HNF1A
76,GO:0000977,0.467555057561939,0.9276166853154,1,2,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HNF1A
83,GO:0001012,0.467555057561939,0.9276166853154,1,2,RNA polymerase II regulatory region DNA binding,MF,HNF1A
6023,GO:0072203,0.467798444935349,0.927527178239322,1,2,cell proliferation involved in metanephros development,BP,BMP7
2116,GO:0016887,0.468041666147642,0.92743765634902,1,2,ATPase activity,MF,ABCG1
3691,GO:0042623,0.468041666147642,0.92743765634902,1,2,ATPase activity, coupled,MF,ABCG1
3897,GO:0043531,0.468041666147642,0.92743765634902,1,2,ADP binding,MF,ABCG1
4335,GO:0046165,0.468411779404478,0.840857482887869,2,5,alcohol biosynthetic process,BP,VDR;ABCG1
4033,GO:0044430,0.468415367027134,0.683435589539847,10,33,cytoskeletal part,CC,ACTN3;PXK;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;KRT10;SPTBN4
458,GO:0003157,0.468511661145222,0.927264451113502,1,2,endocardium development,BP,NOTCH1
525,GO:0003348,0.468511661145222,0.927264451113502,1,2,cardiac endothelial cell differentiation,BP,NOTCH1
5457,GO:0060956,0.468511661145222,0.927264451113502,1,2,endocardial cell differentiation,BP,NOTCH1
6007,GO:0072175,0.46922955523761,0.762963161178178,4,11,epithelial tube formation,BP,FGF8;BMP4;GDNF;BMP7
2554,GO:0030593,0.470257269719549,0.839687050721623,2,5,neutrophil chemotaxis,BP,PIK3CG;CCL20
5866,GO:0071621,0.470257269719549,0.839687050721623,2,5,granulocyte chemotaxis,BP,PIK3CG;CCL20
6338,GO:0097530,0.470257269719549,0.839687050721623,2,5,granulocyte migration,BP,PIK3CG;CCL20
7012,GO:1990266,0.470257269719549,0.839687050721623,2,5,neutrophil migration,BP,PIK3CG;CCL20
3428,GO:0035886,0.470259139946443,0.926617966485236,1,2,vascular smooth muscle cell differentiation,BP,NOTCH1
3329,GO:0035264,0.470281034945413,0.839671945604091,2,5,multicellular organism growth,BP,SPTBN4;PIK3CA
254,GO:0002053,0.470456312015744,0.926544774805059,1,2,positive regulation of mesenchymal cell proliferation,BP,WNT2
3127,GO:0033278,0.470456312015744,0.926544774805059,1,2,cell proliferation in midbrain,BP,WNT2
2417,GO:0030049,0.470474661824627,0.926537960669221,1,2,muscle filament sliding,BP,ACTN3
3126,GO:0033275,0.470474661824627,0.926537960669221,1,2,actin-myosin filament sliding,BP,ACTN3
879,GO:0006007,0.470480487971113,0.92653579705954,1,2,glucose catabolic process,BP,ACTN3
899,GO:0006096,0.470480487971113,0.92653579705954,1,2,glycolytic process,BP,ACTN3
923,GO:0006165,0.470480487971113,0.92653579705954,1,2,nucleoside diphosphate phosphorylation,BP,ACTN3
1059,GO:0006757,0.470480487971113,0.92653579705954,1,2,ATP generation from ADP,BP,ACTN3
1452,GO:0009123,0.470480487971113,0.92653579705954,1,2,nucleoside monophosphate metabolic process,BP,ACTN3
1453,GO:0009126,0.470480487971113,0.92653579705954,1,2,purine nucleoside monophosphate metabolic process,BP,ACTN3
1455,GO:0009135,0.470480487971113,0.92653579705954,1,2,purine nucleoside diphosphate metabolic process,BP,ACTN3
1461,GO:0009161,0.470480487971113,0.92653579705954,1,2,ribonucleoside monophosphate metabolic process,BP,ACTN3
1465,GO:0009167,0.470480487971113,0.92653579705954,1,2,purine ribonucleoside monophosphate metabolic process,BP,ACTN3
1466,GO:0009179,0.470480487971113,0.92653579705954,1,2,purine ribonucleoside diphosphate metabolic process,BP,ACTN3
1467,GO:0009185,0.470480487971113,0.92653579705954,1,2,ribonucleoside diphosphate metabolic process,BP,ACTN3
4322,GO:0046031,0.470480487971113,0.92653579705954,1,2,ADP metabolic process,BP,ACTN3
4323,GO:0046034,0.470480487971113,0.92653579705954,1,2,ATP metabolic process,BP,ACTN3
4468,GO:0046939,0.470480487971113,0.92653579705954,1,2,nucleotide phosphorylation,BP,ACTN3
2933,GO:0032436,0.470619396245839,0.926484198801046,1,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
6608,GO:1901800,0.470619396245839,0.926484198801046,1,2,positive regulation of proteasomal protein catabolic process,BP,RNF144A
2948,GO:0032507,0.470624105482697,0.926482449091291,1,2,maintenance of protein location in cell,BP,SPTBN4
4145,GO:0045185,0.470624105482697,0.926482449091291,1,2,maintenance of protein location,BP,SPTBN4
5051,GO:0051651,0.470624105482697,0.926482449091291,1,2,maintenance of location in cell,BP,SPTBN4
3026,GO:0032794,0.47064768081197,0.926473689282497,1,2,GTPase activating protein binding,MF,CDH1
6315,GO:0097306,0.47064768081197,0.926473689282497,1,2,cellular response to alcohol,BP,CDH1
2807,GO:0031982,0.470732534505185,0.621352734374635,41,133,vesicle,CC,WNT7A;SYT5;ACTN3;BMP6;WNT3;ACAT1;WNT7B;MSRA;KCNG2;AXIN1;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;RAB39A;AMOT;WNT5B;DSG3;ABCG1;PKP1;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;LYPLAL1;TBC1D14;RAB38;BMP7;SPTBN4;DECR1;FSTL3;NOTCH1;RND3;ZFYVE21;RAB20;ETFB;PM20D2;PEPD
4918,GO:0051193,0.470851828415791,0.926397804748297,1,2,regulation of cofactor metabolic process,BP,ACTN3
4921,GO:0051196,0.470851828415791,0.926397804748297,1,2,regulation of coenzyme metabolic process,BP,ACTN3
1366,GO:0008289,0.471037849711215,0.709295735300393,7,21,lipid binding,MF,SYT5;PXK;FZD7;RBP4;VDR;ABCG1;SPTBN4
89,GO:0001077,0.471113845200958,0.926300330385292,1,2,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
102,GO:0001228,0.471113845200958,0.926300330385292,1,2,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,HNF1A
4002,GO:0044304,0.471209778181441,0.926264619575154,1,2,main axon,CC,SPTBN4
4317,GO:0045988,0.471215366471924,0.926262538980656,1,2,negative regulation of striated muscle contraction,BP,PIK3CG
5165,GO:0055118,0.471215366471924,0.926262538980656,1,2,negative regulation of cardiac muscle contraction,BP,PIK3CG
433,GO:0003016,0.471226038215191,0.926258565637023,1,2,respiratory system process,BP,JAG2
3593,GO:0042221,0.471330858801178,0.621836927384658,39,126,response to chemical,BP,WNT7A;GJB2;PIK3CG;CLDN18;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;PMAIP1;WNT2;ACADVL;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;CCL20;INHBB;ABCG1;FGF17;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;NOTCH1;GUCY1B3
6673,GO:1902369,0.471794123666663,0.926046840832445,1,2,negative regulation of RNA catabolic process,BP,PKP1
6674,GO:1902373,0.471794123666663,0.926046840832445,1,2,negative regulation of mRNA catabolic process,BP,PKP1
6781,GO:1903312,0.471794123666663,0.926046840832445,1,2,negative regulation of mRNA metabolic process,BP,PKP1
7004,GO:1990124,0.471794123666663,0.926046840832445,1,2,messenger ribonucleoprotein complex,CC,PKP1
1595,GO:0010256,0.471820015920789,0.718874973406967,6,19,endomembrane system organization,BP,RAB40B;SPTBN5;CDH1;TSPAN15;RAB38;SPTBN4
1371,GO:0008328,0.47274123662067,0.925692921462594,1,2,ionotropic glutamate receptor complex,CC,CPT1C
2869,GO:0032281,0.47274123662067,0.925692921462594,1,2,AMPA glutamate receptor complex,CC,CPT1C
6418,GO:0098878,0.47274123662067,0.925692921462594,1,2,neurotransmitter receptor complex,CC,CPT1C
3920,GO:0043584,0.472886149938593,0.9256386670409,1,2,nose development,BP,AXIN1
4622,GO:0048630,0.473037730136732,0.925581887339525,1,2,skeletal muscle tissue growth,BP,ACTN3
4623,GO:0048631,0.473037730136732,0.925581887339525,1,2,regulation of skeletal muscle tissue growth,BP,ACTN3
4624,GO:0048633,0.473037730136732,0.925581887339525,1,2,positive regulation of skeletal muscle tissue growth,BP,ACTN3
4633,GO:0048643,0.473037730136732,0.925581887339525,1,2,positive regulation of skeletal muscle tissue development,BP,ACTN3
225,GO:0001944,0.473188926802793,0.668259471386567,12,39,vasculature development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;BMP7;PIK3CA;FGF18;NOTCH1
6062,GO:0072358,0.473188926802793,0.668259471386567,12,39,cardiovascular system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FGF8;AMOT;BMP4;BMP7;PIK3CA;FGF18;NOTCH1
4744,GO:0050708,0.47426964843627,0.758956911837641,4,11,regulation of protein secretion,BP,BMP6;KCNG2;RBP4;INHBB
4896,GO:0051149,0.474421309726757,0.837027571310969,2,5,positive regulation of muscle cell differentiation,BP,MAPK12;BMP4
4310,GO:0045940,0.474704428548448,0.836845810330158,2,5,positive regulation of steroid metabolic process,BP,BMP6;ABCG1
2295,GO:0021537,0.474778116516418,0.836798483322936,2,5,telencephalon development,BP,FGF8;BMP4
2894,GO:0032354,0.475598226114222,0.924618231250324,1,2,response to follicle-stimulating hormone,BP,NOTCH1
5818,GO:0071372,0.475598226114222,0.924618231250324,1,2,cellular response to follicle-stimulating hormone stimulus,BP,NOTCH1
3082,GO:0033002,0.476767709710524,0.756959141061754,4,11,muscle cell proliferation,BP,WNT2;RBP4;BMP4;NOTCH1
2249,GO:0019725,0.477238536373504,0.692404716999319,8,25,cellular homeostasis,BP,PIK3CG;BMP6;GJB6;RAB39A;VDR;RAB38;PIK3CA;RAB20
1095,GO:0006879,0.477247266622165,0.923993056732131,1,2,cellular iron ion homeostasis,BP,BMP6
1584,GO:0010039,0.477247266622165,0.923993056732131,1,2,response to iron ion,BP,BMP6
5788,GO:0071281,0.477247266622165,0.923993056732131,1,2,cellular response to iron ion,BP,BMP6
5922,GO:0071944,0.477588507944062,0.611979832477846,49,164,cell periphery,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;SYT5;PIK3CG;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RAB39A;SPTB;FGF8;AMOT;WNT5B;DSG3;INHBB;ABCG1;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;RAB38;FADD;SPTBN4;PIK3CA;DRP2;TSPAN13;NOTCH1;LINGO1;CPT1C;RAB20;GUCY1B3
573,GO:0004095,0.478047835404123,0.923688258349018,1,2,carnitine O-palmitoyltransferase activity,MF,CPT1C
2004,GO:0016406,0.478047835404123,0.923688258349018,1,2,carnitine O-acyltransferase activity,MF,CPT1C
2007,GO:0016409,0.478047835404123,0.923688258349018,1,2,palmitoyltransferase activity,MF,CPT1C
2010,GO:0016416,0.478047835404123,0.923688258349018,1,2,O-palmitoyltransferase activity,MF,CPT1C
24,GO:0000151,0.478266786201547,0.923604750422627,1,2,ubiquitin ligase complex,CC,RNF144A
1295,GO:0007626,0.478584001491109,0.834343030776624,2,5,locomotory behavior,BP,GDNF;SPTBN4
1790,GO:0014044,0.478999307323578,0.923324905606958,1,2,Schwann cell development,BP,POU3F1
2349,GO:0022011,0.478999307323578,0.923324905606958,1,2,myelination in peripheral nervous system,BP,POU3F1
2871,GO:0032292,0.478999307323578,0.923324905606958,1,2,peripheral nervous system axon ensheathment,BP,POU3F1
3155,GO:0033628,0.48012116976498,0.922894942215453,1,2,regulation of cell adhesion mediated by integrin,BP,PIK3CG
724,GO:0005242,0.480215812767851,0.922858593031945,1,2,inward rectifier potassium channel activity,MF,KCNK6
2126,GO:0017022,0.480419895323951,0.833150764396679,2,5,myosin binding,MF,SPTBN5;RAB3D
81,GO:0000988,0.480436848882404,0.749827411108909,4,12,transcription factor activity, protein binding,MF,TLE1;HEY1;POU3F1;NOTCH1
6555,GO:1901363,0.480574137849195,0.619800034769642,30,98,heterocyclic compound binding,MF,GLDC;PIK3CG;HACL1;HEY1;POU3F1;MAPK12;MRPL14;ACADVL;RAB40B;RRAS2;ARL6IP4;RAB39A;VDR;PUS1;NUDT7;WNK4;TSFM;ABCG1;PKN3;HRAS;RAB3D;ETFDH;RAB38;PIK3CA;DECR1;HNF1A;NOTCH1;RND3;RAB20;GUCY1B3
328,GO:0002407,0.480634073904278,0.92269781038506,1,2,dendritic cell chemotaxis,BP,PIK3CG
3487,GO:0036336,0.480634073904278,0.92269781038506,1,2,dendritic cell migration,BP,PIK3CG
2766,GO:0031670,0.480655523777047,0.922689558621446,1,2,cellular response to nutrient,BP,VDR
5791,GO:0071295,0.480655523777047,0.922689558621446,1,2,cellular response to vitamin,BP,VDR
2910,GO:0032387,0.480684369117919,0.922678460856397,1,2,negative regulation of intracellular transport,BP,BMP7
3607,GO:0042308,0.480684369117919,0.922678460856397,1,2,negative regulation of protein import into nucleus,BP,BMP7
4429,GO:0046823,0.480684369117919,0.922678460856397,1,2,negative regulation of nucleocytoplasmic transport,BP,BMP7
6225,GO:0090317,0.480684369117919,0.922678460856397,1,2,negative regulation of intracellular protein transport,BP,BMP7
6904,GO:1904590,0.480684369117919,0.922678460856397,1,2,negative regulation of protein import,BP,BMP7
2815,GO:0032008,0.480977306775817,0.922565695199938,1,2,positive regulation of TOR signaling,BP,PIK3CA
1280,GO:0007601,0.48128394105768,0.832587872027744,2,5,visual perception,BP,GJA3;RBP4
4842,GO:0050953,0.48128394105768,0.832587872027744,2,5,sensory perception of light stimulus,BP,GJA3;RBP4
1176,GO:0007159,0.481619894958402,0.748861910644645,4,12,leukocyte cell-cell adhesion,BP,BMP4;FADD;BMP7;PIK3CA
1510,GO:0009593,0.481817540306873,0.92224161459443,1,2,detection of chemical stimulus,BP,ABCG1
2427,GO:0030097,0.481864327602051,0.687006929852267,8,26,hemopoiesis,BP,CLDN18;JAG2;FZD7;BMP4;FADD;TPD52;FSTL3;NOTCH1
5741,GO:0070848,0.481915982703221,0.672028186341893,10,32,response to growth factor,BP,WNT7A;BMP6;WNT2;FGF8;FGF17;BMP4;BMP7;FGF18;FSTL3;NOTCH1
5815,GO:0071363,0.481915982703221,0.672028186341893,10,32,cellular response to growth factor stimulus,BP,WNT7A;BMP6;WNT2;FGF8;FGF17;BMP4;BMP7;FGF18;FSTL3;NOTCH1
1153,GO:0007034,0.482089837173441,0.832061842137592,2,5,vacuolar transport,BP,SPTBN5;USE1
1155,GO:0007041,0.482089837173441,0.832061842137592,2,5,lysosomal transport,BP,SPTBN5;USE1
6578,GO:1901615,0.482436052284669,0.699293047255396,7,21,organic hydroxy compound metabolic process,BP,ACTN3;BMP6;ACADVL;RBP4;VDR;ABCG1;PNMT
1875,GO:0015248,0.482745197493743,0.921882718986304,1,2,sterol transporter activity,MF,ABCG1
1886,GO:0015485,0.482745197493743,0.921882718986304,1,2,cholesterol binding,MF,ABCG1
2140,GO:0017127,0.482745197493743,0.921882718986304,1,2,cholesterol transporter activity,MF,ABCG1
2898,GO:0032366,0.482745197493743,0.921882718986304,1,2,intracellular sterol transport,BP,ABCG1
2899,GO:0032367,0.482745197493743,0.921882718986304,1,2,intracellular cholesterol transport,BP,ABCG1
3062,GO:0032934,0.482745197493743,0.921882718986304,1,2,sterol binding,MF,ABCG1
3540,GO:0040012,0.483137354696644,0.654564608476638,13,42,regulation of locomotion,BP,WNT7A;WNT3;JAG2;RRAS2;AMOT;ARTN;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
4190,GO:0045540,0.483169664694357,0.921718115293876,1,2,regulation of cholesterol biosynthetic process,BP,ABCG1
6104,GO:0072657,0.483339854924516,0.708890736079043,6,19,protein localization to membrane,BP,PMAIP1;RAB40B;CDH1;TSPAN15;RAB38;SPTBN4
33,GO:0000209,0.483552258671544,0.831104761965143,2,5,protein polyubiquitination,BP,RNF144A;PSMB10
983,GO:0006508,0.48408166321664,0.679212031283262,9,27,proteolysis,BP,RHBDL3;PMAIP1;AXIN1;MAPK12;RNF144A;PSMB10;FADD;PM20D2;PEPD
4802,GO:0050849,0.484117600065535,0.921349643648182,1,2,negative regulation of calcium-mediated signaling,BP,ACTN3
5782,GO:0071248,0.484277161056876,0.775738632682275,3,9,cellular response to metal ion,BP,BMP6;CDH1;FSTL3
5050,GO:0051650,0.484371420727789,0.830567240344287,2,5,establishment of vesicle localization,BP,WNT7A;SYT5
6043,GO:0072273,0.484690243342834,0.830357757325952,2,5,metanephric nephron morphogenesis,BP,BMP4;GDNF
6314,GO:0097305,0.485112847846549,0.78132368637842,3,8,response to alcohol,BP,CLDN18;CDH1;RBP4
4873,GO:0051054,0.485385163600709,0.781116921379071,3,8,positive regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4
888,GO:0006066,0.485414575564499,0.749981528602759,4,11,alcohol metabolic process,BP,ACADVL;RBP4;VDR;ABCG1
5020,GO:0051536,0.48579863560603,0.920693235147596,1,2,iron-sulfur cluster binding,MF,ETFDH
5023,GO:0051540,0.48579863560603,0.920693235147596,1,2,metal cluster binding,MF,ETFDH
1550,GO:0009894,0.485827743478577,0.683436659402701,8,26,regulation of catabolic process,BP,PIK3CG;ACTN3;AXIN1;PKP1;RNF144A;TBC1D14;PSMB10;PIK3CA
2514,GO:0030335,0.485946117798895,0.676323377928923,9,28,positive regulation of cell migration,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
4958,GO:0051272,0.485946117798895,0.676323377928923,9,28,positive regulation of cellular component movement,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
7082,GO:2000147,0.485946117798895,0.676323377928923,9,28,positive regulation of cell motility,BP,WNT7A;RRAS2;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
4790,GO:0050810,0.486032461650895,0.774378594771511,3,9,regulation of steroid biosynthetic process,BP,BMP6;VDR;ABCG1
6022,GO:0072202,0.486070860917791,0.829448828894784,2,5,cell differentiation involved in metanephros development,BP,BMP4;GDNF
4258,GO:0045776,0.486452655671912,0.920436823358293,1,2,negative regulation of blood pressure,BP,KCNK6
4378,GO:0046487,0.48668917539806,0.920343952090588,1,2,glyoxylate metabolic process,BP,GLDC
1996,GO:0016337,0.487136959305884,0.673151872785269,9,30,single organismal cell-cell adhesion,BP,PIK3CG;WNT7B;CDH1;PKP1;BMP4;FADD;BMP7;PIK3CA;FSTL3
1799,GO:0014065,0.487203337632983,0.723410587839534,5,15,phosphatidylinositol 3-kinase signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
4499,GO:0048015,0.487203337632983,0.723410587839534,5,15,phosphatidylinositol-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
4501,GO:0048017,0.487203337632983,0.723410587839534,5,15,inositol lipid-mediated signaling,BP,PIK3CG;FGF8;FGF17;PIK3CA;FGF18
4601,GO:0048546,0.48753381552278,0.828482511923663,2,5,digestive tract morphogenesis,BP,BMP4;NOTCH1
1097,GO:0006886,0.487636069512013,0.705129204847961,6,19,intracellular protein transport,BP,BMP6;CDH1;FZD7;BMP4;TBC1D14;BMP7
4886,GO:0051101,0.487856989858577,0.919884288755132,1,2,regulation of DNA binding,BP,HEY1
7157,GO:2000677,0.487856989858577,0.919884288755132,1,2,regulation of transcription regulatory region DNA binding,BP,HEY1
3061,GO:0032926,0.487996279037184,0.91982933950605,1,2,negative regulation of activin receptor signaling pathway,BP,FSTL3
4529,GO:0048185,0.487996279037184,0.91982933950605,1,2,activin binding,MF,FSTL3
2060,GO:0016645,0.488325608913861,0.919699314672694,1,2,oxidoreductase activity, acting on the CH-NH group of donors,MF,ETFDH
4972,GO:0051301,0.488620926412873,0.743111145080045,4,12,cell division,BP,WNT7A;FZD7;FGF8;NOTCH1
1215,GO:0007264,0.488672208130051,0.706295546455097,6,18,small GTPase mediated signal transduction,BP,RABIF;RRAS2;AMOT;HRAS;RAB38;RND3
1138,GO:0006986,0.488823006531135,0.919502653951102,1,2,response to unfolded protein,BP,ACADVL
2632,GO:0030968,0.488823006531135,0.919502653951102,1,2,endoplasmic reticulum unfolded protein response,BP,ACADVL
3255,GO:0034620,0.488823006531135,0.919502653951102,1,2,cellular response to unfolded protein,BP,ACADVL
3444,GO:0035966,0.488823006531135,0.919502653951102,1,2,response to topologically incorrect protein,BP,ACADVL
3445,GO:0035967,0.488823006531135,0.919502653951102,1,2,cellular response to topologically incorrect protein,BP,ACADVL
6943,GO:1904951,0.489178440199077,0.721722429473571,5,15,positive regulation of establishment of protein localization,BP,BMP6;PMAIP1;CDH1;RBP4;BMP4
7,GO:0000045,0.489231432442912,0.919340918590865,1,2,autophagosome assembly,BP,TBC1D14
3966,GO:0044088,0.489231432442912,0.919340918590865,1,2,regulation of vacuole organization,BP,TBC1D14
6949,GO:1905037,0.489231432442912,0.919340918590865,1,2,autophagosome organization,BP,TBC1D14
7171,GO:2000785,0.489231432442912,0.919340918590865,1,2,regulation of autophagosome assembly,BP,TBC1D14
4064,GO:0044703,0.489487584890649,0.665080044835079,10,32,multi-organism reproductive process,BP,SLC2A14;GJB2;WNT3;JAG2;VDR;INHBB;BMP4;SPTBN4;FSTL3;NOTCH1
2405,GO:0030027,0.489491247804727,0.771685889429802,3,9,lamellipodium,CC,CDH1;AMOT;PIK3CA
7070,GO:2000113,0.489697892998256,0.679935158646284,8,26,negative regulation of cellular macromolecule biosynthetic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;BMP4;BMP7;NOTCH1
6028,GO:0072215,0.489699076066033,0.827046275919194,2,5,regulation of metanephros development,BP,BMP4;GDNF
4124,GO:0045089,0.489748446953255,0.777789573746451,3,8,positive regulation of innate immune response,BP,HRAS;PSMB10;FADD
4265,GO:0045792,0.490676203822116,0.918766964227071,1,2,negative regulation of cell size,BP,DEPTOR
2900,GO:0032368,0.490759980797627,0.826339933871509,2,5,regulation of lipid transport,BP,BMP6;ABCG1
6997,GO:1905952,0.490759980797627,0.826339933871509,2,5,regulation of lipid localization,BP,BMP6;ABCG1
843,GO:0005886,0.49164758650058,0.59859382071074,48,161,plasma membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;SYT5;PIK3CG;CLDN18;GJA3;WNT3;GJB6;WNT7B;JAG2;KCNG2;AXIN1;WNT2;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RAB39A;SPTB;FGF8;AMOT;WNT5B;DSG3;ABCG1;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;RAB38;FADD;SPTBN4;PIK3CA;DRP2;TSPAN13;NOTCH1;LINGO1;CPT1C;RAB20;GUCY1B3
1758,GO:0010942,0.492580312224129,0.690274359065109,7,21,positive regulation of cell death,BP,PMAIP1;VDR;INHBB;BMP4;FADD;BMP7;NOTCH1
3763,GO:0043068,0.492580312224129,0.690274359065109,7,21,positive regulation of programmed cell death,BP,PMAIP1;VDR;INHBB;BMP4;FADD;BMP7;NOTCH1
1863,GO:0015144,0.493256362454586,0.91773483516053,1,2,carbohydrate transmembrane transporter activity,MF,SLC2A14
4888,GO:0051119,0.493256362454586,0.91773483516053,1,2,sugar transmembrane transporter activity,MF,SLC2A14
6560,GO:1901476,0.493256362454586,0.91773483516053,1,2,carbohydrate transporter activity,MF,SLC2A14
2005,GO:0016407,0.493583309123087,0.917603393049559,1,2,acetyltransferase activity,MF,ACAT1
992,GO:0006549,0.493671262186717,0.917568008121297,1,2,isoleucine metabolic process,BP,ACAT1
2733,GO:0031490,0.493994545494357,0.917437854085239,1,2,chromatin DNA binding,MF,NOTCH1
893,GO:0006085,0.494025293675353,0.917425467316327,1,2,acetyl-CoA biosynthetic process,BP,ACAT1
456,GO:0003151,0.494922669786008,0.823551626934927,2,5,outflow tract morphogenesis,BP,FGF8;BMP4
1232,GO:0007346,0.496020445819497,0.719000627468354,5,14,regulation of mitotic cell cycle,BP,FGF8;HRAS;BMP4;PSMB10;BMP7
5934,GO:0072014,0.496116023292581,0.916580148712177,1,2,proximal tubule development,BP,ACAT1
4585,GO:0048519,0.496409754205662,0.59693784478483,40,132,negative regulation of biological process,BP,TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;ACADVL;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;WNT5B;WNK4;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;FSTL3;NOTCH1;LINGO1
1283,GO:0007605,0.496934012877714,0.765833757945368,3,9,sensory perception of sound,BP,GJB2;GJB6;SPTBN4
4843,GO:0050954,0.496934012877714,0.765833757945368,3,9,sensory perception of mechanical stimulus,BP,GJB2;GJB6;SPTBN4
300,GO:0002279,0.497272214263665,0.916110067254717,1,2,mast cell activation involved in immune response,BP,PIK3CG
339,GO:0002448,0.497272214263665,0.916110067254717,1,2,mast cell mediated immunity,BP,PIK3CG
2923,GO:0032418,0.497272214263665,0.916110067254717,1,2,lysosome localization,BP,PIK3CG
3694,GO:0042629,0.497272214263665,0.916110067254717,1,2,mast cell granule,CC,PIK3CG
3844,GO:0043303,0.497272214263665,0.916110067254717,1,2,mast cell degranulation,BP,PIK3CG
4192,GO:0045576,0.497272214263665,0.916110067254717,1,2,mast cell activation,BP,PIK3CG
2450,GO:0030170,0.497781771178933,0.915902299712411,1,2,pyridoxal phosphate binding,MF,GLDC
5657,GO:0070279,0.497781771178933,0.915902299712411,1,2,vitamin B6 binding,MF,GLDC
4340,GO:0046322,0.498155524500301,0.915749673795359,1,2,negative regulation of fatty acid oxidation,BP,ACADVL
137,GO:0001659,0.498710914687579,0.915522512818252,1,2,temperature homeostasis,BP,ACADVL
5302,GO:0060423,0.498934169106399,0.915431077164331,1,2,foregut regionalization,BP,WNT2
5303,GO:0060424,0.498934169106399,0.915431077164331,1,2,lung field specification,BP,WNT2
5309,GO:0060431,0.498934169106399,0.915431077164331,1,2,primary lung bud formation,BP,WNT2
5334,GO:0060492,0.498934169106399,0.915431077164331,1,2,lung induction,BP,WNT2
5500,GO:0061072,0.498934169106399,0.915431077164331,1,2,iris morphogenesis,BP,WNT2
6219,GO:0090287,0.499890745843375,0.733719367762896,4,12,regulation of cellular response to growth factor stimulus,BP,BMP4;FGF18;FSTL3;NOTCH1
4051,GO:0044455,0.499960209152973,0.915009952720343,1,2,mitochondrial membrane part,CC,ETFDH
1063,GO:0006775,0.500115153108795,0.914946229175009,1,2,fat-soluble vitamin metabolic process,BP,VDR
3622,GO:0042359,0.500115153108795,0.914946229175009,1,2,vitamin D metabolic process,BP,VDR
4459,GO:0046903,0.50039616215569,0.627338101065835,16,51,secretion,BP,WNT7A;SYT5;PIK3CG;BMP6;KCNG2;RAB40B;RBP4;VDR;WNK4;INHBB;PKP1;RAB3D;GDNF;USE1;TPD52;NOTCH1
5857,GO:0071549,0.500885153549569,0.914629049810181,1,2,cellular response to dexamethasone stimulus,BP,GJB2
2708,GO:0031334,0.500910262642218,0.819493567416104,2,5,positive regulation of protein complex assembly,BP,PMAIP1;HNF1A
1647,GO:0010629,0.501374042106195,0.653174703765599,10,33,negative regulation of gene expression,BP,TLE1;BMP6;HEY1;AXIN1;VDR;PKP1;HRAS;BMP4;BMP7;NOTCH1
4988,GO:0051353,0.501467914361368,0.81911275624067,2,5,positive regulation of oxidoreductase activity,BP,VDR;GDNF
6991,GO:1905897,0.501595407724563,0.914335738097298,1,2,regulation of response to endoplasmic reticulum stress,BP,PMAIP1
6992,GO:1905898,0.501595407724563,0.914335738097298,1,2,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1
6206,GO:0090207,0.501823543899706,0.91424137375681,1,2,regulation of triglyceride metabolic process,BP,PIK3CG
1445,GO:0009110,0.501844123756192,0.9142328576495,1,2,vitamin biosynthetic process,BP,VDR
4925,GO:0051205,0.501867650327455,0.914223121432722,1,2,protein insertion into membrane,BP,PMAIP1
48,GO:0000303,0.501871799117017,0.914221404419684,1,2,response to superoxide,BP,BMP7
49,GO:0000305,0.501871799117017,0.914221404419684,1,2,response to oxygen radical,BP,BMP7
2227,GO:0019430,0.501871799117017,0.914221404419684,1,2,removal of superoxide radicals,BP,BMP7
5840,GO:0071450,0.501871799117017,0.914221404419684,1,2,cellular response to oxygen radical,BP,BMP7
5841,GO:0071451,0.501871799117017,0.914221404419684,1,2,cellular response to superoxide,BP,BMP7
6226,GO:0090322,0.501871799117017,0.914221404419684,1,2,regulation of superoxide metabolic process,BP,BMP7
7073,GO:2000121,0.501871799117017,0.914221404419684,1,2,regulation of removal of superoxide radicals,BP,BMP7
1174,GO:0007156,0.503146855460064,0.806911451276121,2,6,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH1;DSG3
3375,GO:0035601,0.50327225570928,0.913640416602988,1,2,protein deacylation,BP,LYPLAL1
6388,GO:0098732,0.50327225570928,0.913640416602988,1,2,macromolecule deacylation,BP,LYPLAL1
3581,GO:0042149,0.503349487483784,0.913608295393271,1,2,cellular response to glucose starvation,BP,PMAIP1
6744,GO:1903010,0.503918020721492,0.913371577045593,1,2,regulation of bone development,BP,CLDN18
6745,GO:1903011,0.503918020721492,0.913371577045593,1,2,negative regulation of bone development,BP,CLDN18
5043,GO:0051607,0.504083135322905,0.817320309231489,2,5,defense response to virus,BP,PMAIP1;FADD
4313,GO:0045980,0.504248736084699,0.91323366605475,1,2,negative regulation of nucleotide metabolic process,BP,ACTN3
4500,GO:0048016,0.504248736084699,0.91323366605475,1,2,inositol phosphate-mediated signaling,BP,ACTN3
6504,GO:1900543,0.504248736084699,0.91323366605475,1,2,negative regulation of purine nucleotide metabolic process,BP,ACTN3
794,GO:0005737,0.504852461919826,0.596935952040261,83,270,cytoplasm,CC,MAGEC2;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;RABIF;MBOAT2;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;TMEM160;RBP4;RAB39A;SPTB;PUS1;AMOT;WNT5B;NUDT7;DSG3;CNIH4;WNK4;TSFM;INHBB;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;FSTL3;PTS;NOTCH1;PNMT;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3
5270,GO:0060338,0.504879798206335,0.912970074481597,1,2,regulation of type I interferon-mediated signaling pathway,BP,FADD
5271,GO:0060340,0.504879798206335,0.912970074481597,1,2,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
4222,GO:0045649,0.504975371155883,0.912930104466273,1,2,regulation of macrophage differentiation,BP,FADD
4223,GO:0045651,0.504975371155883,0.912930104466273,1,2,positive regulation of macrophage differentiation,BP,FADD
2247,GO:0019722,0.504981335639427,0.81670219124283,2,5,calcium-mediated signaling,BP,ACTN3;CCL20
1938,GO:0016020,0.505025625844677,0.587687773058817,70,231,membrane,CC,SLC2A14;TJP3;GLDC;WNT7A;GJB2;SYT5;PIK3CG;RHBDL3;CLDN18;RABIF;MBOAT2;GJA3;WNT3;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;TMEM160;RAB39A;SPTB;FGF8;AMOT;WNT5B;DSG3;CNIH4;WNK4;ABCG1;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;ETFDH;USE1;RAB38;FADD;CCDC51;SPTBN4;PIK3CA;PLA2G16;TMEM206;DRP2;TSPAN13;NOTCH1;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;GUCY1B3;DPM3
1327,GO:0008134,0.506046607451264,0.758559980555856,3,9,transcription factor binding,MF,TLE1;HEY1;VDR
4442,GO:0046872,0.506175759222028,0.608300884683674,21,69,metal ion binding,MF,SYT5;RHBDL3;ACTN3;HACL1;RABIF;ACAT1;JAG2;MAPK12;CDH1;VDR;NUDT7;DSG3;RNF144A;ETFDH;TPD52;DRP2;PTS;NOTCH1;ZFYVE21;GUCY1B3;PEPD
6554,GO:1901362,0.506685462554284,0.598309671962122,27,87,organic cyclic compound biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;CDH1;FZD7;FGF8;VDR;TSFM;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3
385,GO:0002697,0.507176557500814,0.815186095451443,2,5,regulation of immune effector process,BP,RBP4;FADD
4670,GO:0048739,0.507526710198756,0.91185825167161,1,2,cardiac muscle fiber development,BP,BMP4
4672,GO:0048747,0.507526710198756,0.91185825167161,1,2,muscle fiber development,BP,BMP4
5644,GO:0070242,0.507549027772783,0.911848834427797,1,2,thymocyte apoptotic process,BP,BMP4
5645,GO:0070243,0.507549027772783,0.911848834427797,1,2,regulation of thymocyte apoptotic process,BP,BMP4
6021,GO:0072201,0.507549027772783,0.911848834427797,1,2,negative regulation of mesenchymal cell proliferation,BP,BMP4
2335,GO:0021904,0.507589391051173,0.911831800696306,1,2,dorsal/ventral neural tube patterning,BP,BMP4
6008,GO:0072176,0.507595608234618,0.911829176770049,1,2,nephric duct development,BP,BMP4
6009,GO:0072178,0.507595608234618,0.911829176770049,1,2,nephric duct morphogenesis,BP,BMP4
3099,GO:0033079,0.507652378679174,0.911805214552886,1,2,immature T cell proliferation,BP,BMP4
3100,GO:0033080,0.507652378679174,0.911805214552886,1,2,immature T cell proliferation in thymus,BP,BMP4
5997,GO:0072161,0.507652378679174,0.911805214552886,1,2,mesenchymal cell differentiation involved in kidney development,BP,BMP4
7192,GO:2001012,0.507652378679174,0.911805214552886,1,2,mesenchymal cell differentiation involved in renal system development,BP,BMP4
2666,GO:0031122,0.507704110157489,0.911783375181102,1,2,cytoplasmic microtubule organization,BP,AXIN1
4080,GO:0044766,0.508530285719285,0.91143406648751,1,2,multi-organism transport,BP,RAB40B
6694,GO:1902579,0.508530285719285,0.91143406648751,1,2,multi-organism localization,BP,RAB40B
3324,GO:0035239,0.508551127712267,0.662660558932515,8,26,tube morphogenesis,BP,WNT2;FGF8;VDR;WNK4;BMP4;GDNF;BMP7;NOTCH1
4013,GO:0044344,0.508718695371653,0.763004622600212,3,8,cellular response to fibroblast growth factor stimulus,BP,FGF8;FGF17;FGF18
5889,GO:0071774,0.508718695371653,0.763004622600212,3,8,response to fibroblast growth factor,BP,FGF8;FGF17;FGF18
6298,GO:0097191,0.509026692117534,0.707732846584998,5,14,extrinsic apoptotic signaling pathway,BP,PMAIP1;BMP4;GDNF;DEPTOR;FADD
2421,GO:0030057,0.509192464943824,0.802537136072167,2,6,desmosome,CC,DSG3;PKP1
2281,GO:0019915,0.509316547019419,0.91110071638742,1,2,lipid storage,BP,ABCG1
2025,GO:0016477,0.509363707288122,0.614945706671093,17,56,cell migration,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;AMOT;ARTN;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;FADD;PIK3CA;FGF18;NOTCH1
1757,GO:0010941,0.509451235422088,0.612543696394452,18,58,regulation of cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;RRAS2;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
1891,GO:0015672,0.509626716244049,0.725470490399871,4,12,monovalent inorganic cation transport,BP,KCNG2;WNK4;KCNK6;SPTBN4
151,GO:0001709,0.509971782886762,0.91082223201471,1,2,cell fate determination,BP,BMP4
815,GO:0005778,0.510345528511669,0.812983914509697,2,5,peroxisomal membrane,CC,PXMP2;PLA2G16
2784,GO:0031903,0.510345528511669,0.812983914509697,2,5,microbody membrane,CC,PXMP2;PLA2G16
3355,GO:0035418,0.510346659909077,0.910662623497192,1,2,protein localization to synapse,BP,WNT7A
6429,GO:0099054,0.510346659909077,0.910662623497192,1,2,presynapse assembly,BP,WNT7A
6680,GO:1902473,0.510346659909077,0.910662623497192,1,2,regulation of protein localization to synapse,BP,WNT7A
6681,GO:1902474,0.510346659909077,0.910662623497192,1,2,positive regulation of protein localization to synapse,BP,WNT7A
6928,GO:1904861,0.510346659909077,0.910662623497192,1,2,excitatory synapse assembly,BP,WNT7A
4687,GO:0048813,0.510356399437208,0.910658474048452,1,2,dendrite morphogenesis,BP,WNT7A
5472,GO:0060996,0.510363893503243,0.910655281167068,1,2,dendritic spine development,BP,WNT7A
6270,GO:0097061,0.510370407115257,0.91065250594625,1,2,dendritic spine organization,BP,WNT7A
5707,GO:0070585,0.510696101676228,0.910513660202937,1,2,protein localization to mitochondrion,BP,PMAIP1
6102,GO:0072655,0.510696101676228,0.910513660202937,1,2,establishment of protein localization to mitochondrion,BP,PMAIP1
6606,GO:1901796,0.510696101676228,0.910513660202937,1,2,regulation of signal transduction by p53 class mediator,BP,PMAIP1
1429,GO:0009063,0.511675507666598,0.812054882838588,2,5,cellular amino acid catabolic process,BP,GLDC;ACAT1
448,GO:0003129,0.511762592112449,0.910057926018333,1,2,heart induction,BP,BMP4
449,GO:0003130,0.511762592112449,0.910057926018333,1,2,BMP signaling pathway involved in heart induction,BP,BMP4
450,GO:0003133,0.511762592112449,0.910057926018333,1,2,endodermal-mesodermal cell signaling,BP,BMP4
451,GO:0003134,0.511762592112449,0.910057926018333,1,2,endodermal-mesodermal cell signaling involved in heart induction,BP,BMP4
2341,GO:0021978,0.511762592112449,0.910057926018333,1,2,telencephalon regionalization,BP,BMP4
3535,GO:0039706,0.511762592112449,0.910057926018333,1,2,co-receptor binding,MF,BMP4
5528,GO:0061209,0.511762592112449,0.910057926018333,1,2,cell proliferation involved in mesonephros development,BP,BMP4
5991,GO:0072138,0.511762592112449,0.910057926018333,1,2,mesenchymal cell proliferation involved in ureteric bud development,BP,BMP4
959,GO:0006412,0.512103333198174,0.760311443432605,3,8,translation,BP,MRPL14;TSFM;BMP4
4634,GO:0048644,0.512433408123201,0.800167769093113,2,6,muscle organ morphogenesis,BP,WNT2;NOTCH1
4774,GO:0050789,0.512461566554234,0.580930285908739,71,235,regulation of biological process,BP,MAGEC2;RHPN1;TLE1;WNT7A;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KCNK6;GDNF;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;LINGO1;RND3;RAB20;GUCY1B3;PM20D2
6865,GO:1903829,0.512685852584274,0.719247532464554,4,13,positive regulation of cellular protein localization,BP,BMP6;PMAIP1;CDH1;BMP4
2299,GO:0021549,0.512755732920013,0.909632041019533,1,2,cerebellum development,BP,WNT7A
2300,GO:0021575,0.512755732920013,0.909632041019533,1,2,hindbrain morphogenesis,BP,WNT7A
2301,GO:0021587,0.512755732920013,0.909632041019533,1,2,cerebellum morphogenesis,BP,WNT7A
2312,GO:0021695,0.512755732920013,0.909632041019533,1,2,cerebellar cortex development,BP,WNT7A
2313,GO:0021696,0.512755732920013,0.909632041019533,1,2,cerebellar cortex morphogenesis,BP,WNT7A
2314,GO:0021697,0.512755732920013,0.909632041019533,1,2,cerebellar cortex formation,BP,WNT7A
2350,GO:0022037,0.512755732920013,0.909632041019533,1,2,metencephalon development,BP,WNT7A
31,GO:0000187,0.513457855306239,0.752554884179818,3,9,activation of MAPK activity,BP,WNT7B;AXIN1;DUSP5
4936,GO:0051234,0.513819488583351,0.578574405775975,43,142,establishment of localization,BP,SLC2A14;WNT7A;GJB2;SYT5;PIK3CG;RABIF;BMP6;GJA3;PMAIP1;KCNG2;RAB40B;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;VDR;CNIH4;WNK4;INHBB;ABCG1;PKP1;HRAS;TSPAN15;BMP4;RAB3D;CLDN15;KCNK6;GDNF;USE1;TBC1D14;PSMB10;RAB38;BMP7;SPTBN4;PIK3CA;TPD52;HNF1A;TSPAN13;NOTCH1;ZFYVE21;RAB20
5542,GO:0061318,0.513908100059682,0.909136062932994,1,2,renal filtration cell differentiation,BP,BMP4
5932,GO:0072010,0.513908100059682,0.909136062932994,1,2,glomerular epithelium development,BP,BMP4
5947,GO:0072050,0.513908100059682,0.909136062932994,1,2,S-shaped body morphogenesis,BP,BMP4
5981,GO:0072112,0.513908100059682,0.909136062932994,1,2,glomerular visceral epithelial cell differentiation,BP,BMP4
6030,GO:0072217,0.513908100059682,0.909136062932994,1,2,negative regulation of metanephros development,BP,BMP4
6046,GO:0072284,0.513908100059682,0.909136062932994,1,2,metanephric S-shaped body morphogenesis,BP,BMP4
6053,GO:0072311,0.513908100059682,0.909136062932994,1,2,glomerular epithelial cell differentiation,BP,BMP4
1115,GO:0006924,0.51392152097492,0.909130275083228,1,2,activation-induced cell death of T cells,BP,FADD
6779,GO:1903307,0.51421078653085,0.90900546315416,1,2,positive regulation of regulated secretory pathway,BP,RAB3D
5851,GO:0071496,0.514465778376396,0.696942430054797,5,16,cellular response to external stimulus,BP,BMP6;PMAIP1;VDR;INHBB;FADD
5540,GO:0061312,0.514664017097287,0.908809655976363,1,2,BMP signaling pathway involved in heart development,BP,BMP4
2006,GO:0016408,0.5148138508984,0.908744857339933,1,2,C-acyltransferase activity,MF,ACAT1
207,GO:0001909,0.515298963947986,0.908534833144873,1,2,leukocyte mediated cytotoxicity,BP,FADD
210,GO:0001913,0.515298963947986,0.908534833144873,1,2,T cell mediated cytotoxicity,BP,FADD
341,GO:0002456,0.515298963947986,0.908534833144873,1,2,T cell mediated immunity,BP,FADD
3250,GO:0034599,0.515430829786532,0.750942600622456,3,9,cellular response to oxidative stress,BP,GJB2;BMP7;GUCY1B3
4705,GO:0048863,0.516686118372841,0.719409852153304,4,12,stem cell differentiation,BP,WNT7A;WNT3;GDNF;NOTCH1
4671,GO:0048745,0.516904308696665,0.907837334959338,1,2,smooth muscle tissue development,BP,BMP4
5522,GO:0061156,0.516904308696665,0.907837334959338,1,2,pulmonary artery morphogenesis,BP,BMP4
23,GO:0000149,0.517767885140602,0.907460541979716,1,2,SNARE binding,MF,SYT5
2279,GO:0019905,0.517767885140602,0.907460541979716,1,2,syntaxin binding,MF,SYT5
401,GO:0002756,0.517806107135814,0.907443839436029,1,2,MyD88-independent toll-like receptor signaling pathway,BP,FADD
3389,GO:0035666,0.517806107135814,0.907443839436029,1,2,TRIF-dependent toll-like receptor signaling pathway,BP,FADD
6320,GO:0097342,0.517806107135814,0.907443839436029,1,2,ripoptosome,CC,FADD
1362,GO:0008283,0.517815771171219,0.597282546070193,21,68,cell proliferation,BP,WNT7A;PIK3CG;BMP6;WNT3;GJB6;WNT7B;JAG2;WNT2;FZD7;RBP4;FGF8;VDR;ARTN;FGF17;HRAS;BMP4;GDNF;FADD;BMP7;FGF18;NOTCH1
6693,GO:1902578,0.51787518093464,0.583508193418296,30,99,single-organism localization,BP,SLC2A14;WNT7A;SYT5;PIK3CG;BMP6;PMAIP1;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;VDR;WNK4;INHBB;ABCG1;PKP1;TSPAN15;BMP4;RAB3D;KCNK6;GDNF;USE1;BMP7;SPTBN4;PIK3CA;TPD52;HNF1A;NOTCH1;RAB20
2704,GO:0031329,0.518094723325556,0.663752224135697,7,23,regulation of cellular catabolic process,BP,PIK3CG;AXIN1;PKP1;RNF144A;TBC1D14;PSMB10;PIK3CA
3382,GO:0035639,0.518630098484916,0.612203919276215,15,50,purine ribonucleoside triphosphate binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2540,GO:0030516,0.518998678232963,0.906921606144934,1,2,regulation of axon extension,BP,WNT3
2541,GO:0030517,0.518998678232963,0.906921606144934,1,2,negative regulation of axon extension,BP,WNT3
4649,GO:0048675,0.518998678232963,0.906921606144934,1,2,axon extension,BP,WNT3
4693,GO:0048841,0.518998678232963,0.906921606144934,1,2,regulation of axon extension involved in axon guidance,BP,WNT3
4694,GO:0048843,0.518998678232963,0.906921606144934,1,2,negative regulation of axon extension involved in axon guidance,BP,WNT3
4697,GO:0048846,0.518998678232963,0.906921606144934,1,2,axon extension involved in axon guidance,BP,WNT3
5564,GO:0061387,0.518998678232963,0.906921606144934,1,2,regulation of extent of cell growth,BP,WNT3
6664,GO:1902284,0.518998678232963,0.906921606144934,1,2,neuron projection extension involved in neuron projection guidance,BP,WNT3
6709,GO:1902667,0.518998678232963,0.906921606144934,1,2,regulation of axon guidance,BP,WNT3
6710,GO:1902668,0.518998678232963,0.906921606144934,1,2,negative regulation of axon guidance,BP,WNT3
5489,GO:0061038,0.519649106233131,0.906635884743362,1,2,uterus morphogenesis,BP,WNT7A
3651,GO:0042481,0.520587253825953,0.805755790248238,2,5,regulation of odontogenesis,BP,FGF8;BMP4
3578,GO:0042129,0.520661231897476,0.805702957628695,2,5,regulation of T cell proliferation,BP,BMP4;FADD
218,GO:0001933,0.521042722965697,0.71563592528296,4,12,negative regulation of protein phosphorylation,BP,DUSP5;BMP4;DEPTOR;BMP7
427,GO:0003008,0.521072812364649,0.598132957485314,19,63,system process,BP,GJB2;PIK3CG;ACTN3;BMP6;GJA3;GJB6;JAG2;KCNG2;RBP4;VDR;WNK4;INHBB;BMP4;KCNK6;GDNF;SPTBN4;PIK3CA;HNF1A;GUCY1B3
7117,GO:2000401,0.521357642243265,0.805205164017879,2,5,regulation of lymphocyte migration,BP,CCL20;FADD
770,GO:0005544,0.52158723250935,0.905780737827655,1,2,calcium-dependent phospholipid binding,MF,SYT5
4932,GO:0051222,0.521605943026069,0.715146145084604,4,12,positive regulation of protein transport,BP,BMP6;CDH1;RBP4;BMP4
5060,GO:0051704,0.521801518402794,0.597745177346379,19,62,multi-organism process,BP,SLC2A14;GJB2;BMP6;WNT3;GJB6;JAG2;PMAIP1;RAB40B;CDH1;VDR;CCL20;INHBB;HRAS;BMP4;PSMB10;FADD;SPTBN4;FSTL3;NOTCH1
5216,GO:0060135,0.522263490867739,0.792875871815327,2,6,maternal process involved in female pregnancy,BP,GJB2;VDR
3974,GO:0044232,0.522561795007952,0.905348601012045,1,2,organelle membrane contact site,CC,RAB38
3975,GO:0044233,0.522561795007952,0.905348601012045,1,2,ER-mitochondrion membrane contact site,CC,RAB38
3364,GO:0035577,0.52257865224926,0.905341113617711,1,2,azurophil granule membrane,CC,RAB3D
2751,GO:0031638,0.522641175599548,0.905313339190188,1,2,zymogen activation,BP,FADD
3067,GO:0032945,0.522755097958404,0.905262716845542,1,2,negative regulation of mononuclear cell proliferation,BP,BMP4
3579,GO:0042130,0.522755097958404,0.905262716845542,1,2,negative regulation of T cell proliferation,BP,BMP4
4730,GO:0050672,0.522755097958404,0.905262716845542,1,2,negative regulation of lymphocyte proliferation,BP,BMP4
4811,GO:0050868,0.522755097958404,0.905262716845542,1,2,negative regulation of T cell activation,BP,BMP4
5720,GO:0070664,0.522755097958404,0.905262716845542,1,2,negative regulation of leukocyte proliferation,BP,BMP4
6753,GO:1903038,0.522755097958404,0.905262716845542,1,2,negative regulation of leukocyte cell-cell adhesion,BP,BMP4
2213,GO:0019318,0.523364795914805,0.713613841128049,4,12,hexose metabolic process,BP,ACTN3;PMAIP1;RBP4;PIK3CA
1663,GO:0010658,0.523582093562402,0.904894645502788,1,2,striated muscle cell apoptotic process,BP,BMP7
1666,GO:0010662,0.523582093562402,0.904894645502788,1,2,regulation of striated muscle cell apoptotic process,BP,BMP7
1667,GO:0010664,0.523582093562402,0.904894645502788,1,2,negative regulation of striated muscle cell apoptotic process,BP,BMP7
3619,GO:0042345,0.523582093562402,0.904894645502788,1,2,regulation of NF-kappaB import into nucleus,BP,BMP7
3621,GO:0042348,0.523582093562402,0.904894645502788,1,2,NF-kappaB import into nucleus,BP,BMP7
3737,GO:0042981,0.523988903389858,0.601178442846666,17,55,regulation of apoptotic process,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
15,GO:0000096,0.524167791213479,0.904633341460019,1,2,sulfur amino acid metabolic process,BP,MSRA
994,GO:0006555,0.524167791213479,0.904633341460019,1,2,methionine metabolic process,BP,MSRA
1431,GO:0009066,0.524167791213479,0.904633341460019,1,2,aspartate family amino acid metabolic process,BP,MSRA
2088,GO:0016787,0.52446574827094,0.598365473138112,18,57,hydrolase activity,MF,RHBDL3;RAB40B;RRAS2;RAB39A;NUDT7;DUSP5;ABCG1;HRAS;RAB3D;LYPLAL1;PSMB10;RAB38;PLA2G16;NUDT6;RND3;RAB20;PM20D2;PEPD
1800,GO:0014066,0.525001216905114,0.712184392140087,4,12,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF8;FGF17;PIK3CA;FGF18
2103,GO:0016836,0.5258274459878,0.801991094969323,2,5,hydro-lyase activity,MF,PUS1;ECI1
2694,GO:0031300,0.526142610202452,0.903748445316436,1,2,intrinsic component of organelle membrane,CC,ETFDH
2695,GO:0031301,0.526142610202452,0.903748445316436,1,2,integral component of organelle membrane,CC,ETFDH
1179,GO:0007163,0.526174052064422,0.742061583566537,3,9,establishment or maintenance of cell polarity,BP,WNT7A;WNT7B;AMOT
731,GO:0005251,0.526445743913068,0.903612087210078,1,2,delayed rectifier potassium channel activity,MF,KCNG2
5684,GO:0070402,0.528345901822502,0.902754133123442,1,2,NADPH binding,MF,DECR1
4193,GO:0045580,0.52849913597233,0.902684703448583,1,2,regulation of T cell differentiation,BP,BMP4
3556,GO:0042056,0.529003010584278,0.799687505980618,2,5,chemoattractant activity,MF,FGF8;BMP4
2263,GO:0019866,0.529072138495373,0.686596523584085,5,15,organelle inner membrane,CC,ACAT1;MRPL14;ACADVL;ECI1;ETFDH
2081,GO:0016758,0.529183225736406,0.799556270889014,2,5,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3
4199,GO:0045598,0.529642145560091,0.787296831735027,2,6,regulation of fat cell differentiation,BP,AXIN1;WNT5B
460,GO:0003159,0.530135742126132,0.90194090481334,1,2,morphogenesis of an endothelium,BP,BMP4
5520,GO:0061154,0.530135742126132,0.90194090481334,1,2,endothelial tube morphogenesis,BP,BMP4
1140,GO:0007005,0.530681269394523,0.745223683700344,3,8,mitochondrion organization,BP,PMAIP1;PUS1;RAB38
188,GO:0001838,0.531845366745408,0.737303199004791,3,9,embryonic epithelial tube formation,BP,BMP4;GDNF;BMP7
1835,GO:0014874,0.532065441785156,0.901058571234699,1,2,response to stimulus involved in regulation of muscle adaptation,BP,ACTN3
1840,GO:0014889,0.532065441785156,0.901058571234699,1,2,muscle atrophy,BP,ACTN3
4337,GO:0046189,0.532269064664597,0.900965129094699,1,2,phenol-containing compound biosynthetic process,BP,PNMT
1002,GO:0006584,0.532317529008128,0.900942879378032,1,2,catecholamine metabolic process,BP,PNMT
1523,GO:0009712,0.532317529008128,0.900942879378032,1,2,catechol-containing compound metabolic process,BP,PNMT
4498,GO:0048013,0.532466357418556,0.900874530162931,1,2,ephrin receptor signaling pathway,BP,HRAS
3116,GO:0033162,0.532594567416105,0.900815622209642,1,2,melanosome membrane,CC,RAB38
4102,GO:0045009,0.532594567416105,0.900815622209642,1,2,chitosome,CC,RAB38
3262,GO:0034641,0.532756286001398,0.564523754204636,35,114,cellular nitrogen compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;PTS;NOTCH1;CPT1C;GUCY1B3
3435,GO:0035914,0.53306650082459,0.900598564368454,1,2,skeletal muscle cell differentiation,BP,NOTCH1
4162,GO:0045296,0.533259835000677,0.784527916593989,2,6,cadherin binding,MF,CDH1;MB21D2
104,GO:0001502,0.533474544651186,0.900410610788718,1,2,cartilage condensation,BP,WNT7A
6391,GO:0098743,0.533474544651186,0.900410610788718,1,2,cell aggregation,BP,WNT7A
5813,GO:0071359,0.53352598456091,0.900386897988732,1,2,cellular response to dsRNA,BP,BMP4
3787,GO:0043169,0.533577069037882,0.579385585114794,22,73,cation binding,MF,GLDC;SYT5;RHBDL3;ACTN3;HACL1;RABIF;ACAT1;JAG2;MAPK12;CDH1;VDR;NUDT7;DSG3;RNF144A;ETFDH;TPD52;DRP2;PTS;NOTCH1;ZFYVE21;GUCY1B3;PEPD
2229,GO:0019433,0.534531964384485,0.89992232715125,1,2,triglyceride catabolic process,BP,PIK3CG
4365,GO:0046461,0.534531964384485,0.89992232715125,1,2,neutral lipid catabolic process,BP,PIK3CG
4367,GO:0046464,0.534531964384485,0.89992232715125,1,2,acylglycerol catabolic process,BP,PIK3CG
4782,GO:0050801,0.534654610585804,0.638137881985308,8,26,ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;WNK4;ABCG1;RAB38;RAB20
6626,GO:1901981,0.534825372222859,0.78332277605858,2,6,phosphatidylinositol phosphate binding,MF,SYT5;FZD7
6740,GO:1902936,0.534825372222859,0.78332277605858,2,6,phosphatidylinositol bisphosphate binding,MF,SYT5;FZD7
5070,GO:0051783,0.535344246307459,0.734343094051495,3,9,regulation of nuclear division,BP,FGF8;BMP4;BMP7
3509,GO:0038034,0.535709545630053,0.794766892105291,2,5,signal transduction in absence of ligand,BP,GDNF;FADD
6299,GO:0097192,0.535709545630053,0.794766892105291,2,5,extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF;FADD
2813,GO:0032006,0.535909900771588,0.782485455946073,2,6,regulation of TOR signaling,BP,DEPTOR;PIK3CA
2329,GO:0021884,0.536475805993212,0.899020134625347,1,2,forebrain neuron development,BP,FGF8
4700,GO:0048853,0.536475805993212,0.899020134625347,1,2,forebrain morphogenesis,BP,FGF8
2296,GO:0021543,0.536517522925241,0.899000707264873,1,2,pallium development,BP,FGF8
1978,GO:0016264,0.537255090431659,0.898656771143248,1,2,gap junction assembly,BP,GJB2
6987,GO:1905867,0.537255090431659,0.898656771143248,1,2,epididymis development,BP,GJB2
191,GO:0001841,0.537784795647667,0.781033167630934,2,6,neural tube formation,BP,BMP4;BMP7
1785,GO:0014020,0.537784795647667,0.781033167630934,2,6,primary neural tube formation,BP,BMP4;BMP7
1460,GO:0009154,0.537787863761756,0.898407796660899,1,2,purine ribonucleotide catabolic process,BP,NUDT7
1480,GO:0009261,0.537787863761756,0.898407796660899,1,2,ribonucleotide catabolic process,BP,NUDT7
4806,GO:0050863,0.538132531778974,0.73197070719284,3,9,regulation of T cell activation,BP,BMP4;FADD;PIK3CA
6752,GO:1903037,0.538132531778974,0.73197070719284,3,9,regulation of leukocyte cell-cell adhesion,BP,BMP4;FADD;PIK3CA
4263,GO:0045786,0.539144631927293,0.660632584681588,6,18,negative regulation of cell cycle,BP,MAPK12;HRAS;BMP4;PSMB10;BMP7;PLA2G16
817,GO:0005783,0.539358243179451,0.590088186711329,16,50,endoplasmic reticulum,CC,WNT7A;MBOAT2;WNT3;WNT7B;RRAS2;WNT5B;CNIH4;ABCG1;ALG5;USE1;RAB38;PLA2G16;TPD52;NOTCH1;CPT1C;DPM3
3577,GO:0042127,0.540023869187405,0.582712074713559,18,58,regulation of cell proliferation,BP,WNT7A;BMP6;WNT3;GJB6;JAG2;WNT2;FZD7;RBP4;FGF8;VDR;FGF17;HRAS;BMP4;GDNF;FADD;BMP7;FGF18;NOTCH1
7222,GO:2001237,0.540395417730439,0.737124980968293,3,8,negative regulation of extrinsic apoptotic signaling pathway,BP,BMP4;GDNF;FADD
5214,GO:0060128,0.540443290070236,0.897160132353246,1,2,corticotropin hormone secreting cell differentiation,BP,FGF8
5272,GO:0060341,0.540517635232882,0.631297396766343,8,27,regulation of cellular localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;GDNF;BMP7
345,GO:0002479,0.540595730107688,0.897088165878557,1,2,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB10
3695,GO:0042632,0.540826174926514,0.896979302888696,1,2,cholesterol homeostasis,BP,ABCG1
5151,GO:0055081,0.540826174926514,0.896979302888696,1,2,anion homeostasis,BP,ABCG1
5157,GO:0055091,0.540826174926514,0.896979302888696,1,2,phospholipid homeostasis,BP,ABCG1
5158,GO:0055092,0.540826174926514,0.896979302888696,1,2,sterol homeostasis,BP,ABCG1
5222,GO:0060157,0.540826680714264,0.89697906385905,1,2,urinary bladder development,BP,RBP4
1279,GO:0007600,0.540992065309947,0.67284411295418,5,16,sensory perception,BP,GJB2;GJA3;GJB6;RBP4;SPTBN4
1488,GO:0009308,0.541126426193309,0.896837335305439,1,2,amine metabolic process,BP,PSMB10
3972,GO:0044106,0.541126426193309,0.896837335305439,1,2,cellular amine metabolic process,BP,PSMB10
1333,GO:0008154,0.541224450131787,0.729325942936838,3,9,actin polymerization or depolymerization,BP,SPTBN5;SPTB;SPTBN4
1601,GO:0010389,0.541546051147336,0.89663868187803,1,2,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
1766,GO:0010972,0.541546051147336,0.89663868187803,1,2,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
6718,GO:1902749,0.541546051147336,0.89663868187803,1,2,regulation of cell cycle G2/M phase transition,BP,PSMB10
6719,GO:1902750,0.541546051147336,0.89663868187803,1,2,negative regulation of cell cycle G2/M phase transition,BP,PSMB10
3253,GO:0034613,0.541593497426359,0.597526917825977,13,44,cellular protein localization,BP,CLDN18;BMP6;PMAIP1;RAB40B;CDH1;FZD7;AMOT;TSPAN15;BMP4;TBC1D14;RAB38;BMP7;SPTBN4
5731,GO:0070727,0.541593497426359,0.597526917825977,13,44,cellular macromolecule localization,BP,CLDN18;BMP6;PMAIP1;RAB40B;CDH1;FZD7;AMOT;TSPAN15;BMP4;TBC1D14;RAB38;BMP7;SPTBN4
3802,GO:0043207,0.541745117313811,0.632720264185923,8,25,response to external biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;FADD;NOTCH1
5061,GO:0051707,0.541745117313811,0.632720264185923,8,25,response to other organism,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;FADD;NOTCH1
2829,GO:0032088,0.542191526566374,0.896332556571339,1,2,negative regulation of NF-kappaB transcription factor activity,BP,BMP7
1638,GO:0010595,0.542593975095122,0.728149741685382,3,9,positive regulation of endothelial cell migration,BP,WNT7A;BMP4;FGF18
5181,GO:0060042,0.543086657496564,0.895906917829665,1,2,retina morphogenesis in camera-type eye,BP,RBP4
2546,GO:0030539,0.544313153726375,0.788342280911776,2,5,male genitalia development,BP,BMP6;FGF8
5069,GO:0051781,0.544678606227982,0.8951467383948,1,2,positive regulation of cell division,BP,FGF8
840,GO:0005881,0.545365193566785,0.894817613504601,1,2,cytoplasmic microtubule,CC,RAB3D
118,GO:0001561,0.545461929383064,0.894771180253918,1,2,fatty acid alpha-oxidation,BP,HACL1
410,GO:0002791,0.545583043212835,0.69388841867927,4,12,regulation of peptide secretion,BP,BMP6;KCNG2;RBP4;INHBB
5124,GO:0055006,0.546392090286083,0.774287953939009,2,6,cardiac cell development,BP,BMP4;NOTCH1
422,GO:0002931,0.546470710633315,0.894286055738316,1,2,response to ischemia,BP,GJB2
2049,GO:0016604,0.546754913698001,0.724558228513357,3,9,nuclear body,CC,ARL6IP4;SPTBN4;LAGE3
3511,GO:0038061,0.547261103467392,0.89390479315418,1,2,NIK/NF-kappaB signaling,BP,PSMB10
389,GO:0002703,0.547317680753381,0.893877462695074,1,2,regulation of leukocyte mediated immunity,BP,FADD
390,GO:0002705,0.547317680753381,0.893877462695074,1,2,positive regulation of leukocyte mediated immunity,BP,FADD
391,GO:0002706,0.547317680753381,0.893877462695074,1,2,regulation of lymphocyte mediated immunity,BP,FADD
392,GO:0002708,0.547317680753381,0.893877462695074,1,2,positive regulation of lymphocyte mediated immunity,BP,FADD
415,GO:0002822,0.547317680753381,0.893877462695074,1,2,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
416,GO:0002824,0.547317680753381,0.893877462695074,1,2,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
796,GO:0005740,0.548055065249832,0.637115959504829,7,22,mitochondrial envelope,CC,ACAT1;PMAIP1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
2800,GO:0031966,0.548055065249832,0.637115959504829,7,22,mitochondrial membrane,CC,ACAT1;PMAIP1;MRPL14;ACADVL;ECI1;ETFDH;CPT1C
261,GO:0002066,0.548217103370523,0.772841146027026,2,6,columnar/cuboidal epithelial cell development,BP,BMP6;BMP4
2076,GO:0016740,0.54822649730178,0.576559285829194,17,57,transferase activity,MF,PIK3CG;MBOAT2;ACAT1;MAPK12;FGF8;WNK4;PKN3;FGF17;ALG5;RNF144A;PIK3CA;PLA2G16;FGF18;PNMT;CPT1C;ZFYVE21;DPM3
1100,GO:0006890,0.548314173776228,0.893395232061594,1,2,retrograde vesicle-mediated transport, Golgi to ER,BP,USE1
588,GO:0004300,0.549120252774877,0.893003954005519,1,2,enoyl-CoA hydratase activity,MF,ECI1
5772,GO:0071214,0.549260304757326,0.722382616545978,3,9,cellular response to abiotic stimulus,BP,BMP6;HRAS;FADD
6961,GO:1905276,0.550126542591639,0.892513988367196,1,2,regulation of epithelial tube formation,BP,GDNF
223,GO:0001941,0.550167038185518,0.892494235919653,1,2,postsynaptic membrane organization,BP,GDNF
523,GO:0003339,0.55021343122421,0.892471603554334,1,2,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
5977,GO:0072108,0.55021343122421,0.892471603554334,1,2,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GDNF
7159,GO:2000696,0.55021343122421,0.892471603554334,1,2,regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
7160,GO:2000698,0.55021343122421,0.892471603554334,1,2,positive regulation of epithelial cell differentiation involved in kidney development,BP,GDNF
182,GO:0001823,0.55036482753284,0.689552317891302,4,12,mesonephros development,BP,FGF8;BMP4;GDNF;BMP7
1164,GO:0007067,0.550370594702969,0.72141531123388,3,9,mitotic nuclear division,BP,FGF8;BMP4;BMP7
106,GO:0001504,0.550590966280103,0.892287294531662,1,2,neurotransmitter uptake,BP,GDNF
762,GO:0005521,0.551161164431269,0.892008481539444,1,2,lamin binding,MF,PKP1
2648,GO:0031069,0.552022328814224,0.891586369927733,1,2,hair follicle morphogenesis,BP,NOTCH1
4665,GO:0048730,0.552022328814224,0.891586369927733,1,2,epidermis morphogenesis,BP,NOTCH1
3959,GO:0044058,0.552111111315319,0.891542781829016,1,2,regulation of digestive system process,BP,WNK4
353,GO:0002548,0.552234160292572,0.891482348776056,1,2,monocyte chemotaxis,BP,CCL20
5869,GO:0071674,0.552234160292572,0.891482348776056,1,2,mononuclear cell migration,BP,CCL20
1425,GO:0009058,0.552312993699122,0.541863183169627,40,130,biosynthetic process,BP,TLE1;WNT7A;PIK3CG;MBOAT2;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;CDH1;FZD7;RBP4;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;FGF17;ALG5;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3;DPM3
6863,GO:1903827,0.552743433061319,0.629493545664291,7,24,regulation of cellular protein localization,BP,CLDN18;BMP6;PMAIP1;CDH1;FZD7;BMP4;BMP7
5395,GO:0060684,0.553355964874705,0.890930232448771,1,2,epithelial-mesenchymal cell signaling,BP,BMP4
171,GO:0001776,0.553546893860662,0.768582205772452,2,6,leukocyte homeostasis,BP,PMAIP1;FADD
6221,GO:0090303,0.553995676554743,0.89061444526968,1,2,positive regulation of wound healing,BP,HRAS
6751,GO:1903036,0.553995676554743,0.89061444526968,1,2,positive regulation of response to wounding,BP,HRAS
5895,GO:0071804,0.554046876779456,0.768180090400008,2,6,cellular potassium ion transport,BP,KCNG2;KCNK6
5896,GO:0071805,0.554046876779456,0.768180090400008,2,6,potassium ion transmembrane transport,BP,KCNG2;KCNK6
1518,GO:0009628,0.556833905840829,0.600894745042267,10,32,response to abiotic stimulus,BP,BMP6;GJB6;PMAIP1;ACADVL;INHBB;HRAS;PSMB10;FADD;BMP7;NOTCH1
734,GO:0005261,0.55702761220457,0.765773536317981,2,6,cation channel activity,MF,KCNG2;KCNK6
2381,GO:0022836,0.55702761220457,0.765773536317981,2,6,gated channel activity,MF,KCNG2;KCNK6
1672,GO:0010675,0.557255770652307,0.765588671989661,2,6,regulation of cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1745,GO:0010906,0.557255770652307,0.765588671989661,2,6,regulation of glucose metabolic process,BP,ACTN3;PMAIP1
3762,GO:0043067,0.557271845996432,0.567929283453057,17,56,regulation of programmed cell death,BP,TLE1;WNT7A;PIK3CG;ACTN3;BMP6;PMAIP1;FGF8;VDR;INHBB;HRAS;BMP4;GDNF;DEPTOR;FADD;BMP7;PIK3CA;NOTCH1
4589,GO:0048523,0.557306107001898,0.537695328293882,38,127,negative regulation of cellular process,BP,TLE1;WNT7A;PIK3CG;ACTN3;CLDN18;BMP6;WNT3;HEY1;GJB6;AXIN1;MAPK12;ACADVL;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;WNT5B;DUSP5;INHBB;ABCG1;PKP1;HRAS;BMP4;GDNF;DEPTOR;TBC1D14;PSMB10;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;FSTL3;NOTCH1;LINGO1
3019,GO:0032770,0.558346639265268,0.88844836733931,1,2,positive regulation of monooxygenase activity,BP,GDNF
1545,GO:0009889,0.558741187666676,0.547777409019516,26,86,regulation of biosynthetic process,BP,TLE1;WNT7A;BMP6;HEY1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;FGF8;VDR;CCL20;TSFM;INHBB;ABCG1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;HNF1A;FSTL3;NOTCH1
1221,GO:0007270,0.558835788536235,0.888202845510513,1,2,neuron-neuron synaptic transmission,BP,GDNF
1269,GO:0007569,0.558865855739004,0.888187740396754,1,2,cell aging,BP,HRAS
1599,GO:0010332,0.558865855739004,0.888187740396754,1,2,response to gamma radiation,BP,HRAS
5847,GO:0071480,0.558865855739004,0.888187740396754,1,2,cellular response to gamma radiation,BP,HRAS
6232,GO:0090398,0.558865855739004,0.888187740396754,1,2,cellular senescence,BP,HRAS
707,GO:0005164,0.558875874921942,0.888182706633361,1,2,tumor necrosis factor receptor binding,MF,FADD
2689,GO:0031264,0.558875874921942,0.888182706633361,1,2,death-inducing signaling complex,CC,FADD
5352,GO:0060544,0.558875874921942,0.888182706633361,1,2,regulation of necroptotic process,BP,FADD
5858,GO:0071550,0.558875874921942,0.888182706633361,1,2,death-inducing signaling complex assembly,BP,FADD
6312,GO:0097296,0.558875874921942,0.888182706633361,1,2,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
6639,GO:1902042,0.558875874921942,0.888182706633361,1,2,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
7234,GO:2001267,0.558875874921942,0.888182706633361,1,2,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
7235,GO:2001269,0.558875874921942,0.888182706633361,1,2,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
5088,GO:0051924,0.559090673350813,0.764098544516845,2,6,regulation of calcium ion transport,BP,PIK3CG;TSPAN13
1141,GO:0007006,0.559619802663831,0.887808469793964,1,2,mitochondrial membrane organization,BP,PMAIP1
4458,GO:0046902,0.559619802663831,0.887808469793964,1,2,regulation of mitochondrial membrane permeability,BP,PMAIP1
6246,GO:0090559,0.559619802663831,0.887808469793964,1,2,regulation of membrane permeability,BP,PMAIP1
6646,GO:1902108,0.559619802663831,0.887808469793964,1,2,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,PMAIP1
4997,GO:0051427,0.56100983443661,0.887106671673933,1,2,hormone receptor binding,MF,VDR
5609,GO:0070059,0.561370249735746,0.886924164745402,1,2,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1
1122,GO:0006941,0.561766210744739,0.7058057663704,3,10,striated muscle contraction,BP,PIK3CG;ACTN3;PIK3CA
696,GO:0005123,0.562524543064085,0.886338150639584,1,2,death receptor binding,MF,FADD
3425,GO:0035877,0.562524543064085,0.886338150639584,1,2,death effector domain binding,MF,FADD
5354,GO:0060547,0.562524543064085,0.886338150639584,1,2,negative regulation of necrotic cell death,BP,FADD
6145,GO:0089720,0.562524543064085,0.886338150639584,1,2,caspase binding,MF,FADD
4001,GO:0044297,0.562796398366696,0.652357980913947,5,16,cell body,CC,GJB2;SYT5;FADD;SPTBN4;DRP2
6160,GO:0090066,0.563191261840083,0.620810318165099,7,23,regulation of anatomical structure size,BP,WNT7A;WNT3;WNT7B;SPTBN5;SPTB;DEPTOR;SPTBN4
752,GO:0005501,0.563368602861063,0.885908182070354,1,2,retinoid binding,MF,RBP4
2257,GO:0019840,0.563368602861063,0.885908182070354,1,2,isoprenoid binding,MF,RBP4
1726,GO:0010872,0.564029751690477,0.885570528548887,1,2,regulation of cholesterol esterification,BP,ABCG1
1926,GO:0015914,0.564029751690477,0.885570528548887,1,2,phospholipid transport,BP,ABCG1
2903,GO:0032371,0.564029751690477,0.885570528548887,1,2,regulation of sterol transport,BP,ABCG1
2906,GO:0032374,0.564029751690477,0.885570528548887,1,2,regulation of cholesterol transport,BP,ABCG1
3132,GO:0033344,0.564029751690477,0.885570528548887,1,2,cholesterol efflux,BP,ABCG1
3163,GO:0033700,0.564029751690477,0.885570528548887,1,2,phospholipid efflux,BP,ABCG1
3220,GO:0034367,0.564029751690477,0.885570528548887,1,2,macromolecular complex remodeling,BP,ABCG1
3221,GO:0034368,0.564029751690477,0.885570528548887,1,2,protein-lipid complex remodeling,BP,ABCG1
3222,GO:0034369,0.564029751690477,0.885570528548887,1,2,plasma lipoprotein particle remodeling,BP,ABCG1
3224,GO:0034375,0.564029751690477,0.885570528548887,1,2,high-density lipoprotein particle remodeling,BP,ABCG1
3237,GO:0034433,0.564029751690477,0.885570528548887,1,2,steroid esterification,BP,ABCG1
3238,GO:0034434,0.564029751690477,0.885570528548887,1,2,sterol esterification,BP,ABCG1
3239,GO:0034435,0.564029751690477,0.885570528548887,1,2,cholesterol esterification,BP,ABCG1
5898,GO:0071825,0.564029751690477,0.885570528548887,1,2,protein-lipid complex subunit organization,BP,ABCG1
5900,GO:0071827,0.564029751690477,0.885570528548887,1,2,plasma lipoprotein particle organization,BP,ABCG1
6256,GO:0097006,0.564029751690477,0.885570528548887,1,2,regulation of plasma lipoprotein particle levels,BP,ABCG1
5267,GO:0060326,0.56415574221908,0.672907780960113,4,13,cell chemotaxis,BP,PIK3CG;CCL20;FGF18;NOTCH1
4871,GO:0051052,0.564779619985728,0.676281824741133,4,12,regulation of DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
5915,GO:0071887,0.566263702873055,0.758214763509013,2,6,leukocyte apoptotic process,BP,BMP4;FADD
4737,GO:0050680,0.566805683164418,0.757766379119671,2,6,negative regulation of epithelial cell proliferation,BP,VDR;BMP4
1376,GO:0008361,0.567666362814343,0.757053222838007,2,6,regulation of cell size,BP,WNT3;DEPTOR
1438,GO:0009083,0.56806877476348,0.883491243932967,1,2,branched-chain amino acid catabolic process,BP,ACAT1
976,GO:0006493,0.569092770475664,0.882959548744108,1,2,protein O-linked glycosylation,BP,DPM3
6287,GO:0097159,0.569573899050994,0.531667882137058,30,101,organic cyclic compound binding,MF,GLDC;PIK3CG;HACL1;HEY1;POU3F1;MAPK12;MRPL14;ACADVL;RAB40B;RRAS2;ARL6IP4;RAB39A;VDR;PUS1;NUDT7;WNK4;TSFM;ABCG1;PKN3;HRAS;RAB3D;ETFDH;RAB38;PIK3CA;DECR1;HNF1A;NOTCH1;RND3;RAB20;GUCY1B3
179,GO:0001819,0.57065299667459,0.703397990065414,3,9,positive regulation of cytokine production,BP,CCL20;HRAS;FADD
5758,GO:0070925,0.571358774941958,0.64159132913974,5,17,organelle assembly,BP,RAB39A;TBC1D14;RAB38;NOTCH1;RAB20
136,GO:0001658,0.571744721689616,0.702409249636506,3,9,branching involved in ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
5391,GO:0060675,0.571744721689616,0.702409249636506,3,9,ureteric bud morphogenesis,BP,FGF8;BMP4;GDNF
6003,GO:0072171,0.571744721689616,0.702409249636506,3,9,mesonephric tubule morphogenesis,BP,FGF8;BMP4;GDNF
4026,GO:0044421,0.57213895415423,0.52409520334568,36,119,extracellular region part,CC,WNT7A;ACTN3;BMP6;WNT3;ACAT1;WNT7B;MSRA;KCNG2;WNT2;RRAS2;SPTBN5;CDH1;RBP4;ARTN;WNT5B;DSG3;CCL20;INHBB;FGF17;PKP1;TSPAN15;BMP4;RAB3D;KRT10;ECI1;LYPLAL1;BMP7;SPTBN4;DECR1;FGF18;FSTL3;LINGO1;RND3;ETFB;PM20D2;PEPD
3040,GO:0032845,0.57323014129945,0.752410062591156,2,6,negative regulation of homeostatic process,BP,CLDN18;FADD
5065,GO:0051767,0.573298898720423,0.880756088890378,1,2,nitric-oxide synthase biosynthetic process,BP,CCL20
5066,GO:0051769,0.573298898720423,0.880756088890378,1,2,regulation of nitric-oxide synthase biosynthetic process,BP,CCL20
5615,GO:0070098,0.573298898720423,0.880756088890378,1,2,chemokine-mediated signaling pathway,BP,CCL20
4985,GO:0051347,0.57336225129317,0.583505486696171,10,33,positive regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PSMB10;PIK3CA;FGF18
6399,GO:0098793,0.57346230110463,0.700849715880632,3,9,presynapse,CC,WNT7A;SYT5;RAB40B
3292,GO:0034976,0.574100751595494,0.751678302135793,2,6,response to endoplasmic reticulum stress,BP,PMAIP1;ACADVL
4937,GO:0051235,0.57416507299843,0.751624182885925,2,6,maintenance of location,BP,ABCG1;SPTBN4
6579,GO:1901617,0.574291885247105,0.663338341286878,4,13,organic hydroxy compound biosynthetic process,BP,BMP6;VDR;ABCG1;PNMT
6193,GO:0090190,0.574342785805661,0.880204338101673,1,2,positive regulation of branching involved in ureteric bud morphogenesis,BP,GDNF
3810,GO:0043229,0.575717489194183,0.52208072189631,78,255,intracellular organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;MBOAT2;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;POU3F1;MAPK12;MRPL14;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;CNIH4;TSFM;DUSP5;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;SPTBN4;PLA2G16;TPD52;NUDT6;DECR1;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;DPM3;PM20D2
1114,GO:0006919,0.575965614581149,0.763580843975662,2,5,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD
4978,GO:0051338,0.576669284190179,0.567852887586905,12,40,regulation of transferase activity,BP,MAGEC2;PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;DEPTOR;PSMB10;BMP7;PIK3CA;FGF18
1709,GO:0010822,0.57682947694977,0.878882080607662,1,2,positive regulation of mitochondrion organization,BP,PMAIP1
6202,GO:0090200,0.57682947694977,0.878882080607662,1,2,positive regulation of release of cytochrome c from mitochondria,BP,PMAIP1
3970,GO:0044092,0.577467819911919,0.587687810752115,9,29,negative regulation of molecular function,BP,HEY1;AMOT;DUSP5;HRAS;BMP4;DEPTOR;PSMB10;BMP7;NOTCH1
3205,GO:0034308,0.577505114331718,0.878520887621549,1,2,primary alcohol metabolic process,BP,RBP4
5320,GO:0060443,0.577769862180703,0.748578753767926,2,6,mammary gland morphogenesis,BP,VDR;BMP4
293,GO:0002253,0.578766268769422,0.659065895418522,4,13,activation of immune response,BP,HRAS;PSMB10;FADD;PIK3CA
1824,GO:0014821,0.578880067165497,0.877783277750902,1,2,phasic smooth muscle contraction,BP,GDNF
1895,GO:0015696,0.578880067165497,0.877783277750902,1,2,ammonium transport,BP,GDNF
5053,GO:0051656,0.578916602514221,0.695864873619622,3,9,establishment of organelle localization,BP,WNT7A;SYT5;PIK3CG
3570,GO:0042104,0.579621364508809,0.877384167597796,1,2,positive regulation of activated T cell proliferation,BP,FADD
4321,GO:0046006,0.579621364508809,0.877384167597796,1,2,regulation of activated T cell proliferation,BP,FADD
4781,GO:0050798,0.579621364508809,0.877384167597796,1,2,activated T cell proliferation,BP,FADD
1334,GO:0008168,0.580054928393049,0.877150272840619,1,2,methyltransferase activity,MF,PNMT
1335,GO:0008170,0.580054928393049,0.877150272840619,1,2,N-methyltransferase activity,MF,PNMT
1419,GO:0008757,0.580054928393049,0.877150272840619,1,2,S-adenosylmethionine-dependent methyltransferase activity,MF,PNMT
2077,GO:0016741,0.580054928393049,0.877150272840619,1,2,transferase activity, transferring one-carbon groups,MF,PNMT
324,GO:0002377,0.580200398682507,0.877071718703564,1,2,immunoglobulin production,BP,RBP4
366,GO:0002637,0.580200398682507,0.877071718703564,1,2,regulation of immunoglobulin production,BP,RBP4
367,GO:0002639,0.580200398682507,0.877071718703564,1,2,positive regulation of immunoglobulin production,BP,RBP4
4240,GO:0045717,0.581055965283682,0.876608924723762,1,2,negative regulation of fatty acid biosynthetic process,BP,ACADVL
4708,GO:0048870,0.582234890271282,0.541943958394034,17,58,cell motility,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;AMOT;ARTN;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;FADD;PIK3CA;FGF18;NOTCH1
5055,GO:0051674,0.582234890271282,0.541943958394034,17,58,localization of cell,BP,WNT7A;PIK3CG;JAG2;RRAS2;FGF8;AMOT;ARTN;WNT5B;CCL20;PKN3;HRAS;BMP4;GDNF;FADD;PIK3CA;FGF18;NOTCH1
862,GO:0005938,0.582240548495358,0.65238637348972,4,14,cell cortex,CC,SPTBN5;CDH1;SPTB;SPTBN4
6445,GO:0099568,0.582240548495358,0.65238637348972,4,14,cytoplasmic region,CC,SPTBN5;CDH1;SPTB;SPTBN4
4710,GO:0048872,0.58276497084059,0.686522812418921,3,10,homeostasis of number of cells,BP,PMAIP1;BMP4;FADD
1541,GO:0009880,0.583633040540775,0.743572910429594,2,6,embryonic pattern specification,BP,WNT7A;BMP7
72,GO:0000959,0.583916118666982,0.875051996985688,1,2,mitochondrial RNA metabolic process,BP,PUS1
73,GO:0000963,0.583916118666982,0.875051996985688,1,2,mitochondrial RNA processing,BP,PUS1
956,GO:0006400,0.583916118666982,0.875051996985688,1,2,tRNA modification,BP,PUS1
1504,GO:0009451,0.583916118666982,0.875051996985688,1,2,RNA modification,BP,PUS1
5698,GO:0070525,0.583916118666982,0.875051996985688,1,2,tRNA threonylcarbamoyladenosine metabolic process,BP,PUS1
5752,GO:0070900,0.583916118666982,0.875051996985688,1,2,mitochondrial tRNA modification,BP,PUS1
6252,GO:0090646,0.583916118666982,0.875051996985688,1,2,mitochondrial tRNA processing,BP,PUS1
6514,GO:1900864,0.583916118666982,0.875051996985688,1,2,mitochondrial RNA modification,BP,PUS1
6027,GO:0072210,0.584435505975453,0.742882686635346,2,6,metanephric nephron development,BP,BMP4;GDNF
3285,GO:0034762,0.585241615857719,0.652829809001941,4,13,regulation of transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
3288,GO:0034765,0.585241615857719,0.652829809001941,4,13,regulation of ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
5921,GO:0071902,0.585734837499881,0.611283574405065,6,20,positive regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;FGF18
2637,GO:0031016,0.585987684246235,0.741544106183283,2,6,pancreas development,BP,BMP6;BMP4
7195,GO:2001020,0.586009615278256,0.873902759095311,1,2,regulation of response to DNA damage stimulus,BP,PMAIP1
7196,GO:2001022,0.586009615278256,0.873902759095311,1,2,positive regulation of response to DNA damage stimulus,BP,PMAIP1
3761,GO:0043066,0.586606382519131,0.563108713712099,11,37,negative regulation of apoptotic process,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;FADD;BMP7;PIK3CA;NOTCH1
3764,GO:0043069,0.586606382519131,0.563108713712099,11,37,negative regulation of programmed cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;FADD;BMP7;PIK3CA;NOTCH1
2056,GO:0016627,0.587480009716338,0.74025276859072,2,6,oxidoreductase activity, acting on the CH-CH group of donors,MF,ACADVL;DECR1
6063,GO:0072359,0.588174220805915,0.545714967935569,14,49,circulatory system development,BP,WNT7A;PIK3CG;HEY1;WNT7B;WNT2;FZD7;RBP4;FGF8;AMOT;BMP4;BMP7;PIK3CA;FGF18;NOTCH1
852,GO:0005912,0.588186570618196,0.593103824192765,7,25,adherens junction,CC,ACTN3;RRAS2;CDH1;SPTBN4;NOTCH1;RND3;ZFYVE21
4683,GO:0048806,0.588602056822973,0.686890052620894,3,9,genitalia development,BP,BMP6;RBP4;FGF8
4596,GO:0048536,0.588741292813984,0.87239081986674,1,2,spleen development,BP,FADD
4598,GO:0048538,0.588741292813984,0.87239081986674,1,2,thymus development,BP,FADD
1582,GO:0010035,0.588863634171993,0.624423938922071,5,17,response to inorganic substance,BP,BMP6;CDH1;BMP7;FSTL3;GUCY1B3
28,GO:0000166,0.589086392264386,0.531902726620045,18,62,nucleotide binding,MF,PIK3CG;MAPK12;ACADVL;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;ETFDH;RAB38;PIK3CA;DECR1;RND3;RAB20;GUCY1B3
6544,GO:1901265,0.589086392264386,0.531902726620045,18,62,nucleoside phosphate binding,MF,PIK3CG;MAPK12;ACADVL;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;ETFDH;RAB38;PIK3CA;DECR1;RND3;RAB20;GUCY1B3
1759,GO:0010948,0.589312920240245,0.686225075987904,3,9,negative regulation of cell cycle process,BP,BMP4;PSMB10;BMP7
3552,GO:0042035,0.589523664983936,0.738477369050457,2,6,regulation of cytokine biosynthetic process,BP,CCL20;INHBB
3563,GO:0042089,0.589523664983936,0.738477369050457,2,6,cytokine biosynthetic process,BP,CCL20;INHBB
3571,GO:0042107,0.589523664983936,0.738477369050457,2,6,cytokine metabolic process,BP,CCL20;INHBB
4123,GO:0045088,0.589964448518893,0.685614845225652,3,9,regulation of innate immune response,BP,HRAS;PSMB10;FADD
4835,GO:0050926,0.590629012343667,0.871337748063425,1,2,regulation of positive chemotaxis,BP,ARTN
4836,GO:0050927,0.590629012343667,0.871337748063425,1,2,positive regulation of positive chemotaxis,BP,ARTN
4837,GO:0050930,0.590629012343667,0.871337748063425,1,2,induction of positive chemotaxis,BP,ARTN
5324,GO:0060449,0.590960868493864,0.871151919722121,1,2,bud elongation involved in lung branching,BP,BMP4
5371,GO:0060592,0.590960868493864,0.871151919722121,1,2,mammary gland formation,BP,BMP4
2133,GO:0017076,0.590967903503113,0.53922680475495,15,52,purine nucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2957,GO:0032553,0.590967903503113,0.53922680475495,15,52,ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
2958,GO:0032555,0.590967903503113,0.53922680475495,15,52,purine ribonucleotide binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;RAB39A;WNK4;ABCG1;PKN3;HRAS;RAB3D;RAB38;PIK3CA;RND3;RAB20;GUCY1B3
1854,GO:0015077,0.59112059815078,0.737084409072397,2,6,monovalent inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6
1649,GO:0010632,0.591734086906389,0.64651361664964,4,13,regulation of epithelial cell migration,BP,WNT7A;BMP4;FGF18;NOTCH1
2513,GO:0030334,0.591873688245663,0.55698732489078,11,38,regulation of cell migration,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
5959,GO:0072079,0.591994498027816,0.870571773007108,1,2,nephron tubule formation,BP,GDNF
1360,GO:0008270,0.592092205557353,0.646163351709327,4,13,zinc ion binding,MF,RABIF;VDR;RNF144A;DRP2
4036,GO:0044433,0.593683935972441,0.541053689455843,14,47,cytoplasmic vesicle part,CC,WNT7A;SYT5;WNT3;WNT7B;FZD7;RAB39A;WNT5B;PKP1;TSPAN15;RNF144A;RAB3D;RAB38;ZFYVE21;RAB20
4079,GO:0044765,0.594248963633917,0.509955830978403,27,91,single-organism transport,BP,SLC2A14;WNT7A;SYT5;PIK3CG;BMP6;KCNG2;RAB40B;CDH1;FZD7;RBP4;RAB39A;VDR;WNK4;INHBB;ABCG1;PKP1;BMP4;RAB3D;KCNK6;GDNF;USE1;BMP7;PIK3CA;TPD52;HNF1A;NOTCH1;RAB20
1512,GO:0009607,0.59712563910493,0.57647279484755,8,26,response to biotic stimulus,BP,GJB2;BMP6;GJB6;PMAIP1;CCL20;HRAS;FADD;NOTCH1
962,GO:0006417,0.599859481352855,0.729373102034483,2,6,regulation of translation,BP,TSFM;BMP4
3199,GO:0034248,0.599859481352855,0.729373102034483,2,6,regulation of cellular amide metabolic process,BP,TSFM;BMP4
5225,GO:0060174,0.600481579663256,0.865730049835931,1,2,limb bud formation,BP,WNT3
4262,GO:0045785,0.600698695406974,0.63425466729102,4,14,positive regulation of cell adhesion,BP,FADD;BMP7;PIK3CA;FSTL3
1458,GO:0009150,0.602665961462898,0.635732372813791,4,13,purine ribonucleotide metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
1478,GO:0009259,0.602665961462898,0.635732372813791,4,13,ribonucleotide metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
3743,GO:0042993,0.604668940274837,0.826762732328527,1,3,positive regulation of transcription factor import into nucleus,BP,CDH1
3185,GO:0034113,0.604680801683067,0.826754184205839,1,3,heterotypic cell-cell adhesion,BP,BMP7
3243,GO:0034446,0.604719562489444,0.826726248328718,1,3,substrate adhesion-dependent cell spreading,BP,FZD7
3507,GO:0038030,0.604783668537204,0.826680037935582,1,3,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
332,GO:0002431,0.604917323186272,0.826583663571809,1,3,Fc receptor mediated stimulatory signaling pathway,BP,PIK3CA
333,GO:0002433,0.604917323186272,0.826583663571809,1,3,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,PIK3CA
3520,GO:0038094,0.604917323186272,0.826583663571809,1,3,Fc-gamma receptor signaling pathway,BP,PIK3CA
3522,GO:0038096,0.604917323186272,0.826583663571809,1,3,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,PIK3CA
6297,GO:0097190,0.605120280383137,0.580508671290187,7,22,apoptotic signaling pathway,BP,PMAIP1;INHBB;HRAS;BMP4;GDNF;DEPTOR;FADD
51,GO:0000313,0.606025767639634,0.862490506118437,1,2,organellar ribosome,CC,MRPL14
52,GO:0000315,0.606025767639634,0.862490506118437,1,2,organellar large ribosomal subunit,CC,MRPL14
551,GO:0003735,0.606025767639634,0.862490506118437,1,2,structural constituent of ribosome,MF,MRPL14
801,GO:0005761,0.606025767639634,0.862490506118437,1,2,mitochondrial ribosome,CC,MRPL14
802,GO:0005762,0.606025767639634,0.862490506118437,1,2,mitochondrial large ribosomal subunit,CC,MRPL14
834,GO:0005840,0.606025767639634,0.862490506118437,1,2,ribosome,CC,MRPL14
961,GO:0006415,0.606025767639634,0.862490506118437,1,2,translational termination,BP,MRPL14
1931,GO:0015934,0.606025767639634,0.862490506118437,1,2,large ribosomal subunit,CC,MRPL14
4020,GO:0044391,0.606025767639634,0.862490506118437,1,2,ribosomal subunit,CC,MRPL14
5619,GO:0070126,0.606025767639634,0.862490506118437,1,2,mitochondrial translational termination,BP,MRPL14
2047,GO:0016597,0.606081129205143,0.825742741329352,1,3,amino acid binding,MF,GLDC
1048,GO:0006729,0.606490723665078,0.862216021009681,1,2,tetrahydrobiopterin biosynthetic process,BP,PTS
3676,GO:0042558,0.606490723665078,0.862216021009681,1,2,pteridine-containing compound metabolic process,BP,PTS
3677,GO:0042559,0.606490723665078,0.862216021009681,1,2,pteridine-containing compound biosynthetic process,BP,PTS
4333,GO:0046146,0.606490723665078,0.862216021009681,1,2,tetrahydrobiopterin metabolic process,BP,PTS
163,GO:0001756,0.606493220173751,0.825444231654549,1,3,somitogenesis,BP,NOTCH1
6284,GO:0097150,0.606528689958917,0.825418519792699,1,3,neuronal stem cell population maintenance,BP,NOTCH1
6842,GO:1903670,0.606531844810727,0.825416232716371,1,3,regulation of sprouting angiogenesis,BP,NOTCH1
5499,GO:0061061,0.60747109736528,0.546943470920682,10,35,muscle structure development,BP,ACTN3;HEY1;AXIN1;MAPK12;WNT2;FZD7;RBP4;FGF8;BMP4;NOTCH1
1575,GO:0009991,0.607680435737809,0.603202469466648,5,18,response to extracellular stimulus,BP,ACAT1;PMAIP1;VDR;INHBB;BMP7
2763,GO:0031667,0.607680435737809,0.603202469466648,5,18,response to nutrient levels,BP,ACAT1;PMAIP1;VDR;INHBB;BMP7
4588,GO:0048522,0.607735165593292,0.486044049299612,38,128,positive regulation of cellular process,BP,MAGEC2;WNT7A;PIK3CG;ACTN3;BMP6;WNT3;HEY1;WNT7B;JAG2;PMAIP1;AXIN1;POU3F1;MAPK12;WNT2;RRAS2;CDH1;FZD7;RBP4;FGF8;VDR;WNT5B;CCL20;DUSP5;INHBB;FGF17;HRAS;BMP4;RNF144A;RAB3D;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;FGF18;FSTL3;NOTCH1
3007,GO:0032729,0.607770383315537,0.722261122064922,2,6,positive regulation of interferon-gamma production,BP,HRAS;FADD
6599,GO:1901698,0.608321608929208,0.53930076895099,11,39,response to nitrogen compound,BP,GJB2;PIK3CG;PMAIP1;CDH1;INHBB;BMP4;FADD;BMP7;PIK3CA;NOTCH1;GUCY1B3
4200,GO:0045599,0.608458657682135,0.824015105460685,1,3,negative regulation of fat cell differentiation,BP,AXIN1
1331,GO:0008150,0.608506805857029,0.590596834293407,106,348,biological_process,BP,MAGEC2;SLC2A14;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;RHBDL3;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
6562,GO:1901522,0.608881930356462,0.823706158204975,1,3,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,NOTCH1
2573,GO:0030695,0.609161412431735,0.711407205247804,2,7,GTPase regulator activity,MF,AXIN1;TBC1D14
5370,GO:0060589,0.609161412431735,0.711407205247804,2,7,nucleoside-triphosphatase regulator activity,MF,AXIN1;TBC1D14
5955,GO:0072075,0.609826035045417,0.823015550945482,1,3,metanephric mesenchyme development,BP,BMP7
4815,GO:0050873,0.610231141510165,0.859991889059522,1,2,brown fat cell differentiation,BP,NUDT7
145,GO:0001702,0.610289853637832,0.822675507835182,1,3,gastrulation with mouth forming second,BP,AMOT
4043,GO:0044445,0.61049695999454,0.719780495063111,2,6,cytosolic part,CC,FADD;GUCY1B3
1442,GO:0009101,0.611287892013334,0.719058059028286,2,6,glycoprotein biosynthetic process,BP,ALG5;DPM3
1304,GO:0008021,0.611435799892573,0.718922817503308,2,6,synaptic vesicle,CC,SYT5;RAB40B
5577,GO:0061515,0.61146128982712,0.821814440101277,1,3,myeloid cell development,BP,CLDN18
1369,GO:0008307,0.611693492558884,0.821643376294204,1,3,structural constituent of muscle,MF,ACTN3
1456,GO:0009141,0.611745771663984,0.821604844782822,1,3,nucleoside triphosphate metabolic process,BP,ACTN3
1457,GO:0009144,0.611745771663984,0.821604844782822,1,3,purine nucleoside triphosphate metabolic process,BP,ACTN3
1470,GO:0009199,0.611745771663984,0.821604844782822,1,3,ribonucleoside triphosphate metabolic process,BP,ACTN3
1471,GO:0009205,0.611745771663984,0.821604844782822,1,3,purine ribonucleoside triphosphate metabolic process,BP,ACTN3
2669,GO:0031143,0.61176681464171,0.821589333565003,1,3,pseudopodium,CC,ACTN3
2375,GO:0022804,0.611849903575075,0.821528076803103,1,3,active transmembrane transporter activity,MF,ABCG1
782,GO:0005615,0.61195298895861,0.512017318058571,17,56,extracellular space,CC,WNT7A;BMP6;WNT3;WNT7B;WNT2;RBP4;ARTN;WNT5B;CCL20;INHBB;FGF17;BMP4;KRT10;BMP7;FGF18;FSTL3;LINGO1
896,GO:0006090,0.612022869390698,0.821400506804093,1,3,pyruvate metabolic process,BP,ACTN3
1975,GO:0016242,0.612089937111284,0.821351022423833,1,3,negative regulation of macroautophagy,BP,PIK3CA
4617,GO:0048596,0.612153943485265,0.821303786910605,1,3,embryonic camera-type eye morphogenesis,BP,BMP7
467,GO:0003174,0.612715748641403,0.820888770891586,1,3,mitral valve development,BP,NOTCH1
474,GO:0003183,0.612715748641403,0.820888770891586,1,3,mitral valve morphogenesis,BP,NOTCH1
160,GO:0001750,0.612854540308044,0.820786128207092,1,3,photoreceptor outer segment,CC,SPTBN5
6352,GO:0097730,0.612854540308044,0.820786128207092,1,3,non-motile cilium,CC,SPTBN5
6353,GO:0097731,0.612854540308044,0.820786128207092,1,3,9+0 non-motile cilium,CC,SPTBN5
6354,GO:0097733,0.612854540308044,0.820786128207092,1,3,photoreceptor cell cilium,CC,SPTBN5
957,GO:0006401,0.612885317357733,0.820763361033676,1,3,RNA catabolic process,BP,PKP1
958,GO:0006402,0.612885317357733,0.820763361033676,1,3,mRNA catabolic process,BP,PKP1
5477,GO:0061013,0.612885317357733,0.820763361033676,1,3,regulation of mRNA catabolic process,BP,PKP1
6780,GO:1903311,0.612885317357733,0.820763361033676,1,3,regulation of mRNA metabolic process,BP,PKP1
1679,GO:0010717,0.613609381924875,0.820227092000424,1,3,regulation of epithelial to mesenchymal transition,BP,NOTCH1
1680,GO:0010718,0.613609381924875,0.820227092000424,1,3,positive regulation of epithelial to mesenchymal transition,BP,NOTCH1
2290,GO:0021510,0.613693051612291,0.82016504320166,1,3,spinal cord development,BP,NOTCH1
3436,GO:0035924,0.613693051612291,0.82016504320166,1,3,cellular response to vascular endothelial growth factor stimulus,BP,NOTCH1
7219,GO:2001234,0.613880581648355,0.662702499101065,3,9,negative regulation of apoptotic signaling pathway,BP,BMP4;GDNF;FADD
79,GO:0000982,0.614616536188599,0.819479091898669,1,3,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
2617,GO:0030878,0.615013828799224,0.857106081113794,1,2,thyroid gland development,BP,FGF8
2627,GO:0030916,0.615013828799224,0.857106081113794,1,2,otic vesicle formation,BP,FGF8
5862,GO:0071599,0.615013828799224,0.857106081113794,1,2,otic vesicle development,BP,FGF8
5863,GO:0071600,0.615013828799224,0.857106081113794,1,2,otic vesicle morphogenesis,BP,FGF8
4348,GO:0046332,0.615016913895375,0.819181067825601,1,3,SMAD binding,MF,AXIN1
874,GO:0005996,0.615488063846996,0.622848371974666,4,13,monosaccharide metabolic process,BP,ACTN3;PMAIP1;RBP4;PIK3CA
4956,GO:0051270,0.616101563375775,0.525944290298671,12,42,regulation of cellular component movement,BP,WNT7A;WNT3;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
3278,GO:0034702,0.617697343982049,0.652795068428344,3,10,ion channel complex,CC,KCNG2;KCNK6;CPT1C
6685,GO:1902495,0.617697343982049,0.652795068428344,3,10,transmembrane transporter complex,CC,KCNG2;KCNK6;CPT1C
7014,GO:1990351,0.617697343982049,0.652795068428344,3,10,transporter complex,CC,KCNG2;KCNK6;CPT1C
4048,GO:0044451,0.618008201824924,0.652485295755247,3,10,nucleoplasm part,CC,ARL6IP4;SPTBN4;LAGE3
3252,GO:0034612,0.618185319186769,0.658470165304762,3,9,response to tumor necrosis factor,BP,CLDN18;CCL20;PSMB10
5811,GO:0071356,0.618185319186769,0.658470165304762,3,9,cellular response to tumor necrosis factor,BP,CLDN18;CCL20;PSMB10
1985,GO:0016301,0.618506764901387,0.54244209622585,9,32,kinase activity,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA;FGF18;ZFYVE21
2085,GO:0016773,0.618506764901387,0.54244209622585,9,32,phosphotransferase activity, alcohol group as acceptor,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA;FGF18;ZFYVE21
1641,GO:0010605,0.618524317268746,0.514698213243059,14,48,negative regulation of macromolecule metabolic process,BP,TLE1;BMP6;HEY1;AXIN1;VDR;DUSP5;INHBB;PKP1;HRAS;BMP4;DEPTOR;PSMB10;BMP7;NOTCH1
3110,GO:0033138,0.618605911843926,0.702523116903252,2,7,positive regulation of peptidyl-serine phosphorylation,BP,AXIN1;PIK3CA
1631,GO:0010562,0.618621746927549,0.507623609459279,16,54,positive regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;BMP7;PIK3CA;FGF18
4308,GO:0045937,0.618621746927549,0.507623609459279,16,54,positive regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;BMP7;PIK3CA;FGF18
3310,GO:0035112,0.618631492860636,0.854891483082749,1,2,genitalia morphogenesis,BP,RBP4
4684,GO:0048807,0.618631492860636,0.854891483082749,1,2,female genitalia morphogenesis,BP,RBP4
3900,GO:0043535,0.618660509359249,0.816451339296043,1,3,regulation of blood vessel endothelial cell migration,BP,NOTCH1
3154,GO:0033627,0.618839010369704,0.816316790381749,1,3,cell adhesion mediated by integrin,BP,PIK3CG
1878,GO:0015276,0.61888467232171,0.816282359382497,1,3,ligand-gated ion channel activity,MF,KCNK6
2379,GO:0022834,0.61888467232171,0.816282359382497,1,3,ligand-gated channel activity,MF,KCNK6
6434,GO:0099094,0.61888467232171,0.816282359382497,1,3,ligand-gated cation channel activity,MF,KCNK6
6118,GO:0085029,0.619116376865997,0.816107567079371,1,3,extracellular matrix assembly,BP,NOTCH1
2186,GO:0019079,0.619174780497868,0.816063488352359,1,3,viral genome replication,BP,NOTCH1
5699,GO:0070527,0.619236553716133,0.816016857552166,1,3,platelet aggregation,BP,PIK3CG
3967,GO:0044089,0.620051480584122,0.59277854396223,5,17,positive regulation of cellular component biogenesis,BP,WNT7A;PMAIP1;HRAS;BMP7;HNF1A
148,GO:0001706,0.620240073335904,0.815258037969121,1,3,endoderm formation,BP,DUSP5
5817,GO:0071371,0.620452557063758,0.815097053942669,1,3,cellular response to gonadotropin stimulus,BP,NOTCH1
4415,GO:0046683,0.620497306254666,0.815063136665172,1,3,response to organophosphorus,BP,PIK3CG
5035,GO:0051591,0.620497306254666,0.815063136665172,1,3,response to cAMP,BP,PIK3CG
5798,GO:0071320,0.620497306254666,0.815063136665172,1,3,cellular response to cAMP,BP,PIK3CG
2814,GO:0032007,0.620531528575405,0.815037194864573,1,3,negative regulation of TOR signaling,BP,DEPTOR
3471,GO:0036094,0.6211170241418,0.489486831223688,22,76,small molecule binding,MF,GLDC;PIK3CG;HACL1;MAPK12;ACADVL;RAB40B;RRAS2;RBP4;RAB39A;VDR;WNK4;ABCG1;PKN3;HRAS;RAB3D;ETFDH;RAB38;PIK3CA;DECR1;RND3;RAB20;GUCY1B3
3122,GO:0033267,0.621725173691233,0.814130587408309,1,3,axon part,CC,SPTBN4
411,GO:0002792,0.621927076212065,0.813976893961574,1,3,negative regulation of peptide secretion,BP,INHBB
4745,GO:0050709,0.621927076212065,0.813976893961574,1,3,negative regulation of protein secretion,BP,INHBB
368,GO:0002673,0.623632652710142,0.812674592924646,1,3,regulation of acute inflammatory response,BP,PIK3CG
2897,GO:0032365,0.624570344747258,0.81195557749076,1,3,intracellular lipid transport,BP,ABCG1
3646,GO:0042471,0.625431090835221,0.705919815218116,2,6,ear morphogenesis,BP,GJB6;FGF8
2760,GO:0031663,0.625645156016323,0.811128758545097,1,3,lipopolysaccharide-mediated signaling pathway,BP,BMP6
4409,GO:0046649,0.625927730492361,0.554114770682398,7,25,lymphocyte activation,BP,PIK3CG;JAG2;FZD7;BMP4;FADD;PIK3CA;TPD52
1764,GO:0010959,0.626009278943836,0.608532393858253,4,14,regulation of metal ion transport,BP,PIK3CG;WNK4;SPTBN4;TSPAN13
2107,GO:0016853,0.626105183191791,0.705283072327112,2,6,isomerase activity,MF,PUS1;ECI1
793,GO:0005730,0.62651705549397,0.611554984271638,4,13,nucleolus,CC,MAGEC2;ACADVL;ARL6IP4;FGF18
2932,GO:0032434,0.626561272503764,0.810421766508502,1,3,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,RNF144A
5512,GO:0061136,0.626561272503764,0.810421766508502,1,3,regulation of proteasomal protein catabolic process,BP,RNF144A
797,GO:0005741,0.626946633799266,0.704486877343249,2,6,mitochondrial outer membrane,CC,PMAIP1;CPT1C
1789,GO:0014037,0.627716552265141,0.809527239733561,1,3,Schwann cell differentiation,BP,POU3F1
143,GO:0001678,0.627982435217795,0.693518945086942,2,7,cellular glucose homeostasis,BP,GJB6;PIK3CA
1972,GO:0016236,0.628039135603127,0.693463929091621,2,7,macroautophagy,BP,TBC1D14;PIK3CA
1974,GO:0016241,0.628039135603127,0.693463929091621,2,7,regulation of macroautophagy,BP,TBC1D14;PIK3CA
1264,GO:0007548,0.628332225428509,0.567587042529316,6,20,sex differentiation,BP,WNT7A;BMP6;RBP4;FGF8;INHBB;FSTL3
702,GO:0005154,0.628802724713121,0.808683193467334,1,3,epidermal growth factor receptor binding,MF,LINGO1
4299,GO:0045926,0.628921828452997,0.641498149637289,3,10,negative regulation of growth,BP,WNT3;RBP4;BMP4
2080,GO:0016757,0.629387737354118,0.702168443467142,2,6,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3
1008,GO:0006629,0.629840081669643,0.481006725520107,22,73,lipid metabolic process,BP,PIK3CG;HACL1;MBOAT2;BMP6;ACAT1;ACADVL;RBP4;FGF8;VDR;NUDT7;ABCG1;FGF17;ECI1;ETFDH;PIK3CA;PLA2G16;DECR1;FGF18;CPT1C;ZFYVE21;ETFB;DPM3
586,GO:0004252,0.630004378561482,0.80774597407566,1,3,serine-type endopeptidase activity,MF,RHBDL3
1357,GO:0008236,0.630004378561482,0.80774597407566,1,3,serine-type peptidase activity,MF,RHBDL3
2150,GO:0017171,0.630004378561482,0.80774597407566,1,3,serine hydrolase activity,MF,RHBDL3
2543,GO:0030529,0.630290463248501,0.701307820950808,2,6,intracellular ribonucleoprotein complex,CC,MRPL14;PKP1
7035,GO:1990904,0.630290463248501,0.701307820950808,2,6,ribonucleoprotein complex,CC,MRPL14;PKP1
1268,GO:0007568,0.630308776164902,0.640086155281355,3,10,aging,BP,GJB2;GJB6;HRAS
3300,GO:0035051,0.631109361883285,0.634385055414181,3,11,cardiocyte differentiation,BP,FZD7;BMP4;NOTCH1
547,GO:0003723,0.631265864759172,0.583790876684258,5,16,RNA binding,MF,MRPL14;ARL6IP4;PUS1;NUDT7;TSFM
5163,GO:0055114,0.633058217857355,0.509312166729303,12,40,oxidation-reduction process,BP,GLDC;ACTN3;HACL1;ACAT1;MSRA;ACADVL;ECI1;ETFDH;PIK3CA;DECR1;CPT1C;ETFB
922,GO:0006164,0.634322842769679,0.697441866592925,2,6,purine nucleotide biosynthetic process,BP,ACAT1;GUCY1B3
1459,GO:0009152,0.634322842769679,0.697441866592925,2,6,purine ribonucleotide biosynthetic process,BP,ACAT1;GUCY1B3
1479,GO:0009260,0.634322842769679,0.697441866592925,2,6,ribonucleotide biosynthetic process,BP,ACAT1;GUCY1B3
4354,GO:0046390,0.634322842769679,0.697441866592925,2,6,ribose phosphate biosynthetic process,BP,ACAT1;GUCY1B3
4414,GO:0046677,0.63444108622294,0.804254095426171,1,3,response to antibiotic,BP,GJB2
4769,GO:0050773,0.634910931603505,0.803881381809168,1,3,regulation of dendrite development,BP,BMP7
581,GO:0004175,0.635004648630397,0.696784685147306,2,6,endopeptidase activity,MF,RHBDL3;PSMB10
2656,GO:0031099,0.635449804209602,0.634820950988491,3,10,regeneration,BP,WNT7A;FZD7;NOTCH1
3704,GO:0042692,0.635463868417363,0.556423352739234,6,22,muscle cell differentiation,BP,HEY1;AXIN1;MAPK12;FZD7;BMP4;NOTCH1
6523,GO:1901031,0.635671163771175,0.803277118613589,1,3,regulation of response to reactive oxygen species,BP,BMP7
4201,GO:0045600,0.636932155929367,0.802271564642712,1,3,positive regulation of fat cell differentiation,BP,WNT5B
7080,GO:2000145,0.636978881641546,0.509031147741548,11,39,regulation of cell motility,BP,WNT7A;JAG2;RRAS2;AMOT;WNT5B;CCL20;HRAS;BMP4;FADD;FGF18;NOTCH1
406,GO:0002763,0.637077161768141,0.8021556705305,1,3,positive regulation of myeloid leukocyte differentiation,BP,FADD
4220,GO:0045639,0.637077161768141,0.8021556705305,1,3,positive regulation of myeloid cell differentiation,BP,FADD
1271,GO:0007585,0.637080131080438,0.802153296778987,1,3,respiratory gaseous exchange,BP,JAG2
4748,GO:0050714,0.637160168892125,0.694700280979508,2,6,positive regulation of protein secretion,BP,BMP6;RBP4
3164,GO:0033762,0.637528184399912,0.801794850064757,1,3,response to glucagon,BP,GJB2
5821,GO:0071377,0.637528184399912,0.801794850064757,1,3,cellular response to glucagon stimulus,BP,GJB2
1632,GO:0010563,0.638715378943431,0.573163522234731,5,17,negative regulation of phosphorus metabolic process,BP,ACTN3;DUSP5;BMP4;DEPTOR;BMP7
4307,GO:0045936,0.638715378943431,0.573163522234731,5,17,negative regulation of phosphate metabolic process,BP,ACTN3;DUSP5;BMP4;DEPTOR;BMP7
4558,GO:0048333,0.638979377506888,0.800630323510469,1,3,mesodermal cell differentiation,BP,BMP4
4186,GO:0045471,0.639708977438667,0.692222292480402,2,6,response to ethanol,BP,CLDN18;RBP4
6552,GO:1901360,0.640552040917993,0.453654790698103,35,117,organic cyclic compound metabolic process,BP,TLE1;WNT7A;ACTN3;BMP6;HEY1;ACAT1;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;CDH1;FZD7;ARL6IP4;FGF8;VDR;PUS1;NUDT7;TSFM;ABCG1;PKP1;HRAS;BMP4;GDNF;PSMB10;FADD;BMP7;PIK3CA;HNF1A;LAGE3;FSTL3;PTS;NOTCH1;PNMT;GUCY1B3
2197,GO:0019209,0.640991202355826,0.79900687170749,1,3,kinase activator activity,MF,PIK3CA
2496,GO:0030295,0.640991202355826,0.79900687170749,1,3,protein kinase activator activity,MF,PIK3CA
6430,GO:0099068,0.641048501111208,0.798960479692515,1,3,postsynapse assembly,BP,WNT7A
2726,GO:0031410,0.641098977950432,0.468314192063139,22,76,cytoplasmic vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;RAB40B;CDH1;FZD7;RAB39A;AMOT;WNT5B;ABCG1;PKP1;TSPAN15;RNF144A;RAB3D;TBC1D14;RAB38;FSTL3;NOTCH1;ZFYVE21;RAB20
6348,GO:0097708,0.641098977950432,0.468314192063139,22,76,intracellular vesicle,CC,WNT7A;SYT5;WNT3;WNT7B;AXIN1;RAB40B;CDH1;FZD7;RAB39A;AMOT;WNT5B;ABCG1;PKP1;TSPAN15;RNF144A;RAB3D;TBC1D14;RAB38;FSTL3;NOTCH1;ZFYVE21;RAB20
4303,GO:0045932,0.641140966991376,0.798885596471582,1,3,negative regulation of muscle contraction,BP,PIK3CG
4007,GO:0044321,0.642745651259584,0.797582481104218,1,3,response to leptin,BP,INHBB
5919,GO:0071900,0.643193435725184,0.525557877948851,8,28,regulation of protein serine/threonine kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;BMP7;FGF18
1075,GO:0006813,0.643376106232165,0.678326399862005,2,7,potassium ion transport,BP,KCNG2;KCNK6
1825,GO:0014823,0.643622489403055,0.796867568743464,1,3,response to activity,BP,BMP6
2732,GO:0031489,0.64475727972017,0.795939327473834,1,3,myosin V binding,MF,RAB3D
1016,GO:0006641,0.645452742440093,0.686584851712509,2,6,triglyceride metabolic process,BP,PIK3CG;PLA2G16
58,GO:0000578,0.64566298796504,0.795196023794667,1,3,embryonic axis specification,BP,WNT7A
909,GO:0006109,0.645750722655858,0.675936256308232,2,7,regulation of carbohydrate metabolic process,BP,ACTN3;PMAIP1
2472,GO:0030218,0.645953428640593,0.79495720113505,1,3,erythrocyte differentiation,BP,BMP4
3180,GO:0034101,0.645953428640593,0.79495720113505,1,3,erythrocyte homeostasis,BP,BMP4
431,GO:0003014,0.646288973811895,0.618562702204235,3,11,renal system process,BP,WNK4;BMP4;HNF1A
284,GO:0002221,0.64655186648941,0.794464411205754,1,3,pattern recognition receptor signaling pathway,BP,FADD
286,GO:0002224,0.64655186648941,0.794464411205754,1,3,toll-like receptor signaling pathway,BP,FADD
5046,GO:0051640,0.647196783586468,0.622602129981204,3,10,organelle localization,BP,WNT7A;SYT5;PIK3CG
4897,GO:0051150,0.647450779184791,0.793722395785994,1,3,regulation of smooth muscle cell differentiation,BP,BMP4
7006,GO:1990138,0.64748927458656,0.793690571163529,1,3,neuron projection extension,BP,WNT3
4867,GO:0051048,0.647749521111834,0.617017281319548,3,11,negative regulation of secretion,BP,WNK4;INHBB;NOTCH1
5202,GO:0060078,0.647991418444555,0.793275078976407,1,3,regulation of postsynaptic membrane potential,BP,WNT7A
5203,GO:0060079,0.647991418444555,0.793275078976407,1,3,excitatory postsynaptic potential,BP,WNT7A
6374,GO:0098609,0.648448971810596,0.490307496463411,12,44,cell-cell adhesion,BP,PIK3CG;CLDN18;WNT7B;CDH1;DSG3;PKP1;BMP4;CLDN15;FADD;BMP7;PIK3CA;FSTL3
1529,GO:0009743,0.649005355689729,0.672639716891432,2,7,response to carbohydrate,BP,GJB6;PIK3CA
1531,GO:0009746,0.649005355689729,0.672639716891432,2,7,response to hexose,BP,GJB6;PIK3CA
1532,GO:0009749,0.649005355689729,0.672639716891432,2,7,response to glucose,BP,GJB6;PIK3CA
3203,GO:0034284,0.649005355689729,0.672639716891432,2,7,response to monosaccharide,BP,GJB6;PIK3CA
774,GO:0005575,0.649561347888599,0.763413323723458,111,363,cellular_component,CC,MAGEC2;SLC2A14;TJP3;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;RHBDL3;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;FGF8;VDR;PUS1;AMOT;ARTN;WNT5B;NUDT7;DSG3;CNIH4;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;CLDN15;KRT10;KCNK6;ECI1;BOLA1;GDNF;ETFDH;USE1;DEPTOR;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;NUDT6;DECR1;TMEM206;DRP2;HNF1A;LAGE3;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;PNMT;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PM20D2;PEPD
383,GO:0002695,0.650188185408552,0.791449423472308,1,3,negative regulation of leukocyte activation,BP,BMP4
4946,GO:0051250,0.650188185408552,0.791449423472308,1,3,negative regulation of lymphocyte activation,BP,BMP4
4472,GO:0046950,0.650374688443492,0.791293827653678,1,3,cellular ketone body metabolic process,BP,ACAT1
4473,GO:0046951,0.650374688443492,0.791293827653678,1,3,ketone body biosynthetic process,BP,ACAT1
6657,GO:1902224,0.650374688443492,0.791293827653678,1,3,ketone body metabolic process,BP,ACAT1
4801,GO:0050848,0.650599898800863,0.791105813552648,1,3,regulation of calcium-mediated signaling,BP,ACTN3
4131,GO:0045121,0.650664691271615,0.670949770904097,2,7,membrane raft,CC,CDH1;FADD
6413,GO:0098857,0.650664691271615,0.670949770904097,2,7,membrane microdomain,CC,CDH1;FADD
5929,GO:0072007,0.651142925562839,0.790651908885011,1,3,mesangial cell differentiation,BP,NOTCH1
5930,GO:0072008,0.651142925562839,0.790651908885011,1,3,glomerular mesangial cell differentiation,BP,NOTCH1
5992,GO:0072143,0.651142925562839,0.790651908885011,1,3,mesangial cell development,BP,NOTCH1
5993,GO:0072144,0.651142925562839,0.790651908885011,1,3,glomerular mesangial cell development,BP,NOTCH1
6890,GO:1904238,0.651142925562839,0.790651908885011,1,3,pericyte cell differentiation,BP,NOTCH1
4951,GO:0051258,0.651174352616398,0.618404416511453,3,10,protein polymerization,BP,SPTBN5;SPTB;SPTBN4
3553,GO:0042036,0.652545754366759,0.789475603530021,1,3,negative regulation of cytokine biosynthetic process,BP,INHBB
141,GO:0001669,0.653213835637464,0.788913514640681,1,3,acrosomal vesicle,CC,NOTCH1
6306,GO:0097223,0.653213835637464,0.788913514640681,1,3,sperm part,CC,NOTCH1
85,GO:0001047,0.65363322288108,0.788560040014243,1,3,core promoter binding,MF,NOTCH1
2206,GO:0019220,0.653868746518635,0.46364466447762,18,62,regulation of phosphate metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;DEPTOR;BMP7;SPTBN4;PIK3CA;FGF18
5349,GO:0060538,0.654111221927221,0.667419543266374,2,7,skeletal muscle organ development,BP,ACTN3;NOTCH1
3119,GO:0033209,0.654409128620459,0.677644426026573,2,6,tumor necrosis factor-mediated signaling pathway,BP,CLDN18;PSMB10
4296,GO:0045921,0.654880007410547,0.787506354504114,1,3,positive regulation of exocytosis,BP,RAB3D
6543,GO:1901264,0.655245627941906,0.787196549273003,1,3,carbohydrate derivative transport,BP,ABCG1
3541,GO:0040013,0.65572908884101,0.665752957637271,2,7,negative regulation of locomotion,BP,WNT3;NOTCH1
4957,GO:0051271,0.65572908884101,0.665752957637271,2,7,negative regulation of cellular component movement,BP,WNT3;NOTCH1
1676,GO:0010712,0.656125131417122,0.786449798380907,1,3,regulation of collagen metabolic process,BP,BMP4
1677,GO:0010714,0.656125131417122,0.786449798380907,1,3,positive regulation of collagen metabolic process,BP,BMP4
3072,GO:0032964,0.656125131417122,0.786449798380907,1,3,collagen biosynthetic process,BP,BMP4
3073,GO:0032965,0.656125131417122,0.786449798380907,1,3,regulation of collagen biosynthetic process,BP,BMP4
3074,GO:0032967,0.656125131417122,0.786449798380907,1,3,positive regulation of collagen biosynthetic process,BP,BMP4
3981,GO:0044246,0.656125131417122,0.786449798380907,1,3,regulation of multicellular organismal metabolic process,BP,BMP4
3984,GO:0044253,0.656125131417122,0.786449798380907,1,3,positive regulation of multicellular organismal metabolic process,BP,BMP4
2445,GO:0030162,0.656685675746219,0.537122844838554,6,20,regulation of proteolysis,BP,PMAIP1;AXIN1;MAPK12;RNF144A;PSMB10;FADD
2252,GO:0019752,0.657274515546211,0.473747352959322,14,47,carboxylic acid metabolic process,BP,GLDC;ACTN3;HACL1;ACAT1;MSRA;ACADVL;ECI1;ETFDH;PSMB10;DECR1;PTS;CPT1C;ETFB;PEPD
4512,GO:0048066,0.657373379844932,0.785386282928288,1,3,developmental pigmentation,BP,RAB38
4838,GO:0050931,0.657373379844932,0.785386282928288,1,3,pigment cell differentiation,BP,RAB38
3344,GO:0035313,0.657647459169359,0.785152186008842,1,3,wound healing, spreading of epidermal cells,BP,WNT7A
3931,GO:0043623,0.657852159294182,0.574681513128925,4,14,cellular protein complex assembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
1068,GO:0006801,0.658170895914398,0.784704526200096,1,3,superoxide metabolic process,BP,BMP7
1274,GO:0007589,0.658278911118687,0.663114028665289,2,7,body fluid secretion,BP,VDR;WNK4
643,GO:0004702,0.658322448643219,0.784574770803303,1,3,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,MAPK12
30,GO:0000186,0.659416675878776,0.783636017145661,1,3,activation of MAPKK activity,BP,BMP4
1142,GO:0007009,0.659668061888088,0.569626686814278,4,15,plasma membrane organization,BP,RAB40B;CDH1;TSPAN15;SPTBN4
6105,GO:0072659,0.659668061888088,0.569626686814278,4,15,protein localization to plasma membrane,BP,RAB40B;CDH1;TSPAN15;SPTBN4
7028,GO:1990778,0.659668061888088,0.569626686814278,4,15,protein localization to cell periphery,BP,RAB40B;CDH1;TSPAN15;SPTBN4
1051,GO:0006734,0.660068174852715,0.783075492759188,1,3,NADH metabolic process,BP,ACTN3
4701,GO:0048854,0.660248022490759,0.782920548787424,1,3,brain morphogenesis,BP,FGF8
177,GO:0001817,0.660721239702712,0.571546129369214,4,14,regulation of cytokine production,BP,CCL20;INHBB;HRAS;FADD
2401,GO:0030010,0.660787132056112,0.660503342148348,2,7,establishment of cell polarity,BP,WNT7A;AMOT
3807,GO:0043226,0.660827188935517,0.442479791388577,86,284,organelle,CC,MAGEC2;SLC2A14;TJP3;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;HACL1;MBOAT2;BMP6;WNT3;HEY1;ACAT1;WNT7B;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;ACADVL;PXK;PXMP2;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;ARL6IP4;TMEM160;RBP4;RAB39A;SPTB;VDR;PUS1;AMOT;WNT5B;NUDT7;DSG3;CNIH4;TSFM;DUSP5;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;KRT10;ECI1;BOLA1;ETFDH;USE1;LYPLAL1;TBC1D14;PSMB10;RAB38;FADD;CCDC51;BMP7;SPTBN4;PLA2G16;TPD52;NUDT6;DECR1;DRP2;HNF1A;LAGE3;FGF18;FSTL3;PTS;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;DPM3;PM20D2;PEPD
555,GO:0003824,0.661118808547245,0.42698000225598,44,147,catalytic activity,MF,GLDC;PIK3CG;RHBDL3;HACL1;MBOAT2;ACAT1;MSRA;MAPK12;ACADVL;RAB40B;RRAS2;RAB39A;FGF8;PUS1;NUDT7;WNK4;DUSP5;ABCG1;PKN3;FGF17;ALG5;HRAS;RNF144A;RAB3D;ECI1;ETFDH;LYPLAL1;PSMB10;RAB38;PIK3CA;PLA2G16;NUDT6;DECR1;FGF18;PTS;PNMT;RND3;CPT1C;ZFYVE21;RAB20;GUCY1B3;DPM3;PM20D2;PEPD
4901,GO:0051155,0.662109692406778,0.781311307445571,1,3,positive regulation of striated muscle cell differentiation,BP,BMP4
6959,GO:1905209,0.662109692406778,0.781311307445571,1,3,positive regulation of cardiocyte differentiation,BP,BMP4
7165,GO:2000727,0.662109692406778,0.781311307445571,1,3,positive regulation of cardiac muscle cell differentiation,BP,BMP4
1776,GO:0012505,0.663019029023223,0.431123493261399,33,111,endomembrane system,CC,WNT7A;SYT5;MBOAT2;WNT3;WNT7B;RAB40B;RRAS2;CDH1;FZD7;RAB39A;SPTB;WNT5B;CNIH4;ABCG1;PKN3;ALG5;PKP1;HRAS;TSPAN15;RNF144A;RAB3D;USE1;TBC1D14;RAB38;PLA2G16;TPD52;FSTL3;NOTCH1;RND3;CPT1C;ZFYVE21;RAB20;DPM3
2343,GO:0021984,0.663203585272749,0.780361161023724,1,3,adenohypophysis development,BP,FGF8
5215,GO:0060129,0.663203585272749,0.780361161023724,1,3,thyroid-stimulating hormone-secreting cell differentiation,BP,FGF8
5505,GO:0061101,0.663203585272749,0.780361161023724,1,3,neuroendocrine cell differentiation,BP,FGF8
5197,GO:0060068,0.663465679945091,0.780133002419397,1,3,vagina development,BP,RBP4
4456,GO:0046889,0.663667693607813,0.657486832678216,2,7,positive regulation of lipid biosynthetic process,BP,BMP6;ABCG1
82,GO:0000989,0.66420652377,0.599316456286226,3,11,transcription factor activity, transcription factor binding,MF,TLE1;POU3F1;NOTCH1
5155,GO:0055088,0.664228583459747,0.779467764836851,1,3,lipid homeostasis,BP,ABCG1
115,GO:0001541,0.664561218759368,0.779177192550312,1,3,ovarian follicle development,BP,INHBB
2364,GO:0022602,0.664561218759368,0.779177192550312,1,3,ovulation cycle process,BP,INHBB
2783,GO:0031902,0.665049393749089,0.778750175594827,1,3,late endosome membrane,CC,TSPAN15
4631,GO:0048641,0.66555298063507,0.778308961354325,1,3,regulation of skeletal muscle tissue development,BP,ACTN3
6596,GO:1901681,0.665865333376638,0.602628337873812,3,10,sulfur compound binding,MF,HACL1;BMP4;BMP7
1208,GO:0007249,0.666175315338983,0.602290767775121,3,10,I-kappaB kinase/NF-kappaB signaling,BP,TLE1;FADD;BMP7
3777,GO:0043122,0.666175315338983,0.602290767775121,3,10,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TLE1;FADD;BMP7
921,GO:0006163,0.666633856560634,0.565038696663288,4,14,purine nucleotide metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
4812,GO:0050870,0.666988413901451,0.653984933117743,2,7,positive regulation of T cell activation,BP,FADD;PIK3CA
6754,GO:1903039,0.666988413901451,0.653984933117743,2,7,positive regulation of leukocyte cell-cell adhesion,BP,FADD;PIK3CA
2834,GO:0032101,0.667045159063731,0.522015737562041,6,22,regulation of response to external stimulus,BP,PIK3CG;BMP6;WNT3;ARTN;FGF18;NOTCH1
4211,GO:0045619,0.667117877340343,0.776933230110475,1,3,regulation of lymphocyte differentiation,BP,BMP4
2028,GO:0016485,0.667291045001041,0.653664479201164,2,7,protein processing,BP,RHBDL3;FADD
432,GO:0003015,0.66768430806599,0.539231378250784,5,18,heart process,BP,PIK3CG;KCNG2;KCNK6;SPTBN4;PIK3CA
5185,GO:0060047,0.66768430806599,0.539231378250784,5,18,heart contraction,BP,PIK3CG;KCNG2;KCNK6;SPTBN4;PIK3CA
4973,GO:0051302,0.667891468392456,0.77625053819291,1,3,regulation of cell division,BP,FGF8
4826,GO:0050896,0.668117963929188,0.418403297177225,62,212,response to stimulus,BP,RHPN1;TLE1;WNT7A;GJB2;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;AXIN1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RAB3D;GDNF;ETFDH;DEPTOR;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;FGF18;FSTL3;TSPAN13;NOTCH1;LINGO1;RND3;GUCY1B3
5106,GO:0051963,0.668519705789825,0.775694843346656,1,3,regulation of synapse assembly,BP,WNT7A
206,GO:0001906,0.668769856913696,0.775473257813224,1,3,cell killing,BP,FADD
2737,GO:0031503,0.669212868354957,0.77508038822461,1,3,protein complex localization,BP,BMP7
6337,GO:0097529,0.669440787333349,0.651381790127526,2,7,myeloid leukocyte migration,BP,PIK3CG;CCL20
1760,GO:0010950,0.670289864908021,0.6613286156557,2,6,positive regulation of endopeptidase activity,BP,PMAIP1;FADD
3837,GO:0043280,0.670289864908021,0.6613286156557,2,6,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD
7204,GO:2001056,0.670289864908021,0.6613286156557,2,6,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1;FADD
2084,GO:0016772,0.670756951440936,0.485057635532028,9,33,transferase activity, transferring phosphorus-containing groups,MF,PIK3CG;MAPK12;FGF8;WNK4;PKN3;FGF17;PIK3CA;FGF18;ZFYVE21
1077,GO:0006816,0.670815094932971,0.592056495917565,3,11,calcium ion transport,BP,PIK3CG;VDR;TSPAN13
5355,GO:0060548,0.671365124939301,0.471555076839447,11,39,negative regulation of cell death,BP,TLE1;WNT7A;PIK3CG;FGF8;HRAS;BMP4;GDNF;FADD;BMP7;PIK3CA;NOTCH1
1716,GO:0010837,0.671724148836589,0.772842495769767,1,3,regulation of keratinocyte proliferation,BP,VDR
3926,GO:0043616,0.671724148836589,0.772842495769767,1,3,keratinocyte proliferation,BP,VDR
3095,GO:0033043,0.672509215418786,0.483106352490492,9,33,regulation of organelle organization,BP,PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;TBC1D14;BMP7;SPTBN4
4827,GO:0050900,0.672592984865446,0.515821901763042,6,22,leukocyte migration,BP,PIK3CG;ARTN;CCL20;HRAS;FADD;PIK3CA
1552,GO:0009896,0.672897710259537,0.554965921753977,4,15,positive regulation of catabolic process,BP,ACTN3;AXIN1;RNF144A;PSMB10
1661,GO:0010656,0.673109991333884,0.771599577209106,1,3,negative regulation of muscle cell apoptotic process,BP,BMP7
1662,GO:0010657,0.673109991333884,0.771599577209106,1,3,muscle cell apoptotic process,BP,BMP7
1665,GO:0010660,0.673109991333884,0.771599577209106,1,3,regulation of muscle cell apoptotic process,BP,BMP7
1305,GO:0008022,0.673439507952317,0.771303207861055,1,3,protein C-terminus binding,MF,HRAS
2568,GO:0030672,0.674298307864761,0.770529282576107,1,3,synaptic vesicle membrane,CC,SYT5
6436,GO:0099501,0.674298307864761,0.770529282576107,1,3,exocytic vesicle membrane,CC,SYT5
5708,GO:0070588,0.674764689813864,0.645680378608823,2,7,calcium ion transmembrane transport,BP,PIK3CG;TSPAN13
340,GO:0002449,0.675186881427434,0.769726214330987,1,3,lymphocyte mediated immunity,BP,FADD
926,GO:0006195,0.675635048307239,0.769320278791365,1,3,purine nucleotide catabolic process,BP,NUDT7
1968,GO:0016197,0.676148930260361,0.586131761699726,3,11,endosomal transport,BP,TBC1D14;RAB38;ZFYVE21
1427,GO:0009060,0.676316805905601,0.768701610436084,1,3,aerobic respiration,BP,ACTN3
977,GO:0006497,0.676507485388143,0.768528326675003,1,3,protein lipidation,BP,DPM3
3583,GO:0042158,0.676507485388143,0.768528326675003,1,3,lipoprotein biosynthetic process,BP,DPM3
3868,GO:0043433,0.676809900405312,0.768253276939416,1,3,negative regulation of sequence-specific DNA binding transcription factor activity,BP,BMP7
6188,GO:0090184,0.676967414754648,0.64330114357391,2,7,positive regulation of kidney development,BP,BMP4;GDNF
2715,GO:0031347,0.67702960635774,0.553444354592231,4,14,regulation of defense response,BP,PIK3CG;HRAS;PSMB10;FADD
3933,GO:0043627,0.67752724529713,0.767599742837013,1,3,response to estrogen,BP,WNT7A
6381,GO:0098657,0.67754914633703,0.76757976557879,1,3,import into cell,BP,GDNF
6093,GO:0072583,0.677886998771711,0.767271406517903,1,3,clathrin-dependent endocytosis,BP,SYT5
175,GO:0001786,0.678040075035834,0.767131579757933,1,3,phosphatidylserine binding,MF,SYT5
3064,GO:0032941,0.678076789055518,0.767098032982489,1,3,secretion by tissue,BP,WNK4
3888,GO:0043500,0.678946966140224,0.766301729428161,1,3,muscle adaptation,BP,ACTN3
3890,GO:0043502,0.678946966140224,0.766301729428161,1,3,regulation of muscle adaptation,BP,ACTN3
6396,GO:0098773,0.679031305570685,0.641060963669132,2,7,skin epidermis development,BP,KRT10;NOTCH1
3958,GO:0044057,0.679770518609658,0.484113593402519,8,29,regulation of system process,BP,PIK3CG;ACTN3;BMP6;KCNG2;WNK4;INHBB;KCNK6;SPTBN4
112,GO:0001523,0.680051356428827,0.765287785029749,1,3,retinoid metabolic process,BP,RBP4
925,GO:0006182,0.680198351457456,0.765152548274151,1,3,cGMP biosynthetic process,BP,GUCY1B3
2519,GO:0030424,0.680288782349477,0.639690875420386,2,7,axon,CC,SPTBN4;CPT1C
4913,GO:0051183,0.682378945209176,0.763138615614364,1,3,vitamin transporter activity,MF,RBP4
4909,GO:0051174,0.682507052626035,0.431983329766002,18,63,regulation of phosphorus metabolic process,BP,WNT7A;PIK3CG;ACTN3;BMP6;WNT7B;AXIN1;FZD7;FGF8;CCL20;DUSP5;INHBB;HRAS;BMP4;DEPTOR;BMP7;SPTBN4;PIK3CA;FGF18
2272,GO:0019898,0.683434523837057,0.573766480359322,3,12,extrinsic component of membrane,CC,PIK3CG;CDH1;PIK3CA
1437,GO:0009081,0.683459173942441,0.762135531932927,1,3,branched-chain amino acid metabolic process,BP,ACAT1
4256,GO:0045765,0.684798113557641,0.62690827375097,2,8,regulation of angiogenesis,BP,AMOT;NOTCH1
554,GO:0003779,0.684818890581893,0.517799922846539,5,19,actin binding,MF,ACTN3;PXK;SPTBN5;SPTB;SPTBN4
5653,GO:0070266,0.685143208305584,0.760564556020444,1,3,necroptotic process,BP,FADD
6313,GO:0097300,0.685143208305584,0.760564556020444,1,3,programmed necrotic cell death,BP,FADD
650,GO:0004721,0.685716247604883,0.760027975895305,1,3,phosphoprotein phosphatase activity,MF,DUSP5
651,GO:0004725,0.685716247604883,0.760027975895305,1,3,protein tyrosine phosphatase activity,MF,DUSP5
3347,GO:0035335,0.685716247604883,0.760027975895305,1,3,peptidyl-tyrosine dephosphorylation,BP,DUSP5
6998,GO:1905953,0.686316458475769,0.759464853012152,1,3,negative regulation of lipid localization,BP,ABCG1
121,GO:0001569,0.686590637644316,0.759207240565941,1,3,branching involved in blood vessel morphogenesis,BP,FGF8
3758,GO:0043043,0.687060707392388,0.579084377211174,3,10,peptide biosynthetic process,BP,MRPL14;TSFM;BMP4
3924,GO:0043604,0.687060707392388,0.579084377211174,3,10,amide biosynthetic process,BP,MRPL14;TSFM;BMP4
1786,GO:0014031,0.687311223964771,0.631966283133139,2,7,mesenchymal cell development,BP,GDNF;NOTCH1
2452,GO:0030176,0.687358178115498,0.758484822746602,1,3,integral component of endoplasmic reticulum membrane,CC,DPM3
2681,GO:0031227,0.687358178115498,0.758484822746602,1,3,intrinsic component of endoplasmic reticulum membrane,CC,DPM3
3811,GO:0043230,0.687615190144887,0.412737698322813,25,87,extracellular organelle,CC,WNT7A;ACTN3;WNT3;ACAT1;WNT7B;MSRA;KCNG2;RRAS2;SPTBN5;CDH1;RBP4;WNT5B;DSG3;PKP1;TSPAN15;RAB3D;KRT10;ECI1;LYPLAL1;SPTBN4;DECR1;RND3;ETFB;PM20D2;PEPD
5610,GO:0070062,0.687615190144887,0.412737698322813,25,87,extracellular exosome,CC,WNT7A;ACTN3;WNT3;ACAT1;WNT7B;MSRA;KCNG2;RRAS2;SPTBN5;CDH1;RBP4;WNT5B;DSG3;PKP1;TSPAN15;RAB3D;KRT10;ECI1;LYPLAL1;SPTBN4;DECR1;RND3;ETFB;PM20D2;PEPD
6826,GO:1903561,0.687615190144887,0.412737698322813,25,87,extracellular vesicle,CC,WNT7A;ACTN3;WNT3;ACAT1;WNT7B;MSRA;KCNG2;RRAS2;SPTBN5;CDH1;RBP4;WNT5B;DSG3;PKP1;TSPAN15;RAB3D;KRT10;ECI1;LYPLAL1;SPTBN4;DECR1;RND3;ETFB;PM20D2;PEPD
4280,GO:0045840,0.68762491670674,0.758233331710313,1,3,positive regulation of mitotic nuclear division,BP,FGF8
6329,GO:0097458,0.688022394396531,0.465663303155981,9,33,neuron part,CC,WNT7A;SYT5;RAB40B;SPTBN5;FADD;SPTBN4;DRP2;FSTL3;CPT1C
3628,GO:0042391,0.688116371437807,0.572621836139406,3,11,regulation of membrane potential,BP,WNT7A;PMAIP1;KCNK6
3060,GO:0032925,0.688303250732894,0.757592763095663,1,3,regulation of activin receptor signaling pathway,BP,FSTL3
4035,GO:0044432,0.688310770963919,0.453309666126116,11,38,endoplasmic reticulum part,CC,WNT7A;MBOAT2;WNT3;WNT7B;WNT5B;ABCG1;ALG5;USE1;NOTCH1;CPT1C;DPM3
1927,GO:0015918,0.68930808584267,0.75664119849184,1,3,sterol transport,BP,ABCG1
2498,GO:0030301,0.68930808584267,0.75664119849184,1,3,cholesterol transport,BP,ABCG1
3727,GO:0042803,0.690770891815854,0.472772319016287,8,28,protein homodimerization activity,MF,ACTN3;ACAT1;AXIN1;INHBB;ABCG1;GDNF;TPD52;PTS
5180,GO:0060041,0.691200617418334,0.754840288884672,1,3,retina development in camera-type eye,BP,RBP4
6115,GO:0080134,0.69126646724189,0.455140836805262,10,36,regulation of response to stress,BP,WNT7A;PIK3CG;WNT7B;PMAIP1;AXIN1;FZD7;HRAS;PSMB10;FADD;BMP7
6463,GO:0120025,0.691369163512879,0.442326721197394,12,45,plasma membrane bounded cell projection,CC,GJB2;SYT5;ACTN3;SPTBN5;CDH1;AMOT;FADD;SPTBN4;PIK3CA;DRP2;FSTL3;CPT1C
954,GO:0006397,0.691908252062297,0.754163974908406,1,3,mRNA processing,BP,ARL6IP4
2980,GO:0032637,0.691917517240592,0.754155109172035,1,3,interleukin-8 production,BP,FADD
2994,GO:0032677,0.691917517240592,0.754155109172035,1,3,regulation of interleukin-8 production,BP,FADD
3014,GO:0032757,0.691917517240592,0.754155109172035,1,3,positive regulation of interleukin-8 production,BP,FADD
5529,GO:0061213,0.69208114291438,0.753998492361361,1,3,positive regulation of mesonephros development,BP,GDNF
6534,GO:1901137,0.692174847137715,0.536194379903694,4,14,carbohydrate derivative biosynthetic process,BP,ACAT1;ALG5;GUCY1B3;DPM3
4284,GO:0045859,0.692215907787333,0.454062569100823,10,36,regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;DEPTOR;BMP7;PIK3CA;FGF18
2146,GO:0017148,0.692242274824825,0.753844178484201,1,3,negative regulation of translation,BP,BMP4
3200,GO:0034249,0.692242274824825,0.753844178484201,1,3,negative regulation of cellular amide metabolic process,BP,BMP4
387,GO:0002700,0.692342897101504,0.753747771564213,1,3,regulation of production of molecular mediator of immune response,BP,RBP4
388,GO:0002702,0.692342897101504,0.753747771564213,1,3,positive regulation of production of molecular mediator of immune response,BP,RBP4
5681,GO:0070382,0.692625353563155,0.626036938046292,2,7,exocytic vesicle,CC,SYT5;RAB40B
2972,GO:0032609,0.692825159720067,0.625812570763231,2,7,interferon-gamma production,BP,HRAS;FADD
2986,GO:0032649,0.692825159720067,0.625812570763231,2,7,regulation of interferon-gamma production,BP,HRAS;FADD
6179,GO:0090150,0.693761593259634,0.528521504008572,4,16,establishment of protein localization to membrane,BP,PMAIP1;CDH1;TSPAN15;SPTBN4
3885,GO:0043491,0.694835743461693,0.615582877171615,2,8,protein kinase B signaling,BP,PIK3CG;PIK3CA
2398,GO:0030001,0.69642611403232,0.474998896832123,7,26,metal ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;SPTBN4;TSPAN13
1080,GO:0006821,0.697050133994181,0.749201113205708,1,3,chloride transport,BP,WNK4
1896,GO:0015698,0.697050133994181,0.749201113205708,1,3,inorganic anion transport,BP,WNK4
3025,GO:0032787,0.698249968351187,0.447183519297505,10,36,monocarboxylic acid metabolic process,BP,GLDC;ACTN3;HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
2063,GO:0016667,0.698338633926331,0.747943954768296,1,3,oxidoreductase activity, acting on a sulfur group of donors,MF,MSRA
4297,GO:0045922,0.698597244530347,0.747690975337344,1,3,negative regulation of fatty acid metabolic process,BP,ACADVL
2801,GO:0031967,0.699376418735089,0.462900941471397,8,28,organelle envelope,CC,ACAT1;PMAIP1;MRPL14;ACADVL;RAB40B;ECI1;ETFDH;CPT1C
2805,GO:0031975,0.699376418735089,0.462900941471397,8,28,envelope,CC,ACAT1;PMAIP1;MRPL14;ACADVL;RAB40B;ECI1;ETFDH;CPT1C
1105,GO:0006904,0.699497051449732,0.746809037647593,1,3,vesicle docking involved in exocytosis,BP,RAB40B
4545,GO:0048278,0.699497051449732,0.746809037647593,1,3,vesicle docking,BP,RAB40B
2110,GO:0016863,0.699784963208979,0.746526276778249,1,3,intramolecular oxidoreductase activity, transposing C=C bonds,MF,ECI1
288,GO:0002237,0.700110883405497,0.502282209892696,5,18,response to molecule of bacterial origin,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
2943,GO:0032496,0.700110883405497,0.502282209892696,5,18,response to lipopolysaccharide,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
1074,GO:0006812,0.700221531146526,0.460793882682967,8,29,cation transport,BP,PIK3CG;KCNG2;VDR;WNK4;KCNK6;GDNF;SPTBN4;TSPAN13
528,GO:0003401,0.700247676676572,0.74607126444523,1,3,axis elongation,BP,BMP4
5376,GO:0060602,0.700247676676572,0.74607126444523,1,3,branch elongation of an epithelium,BP,BMP4
2786,GO:0031929,0.700939581479688,0.608568540132642,2,8,TOR signaling,BP,DEPTOR;PIK3CA
714,GO:0005179,0.701037148407262,0.74529328603374,1,3,hormone activity,MF,INHBB
4955,GO:0051262,0.703935876815819,0.742418843733284,1,3,protein tetramerization,BP,DECR1
4966,GO:0051289,0.703935876815819,0.742418843733284,1,3,protein homotetramerization,BP,DECR1
4772,GO:0050778,0.704355315437755,0.518814456640868,4,15,positive regulation of immune response,BP,HRAS;PSMB10;FADD;PIK3CA
3569,GO:0042102,0.705067224131662,0.741289279587769,1,3,positive regulation of T cell proliferation,BP,FADD
2366,GO:0022604,0.705847032967123,0.552035144627847,3,11,regulation of cell morphogenesis,BP,WNT7A;WNT3;LINGO1
898,GO:0006094,0.706076161039553,0.740278260363602,1,3,gluconeogenesis,BP,RBP4
2214,GO:0019319,0.706076161039553,0.740278260363602,1,3,hexose biosynthetic process,BP,RBP4
4706,GO:0048864,0.706583576200291,0.61010805487688,2,7,stem cell development,BP,WNT7A;GDNF
2629,GO:0030947,0.706834535134931,0.739516031580772,1,3,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
2630,GO:0030949,0.706834535134931,0.739516031580772,1,3,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
4851,GO:0050999,0.707119900636842,0.73922870523211,1,3,regulation of nitric-oxide synthase activity,BP,PTS
2264,GO:0019867,0.707150809517918,0.60944961724907,2,7,outer membrane,CC,PMAIP1;CPT1C
2802,GO:0031968,0.707150809517918,0.60944961724907,2,7,organelle outer membrane,CC,PMAIP1;CPT1C
6058,GO:0072332,0.707457282372763,0.738888644440886,1,3,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PMAIP1
4833,GO:0050921,0.707505776921022,0.609037125595644,2,7,positive regulation of chemotaxis,BP,ARTN;FGF18
2764,GO:0031668,0.708741285219789,0.544321152914903,3,12,cellular response to extracellular stimulus,BP,PMAIP1;VDR;INHBB
2765,GO:0031669,0.708741285219789,0.544321152914903,3,12,cellular response to nutrient levels,BP,PMAIP1;VDR;INHBB
1125,GO:0006952,0.709214616056668,0.434565617056717,10,36,defense response,BP,PIK3CG;BMP6;PMAIP1;PXK;CCL20;INHBB;HRAS;PSMB10;FADD;NOTCH1
377,GO:0002687,0.709608454034714,0.606586572990625,2,7,positive regulation of leukocyte migration,BP,CCL20;FADD
4021,GO:0044403,0.709684322368111,0.488872501052074,5,19,symbiosis, encompassing mutualism through parasitism,BP,PMAIP1;CDH1;PSMB10;FADD;NOTCH1
4024,GO:0044419,0.709684322368111,0.488872501052074,5,19,interspecies interaction between organisms,BP,PMAIP1;CDH1;PSMB10;FADD;NOTCH1
1515,GO:0009615,0.709685079222399,0.606497039628034,2,7,response to virus,BP,PMAIP1;FADD
1123,GO:0006942,0.709923573610451,0.598064034680327,2,8,regulation of striated muscle contraction,BP,PIK3CG;ACTN3
5321,GO:0060444,0.7104785027462,0.712380273942957,1,4,branching involved in mammary gland duct morphogenesis,BP,VDR
4078,GO:0044764,0.710576744268035,0.487814121827797,5,19,multi-organism cellular process,BP,PMAIP1;INHBB;PSMB10;FADD;NOTCH1
343,GO:0002474,0.710917919558861,0.735377815488575,1,3,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMB10
344,GO:0002478,0.710917919558861,0.735377815488575,1,3,antigen processing and presentation of exogenous peptide antigen,BP,PSMB10
2267,GO:0019884,0.710917919558861,0.735377815488575,1,3,antigen processing and presentation of exogenous antigen,BP,PSMB10
3687,GO:0042590,0.710917919558861,0.735377815488575,1,3,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMB10
4523,GO:0048168,0.711573728196352,0.734707798313945,1,3,regulation of neuronal synaptic plasticity,BP,HRAS
6600,GO:1901699,0.711674991955665,0.454949395234373,7,28,cellular response to nitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;BMP4;PIK3CA;GUCY1B3
5497,GO:0061053,0.711768940600671,0.710977157783163,1,4,somite development,BP,NOTCH1
1901,GO:0015748,0.712021761055786,0.734249191973866,1,3,organophosphate ester transport,BP,ABCG1
775,GO:0005576,0.712349774888074,0.373030917787113,39,133,extracellular region,CC,WNT7A;ACTN3;BMP6;WNT3;ACAT1;WNT7B;MSRA;KCNG2;WNT2;RRAS2;SPTBN5;CDH1;RBP4;FGF8;ARTN;WNT5B;DSG3;CCL20;INHBB;FGF17;PKP1;TSPAN15;BMP4;RAB3D;KRT10;ECI1;GDNF;LYPLAL1;BMP7;SPTBN4;DECR1;FGF18;FSTL3;NOTCH1;LINGO1;RND3;ETFB;PM20D2;PEPD
3745,GO:0043005,0.712552390836413,0.468238698967095,6,23,neuron projection,CC,SYT5;FADD;SPTBN4;DRP2;FSTL3;CPT1C
412,GO:0002793,0.713923118098182,0.60151957184188,2,7,positive regulation of peptide secretion,BP,BMP6;RBP4
1756,GO:0010939,0.714429205971353,0.731772820795951,1,3,regulation of necrotic cell death,BP,FADD
3032,GO:0032813,0.714429205971353,0.731772820795951,1,3,tumor necrosis factor receptor superfamily binding,MF,FADD
2750,GO:0031625,0.714469154668558,0.592665378847037,2,8,ubiquitin protein ligase binding,MF,MAGEC2;AXIN1
4018,GO:0044389,0.714469154668558,0.592665378847037,2,8,ubiquitin-like protein ligase binding,MF,MAGEC2;AXIN1
3209,GO:0034332,0.714597223396982,0.592512446827755,2,8,adherens junction organization,BP,ACTN3;CDH1
2837,GO:0032147,0.714601973392131,0.483022478918164,5,19,activation of protein kinase activity,BP,WNT7B;AXIN1;DUSP5;BMP4;PIK3CA
2316,GO:0021700,0.715414168409826,0.599756375383819,2,7,developmental maturation,BP,RAB38;SPTBN4
4395,GO:0046579,0.715446458088568,0.730720269465918,1,3,positive regulation of Ras protein signal transduction,BP,HRAS
4876,GO:0051057,0.715446458088568,0.730720269465918,1,3,positive regulation of small GTPase mediated signal transduction,BP,HRAS
2692,GO:0031294,0.715839995130665,0.70651163131497,1,4,lymphocyte costimulation,BP,PIK3CA
2693,GO:0031295,0.715839995130665,0.70651163131497,1,4,T cell costimulation,BP,PIK3CA
6080,GO:0072522,0.716100101274775,0.598943132366102,2,7,purine-containing compound biosynthetic process,BP,ACAT1;GUCY1B3
139,GO:0001666,0.716147518047507,0.507979059737421,4,14,response to hypoxia,BP,PMAIP1;PSMB10;BMP7;NOTCH1
7097,GO:2000243,0.716208336436928,0.706104652829153,1,4,positive regulation of reproductive process,BP,INHBB
3010,GO:0032732,0.716442863523938,0.729685707222681,1,3,positive regulation of interleukin-1 production,BP,CCL20
3063,GO:0032940,0.717246842186675,0.409434320273265,13,46,secretion by cell,BP,WNT7A;SYT5;PIK3CG;BMP6;KCNG2;RAB40B;RBP4;INHBB;PKP1;RAB3D;GDNF;USE1;NOTCH1
6079,GO:0072521,0.717486802990493,0.503155873434769,4,15,purine-containing compound metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
1090,GO:0006869,0.717818938496293,0.537732254022391,3,11,lipid transport,BP,BMP6;RBP4;ABCG1
413,GO:0002819,0.71840962664204,0.727633161143912,1,3,regulation of adaptive immune response,BP,FADD
414,GO:0002821,0.71840962664204,0.727633161143912,1,3,positive regulation of adaptive immune response,BP,FADD
3690,GO:0042594,0.718592401104409,0.532472098809553,3,12,response to starvation,BP,ACAT1;PMAIP1;INHBB
546,GO:0003714,0.719340038793867,0.702624480181506,1,4,transcription corepressor activity,MF,TLE1
2142,GO:0017137,0.719731864812828,0.702186524998239,1,4,Rab GTPase binding,MF,TBC1D14
1009,GO:0006631,0.719987720873298,0.437696699571333,8,29,fatty acid metabolic process,BP,HACL1;ACAT1;ACADVL;ECI1;ETFDH;DECR1;CPT1C;ETFB
4382,GO:0046503,0.720520412974815,0.72541472734937,1,3,glycerolipid catabolic process,BP,PIK3CG
5592,GO:0061695,0.720886099156891,0.584946037627019,2,8,transferase complex, transferring phosphorus-containing groups,CC,PIK3CG;PIK3CA
3184,GO:0034109,0.721075595210771,0.700680294206552,1,4,homotypic cell-cell adhesion,BP,PIK3CG
2916,GO:0032403,0.721703144106898,0.444165410279347,7,27,protein complex binding,MF,ACTN3;SPTB;PKP1;RAB38;FADD;FSTL3;MB21D2
47,GO:0000302,0.722299275532064,0.583230369323205,2,8,response to reactive oxygen species,BP,BMP7;GUCY1B3
1635,GO:0010566,0.722417289781664,0.699169663925977,1,4,regulation of ketone biosynthetic process,BP,BMP6
2882,GO:0032341,0.722417289781664,0.699169663925977,1,4,aldosterone metabolic process,BP,BMP6
2883,GO:0032342,0.722417289781664,0.699169663925977,1,4,aldosterone biosynthetic process,BP,BMP6
2884,GO:0032344,0.722417289781664,0.699169663925977,1,4,regulation of aldosterone metabolic process,BP,BMP6
2887,GO:0032347,0.722417289781664,0.699169663925977,1,4,regulation of aldosterone biosynthetic process,BP,BMP6
2890,GO:0032350,0.722417289781664,0.699169663925977,1,4,regulation of hormone metabolic process,BP,BMP6
4336,GO:0046184,0.722417289781664,0.699169663925977,1,4,aldehyde biosynthetic process,BP,BMP6
4452,GO:0046885,0.722417289781664,0.699169663925977,1,4,regulation of hormone biosynthetic process,BP,BMP6
6153,GO:0090030,0.722417289781664,0.699169663925977,1,4,regulation of steroid hormone biosynthetic process,BP,BMP6
3744,GO:0042995,0.723037603681044,0.405494450294328,12,46,cell projection,CC,GJB2;SYT5;ACTN3;SPTBN5;CDH1;AMOT;FADD;SPTBN4;PIK3CA;DRP2;FSTL3;CPT1C
2319,GO:0021782,0.723474255499501,0.69797488521173,1,4,glial cell development,BP,POU3F1
5153,GO:0055085,0.723811791404258,0.424220310103283,9,33,transmembrane transport,BP,SLC2A14;GJB2;PIK3CG;GJA3;KCNG2;ABCG1;KCNK6;PSMB10;TSPAN13
2244,GO:0019693,0.724415273229223,0.49475216645005,4,15,ribose phosphate metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
3256,GO:0034622,0.726155471964097,0.492625677304154,4,15,cellular macromolecular complex assembly,BP,AXIN1;SPTBN5;SPTB;SPTBN4
5145,GO:0055072,0.727310763073502,0.693602807704977,1,4,iron ion homeostasis,BP,BMP6
7083,GO:2000177,0.72836160842862,0.69239550874706,1,4,regulation of neural precursor cell proliferation,BP,NOTCH1
2515,GO:0030336,0.729049797275755,0.691602566619732,1,4,negative regulation of cell migration,BP,NOTCH1
1805,GO:0014074,0.729211251223165,0.691416273182249,1,4,response to purine-containing compound,BP,PIK3CG
5601,GO:0065008,0.729700167343061,0.357081656134829,33,116,regulation of biological quality,BP,WNT7A;SYT5;PIK3CG;CLDN18;BMP6;WNT3;GJB6;WNT7B;PMAIP1;KCNG2;ACADVL;SPTBN5;RBP4;RAB39A;SPTB;VDR;WNK4;INHBB;ABCG1;HRAS;BMP4;RAB3D;KCNK6;GDNF;DEPTOR;PSMB10;RAB38;FADD;SPTBN4;PIK3CA;HNF1A;RAB20;DPM3
539,GO:0003682,0.729848836468206,0.690679614890002,1,4,chromatin binding,MF,NOTCH1
5150,GO:0055080,0.73036637107728,0.446880393306386,6,23,cation homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20
6394,GO:0098771,0.73036637107728,0.446880393306386,6,23,inorganic ion homeostasis,BP,PIK3CG;BMP6;RAB39A;VDR;RAB38;RAB20
6531,GO:1901099,0.731271098330625,0.713859372323628,1,3,negative regulation of signal transduction in absence of ligand,BP,GDNF
7224,GO:2001239,0.731271098330625,0.713859372323628,1,3,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
7225,GO:2001240,0.731271098330625,0.713859372323628,1,3,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,GDNF
4086,GO:0044782,0.732498968873317,0.68760081022527,1,4,cilium organization,BP,NOTCH1
5245,GO:0060271,0.732498968873317,0.68760081022527,1,4,cilium assembly,BP,NOTCH1
5600,GO:0065007,0.733307832297607,0.351123516017464,73,249,biological regulation,BP,MAGEC2;RHPN1;TLE1;WNT7A;SYT5;PIK3CG;ACTN3;CLDN18;RABIF;BMP6;WNT3;HEY1;GJB6;WNT7B;JAG2;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;WNK4;CCL20;TSFM;DUSP5;INHBB;ABCG1;PKN3;FGF17;PKP1;HRAS;TSPAN15;BMP4;RNF144A;RAB3D;KCNK6;GDNF;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;HNF1A;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;LINGO1;RND3;RAB20;GUCY1B3;DPM3;PM20D2
7096,GO:2000242,0.733894634934581,0.568934095679929,2,8,negative regulation of reproductive process,BP,BMP4;BMP7
5083,GO:0051896,0.733989924431533,0.68585663832071,1,4,regulation of protein kinase B signaling,BP,PIK3CG
5084,GO:0051897,0.733989924431533,0.68585663832071,1,4,positive regulation of protein kinase B signaling,BP,PIK3CG
4358,GO:0046425,0.735287694623294,0.684331339357069,1,4,regulation of JAK-STAT cascade,BP,NOTCH1
4359,GO:0046427,0.735287694623294,0.684331339357069,1,4,positive regulation of JAK-STAT cascade,BP,NOTCH1
6935,GO:1904892,0.735287694623294,0.684331339357069,1,4,regulation of STAT cascade,BP,NOTCH1
6936,GO:1904894,0.735287694623294,0.684331339357069,1,4,positive regulation of STAT cascade,BP,NOTCH1
3070,GO:0032956,0.73566363054817,0.478154395054916,4,16,regulation of actin cytoskeleton organization,BP,SPTBN5;SPTB;HRAS;SPTBN4
3712,GO:0042742,0.735710577231971,0.708958963774364,1,3,defense response to bacterium,BP,CCL20
1013,GO:0006637,0.735810368813735,0.566533834589561,2,8,acyl-CoA metabolic process,BP,ACAT1;NUDT7
3351,GO:0035383,0.735810368813735,0.566533834589561,2,8,thioester metabolic process,BP,ACAT1;NUDT7
1108,GO:0006909,0.736214638002113,0.510702915055347,3,12,phagocytosis,BP,RAB39A;PIK3CA;RAB20
2456,GO:0030183,0.73657837291235,0.682807758682233,1,4,B cell differentiation,BP,TPD52
6979,GO:1905477,0.737260502297654,0.681999860090904,1,4,positive regulation of protein localization to membrane,BP,PMAIP1
1784,GO:0014015,0.737539541416009,0.681668836583901,1,4,positive regulation of gliogenesis,BP,NOTCH1
4237,GO:0045685,0.737539541416009,0.681668836583901,1,4,regulation of glial cell differentiation,BP,NOTCH1
4239,GO:0045687,0.737539541416009,0.681668836583901,1,4,positive regulation of glial cell differentiation,BP,NOTCH1
4660,GO:0048710,0.737539541416009,0.681668836583901,1,4,regulation of astrocyte differentiation,BP,NOTCH1
4661,GO:0048711,0.737539541416009,0.681668836583901,1,4,positive regulation of astrocyte differentiation,BP,NOTCH1
5736,GO:0070820,0.740654547513328,0.677952248209918,1,4,tertiary granule,CC,PKP1
2741,GO:0031532,0.741009981780392,0.703007475617597,1,3,actin cytoskeleton reorganization,BP,HRAS
238,GO:0001968,0.742445005656962,0.675798197081433,1,4,fibronectin binding,MF,FSTL3
6146,GO:0090002,0.742474296415028,0.499199646279136,3,13,establishment of protein localization to plasma membrane,BP,CDH1;TSPAN15;SPTBN4
4465,GO:0046916,0.743937344827043,0.67399276556276,1,4,cellular transition metal ion homeostasis,BP,BMP6
1014,GO:0006638,0.745495739570549,0.562787163680638,2,7,neutral lipid metabolic process,BP,PIK3CG;PLA2G16
1015,GO:0006639,0.745495739570549,0.562787163680638,2,7,acylglycerol metabolic process,BP,PIK3CG;PLA2G16
4885,GO:0051100,0.745690947409952,0.671859496980301,1,4,negative regulation of binding,BP,HEY1
2269,GO:0019887,0.746738863127374,0.670578592276369,1,4,protein kinase regulator activity,MF,PIK3CA
6444,GO:0099565,0.746911783561543,0.670366784043436,1,4,chemical synaptic transmission, postsynaptic,BP,WNT7A
4809,GO:0050866,0.748347931889627,0.668602809256021,1,4,negative regulation of cell activation,BP,BMP4
813,GO:0005776,0.749236458922188,0.66750710388929,1,4,autophagosome,CC,TBC1D14
4005,GO:0044319,0.749351212526253,0.667365349326759,1,4,wound healing, spreading of cells,BP,WNT7A
6241,GO:0090504,0.749351212526253,0.667365349326759,1,4,epiboly,BP,WNT7A
6242,GO:0090505,0.749351212526253,0.667365349326759,1,4,epiboly involved in wound healing,BP,WNT7A
5856,GO:0071548,0.74998317700103,0.66658368469502,1,4,response to dexamethasone,BP,GJB2
1701,GO:0010810,0.750365368555949,0.541568638340211,2,9,regulation of cell-substrate adhesion,BP,FZD7;NOTCH1
292,GO:0002252,0.750608074955513,0.409037104076331,7,27,immune effector process,BP,PIK3CG;PMAIP1;RBP4;PKP1;RAB3D;FADD;PIK3CA
155,GO:0001726,0.750825241733243,0.66553950847577,1,4,ruffle,CC,AMOT
1385,GO:0008406,0.750840454313919,0.492048803055749,3,12,gonad development,BP,FGF8;INHBB;FSTL3
4136,GO:0045137,0.750840454313919,0.492048803055749,3,12,development of primary sexual characteristics,BP,FGF8;INHBB;FSTL3
1516,GO:0009617,0.751076498461496,0.438210698532777,5,19,response to bacterium,BP,GJB2;BMP6;GJB6;CCL20;NOTCH1
2089,GO:0016788,0.751874918730382,0.460429907408625,4,15,hydrolase activity, acting on ester bonds,MF,NUDT7;DUSP5;LYPLAL1;PLA2G16
4067,GO:0044708,0.75251597102756,0.489876403472908,3,12,single-organism behavior,BP,GDNF;FADD;SPTBN4
4003,GO:0044306,0.753012233089403,0.662813406523755,1,4,neuron projection terminus,CC,FSTL3
2112,GO:0016874,0.753428588669987,0.662292080448693,1,4,ligase activity,MF,ACAT1
3870,GO:0043436,0.753842120498031,0.362134443821876,14,50,oxoacid metabolic process,BP,GLDC;ACTN3;HACL1;ACAT1;MSRA;ACADVL;ECI1;ETFDH;PSMB10;DECR1;PTS;CPT1C;ETFB;PEPD
3751,GO:0043025,0.754008504877672,0.487934980882865,3,12,neuronal cell body,CC,SYT5;SPTBN4;DRP2
3707,GO:0042698,0.754382442256881,0.661094910499296,1,4,ovulation cycle,BP,INHBB
2179,GO:0018958,0.755876940733687,0.659211212798674,1,4,phenol-containing compound metabolic process,BP,PNMT
3908,GO:0043549,0.756430011612983,0.376986324715739,10,38,regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;DEPTOR;BMP7;PIK3CA;FGF18
4784,GO:0050803,0.757272807835979,0.657442985070446,1,4,regulation of synapse structure or activity,BP,WNT7A
4788,GO:0050807,0.757272807835979,0.657442985070446,1,4,regulation of synapse organization,BP,WNT7A
4613,GO:0048588,0.758384341764752,0.656028785226257,1,4,developmental cell growth,BP,WNT3
804,GO:0005765,0.759363538790097,0.654778409386643,1,4,lysosomal membrane,CC,RAB3D
811,GO:0005774,0.759363538790097,0.654778409386643,1,4,vacuolar membrane,CC,RAB3D
6412,GO:0098852,0.759363538790097,0.654778409386643,1,4,lytic vacuole membrane,CC,RAB3D
1139,GO:0006996,0.760082199036281,0.337729305284716,20,74,organelle organization,BP,SYT5;PMAIP1;AXIN1;SPTBN5;RAB39A;SPTB;FGF8;PUS1;AMOT;PKP1;HRAS;BMP4;TBC1D14;RAB38;BMP7;SPTBN4;PLA2G16;NOTCH1;RND3;RAB20
2384,GO:0022857,0.760208770319457,0.409843362013571,6,23,transmembrane transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;ABCG1;KCNK6
719,GO:0005216,0.760326016574436,0.534808583957884,2,8,ion channel activity,MF,KCNG2;KCNK6
2382,GO:0022838,0.760326016574436,0.534808583957884,2,8,substrate-specific channel activity,MF,KCNG2;KCNK6
2215,GO:0019320,0.760327940030268,0.653542740935229,1,4,hexose catabolic process,BP,ACTN3
4352,GO:0046365,0.760327940030268,0.653542740935229,1,4,monosaccharide catabolic process,BP,ACTN3
236,GO:0001961,0.76038322541953,0.653471778512908,1,4,positive regulation of cytokine-mediated signaling pathway,BP,FADD
5420,GO:0060760,0.76038322541953,0.653471778512908,1,4,positive regulation of response to cytokine stimulus,BP,FADD
6322,GO:0097367,0.760837074862652,0.341077546400426,18,67,carbohydrate derivative binding,MF,PIK3CG;MAPK12;RAB40B;RRAS2;CDH1;RAB39A;WNK4;ABCG1;PKN3;HRAS;BMP4;RAB3D;RAB38;BMP7;PIK3CA;RND3;RAB20;GUCY1B3
4516,GO:0048144,0.761511028804575,0.533225783006394,2,8,fibroblast proliferation,BP,WNT7B;WNT2
1309,GO:0008047,0.762399692488391,0.476908412579538,3,12,enzyme activator activity,MF,AXIN1;TBC1D14;PIK3CA
6081,GO:0072523,0.762485820266827,0.65076273653976,1,4,purine-containing compound catabolic process,BP,NUDT7
2520,GO:0030425,0.762928797586269,0.524880025853784,2,9,dendrite,CC,DRP2;CPT1C
3572,GO:0042108,0.763228231352786,0.649801409615277,1,4,positive regulation of cytokine biosynthetic process,BP,CCL20
4053,GO:0044459,0.763958814519688,0.332744653922265,20,76,plasma membrane part,CC,GJB2;GJA3;GJB6;JAG2;KCNG2;AXIN1;SPTBN5;CDH1;SPTB;FGF8;AMOT;ABCG1;TSPAN15;CLDN15;KCNK6;FADD;DRP2;TSPAN13;NOTCH1;CPT1C
2650,GO:0031076,0.764185286458588,0.64855843772045,1,4,embryonic camera-type eye development,BP,BMP7
3836,GO:0043279,0.764362273067681,0.648328117828248,1,4,response to alkaloid,BP,FADD
1413,GO:0008645,0.764405285148308,0.522884738479435,2,9,hexose transport,BP,SLC2A14;HNF1A
1902,GO:0015749,0.764405285148308,0.522884738479435,2,9,monosaccharide transport,BP,SLC2A14;HNF1A
1903,GO:0015758,0.764405285148308,0.522884738479435,2,9,glucose transport,BP,SLC2A14;HNF1A
4770,GO:0050776,0.764633678760945,0.441142540889271,4,16,regulation of immune response,BP,HRAS;PSMB10;FADD;PIK3CA
1589,GO:0010171,0.764634464848567,0.647973623161615,1,4,body morphogenesis,BP,WNT3
5264,GO:0060323,0.764634464848567,0.647973623161615,1,4,head morphogenesis,BP,WNT3
4008,GO:0044325,0.765727831608537,0.646546220395326,1,4,ion channel binding,MF,ACTN3
4725,GO:0050661,0.765804914601807,0.646445379645601,1,4,NADP binding,MF,DECR1
4326,GO:0046068,0.765823659330759,0.646420853451564,1,4,cGMP metabolic process,BP,GUCY1B3
6029,GO:0072216,0.765938940155568,0.64626998067412,1,4,positive regulation of metanephros development,BP,GDNF
1651,GO:0010634,0.766046819163077,0.472055640678503,3,12,positive regulation of epithelial cell migration,BP,WNT7A;BMP4;FGF18
2725,GO:0031406,0.766587081856609,0.526392005257493,2,8,carboxylic acid binding,MF,GLDC;VDR
3789,GO:0043177,0.766587081856609,0.526392005257493,2,8,organic acid binding,MF,GLDC;VDR
3482,GO:0036293,0.767330890986876,0.44035435021158,4,15,response to decreased oxygen levels,BP,PMAIP1;PSMB10;BMP7;NOTCH1
4339,GO:0046320,0.767705398827615,0.643950433589237,1,4,regulation of fatty acid oxidation,BP,ACADVL
5186,GO:0060048,0.767783071317947,0.518292505417237,2,9,cardiac muscle contraction,BP,PIK3CG;PIK3CA
14,GO:0000086,0.767875866986208,0.643725822209715,1,4,G2/M transition of mitotic cell cycle,BP,PSMB10
4095,GO:0044839,0.767875866986208,0.643725822209715,1,4,cell cycle G2/M phase transition,BP,PSMB10
4412,GO:0046661,0.768035009489703,0.469394543800405,3,12,male sex differentiation,BP,BMP6;FGF8;FSTL3
6498,GO:1900407,0.768109232875232,0.643418115596313,1,4,regulation of cellular response to oxidative stress,BP,BMP7
3097,GO:0033059,0.768324033172551,0.643134663570466,1,4,cellular pigmentation,BP,RAB38
4869,GO:0051050,0.768594638941884,0.368214039356019,9,35,positive regulation of transport,BP,BMP6;PMAIP1;CDH1;RBP4;INHBB;ABCG1;BMP4;RAB3D;GDNF
3158,GO:0033674,0.769199281293491,0.375649160443144,8,31,positive regulation of kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;FGF18
4285,GO:0045860,0.769199281293491,0.375649160443144,8,31,positive regulation of protein kinase activity,BP,PIK3CG;WNT7B;AXIN1;DUSP5;HRAS;BMP4;PIK3CA;FGF18
1036,GO:0006695,0.769779501685101,0.641208309259745,1,4,cholesterol biosynthetic process,BP,ABCG1
1959,GO:0016126,0.769779501685101,0.641208309259745,1,4,sterol biosynthetic process,BP,ABCG1
6707,GO:1902653,0.769779501685101,0.641208309259745,1,4,secondary alcohol biosynthetic process,BP,ABCG1
2685,GO:0031252,0.769916821359988,0.463231025546329,3,13,cell leading edge,CC,CDH1;AMOT;PIK3CA
545,GO:0003713,0.7699274103989,0.641011989207365,1,4,transcription coactivator activity,MF,POU3F1
3559,GO:0042060,0.770029230067516,0.373744953466474,8,32,wound healing,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
1634,GO:0010565,0.77093956669698,0.46548682875838,3,12,regulation of cellular ketone metabolic process,BP,BMP6;ACADVL;PSMB10
4848,GO:0050995,0.771679676016767,0.638678306149107,1,4,negative regulation of lipid catabolic process,BP,PIK3CG
2499,GO:0030307,0.773744915835905,0.635908979362397,1,4,positive regulation of cell growth,BP,WNT3
1337,GO:0008194,0.773752509751848,0.635898758664404,1,4,UDP-glycosyltransferase activity,MF,ALG5
835,GO:0005856,0.773772231410223,0.3486902774831,11,44,cytoskeleton,CC,ACTN3;MSRA;PXK;SPTBN5;CDH1;SPTB;AMOT;PKP1;RAB3D;KRT10;SPTBN4
4463,GO:0046914,0.774696902321891,0.391253919100723,6,23,transition metal ion binding,MF,RABIF;VDR;NUDT7;RNF144A;DRP2;PEPD
1085,GO:0006839,0.774958043833503,0.63427268548499,1,4,mitochondrial transport,BP,PMAIP1
6393,GO:0098754,0.775372618519447,0.633711860808297,1,4,detoxification,BP,BMP7
6417,GO:0098869,0.775372618519447,0.633711860808297,1,4,cellular oxidant detoxification,BP,BMP7
7024,GO:1990748,0.775372618519447,0.633711860808297,1,4,cellular detoxification,BP,BMP7
1073,GO:0006811,0.776393911055731,0.352286036736196,10,38,ion transport,BP,PIK3CG;KCNG2;VDR;WNK4;ABCG1;CLDN15;KCNK6;GDNF;SPTBN4;TSPAN13
1407,GO:0008610,0.776553362752574,0.342235585936783,12,44,lipid biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;ACADVL;FGF8;VDR;ABCG1;FGF17;PIK3CA;PLA2G16;FGF18;DPM3
890,GO:0006081,0.777082092355208,0.505447566712129,2,9,cellular aldehyde metabolic process,BP,GLDC;BMP6
4787,GO:0050806,0.777167327430651,0.631274348985531,1,4,positive regulation of synaptic transmission,BP,WNT7A
1381,GO:0008380,0.777324536250412,0.631060080795559,1,4,RNA splicing,BP,ARL6IP4
3065,GO:0032943,0.777426931861071,0.45667128634753,3,12,mononuclear cell proliferation,BP,PIK3CG;BMP4;FADD
4410,GO:0046651,0.777426931861071,0.45667128634753,3,12,lymphocyte proliferation,BP,PIK3CG;BMP4;FADD
2511,GO:0030330,0.778110569138513,0.62998692737385,1,4,DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
3722,GO:0042770,0.778110569138513,0.62998692737385,1,4,signal transduction in response to DNA damage,BP,PMAIP1
1730,GO:0010876,0.778595271125736,0.45507059528,3,12,lipid localization,BP,BMP6;RBP4;ABCG1
3211,GO:0034340,0.778914468742961,0.628886219605418,1,4,response to type I interferon,BP,FADD
5269,GO:0060337,0.778914468742961,0.628886219605418,1,4,type I interferon signaling pathway,BP,FADD
5812,GO:0071357,0.778914468742961,0.628886219605418,1,4,cellular response to type I interferon,BP,FADD
1341,GO:0008201,0.779025411456238,0.509267213827593,2,8,heparin binding,MF,BMP4;BMP7
1343,GO:0008203,0.77988217069628,0.508067237683378,2,8,cholesterol metabolic process,BP,ACADVL;ABCG1
6706,GO:1902652,0.77988217069628,0.508067237683378,2,8,secondary alcohol metabolic process,BP,ACADVL;ABCG1
3015,GO:0032760,0.78034874642771,0.626914406014226,1,4,positive regulation of tumor necrosis factor production,BP,FADD
6825,GO:1903557,0.78034874642771,0.626914406014226,1,4,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
2835,GO:0032102,0.780799176877301,0.500227824981871,2,9,negative regulation of response to external stimulus,BP,WNT3;NOTCH1
2678,GO:0031224,0.781789472418265,0.296826436435604,33,119,intrinsic component of membrane,CC,SLC2A14;GJB2;SYT5;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;PXMP2;CDH1;FZD7;TMEM160;SPTB;DSG3;CNIH4;ABCG1;ALG5;TSPAN15;RNF144A;CLDN15;KCNK6;ETFDH;USE1;CCDC51;PLA2G16;TMEM206;TSPAN13;NOTCH1;LINGO1;CPT1C;DPM3
2706,GO:0031331,0.781945029318686,0.446812075953617,3,13,positive regulation of cellular catabolic process,BP,AXIN1;RNF144A;PSMB10
891,GO:0006082,0.782310003293671,0.327147219639947,14,51,organic acid metabolic process,BP,GLDC;ACTN3;HACL1;ACAT1;MSRA;ACADVL;ECI1;ETFDH;PSMB10;DECR1;PTS;CPT1C;ETFB;PEPD
336,GO:0002443,0.783054023775791,0.416574033896284,4,16,leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D;FADD
1464,GO:0009166,0.784187530154606,0.62158598743401,1,4,nucleotide catabolic process,BP,NUDT7
6545,GO:1901292,0.784187530154606,0.62158598743401,1,4,nucleoside phosphate catabolic process,BP,NUDT7
4548,GO:0048286,0.784774832356625,0.620764167285914,1,4,lung alveolus development,BP,BMP4
3497,GO:0036477,0.785044722644184,0.411512477851029,4,17,somatodendritic compartment,CC,SYT5;SPTBN4;DRP2;CPT1C
5381,GO:0060627,0.785203230801224,0.391924697028988,5,20,regulation of vesicle-mediated transport,BP,SYT5;RAB3D;TBC1D14;NOTCH1;RAB20
1173,GO:0007155,0.786611201203987,0.311558549240096,17,67,cell adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;FADD;BMP7;PIK3CA;FSTL3;NOTCH1;RND3
2368,GO:0022610,0.786611201203987,0.311558549240096,17,67,biological adhesion,BP,PIK3CG;ACTN3;CLDN18;WNT7B;JAG2;CDH1;FZD7;DSG3;PKP1;BMP4;CLDN15;FADD;BMP7;PIK3CA;FSTL3;NOTCH1;RND3
1583,GO:0010038,0.788257197818779,0.438025769602034,3,13,response to metal ion,BP,BMP6;CDH1;FSTL3
6431,GO:0099080,0.789633959253054,0.384312631622373,5,21,supramolecular complex,CC,ACTN3;AMOT;PKP1;RAB3D;KRT10
6432,GO:0099081,0.789633959253054,0.384312631622373,5,21,supramolecular polymer,CC,ACTN3;AMOT;PKP1;RAB3D;KRT10
6439,GO:0099512,0.789633959253054,0.384312631622373,5,21,supramolecular fiber,CC,ACTN3;AMOT;PKP1;RAB3D;KRT10
372,GO:0002682,0.790577094360448,0.333744813845213,10,39,regulation of immune system process,BP,CLDN18;RBP4;CCL20;HRAS;BMP4;PSMB10;FADD;PIK3CA;FSTL3;NOTCH1
1536,GO:0009791,0.791062234223438,0.611853776917525,1,4,post-embryonic development,BP,BMP4
1463,GO:0009165,0.791536325136223,0.491472413004809,2,8,nucleotide biosynthetic process,BP,ACAT1;GUCY1B3
6546,GO:1901293,0.791536325136223,0.491472413004809,2,8,nucleoside phosphate biosynthetic process,BP,ACAT1;GUCY1B3
4394,GO:0046578,0.791703304730206,0.610933546640046,1,4,regulation of Ras protein signal transduction,BP,HRAS
2276,GO:0019902,0.791911500070378,0.594510092032335,1,5,phosphatase binding,MF,SPTBN4
4154,GO:0045211,0.79210519162131,0.594224959981456,1,5,postsynaptic membrane,CC,DRP2
1802,GO:0014069,0.792121136409194,0.594201478916703,1,5,postsynaptic density,CC,DRP2
2868,GO:0032279,0.792121136409194,0.594201478916703,1,5,asymmetric synapse,CC,DRP2
6425,GO:0098984,0.792121136409194,0.594201478916703,1,5,neuron to neuron synapse,CC,DRP2
6446,GO:0099572,0.792121136409194,0.594201478916703,1,5,postsynaptic specialization,CC,DRP2
3604,GO:0042304,0.792576600276461,0.609676423552202,1,4,regulation of fatty acid biosynthetic process,BP,ACADVL
1167,GO:0007093,0.792640558095825,0.60958419411356,1,4,mitotic cell cycle checkpoint,BP,HRAS
5740,GO:0070838,0.792758744765857,0.431685827097803,3,13,divalent metal ion transport,BP,PIK3CG;VDR;TSPAN13
6077,GO:0072511,0.792758744765857,0.431685827097803,3,13,divalent inorganic cation transport,BP,PIK3CG;VDR;TSPAN13
43,GO:0000280,0.793021261874178,0.431314167279341,3,13,nuclear division,BP,FGF8;BMP4;BMP7
4547,GO:0048285,0.793021261874178,0.431314167279341,3,13,organelle fission,BP,FGF8;BMP4;BMP7
1913,GO:0015844,0.793030755327762,0.609021038307467,1,4,monoamine transport,BP,GDNF
4718,GO:0050432,0.793030755327762,0.609021038307467,1,4,catecholamine secretion,BP,GDNF
4719,GO:0050433,0.793030755327762,0.609021038307467,1,4,regulation of catecholamine secretion,BP,GDNF
5095,GO:0051937,0.793030755327762,0.609021038307467,1,4,catecholamine transport,BP,GDNF
5648,GO:0070252,0.793384870411746,0.59233615021555,1,5,actin-mediated cell contraction,BP,ACTN3
3647,GO:0042472,0.793492759431495,0.608353183492404,1,4,inner ear morphogenesis,BP,FGF8
4274,GO:0045833,0.793838300646909,0.48151623157559,2,9,negative regulation of lipid metabolic process,BP,PIK3CG;ACADVL
4101,GO:0044877,0.794886414108975,0.350360518513546,7,29,macromolecular complex binding,MF,ACTN3;SPTB;PKP1;RAB38;FADD;FSTL3;MB21D2
1126,GO:0006954,0.795441888421067,0.376443944459982,5,21,inflammatory response,BP,PIK3CG;BMP6;PXK;CCL20;NOTCH1
6630,GO:1901988,0.795501833680294,0.605435462495005,1,4,negative regulation of cell cycle phase transition,BP,PSMB10
6632,GO:1901991,0.795501833680294,0.605435462495005,1,4,negative regulation of mitotic cell cycle phase transition,BP,PSMB10
1939,GO:0016021,0.795811548441942,0.280890014696254,32,116,integral component of membrane,CC,SLC2A14;GJB2;SYT5;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;PXMP2;CDH1;FZD7;TMEM160;DSG3;CNIH4;ABCG1;ALG5;TSPAN15;RNF144A;CLDN15;KCNK6;ETFDH;USE1;CCDC51;PLA2G16;TMEM206;TSPAN13;NOTCH1;LINGO1;CPT1C;DPM3
4893,GO:0051146,0.79631904912663,0.42359994327411,3,14,striated muscle cell differentiation,BP,FZD7;BMP4;NOTCH1
5652,GO:0070265,0.7964383095978,0.604067901592543,1,4,necrotic cell death,BP,FADD
2556,GO:0030595,0.79669322665945,0.477333227344129,2,9,leukocyte chemotaxis,BP,PIK3CG;CCL20
657,GO:0004842,0.796838866770355,0.587194235637368,1,5,ubiquitin-protein transferase activity,MF,RNF144A
2253,GO:0019787,0.796838866770355,0.587194235637368,1,5,ubiquitin-like protein transferase activity,MF,RNF144A
4457,GO:0046890,0.797273575235098,0.394663532622556,4,17,regulation of lipid biosynthetic process,BP,BMP6;ACADVL;VDR;ABCG1
1206,GO:0007224,0.797321602371745,0.602773574926566,1,4,smoothened signaling pathway,BP,BMP4
1158,GO:0007045,0.798292824310737,0.585010397067866,1,5,cell-substrate adherens junction assembly,BP,ACTN3
3210,GO:0034333,0.798292824310737,0.585010397067866,1,5,adherens junction assembly,BP,ACTN3
4510,GO:0048041,0.798292824310737,0.585010397067866,1,5,focal adhesion assembly,BP,ACTN3
5064,GO:0051726,0.79838453842778,0.347742845587501,7,27,regulation of cell cycle,BP,MAPK12;FGF8;HRAS;BMP4;PSMB10;BMP7;PLA2G16
6756,GO:1903047,0.798584788278424,0.373802670399934,5,20,mitotic cell cycle process,BP,FGF8;HRAS;BMP4;PSMB10;BMP7
1160,GO:0007050,0.798721819790067,0.480979585433229,2,8,cell cycle arrest,BP,MAPK12;HRAS
6300,GO:0097193,0.798879460089782,0.480747079703933,2,8,intrinsic apoptotic signaling pathway,BP,PMAIP1;HRAS
544,GO:0003712,0.798964935877543,0.473981962238425,2,9,transcription cofactor activity,MF,TLE1;POU3F1
985,GO:0006518,0.799390605804116,0.425883507169677,3,12,peptide metabolic process,BP,MRPL14;TSFM;BMP4
667,GO:0004871,0.799998593104938,0.334379304502873,8,33,signal transducer activity,MF,WNT7A;WNT3;AXIN1;MAPK12;WNT2;FZD7;VDR;PKP1
2975,GO:0032612,0.800115607193187,0.598650808392154,1,4,interleukin-1 production,BP,CCL20
2989,GO:0032652,0.800115607193187,0.598650808392154,1,4,regulation of interleukin-1 production,BP,CCL20
1576,GO:0009994,0.800272854375265,0.598417476432122,1,4,oocyte differentiation,BP,INHBB
4619,GO:0048599,0.800272854375265,0.598417476432122,1,4,oocyte development,BP,INHBB
853,GO:0005913,0.800279235751431,0.582008025377625,1,5,cell-cell adherens junction,CC,CDH1
2387,GO:0022892,0.801019100043476,0.370459429196793,5,20,substrate-specific transporter activity,MF,SLC2A14;KCNG2;RBP4;ABCG1;KCNK6
5846,GO:0071479,0.801033325047858,0.597287075559942,1,4,cellular response to ionizing radiation,BP,HRAS
4351,GO:0046364,0.801297011934056,0.59689435310668,1,4,monosaccharide biosynthetic process,BP,RBP4
4061,GO:0044699,0.80298077211706,0.292796805342328,92,311,single-organism process,BP,SLC2A14;RHPN1;GLDC;TLE1;WNT7A;GJB2;SYT5;PIK3CG;ACTN3;CLDN18;HACL1;RABIF;MBOAT2;BMP6;GJA3;WNT3;HEY1;GJB6;ACAT1;WNT7B;JAG2;MSRA;PMAIP1;KCNG2;AXIN1;POU3F1;MAPK12;MRPL14;WNT2;ACADVL;PXK;RAB40B;RRAS2;SPTBN5;CDH1;FZD7;RBP4;RAB39A;SPTB;FGF8;VDR;AMOT;ARTN;WNT5B;NUDT7;DSG3;WNK4;CCL20;DUSP5;INHBB;ABCG1;PKN3;FGF17;ALG5;PKP1;HRAS;TSPAN15;BMP4;RAB3D;KRT10;KCNK6;ECI1;GDNF;ETFDH;USE1;DEPTOR;TBC1D14;PSMB10;RAB38;FADD;BMP7;SPTBN4;PIK3CA;PLA2G16;TPD52;DECR1;DRP2;HNF1A;FGF18;FSTL3;TSPAN13;PTS;NOTCH1;LINGO1;RND3;CPT1C;ZFYVE21;RAB20;ETFB;GUCY1B3;DPM3;PEPD
186,GO:0001836,0.803186713191244,0.594068320185327,1,4,release of cytochrome c from mitochondria,BP,PMAIP1
1411,GO:0008637,0.803186713191244,0.594068320185327,1,4,apoptotic mitochondrial changes,BP,PMAIP1
1708,GO:0010821,0.803186713191244,0.594068320185327,1,4,regulation of mitochondrion organization,BP,PMAIP1
6201,GO:0090199,0.803186713191244,0.594068320185327,1,4,regulation of release of cytochrome c from mitochondria,BP,PMAIP1
7226,GO:2001242,0.803186713191244,0.594068320185327,1,4,regulation of intrinsic apoptotic signaling pathway,BP,PMAIP1
1302,GO:0008016,0.805481721099354,0.383126919960295,4,17,regulation of heart contraction,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
3129,GO:0033293,0.805526334315343,0.590540948832233,1,4,monocarboxylic acid binding,MF,VDR
810,GO:0005773,0.805552499449467,0.364193948577777,5,20,vacuole,CC,PIK3CG;RAB39A;RAB3D;TBC1D14;RAB38
1025,GO:0006664,0.806482584859228,0.589090066050755,1,4,glycolipid metabolic process,BP,DPM3
6805,GO:1903509,0.806482584859228,0.589090066050755,1,4,liposaccharide metabolic process,BP,DPM3
2509,GO:0030325,0.807036323524092,0.571629162423386,1,5,adrenal gland development,BP,FSTL3
859,GO:0005924,0.807448416202939,0.37831492942549,4,18,cell-substrate adherens junction,CC,ACTN3;RRAS2;RND3;ZFYVE21
860,GO:0005925,0.807448416202939,0.37831492942549,4,18,focal adhesion,CC,ACTN3;RRAS2;RND3;ZFYVE21
1782,GO:0014013,0.807955784246882,0.57019666667775,1,5,regulation of gliogenesis,BP,NOTCH1
248,GO:0002027,0.808212284322324,0.569796168430156,1,5,regulation of heart rate,BP,SPTBN4
929,GO:0006259,0.808413285424292,0.381296263613431,4,16,DNA metabolic process,BP,BMP6;HRAS;BMP4;PIK3CA
1520,GO:0009636,0.808637727329388,0.459480486558833,2,9,response to toxic substance,BP,CDH1;BMP7
4878,GO:0051090,0.808707102331258,0.459375092624459,2,9,regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2;BMP7
4875,GO:0051056,0.810157224897093,0.457167464091668,2,9,regulation of small GTPase mediated signal transduction,BP,AMOT;HRAS
1112,GO:0006914,0.81017490536238,0.403527931024796,3,14,autophagy,BP,RAB39A;TBC1D14;PIK3CA
4569,GO:0048469,0.810210111599898,0.583382827695159,1,4,cell maturation,BP,SPTBN4
4302,GO:0045931,0.810217675092173,0.583371162828161,1,4,positive regulation of mitotic cell cycle,BP,FGF8
5547,GO:0061337,0.810908773964788,0.456019845854082,2,9,cardiac conduction,BP,KCNK6;SPTBN4
1092,GO:0006874,0.811519557798503,0.4550854176089,2,9,cellular calcium ion homeostasis,BP,PIK3CG;VDR
5146,GO:0055074,0.811519557798503,0.4550854176089,2,9,calcium ion homeostasis,BP,PIK3CG;VDR
6073,GO:0072503,0.811519557798503,0.4550854176089,2,9,cellular divalent inorganic cation homeostasis,BP,PIK3CG;VDR
6074,GO:0072507,0.811519557798503,0.4550854176089,2,9,divalent inorganic cation homeostasis,BP,PIK3CG;VDR
5692,GO:0070482,0.81202069747466,0.376130886997929,4,16,response to oxygen levels,BP,PMAIP1;PSMB10;BMP7;NOTCH1
5703,GO:0070555,0.812657871851245,0.579589665859586,1,4,response to interleukin-1,BP,CCL20
5808,GO:0071347,0.812657871851245,0.579589665859586,1,4,cellular response to interleukin-1,BP,CCL20
193,GO:0001843,0.812984847383404,0.562273571179201,1,5,neural tube closure,BP,BMP4
6886,GO:1904062,0.813241642466027,0.452442286119829,2,9,regulation of cation transmembrane transport,BP,PIK3CG;TSPAN13
2565,GO:0030667,0.813986588726844,0.451294979236984,2,9,secretory granule membrane,CC,PKP1;RAB3D
1412,GO:0008643,0.814450917188453,0.445453266907265,2,10,carbohydrate transport,BP,SLC2A14;HNF1A
6588,GO:1901655,0.814616664921859,0.559670231565601,1,5,cellular response to ketone,BP,GJB2
765,GO:0005524,0.814655758799452,0.333030005858261,6,27,ATP binding,MF,PIK3CG;MAPK12;WNK4;ABCG1;PKN3;PIK3CA
819,GO:0005789,0.814789308260641,0.325653166975764,7,27,endoplasmic reticulum membrane,CC,MBOAT2;ABCG1;ALG5;USE1;NOTCH1;CPT1C;DPM3
3075,GO:0032970,0.81494813999758,0.367573414693543,4,18,regulation of actin filament-based process,BP,SPTBN5;SPTB;HRAS;SPTBN4
1042,GO:0006705,0.815162075133049,0.558796501798395,1,5,mineralocorticoid biosynthetic process,BP,BMP6
1349,GO:0008212,0.815162075133049,0.558796501798395,1,5,mineralocorticoid metabolic process,BP,BMP6
1594,GO:0010243,0.816216578655251,0.312103093946725,8,34,response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;FADD;BMP7;PIK3CA;NOTCH1
7081,GO:2000146,0.816912192253808,0.55598057557271,1,5,negative regulation of cell motility,BP,NOTCH1
241,GO:0001974,0.817725159835734,0.571619931282563,1,4,blood vessel remodeling,BP,FGF8
1124,GO:0006950,0.817834476924567,0.260412276240246,25,93,response to stress,BP,WNT7A;GJB2;PIK3CG;BMP6;ACAT1;WNT7B;MSRA;PMAIP1;AXIN1;MAPK12;ACADVL;PXK;FZD7;FGF8;WNT5B;CCL20;INHBB;HRAS;ETFDH;PSMB10;FADD;BMP7;PIK3CA;NOTCH1;GUCY1B3
6649,GO:1902115,0.818009398846677,0.554205545906147,1,5,regulation of organelle assembly,BP,TBC1D14
1265,GO:0007565,0.818295466613874,0.439479930795346,2,10,female pregnancy,BP,GJB2;VDR
351,GO:0002526,0.818517201292487,0.553381506089814,1,5,acute inflammatory response,BP,PIK3CG
5717,GO:0070661,0.818718045227733,0.393849971383719,3,13,leukocyte proliferation,BP,PIK3CG;BMP4;FADD
3268,GO:0034655,0.818752030455239,0.443898682060425,2,9,nucleobase-containing compound catabolic process,BP,NUDT7;PKP1
5129,GO:0055013,0.818942643484246,0.552689878177362,1,5,cardiac muscle cell development,BP,BMP4
4052,GO:0044456,0.819218141678066,0.361384214132837,4,18,synapse part,CC,WNT7A;SYT5;RAB40B;DRP2
2202,GO:0019216,0.819392651854641,0.341674580570374,5,22,regulation of lipid metabolic process,BP,PIK3CG;BMP6;ACADVL;VDR;ABCG1
5125,GO:0055007,0.819462064547077,0.437654757877025,2,10,cardiac muscle cell differentiation,BP,FZD7;BMP4
807,GO:0005769,0.820053160166112,0.441861894364489,2,9,early endosome,CC,RAB38;RAB20
4492,GO:0048002,0.820499284962469,0.567188290199249,1,4,antigen processing and presentation of peptide antigen,BP,PSMB10
6645,GO:1902107,0.820706297520093,0.549810643500989,1,5,positive regulation of leukocyte differentiation,BP,FADD
6847,GO:1903708,0.820706297520093,0.549810643500989,1,5,positive regulation of hemopoiesis,BP,FADD
2449,GO:0030168,0.820962401536044,0.435298700746703,2,10,platelet activation,BP,PIK3CG;PIK3CA
439,GO:0003073,0.821358481846468,0.548740950052579,1,5,regulation of systemic arterial blood pressure,BP,KCNK6
4870,GO:0051051,0.821395014659481,0.358207911436052,4,18,negative regulation of transport,BP,WNK4;INHBB;BMP7;NOTCH1
5042,GO:0051606,0.821680402788208,0.548211948199011,1,5,detection of stimulus,BP,ABCG1
2832,GO:0032092,0.823117306200728,0.545842657066371,1,5,positive regulation of protein binding,BP,BMP4
4884,GO:0051099,0.823117306200728,0.545842657066371,1,5,positive regulation of binding,BP,BMP4
1441,GO:0009100,0.823939648032686,0.435732813850574,2,9,glycoprotein metabolic process,BP,ALG5;DPM3
5377,GO:0060603,0.82419942444459,0.544049599341912,1,5,mammary gland duct morphogenesis,BP,VDR
1483,GO:0009266,0.82458030106715,0.543416687012496,1,5,response to temperature stimulus,BP,ACADVL
1212,GO:0007259,0.827557655535049,0.538436437361974,1,5,JAK-STAT cascade,BP,NOTCH1
6347,GO:0097696,0.827557655535049,0.538436437361974,1,5,STAT cascade,BP,NOTCH1
6732,GO:1902903,0.82945676351645,0.37451469866329,3,14,regulation of supramolecular fiber organization,BP,SPTBN5;SPTB;SPTBN4
2434,GO:0030133,0.83031505335712,0.376192148853819,3,13,transport vesicle,CC,SYT5;RAB40B;RAB3D
3877,GO:0043473,0.830520916286832,0.533421329645131,1,5,pigmentation,BP,RAB38
6725,GO:1902882,0.830772089373227,0.532993517942591,1,5,regulation of response to oxidative stress,BP,BMP7
5333,GO:0060491,0.830831275550356,0.532892646472113,1,5,regulation of cell projection assembly,BP,HRAS
6814,GO:1903531,0.830994022774114,0.419286377241865,2,10,negative regulation of secretion by cell,BP,INHBB;NOTCH1
42,GO:0000278,0.831268698631927,0.326027352859077,5,21,mitotic cell cycle,BP,FGF8;HRAS;BMP4;PSMB10;BMP7
680,GO:0005057,0.831495063793704,0.531759714324209,1,5,signal transducer activity, downstream of receptor,MF,MAPK12
1572,GO:0009986,0.832533008903181,0.289867163209705,8,34,cell surface,CC,WNT7A;FGF8;AMOT;WNT5B;ABCG1;TSPAN15;TMEM206;NOTCH1
6367,GO:0098589,0.83266604154527,0.416572506944184,2,10,membrane region,CC,CDH1;FADD
5072,GO:0051785,0.832716175637822,0.529667693822538,1,5,positive regulation of nuclear division,BP,FGF8
4639,GO:0048661,0.833542330187864,0.528246499538659,1,5,positive regulation of smooth muscle cell proliferation,BP,BMP4
4727,GO:0050663,0.834246494090227,0.527031428271813,1,5,cytokine secretion,BP,NOTCH1
6379,GO:0098655,0.835445577919775,0.339328323285822,4,17,cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
6383,GO:0098660,0.835445577919775,0.339328323285822,4,17,inorganic ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
6385,GO:0098662,0.835445577919775,0.339328323285822,4,17,inorganic cation transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
430,GO:0003013,0.83577231830443,0.304298294538477,6,26,circulatory system process,BP,PIK3CG;KCNG2;KCNK6;SPTBN4;PIK3CA;GUCY1B3
1301,GO:0008015,0.83577231830443,0.304298294538477,6,26,blood circulation,BP,PIK3CG;KCNG2;KCNK6;SPTBN4;PIK3CA;GUCY1B3
1940,GO:0016032,0.835789425656249,0.336834119865912,4,18,viral process,BP,PMAIP1;PSMB10;FADD;NOTCH1
4799,GO:0050839,0.83603943987895,0.361786455892165,3,15,cell adhesion molecule binding,MF,ACTN3;CDH1;MB21D2
3997,GO:0044281,0.836110360781161,0.240301594884464,23,84,small molecule metabolic process,BP,GLDC;ACTN3;HACL1;BMP6;ACAT1;MSRA;PMAIP1;ACADVL;RBP4;VDR;NUDT7;ABCG1;ECI1;ETFDH;PSMB10;PIK3CA;PLA2G16;DECR1;PTS;CPT1C;ETFB;GUCY1B3;PEPD
767,GO:0005539,0.836350986285924,0.415690023374879,2,9,glycosaminoglycan binding,MF,BMP4;BMP7
2057,GO:0016628,0.837130663255468,0.522018418216499,1,5,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,DECR1
1958,GO:0016125,0.83721315692625,0.414270173488615,2,9,sterol metabolic process,BP,ACADVL;ABCG1
4891,GO:0051130,0.837635058517346,0.291135475950438,7,30,positive regulation of cellular component organization,BP,WNT7A;WNT3;PMAIP1;FGF8;HRAS;BMP7;HNF1A
1505,GO:0009566,0.837661629518088,0.521089127468282,1,5,fertilization,BP,SPTBN4
4111,GO:0045055,0.837967323395586,0.314803390043579,5,22,regulated exocytosis,BP,SYT5;PIK3CG;PKP1;RAB3D;NOTCH1
4072,GO:0044724,0.838357422041854,0.519868310907938,1,5,single-organism carbohydrate catabolic process,BP,ACTN3
2355,GO:0022406,0.839101739661383,0.518558506130727,1,5,membrane docking,BP,RAB40B
1103,GO:0006897,0.839526585678083,0.298893650456644,6,26,endocytosis,BP,SYT5;PIK3CG;RAB39A;HRAS;PIK3CA;RAB20
808,GO:0005770,0.839841700979318,0.517252403441322,1,5,late endosome,CC,TSPAN15
2419,GO:0030055,0.84021379206427,0.328415753003382,4,19,cell-substrate junction,CC,ACTN3;RRAS2;RND3;ZFYVE21
3587,GO:0042175,0.841376496681473,0.287565148987022,7,28,nuclear outer membrane-endoplasmic reticulum membrane network,CC,MBOAT2;ABCG1;ALG5;USE1;NOTCH1;CPT1C;DPM3
4164,GO:0045321,0.842146116355368,0.269760125873729,9,38,leukocyte activation,BP,PIK3CG;JAG2;FZD7;PKP1;BMP4;RAB3D;FADD;PIK3CA;TPD52
6060,GO:0072341,0.842578509921998,0.512386964868008,1,5,modified amino acid binding,MF,SYT5
224,GO:0001942,0.843388175787878,0.510936970174676,1,5,hair follicle development,BP,NOTCH1
2353,GO:0022404,0.843388175787878,0.510936970174676,1,5,molting cycle process,BP,NOTCH1
2354,GO:0022405,0.843388175787878,0.510936970174676,1,5,hair cycle process,BP,NOTCH1
3603,GO:0042303,0.843388175787878,0.510936970174676,1,5,molting cycle,BP,NOTCH1
3696,GO:0042633,0.843388175787878,0.510936970174676,1,5,hair cycle,BP,NOTCH1
2241,GO:0019674,0.843593126398416,0.510569159037389,1,5,NAD metabolic process,BP,ACTN3
838,GO:0005874,0.843819082867679,0.510163286443105,1,5,microtubule,CC,RAB3D
1199,GO:0007204,0.844242807774862,0.509401143370471,1,5,positive regulation of cytosolic calcium ion concentration,BP,PIK3CG
3043,GO:0032869,0.844495574578197,0.39292976250467,2,11,cellular response to insulin stimulus,BP,INHBB;PIK3CA
53,GO:0000323,0.844554941796683,0.325442846266812,4,17,lytic vacuole,CC,PIK3CG;RAB39A;RAB3D;RAB38
803,GO:0005764,0.844554941796683,0.325442846266812,4,17,lysosome,CC,PIK3CG;RAB39A;RAB3D;RAB38
6567,GO:1901564,0.844620352563396,0.241444797259688,16,60,organonitrogen compound metabolic process,BP,GLDC;ACTN3;MBOAT2;ACAT1;MSRA;MRPL14;NUDT7;TSFM;BMP4;PSMB10;PLA2G16;PTS;PNMT;CPT1C;GUCY1B3;PEPD
2859,GO:0032269,0.844676486070206,0.30624811870627,5,21,negative regulation of cellular protein metabolic process,BP,DUSP5;BMP4;DEPTOR;PSMB10;BMP7
718,GO:0005215,0.844820064939261,0.281740445705455,7,29,transporter activity,MF,SLC2A14;GJB2;GJA3;KCNG2;RBP4;ABCG1;KCNK6
2981,GO:0032640,0.845299739569017,0.507494183707877,1,5,tumor necrosis factor production,BP,FADD
2995,GO:0032680,0.845299739569017,0.507494183707877,1,5,regulation of tumor necrosis factor production,BP,FADD
5881,GO:0071706,0.845299739569017,0.507494183707877,1,5,tumor necrosis factor superfamily cytokine production,BP,FADD
6823,GO:1903555,0.845299739569017,0.507494183707877,1,5,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD
4883,GO:0051098,0.846027419583225,0.394398368815849,2,10,regulation of binding,BP,HEY1;BMP4
4152,GO:0045202,0.846058679047949,0.301542733271447,5,23,synapse,CC,WNT7A;SYT5;RAB40B;DRP2;CPT1C
4944,GO:0051248,0.846505552857758,0.289793604549643,6,25,negative regulation of protein metabolic process,BP,DUSP5;INHBB;BMP4;DEPTOR;PSMB10;BMP7
1093,GO:0006875,0.846646876208301,0.347485025701776,3,14,cellular metal ion homeostasis,BP,PIK3CG;BMP6;VDR
1046,GO:0006721,0.846780413065835,0.504808456325018,1,5,terpenoid metabolic process,BP,RBP4
1957,GO:0016101,0.846780413065835,0.504808456325018,1,5,diterpenoid metabolic process,BP,RBP4
1364,GO:0008285,0.846840476444969,0.278840105668736,7,29,negative regulation of cell proliferation,BP,GJB6;RBP4;VDR;HRAS;BMP4;BMP7;NOTCH1
969,GO:0006470,0.847604648104425,0.503306152007961,1,5,protein dephosphorylation,BP,DUSP5
2051,GO:0016607,0.847735300050686,0.503067537380651,1,5,nuclear speck,CC,ARL6IP4
6269,GO:0097060,0.847989015439149,0.49135559976286,1,6,synaptic membrane,CC,DRP2
6390,GO:0098742,0.848503916464925,0.315692406752663,4,19,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN18;CDH1;DSG3;CLDN15
4522,GO:0048167,0.848585051722392,0.501512383532884,1,5,regulation of synaptic plasticity,BP,HRAS
2288,GO:0020037,0.848874452887223,0.500981464013815,1,5,heme binding,MF,GUCY1B3
4460,GO:0046906,0.848874452887223,0.500981464013815,1,5,tetrapyrrole binding,MF,GUCY1B3
2416,GO:0030048,0.848910647581096,0.489654054749092,1,6,actin filament-based movement,BP,ACTN3
2091,GO:0016791,0.848917931050001,0.500901645054246,1,5,phosphatase activity,MF,DUSP5
3066,GO:0032944,0.849376605479321,0.393835755324583,2,9,regulation of mononuclear cell proliferation,BP,BMP4;FADD
4728,GO:0050670,0.849376605479321,0.393835755324583,2,9,regulation of lymphocyte proliferation,BP,BMP4;FADD
162,GO:0001755,0.849834552295818,0.499215439810202,1,5,neural crest cell migration,BP,GDNF
2124,GO:0017016,0.850014139909852,0.487608235364622,1,6,Ras GTPase binding,MF,TBC1D14
2691,GO:0031267,0.850014139909852,0.487608235364622,1,6,small GTPase binding,MF,TBC1D14
4860,GO:0051020,0.850014139909852,0.487608235364622,1,6,GTPase binding,MF,TBC1D14
5773,GO:0071216,0.850559029171072,0.386672515816444,2,10,cellular response to biotic stimulus,BP,BMP6;CCL20
5774,GO:0071219,0.850559029171072,0.386672515816444,2,10,cellular response to molecule of bacterial origin,BP,BMP6;CCL20
5775,GO:0071222,0.850559029171072,0.386672515816444,2,10,cellular response to lipopolysaccharide,BP,BMP6;CCL20
10,GO:0000075,0.851140049247215,0.496802471192368,1,5,cell cycle checkpoint,BP,HRAS
6327,GO:0097435,0.851189479149286,0.293828793432725,5,23,supramolecular fiber organization,BP,AXIN1;SPTBN5;SPTB;PKP1;SPTBN4
1912,GO:0015837,0.851586782586365,0.495973671398273,1,5,amine transport,BP,GDNF
5098,GO:0051952,0.851586782586365,0.495973671398273,1,5,regulation of amine transport,BP,GDNF
3381,GO:0035637,0.851908891422599,0.384350160772355,2,10,multicellular organismal signaling,BP,KCNK6;SPTBN4
335,GO:0002440,0.852166137815487,0.494896459275413,1,5,production of molecular mediator of immune response,BP,RBP4
2547,GO:0030540,0.853298767231541,0.492782764599895,1,5,female genitalia development,BP,RBP4
6569,GO:1901566,0.853970520502582,0.269402092600123,7,28,organonitrogen compound biosynthetic process,BP,ACAT1;MRPL14;TSFM;BMP4;PTS;PNMT;GUCY1B3
2108,GO:0016860,0.854712108204368,0.490130679480734,1,5,intramolecular oxidoreductase activity,MF,ECI1
4443,GO:0046873,0.855720168441758,0.377739848480727,2,10,metal ion transmembrane transporter activity,MF,KCNG2;KCNK6
3832,GO:0043271,0.855781508000961,0.476761638859001,1,6,negative regulation of ion transport,BP,WNK4
337,GO:0002444,0.85582164664187,0.332566359521976,3,14,myeloid leukocyte mediated immunity,BP,PIK3CG;PKP1;RAB3D
3843,GO:0043299,0.85582164664187,0.332566359521976,3,14,leukocyte degranulation,BP,PIK3CG;PKP1;RAB3D
6368,GO:0098590,0.85751757374383,0.283105419872826,5,24,plasma membrane region,CC,GJB6;SPTBN5;CDH1;DRP2;NOTCH1
4275,GO:0045834,0.857606473191784,0.374438632585661,2,10,positive regulation of lipid metabolic process,BP,BMP6;ABCG1
3838,GO:0043281,0.858057210619368,0.378768049805407,2,9,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;FADD
7071,GO:2000116,0.858057210619368,0.378768049805407,2,9,regulation of cysteine-type endopeptidase activity,BP,PMAIP1;FADD
3993,GO:0044270,0.85815280383092,0.373478785229782,2,10,cellular nitrogen compound catabolic process,BP,NUDT7;PKP1
4419,GO:0046700,0.85815280383092,0.373478785229782,2,10,heterocycle catabolic process,BP,NUDT7;PKP1
1591,GO:0010212,0.858550041841656,0.482846087654943,1,5,response to ionizing radiation,BP,HRAS
2686,GO:0031253,0.858727043413758,0.471119503001,1,6,cell projection membrane,CC,SPTBN5
374,GO:0002684,0.859151825238426,0.270004555079,6,26,positive regulation of immune system process,BP,RBP4;CCL20;HRAS;PSMB10;FADD;PIK3CA
1049,GO:0006732,0.85929916841929,0.300427995669847,4,18,coenzyme metabolic process,BP,ACTN3;ACAT1;NUDT7;PTS
6977,GO:1905475,0.859460098497597,0.469704294307994,1,6,regulation of protein localization to membrane,BP,PMAIP1
5112,GO:0052547,0.859738278991983,0.329011330299895,3,13,regulation of peptidase activity,BP,PMAIP1;MAPK12;FADD
6585,GO:1901652,0.860012952858311,0.279277848341152,5,24,response to peptide,BP,GJB2;INHBB;BMP7;PIK3CA;NOTCH1
1633,GO:0010564,0.860206754199399,0.298982227812111,4,18,regulation of cell cycle process,BP,FGF8;BMP4;PSMB10;BMP7
375,GO:0002685,0.860309330941288,0.369673501923213,2,10,regulation of leukocyte migration,BP,CCL20;FADD
3816,GO:0043235,0.861377694478479,0.318812964432705,3,16,receptor complex,CC,VDR;NOTCH1;CPT1C
295,GO:0002262,0.861426807224535,0.46588533736331,1,6,myeloid cell homeostasis,BP,BMP4
1342,GO:0008202,0.861534645404004,0.296861206474029,4,18,steroid metabolic process,BP,BMP6;ACADVL;VDR;ABCG1
246,GO:0002020,0.861568143827754,0.477030516149067,1,5,protease binding,MF,FADD
1614,GO:0010506,0.861777150376321,0.363041221441466,2,11,regulation of autophagy,BP,TBC1D14;PIK3CA
1104,GO:0006898,0.861806739370394,0.476567430984776,1,5,receptor-mediated endocytosis,BP,SYT5
4816,GO:0050877,0.862867646047408,0.275956402463824,5,23,neurological system process,BP,GJB2;GJA3;GJB6;RBP4;SPTBN4
3352,GO:0035384,0.863154893864554,0.462502825007606,1,6,thioester biosynthetic process,BP,ACAT1
5864,GO:0071616,0.863154893864554,0.462502825007606,1,6,acyl-CoA biosynthetic process,BP,ACAT1
2195,GO:0019207,0.864553690573097,0.459746152099152,1,6,kinase regulator activity,MF,PIK3CA
1017,GO:0006643,0.864894795658352,0.470528958086376,1,5,membrane lipid metabolic process,BP,DPM3
1469,GO:0009190,0.865032342025621,0.470258035741174,1,5,cyclic nucleotide biosynthetic process,BP,GUCY1B3
5114,GO:0052652,0.865032342025621,0.470258035741174,1,5,cyclic purine nucleotide metabolic process,BP,GUCY1B3
1443,GO:0009108,0.865310750877272,0.360745031907601,2,10,coenzyme biosynthetic process,BP,ACAT1;PTS
1228,GO:0007292,0.865369088471923,0.469594039802379,1,5,female gamete generation,BP,INHBB
4571,GO:0048477,0.865369088471923,0.469594039802379,1,5,oogenesis,BP,INHBB
2271,GO:0019897,0.865455429307213,0.457960079778707,1,6,extrinsic component of plasma membrane,CC,CDH1
1038,GO:0006700,0.866222446791904,0.456435262944018,1,6,C21-steroid hormone biosynthetic process,BP,BMP6
4029,GO:0044425,0.866340761698271,0.190224427742025,41,152,membrane part,CC,SLC2A14;GJB2;SYT5;PIK3CG;RHBDL3;CLDN18;MBOAT2;GJA3;GJB6;JAG2;KCNG2;AXIN1;PXMP2;SPTBN5;CDH1;FZD7;TMEM160;SPTB;FGF8;AMOT;DSG3;CNIH4;ABCG1;ALG5;TSPAN15;RNF144A;CLDN15;KCNK6;ETFDH;USE1;FADD;CCDC51;PIK3CA;PLA2G16;TMEM206;DRP2;TSPAN13;NOTCH1;LINGO1;CPT1C;DPM3
5148,GO:0055076,0.867004989810854,0.454874251017287,1,6,transition metal ion homeostasis,BP,BMP6
2552,GO:0030554,0.868784140528205,0.252915346942328,6,29,adenyl nucleotide binding,MF,PIK3CG;MAPK12;WNK4;ABCG1;PKN3;PIK3CA
2959,GO:0032559,0.868784140528205,0.252915346942328,6,29,adenyl ribonucleotide binding,MF,PIK3CG;MAPK12;WNK4;ABCG1;PKN3;PIK3CA
3589,GO:0042180,0.868822977946233,0.31078481882208,3,14,cellular ketone metabolic process,BP,BMP6;ACADVL;PSMB10
1484,GO:0009267,0.868988420293105,0.350078707950136,2,11,cellular response to starvation,BP,PMAIP1;INHBB
805,GO:0005766,0.87017159597963,0.460012487755861,1,5,primary lysosome,CC,RAB3D
3683,GO:0042582,0.87017159597963,0.460012487755861,1,5,azurophil granule,CC,RAB3D
5834,GO:0071417,0.870252212955373,0.262390477322845,5,25,cellular response to organonitrogen compound,BP,GJB2;PIK3CG;CDH1;INHBB;PIK3CA
3574,GO:0042113,0.870616820736394,0.44759854724853,1,6,B cell activation,BP,TPD52
5122,GO:0055002,0.871105888155538,0.446604281822986,1,6,striated muscle cell development,BP,BMP4
2266,GO:0019882,0.871555113972411,0.457212600720693,1,5,antigen processing and presentation,BP,PSMB10
1119,GO:0006937,0.872488476493548,0.343675480230077,2,11,regulation of muscle contraction,BP,PIK3CG;ACTN3
3039,GO:0032844,0.873021680045606,0.342693397364545,2,11,regulation of homeostatic process,BP,CLDN18;FADD
868,GO:0005975,0.87316057047779,0.26099657950061,5,22,carbohydrate metabolic process,BP,ACTN3;PMAIP1;RBP4;PIK3CA;DPM3
1286,GO:0007610,0.87389096947913,0.299670352471381,3,15,behavior,BP,GDNF;FADD;SPTBN4
668,GO:0004872,0.874598080719507,0.243998186224388,6,29,receptor activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
5206,GO:0060089,0.874598080719507,0.243998186224388,6,29,molecular transducer activity,MF,FZD7;VDR;AMOT;KCNK6;NOTCH1;GUCY1B3
4579,GO:0048511,0.874796892801384,0.439028984435456,1,6,rhythmic process,BP,INHBB
3590,GO:0042181,0.875075036305867,0.438452941249331,1,6,ketone biosynthetic process,BP,BMP6
1183,GO:0007167,0.875461047213403,0.209163272667396,12,51,enzyme linked receptor protein signaling pathway,BP,BMP6;MAPK12;FGF8;INHBB;FGF17;HRAS;BMP4;BMP7;PIK3CA;FGF18;FSTL3;NOTCH1
3645,GO:0042470,0.876114779343248,0.43629306003177,1,6,melanosome,CC,RAB38
4678,GO:0048770,0.876114779343248,0.43629306003177,1,6,pigment granule,CC,RAB38
3989,GO:0044262,0.876404968020095,0.336420330230077,2,11,cellular carbohydrate metabolic process,BP,ACTN3;PMAIP1
1216,GO:0007265,0.876531072252439,0.340163496665332,2,10,Ras protein signal transduction,BP,RRAS2;HRAS
1402,GO:0008585,0.876613245043417,0.43525390370474,1,6,female gonad development,BP,INHBB
4391,GO:0046545,0.876613245043417,0.43525390370474,1,6,development of primary female sexual characteristics,BP,INHBB
2408,GO:0030031,0.878051353644962,0.333341337763595,2,11,cell projection assembly,BP,HRAS;NOTCH1
4967,GO:0051291,0.878071251024704,0.443777695352068,1,5,protein heterooligomerization,BP,HRAS
3726,GO:0042802,0.878812819422055,0.20213845718264,13,52,identical protein binding,MF,TLE1;ACTN3;CLDN18;HACL1;ACAT1;AXIN1;INHBB;ABCG1;CLDN15;GDNF;FADD;TPD52;PTS
1133,GO:0006974,0.87890973324296,0.335697222848346,2,10,cellular response to DNA damage stimulus,BP,PMAIP1;MAPK12
1186,GO:0007173,0.882425309481783,0.325075203060464,2,11,epidermal growth factor receptor signaling pathway,BP,HRAS;PIK3CA
3523,GO:0038127,0.882425309481783,0.325075203060464,2,11,ERBB signaling pathway,BP,HRAS;PIK3CA
5719,GO:0070663,0.882791754817483,0.328326762516208,2,10,regulation of leukocyte proliferation,BP,BMP4;FADD
2657,GO:0031100,0.88381833822596,0.41995917774683,1,6,animal organ regeneration,BP,NOTCH1
5015,GO:0051493,0.883913481018332,0.257052919044007,4,20,regulation of cytoskeleton organization,BP,SPTBN5;SPTB;HRAS;SPTBN4
4847,GO:0050994,0.884106665047014,0.419336171737751,1,6,regulation of lipid catabolic process,BP,PIK3CG
4915,GO:0051186,0.885682721393003,0.255447697782986,4,19,cofactor metabolic process,BP,ACTN3;ACAT1;NUDT7;PTS
4874,GO:0051055,0.885819525332792,0.415617165261609,1,6,negative regulation of lipid biosynthetic process,BP,ACADVL
298,GO:0002275,0.886061480984479,0.278275042769107,3,15,myeloid cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
4122,GO:0045087,0.886130696586038,0.240062020546112,5,22,innate immune response,BP,PIK3CG;CCL20;HRAS;PSMB10;FADD
5010,GO:0051480,0.886202753687136,0.414780856054616,1,6,regulation of cytosolic calcium ion concentration,BP,PIK3CG
4945,GO:0051249,0.886236387646834,0.277961828581817,3,15,regulation of lymphocyte activation,BP,BMP4;FADD;PIK3CA
5378,GO:0060606,0.886650589154831,0.413801577612093,1,6,tube closure,BP,BMP4
4518,GO:0048146,0.887446263331281,0.412056392629203,1,6,positive regulation of fibroblast proliferation,BP,WNT2
1652,GO:0010638,0.887523661901332,0.275651443304726,3,15,positive regulation of organelle organization,BP,PMAIP1;FGF8;HRAS
2207,GO:0019221,0.888957108017284,0.251424996901083,4,18,cytokine-mediated signaling pathway,BP,CLDN18;CCL20;PSMB10;FADD
178,GO:0001818,0.889462819012037,0.407602729974214,1,6,negative regulation of cytokine production,BP,INHBB
1144,GO:0007015,0.88973043761766,0.269685583892861,3,16,actin filament organization,BP,SPTBN5;SPTB;SPTBN4
4341,GO:0046323,0.889834082554888,0.398816070464811,1,7,glucose import,BP,HNF1A
5820,GO:0071375,0.890863612495199,0.265932205592844,3,17,cellular response to peptide hormone stimulus,BP,GJB2;INHBB;PIK3CA
1058,GO:0006753,0.891134370840929,0.246118205855481,4,19,nucleoside phosphate metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
1449,GO:0009117,0.891134370840929,0.246118205855481,4,19,nucleotide metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
323,GO:0002376,0.891194190975383,0.172419910639498,19,76,immune system process,BP,PIK3CG;CLDN18;BMP6;JAG2;PMAIP1;FZD7;RBP4;ARTN;CCL20;PKP1;HRAS;BMP4;RAB3D;PSMB10;FADD;PIK3CA;TPD52;FSTL3;NOTCH1
4071,GO:0044723,0.89119943523155,0.246006003147566,4,19,single-organism carbohydrate metabolic process,BP,ACTN3;PMAIP1;RBP4;PIK3CA
170,GO:0001775,0.891234382526609,0.193519207644219,10,44,cell activation,BP,WNT7A;PIK3CG;JAG2;FZD7;PKP1;BMP4;RAB3D;FADD;PIK3CA;TPD52
2485,GO:0030260,0.891763489431757,0.394503642718081,1,7,entry into host cell,BP,CDH1
4023,GO:0044409,0.891763489431757,0.394503642718081,1,7,entry into host,BP,CDH1
5059,GO:0051701,0.891763489431757,0.394503642718081,1,7,interaction with host,BP,CDH1
5075,GO:0051806,0.891763489431757,0.394503642718081,1,7,entry into cell of other organism involved in symbiotic interaction,BP,CDH1
5076,GO:0051828,0.891763489431757,0.394503642718081,1,7,entry into other organism involved in symbiotic interaction,BP,CDH1
998,GO:0006575,0.892261705782925,0.401346905554262,1,6,cellular modified amino acid metabolic process,BP,PLA2G16
1157,GO:0007044,0.892277217453824,0.393348534396017,1,7,cell-substrate junction assembly,BP,ACTN3
1947,GO:0016052,0.892727706341134,0.400296790192295,1,6,carbohydrate catabolic process,BP,ACTN3
1159,GO:0007049,0.892994973020034,0.201293703908832,8,35,cell cycle,BP,JAG2;MAPK12;FGF8;HRAS;BMP4;PSMB10;BMP7;PLA2G16
1991,GO:0016324,0.893484063974992,0.300452201807285,2,12,apical plasma membrane,CC,GJB6;NOTCH1
5845,GO:0071478,0.893703193253859,0.398090539488739,1,6,cellular response to radiation,BP,HRAS
4069,GO:0044711,0.893857863230163,0.173916549298209,16,63,single-organism biosynthetic process,BP,PIK3CG;MBOAT2;BMP6;ACAT1;ACADVL;RBP4;FGF8;VDR;ABCG1;FGF17;BMP4;PIK3CA;PLA2G16;FGF18;GUCY1B3;DPM3
6877,GO:1904018,0.894445301184193,0.388441274984349,1,7,positive regulation of vasculature development,BP,NOTCH1
1156,GO:0007043,0.894691862602703,0.395843290459322,1,6,cell-cell junction assembly,BP,GJB2
1997,GO:0016338,0.8951521950177,0.300269206419212,2,11,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN18;CLDN15
861,GO:0005929,0.895215655018279,0.386684892940846,1,7,cilium,CC,SPTBN5
4041,GO:0044441,0.895215655018279,0.386684892940846,1,7,ciliary part,CC,SPTBN5
4411,GO:0046660,0.895458013915105,0.299658548514894,2,11,female sex differentiation,BP,RBP4;INHBB
4917,GO:0051188,0.896581558812594,0.297408903931428,2,11,cofactor biosynthetic process,BP,ACAT1;PTS
4889,GO:0051128,0.897194896015661,0.170460038827983,15,63,regulation of cellular component organization,BP,WNT7A;WNT3;PMAIP1;SPTBN5;SPTB;FGF8;HRAS;BMP4;TBC1D14;BMP7;SPTBN4;HNF1A;NOTCH1;LINGO1;RAB20
2182,GO:0019003,0.89726669135967,0.38993695307881,1,6,GDP binding,MF,HRAS
1787,GO:0014032,0.897366887423819,0.389705524133051,1,6,neural crest cell development,BP,GDNF
1788,GO:0014033,0.897366887423819,0.389705524133051,1,6,neural crest cell differentiation,BP,GDNF
6810,GO:1903522,0.897417735110679,0.233846770920008,4,20,regulation of blood circulation,BP,PIK3CG;KCNG2;KCNK6;SPTBN4
1513,GO:0009611,0.898263922457924,0.192186905501849,8,37,response to wounding,BP,WNT7A;PIK3CG;FZD7;WNT5B;CCL20;HRAS;PIK3CA;NOTCH1
1118,GO:0006936,0.898396837684736,0.232129552510747,4,20,muscle contraction,BP,PIK3CG;ACTN3;GDNF;PIK3CA
4156,GO:0045216,0.900268530962475,0.250331301391592,3,16,cell-cell junction organization,BP,GJB2;ACTN3;CDH1
4065,GO:0044706,0.900847094036321,0.285687105071082,2,12,multi-multicellular organism process,BP,GJB2;VDR
6057,GO:0072331,0.901328854704706,0.380456294892521,1,6,signal transduction by p53 class mediator,BP,PMAIP1
1225,GO:0007281,0.901371917134575,0.287706359560925,2,11,germ cell development,BP,INHBB;BMP4
3778,GO:0043123,0.901511209645961,0.380025906549361,1,6,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD
4314,GO:0045981,0.903007883814628,0.376477592570086,1,6,positive regulation of nucleotide metabolic process,BP,ACTN3
6505,GO:1900544,0.903007883814628,0.376477592570086,1,6,positive regulation of purine nucleotide metabolic process,BP,ACTN3
1704,GO:0010817,0.903423840745247,0.22323432720568,4,20,regulation of hormone levels,BP,BMP6;KCNG2;RBP4;INHBB
5164,GO:0055117,0.904077135143503,0.36597834826566,1,7,regulation of cardiac muscle contraction,BP,PIK3CG
2411,GO:0030036,0.904562925496714,0.196149975150661,6,29,actin cytoskeleton organization,BP,SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
3283,GO:0034754,0.904672093154277,0.280914058691691,2,11,cellular hormone metabolic process,BP,BMP6;RBP4
1098,GO:0006887,0.904951966564853,0.196176036995686,6,28,exocytosis,BP,SYT5;PIK3CG;RAB40B;PKP1;RAB3D;NOTCH1
4455,GO:0046888,0.90522428540128,0.363227345781078,1,7,negative regulation of hormone secretion,BP,INHBB
4755,GO:0050727,0.905343684664687,0.362940046628782,1,7,regulation of inflammatory response,BP,PIK3CG
2559,GO:0030658,0.905842460094991,0.369678214858161,1,6,transport vesicle membrane,CC,SYT5
2203,GO:0019217,0.906246942032124,0.368699359836181,1,6,regulation of fatty acid metabolic process,BP,ACADVL
6568,GO:1901565,0.908687333378932,0.236256440592963,3,15,organonitrogen compound catabolic process,BP,GLDC;ACAT1;NUDT7
3869,GO:0043434,0.909398173795443,0.210339044105339,4,22,response to peptide hormone,BP,GJB2;INHBB;BMP7;PIK3CA
6211,GO:0090257,0.909988621923895,0.266751966916438,2,12,regulation of muscle system process,BP,PIK3CG;ACTN3
3674,GO:0042552,0.910050103355375,0.351466823686139,1,7,myelination,BP,POU3F1
4360,GO:0046434,0.910232915629117,0.358934640587016,1,6,organophosphate catabolic process,BP,NUDT7
1345,GO:0008207,0.910239110048901,0.350999884731137,1,7,C21-steroid hormone metabolic process,BP,BMP6
1035,GO:0006694,0.910728450456372,0.230438482597676,3,16,steroid biosynthetic process,BP,BMP6;VDR;ABCG1
6629,GO:1901987,0.911100984345447,0.356778872444495,1,6,regulation of cell cycle phase transition,BP,PSMB10
6631,GO:1901990,0.911100984345447,0.356778872444495,1,6,regulation of mitotic cell cycle phase transition,BP,PSMB10
5154,GO:0055086,0.911372811895904,0.208887456203513,4,20,nucleobase-containing small molecule metabolic process,BP,ACTN3;ACAT1;NUDT7;GUCY1B3
2273,GO:0019899,0.912229880686443,0.161111038027499,10,46,enzyme binding,MF,MAGEC2;GLDC;ACAT1;AXIN1;TSPAN15;RNF144A;TBC1D14;FADD;SPTBN4;NOTCH1
4658,GO:0048708,0.912427916760504,0.345556631978585,1,7,astrocyte differentiation,BP,NOTCH1
4857,GO:0051015,0.912557848070068,0.34523141448879,1,7,actin filament binding,MF,SPTB
1578,GO:0010001,0.913076720333023,0.260193127113557,2,12,glial cell differentiation,BP,POU3F1;NOTCH1
2406,GO:0030029,0.913388843402185,0.173587481530357,7,34,actin filament-based process,BP,ACTN3;SPTBN5;SPTB;AMOT;HRAS;SPTBN4;RND3
2386,GO:0022891,0.91527243334085,0.221565060030938,3,16,substrate-specific transmembrane transporter activity,MF,SLC2A14;KCNG2;KCNK6
3809,GO:0043228,0.915597998919711,0.141961449456131,16,68,non-membrane-bounded organelle,CC,MAGEC2;ACTN3;MSRA;MRPL14;ACADVL;PXK;SPTBN5;CDH1;ARL6IP4;SPTB;AMOT;PKP1;RAB3D;KRT10;SPTBN4;FGF18
3813,GO:0043232,0.915597998919711,0.141961449456131,16,68,intracellular non-membrane-bounded organelle,CC,MAGEC2;ACTN3;MSRA;MRPL14;ACADVL;PXK;SPTBN5;CDH1;ARL6IP4;SPTB;AMOT;PKP1;RAB3D;KRT10;SPTBN4;FGF18
5490,GO:0061041,0.917270343445697,0.333272224521627,1,7,regulation of wound healing,BP,HRAS
6749,GO:1903034,0.917270343445697,0.333272224521627,1,7,regulation of response to wounding,BP,HRAS
4142,GO:0045177,0.918409226641412,0.246234750855985,2,13,apical part of cell,CC,GJB6;NOTCH1
1320,GO:0008092,0.919304493811067,0.16377912823588,7,34,cytoskeletal protein binding,MF,ACTN3;PXK;SPTBN5;CDH1;SPTB;RAB3D;SPTBN4
1365,GO:0008286,0.919949311448514,0.320652309066373,1,8,insulin receptor signaling pathway,BP,PIK3CA
6586,GO:1901653,0.919981976164489,0.209317289143524,3,18,cellular response to peptide,BP,GJB2;INHBB;PIK3CA
3680,GO:0042578,0.921007146330348,0.323553351049535,1,7,phosphoric ester hydrolase activity,MF,DUSP5
429,GO:0003012,0.92340235666661,0.185393624527117,4,21,muscle system process,BP,PIK3CG;ACTN3;GDNF;PIK3CA
2385,GO:0022890,0.923810652288475,0.23669565500798,2,12,inorganic cation transmembrane transporter activity,MF,KCNG2;KCNK6
4879,GO:0051091,0.925065862184956,0.312746561305857,1,7,positive regulation of sequence-specific DNA binding transcription factor activity,BP,WNT2
4947,GO:0051251,0.926265471672606,0.231158038828982,2,12,positive regulation of lymphocyte activation,BP,FADD;PIK3CA
2361,GO:0022412,0.926775256946435,0.22999992301707,2,12,cellular process involved in reproduction in multicellular organism,BP,INHBB;BMP4
1946,GO:0016051,0.927117733274267,0.307178927832896,1,7,carbohydrate biosynthetic process,BP,RBP4
297,GO:0002274,0.92761582296674,0.195179580214309,3,17,myeloid leukocyte activation,BP,PIK3CG;PKP1;RAB3D
302,GO:0002283,0.927617816137846,0.228079574791602,2,12,neutrophil activation involved in immune response,BP,PKP1;RAB3D
338,GO:0002446,0.927617816137846,0.228079574791602,2,12,neutrophil mediated immunity,BP,PKP1;RAB3D
3480,GO:0036230,0.927617816137846,0.228079574791602,2,12,granulocyte activation,BP,PKP1;RAB3D
3576,GO:0042119,0.927617816137846,0.228079574791602,2,12,neutrophil activation,BP,PKP1;RAB3D
3845,GO:0043312,0.927617816137846,0.228079574791602,2,12,neutrophil degranulation,BP,PKP1;RAB3D
1065,GO:0006790,0.927653887010365,0.195101189104847,3,17,sulfur compound metabolic process,BP,ACAT1;MSRA;NUDT7
382,GO:0002694,0.927733341170672,0.194937517425031,3,17,regulation of leukocyte activation,BP,BMP4;FADD;PIK3CA
3638,GO:0042445,0.928068378186911,0.227049438608744,2,12,hormone metabolic process,BP,BMP6;RBP4
2278,GO:0019904,0.928114885845908,0.175450964163336,4,22,protein domain specific binding,MF,WNT3;AXIN1;FZD7;FADD
1120,GO:0006939,0.928708395737952,0.302812618622389,1,7,smooth muscle contraction,BP,GDNF
713,GO:0005178,0.928844242125354,0.296851955874213,1,8,integrin binding,MF,ACTN3
6553,GO:1901361,0.92911089971272,0.224657177015385,2,12,organic cyclic compound catabolic process,BP,NUDT7;PKP1
1045,GO:0006720,0.929402000194632,0.300894672013813,1,7,isoprenoid metabolic process,BP,RBP4
4517,GO:0048145,0.929582375415226,0.300394486264747,1,7,regulation of fibroblast proliferation,BP,WNT2
2231,GO:0019439,0.930182169855377,0.222186116649398,2,12,aromatic compound catabolic process,BP,NUDT7;PKP1
2748,GO:0031589,0.931966296980241,0.183763059296536,3,19,cell-substrate adhesion,BP,ACTN3;FZD7;NOTCH1
1401,GO:0008584,0.933372898959802,0.284217485885021,1,8,male gonad development,BP,FSTL3
4392,GO:0046546,0.933372898959802,0.284217485885021,1,8,development of primary male sexual characteristics,BP,FSTL3
1888,GO:0015630,0.933791032074449,0.211482287945491,2,13,microtubule cytoskeleton,CC,PXK;RAB3D
916,GO:0006140,0.93380586334658,0.288510980044784,1,7,regulation of nucleotide metabolic process,BP,ACTN3
6503,GO:1900542,0.93380586334658,0.288510980044784,1,7,regulation of purine nucleotide metabolic process,BP,ACTN3
3212,GO:0034341,0.933980588712545,0.288012083586161,1,7,response to interferon-gamma,BP,CCL20
5807,GO:0071346,0.933980588712545,0.288012083586161,1,7,cellular response to interferon-gamma,BP,CCL20
672,GO:0004930,0.934805044093652,0.280143402617679,1,8,G-protein coupled receptor activity,MF,FZD7
4984,GO:0051346,0.935849482246982,0.208888296710799,2,12,negative regulation of hydrolase activity,BP,AMOT;HRAS
1222,GO:0007272,0.935926927331122,0.276924496205575,1,8,ensheathment of neurons,BP,POU3F1
1377,GO:0008366,0.935926927331122,0.276924496205575,1,8,axon ensheathment,BP,POU3F1
6587,GO:1901654,0.936551519165995,0.275121777149503,1,8,response to ketone,BP,GJB2
3207,GO:0034330,0.9369482872529,0.174346221198919,3,18,cell junction organization,BP,GJB2;ACTN3;CDH1
3560,GO:0042063,0.93714601837093,0.203547797049703,2,13,gliogenesis,BP,POU3F1;NOTCH1
3042,GO:0032868,0.937418124691556,0.201028062921493,2,14,response to insulin,BP,INHBB;PIK3CA
2352,GO:0022402,0.937490608353088,0.138521244608672,6,30,cell cycle process,BP,MAPK12;FGF8;HRAS;BMP4;PSMB10;BMP7
234,GO:0001959,0.937802722862652,0.276946970120173,1,7,regulation of cytokine-mediated signaling pathway,BP,FADD
5419,GO:0060759,0.937802722862652,0.276946970120173,1,7,regulation of response to cytokine stimulus,BP,FADD
2500,GO:0030308,0.937900144268382,0.271202888504209,1,8,negative regulation of cell growth,BP,WNT3
1127,GO:0006955,0.940558970628429,0.115757999119154,10,46,immune response,BP,PIK3CG;BMP6;CCL20;PKP1;HRAS;RAB3D;PSMB10;FADD;PIK3CA;NOTCH1
3068,GO:0032946,0.941507972004795,0.265929942450258,1,7,positive regulation of mononuclear cell proliferation,BP,FADD
4729,GO:0050671,0.941507972004795,0.265929942450258,1,7,positive regulation of lymphocyte proliferation,BP,FADD
1370,GO:0008324,0.941564757931582,0.19287910918799,2,13,cation transmembrane transporter activity,MF,KCNG2;KCNK6
6400,GO:0098794,0.942013306347769,0.254958982694426,1,9,postsynapse,CC,DRP2
2183,GO:0019058,0.942407879488193,0.25377717566316,1,9,viral life cycle,BP,NOTCH1
3195,GO:0034220,0.94247395294062,0.147025735140143,4,22,ion transmembrane transport,BP,PIK3CG;KCNG2;KCNK6;TSPAN13
3856,GO:0043393,0.942550155927815,0.257402038044978,1,8,regulation of protein binding,BP,BMP4
384,GO:0002696,0.943308530527207,0.18859671722749,2,13,positive regulation of leukocyte activation,BP,FADD;PIK3CA
1143,GO:0007010,0.943823181147362,0.116301865087495,8,40,cytoskeleton organization,BP,AXIN1;SPTBN5;SPTB;AMOT;PKP1;HRAS;SPTBN4;RND3
786,GO:0005635,0.944817481900172,0.255830762002648,1,7,nuclear envelope,CC,RAB40B
2438,GO:0030141,0.94511253048192,0.1316476612655,5,26,secretory granule,CC,SYT5;PKP1;RAB3D;FSTL3;NOTCH1
5113,GO:0052548,0.946045569304313,0.183915667898251,2,12,regulation of endopeptidase activity,BP,PMAIP1;FADD
6437,GO:0099503,0.946065251823083,0.122655582891877,6,30,secretory vesicle,CC,SYT5;RAB40B;PKP1;RAB3D;FSTL3;NOTCH1
1079,GO:0006820,0.946442384532187,0.18079185440762,2,13,anion transport,BP,WNK4;ABCG1
296,GO:0002263,0.946644736584203,0.153154391852301,3,18,cell activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
320,GO:0002366,0.946644736584203,0.153154391852301,3,18,leukocyte activation involved in immune response,BP,PIK3CG;PKP1;RAB3D
1050,GO:0006733,0.947463040039995,0.242299307680706,1,8,oxidoreduction coenzyme metabolic process,BP,ACTN3
2217,GO:0019362,0.947463040039995,0.242299307680706,1,8,pyridine nucleotide metabolic process,BP,ACTN3
4381,GO:0046496,0.947463040039995,0.242299307680706,1,8,nicotinamide nucleotide metabolic process,BP,ACTN3
3206,GO:0034329,0.948347681345496,0.174228649594197,2,14,cell junction assembly,BP,GJB2;ACTN3
1060,GO:0006766,0.94872119342659,0.238338877606758,1,8,vitamin metabolic process,BP,VDR
2155,GO:0018108,0.949063134766984,0.147708877652599,3,18,peptidyl-tyrosine phosphorylation,BP,FGF8;FGF17;FGF18
2168,GO:0018212,0.949063134766984,0.147708877652599,3,18,peptidyl-tyrosine modification,BP,FGF8;FGF17;FGF18
3999,GO:0044283,0.949901138811287,0.114970836196298,6,31,small molecule biosynthetic process,BP,BMP6;ACAT1;ACADVL;RBP4;VDR;ABCG1
1468,GO:0009187,0.951159494350507,0.230549068950333,1,8,cyclic nucleotide metabolic process,BP,GUCY1B3
34,GO:0000226,0.952513318596463,0.226156161625144,1,8,microtubule cytoskeleton organization,BP,AXIN1
1146,GO:0007017,0.952513318596463,0.226156161625144,1,8,microtubule-based process,BP,AXIN1
5017,GO:0051495,0.952525361852282,0.226116859965742,1,8,positive regulation of cytoskeleton organization,BP,HRAS
5142,GO:0055065,0.952570096612161,0.138733867374233,3,19,metal ion homeostasis,BP,PIK3CG;BMP6;VDR
4637,GO:0048659,0.955179888145712,0.21735479844745,1,8,smooth muscle cell proliferation,BP,BMP4
4638,GO:0048660,0.955179888145712,0.21735479844745,1,8,regulation of smooth muscle cell proliferation,BP,BMP4
3923,GO:0043603,0.956008413317183,0.131668329655926,3,18,cellular amide metabolic process,BP,MRPL14;TSFM;BMP4
4808,GO:0050865,0.957049398934101,0.128298108258936,3,19,regulation of cell activation,BP,BMP4;FADD;PIK3CA
5721,GO:0070665,0.957377817336784,0.209944003140202,1,8,positive regulation of leukocyte proliferation,BP,FADD
2756,GO:0031647,0.957858580128088,0.208303314270045,1,8,regulation of protein stability,BP,DPM3
1351,GO:0008217,0.957885074936449,0.204468164894204,1,9,regulation of blood pressure,BP,KCNK6
5860,GO:0071559,0.957978503698547,0.14774046760472,2,15,response to transforming growth factor beta,BP,WNT7A;WNT2
5861,GO:0071560,0.957978503698547,0.14774046760472,2,15,cellular response to transforming growth factor beta stimulus,BP,WNT7A;WNT2
4810,GO:0050867,0.958272587155975,0.148310312255902,2,14,positive regulation of cell activation,BP,FADD;PIK3CA
2680,GO:0031226,0.958276595547156,0.0899393502104776,8,42,intrinsic component of plasma membrane,CC,JAG2;KCNG2;SPTB;ABCG1;TSPAN15;KCNK6;TSPAN13;CPT1C
6405,GO:0098802,0.959136523874797,0.197305743284051,1,10,plasma membrane receptor complex,CC,CPT1C
1192,GO:0007186,0.959602910619531,0.121444158857491,3,20,G-protein coupled receptor signaling pathway,BP,PIK3CG;FZD7;CCL20
1185,GO:0007169,0.95974239610069,0.0951602907729244,6,33,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MAPK12;FGF8;FGF17;HRAS;PIK3CA;FGF18
6082,GO:0072524,0.961735448356552,0.191159140592748,1,9,pyridine-containing compound metabolic process,BP,ACTN3
6532,GO:1901135,0.962307777970471,0.0903508458637476,6,32,carbohydrate derivative metabolic process,BP,ACTN3;ACAT1;NUDT7;ALG5;GUCY1B3;DPM3
6161,GO:0090068,0.962779123009768,0.187466840750831,1,9,positive regulation of cell cycle process,BP,FGF8
1989,GO:0016311,0.963102308081148,0.186315772304411,1,9,dephosphorylation,BP,DUSP5
2477,GO:0030234,0.963811421791054,0.100083183863217,4,24,enzyme regulator activity,MF,AXIN1;TBC1D14;PIK3CA;NOTCH1
4054,GO:0044463,0.963811665943955,0.110600763389891,3,21,cell projection part,CC,SPTBN5;SPTBN4;FSTL3
5806,GO:0071345,0.963904986922129,0.100407594534486,4,23,cellular response to cytokine stimulus,BP,CLDN18;CCL20;PSMB10;FADD
6095,GO:0072593,0.965606462370578,0.126713147821273,2,15,reactive oxygen species metabolic process,BP,PMAIP1;BMP7
4817,GO:0050878,0.966670121803584,0.0926863599372054,4,26,regulation of body fluid levels,BP,PIK3CG;VDR;WNK4;PIK3CA
3831,GO:0043270,0.966694775730816,0.173262368869187,1,9,positive regulation of ion transport,BP,GDNF
2460,GO:0030198,0.9685117103978,0.116447467547076,2,17,extracellular matrix organization,BP,CDH1;NOTCH1
3759,GO:0043062,0.9685117103978,0.116447467547076,2,17,extracellular structure organization,BP,CDH1;NOTCH1
3995,GO:0044272,0.968606155187792,0.163460709491597,1,10,sulfur compound biosynthetic process,BP,ACAT1
659,GO:0004857,0.970466556106313,0.159002226592093,1,9,enzyme inhibitor activity,MF,NOTCH1
6533,GO:1901136,0.970798912976417,0.157715884511973,1,9,carbohydrate derivative catabolic process,BP,NUDT7
1853,GO:0015075,0.971227433125502,0.110370645033398,2,15,ion transmembrane transporter activity,MF,KCNG2;KCNK6
1897,GO:0015711,0.973994210080639,0.142604043881569,1,10,organic anion transport,BP,ABCG1
1492,GO:0009314,0.974527572290472,0.140463817829114,1,10,response to radiation,BP,HRAS
7112,GO:2000377,0.974534226683442,0.140437022527548,1,10,regulation of reactive oxygen species metabolic process,BP,BMP7
2029,GO:0016491,0.974553993765557,0.0690752373032867,5,28,oxidoreductase activity,MF,GLDC;MSRA;ACADVL;ETFDH;DECR1
4082,GO:0044770,0.976781216886571,0.131252201836379,1,10,cell cycle phase transition,BP,PSMB10
4083,GO:0044772,0.976781216886571,0.131252201836379,1,10,mitotic cell cycle phase transition,BP,PSMB10
830,GO:0005815,0.97739440575964,0.12682870940188,1,11,microtubule organizing center,CC,PXK
6448,GO:0099600,0.978308011875596,0.0868951686190763,2,17,transmembrane receptor activity,MF,FZD7;KCNK6
3179,GO:0034097,0.978676608569765,0.0643782848771205,4,25,response to cytokine,BP,CLDN18;CCL20;PSMB10;FADD
844,GO:0005887,0.979701143216171,0.0500330943479444,7,41,integral component of plasma membrane,CC,JAG2;KCNG2;ABCG1;TSPAN15;KCNK6;TSPAN13;CPT1C
4037,GO:0044437,0.980439055377228,0.115658656563134,1,10,vacuolar part,CC,RAB3D
2275,GO:0019901,0.980551772654591,0.0790713086421827,2,18,protein kinase binding,MF,AXIN1;TBC1D14
3639,GO:0042446,0.98233254280142,0.105546678567064,1,11,hormone biosynthetic process,BP,BMP6
1010,GO:0006633,0.983059674436965,0.102267642717514,1,11,fatty acid biosynthetic process,BP,ACADVL
3505,GO:0038023,0.983604293525625,0.0689781229075995,2,18,signaling receptor activity,MF,FZD7;VDR
1177,GO:0007160,0.98537560417829,0.0892325018241389,1,13,cell-matrix adhesion,BP,ACTN3
2430,GO:0030100,0.986388210163368,0.0866837016318212,1,11,regulation of endocytosis,BP,RAB20
1276,GO:0007596,0.986434275029521,0.058777392596246,2,19,blood coagulation,BP,PIK3CG;PIK3CA
1278,GO:0007599,0.986434275029521,0.058777392596246,2,19,hemostasis,BP,PIK3CG;PIK3CA
4792,GO:0050817,0.986434275029521,0.058777392596246,2,19,coagulation,BP,PIK3CG;PIK3CA
3657,GO:0042493,0.989196058669169,0.0492424194315495,2,18,response to drug,BP,CDH1;FGF8
2274,GO:0019900,0.991029416002276,0.0416544606581326,2,20,kinase binding,MF,AXIN1;TBC1D14
6056,GO:0072330,0.991344493118347,0.0594783956240196,1,13,monocarboxylic acid biosynthetic process,BP,ACADVL
117,GO:0001558,0.992440041088813,0.0528663132466741,1,14,regulation of cell growth,BP,WNT3
1944,GO:0016049,0.992440041088813,0.0528663132466741,1,14,cell growth,BP,WNT3
4264,GO:0045787,0.992855525480137,0.0511679289582931,1,13,positive regulation of cell cycle,BP,FGF8
670,GO:0004888,0.994835789323024,0.0386351630923128,1,15,transmembrane signaling receptor activity,MF,FZD7
1948,GO:0016053,0.996238797625108,0.0299327946640193,1,15,organic acid biosynthetic process,BP,ACADVL
4355,GO:0046394,0.996238797625108,0.0299327946640193,1,15,carboxylic acid biosynthetic process,BP,ACADVL
2640,GO:0031032,1,0.0367038694591506,0,10,actomyosin structure organization,BP,
1,GO:0000002,1,0.732887609658439,0,1,mitochondrial genome maintenance,BP,
3,GO:0000018,1,0.67186132548751,0,1,regulation of DNA recombination,BP,
5,GO:0000038,1,0.730712451364202,0,1,very long-chain fatty acid metabolic process,BP,
6,GO:0000041,1,0.237263958889628,0,4,transition metal ion transport,BP,
8,GO:0000060,1,0.352678915849652,0,3,protein import into nucleus, translocation,BP,
9,GO:0000070,1,0.668902320485507,0,1,mitotic sister chromatid segregation,BP,
11,GO:0000077,1,0.32683251076091,0,3,DNA damage checkpoint,BP,
12,GO:0000079,1,0.0935547196083433,0,6,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
13,GO:0000082,1,0.0972141658790313,0,6,G1/S transition of mitotic cell cycle,BP,
16,GO:0000097,1,0.727559953538537,0,1,sulfur amino acid biosynthetic process,BP,
17,GO:0000118,1,0.734627459219659,0,1,histone deacetylase complex,CC,
19,GO:0000132,1,0.610551717868249,0,1,establishment of mitotic spindle orientation,BP,
21,GO:0000145,1,0.696012829206827,0,1,exocyst,CC,
22,GO:0000146,1,0.734698187201066,0,1,microfilament motor activity,MF,
25,GO:0000155,1,0.729209164791576,0,1,phosphorelay sensor kinase activity,MF,
26,GO:0000160,1,0.729209164791576,0,1,phosphorelay signal transduction system,BP,
29,GO:0000185,1,0.64792184421252,0,1,activation of MAPKKK activity,BP,
35,GO:0000228,1,0.734627459219659,0,1,nuclear chromosome,CC,
36,GO:0000242,1,0.673243059840652,0,1,pericentriolar material,CC,
37,GO:0000245,1,0.649356158897709,0,1,spliceosomal complex assembly,BP,
38,GO:0000247,1,0.637466954542453,0,1,C-8 sterol isomerase activity,MF,
39,GO:0000248,1,0.734591748630676,0,1,C-5 sterol desaturase activity,MF,
40,GO:0000255,1,0.734588622258976,0,1,allantoin metabolic process,BP,
41,GO:0000271,1,0.372194981503033,0,3,polysaccharide biosynthetic process,BP,
44,GO:0000281,1,0.734630587357061,0,1,mitotic cytokinesis,BP,
50,GO:0000307,1,0.693238114134537,0,1,cyclin-dependent protein kinase holoenzyme complex,CC,
54,GO:0000375,1,0.649356158897709,0,1,RNA splicing, via transesterification reactions,BP,
55,GO:0000377,1,0.649356158897709,0,1,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
56,GO:0000398,1,0.649356158897709,0,1,mRNA splicing, via spliceosome,BP,
59,GO:0000785,1,0.370022514905198,0,3,chromatin,CC,
60,GO:0000790,1,0.734627459219659,0,1,nuclear chromatin,CC,
61,GO:0000792,1,0.73282247487454,0,1,heterochromatin,CC,
62,GO:0000803,1,0.734627459219659,0,1,sex chromosome,CC,
63,GO:0000805,1,0.734627459219659,0,1,X chromosome,CC,
64,GO:0000806,1,0.734627459219659,0,1,Y chromosome,CC,
65,GO:0000819,1,0.668902320485507,0,1,sister chromatid segregation,BP,
68,GO:0000910,1,0.357295856411962,0,3,cytokinesis,BP,
69,GO:0000922,1,0.321405839695494,0,3,spindle pole,CC,
70,GO:0000930,1,0.493997556399147,0,2,gamma-tubulin complex,CC,
71,GO:0000932,1,0.734588622258976,0,1,P-body,CC,
77,GO:0000979,1,0.730064105565976,0,1,RNA polymerase II core promoter sequence-specific DNA binding,MF,
84,GO:0001046,1,0.730064105565976,0,1,core promoter sequence-specific DNA binding,MF,
90,GO:0001078,1,0.730064105565976,0,1,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
91,GO:0001085,1,0.446033844119448,0,2,RNA polymerase II transcription factor binding,MF,
93,GO:0001102,1,0.446033844119448,0,2,RNA polymerase II activating transcription factor binding,MF,
97,GO:0001134,1,0.734513896772137,0,1,transcription factor activity, transcription factor recruiting,MF,
98,GO:0001135,1,0.734513896772137,0,1,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
101,GO:0001227,1,0.730064105565976,0,1,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
108,GO:0001508,1,0.535200859247393,0,2,action potential,BP,
109,GO:0001510,1,0.6269280304009,0,1,RNA methylation,BP,
110,GO:0001516,1,0.461029926266115,0,2,prostaglandin biosynthetic process,BP,
116,GO:0001556,1,0.375238641027046,0,2,oocyte maturation,BP,
123,GO:0001573,1,0.497462254677469,0,2,ganglioside metabolic process,BP,
124,GO:0001578,1,0.490827732468161,0,2,microtubule bundle formation,BP,
125,GO:0001608,1,0.710841574163711,0,1,G-protein coupled nucleotide receptor activity,MF,
126,GO:0001609,1,0.720481830454823,0,1,G-protein coupled adenosine receptor activity,MF,
127,GO:0001614,1,0.710841574163711,0,1,purinergic nucleotide receptor activity,MF,
128,GO:0001618,1,0.210457063073444,0,5,virus receptor activity,MF,
130,GO:0001650,1,0.727559953538537,0,1,fibrillar center,CC,
131,GO:0001653,1,0.734579420052926,0,1,peptide receptor activity,MF,
142,GO:0001676,1,0.263009673937275,0,4,long-chain fatty acid metabolic process,BP,
158,GO:0001741,1,0.734627459219659,0,1,XY body,CC,
161,GO:0001754,1,0.734698187201066,0,1,eye photoreceptor cell differentiation,BP,
164,GO:0001757,1,0.731051540942314,0,1,somite specification,BP,
167,GO:0001764,1,0.519353342327689,0,2,neuron migration,BP,
168,GO:0001771,1,0.734550444064761,0,1,immunological synapse formation,BP,
169,GO:0001773,1,0.624051270746175,0,1,myeloid dendritic cell activation,BP,
172,GO:0001779,1,0.519299642169734,0,2,natural killer cell differentiation,BP,
173,GO:0001780,1,0.538659868428263,0,2,neutrophil homeostasis,BP,
174,GO:0001784,1,0.539137129467295,0,2,phosphotyrosine binding,MF,
180,GO:0001821,1,0.687857981162908,0,1,histamine secretion,BP,
183,GO:0001824,1,0.73282247487454,0,1,blastocyst development,BP,
184,GO:0001832,1,0.73282247487454,0,1,blastocyst growth,BP,
185,GO:0001833,1,0.73282247487454,0,1,inner cell mass cell proliferation,BP,
196,GO:0001848,1,0.713203645219262,0,1,complement binding,MF,
205,GO:0001895,1,0.527794187457143,0,2,retina homeostasis,BP,
213,GO:0001917,1,0.734698187201066,0,1,photoreceptor inner segment,CC,
214,GO:0001927,1,0.696012829206827,0,1,exocyst assembly,BP,
215,GO:0001928,1,0.696012829206827,0,1,regulation of exocyst assembly,BP,
216,GO:0001931,1,0.734550444064761,0,1,uropod,CC,
226,GO:0001945,1,0.734586008862106,0,1,lymph vessel development,BP,
229,GO:0001952,1,0.197924532126201,0,5,regulation of cell-matrix adhesion,BP,
230,GO:0001953,1,0.734654319492406,0,1,negative regulation of cell-matrix adhesion,BP,
231,GO:0001954,1,0.522474176558044,0,2,positive regulation of cell-matrix adhesion,BP,
235,GO:0001960,1,0.458925695168661,0,2,negative regulation of cytokine-mediated signaling pathway,BP,
239,GO:0001972,1,0.698707300486311,0,1,retinoic acid binding,MF,
240,GO:0001973,1,0.720481830454823,0,1,adenosine receptor signaling pathway,BP,
242,GO:0001977,1,0.366825880987333,0,3,renal system process involved in regulation of blood volume,BP,
243,GO:0001990,1,0.687857981162908,0,1,regulation of systemic arterial blood pressure by hormone,BP,
247,GO:0002026,1,0.685061814505026,0,1,regulation of the force of heart contraction,BP,
255,GO:0002054,1,0.703491083600584,0,1,nucleobase binding,MF,
256,GO:0002060,1,0.703491083600584,0,1,purine nucleobase binding,MF,
264,GO:0002069,1,0.693238114134537,0,1,columnar/cuboidal epithelial cell maturation,BP,
265,GO:0002070,1,0.693238114134537,0,1,epithelial cell maturation,BP,
266,GO:0002072,1,0.734655294999483,0,1,optic cup morphogenesis involved in camera-type eye development,BP,
267,GO:0002080,1,0.698707300486311,0,1,acrosomal membrane,CC,
271,GO:0002087,1,0.720481830454823,0,1,regulation of respiratory gaseous exchange by neurological system process,BP,
274,GO:0002093,1,0.734698187201066,0,1,auditory receptor cell morphogenesis,BP,
275,GO:0002139,1,0.734698187201066,0,1,stereocilia coupling link,CC,
276,GO:0002140,1,0.734698187201066,0,1,stereocilia tip link,CC,
277,GO:0002159,1,0.719693492985385,0,1,desmosome assembly,BP,
279,GO:0002200,1,0.67186132548751,0,1,somatic diversification of immune receptors,BP,
280,GO:0002204,1,0.67186132548751,0,1,somatic recombination of immunoglobulin genes involved in immune response,BP,
281,GO:0002208,1,0.67186132548751,0,1,somatic diversification of immunoglobulins involved in immune response,BP,
287,GO:0002228,1,0.719239884495386,0,1,natural killer cell mediated immunity,BP,
291,GO:0002251,1,0.678660193884167,0,1,organ or tissue specific immune response,BP,
299,GO:0002277,1,0.624051270746175,0,1,myeloid dendritic cell activation involved in immune response,BP,
301,GO:0002281,1,0.71553036272411,0,1,macrophage activation involved in immune response,BP,
303,GO:0002285,1,0.256258901335638,0,4,lymphocyte activation involved in immune response,BP,
304,GO:0002286,1,0.524576432584739,0,2,T cell activation involved in immune response,BP,
305,GO:0002287,1,0.730064105565976,0,1,alpha-beta T cell activation involved in immune response,BP,
306,GO:0002292,1,0.730064105565976,0,1,T cell differentiation involved in immune response,BP,
307,GO:0002293,1,0.730064105565976,0,1,alpha-beta T cell differentiation involved in immune response,BP,
308,GO:0002294,1,0.730064105565976,0,1,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
309,GO:0002295,1,0.730064105565976,0,1,T-helper cell lineage commitment,BP,
310,GO:0002312,1,0.490603995820534,0,2,B cell activation involved in immune response,BP,
311,GO:0002313,1,0.731051540942314,0,1,mature B cell differentiation involved in immune response,BP,
312,GO:0002315,1,0.731051540942314,0,1,marginal zone B cell differentiation,BP,
313,GO:0002318,1,0.733958464826053,0,1,myeloid progenitor cell differentiation,BP,
315,GO:0002323,1,0.719239884495386,0,1,natural killer cell activation involved in immune response,BP,
317,GO:0002335,1,0.731051540942314,0,1,mature B cell differentiation,BP,
318,GO:0002360,1,0.730064105565976,0,1,T cell lineage commitment,BP,
319,GO:0002363,1,0.730064105565976,0,1,alpha-beta T cell lineage commitment,BP,
321,GO:0002367,1,0.354997151842348,0,3,cytokine production involved in immune response,BP,
322,GO:0002374,1,0.734655294999483,0,1,cytokine secretion involved in immune response,BP,
325,GO:0002381,1,0.67186132548751,0,1,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
326,GO:0002385,1,0.678660193884167,0,1,mucosal immune response,BP,
327,GO:0002386,1,0.678660193884167,0,1,immune response in mucosal-associated lymphoid tissue,BP,
329,GO:0002414,1,0.678660193884167,0,1,immunoglobulin transcytosis in epithelial cells,BP,
330,GO:0002415,1,0.678660193884167,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
346,GO:0002495,1,0.393189119704647,0,2,antigen processing and presentation of peptide antigen via MHC class II,BP,
347,GO:0002504,1,0.393189119704647,0,2,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
350,GO:0002523,1,0.733958464826053,0,1,leukocyte migration involved in inflammatory response,BP,
352,GO:0002544,1,0.671129001439236,0,1,chronic inflammatory response,BP,
354,GO:0002551,1,0.685061814505026,0,1,mast cell chemotaxis,BP,
355,GO:0002562,1,0.67186132548751,0,1,somatic diversification of immune receptors via germline recombination within a single locus,BP,
357,GO:0002576,1,0.268205193374699,0,4,platelet degranulation,BP,
358,GO:0002577,1,0.624051270746175,0,1,regulation of antigen processing and presentation,BP,
359,GO:0002579,1,0.624051270746175,0,1,positive regulation of antigen processing and presentation,BP,
360,GO:0002580,1,0.624051270746175,0,1,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
361,GO:0002582,1,0.624051270746175,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
362,GO:0002583,1,0.624051270746175,0,1,regulation of antigen processing and presentation of peptide antigen,BP,
363,GO:0002585,1,0.624051270746175,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
364,GO:0002586,1,0.624051270746175,0,1,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
365,GO:0002588,1,0.624051270746175,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
369,GO:0002674,1,0.720481830454823,0,1,negative regulation of acute inflammatory response,BP,
376,GO:0002686,1,0.720481830454823,0,1,negative regulation of leukocyte migration,BP,
378,GO:0002688,1,0.260833718245486,0,4,regulation of leukocyte chemotaxis,BP,
379,GO:0002690,1,0.35645344757678,0,3,positive regulation of leukocyte chemotaxis,BP,
395,GO:0002712,1,0.67186132548751,0,1,regulation of B cell mediated immunity,BP,
396,GO:0002714,1,0.67186132548751,0,1,positive regulation of B cell mediated immunity,BP,
397,GO:0002718,1,0.734655294999483,0,1,regulation of cytokine production involved in immune response,BP,
398,GO:0002720,1,0.734655294999483,0,1,positive regulation of cytokine production involved in immune response,BP,
399,GO:0002739,1,0.734655294999483,0,1,regulation of cytokine secretion involved in immune response,BP,
400,GO:0002741,1,0.734655294999483,0,1,positive regulation of cytokine secretion involved in immune response,BP,
419,GO:0002889,1,0.67186132548751,0,1,regulation of immunoglobulin mediated immune response,BP,
420,GO:0002891,1,0.67186132548751,0,1,positive regulation of immunoglobulin mediated immune response,BP,
421,GO:0002920,1,0.713203645219262,0,1,regulation of humoral immune response,BP,
423,GO:0002934,1,0.719693492985385,0,1,desmosome organization,BP,
434,GO:0003018,1,0.0337337186438115,0,9,vascular process in circulatory system,BP,
435,GO:0003044,1,0.687857981162908,0,1,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
436,GO:0003062,1,0.729209164791576,0,1,regulation of heart rate by chemical signal,BP,
437,GO:0003064,1,0.729209164791576,0,1,regulation of heart rate by hormone,BP,
438,GO:0003071,1,0.366825880987333,0,3,renal system process involved in regulation of systemic arterial blood pressure,BP,
441,GO:0003091,1,0.519400362978979,0,2,renal water homeostasis,BP,
442,GO:0003093,1,0.366825880987333,0,3,regulation of glomerular filtration,BP,
443,GO:0003094,1,0.366825880987333,0,3,glomerular filtration,BP,
445,GO:0003100,1,0.687857981162908,0,1,regulation of systemic arterial blood pressure by endothelin,BP,
446,GO:0003104,1,0.51019347053769,0,2,positive regulation of glomerular filtration,BP,
468,GO:0003175,1,0.730064105565976,0,1,tricuspid valve development,BP,
476,GO:0003186,1,0.730064105565976,0,1,tricuspid valve morphogenesis,BP,
480,GO:0003195,1,0.730064105565976,0,1,tricuspid valve formation,BP,
506,GO:0003274,1,0.724071876739581,0,1,endocardial cushion fusion,BP,
509,GO:0003283,1,0.528109275263181,0,2,atrial septum development,BP,
510,GO:0003284,1,0.724071876739581,0,1,septum primum development,BP,
511,GO:0003289,1,0.724071876739581,0,1,atrial septum primum morphogenesis,BP,
512,GO:0003298,1,0.687857981162908,0,1,physiological muscle hypertrophy,BP,
513,GO:0003300,1,0.687857981162908,0,1,cardiac muscle hypertrophy,BP,
514,GO:0003301,1,0.687857981162908,0,1,physiological cardiac muscle hypertrophy,BP,
515,GO:0003306,1,0.534614034603587,0,2,Wnt signaling pathway involved in heart development,BP,
516,GO:0003307,1,0.728387748399053,0,1,regulation of Wnt signaling pathway involved in heart development,BP,
517,GO:0003308,1,0.728387748399053,0,1,negative regulation of Wnt signaling pathway involved in heart development,BP,
520,GO:0003333,1,0.733899513955252,0,1,amino acid transmembrane transport,BP,
527,GO:0003382,1,0.643431355609946,0,1,epithelial cell morphogenesis,BP,
529,GO:0003402,1,0.734655294999483,0,1,planar cell polarity pathway involved in axis elongation,BP,
530,GO:0003408,1,0.734655294999483,0,1,optic cup formation involved in camera-type eye development,BP,
531,GO:0003413,1,0.598426664068228,0,1,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
532,GO:0003416,1,0.598426664068228,0,1,endochondral bone growth,BP,
533,GO:0003417,1,0.598426664068228,0,1,growth plate cartilage development,BP,
534,GO:0003418,1,0.598426664068228,0,1,growth plate cartilage chondrocyte differentiation,BP,
535,GO:0003419,1,0.598426664068228,0,1,growth plate cartilage chondrocyte proliferation,BP,
548,GO:0003725,1,0.734550444064761,0,1,double-stranded RNA binding,MF,
549,GO:0003729,1,0.71794240190076,0,1,mRNA binding,MF,
550,GO:0003730,1,0.71794240190076,0,1,mRNA 3'-UTR binding,MF,
553,GO:0003774,1,0.395444357296567,0,3,motor activity,MF,
557,GO:0003854,1,0.669038180478943,0,1,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
558,GO:0003857,1,0.6269280304009,0,1,3-hydroxyacyl-CoA dehydrogenase activity,MF,
559,GO:0003858,1,0.723051447612026,0,1,3-hydroxybutyrate dehydrogenase activity,MF,
560,GO:0003873,1,0.734590273582109,0,1,6-phosphofructo-2-kinase activity,MF,
563,GO:0003940,1,0.692808616325038,0,1,L-iduronidase activity,MF,
567,GO:0003993,1,0.660154918812215,0,1,acid phosphatase activity,MF,
569,GO:0003996,1,0.489143739410573,0,2,acyl-CoA ligase activity,MF,
570,GO:0004031,1,0.734619092483416,0,1,aldehyde oxidase activity,MF,
571,GO:0004033,1,0.62028039706305,0,1,aldo-keto reductase (NADP) activity,MF,
572,GO:0004064,1,0.663248360975453,0,1,arylesterase activity,MF,
574,GO:0004112,1,0.734583504697188,0,1,cyclic-nucleotide phosphodiesterase activity,MF,
575,GO:0004114,1,0.734583504697188,0,1,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
576,GO:0004115,1,0.734583504697188,0,1,3',5'-cyclic-AMP phosphodiesterase activity,MF,
577,GO:0004129,1,0.62028039706305,0,1,cytochrome-c oxidase activity,MF,
578,GO:0004139,1,0.668032632215708,0,1,deoxyribose-phosphate aldolase activity,MF,
585,GO:0004197,1,0.402924638225269,0,2,cysteine-type endopeptidase activity,MF,
589,GO:0004303,1,0.67605262318362,0,1,estradiol 17-beta-dehydrogenase activity,MF,
590,GO:0004312,1,0.536368735487814,0,2,fatty acid synthase activity,MF,
591,GO:0004313,1,0.734715871907028,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
592,GO:0004314,1,0.734715871907028,0,1,[acyl-carrier-protein] S-malonyltransferase activity,MF,
593,GO:0004315,1,0.734715871907028,0,1,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
594,GO:0004316,1,0.734715871907028,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
595,GO:0004317,1,0.734715871907028,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
596,GO:0004319,1,0.734715871907028,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
597,GO:0004320,1,0.734715871907028,0,1,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
598,GO:0004321,1,0.703997935140284,0,1,fatty-acyl-CoA synthase activity,MF,
599,GO:0004331,1,0.734590273582109,0,1,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
600,GO:0004341,1,0.678874584138857,0,1,gluconolactonase activity,MF,
601,GO:0004364,1,0.61919681818651,0,1,glutathione transferase activity,MF,
603,GO:0004379,1,0.734621422421857,0,1,glycylpeptide N-tetradecanoyltransferase activity,MF,
605,GO:0004407,1,0.734627459219659,0,1,histone deacetylase activity,MF,
606,GO:0004421,1,0.703143825629313,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
607,GO:0004448,1,0.69967224305375,0,1,isocitrate dehydrogenase activity,MF,
608,GO:0004450,1,0.69967224305375,0,1,isocitrate dehydrogenase (NADP+) activity,MF,
609,GO:0004454,1,0.703675733824822,0,1,ketohexokinase activity,MF,
610,GO:0004457,1,0.684719928583765,0,1,lactate dehydrogenase activity,MF,
611,GO:0004458,1,0.684719928583765,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
612,GO:0004464,1,0.61919681818651,0,1,leukotriene-C4 synthase activity,MF,
614,GO:0004467,1,0.734629515296733,0,1,long-chain fatty acid-CoA ligase activity,MF,
615,GO:0004470,1,0.643589205720551,0,1,malic enzyme activity,MF,
616,GO:0004497,1,0.288634557217956,0,3,monooxygenase activity,MF,
617,GO:0004505,1,0.629717088917049,0,1,phenylalanine 4-monooxygenase activity,MF,
618,GO:0004508,1,0.675836959389896,0,1,steroid 17-alpha-monooxygenase activity,MF,
619,GO:0004518,1,0.460926171262399,0,2,nuclease activity,MF,
620,GO:0004519,1,0.460926171262399,0,2,endonuclease activity,MF,
621,GO:0004521,1,0.734576401742655,0,1,endoribonuclease activity,MF,
622,GO:0004540,1,0.460926171262399,0,2,ribonuclease activity,MF,
623,GO:0004553,1,0.304657085131264,0,3,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
624,GO:0004557,1,0.651434792770337,0,1,alpha-galactosidase activity,MF,
625,GO:0004563,1,0.677828420297706,0,1,beta-N-acetylhexosaminidase activity,MF,
629,GO:0004601,1,0.61919681818651,0,1,peroxidase activity,MF,
630,GO:0004602,1,0.61919681818651,0,1,glutathione peroxidase activity,MF,
635,GO:0004629,1,0.720481830454823,0,1,phospholipase C activity,MF,
637,GO:0004673,1,0.729209164791576,0,1,protein histidine kinase activity,MF,
639,GO:0004675,1,0.724071876739581,0,1,transmembrane receptor protein serine/threonine kinase activity,MF,
640,GO:0004690,1,0.734595256616651,0,1,cyclic nucleotide-dependent protein kinase activity,MF,
641,GO:0004691,1,0.734595256616651,0,1,cAMP-dependent protein kinase activity,MF,
645,GO:0004709,1,0.706886301239446,0,1,MAP kinase kinase kinase activity,MF,
646,GO:0004712,1,0.721277899526339,0,1,protein serine/threonine/tyrosine kinase activity,MF,
648,GO:0004714,1,0.53896838878504,0,2,transmembrane receptor protein tyrosine kinase activity,MF,
649,GO:0004716,1,0.734544012449274,0,1,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
653,GO:0004731,1,0.703491083600584,0,1,purine-nucleoside phosphorylase activity,MF,
654,GO:0004740,1,0.734076412283897,0,1,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
655,GO:0004745,1,0.728387748399053,0,1,retinol dehydrogenase activity,MF,
656,GO:0004769,1,0.425824912125201,0,2,steroid delta-isomerase activity,MF,
658,GO:0004854,1,0.734619092483416,0,1,xanthine dehydrogenase activity,MF,
660,GO:0004859,1,0.602424533559327,0,1,phospholipase inhibitor activity,MF,
661,GO:0004860,1,0.490083871081733,0,2,protein kinase inhibitor activity,MF,
662,GO:0004861,1,0.693238114134537,0,1,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
663,GO:0004862,1,0.707766673908358,0,1,cAMP-dependent protein kinase inhibitor activity,MF,
664,GO:0004866,1,0.140812601355857,0,5,endopeptidase inhibitor activity,MF,
665,GO:0004867,1,0.494704578990322,0,2,serine-type endopeptidase inhibitor activity,MF,
666,GO:0004869,1,0.286893244502848,0,3,cysteine-type endopeptidase inhibitor activity,MF,
671,GO:0004896,1,0.734588622258976,0,1,cytokine receptor activity,MF,
673,GO:0004935,1,0.496169850027802,0,2,adrenergic receptor activity,MF,
674,GO:0004936,1,0.496169850027802,0,2,alpha-adrenergic receptor activity,MF,
675,GO:0004938,1,0.496169850027802,0,2,alpha2-adrenergic receptor activity,MF,
676,GO:0004970,1,0.734629361512883,0,1,ionotropic glutamate receptor activity,MF,
677,GO:0004971,1,0.734629361512883,0,1,AMPA glutamate receptor activity,MF,
678,GO:0005024,1,0.724071876739581,0,1,transforming growth factor beta-activated receptor activity,MF,
679,GO:0005025,1,0.724071876739581,0,1,transforming growth factor beta receptor activity, type I,MF,
681,GO:0005068,1,0.734654319492406,0,1,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
682,GO:0005080,1,0.513043602237401,0,2,protein kinase C binding,MF,
685,GO:0005092,1,0.373869940463981,0,3,GDP-dissociation inhibitor activity,MF,
691,GO:0005110,1,0.734655294999483,0,1,frizzled-2 binding,MF,
694,GO:0005113,1,0.679008521833097,0,1,patched binding,MF,
695,GO:0005115,1,0.734655294999483,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
699,GO:0005127,1,0.67186132548751,0,1,ciliary neurotrophic factor receptor binding,MF,
700,GO:0005138,1,0.624051270746175,0,1,interleukin-6 receptor binding,MF,
701,GO:0005146,1,0.734513896772137,0,1,leukemia inhibitory factor receptor binding,MF,
703,GO:0005158,1,0.49666677525388,0,2,insulin receptor binding,MF,
704,GO:0005159,1,0.734654319492406,0,1,insulin-like growth factor receptor binding,MF,
706,GO:0005161,1,0.529639535638621,0,2,platelet-derived growth factor receptor binding,MF,
708,GO:0005165,1,0.734654319492406,0,1,neurotrophin receptor binding,MF,
709,GO:0005167,1,0.734654319492406,0,1,neurotrophin TRK receptor binding,MF,
710,GO:0005168,1,0.734654319492406,0,1,neurotrophin TRKA receptor binding,MF,
711,GO:0005172,1,0.734583532995424,0,1,vascular endothelial growth factor receptor binding,MF,
712,GO:0005173,1,0.734638208028596,0,1,stem cell factor receptor binding,MF,
717,GO:0005201,1,0.496833722622451,0,2,extracellular matrix structural constituent,MF,
720,GO:0005225,1,0.683400968465533,0,1,volume-sensitive anion channel activity,MF,
721,GO:0005230,1,0.734629361512883,0,1,extracellular ligand-gated ion channel activity,MF,
722,GO:0005231,1,0.734629361512883,0,1,excitatory extracellular ligand-gated ion channel activity,MF,
723,GO:0005234,1,0.734629361512883,0,1,extracellular-glutamate-gated ion channel activity,MF,
727,GO:0005245,1,0.707679132473116,0,1,voltage-gated calcium channel activity,MF,
730,GO:0005250,1,0.734607439241621,0,1,A-type (transient outward) potassium channel activity,MF,
732,GO:0005253,1,0.413435230092464,0,2,anion channel activity,MF,
733,GO:0005254,1,0.413435230092464,0,2,chloride channel activity,MF,
735,GO:0005262,1,0.707679132473116,0,1,calcium channel activity,MF,
737,GO:0005310,1,0.733899513955252,0,1,dicarboxylic acid transmembrane transporter activity,MF,
738,GO:0005313,1,0.733899513955252,0,1,L-glutamate transmembrane transporter activity,MF,
739,GO:0005314,1,0.733899513955252,0,1,high-affinity glutamate transmembrane transporter activity,MF,
741,GO:0005324,1,0.634405611216108,0,1,long-chain fatty acid transporter activity,MF,
742,GO:0005342,1,0.733899513955252,0,1,organic acid transmembrane transporter activity,MF,
743,GO:0005351,1,0.731839027449961,0,1,sugar:proton symporter activity,MF,
745,GO:0005375,1,0.670477648906454,0,1,copper ion transmembrane transporter activity,MF,
746,GO:0005381,1,0.490953622498712,0,2,iron ion transmembrane transporter activity,MF,
747,GO:0005402,1,0.731839027449961,0,1,cation:sugar symporter activity,MF,
748,GO:0005484,1,0.716792886639055,0,1,SNAP receptor activity,MF,
753,GO:0005504,1,0.381448757959453,0,2,fatty acid binding,MF,
754,GO:0005506,1,0.104737895618364,0,6,iron ion binding,MF,
755,GO:0005507,1,0.460909563164703,0,2,copper ion binding,MF,
757,GO:0005513,1,0.715718629020694,0,1,detection of calcium ion,BP,
759,GO:0005516,1,0.247957548370275,0,4,calmodulin binding,MF,
760,GO:0005518,1,0.388265637682807,0,3,collagen binding,MF,
761,GO:0005520,1,0.513767863322437,0,2,insulin-like growth factor binding,MF,
763,GO:0005522,1,0.734598124981224,0,1,profilin binding,MF,
764,GO:0005523,1,0.402709618498799,0,2,tropomyosin binding,MF,
768,GO:0005540,1,0.676968220787531,0,1,hyaluronic acid binding,MF,
772,GO:0005547,1,0.721277899526339,0,1,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
777,GO:0005604,1,0.337977722876629,0,3,basement membrane,CC,
778,GO:0005605,1,0.337977722876629,0,3,basal lamina,CC,
779,GO:0005606,1,0.734725360877515,0,1,laminin-1 complex,CC,
780,GO:0005608,1,0.734725360877515,0,1,laminin-3 complex,CC,
781,GO:0005610,1,0.734731427506846,0,1,laminin-5 complex,CC,
787,GO:0005637,1,0.611793019492039,0,1,nuclear inner membrane,CC,
788,GO:0005640,1,0.71385568806396,0,1,nuclear outer membrane,CC,
789,GO:0005641,1,0.671129001439236,0,1,nuclear envelope lumen,CC,
792,GO:0005694,1,0.370022514905198,0,3,chromosome,CC,
799,GO:0005758,1,0.477404338002382,0,2,mitochondrial intermembrane space,CC,
809,GO:0005771,1,0.719239884495386,0,1,multivesicular body,CC,
812,GO:0005775,1,0.0839287772780006,0,6,vacuolar lumen,CC,
820,GO:0005790,1,0.456602885212195,0,2,smooth endoplasmic reticulum,CC,
821,GO:0005791,1,0.687857981162908,0,1,rough endoplasmic reticulum,CC,
825,GO:0005798,1,0.734598124981224,0,1,Golgi-associated vesicle,CC,
826,GO:0005801,1,0.513769612675834,0,2,cis-Golgi network,CC,
828,GO:0005811,1,0.310337714596484,0,3,lipid particle,CC,
829,GO:0005813,1,0.0879792845495832,0,7,centrosome,CC,
831,GO:0005819,1,0.15473336137373,0,5,spindle,CC,
836,GO:0005859,1,0.734688491282273,0,1,muscle myosin complex,CC,
837,GO:0005865,1,0.474306168911428,0,2,striated muscle thin filament,CC,
839,GO:0005876,1,0.449704456689423,0,2,spindle microtubule,CC,
845,GO:0005890,1,0.60595713946183,0,1,sodium:potassium-exchanging ATPase complex,CC,
846,GO:0005891,1,0.525241663252816,0,2,voltage-gated calcium channel complex,CC,
848,GO:0005902,1,0.394626292964064,0,3,microvillus,CC,
849,GO:0005903,1,0.733251487847435,0,1,brush border,CC,
850,GO:0005905,1,0.372357876047393,0,3,clathrin-coated pit,CC,
854,GO:0005915,1,0.706886301239446,0,1,zonula adherens,CC,
855,GO:0005916,1,0.734589394501328,0,1,fascia adherens,CC,
866,GO:0005952,1,0.519400362978979,0,2,cAMP-dependent protein kinase complex,CC,
869,GO:0005976,1,0.372194981503033,0,3,polysaccharide metabolic process,BP,
870,GO:0005977,1,0.721277899526339,0,1,glycogen metabolic process,BP,
871,GO:0005978,1,0.721277899526339,0,1,glycogen biosynthetic process,BP,
872,GO:0005979,1,0.721277899526339,0,1,regulation of glycogen biosynthetic process,BP,
873,GO:0005984,1,0.692808616325038,0,1,disaccharide metabolic process,BP,
875,GO:0006000,1,0.516387479317128,0,2,fructose metabolic process,BP,
876,GO:0006001,1,0.703675733824822,0,1,fructose catabolic process,BP,
877,GO:0006003,1,0.734590273582109,0,1,fructose 2,6-bisphosphate metabolic process,BP,
880,GO:0006011,1,0.647073695085383,0,1,UDP-glucose metabolic process,BP,
881,GO:0006012,1,0.647073695085383,0,1,galactose metabolic process,BP,
882,GO:0006022,1,0.0896217875102354,0,7,aminoglycan metabolic process,BP,
883,GO:0006023,1,0.269088287754078,0,4,aminoglycan biosynthetic process,BP,
884,GO:0006024,1,0.269088287754078,0,4,glycosaminoglycan biosynthetic process,BP,
885,GO:0006026,1,0.33316625597461,0,3,aminoglycan catabolic process,BP,
886,GO:0006027,1,0.33316625597461,0,3,glycosaminoglycan catabolic process,BP,
887,GO:0006029,1,0.249604335154738,0,4,proteoglycan metabolic process,BP,
889,GO:0006073,1,0.721277899526339,0,1,cellular glucan metabolic process,BP,
894,GO:0006086,1,0.734076412283897,0,1,acetyl-CoA biosynthetic process from pyruvate,BP,
900,GO:0006097,1,0.69967224305375,0,1,glyoxylate cycle,BP,
901,GO:0006098,1,0.490058217144967,0,2,pentose-phosphate shunt,BP,
902,GO:0006099,1,0.449676732101172,0,2,tricarboxylic acid cycle,BP,
903,GO:0006101,1,0.329577650941292,0,3,citrate metabolic process,BP,
904,GO:0006102,1,0.69967224305375,0,1,isocitrate metabolic process,BP,
905,GO:0006103,1,0.340424748030387,0,3,2-oxoglutarate metabolic process,BP,
906,GO:0006105,1,0.734588622258976,0,1,succinate metabolic process,BP,
907,GO:0006107,1,0.472190905154906,0,2,oxaloacetate metabolic process,BP,
908,GO:0006108,1,0.643589205720551,0,1,malate metabolic process,BP,
911,GO:0006111,1,0.732887609658439,0,1,regulation of gluconeogenesis,BP,
912,GO:0006112,1,0.721277899526339,0,1,energy reserve metabolic process,BP,
917,GO:0006144,1,0.734619092483416,0,1,purine nucleobase metabolic process,BP,
918,GO:0006145,1,0.734619092483416,0,1,purine nucleobase catabolic process,BP,
919,GO:0006148,1,0.703491083600584,0,1,inosine catabolic process,BP,
920,GO:0006152,1,0.703491083600584,0,1,purine nucleoside catabolic process,BP,
924,GO:0006171,1,0.425675672414994,0,2,cAMP biosynthetic process,BP,
927,GO:0006198,1,0.734583504697188,0,1,cAMP catabolic process,BP,
928,GO:0006258,1,0.647073695085383,0,1,UDP-glucose catabolic process,BP,
933,GO:0006281,1,0.394878022978175,0,2,DNA repair,BP,
934,GO:0006282,1,0.610551717868249,0,1,regulation of DNA repair,BP,
938,GO:0006308,1,0.678874584138857,0,1,DNA catabolic process,BP,
939,GO:0006310,1,0.67186132548751,0,1,DNA recombination,BP,
940,GO:0006325,1,0.269966043135718,0,4,chromatin organization,BP,
946,GO:0006359,1,0.716018004067463,0,1,regulation of transcription from RNA polymerase III promoter,BP,
947,GO:0006364,1,0.734576401742655,0,1,rRNA processing,BP,
951,GO:0006376,1,0.649356158897709,0,1,mRNA splice site selection,BP,
952,GO:0006383,1,0.716018004067463,0,1,transcription from RNA polymerase III promoter,BP,
963,GO:0006457,1,0.598426664068228,0,1,protein folding,BP,
966,GO:0006465,1,0.707679132473116,0,1,signal peptide processing,BP,
970,GO:0006473,1,0.734513896772137,0,1,protein acetylation,BP,
971,GO:0006475,1,0.734513896772137,0,1,internal protein amino acid acetylation,BP,
972,GO:0006476,1,0.734627459219659,0,1,protein deacetylation,BP,
978,GO:0006498,1,0.734621422421857,0,1,N-terminal protein lipidation,BP,
979,GO:0006499,1,0.734621422421857,0,1,N-terminal protein myristoylation,BP,
980,GO:0006501,1,0.734550021650832,0,1,C-terminal protein lipidation,BP,
988,GO:0006536,1,0.733899513955252,0,1,glutamate metabolic process,BP,
989,GO:0006537,1,0.733899513955252,0,1,glutamate biosynthetic process,BP,
995,GO:0006558,1,0.629717088917049,0,1,L-phenylalanine metabolic process,BP,
996,GO:0006559,1,0.629717088917049,0,1,L-phenylalanine catabolic process,BP,
997,GO:0006573,1,0.734588622258976,0,1,valine metabolic process,BP,
999,GO:0006576,1,0.731018562409083,0,1,cellular biogenic amine metabolic process,BP,
1001,GO:0006582,1,0.734655294999483,0,1,melanin metabolic process,BP,
1003,GO:0006600,1,0.734588622258976,0,1,creatine metabolic process,BP,
1006,GO:0006611,1,0.432310550574597,0,2,protein export from nucleus,BP,
1007,GO:0006612,1,0.509332234722859,0,2,protein targeting to membrane,BP,
1012,GO:0006636,1,0.337920429020916,0,3,unsaturated fatty acid biosynthetic process,BP,
1020,GO:0006651,1,0.62828243039627,0,1,diacylglycerol biosynthetic process,BP,
1021,GO:0006656,1,0.634405611216108,0,1,phosphatidylcholine biosynthetic process,BP,
1026,GO:0006665,1,0.22600378437517,0,4,sphingolipid metabolic process,BP,
1027,GO:0006672,1,0.22600378437517,0,4,ceramide metabolic process,BP,
1028,GO:0006677,1,0.651434792770337,0,1,glycosylceramide metabolic process,BP,
1029,GO:0006687,1,0.32320134274642,0,3,glycosphingolipid metabolic process,BP,
1030,GO:0006689,1,0.677828420297706,0,1,ganglioside catabolic process,BP,
1031,GO:0006690,1,0.137365523454399,0,5,icosanoid metabolic process,BP,
1032,GO:0006691,1,0.61919681818651,0,1,leukotriene metabolic process,BP,
1033,GO:0006692,1,0.461029926266115,0,2,prostanoid metabolic process,BP,
1034,GO:0006693,1,0.461029926266115,0,2,prostaglandin metabolic process,BP,
1037,GO:0006699,1,0.71444051523567,0,1,bile acid biosynthetic process,BP,
1039,GO:0006702,1,0.209760440278885,0,4,androgen biosynthetic process,BP,
1040,GO:0006703,1,0.482422568195029,0,2,estrogen biosynthetic process,BP,
1041,GO:0006704,1,0.171567694644783,0,5,glucocorticoid biosynthetic process,BP,
1043,GO:0006706,1,0.67605262318362,0,1,steroid catabolic process,BP,
1044,GO:0006710,1,0.67605262318362,0,1,androgen catabolic process,BP,
1052,GO:0006735,1,0.734590273582109,0,1,NADH regeneration,BP,
1053,GO:0006738,1,0.703491083600584,0,1,nicotinamide riboside catabolic process,BP,
1054,GO:0006739,1,0.342082967624098,0,3,NADP metabolic process,BP,
1055,GO:0006740,1,0.69967224305375,0,1,NADPH regeneration,BP,
1056,GO:0006749,1,0.432588611841924,0,2,glutathione metabolic process,BP,
1057,GO:0006750,1,0.61919681818651,0,1,glutathione biosynthetic process,BP,
1061,GO:0006767,1,0.104071356190009,0,6,water-soluble vitamin metabolic process,BP,
1062,GO:0006771,1,0.466053539039796,0,2,riboflavin metabolic process,BP,
1064,GO:0006778,1,0.723051447612026,0,1,porphyrin-containing compound metabolic process,BP,
1069,GO:0006805,1,0.323746084995579,0,3,xenobiotic metabolic process,BP,
1071,GO:0006809,1,0.155059743150086,0,5,nitric oxide biosynthetic process,BP,
1078,GO:0006818,1,0.62028039706305,0,1,hydrogen transport,BP,
1081,GO:0006825,1,0.670477648906454,0,1,copper ion transport,BP,
1082,GO:0006826,1,0.355199226720804,0,3,iron ion transport,BP,
1083,GO:0006835,1,0.528252082230585,0,2,dicarboxylic acid transport,BP,
1086,GO:0006853,1,0.727254309212684,0,1,carnitine shuttle,BP,
1087,GO:0006855,1,0.637466954542453,0,1,drug transmembrane transport,BP,
1088,GO:0006862,1,0.662515033806693,0,1,nucleotide transport,BP,
1089,GO:0006865,1,0.528252082230585,0,2,amino acid transport,BP,
1094,GO:0006878,1,0.49194105018732,0,2,cellular copper ion homeostasis,BP,
1101,GO:0006891,1,0.726840642387705,0,1,intra-Golgi vesicle-mediated transport,BP,
1107,GO:0006907,1,0.624051270746175,0,1,pinocytosis,BP,
1109,GO:0006910,1,0.67801637721819,0,1,phagocytosis, recognition,BP,
1110,GO:0006911,1,0.67801637721819,0,1,phagocytosis, engulfment,BP,
1121,GO:0006940,1,0.244507440122623,0,4,regulation of smooth muscle contraction,BP,
1128,GO:0006956,1,0.713203645219262,0,1,complement activation,BP,
1129,GO:0006957,1,0.713203645219262,0,1,complement activation, alternative pathway,BP,
1131,GO:0006970,1,0.73224972901803,0,1,response to osmotic stress,BP,
1132,GO:0006972,1,0.73224972901803,0,1,hyperosmotic response,BP,
1135,GO:0006977,1,0.448535957280229,0,2,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
1136,GO:0006978,1,0.693238114134537,0,1,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
1147,GO:0007020,1,0.673243059840652,0,1,microtubule nucleation,BP,
1148,GO:0007029,1,0.734254180896456,0,1,endoplasmic reticulum organization,BP,
1151,GO:0007032,1,0.719239884495386,0,1,endosome organization,BP,
1161,GO:0007051,1,0.668902320485507,0,1,spindle organization,BP,
1162,GO:0007052,1,0.668902320485507,0,1,mitotic spindle organization,BP,
1163,GO:0007059,1,0.668902320485507,0,1,chromosome segregation,BP,
1165,GO:0007080,1,0.668902320485507,0,1,mitotic metaphase plate congression,BP,
1168,GO:0007095,1,0.730352294167363,0,1,mitotic G2 DNA damage checkpoint,BP,
1169,GO:0007098,1,0.470347636274046,0,2,centrosome cycle,BP,
1170,GO:0007126,1,0.272807244947581,0,4,meiotic nuclear division,BP,
1171,GO:0007140,1,0.692403339974325,0,1,male meiosis,BP,
1175,GO:0007157,1,0.539124049474056,0,2,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
1184,GO:0007168,1,0.438973466284748,0,2,receptor guanylyl cyclase signaling pathway,BP,
1187,GO:0007176,1,0.356717845346648,0,3,regulation of epidermal growth factor-activated receptor activity,BP,
1189,GO:0007179,1,0.0667522846646303,0,8,transforming growth factor beta receptor signaling pathway,BP,
1193,GO:0007187,1,0.178143935897464,0,5,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
1194,GO:0007188,1,0.178143935897464,0,5,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
1195,GO:0007189,1,0.339090043736765,0,3,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
1196,GO:0007193,1,0.720481830454823,0,1,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
1197,GO:0007200,1,0.344975858383494,0,3,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
1198,GO:0007202,1,0.421192418256224,0,2,activation of phospholipase C activity,BP,
1200,GO:0007205,1,0.687857981162908,0,1,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
1201,GO:0007215,1,0.734629361512883,0,1,glutamate receptor signaling pathway,BP,
1205,GO:0007223,1,0.734655294999483,0,1,Wnt signaling pathway, calcium modulating pathway,BP,
1207,GO:0007229,1,0.0532509430785249,0,9,integrin-mediated signaling pathway,BP,
1209,GO:0007252,1,0.721277899526339,0,1,I-kappaB phosphorylation,BP,
1213,GO:0007260,1,0.361362200801133,0,3,tyrosine phosphorylation of STAT protein,BP,
1217,GO:0007266,1,0.34782563024186,0,3,Rho protein signal transduction,BP,
1227,GO:0007286,1,0.497813076500956,0,2,spermatid development,BP,
1229,GO:0007338,1,0.221935660014162,0,4,single fertilization,BP,
1230,GO:0007341,1,0.677828420297706,0,1,penetration of zona pellucida,BP,
1231,GO:0007342,1,0.698707300486311,0,1,fusion of sperm to egg plasma membrane,BP,
1233,GO:0007350,1,0.532265997600139,0,2,blastoderm segmentation,BP,
1234,GO:0007351,1,0.532265997600139,0,2,tripartite regional subdivision,BP,
1235,GO:0007354,1,0.725196311092909,0,1,zygotic determination of anterior/posterior axis, embryo,BP,
1236,GO:0007356,1,0.725196311092909,0,1,thorax and anterior abdomen determination,BP,
1239,GO:0007379,1,0.731051540942314,0,1,segment specification,BP,
1255,GO:0007442,1,0.734655294999483,0,1,hindgut morphogenesis,BP,
1257,GO:0007494,1,0.734655294999483,0,1,midgut development,BP,
1263,GO:0007530,1,0.360524626850592,0,3,sex determination,BP,
1266,GO:0007566,1,0.538946238360689,0,2,embryo implantation,BP,
1267,GO:0007567,1,0.687857981162908,0,1,parturition,BP,
1273,GO:0007588,1,0.236909676179025,0,4,excretion,BP,
1277,GO:0007598,1,0.708829925476856,0,1,blood coagulation, extrinsic pathway,BP,
1281,GO:0007602,1,0.481811177764048,0,2,phototransduction,BP,
1282,GO:0007603,1,0.734621422421857,0,1,phototransduction, visible light,BP,
1284,GO:0007606,1,0.717192339181394,0,1,sensory perception of chemical stimulus,BP,
1285,GO:0007608,1,0.717192339181394,0,1,sensory perception of smell,BP,
1287,GO:0007611,1,0.117584052387991,0,6,learning or memory,BP,
1288,GO:0007612,1,0.491686164160946,0,2,learning,BP,
1289,GO:0007613,1,0.342205527316592,0,3,memory,BP,
1290,GO:0007617,1,0.677828420297706,0,1,mating behavior,BP,
1291,GO:0007618,1,0.677828420297706,0,1,mating,BP,
1292,GO:0007619,1,0.677828420297706,0,1,courtship behavior,BP,
1293,GO:0007622,1,0.514210881806709,0,2,rhythmic behavior,BP,
1294,GO:0007623,1,0.514210881806709,0,2,circadian rhythm,BP,
1297,GO:0007631,1,0.720739389914957,0,1,feeding behavior,BP,
1298,GO:0007638,1,0.528441378382452,0,2,mechanosensory behavior,BP,
1303,GO:0008017,1,0.18540912253014,0,5,microtubule binding,MF,
1307,GO:0008037,1,0.36477827482678,0,3,cell recognition,BP,
1310,GO:0008049,1,0.677828420297706,0,1,male courtship behavior,BP,
1312,GO:0008065,1,0.73224972901803,0,1,establishment of blood-nerve barrier,BP,
1313,GO:0008066,1,0.734629361512883,0,1,glutamate receptor activity,MF,
1317,GO:0008081,1,0.528745652561692,0,2,phosphoric diester hydrolase activity,MF,
1323,GO:0008108,1,0.647073695085383,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
1324,GO:0008112,1,0.659829811851762,0,1,nicotinamide N-methyltransferase activity,MF,
1326,GO:0008124,1,0.629717088917049,0,1,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
1330,GO:0008144,1,0.516340151655059,0,2,drug binding,MF,
1338,GO:0008198,1,0.314339479712854,0,3,ferrous iron binding,MF,
1339,GO:0008199,1,0.474212140576256,0,2,ferric iron binding,MF,
1344,GO:0008206,1,0.71444051523567,0,1,bile acid metabolic process,BP,
1346,GO:0008209,1,0.141039504984883,0,5,androgen metabolic process,BP,
1347,GO:0008210,1,0.482422568195029,0,2,estrogen metabolic process,BP,
1348,GO:0008211,1,0.121900424663148,0,6,glucocorticoid metabolic process,BP,
1353,GO:0008227,1,0.496169850027802,0,2,G-protein coupled amine receptor activity,MF,
1355,GO:0008234,1,0.402924638225269,0,2,cysteine-type peptidase activity,MF,
1361,GO:0008277,1,0.123888485311452,0,6,regulation of G-protein coupled receptor protein signaling pathway,BP,
1367,GO:0008299,1,0.703143825629313,0,1,isoprenoid biosynthetic process,BP,
1368,GO:0008305,1,0.211214773844819,0,5,integrin complex,CC,
1372,GO:0008333,1,0.354181134822617,0,3,endosome to lysosome transport,BP,
1374,GO:0008347,1,0.677828420297706,0,1,glial cell migration,BP,
1375,GO:0008360,1,0.103536045816818,0,6,regulation of cell shape,BP,
1379,GO:0008375,1,0.355932041309264,0,3,acetylglucosaminyltransferase activity,MF,
1380,GO:0008378,1,0.717192339181394,0,1,galactosyltransferase activity,MF,
1382,GO:0008385,1,0.624051270746175,0,1,IkappaB kinase complex,CC,
1383,GO:0008386,1,0.68122511725375,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
1384,GO:0008395,1,0.459783300800874,0,2,steroid hydroxylase activity,MF,
1386,GO:0008429,1,0.67801637721819,0,1,phosphatidylethanolamine binding,MF,
1388,GO:0008443,1,0.734590273582109,0,1,phosphofructokinase activity,MF,
1390,GO:0008480,1,0.731018562409083,0,1,sarcosine dehydrogenase activity,MF,
1391,GO:0008499,1,0.717192339181394,0,1,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
1392,GO:0008506,1,0.731839027449961,0,1,sucrose:proton symporter activity,MF,
1393,GO:0008509,1,0.302668000611213,0,3,anion transmembrane transporter activity,MF,
1394,GO:0008514,1,0.733899513955252,0,1,organic anion transmembrane transporter activity,MF,
1395,GO:0008515,1,0.731839027449961,0,1,sucrose transmembrane transporter activity,MF,
1396,GO:0008528,1,0.734579420052926,0,1,G-protein coupled peptide receptor activity,MF,
1397,GO:0008532,1,0.717192339181394,0,1,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
1403,GO:0008589,1,0.44789907331357,0,2,regulation of smoothened signaling pathway,BP,
1405,GO:0008595,1,0.532265997600139,0,2,anterior/posterior axis specification, embryo,BP,
1406,GO:0008603,1,0.707766673908358,0,1,cAMP-dependent protein kinase regulator activity,MF,
1409,GO:0008630,1,0.316595178482019,0,3,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
1410,GO:0008631,1,0.467772416492944,0,2,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
1414,GO:0008652,1,0.533454285322874,0,2,cellular amino acid biosynthetic process,BP,
1416,GO:0008656,1,0.624051270746175,0,1,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
1418,GO:0008709,1,0.6269280304009,0,1,cholate 7-alpha-dehydrogenase activity,MF,
1421,GO:0009052,1,0.734423653901122,0,1,pentose-phosphate shunt, non-oxidative branch,BP,
1430,GO:0009064,1,0.733899513955252,0,1,glutamine family amino acid metabolic process,BP,
1432,GO:0009067,1,0.727559953538537,0,1,aspartate family amino acid biosynthetic process,BP,
1435,GO:0009072,1,0.629717088917049,0,1,aromatic amino acid family metabolic process,BP,
1436,GO:0009074,1,0.629717088917049,0,1,aromatic amino acid family catabolic process,BP,
1439,GO:0009084,1,0.733899513955252,0,1,glutamine family amino acid biosynthetic process,BP,
1440,GO:0009086,1,0.727559953538537,0,1,methionine biosynthetic process,BP,
1446,GO:0009112,1,0.734619092483416,0,1,nucleobase metabolic process,BP,
1447,GO:0009115,1,0.734619092483416,0,1,xanthine catabolic process,BP,
1448,GO:0009116,1,0.344042349141004,0,3,nucleoside metabolic process,BP,
1450,GO:0009119,1,0.516257181557568,0,2,ribonucleoside metabolic process,BP,
1451,GO:0009120,1,0.668032632215708,0,1,deoxyribonucleoside metabolic process,BP,
1462,GO:0009164,1,0.469357779951687,0,2,nucleoside catabolic process,BP,
1472,GO:0009214,1,0.734583504697188,0,1,cyclic nucleotide catabolic process,BP,
1473,GO:0009225,1,0.647073695085383,0,1,nucleotide-sugar metabolic process,BP,
1474,GO:0009227,1,0.647073695085383,0,1,nucleotide-sugar catabolic process,BP,
1475,GO:0009237,1,0.723051447612026,0,1,siderophore metabolic process,BP,
1477,GO:0009250,1,0.721277899526339,0,1,glucan biosynthetic process,BP,
1481,GO:0009262,1,0.668032632215708,0,1,deoxyribonucleotide metabolic process,BP,
1482,GO:0009264,1,0.668032632215708,0,1,deoxyribonucleotide catabolic process,BP,
1486,GO:0009303,1,0.62828243039627,0,1,rRNA transcription,BP,
1489,GO:0009310,1,0.731018562409083,0,1,amine catabolic process,BP,
1490,GO:0009311,1,0.304657085131264,0,3,oligosaccharide metabolic process,BP,
1491,GO:0009313,1,0.677828420297706,0,1,oligosaccharide catabolic process,BP,
1493,GO:0009395,1,0.420839809132828,0,2,phospholipid catabolic process,BP,
1494,GO:0009404,1,0.71444051523567,0,1,toxin metabolic process,BP,
1495,GO:0009408,1,0.352281714549303,0,3,response to heat,BP,
1497,GO:0009410,1,0.323746084995579,0,3,response to xenobiotic stimulus,BP,
1498,GO:0009411,1,0.366194616945818,0,3,response to UV,BP,
1499,GO:0009416,1,0.12795698786957,0,6,response to light stimulus,BP,
1500,GO:0009435,1,0.463579231864392,0,2,NAD biosynthetic process,BP,
1502,GO:0009448,1,0.733899513955252,0,1,gamma-aminobutyric acid metabolic process,BP,
1503,GO:0009449,1,0.733899513955252,0,1,gamma-aminobutyric acid biosynthetic process,BP,
1506,GO:0009581,1,0.346369053543677,0,3,detection of external stimulus,BP,
1507,GO:0009582,1,0.346369053543677,0,3,detection of abiotic stimulus,BP,
1508,GO:0009583,1,0.481811177764048,0,2,detection of light stimulus,BP,
1509,GO:0009584,1,0.734621422421857,0,1,detection of visible light,BP,
1517,GO:0009620,1,0.685061814505026,0,1,response to fungus,BP,
1519,GO:0009635,1,0.71444051523567,0,1,response to herbicide,BP,
1521,GO:0009651,1,0.73224972901803,0,1,response to salt stress,BP,
1530,GO:0009744,1,0.703675733824822,0,1,response to sucrose,BP,
1533,GO:0009750,1,0.703675733824822,0,1,response to fructose,BP,
1542,GO:0009886,1,0.734698187201066,0,1,post-embryonic animal morphogenesis,BP,
1558,GO:0009918,1,0.71385568806396,0,1,sterol delta7 reductase activity,MF,
1559,GO:0009922,1,0.730712451364202,0,1,fatty acid elongase activity,MF,
1560,GO:0009925,1,0.719222945349914,0,1,basal plasma membrane,CC,
1561,GO:0009946,1,0.610551717868249,0,1,proximal/distal axis specification,BP,
1566,GO:0009954,1,0.44573081598856,0,2,proximal/distal pattern formation,BP,
1574,GO:0009988,1,0.734550444064761,0,1,cell-cell recognition,BP,
1585,GO:0010043,1,0.703675733824822,0,1,response to zinc ion,BP,
1588,GO:0010165,1,0.693238114134537,0,1,response to X-ray,BP,
1590,GO:0010193,1,0.687857981162908,0,1,response to ozone,BP,
1592,GO:0010224,1,0.693238114134537,0,1,response to UV-B,BP,
1596,GO:0010259,1,0.687857981162908,0,1,multicellular organism aging,BP,
1597,GO:0010288,1,0.522631458592721,0,2,response to lead ion,BP,
1598,GO:0010324,1,0.497540454624916,0,2,membrane invagination,BP,
1600,GO:0010385,1,0.725196311092909,0,1,double-stranded methylated DNA binding,MF,
1605,GO:0010460,1,0.687857981162908,0,1,positive regulation of heart rate,BP,
1608,GO:0010466,1,0.100968301771564,0,6,negative regulation of peptidase activity,BP,
1611,GO:0010469,1,0.131187900122125,0,6,regulation of receptor activity,BP,
1616,GO:0010508,1,0.126009182760889,0,6,positive regulation of autophagy,BP,
1617,GO:0010510,1,0.734076412283897,0,1,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
1618,GO:0010511,1,0.721696904193942,0,1,regulation of phosphatidylinositol biosynthetic process,BP,
1619,GO:0010512,1,0.721696904193942,0,1,negative regulation of phosphatidylinositol biosynthetic process,BP,
1620,GO:0010517,1,0.421192418256224,0,2,regulation of phospholipase activity,BP,
1621,GO:0010518,1,0.421192418256224,0,2,positive regulation of phospholipase activity,BP,
1622,GO:0010522,1,0.715718629020694,0,1,regulation of calcium ion transport into cytosol,BP,
1623,GO:0010523,1,0.715718629020694,0,1,negative regulation of calcium ion transport into cytosol,BP,
1624,GO:0010543,1,0.721696904193942,0,1,regulation of platelet activation,BP,
1625,GO:0010544,1,0.721696904193942,0,1,negative regulation of platelet activation,BP,
1629,GO:0010559,1,0.700866560072831,0,1,regulation of glycoprotein biosynthetic process,BP,
1630,GO:0010561,1,0.700866560072831,0,1,negative regulation of glycoprotein biosynthetic process,BP,
1643,GO:0010611,1,0.687857981162908,0,1,regulation of cardiac muscle hypertrophy,BP,
1644,GO:0010613,1,0.687857981162908,0,1,positive regulation of cardiac muscle hypertrophy,BP,
1645,GO:0010623,1,0.734638208028596,0,1,programmed cell death involved in cell development,BP,
1654,GO:0010640,1,0.721696904193942,0,1,regulation of platelet-derived growth factor receptor signaling pathway,BP,
1655,GO:0010642,1,0.721696904193942,0,1,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
1656,GO:0010644,1,0.715718629020694,0,1,cell communication by electrical coupling,BP,
1660,GO:0010649,1,0.715718629020694,0,1,regulation of cell communication by electrical coupling,BP,
1664,GO:0010659,1,0.649356158897709,0,1,cardiac muscle cell apoptotic process,BP,
1668,GO:0010665,1,0.649356158897709,0,1,regulation of cardiac muscle cell apoptotic process,BP,
1669,GO:0010667,1,0.649356158897709,0,1,negative regulation of cardiac muscle cell apoptotic process,BP,
1675,GO:0010700,1,0.496169850027802,0,2,negative regulation of norepinephrine secretion,BP,
1678,GO:0010715,1,0.734417317850469,0,1,regulation of extracellular matrix disassembly,BP,
1683,GO:0010724,1,0.730064105565976,0,1,regulation of definitive erythrocyte differentiation,BP,
1687,GO:0010746,1,0.721277899526339,0,1,regulation of plasma membrane long-chain fatty acid transport,BP,
1688,GO:0010748,1,0.721277899526339,0,1,negative regulation of plasma membrane long-chain fatty acid transport,BP,
1689,GO:0010761,1,0.37597602639793,0,3,fibroblast migration,BP,
1690,GO:0010762,1,0.37597602639793,0,3,regulation of fibroblast migration,BP,
1691,GO:0010763,1,0.721277899526339,0,1,positive regulation of fibroblast migration,BP,
1692,GO:0010765,1,0.436433355371903,0,2,positive regulation of sodium ion transport,BP,
1699,GO:0010803,1,0.186065133957563,0,4,regulation of tumor necrosis factor-mediated signaling pathway,BP,
1700,GO:0010804,1,0.458925695168661,0,2,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
1702,GO:0010811,1,0.28061255073142,0,4,positive regulation of cell-substrate adhesion,BP,
1706,GO:0010819,1,0.734655294999483,0,1,regulation of T cell chemotaxis,BP,
1707,GO:0010820,1,0.734655294999483,0,1,positive regulation of T cell chemotaxis,BP,
1710,GO:0010823,1,0.467772416492944,0,2,negative regulation of mitochondrion organization,BP,
1711,GO:0010824,1,0.726840642387705,0,1,regulation of centrosome duplication,BP,
1712,GO:0010827,1,0.208071299217913,0,5,regulation of glucose transport,BP,
1713,GO:0010828,1,0.208071299217913,0,5,positive regulation of glucose transport,BP,
1717,GO:0010838,1,0.610551717868249,0,1,positive regulation of keratinocyte proliferation,BP,
1719,GO:0010861,1,0.734598335802591,0,1,thyroid hormone receptor activator activity,MF,
1721,GO:0010863,1,0.421192418256224,0,2,positive regulation of phospholipase C activity,BP,
1722,GO:0010866,1,0.678874584138857,0,1,regulation of triglyceride biosynthetic process,BP,
1723,GO:0010867,1,0.678874584138857,0,1,positive regulation of triglyceride biosynthetic process,BP,
1724,GO:0010869,1,0.687857981162908,0,1,regulation of receptor biosynthetic process,BP,
1725,GO:0010870,1,0.687857981162908,0,1,positive regulation of receptor biosynthetic process,BP,
1727,GO:0010873,1,0.602424533559327,0,1,positive regulation of cholesterol esterification,BP,
1732,GO:0010880,1,0.715718629020694,0,1,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1733,GO:0010881,1,0.715718629020694,0,1,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
1734,GO:0010882,1,0.715718629020694,0,1,regulation of cardiac muscle contraction by calcium ion signaling,BP,
1740,GO:0010894,1,0.382643336970993,0,3,negative regulation of steroid biosynthetic process,BP,
1743,GO:0010899,1,0.602424533559327,0,1,regulation of phosphatidylcholine catabolic process,BP,
1744,GO:0010900,1,0.602424533559327,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
1747,GO:0010915,1,0.602424533559327,0,1,regulation of very-low-density lipoprotein particle clearance,BP,
1748,GO:0010916,1,0.602424533559327,0,1,negative regulation of very-low-density lipoprotein particle clearance,BP,
1750,GO:0010921,1,0.348364432976908,0,3,regulation of phosphatase activity,BP,
1751,GO:0010922,1,0.493926177843733,0,2,positive regulation of phosphatase activity,BP,
1752,GO:0010923,1,0.479304515192597,0,2,negative regulation of phosphatase activity,BP,
1753,GO:0010927,1,0.193227942111239,0,5,cellular component assembly involved in morphogenesis,BP,
1754,GO:0010934,1,0.519378522294472,0,2,macrophage cytokine production,BP,
1755,GO:0010935,1,0.734655294999483,0,1,regulation of macrophage cytokine production,BP,
1761,GO:0010951,1,0.100968301771564,0,6,negative regulation of endopeptidase activity,BP,
1763,GO:0010955,1,0.649356158897709,0,1,negative regulation of protein processing,BP,
1765,GO:0010962,1,0.721277899526339,0,1,regulation of glucan biosynthetic process,BP,
1772,GO:0010984,1,0.602424533559327,0,1,regulation of lipoprotein particle clearance,BP,
1773,GO:0010985,1,0.602424533559327,0,1,negative regulation of lipoprotein particle clearance,BP,
1774,GO:0010996,1,0.528441378382452,0,2,response to auditory stimulus,BP,
1778,GO:0014002,1,0.532835825612824,0,2,astrocyte development,BP,
1779,GO:0014004,1,0.729549678474768,0,1,microglia differentiation,BP,
1780,GO:0014005,1,0.729549678474768,0,1,microglia development,BP,
1793,GO:0014047,1,0.528252082230585,0,2,glutamate secretion,BP,
1794,GO:0014048,1,0.720481830454823,0,1,regulation of glutamate secretion,BP,
1795,GO:0014050,1,0.720481830454823,0,1,negative regulation of glutamate secretion,BP,
1797,GO:0014060,1,0.496169850027802,0,2,regulation of epinephrine secretion,BP,
1798,GO:0014061,1,0.496169850027802,0,2,regulation of norepinephrine secretion,BP,
1801,GO:0014068,1,0.529412641866191,0,2,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
1806,GO:0014701,1,0.715718629020694,0,1,junctional sarcoplasmic reticulum membrane,CC,
1807,GO:0014704,1,0.5391591945421,0,2,intercalated disc,CC,
1814,GO:0014735,1,0.649356158897709,0,1,regulation of muscle atrophy,BP,
1815,GO:0014736,1,0.649356158897709,0,1,negative regulation of muscle atrophy,BP,
1816,GO:0014742,1,0.687857981162908,0,1,positive regulation of muscle hypertrophy,BP,
1817,GO:0014743,1,0.687857981162908,0,1,regulation of muscle hypertrophy,BP,
1818,GO:0014745,1,0.649356158897709,0,1,negative regulation of muscle adaptation,BP,
1820,GO:0014808,1,0.46415575177156,0,2,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
1821,GO:0014812,1,0.272589794976917,0,4,muscle cell migration,BP,
1823,GO:0014820,1,0.687857981162908,0,1,tonic smooth muscle contraction,BP,
1826,GO:0014824,1,0.687857981162908,0,1,artery smooth muscle contraction,BP,
1827,GO:0014826,1,0.687857981162908,0,1,vein smooth muscle contraction,BP,
1828,GO:0014829,1,0.453451709228299,0,2,vascular smooth muscle contraction,BP,
1833,GO:0014866,1,0.734688491282273,0,1,skeletal myofibril assembly,BP,
1836,GO:0014876,1,0.649356158897709,0,1,response to injury involved in regulation of muscle adaptation,BP,
1843,GO:0014896,1,0.687857981162908,0,1,muscle hypertrophy,BP,
1844,GO:0014897,1,0.687857981162908,0,1,striated muscle hypertrophy,BP,
1846,GO:0014909,1,0.272589794976917,0,4,smooth muscle cell migration,BP,
1847,GO:0014910,1,0.372245592805306,0,3,regulation of smooth muscle cell migration,BP,
1848,GO:0014911,1,0.526581145142827,0,2,positive regulation of smooth muscle cell migration,BP,
1849,GO:0015002,1,0.62028039706305,0,1,heme-copper terminal oxidase activity,MF,
1850,GO:0015012,1,0.734563521305442,0,1,heparan sulfate proteoglycan biosynthetic process,BP,
1852,GO:0015065,1,0.710841574163711,0,1,uridine nucleotide receptor activity,MF,
1855,GO:0015078,1,0.62028039706305,0,1,hydrogen ion transmembrane transporter activity,MF,
1857,GO:0015081,1,0.733899513955252,0,1,sodium ion transmembrane transporter activity,MF,
1858,GO:0015085,1,0.707679132473116,0,1,calcium ion transmembrane transporter activity,MF,
1859,GO:0015091,1,0.719222945349914,0,1,ferric iron transmembrane transporter activity,MF,
1860,GO:0015095,1,0.655347613928356,0,1,magnesium ion transmembrane transporter activity,MF,
1861,GO:0015103,1,0.413435230092464,0,2,inorganic anion transmembrane transporter activity,MF,
1862,GO:0015108,1,0.413435230092464,0,2,chloride transmembrane transporter activity,MF,
1866,GO:0015154,1,0.731839027449961,0,1,disaccharide transmembrane transporter activity,MF,
1867,GO:0015157,1,0.731839027449961,0,1,oligosaccharide transmembrane transporter activity,MF,
1868,GO:0015171,1,0.733899513955252,0,1,amino acid transmembrane transporter activity,MF,
1869,GO:0015172,1,0.733899513955252,0,1,acidic amino acid transmembrane transporter activity,MF,
1870,GO:0015179,1,0.733899513955252,0,1,L-amino acid transmembrane transporter activity,MF,
1872,GO:0015232,1,0.733916729266681,0,1,heme transporter activity,MF,
1873,GO:0015238,1,0.637466954542453,0,1,drug transmembrane transporter activity,MF,
1874,GO:0015245,1,0.634405611216108,0,1,fatty acid transporter activity,MF,
1877,GO:0015271,1,0.734607439241621,0,1,outward rectifier potassium channel activity,MF,
1879,GO:0015291,1,0.536599332175526,0,2,secondary active transmembrane transporter activity,MF,
1880,GO:0015293,1,0.536599332175526,0,2,symporter activity,MF,
1881,GO:0015294,1,0.536599332175526,0,2,solute:cation symporter activity,MF,
1882,GO:0015295,1,0.731839027449961,0,1,solute:proton symporter activity,MF,
1883,GO:0015370,1,0.733899513955252,0,1,solute:sodium symporter activity,MF,
1889,GO:0015631,1,0.098962979819126,0,7,tubulin binding,MF,
1890,GO:0015645,1,0.516652164896921,0,2,fatty acid ligase activity,MF,
1892,GO:0015682,1,0.719222945349914,0,1,ferric iron transport,BP,
1893,GO:0015684,1,0.719222945349914,0,1,ferrous iron transport,BP,
1894,GO:0015693,1,0.655347613928356,0,1,magnesium ion transport,BP,
1898,GO:0015718,1,0.166215519579279,0,5,monocarboxylic acid transport,BP,
1899,GO:0015732,1,0.687857981162908,0,1,prostaglandin transport,BP,
1900,GO:0015740,1,0.733899513955252,0,1,C4-dicarboxylate transport,BP,
1904,GO:0015766,1,0.731839027449961,0,1,disaccharide transport,BP,
1905,GO:0015770,1,0.731839027449961,0,1,sucrose transport,BP,
1906,GO:0015772,1,0.731839027449961,0,1,oligosaccharide transport,BP,
1907,GO:0015800,1,0.733899513955252,0,1,acidic amino acid transport,BP,
1908,GO:0015807,1,0.733899513955252,0,1,L-amino acid transport,BP,
1909,GO:0015810,1,0.733899513955252,0,1,aspartate transport,BP,
1910,GO:0015813,1,0.733899513955252,0,1,L-glutamate transport,BP,
1914,GO:0015849,1,0.0868645229275558,0,7,organic acid transport,BP,
1916,GO:0015858,1,0.720481830454823,0,1,nucleoside transport,BP,
1917,GO:0015865,1,0.662515033806693,0,1,purine nucleotide transport,BP,
1918,GO:0015868,1,0.662515033806693,0,1,purine ribonucleotide transport,BP,
1920,GO:0015874,1,0.496169850027802,0,2,norepinephrine transport,BP,
1921,GO:0015886,1,0.733916729266681,0,1,heme transport,BP,
1922,GO:0015893,1,0.466194412636722,0,2,drug transport,BP,
1923,GO:0015908,1,0.166215519579279,0,5,fatty acid transport,BP,
1924,GO:0015909,1,0.331576830790768,0,3,long-chain fatty acid transport,BP,
1925,GO:0015911,1,0.721277899526339,0,1,plasma membrane long-chain fatty acid transport,BP,
1928,GO:0015925,1,0.651434792770337,0,1,galactosidase activity,MF,
1929,GO:0015929,1,0.677828420297706,0,1,hexosaminidase activity,MF,
1930,GO:0015931,1,0.476747325238848,0,2,nucleobase-containing compound transport,BP,
1935,GO:0015939,1,0.734715871907028,0,1,pantothenate metabolic process,BP,
1937,GO:0015992,1,0.62028039706305,0,1,proton transport,BP,
1943,GO:0016048,1,0.720481830454823,0,1,detection of temperature stimulus,BP,
1951,GO:0016056,1,0.734621422421857,0,1,rhodopsin mediated signaling pathway,BP,
1952,GO:0016064,1,0.67186132548751,0,1,immunoglobulin mediated immune response,BP,
1955,GO:0016072,1,0.460926171262399,0,2,rRNA metabolic process,BP,
1960,GO:0016128,1,0.71385568806396,0,1,phytosteroid metabolic process,BP,
1961,GO:0016129,1,0.71385568806396,0,1,phytosteroid biosynthetic process,BP,
1962,GO:0016131,1,0.71385568806396,0,1,brassinosteroid metabolic process,BP,
1963,GO:0016132,1,0.71385568806396,0,1,brassinosteroid biosynthetic process,BP,
1964,GO:0016137,1,0.651434792770337,0,1,glycoside metabolic process,BP,
1965,GO:0016139,1,0.651434792770337,0,1,glycoside catabolic process,BP,
1966,GO:0016176,1,0.721696904193942,0,1,superoxide-generating NADPH oxidase activator activity,MF,
1970,GO:0016209,1,0.453196885567789,0,2,antioxidant activity,MF,
1971,GO:0016229,1,0.178836488464232,0,4,steroid dehydrogenase activity,MF,
1973,GO:0016239,1,0.350768484562689,0,3,positive regulation of macroautophagy,BP,
1979,GO:0016266,1,0.717192339181394,0,1,O-glycan processing,BP,
1981,GO:0016295,1,0.734715871907028,0,1,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
1982,GO:0016296,1,0.734715871907028,0,1,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
1983,GO:0016297,1,0.734715871907028,0,1,acyl-[acyl-carrier-protein] hydrolase activity,MF,
1990,GO:0016323,1,0.0984705377427965,0,7,basolateral plasma membrane,CC,
1992,GO:0016327,1,0.438805284099111,0,2,apicolateral plasma membrane,CC,
1998,GO:0016339,1,0.539098111745315,0,2,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
2001,GO:0016361,1,0.724071876739581,0,1,activin receptor activity, type I,MF,
2003,GO:0016405,1,0.489143739410573,0,2,CoA-ligase activity,MF,
2008,GO:0016410,1,0.734621422421857,0,1,N-acyltransferase activity,MF,
2011,GO:0016417,1,0.734715871907028,0,1,S-acyltransferase activity,MF,
2012,GO:0016418,1,0.734715871907028,0,1,S-acetyltransferase activity,MF,
2013,GO:0016419,1,0.734715871907028,0,1,S-malonyltransferase activity,MF,
2014,GO:0016420,1,0.734715871907028,0,1,malonyltransferase activity,MF,
2016,GO:0016444,1,0.67186132548751,0,1,somatic cell DNA recombination,BP,
2017,GO:0016445,1,0.67186132548751,0,1,somatic diversification of immunoglobulins,BP,
2018,GO:0016447,1,0.67186132548751,0,1,somatic recombination of immunoglobulin gene segments,BP,
2021,GO:0016459,1,0.395444357296567,0,3,myosin complex,CC,
2022,GO:0016460,1,0.734688491282273,0,1,myosin II complex,CC,
2023,GO:0016461,1,0.734698187201066,0,1,unconventional myosin complex,CC,
2026,GO:0016480,1,0.716018004067463,0,1,negative regulation of transcription from RNA polymerase III promoter,BP,
2030,GO:0016502,1,0.710841574163711,0,1,nucleotide receptor activity,MF,
2031,GO:0016504,1,0.624051270746175,0,1,peptidase activator activity,MF,
2032,GO:0016505,1,0.624051270746175,0,1,peptidase activator activity involved in apoptotic process,MF,
2034,GO:0016528,1,0.293570617473814,0,3,sarcoplasm,CC,
2035,GO:0016529,1,0.46415575177156,0,2,sarcoplasmic reticulum,CC,
2036,GO:0016538,1,0.693238114134537,0,1,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
2039,GO:0016569,1,0.370881010560867,0,3,covalent chromatin modification,BP,
2040,GO:0016570,1,0.539100819986485,0,2,histone modification,BP,
2041,GO:0016573,1,0.734513896772137,0,1,histone acetylation,BP,
2042,GO:0016575,1,0.734627459219659,0,1,histone deacetylation,BP,
2044,GO:0016580,1,0.734627459219659,0,1,Sin3 complex,CC,
2046,GO:0016595,1,0.733899513955252,0,1,glutamate binding,MF,
2052,GO:0016614,1,0.00897922901791993,0,12,oxidoreductase activity, acting on CH-OH group of donors,MF,
2053,GO:0016615,1,0.643589205720551,0,1,malate dehydrogenase activity,MF,
2054,GO:0016616,1,0.018328595264958,0,10,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
2055,GO:0016623,1,0.734619092483416,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
2065,GO:0016675,1,0.62028039706305,0,1,oxidoreductase activity, acting on a heme group of donors,MF,
2066,GO:0016676,1,0.62028039706305,0,1,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
2067,GO:0016684,1,0.453196885567789,0,2,oxidoreductase activity, acting on peroxide as acceptor,MF,
2068,GO:0016705,1,0.139645109064987,0,5,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
2069,GO:0016706,1,0.664661465181863,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
2070,GO:0016713,1,0.68122511725375,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
2071,GO:0016714,1,0.629717088917049,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
2072,GO:0016717,1,0.734591748630676,0,1,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
2074,GO:0016725,1,0.734619092483416,0,1,oxidoreductase activity, acting on CH or CH2 groups,MF,
2075,GO:0016726,1,0.734619092483416,0,1,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
2082,GO:0016763,1,0.703491083600584,0,1,transferase activity, transferring pentosyl groups,MF,
2083,GO:0016765,1,0.61919681818651,0,1,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
2086,GO:0016775,1,0.729209164791576,0,1,phosphotransferase activity, nitrogenous group as acceptor,MF,
2087,GO:0016779,1,0.647073695085383,0,1,nucleotidyltransferase activity,MF,
2092,GO:0016798,1,0.304657085131264,0,3,hydrolase activity, acting on glycosyl bonds,MF,
2094,GO:0016810,1,0.515042757670242,0,2,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
2095,GO:0016811,1,0.515042757670242,0,2,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
2101,GO:0016832,1,0.450853592533708,0,2,aldehyde-lyase activity,MF,
2105,GO:0016846,1,0.61919681818651,0,1,carbon-sulfur lyase activity,MF,
2109,GO:0016861,1,0.727559953538537,0,1,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
2113,GO:0016877,1,0.35859671393697,0,3,ligase activity, forming carbon-sulfur bonds,MF,
2114,GO:0016878,1,0.35859671393697,0,3,acid-thiol ligase activity,MF,
2117,GO:0016898,1,0.684719928583765,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
2118,GO:0016903,1,0.734619092483416,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
2120,GO:0016936,1,0.418956879681028,0,2,galactoside binding,MF,
2121,GO:0016941,1,0.734579420052926,0,1,natriuretic peptide receptor activity,MF,
2122,GO:0017002,1,0.724071876739581,0,1,activin-activated receptor activity,MF,
2123,GO:0017015,1,0.357172847313627,0,3,regulation of transforming growth factor beta receptor signaling pathway,BP,
2127,GO:0017024,1,0.624051270746175,0,1,myosin I binding,MF,
2129,GO:0017040,1,0.701812152197462,0,1,ceramidase activity,MF,
2130,GO:0017046,1,0.285436557914071,0,4,peptide hormone binding,MF,
2131,GO:0017048,1,0.734668678059205,0,1,Rho GTPase binding,MF,
2132,GO:0017053,1,0.730064105565976,0,1,transcriptional repressor complex,CC,
2134,GO:0017080,1,0.60595713946183,0,1,sodium channel regulator activity,MF,
2136,GO:0017085,1,0.71444051523567,0,1,response to insecticide,BP,
2138,GO:0017112,1,0.734438716833388,0,1,Rab guanyl-nucleotide exchange factor activity,MF,
2139,GO:0017124,1,0.535054341206471,0,2,SH3 domain binding,MF,
2143,GO:0017143,1,0.71444051523567,0,1,insecticide metabolic process,BP,
2151,GO:0018008,1,0.734621422421857,0,1,N-terminal peptidyl-glycine N-myristoylation,BP,
2158,GO:0018146,1,0.717192339181394,0,1,keratan sulfate biosynthetic process,BP,
2163,GO:0018201,1,0.734621422421857,0,1,peptidyl-glycine modification,BP,
2164,GO:0018205,1,0.734513896772137,0,1,peptidyl-lysine modification,BP,
2171,GO:0018377,1,0.734621422421857,0,1,protein myristoylation,BP,
2172,GO:0018393,1,0.734513896772137,0,1,internal peptidyl-lysine acetylation,BP,
2173,GO:0018394,1,0.734513896772137,0,1,peptidyl-lysine acetylation,BP,
2175,GO:0018410,1,0.734550021650832,0,1,C-terminal protein amino acid modification,BP,
2176,GO:0018879,1,0.71444051523567,0,1,biphenyl metabolic process,BP,
2177,GO:0018894,1,0.71444051523567,0,1,dibenzo-p-dioxin metabolic process,BP,
2180,GO:0018963,1,0.71444051523567,0,1,phthalate metabolic process,BP,
2184,GO:0019062,1,0.707679132473116,0,1,virion attachment to host cell,BP,
2185,GO:0019064,1,0.707679132473116,0,1,fusion of virus membrane with host plasma membrane,BP,
2187,GO:0019098,1,0.677828420297706,0,1,reproductive behavior,BP,
2188,GO:0019107,1,0.734621422421857,0,1,myristoyltransferase activity,MF,
2189,GO:0019166,1,0.676160423272601,0,1,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
2190,GO:0019171,1,0.734715871907028,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
2191,GO:0019184,1,0.447093759887819,0,2,nonribosomal peptide biosynthetic process,BP,
2192,GO:0019199,1,0.389509152272128,0,3,transmembrane receptor protein kinase activity,MF,
2193,GO:0019200,1,0.516387479317128,0,2,carbohydrate kinase activity,MF,
2194,GO:0019203,1,0.734590273582109,0,1,carbohydrate phosphatase activity,MF,
2196,GO:0019208,1,0.728387748399053,0,1,phosphatase regulator activity,MF,
2198,GO:0019210,1,0.490083871081733,0,2,kinase inhibitor activity,MF,
2199,GO:0019211,1,0.728387748399053,0,1,phosphatase activator activity,MF,
2200,GO:0019213,1,0.734627459219659,0,1,deacetylase activity,MF,
2210,GO:0019229,1,0.244779802653984,0,4,regulation of vasoconstriction,BP,
2211,GO:0019233,1,0.335888515411797,0,3,sensory perception of pain,BP,
2212,GO:0019290,1,0.723051447612026,0,1,siderophore biosynthetic process,BP,
2216,GO:0019359,1,0.463579231864392,0,2,nicotinamide nucleotide biosynthetic process,BP,
2218,GO:0019363,1,0.463579231864392,0,2,pyridine nucleotide biosynthetic process,BP,
2219,GO:0019367,1,0.730712451364202,0,1,fatty acid elongation, saturated fatty acid,BP,
2220,GO:0019369,1,0.671129001439236,0,1,arachidonic acid metabolic process,BP,
2221,GO:0019370,1,0.61919681818651,0,1,leukotriene biosynthetic process,BP,
2222,GO:0019371,1,0.671129001439236,0,1,cyclooxygenase pathway,BP,
2223,GO:0019372,1,0.663248360975453,0,1,lipoxygenase pathway,BP,
2224,GO:0019377,1,0.440919064064122,0,2,glycolipid catabolic process,BP,
2225,GO:0019388,1,0.647073695085383,0,1,galactose catabolic process,BP,
2228,GO:0019432,1,0.678874584138857,0,1,triglyceride biosynthetic process,BP,
2233,GO:0019509,1,0.727559953538537,0,1,L-methionine salvage from methylthioadenosine,BP,
2234,GO:0019530,1,0.734588622258976,0,1,taurine metabolic process,BP,
2242,GO:0019682,1,0.344050944113969,0,3,glyceraldehyde-3-phosphate metabolic process,BP,
2243,GO:0019692,1,0.668032632215708,0,1,deoxyribose phosphate metabolic process,BP,
2245,GO:0019694,1,0.734588622258976,0,1,alkanesulfonate metabolic process,BP,
2246,GO:0019695,1,0.731018562409083,0,1,choline metabolic process,BP,
2248,GO:0019724,1,0.67186132548751,0,1,B cell mediated immunity,BP,
2250,GO:0019730,1,0.685061814505026,0,1,antimicrobial humoral response,BP,
2251,GO:0019748,1,0.378383871558962,0,3,secondary metabolic process,BP,
2254,GO:0019825,1,0.675836959389896,0,1,oxygen binding,MF,
2256,GO:0019838,1,0.267116440401242,0,4,growth factor binding,MF,
2260,GO:0019843,1,0.293562182423388,0,3,rRNA binding,MF,
2261,GO:0019852,1,0.42042307613993,0,2,L-ascorbic acid metabolic process,BP,
2262,GO:0019853,1,0.678874584138857,0,1,L-ascorbic acid biosynthetic process,BP,
2268,GO:0019886,1,0.631206911498226,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
2277,GO:0019903,1,0.284310696369325,0,4,protein phosphatase binding,MF,
2280,GO:0019912,1,0.693238114134537,0,1,cyclin-dependent protein kinase activating kinase activity,MF,
2287,GO:0019955,1,0.724071876739581,0,1,cytokine binding,MF,
2298,GO:0021545,1,0.733899513955252,0,1,cranial nerve development,BP,
2302,GO:0021675,1,0.465150992033512,0,2,nerve development,BP,
2303,GO:0021679,1,0.731051540942314,0,1,cerebellar molecular layer development,BP,
2304,GO:0021680,1,0.731051540942314,0,1,cerebellar Purkinje cell layer development,BP,
2308,GO:0021687,1,0.731051540942314,0,1,cerebellar molecular layer morphogenesis,BP,
2309,GO:0021688,1,0.731051540942314,0,1,cerebellar molecular layer formation,BP,
2310,GO:0021692,1,0.731051540942314,0,1,cerebellar Purkinje cell layer morphogenesis,BP,
2311,GO:0021693,1,0.731051540942314,0,1,cerebellar Purkinje cell layer structural organization,BP,
2315,GO:0021698,1,0.731051540942314,0,1,cerebellar cortex structural organization,BP,
2318,GO:0021772,1,0.734655294999483,0,1,olfactory bulb development,BP,
2330,GO:0021885,1,0.734544012449274,0,1,forebrain cell migration,BP,
2331,GO:0021889,1,0.734655294999483,0,1,olfactory bulb interneuron differentiation,BP,
2332,GO:0021891,1,0.734655294999483,0,1,olfactory bulb interneuron development,BP,
2344,GO:0021987,1,0.734589394501328,0,1,cerebral cortex development,BP,
2345,GO:0021988,1,0.734655294999483,0,1,olfactory lobe development,BP,
2351,GO:0022400,1,0.734621422421857,0,1,regulation of rhodopsin mediated signaling pathway,BP,
2359,GO:0022410,1,0.514210881806709,0,2,circadian sleep/wake cycle process,BP,
2370,GO:0022613,1,0.476424303702565,0,2,ribonucleoprotein complex biogenesis,BP,
2371,GO:0022614,1,0.734550444064761,0,1,membrane to membrane docking,BP,
2373,GO:0022618,1,0.649356158897709,0,1,ribonucleoprotein complex assembly,BP,
2376,GO:0022824,1,0.734629361512883,0,1,transmitter-gated ion channel activity,MF,
2380,GO:0022835,1,0.734629361512883,0,1,transmitter-gated channel activity,MF,
2388,GO:0022898,1,0.156948511635248,0,5,regulation of transmembrane transporter activity,BP,
2402,GO:0030016,1,0.0598455203108783,0,8,myofibril,CC,
2403,GO:0030017,1,0.0847084046762614,0,7,sarcomere,CC,
2404,GO:0030018,1,0.132085357958389,0,6,Z disc,CC,
2409,GO:0030032,1,0.669065351404653,0,1,lamellipodium assembly,BP,
2410,GO:0030035,1,0.734598335802591,0,1,microspike assembly,BP,
2412,GO:0030038,1,0.194889289079958,0,5,contractile actin filament bundle assembly,BP,
2415,GO:0030046,1,0.733251487847435,0,1,parallel actin filament bundle assembly,BP,
2420,GO:0030056,1,0.7346518247608,0,1,hemidesmosome,CC,
2422,GO:0030060,1,0.643589205720551,0,1,L-malate dehydrogenase activity,MF,
2423,GO:0030061,1,0.71444051523567,0,1,mitochondrial crista,CC,
2431,GO:0030101,1,0.265882653237108,0,4,natural killer cell activation,BP,
2432,GO:0030104,1,0.379593401532809,0,3,water homeostasis,BP,
2435,GO:0030135,1,0.0664986887038944,0,8,coated vesicle,CC,
2436,GO:0030136,1,0.0967518047744536,0,7,clathrin-coated vesicle,CC,
2440,GO:0030149,1,0.440919064064122,0,2,sphingolipid catabolic process,BP,
2448,GO:0030166,1,0.734563521305442,0,1,proteoglycan biosynthetic process,BP,
2451,GO:0030175,1,0.129282142978115,0,6,filopodium,CC,
2457,GO:0030185,1,0.687857981162908,0,1,nitric oxide transport,BP,
2458,GO:0030193,1,0.256693797637455,0,4,regulation of blood coagulation,BP,
2459,GO:0030195,1,0.350478925022211,0,3,negative regulation of blood coagulation,BP,
2461,GO:0030201,1,0.734563521305442,0,1,heparan sulfate proteoglycan metabolic process,BP,
2462,GO:0030203,1,0.0896217875102354,0,7,glycosaminoglycan metabolic process,BP,
2463,GO:0030204,1,0.469006068069894,0,2,chondroitin sulfate metabolic process,BP,
2464,GO:0030205,1,0.692808616325038,0,1,dermatan sulfate metabolic process,BP,
2465,GO:0030207,1,0.469006068069894,0,2,chondroitin sulfate catabolic process,BP,
2466,GO:0030209,1,0.692808616325038,0,1,dermatan sulfate catabolic process,BP,
2467,GO:0030212,1,0.351666560893934,0,3,hyaluronan metabolic process,BP,
2468,GO:0030213,1,0.721696904193942,0,1,hyaluronan biosynthetic process,BP,
2469,GO:0030214,1,0.677828420297706,0,1,hyaluronan catabolic process,BP,
2473,GO:0030219,1,0.730064105565976,0,1,megakaryocyte differentiation,BP,
2474,GO:0030220,1,0.730064105565976,0,1,platelet formation,BP,
2478,GO:0030235,1,0.721277899526339,0,1,nitric-oxide synthase regulator activity,MF,
2479,GO:0030237,1,0.734501565602613,0,1,female sex determination,BP,
2480,GO:0030238,1,0.679008521833097,0,1,male sex determination,BP,
2481,GO:0030239,1,0.193227942111239,0,5,myofibril assembly,BP,
2482,GO:0030241,1,0.734688491282273,0,1,skeletal muscle myosin thick filament assembly,BP,
2483,GO:0030246,1,0.42749079514975,0,2,carbohydrate binding,MF,
2486,GO:0030274,1,0.521878389168612,0,2,LIM domain binding,MF,
2493,GO:0030283,1,0.6269280304009,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
2494,GO:0030285,1,0.677129625885184,0,1,integral component of synaptic vesicle membrane,CC,
2495,GO:0030291,1,0.490083871081733,0,2,protein serine/threonine kinase inhibitor activity,MF,
2497,GO:0030296,1,0.707679132473116,0,1,protein tyrosine kinase activator activity,MF,
2501,GO:0030309,1,0.717192339181394,0,1,poly-N-acetyllactosamine metabolic process,BP,
2502,GO:0030311,1,0.717192339181394,0,1,poly-N-acetyllactosamine biosynthetic process,BP,
2503,GO:0030314,1,0.715718629020694,0,1,junctional membrane complex,CC,
2505,GO:0030317,1,0.678874584138857,0,1,flagellated sperm motility,BP,
2506,GO:0030318,1,0.527871431639663,0,2,melanocyte differentiation,BP,
2512,GO:0030332,1,0.693238114134537,0,1,cyclin binding,MF,
2516,GO:0030374,1,0.508436491654313,0,2,ligand-dependent nuclear receptor transcription coactivator activity,MF,
2517,GO:0030375,1,0.734598335802591,0,1,thyroid hormone receptor coactivator activity,MF,
2518,GO:0030414,1,0.140812601355857,0,5,peptidase inhibitor activity,MF,
2521,GO:0030426,1,0.46095347559745,0,2,growth cone,CC,
2522,GO:0030427,1,0.46095347559745,0,2,site of polarized growth,CC,
2523,GO:0030431,1,0.514210881806709,0,2,sleep,BP,
2525,GO:0030449,1,0.713203645219262,0,1,regulation of complement activation,BP,
2526,GO:0030485,1,0.660127822057299,0,1,smooth muscle contractile fiber,CC,
2527,GO:0030488,1,0.6269280304009,0,1,tRNA methylation,BP,
2528,GO:0030496,1,0.464959821546432,0,2,midbody,CC,
2529,GO:0030497,1,0.730712451364202,0,1,fatty acid elongation,BP,
2536,GO:0030512,1,0.680024981343857,0,1,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
2545,GO:0030538,1,0.610551717868249,0,1,embryonic genitalia morphogenesis,BP,
2550,GO:0030551,1,0.519392031869568,0,2,cyclic nucleotide binding,MF,
2551,GO:0030552,1,0.519392031869568,0,2,cAMP binding,MF,
2555,GO:0030594,1,0.734629361512883,0,1,neurotransmitter receptor activity,MF,
2561,GO:0030660,1,0.734598124981224,0,1,Golgi-associated vesicle membrane,CC,
2562,GO:0030662,1,0.369184511951133,0,3,coated vesicle membrane,CC,
2563,GO:0030665,1,0.369184511951133,0,3,clathrin-coated vesicle membrane,CC,
2566,GO:0030669,1,0.5143666840257,0,2,clathrin-coated endocytic vesicle membrane,CC,
2569,GO:0030673,1,0.720481830454823,0,1,axolemma,CC,
2570,GO:0030674,1,0.734654319492406,0,1,protein binding, bridging,MF,
2571,GO:0030677,1,0.6269280304009,0,1,ribonuclease P complex,CC,
2572,GO:0030678,1,0.6269280304009,0,1,mitochondrial ribonuclease P complex,CC,
2576,GO:0030760,1,0.659829811851762,0,1,pyridine N-methyltransferase activity,MF,
2577,GO:0030799,1,0.0924004200167207,0,6,regulation of cyclic nucleotide metabolic process,BP,
2578,GO:0030800,1,0.687857981162908,0,1,negative regulation of cyclic nucleotide metabolic process,BP,
2579,GO:0030801,1,0.135233823293461,0,5,positive regulation of cyclic nucleotide metabolic process,BP,
2580,GO:0030802,1,0.18572194535739,0,4,regulation of cyclic nucleotide biosynthetic process,BP,
2581,GO:0030803,1,0.687857981162908,0,1,negative regulation of cyclic nucleotide biosynthetic process,BP,
2582,GO:0030804,1,0.27116363370479,0,3,positive regulation of cyclic nucleotide biosynthetic process,BP,
2583,GO:0030808,1,0.18572194535739,0,4,regulation of nucleotide biosynthetic process,BP,
2584,GO:0030809,1,0.687857981162908,0,1,negative regulation of nucleotide biosynthetic process,BP,
2585,GO:0030810,1,0.27116363370479,0,3,positive regulation of nucleotide biosynthetic process,BP,
2586,GO:0030814,1,0.173082592182906,0,4,regulation of cAMP metabolic process,BP,
2587,GO:0030815,1,0.687857981162908,0,1,negative regulation of cAMP metabolic process,BP,
2588,GO:0030816,1,0.423939370372829,0,2,positive regulation of cAMP metabolic process,BP,
2589,GO:0030817,1,0.425675672414994,0,2,regulation of cAMP biosynthetic process,BP,
2590,GO:0030818,1,0.687857981162908,0,1,negative regulation of cAMP biosynthetic process,BP,
2591,GO:0030819,1,0.619801351202952,0,1,positive regulation of cAMP biosynthetic process,BP,
2592,GO:0030823,1,0.321743668772933,0,3,regulation of cGMP metabolic process,BP,
2593,GO:0030825,1,0.321743668772933,0,3,positive regulation of cGMP metabolic process,BP,
2594,GO:0030826,1,0.438973466284748,0,2,regulation of cGMP biosynthetic process,BP,
2595,GO:0030828,1,0.438973466284748,0,2,positive regulation of cGMP biosynthetic process,BP,
2600,GO:0030836,1,0.734598335802591,0,1,positive regulation of actin filament depolymerization,BP,
2602,GO:0030838,1,0.624051270746175,0,1,positive regulation of actin filament polymerization,BP,
2603,GO:0030849,1,0.734627459219659,0,1,autosome,CC,
2605,GO:0030851,1,0.730064105565976,0,1,granulocyte differentiation,BP,
2610,GO:0030859,1,0.539148185841117,0,2,polarized epithelial cell differentiation,BP,
2613,GO:0030865,1,0.734598124981224,0,1,cortical cytoskeleton organization,BP,
2614,GO:0030866,1,0.734598124981224,0,1,cortical actin cytoskeleton organization,BP,
2615,GO:0030868,1,0.456602885212195,0,2,smooth endoplasmic reticulum membrane,CC,
2619,GO:0030888,1,0.332054355296759,0,3,regulation of B cell proliferation,BP,
2620,GO:0030890,1,0.332054355296759,0,3,positive regulation of B cell proliferation,BP,
2621,GO:0030898,1,0.734698187201066,0,1,actin-dependent ATPase activity,MF,
2625,GO:0030903,1,0.734655294999483,0,1,notochord development,BP,
2631,GO:0030957,1,0.731051540942314,0,1,Tat protein binding,MF,
2633,GO:0030971,1,0.278915684159176,0,4,receptor tyrosine kinase binding,MF,
2635,GO:0031000,1,0.715718629020694,0,1,response to caffeine,BP,
2639,GO:0031023,1,0.470347636274046,0,2,microtubule organizing center organization,BP,
2641,GO:0031033,1,0.734688491282273,0,1,myosin filament organization,BP,
2642,GO:0031034,1,0.734688491282273,0,1,myosin filament assembly,BP,
2646,GO:0031056,1,0.734513896772137,0,1,regulation of histone modification,BP,
2647,GO:0031058,1,0.734513896772137,0,1,positive regulation of histone modification,BP,
2649,GO:0031072,1,0.720481830454823,0,1,heat shock protein binding,MF,
2652,GO:0031091,1,0.260497521579966,0,4,platelet alpha granule,CC,
2653,GO:0031093,1,0.374050558532963,0,3,platelet alpha granule lumen,CC,
2654,GO:0031094,1,0.698707300486311,0,1,platelet dense tubular network,CC,
2658,GO:0031102,1,0.733958464826053,0,1,neuron projection regeneration,BP,
2659,GO:0031103,1,0.733958464826053,0,1,axon regeneration,BP,
2660,GO:0031109,1,0.449704456689423,0,2,microtubule polymerization or depolymerization,BP,
2661,GO:0031110,1,0.668902320485507,0,1,regulation of microtubule polymerization or depolymerization,BP,
2662,GO:0031112,1,0.668902320485507,0,1,positive regulation of microtubule polymerization or depolymerization,BP,
2663,GO:0031113,1,0.668902320485507,0,1,regulation of microtubule polymerization,BP,
2664,GO:0031116,1,0.668902320485507,0,1,positive regulation of microtubule polymerization,BP,
2673,GO:0031177,1,0.734715871907028,0,1,phosphopantetheine binding,MF,
2674,GO:0031201,1,0.716792886639055,0,1,SNARE complex,CC,
2675,GO:0031210,1,0.420257328523098,0,2,phosphatidylcholine binding,MF,
2677,GO:0031223,1,0.528441378382452,0,2,auditory behavior,BP,
2679,GO:0031225,1,0.520150401656977,0,2,anchored component of membrane,CC,
2682,GO:0031232,1,0.719222945349914,0,1,extrinsic component of external side of plasma membrane,CC,
2683,GO:0031234,1,0.518777756422166,0,2,extrinsic component of cytoplasmic side of plasma membrane,CC,
2687,GO:0031254,1,0.734550444064761,0,1,cell trailing edge,CC,
2688,GO:0031256,1,0.528745672981829,0,2,leading edge membrane,CC,
2716,GO:0031348,1,0.345333660682368,0,3,negative regulation of defense response,BP,
2718,GO:0031365,1,0.734621422421857,0,1,N-terminal protein amino acid modification,BP,
2727,GO:0031418,1,0.664661465181863,0,1,L-ascorbic acid binding,MF,
2729,GO:0031432,1,0.734598335802591,0,1,titin binding,MF,
2730,GO:0031434,1,0.706886301239446,0,1,mitogen-activated protein kinase kinase binding,MF,
2731,GO:0031477,1,0.734698187201066,0,1,myosin VII complex,CC,
2734,GO:0031491,1,0.689436588711632,0,1,nucleosome binding,MF,
2735,GO:0031492,1,0.689436588711632,0,1,nucleosomal DNA binding,MF,
2738,GO:0031527,1,0.501493903319643,0,2,filopodium membrane,CC,
2739,GO:0031528,1,0.734550444064761,0,1,microvillus membrane,CC,
2742,GO:0031570,1,0.32683251076091,0,3,DNA integrity checkpoint,BP,
2743,GO:0031571,1,0.448535957280229,0,2,mitotic G1 DNA damage checkpoint,BP,
2744,GO:0031572,1,0.730352294167363,0,1,G2 DNA damage checkpoint,BP,
2745,GO:0031581,1,0.7346518247608,0,1,hemidesmosome assembly,BP,
2746,GO:0031583,1,0.687857981162908,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
2747,GO:0031588,1,0.732887609658439,0,1,nucleotide-activated protein kinase complex,CC,
2752,GO:0031639,1,0.708376329021044,0,1,plasminogen activation,BP,
2753,GO:0031640,1,0.685061814505026,0,1,killing of cells of other organism,BP,
2754,GO:0031641,1,0.721277899526339,0,1,regulation of myelination,BP,
2755,GO:0031644,1,0.335888515411797,0,3,regulation of neurological system process,BP,
2757,GO:0031648,1,0.728387748399053,0,1,protein destabilization,BP,
2758,GO:0031657,1,0.439750907916727,0,2,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2759,GO:0031659,1,0.439750907916727,0,2,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
2767,GO:0031674,1,0.132085357958389,0,6,I band,CC,
2768,GO:0031683,1,0.720481830454823,0,1,G-protein beta/gamma-subunit complex binding,MF,
2769,GO:0031690,1,0.680185229568388,0,1,adrenergic receptor binding,MF,
2770,GO:0031694,1,0.680185229568388,0,1,alpha-2A adrenergic receptor binding,MF,
2771,GO:0031705,1,0.687857981162908,0,1,bombesin receptor binding,MF,
2772,GO:0031707,1,0.687857981162908,0,1,endothelin A receptor binding,MF,
2773,GO:0031708,1,0.687857981162908,0,1,endothelin B receptor binding,MF,
2776,GO:0031779,1,0.619801351202952,0,1,melanocortin receptor binding,MF,
2777,GO:0031780,1,0.619801351202952,0,1,corticotropin hormone receptor binding,MF,
2778,GO:0031781,1,0.619801351202952,0,1,type 3 melanocortin receptor binding,MF,
2779,GO:0031782,1,0.619801351202952,0,1,type 4 melanocortin receptor binding,MF,
2780,GO:0031783,1,0.619801351202952,0,1,type 5 melanocortin receptor binding,MF,
2781,GO:0031849,1,0.734254180896456,0,1,olfactory receptor binding,MF,
2782,GO:0031901,1,0.492913851143979,0,2,early endosome membrane,CC,
2787,GO:0031932,1,0.537641688891737,0,2,TORC2 complex,CC,
2788,GO:0031941,1,0.733251487847435,0,1,filamentous actin,CC,
2789,GO:0031943,1,0.382643336970993,0,3,regulation of glucocorticoid metabolic process,BP,
2790,GO:0031944,1,0.521954174827692,0,2,negative regulation of glucocorticoid metabolic process,BP,
2791,GO:0031945,1,0.734501565602613,0,1,positive regulation of glucocorticoid metabolic process,BP,
2792,GO:0031946,1,0.382643336970993,0,3,regulation of glucocorticoid biosynthetic process,BP,
2793,GO:0031947,1,0.521954174827692,0,2,negative regulation of glucocorticoid biosynthetic process,BP,
2794,GO:0031948,1,0.734501565602613,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
2795,GO:0031952,1,0.721696904193942,0,1,regulation of protein autophosphorylation,BP,
2796,GO:0031954,1,0.721696904193942,0,1,positive regulation of protein autophosphorylation,BP,
2797,GO:0031957,1,0.734629515296733,0,1,very long-chain fatty acid-CoA ligase activity,MF,
2799,GO:0031965,1,0.436096990395202,0,2,nuclear membrane,CC,
2803,GO:0031970,1,0.319558428740241,0,3,organelle envelope lumen,CC,
2808,GO:0031983,1,0.0119205249740166,0,12,vesicle lumen,CC,
2810,GO:0031994,1,0.7346518247608,0,1,insulin-like growth factor I binding,MF,
2811,GO:0031998,1,0.721277899526339,0,1,regulation of fatty acid beta-oxidation,BP,
2812,GO:0031999,1,0.721277899526339,0,1,negative regulation of fatty acid beta-oxidation,BP,
2820,GO:0032042,1,0.732887609658439,0,1,mitochondrial DNA metabolic process,BP,
2822,GO:0032055,1,0.732887609658439,0,1,negative regulation of translation in response to stress,BP,
2823,GO:0032069,1,0.721277899526339,0,1,regulation of nuclease activity,BP,
2824,GO:0032070,1,0.721277899526339,0,1,regulation of deoxyribonuclease activity,BP,
2825,GO:0032071,1,0.721277899526339,0,1,regulation of endodeoxyribonuclease activity,BP,
2826,GO:0032075,1,0.721277899526339,0,1,positive regulation of nuclease activity,BP,
2827,GO:0032077,1,0.721277899526339,0,1,positive regulation of deoxyribonuclease activity,BP,
2828,GO:0032079,1,0.721277899526339,0,1,positive regulation of endodeoxyribonuclease activity,BP,
2830,GO:0032090,1,0.624051270746175,0,1,Pyrin domain binding,MF,
2831,GO:0032091,1,0.365571643434626,0,3,negative regulation of protein binding,BP,
2833,GO:0032094,1,0.721277899526339,0,1,response to food,BP,
2838,GO:0032148,1,0.115057106743656,0,6,activation of protein kinase B activity,BP,
2839,GO:0032153,1,0.701056391605478,0,1,cell division site,CC,
2840,GO:0032154,1,0.701056391605478,0,1,cleavage furrow,CC,
2841,GO:0032155,1,0.701056391605478,0,1,cell division site part,CC,
2842,GO:0032182,1,0.734617631152968,0,1,ubiquitin-like protein binding,MF,
2843,GO:0032190,1,0.698707300486311,0,1,acrosin binding,MF,
2844,GO:0032217,1,0.706886301239446,0,1,riboflavin transporter activity,MF,
2845,GO:0032218,1,0.706886301239446,0,1,riboflavin transport,BP,
2847,GO:0032228,1,0.720481830454823,0,1,regulation of synaptic transmission, GABAergic,BP,
2848,GO:0032229,1,0.720481830454823,0,1,negative regulation of synaptic transmission, GABAergic,BP,
2849,GO:0032231,1,0.267339795763795,0,4,regulation of actin filament bundle assembly,BP,
2850,GO:0032233,1,0.364974984478449,0,3,positive regulation of actin filament bundle assembly,BP,
2851,GO:0032239,1,0.720481830454823,0,1,regulation of nucleobase-containing compound transport,BP,
2852,GO:0032241,1,0.720481830454823,0,1,positive regulation of nucleobase-containing compound transport,BP,
2853,GO:0032242,1,0.720481830454823,0,1,regulation of nucleoside transport,BP,
2854,GO:0032244,1,0.720481830454823,0,1,positive regulation of nucleoside transport,BP,
2857,GO:0032266,1,0.728771581610548,0,1,phosphatidylinositol-3-phosphate binding,MF,
2863,GO:0032273,1,0.416752047450746,0,2,positive regulation of protein polymerization,BP,
2870,GO:0032287,1,0.721277899526339,0,1,peripheral nervous system myelin maintenance,BP,
2872,GO:0032303,1,0.687857981162908,0,1,regulation of icosanoid secretion,BP,
2873,GO:0032305,1,0.687857981162908,0,1,positive regulation of icosanoid secretion,BP,
2874,GO:0032306,1,0.687857981162908,0,1,regulation of prostaglandin secretion,BP,
2875,GO:0032308,1,0.687857981162908,0,1,positive regulation of prostaglandin secretion,BP,
2876,GO:0032309,1,0.687857981162908,0,1,icosanoid secretion,BP,
2877,GO:0032310,1,0.687857981162908,0,1,prostaglandin secretion,BP,
2878,GO:0032311,1,0.62828243039627,0,1,angiogenin-PRI complex,CC,
2885,GO:0032345,1,0.521954174827692,0,2,negative regulation of aldosterone metabolic process,BP,
2888,GO:0032348,1,0.521954174827692,0,2,negative regulation of aldosterone biosynthetic process,BP,
2891,GO:0032351,1,0.521954174827692,0,2,negative regulation of hormone metabolic process,BP,
2893,GO:0032353,1,0.521954174827692,0,2,negative regulation of hormone biosynthetic process,BP,
2901,GO:0032369,1,0.433882651471528,0,2,negative regulation of lipid transport,BP,
2904,GO:0032372,1,0.602424533559327,0,1,negative regulation of sterol transport,BP,
2907,GO:0032375,1,0.602424533559327,0,1,negative regulation of cholesterol transport,BP,
2913,GO:0032400,1,0.487550780068626,0,2,melanosome localization,BP,
2914,GO:0032401,1,0.487550780068626,0,2,establishment of melanosome localization,BP,
2915,GO:0032402,1,0.487550780068626,0,2,melanosome transport,BP,
2917,GO:0032409,1,0.156948511635248,0,5,regulation of transporter activity,BP,
2918,GO:0032410,1,0.525252294946068,0,2,negative regulation of transporter activity,BP,
2919,GO:0032411,1,0.498149804743486,0,2,positive regulation of transporter activity,BP,
2920,GO:0032412,1,0.156948511635248,0,5,regulation of ion transmembrane transporter activity,BP,
2921,GO:0032413,1,0.525252294946068,0,2,negative regulation of ion transmembrane transporter activity,BP,
2922,GO:0032414,1,0.498149804743486,0,2,positive regulation of ion transmembrane transporter activity,BP,
2924,GO:0032420,1,0.394625122759368,0,3,stereocilium,CC,
2925,GO:0032421,1,0.394625122759368,0,3,stereocilium bundle,CC,
2926,GO:0032426,1,0.733251487847435,0,1,stereocilium tip,CC,
2927,GO:0032427,1,0.734598124981224,0,1,GBD domain binding,MF,
2928,GO:0032429,1,0.62828243039627,0,1,regulation of phospholipase A2 activity,BP,
2929,GO:0032430,1,0.62828243039627,0,1,positive regulation of phospholipase A2 activity,BP,
2930,GO:0032431,1,0.62828243039627,0,1,activation of phospholipase A2 activity,BP,
2931,GO:0032433,1,0.683400968465533,0,1,filopodium tip,CC,
2936,GO:0032456,1,0.497992109329539,0,2,endocytic recycling,BP,
2939,GO:0032479,1,0.213103524033804,0,4,regulation of type I interferon production,BP,
2940,GO:0032480,1,0.407908918373462,0,2,negative regulation of type I interferon production,BP,
2941,GO:0032481,1,0.71553036272411,0,1,positive regulation of type I interferon production,BP,
2947,GO:0032506,1,0.734630587357061,0,1,cytokinetic process,BP,
2949,GO:0032515,1,0.678874584138857,0,1,negative regulation of phosphoprotein phosphatase activity,BP,
2953,GO:0032542,1,0.732887609658439,0,1,sulfiredoxin activity,MF,
2962,GO:0032571,1,0.707679132473116,0,1,response to vitamin K,BP,
2963,GO:0032585,1,0.719239884495386,0,1,multivesicular body membrane,CC,
2964,GO:0032587,1,0.734583532995424,0,1,ruffle membrane,CC,
2965,GO:0032589,1,0.720481830454823,0,1,neuron projection membrane,CC,
2967,GO:0032602,1,0.237831848914163,0,4,chemokine production,BP,
2969,GO:0032606,1,0.213103524033804,0,4,type I interferon production,BP,
2970,GO:0032607,1,0.654756153569277,0,1,interferon-alpha production,BP,
2971,GO:0032608,1,0.291090475853777,0,3,interferon-beta production,BP,
2974,GO:0032611,1,0.457863957762274,0,2,interleukin-1 beta production,BP,
2976,GO:0032613,1,0.455610387146653,0,2,interleukin-10 production,BP,
2977,GO:0032623,1,0.516246879410877,0,2,interleukin-2 production,BP,
2979,GO:0032635,1,0.230479248266752,0,4,interleukin-6 production,BP,
2982,GO:0032642,1,0.237831848914163,0,4,regulation of chemokine production,BP,
2984,GO:0032647,1,0.654756153569277,0,1,regulation of interferon-alpha production,BP,
2985,GO:0032648,1,0.291090475853777,0,3,regulation of interferon-beta production,BP,
2988,GO:0032651,1,0.457863957762274,0,2,regulation of interleukin-1 beta production,BP,
2990,GO:0032653,1,0.455610387146653,0,2,regulation of interleukin-10 production,BP,
2991,GO:0032663,1,0.734583504697188,0,1,regulation of interleukin-2 production,BP,
2992,GO:0032673,1,0.730064105565976,0,1,regulation of interleukin-4 production,BP,
2993,GO:0032675,1,0.230479248266752,0,4,regulation of interleukin-6 production,BP,
2997,GO:0032687,1,0.654756153569277,0,1,negative regulation of interferon-alpha production,BP,
2998,GO:0032688,1,0.407908918373462,0,2,negative regulation of interferon-beta production,BP,
2999,GO:0032689,1,0.707679132473116,0,1,negative regulation of interferon-gamma production,BP,
3000,GO:0032692,1,0.707679132473116,0,1,negative regulation of interleukin-1 production,BP,
3001,GO:0032693,1,0.731051540942314,0,1,negative regulation of interleukin-10 production,BP,
3002,GO:0032713,1,0.730064105565976,0,1,negative regulation of interleukin-4 production,BP,
3003,GO:0032715,1,0.707679132473116,0,1,negative regulation of interleukin-6 production,BP,
3004,GO:0032720,1,0.707679132473116,0,1,negative regulation of tumor necrosis factor production,BP,
3005,GO:0032722,1,0.326836320567893,0,3,positive regulation of chemokine production,BP,
3006,GO:0032728,1,0.71553036272411,0,1,positive regulation of interferon-beta production,BP,
3009,GO:0032731,1,0.457863957762274,0,2,positive regulation of interleukin-1 beta production,BP,
3011,GO:0032733,1,0.624051270746175,0,1,positive regulation of interleukin-10 production,BP,
3012,GO:0032743,1,0.734583504697188,0,1,positive regulation of interleukin-2 production,BP,
3013,GO:0032755,1,0.326836320567893,0,3,positive regulation of interleukin-6 production,BP,
3016,GO:0032762,1,0.685061814505026,0,1,mast cell cytokine production,BP,
3018,GO:0032769,1,0.651434792770337,0,1,negative regulation of monooxygenase activity,BP,
3021,GO:0032780,1,0.678874584138857,0,1,negative regulation of ATPase activity,BP,
3022,GO:0032781,1,0.413810175706029,0,2,positive regulation of ATPase activity,BP,
3027,GO:0032795,1,0.720481830454823,0,1,heterotrimeric G-protein binding,MF,
3028,GO:0032800,1,0.687857981162908,0,1,receptor biosynthetic process,BP,
3029,GO:0032801,1,0.734656689076872,0,1,receptor catabolic process,BP,
3030,GO:0032808,1,0.610551717868249,0,1,lacrimal gland development,BP,
3031,GO:0032811,1,0.496169850027802,0,2,negative regulation of epinephrine secretion,BP,
3033,GO:0032814,1,0.505822708163426,0,2,regulation of natural killer cell activation,BP,
3034,GO:0032816,1,0.505822708163426,0,2,positive regulation of natural killer cell activation,BP,
3035,GO:0032823,1,0.707679132473116,0,1,regulation of natural killer cell differentiation,BP,
3036,GO:0032825,1,0.707679132473116,0,1,positive regulation of natural killer cell differentiation,BP,
3038,GO:0032836,1,0.725196311092909,0,1,glomerular basement membrane development,BP,
3041,GO:0032846,1,0.360486707478648,0,3,positive regulation of homeostatic process,BP,
3046,GO:0032873,1,0.721277899526339,0,1,negative regulation of stress-activated MAPK cascade,BP,
3050,GO:0032881,1,0.520022212716508,0,2,regulation of polysaccharide metabolic process,BP,
3051,GO:0032885,1,0.520022212716508,0,2,regulation of polysaccharide biosynthetic process,BP,
3052,GO:0032886,1,0.342488127188183,0,3,regulation of microtubule-based process,BP,
3053,GO:0032890,1,0.356292375445844,0,3,regulation of organic acid transport,BP,
3054,GO:0032891,1,0.519144485214915,0,2,negative regulation of organic acid transport,BP,
3055,GO:0032892,1,0.687857981162908,0,1,positive regulation of organic acid transport,BP,
3056,GO:0032898,1,0.720481830454823,0,1,neurotrophin production,BP,
3057,GO:0032899,1,0.720481830454823,0,1,regulation of neurotrophin production,BP,
3058,GO:0032900,1,0.720481830454823,0,1,negative regulation of neurotrophin production,BP,
3076,GO:0032982,1,0.734688491282273,0,1,myosin filament,CC,
3081,GO:0032994,1,0.602424533559327,0,1,protein-lipid complex,CC,
3083,GO:0033010,1,0.733958464826053,0,1,paranodal junction,CC,
3084,GO:0033013,1,0.723051447612026,0,1,tetrapyrrole metabolic process,BP,
3085,GO:0033017,1,0.715718629020694,0,1,sarcoplasmic reticulum membrane,CC,
3086,GO:0033018,1,0.715718629020694,0,1,sarcoplasmic reticulum lumen,CC,
3087,GO:0033023,1,0.734638208028596,0,1,mast cell homeostasis,BP,
3088,GO:0033024,1,0.734638208028596,0,1,mast cell apoptotic process,BP,
3089,GO:0033025,1,0.734638208028596,0,1,regulation of mast cell apoptotic process,BP,
3090,GO:0033026,1,0.734638208028596,0,1,negative regulation of mast cell apoptotic process,BP,
3091,GO:0033028,1,0.734638208028596,0,1,myeloid cell apoptotic process,BP,
3092,GO:0033032,1,0.734638208028596,0,1,regulation of myeloid cell apoptotic process,BP,
3093,GO:0033033,1,0.734638208028596,0,1,negative regulation of myeloid cell apoptotic process,BP,
3096,GO:0033044,1,0.734513896772137,0,1,regulation of chromosome organization,BP,
3107,GO:0033093,1,0.494175337646771,0,2,Weibel-Palade body,CC,
3108,GO:0033120,1,0.734654319492406,0,1,positive regulation of RNA splicing,BP,
3111,GO:0033139,1,0.734513896772137,0,1,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
3112,GO:0033141,1,0.734513896772137,0,1,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
3114,GO:0033158,1,0.490023087273002,0,2,regulation of protein import into nucleus, translocation,BP,
3115,GO:0033159,1,0.707679132473116,0,1,negative regulation of protein import into nucleus, translocation,BP,
3120,GO:0033218,1,0.0868753531694007,0,7,amide binding,MF,
3130,GO:0033306,1,0.676160423272601,0,1,phytol metabolic process,BP,
3131,GO:0033327,1,0.679008521833097,0,1,Leydig cell differentiation,BP,
3136,GO:0033489,1,0.454446011661567,0,2,cholesterol biosynthetic process via desmosterol,BP,
3137,GO:0033490,1,0.454446011661567,0,2,cholesterol biosynthetic process via lathosterol,BP,
3142,GO:0033558,1,0.734627459219659,0,1,protein deacetylase activity,MF,
3143,GO:0033559,1,0.337920429020916,0,3,unsaturated fatty acid metabolic process,BP,
3144,GO:0033561,1,0.73224972901803,0,1,regulation of water loss via skin,BP,
3146,GO:0033572,1,0.719222945349914,0,1,transferrin transport,BP,
3147,GO:0033574,1,0.504724677327188,0,2,response to testosterone,BP,
3148,GO:0033598,1,0.734655294999483,0,1,mammary gland epithelial cell proliferation,BP,
3150,GO:0033604,1,0.339090043736765,0,3,negative regulation of catecholamine secretion,BP,
3153,GO:0033613,1,0.446033844119448,0,2,activating transcription factor binding,MF,
3156,GO:0033631,1,0.734583532995424,0,1,cell-cell adhesion mediated by integrin,BP,
3159,GO:0033687,1,0.728387748399053,0,1,osteoblast proliferation,BP,
3160,GO:0033688,1,0.728387748399053,0,1,regulation of osteoblast proliferation,BP,
3161,GO:0033690,1,0.728387748399053,0,1,positive regulation of osteoblast proliferation,BP,
3162,GO:0033692,1,0.516768288390107,0,2,cellular polysaccharide biosynthetic process,BP,
3165,GO:0033764,1,0.178836488464232,0,4,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
3178,GO:0034059,1,0.700055882594153,0,1,response to anoxia,BP,
3188,GO:0034121,1,0.525074866024302,0,2,regulation of toll-like receptor signaling pathway,BP,
3189,GO:0034122,1,0.525074866024302,0,2,negative regulation of toll-like receptor signaling pathway,BP,
3190,GO:0034127,1,0.71553036272411,0,1,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
3191,GO:0034128,1,0.71553036272411,0,1,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
3192,GO:0034198,1,0.693238114134537,0,1,cellular response to amino acid starvation,BP,
3193,GO:0034199,1,0.519400362978979,0,2,activation of protein kinase A activity,BP,
3196,GO:0034236,1,0.707766673908358,0,1,protein kinase A catalytic subunit binding,MF,
3201,GO:0034250,1,0.71794240190076,0,1,positive regulation of cellular amide metabolic process,BP,
3204,GO:0034285,1,0.703675733824822,0,1,response to disaccharide,BP,
3208,GO:0034331,1,0.706886301239446,0,1,cell junction maintenance,BP,
3213,GO:0034349,1,0.516824098442572,0,2,glial cell apoptotic process,BP,
3214,GO:0034350,1,0.516824098442572,0,2,regulation of glial cell apoptotic process,BP,
3215,GO:0034351,1,0.516824098442572,0,2,negative regulation of glial cell apoptotic process,BP,
3216,GO:0034356,1,0.463579231864392,0,2,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
3217,GO:0034358,1,0.602424533559327,0,1,plasma lipoprotein particle,CC,
3218,GO:0034361,1,0.602424533559327,0,1,very-low-density lipoprotein particle,CC,
3219,GO:0034364,1,0.602424533559327,0,1,high-density lipoprotein particle,CC,
3225,GO:0034377,1,0.602424533559327,0,1,plasma lipoprotein particle assembly,BP,
3226,GO:0034379,1,0.602424533559327,0,1,very-low-density lipoprotein particle assembly,BP,
3227,GO:0034381,1,0.602424533559327,0,1,plasma lipoprotein particle clearance,BP,
3228,GO:0034382,1,0.602424533559327,0,1,chylomicron remnant clearance,BP,
3229,GO:0034385,1,0.602424533559327,0,1,triglyceride-rich plasma lipoprotein particle,CC,
3230,GO:0034390,1,0.687857981162908,0,1,smooth muscle cell apoptotic process,BP,
3231,GO:0034391,1,0.687857981162908,0,1,regulation of smooth muscle cell apoptotic process,BP,
3232,GO:0034392,1,0.687857981162908,0,1,negative regulation of smooth muscle cell apoptotic process,BP,
3233,GO:0034394,1,0.276697487490503,0,3,protein localization to cell surface,BP,
3235,GO:0034405,1,0.721277899526339,0,1,response to fluid shear stress,BP,
3236,GO:0034418,1,0.703491083600584,0,1,urate biosynthetic process,BP,
3244,GO:0034447,1,0.602424533559327,0,1,very-low-density lipoprotein particle clearance,BP,
3246,GO:0034453,1,0.706886301239446,0,1,microtubule anchoring,BP,
3249,GO:0034505,1,0.666510188931046,0,1,tooth mineralization,BP,
3251,GO:0034605,1,0.489472591157943,0,2,cellular response to heat,BP,
3257,GO:0034629,1,0.696012829206827,0,1,cellular protein complex localization,BP,
3260,GO:0034637,1,0.516768288390107,0,2,cellular carbohydrate biosynthetic process,BP,
3261,GO:0034638,1,0.602424533559327,0,1,phosphatidylcholine catabolic process,BP,
3263,GO:0034644,1,0.508754089074775,0,2,cellular response to UV,BP,
3265,GO:0034650,1,0.382643336970993,0,3,cortisol metabolic process,BP,
3266,GO:0034651,1,0.382643336970993,0,3,cortisol biosynthetic process,BP,
3270,GO:0034667,1,0.734619771595464,0,1,integrin alpha3-beta1 complex,CC,
3271,GO:0034684,1,0.731861183263379,0,1,integrin alphav-beta5 complex,CC,
3272,GO:0034686,1,0.734719033698558,0,1,integrin alphav-beta8 complex,CC,
3273,GO:0034694,1,0.495579542709413,0,2,response to prostaglandin,BP,
3274,GO:0034695,1,0.721277899526339,0,1,response to prostaglandin E,BP,
3275,GO:0034696,1,0.687857981162908,0,1,response to prostaglandin F,BP,
3277,GO:0034699,1,0.71444051523567,0,1,response to luteinizing hormone,BP,
3280,GO:0034704,1,0.525241663252816,0,2,calcium channel complex,CC,
3282,GO:0034707,1,0.413435230092464,0,2,chloride channel complex,CC,
3284,GO:0034755,1,0.683400968465533,0,1,iron ion transmembrane transport,BP,
3286,GO:0034763,1,0.27490924442983,0,4,negative regulation of transmembrane transport,BP,
3287,GO:0034764,1,0.218684188357222,0,4,positive regulation of transmembrane transport,BP,
3289,GO:0034766,1,0.27490924442983,0,4,negative regulation of ion transmembrane transport,BP,
3290,GO:0034767,1,0.218684188357222,0,4,positive regulation of ion transmembrane transport,BP,
3291,GO:0034774,1,0.0119205249740166,0,12,secretory granule lumen,CC,
3295,GO:0035014,1,0.539137129467295,0,2,phosphatidylinositol 3-kinase regulator activity,MF,
3297,GO:0035023,1,0.734619771595464,0,1,regulation of Rho protein signal transduction,BP,
3298,GO:0035024,1,0.734619771595464,0,1,negative regulation of Rho protein signal transduction,BP,
3301,GO:0035054,1,0.728387748399053,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
3302,GO:0035065,1,0.734513896772137,0,1,regulation of histone acetylation,BP,
3303,GO:0035066,1,0.734513896772137,0,1,positive regulation of histone acetylation,BP,
3304,GO:0035088,1,0.539148185841117,0,2,establishment or maintenance of apical/basal cell polarity,BP,
3305,GO:0035089,1,0.539148185841117,0,2,establishment of apical/basal cell polarity,BP,
3307,GO:0035094,1,0.490868586097479,0,2,response to nicotine,BP,
3317,GO:0035150,1,0.0337337186438115,0,9,regulation of tube size,BP,
3318,GO:0035162,1,0.535834897726565,0,2,embryonic hemopoiesis,BP,
3322,GO:0035234,1,0.734638208028596,0,1,ectopic germ cell programmed cell death,BP,
3323,GO:0035235,1,0.734629361512883,0,1,ionotropic glutamate receptor signaling pathway,BP,
3325,GO:0035249,1,0.720481830454823,0,1,synaptic transmission, glutamatergic,BP,
3326,GO:0035250,1,0.717192339181394,0,1,UDP-galactosyltransferase activity,MF,
3337,GO:0035296,1,0.0337337186438115,0,9,regulation of tube diameter,BP,
3338,GO:0035303,1,0.250182897532234,0,4,regulation of dephosphorylation,BP,
3339,GO:0035304,1,0.488549758634843,0,2,regulation of protein dephosphorylation,BP,
3340,GO:0035305,1,0.479304515192597,0,2,negative regulation of dephosphorylation,BP,
3341,GO:0035306,1,0.355100702979169,0,3,positive regulation of dephosphorylation,BP,
3342,GO:0035307,1,0.720481830454823,0,1,positive regulation of protein dephosphorylation,BP,
3343,GO:0035308,1,0.678874584138857,0,1,negative regulation of protein dephosphorylation,BP,
3348,GO:0035336,1,0.272723595217001,0,4,long-chain fatty-acyl-CoA metabolic process,BP,
3349,GO:0035337,1,0.272723595217001,0,4,fatty-acyl-CoA metabolic process,BP,
3350,GO:0035338,1,0.272723595217001,0,4,long-chain fatty-acyl-CoA biosynthetic process,BP,
3357,GO:0035434,1,0.670477648906454,0,1,copper ion transmembrane transport,BP,
3358,GO:0035455,1,0.505050249009675,0,2,response to interferon-alpha,BP,
3359,GO:0035457,1,0.505050249009675,0,2,cellular response to interferon-alpha,BP,
3360,GO:0035493,1,0.716792886639055,0,1,SNARE complex assembly,BP,
3361,GO:0035502,1,0.725196311092909,0,1,metanephric part of ureteric bud development,BP,
3365,GO:0035578,1,0.274248539199812,0,3,azurophil granule lumen,CC,
3366,GO:0035579,1,0.357764252874843,0,3,specific granule membrane,CC,
3367,GO:0035580,1,0.719239884495386,0,1,specific granule lumen,CC,
3369,GO:0035586,1,0.511614066641936,0,2,purinergic receptor activity,MF,
3370,GO:0035587,1,0.511614066641936,0,2,purinergic receptor signaling pathway,BP,
3371,GO:0035588,1,0.511614066641936,0,2,G-protein coupled purinergic receptor signaling pathway,BP,
3372,GO:0035589,1,0.710841574163711,0,1,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
3373,GO:0035590,1,0.710841574163711,0,1,purinergic nucleotide receptor signaling pathway,BP,
3374,GO:0035591,1,0.734654319492406,0,1,signaling adaptor activity,MF,
3377,GO:0035624,1,0.496169850027802,0,2,receptor transactivation,BP,
3378,GO:0035625,1,0.496169850027802,0,2,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
3379,GO:0035630,1,0.728387748399053,0,1,bone mineralization involved in bone maturation,BP,
3383,GO:0035640,1,0.734619771595464,0,1,exploration behavior,BP,
3387,GO:0035655,1,0.520022212716508,0,2,interleukin-18-mediated signaling pathway,BP,
3390,GO:0035690,1,0.25910714538293,0,4,cellular response to drug,BP,
3393,GO:0035701,1,0.707679132473116,0,1,hematopoietic stem cell migration,BP,
3394,GO:0035710,1,0.730064105565976,0,1,CD4-positive, alpha-beta T cell activation,BP,
3395,GO:0035725,1,0.60595713946183,0,1,sodium ion transmembrane transport,BP,
3396,GO:0035728,1,0.730381896558346,0,1,response to hepatocyte growth factor,BP,
3397,GO:0035729,1,0.730381896558346,0,1,cellular response to hepatocyte growth factor stimulus,BP,
3399,GO:0035754,1,0.707679132473116,0,1,B cell chemotaxis,BP,
3403,GO:0035770,1,0.734588622258976,0,1,ribonucleoprotein granule,CC,
3404,GO:0035787,1,0.721696904193942,0,1,cell migration involved in kidney development,BP,
3405,GO:0035788,1,0.721696904193942,0,1,cell migration involved in metanephros development,BP,
3406,GO:0035789,1,0.721696904193942,0,1,metanephric mesenchymal cell migration,BP,
3407,GO:0035791,1,0.721696904193942,0,1,platelet-derived growth factor receptor-beta signaling pathway,BP,
3408,GO:0035793,1,0.721696904193942,0,1,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
3410,GO:0035795,1,0.649356158897709,0,1,negative regulation of mitochondrial membrane permeability,BP,
3411,GO:0035801,1,0.725196311092909,0,1,adrenal cortex development,BP,
3412,GO:0035802,1,0.725196311092909,0,1,adrenal cortex formation,BP,
3413,GO:0035809,1,0.504744643056275,0,2,regulation of urine volume,BP,
3414,GO:0035810,1,0.504744643056275,0,2,positive regulation of urine volume,BP,
3415,GO:0035812,1,0.362898355912859,0,3,renal sodium excretion,BP,
3416,GO:0035813,1,0.362898355912859,0,3,regulation of renal sodium excretion,BP,
3417,GO:0035814,1,0.720481830454823,0,1,negative regulation of renal sodium excretion,BP,
3418,GO:0035815,1,0.504744643056275,0,2,positive regulation of renal sodium excretion,BP,
3419,GO:0035821,1,0.685061814505026,0,1,modification of morphology or physiology of other organism,BP,
3422,GO:0035855,1,0.730064105565976,0,1,megakaryocyte development,BP,
3423,GO:0035859,1,0.732887609658439,0,1,Seh1-associated complex,CC,
3426,GO:0035878,1,0.7346518247608,0,1,nail development,BP,
3430,GO:0035902,1,0.730352294167363,0,1,response to immobilization stress,BP,
3442,GO:0035962,1,0.734423653901122,0,1,response to interleukin-13,BP,
3443,GO:0035963,1,0.734423653901122,0,1,cellular response to interleukin-13,BP,
3447,GO:0035987,1,0.537116974969497,0,2,endodermal cell differentiation,BP,
3448,GO:0035988,1,0.700055882594153,0,1,chondrocyte proliferation,BP,
3453,GO:0035994,1,0.687857981162908,0,1,response to muscle stretch,BP,
3455,GO:0036010,1,0.734550444064761,0,1,protein localization to endosome,BP,
3456,GO:0036024,1,0.698707300486311,0,1,protein C inhibitor-TMPRSS7 complex,CC,
3457,GO:0036025,1,0.698707300486311,0,1,protein C inhibitor-TMPRSS11E complex,CC,
3458,GO:0036026,1,0.698707300486311,0,1,protein C inhibitor-PLAT complex,CC,
3459,GO:0036027,1,0.698707300486311,0,1,protein C inhibitor-PLAU complex,CC,
3460,GO:0036028,1,0.698707300486311,0,1,protein C inhibitor-thrombin complex,CC,
3461,GO:0036029,1,0.698707300486311,0,1,protein C inhibitor-KLK3 complex,CC,
3462,GO:0036030,1,0.698707300486311,0,1,protein C inhibitor-plasma kallikrein complex,CC,
3464,GO:0036041,1,0.634405611216108,0,1,long-chain fatty acid binding,MF,
3465,GO:0036064,1,0.529355929114409,0,2,ciliary basal body,CC,
3468,GO:0036089,1,0.734630587357061,0,1,cleavage furrow formation,BP,
3469,GO:0036091,1,0.732887609658439,0,1,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3472,GO:0036109,1,0.734591748630676,0,1,alpha-linolenic acid metabolic process,BP,
3478,GO:0036166,1,0.721696904193942,0,1,phenotypic switching,BP,
3481,GO:0036257,1,0.719239884495386,0,1,multivesicular body organization,BP,
3484,GO:0036296,1,0.693238114134537,0,1,response to increased oxygen levels,BP,
3486,GO:0036312,1,0.734654319492406,0,1,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
3488,GO:0036342,1,0.734655294999483,0,1,post-anal tail morphogenesis,BP,
3489,GO:0036344,1,0.730064105565976,0,1,platelet morphogenesis,BP,
3490,GO:0036376,1,0.60595713946183,0,1,sodium ion export from cell,BP,
3491,GO:0036379,1,0.474306168911428,0,2,myofilament,CC,
3494,GO:0036464,1,0.734588622258976,0,1,cytoplasmic ribonucleoprotein granule,CC,
3496,GO:0036473,1,0.467772416492944,0,2,cell death in response to oxidative stress,BP,
3498,GO:0036490,1,0.732887609658439,0,1,regulation of translation in response to endoplasmic reticulum stress,BP,
3500,GO:0036514,1,0.734655294999483,0,1,dopaminergic neuron axon guidance,BP,
3501,GO:0036515,1,0.734655294999483,0,1,serotonergic neuron axon guidance,BP,
3502,GO:0036517,1,0.734655294999483,0,1,chemoattraction of serotonergic neuron axon,BP,
3503,GO:0036518,1,0.734655294999483,0,1,chemorepulsion of dopaminergic neuron axon,BP,
3504,GO:0038001,1,0.721696904193942,0,1,paracrine signaling,BP,
3512,GO:0038062,1,0.734417317850469,0,1,protein tyrosine kinase collagen receptor activity,MF,
3513,GO:0038063,1,0.734417317850469,0,1,collagen-activated tyrosine kinase receptor signaling pathway,BP,
3514,GO:0038064,1,0.734417317850469,0,1,collagen receptor activity,MF,
3515,GO:0038065,1,0.734417317850469,0,1,collagen-activated signaling pathway,BP,
3516,GO:0038066,1,0.471351952923282,0,2,p38MAPK cascade,BP,
3517,GO:0038083,1,0.734417317850469,0,1,peptidyl-tyrosine autophosphorylation,BP,
3518,GO:0038084,1,0.731051540942314,0,1,vascular endothelial growth factor signaling pathway,BP,
3525,GO:0038132,1,0.7346518247608,0,1,neuregulin binding,MF,
3526,GO:0038166,1,0.734598335802591,0,1,angiotensin-activated signaling pathway,BP,
3527,GO:0038179,1,0.730381896558346,0,1,neurotrophin signaling pathway,BP,
3531,GO:0038201,1,0.537641688891737,0,2,TOR complex,CC,
3532,GO:0038202,1,0.732887609658439,0,1,TORC1 signaling,BP,
3533,GO:0038203,1,0.734269630851481,0,1,TORC2 signaling,BP,
3534,GO:0039663,1,0.707679132473116,0,1,membrane fusion involved in viral entry into host cell,BP,
3536,GO:0040001,1,0.610551717868249,0,1,establishment of mitotic spindle localization,BP,
3546,GO:0040020,1,0.39525936393313,0,3,regulation of meiotic nuclear division,BP,
3549,GO:0040036,1,0.539112223566813,0,2,regulation of fibroblast growth factor receptor signaling pathway,BP,
3550,GO:0040037,1,0.539112223566813,0,2,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
3551,GO:0042033,1,0.525154618129057,0,2,chemokine biosynthetic process,BP,
3554,GO:0042044,1,0.687857981162908,0,1,fluid transport,BP,
3555,GO:0042045,1,0.687857981162908,0,1,epithelial fluid transport,BP,
3557,GO:0042058,1,0.121428160489125,0,6,regulation of epidermal growth factor receptor signaling pathway,BP,
3558,GO:0042059,1,0.706886301239446,0,1,negative regulation of epidermal growth factor receptor signaling pathway,BP,
3564,GO:0042093,1,0.730064105565976,0,1,T-helper cell differentiation,BP,
3565,GO:0042095,1,0.730064105565976,0,1,interferon-gamma biosynthetic process,BP,
3566,GO:0042097,1,0.730064105565976,0,1,interleukin-4 biosynthetic process,BP,
3568,GO:0042100,1,0.332054355296759,0,3,B cell proliferation,BP,
3575,GO:0042116,1,0.384954209898689,0,3,macrophage activation,BP,
3585,GO:0042168,1,0.723051447612026,0,1,heme metabolic process,BP,
3591,GO:0042219,1,0.731018562409083,0,1,cellular modified amino acid catabolic process,BP,
3596,GO:0042249,1,0.734655294999483,0,1,establishment of planar polarity of embryonic epithelium,BP,
3597,GO:0042254,1,0.734576401742655,0,1,ribosome biogenesis,BP,
3598,GO:0042267,1,0.719239884495386,0,1,natural killer cell mediated cytotoxicity,BP,
3599,GO:0042277,1,0.118980775426674,0,6,peptide binding,MF,
3600,GO:0042278,1,0.516257181557568,0,2,purine nucleoside metabolic process,BP,
3601,GO:0042297,1,0.720739389914957,0,1,vocal learning,BP,
3602,GO:0042301,1,0.703491083600584,0,1,phosphate ion binding,MF,
3608,GO:0042310,1,0.160740666323561,0,5,vasoconstriction,BP,
3609,GO:0042311,1,0.720481830454823,0,1,vasodilation,BP,
3610,GO:0042313,1,0.687857981162908,0,1,protein kinase C deactivation,BP,
3611,GO:0042321,1,0.720481830454823,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
3612,GO:0042323,1,0.720481830454823,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
3617,GO:0042339,1,0.485561459252131,0,2,keratan sulfate metabolic process,BP,
3618,GO:0042340,1,0.677828420297706,0,1,keratan sulfate catabolic process,BP,
3624,GO:0042364,1,0.678874584138857,0,1,water-soluble vitamin biosynthetic process,BP,
3627,GO:0042383,1,0.444516858505281,0,2,sarcolemma,CC,
3629,GO:0042398,1,0.61919681818651,0,1,cellular modified amino acid biosynthetic process,BP,
3630,GO:0042402,1,0.731018562409083,0,1,cellular biogenic amine catabolic process,BP,
3632,GO:0042417,1,0.734579420052926,0,1,dopamine metabolic process,BP,
3635,GO:0042426,1,0.731018562409083,0,1,choline catabolic process,BP,
3636,GO:0042438,1,0.734655294999483,0,1,melanin biosynthetic process,BP,
3637,GO:0042440,1,0.530687970511746,0,2,pigment metabolic process,BP,
3640,GO:0042447,1,0.67605262318362,0,1,hormone catabolic process,BP,
3641,GO:0042448,1,0.675836959389896,0,1,progesterone metabolic process,BP,
3642,GO:0042454,1,0.703491083600584,0,1,ribonucleoside catabolic process,BP,
3643,GO:0042461,1,0.734698187201066,0,1,photoreceptor cell development,BP,
3644,GO:0042462,1,0.734698187201066,0,1,eye photoreceptor cell development,BP,
3648,GO:0042474,1,0.687857981162908,0,1,middle ear morphogenesis,BP,
3652,GO:0042482,1,0.332732162541005,0,3,positive regulation of odontogenesis,BP,
3658,GO:0042501,1,0.734513896772137,0,1,serine phosphorylation of STAT protein,BP,
3659,GO:0042503,1,0.361362200801133,0,3,tyrosine phosphorylation of Stat3 protein,BP,
3660,GO:0042506,1,0.734588622258976,0,1,tyrosine phosphorylation of Stat5 protein,BP,
3661,GO:0042508,1,0.734513896772137,0,1,tyrosine phosphorylation of Stat1 protein,BP,
3662,GO:0042509,1,0.361362200801133,0,3,regulation of tyrosine phosphorylation of STAT protein,BP,
3663,GO:0042510,1,0.734513896772137,0,1,regulation of tyrosine phosphorylation of Stat1 protein,BP,
3664,GO:0042511,1,0.734513896772137,0,1,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
3665,GO:0042516,1,0.361362200801133,0,3,regulation of tyrosine phosphorylation of Stat3 protein,BP,
3666,GO:0042517,1,0.361362200801133,0,3,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,
3667,GO:0042522,1,0.734588622258976,0,1,regulation of tyrosine phosphorylation of Stat5 protein,BP,
3668,GO:0042523,1,0.734588622258976,0,1,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,
3669,GO:0042531,1,0.361362200801133,0,3,positive regulation of tyrosine phosphorylation of STAT protein,BP,
3670,GO:0042537,1,0.71444051523567,0,1,benzene-containing compound metabolic process,BP,
3671,GO:0042538,1,0.73224972901803,0,1,hyperosmotic salinity response,BP,
3672,GO:0042542,1,0.500311687368313,0,2,response to hydrogen peroxide,BP,
3675,GO:0042554,1,0.687857981162908,0,1,superoxide anion generation,BP,
3678,GO:0042562,1,0.285436557914071,0,4,hormone binding,MF,
3682,GO:0042581,1,0.256504457795735,0,4,specific granule,CC,
3684,GO:0042583,1,0.685061814505026,0,1,chromaffin granule,CC,
3685,GO:0042587,1,0.734715871907028,0,1,glycogen granule,CC,
3693,GO:0042627,1,0.602424533559327,0,1,chylomicron,CC,
3697,GO:0042634,1,0.480447540547715,0,2,regulation of hair cycle,BP,
3698,GO:0042635,1,0.480447540547715,0,2,positive regulation of hair cycle,BP,
3699,GO:0042640,1,0.734655294999483,0,1,anagen,BP,
3705,GO:0042693,1,0.319379791103568,0,3,muscle cell fate commitment,BP,
3706,GO:0042695,1,0.734655294999483,0,1,thelarche,BP,
3708,GO:0042726,1,0.466053539039796,0,2,flavin-containing compound metabolic process,BP,
3709,GO:0042730,1,0.708376329021044,0,1,fibrinolysis,BP,
3711,GO:0042734,1,0.720481830454823,0,1,presynaptic membrane,CC,
3713,GO:0042745,1,0.514210881806709,0,2,circadian sleep/wake cycle,BP,
3714,GO:0042747,1,0.71444051523567,0,1,circadian sleep/wake cycle, REM sleep,BP,
3715,GO:0042748,1,0.720481830454823,0,1,circadian sleep/wake cycle, non-REM sleep,BP,
3716,GO:0042749,1,0.720481830454823,0,1,regulation of circadian sleep/wake cycle,BP,
3717,GO:0042752,1,0.720481830454823,0,1,regulation of circadian rhythm,BP,
3718,GO:0042754,1,0.720481830454823,0,1,negative regulation of circadian rhythm,BP,
3719,GO:0042759,1,0.730712451364202,0,1,long-chain fatty acid biosynthetic process,BP,
3720,GO:0042761,1,0.730712451364202,0,1,very long-chain fatty acid biosynthetic process,BP,
3721,GO:0042762,1,0.734076412283897,0,1,regulation of sulfur metabolic process,BP,
3723,GO:0042771,1,0.43196643577054,0,2,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
3724,GO:0042772,1,0.693238114134537,0,1,DNA damage response, signal transduction resulting in transcription,BP,
3729,GO:0042816,1,0.734619092483416,0,1,vitamin B6 metabolic process,BP,
3732,GO:0042940,1,0.733899513955252,0,1,D-amino acid transport,BP,
3733,GO:0042953,1,0.656640353294477,0,1,lipoprotein transport,BP,
3735,GO:0042976,1,0.734588622258976,0,1,activation of Janus kinase activity,BP,
3736,GO:0042977,1,0.734588622258976,0,1,activation of JAK2 kinase activity,BP,
3748,GO:0043014,1,0.734541433279854,0,1,alpha-tubulin binding,MF,
3749,GO:0043015,1,0.539144801722991,0,2,gamma-tubulin binding,MF,
3750,GO:0043021,1,0.734576401742655,0,1,ribonucleoprotein complex binding,MF,
3752,GO:0043027,1,0.458925695168661,0,2,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
3753,GO:0043028,1,0.285487331903761,0,3,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
3755,GO:0043030,1,0.539054900130722,0,2,regulation of macrophage activation,BP,
3756,GO:0043032,1,0.734655294999483,0,1,positive regulation of macrophage activation,BP,
3757,GO:0043034,1,0.712035988887385,0,1,costamere,CC,
3765,GO:0043083,1,0.734731427506846,0,1,synaptic cleft,CC,
3769,GO:0043090,1,0.733899513955252,0,1,amino acid import,BP,
3770,GO:0043092,1,0.733899513955252,0,1,L-amino acid import,BP,
3771,GO:0043094,1,0.511297814604135,0,2,cellular metabolic compound salvage,BP,
3772,GO:0043101,1,0.703491083600584,0,1,purine-containing compound salvage,BP,
3773,GO:0043102,1,0.727559953538537,0,1,amino acid salvage,BP,
3774,GO:0043112,1,0.504797884819805,0,2,receptor metabolic process,BP,
3775,GO:0043113,1,0.734589394501328,0,1,receptor clustering,BP,
3776,GO:0043114,1,0.734579420052926,0,1,regulation of vascular permeability,BP,
3780,GO:0043125,1,0.734654319492406,0,1,ErbB-3 class receptor binding,MF,
3781,GO:0043130,1,0.734617631152968,0,1,ubiquitin binding,MF,
3782,GO:0043149,1,0.194889289079958,0,5,stress fiber assembly,BP,
3783,GO:0043154,1,0.330242903962089,0,3,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
3791,GO:0043179,1,0.687857981162908,0,1,rhythmic excitation,BP,
3792,GO:0043184,1,0.734583532995424,0,1,vascular endothelial growth factor receptor 2 binding,MF,
3794,GO:0043195,1,0.515908252631411,0,2,terminal bouton,CC,
3795,GO:0043197,1,0.284011168278666,0,4,dendritic spine,CC,
3796,GO:0043198,1,0.734640725657069,0,1,dendritic shaft,CC,
3797,GO:0043200,1,0.257613917740185,0,4,response to amino acid,BP,
3798,GO:0043201,1,0.732887609658439,0,1,response to leucine,BP,
3799,GO:0043202,1,0.135589431623642,0,5,lysosomal lumen,CC,
3803,GO:0043209,1,0.179721723569353,0,5,myelin sheath,CC,
3804,GO:0043217,1,0.721277899526339,0,1,myelin maintenance,BP,
3805,GO:0043218,1,0.733958464826053,0,1,compact myelin,CC,
3806,GO:0043220,1,0.733958464826053,0,1,Schmidt-Lanterman incisure,CC,
3817,GO:0043236,1,0.734619771595464,0,1,laminin binding,MF,
3820,GO:0043243,1,0.734598335802591,0,1,positive regulation of protein complex disassembly,BP,
3823,GO:0043255,1,0.380381712370333,0,3,regulation of carbohydrate biosynthetic process,BP,
3824,GO:0043256,1,0.539332900500415,0,2,laminin complex,CC,
3825,GO:0043259,1,0.734731427506846,0,1,laminin-10 complex,CC,
3826,GO:0043260,1,0.734731427506846,0,1,laminin-11 complex,CC,
3827,GO:0043266,1,0.274603568858378,0,4,regulation of potassium ion transport,BP,
3828,GO:0043267,1,0.382278693217935,0,3,negative regulation of potassium ion transport,BP,
3829,GO:0043268,1,0.384835231821028,0,3,positive regulation of potassium ion transport,BP,
3834,GO:0043277,1,0.351274377365973,0,3,apoptotic cell clearance,BP,
3839,GO:0043292,1,0.0284474636235428,0,10,contractile fiber,CC,
3840,GO:0043295,1,0.671129001439236,0,1,glutathione binding,MF,
3842,GO:0043297,1,0.470566950363031,0,2,apical junction assembly,BP,
3846,GO:0043316,1,0.719239884495386,0,1,cytotoxic T cell degranulation,BP,
3847,GO:0043320,1,0.719239884495386,0,1,natural killer cell degranulation,BP,
3848,GO:0043325,1,0.721277899526339,0,1,phosphatidylinositol-3,4-bisphosphate binding,MF,
3849,GO:0043330,1,0.497462870425957,0,2,response to exogenous dsRNA,BP,
3851,GO:0043367,1,0.730064105565976,0,1,CD4-positive, alpha-beta T cell differentiation,BP,
3852,GO:0043368,1,0.730064105565976,0,1,positive T cell selection,BP,
3853,GO:0043369,1,0.730064105565976,0,1,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
3854,GO:0043373,1,0.730064105565976,0,1,CD4-positive, alpha-beta T cell lineage commitment,BP,
3871,GO:0043455,1,0.734655294999483,0,1,regulation of secondary metabolic process,BP,
3873,GO:0043462,1,0.413810175706029,0,2,regulation of ATPase activity,BP,
3880,GO:0043484,1,0.734654319492406,0,1,regulation of RNA splicing,BP,
3887,GO:0043496,1,0.449963648669571,0,2,regulation of protein homodimerization activity,BP,
3901,GO:0043536,1,0.520022212716508,0,2,positive regulation of blood vessel endothelial cell migration,BP,
3904,GO:0043543,1,0.539096379269584,0,2,protein acylation,BP,
3905,GO:0043546,1,0.734619092483416,0,1,molybdopterin cofactor binding,MF,
3907,GO:0043548,1,0.539142736166612,0,2,phosphatidylinositol 3-kinase binding,MF,
3909,GO:0043550,1,0.388347251583395,0,3,regulation of lipid kinase activity,BP,
3910,GO:0043551,1,0.388347251583395,0,3,regulation of phosphatidylinositol 3-kinase activity,BP,
3911,GO:0043552,1,0.721696904193942,0,1,positive regulation of phosphatidylinositol 3-kinase activity,BP,
3912,GO:0043555,1,0.732887609658439,0,1,regulation of translation in response to stress,BP,
3913,GO:0043559,1,0.734654319492406,0,1,insulin binding,MF,
3916,GO:0043567,1,0.728387748399053,0,1,regulation of insulin-like growth factor receptor signaling pathway,BP,
3917,GO:0043569,1,0.728387748399053,0,1,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
3918,GO:0043576,1,0.720481830454823,0,1,regulation of respiratory gaseous exchange,BP,
3921,GO:0043585,1,0.720739389914957,0,1,nose morphogenesis,BP,
3925,GO:0043615,1,0.677828420297706,0,1,astrocyte cell migration,BP,
3928,GO:0043619,1,0.732887609658439,0,1,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
3935,GO:0043648,1,0.113245843403803,0,6,dicarboxylic acid metabolic process,BP,
3936,GO:0043650,1,0.733899513955252,0,1,dicarboxylic acid biosynthetic process,BP,
3937,GO:0043651,1,0.734591748630676,0,1,linoleic acid metabolic process,BP,
3938,GO:0043666,1,0.678874584138857,0,1,regulation of phosphoprotein phosphatase activity,BP,
3939,GO:0043679,1,0.350095688639791,0,3,axon terminus,CC,
3940,GO:0043687,1,0.734550021650832,0,1,post-translational protein modification,BP,
3942,GO:0043696,1,0.721696904193942,0,1,dedifferentiation,BP,
3943,GO:0043697,1,0.721696904193942,0,1,cell dedifferentiation,BP,
3946,GO:0043901,1,0.438971656032627,0,2,negative regulation of multi-organism process,BP,
3949,GO:0043931,1,0.728387748399053,0,1,ossification involved in bone maturation,BP,
3951,GO:0043954,1,0.518770098471227,0,2,cellular component maintenance,BP,
3952,GO:0043966,1,0.734513896772137,0,1,histone H3 acetylation,BP,
3953,GO:0043974,1,0.734513896772137,0,1,histone H3-K27 acetylation,BP,
3957,GO:0044042,1,0.721277899526339,0,1,glucan metabolic process,BP,
3961,GO:0044062,1,0.362898355912859,0,3,regulation of excretion,BP,
3962,GO:0044065,1,0.720481830454823,0,1,regulation of respiratory system process,BP,
3963,GO:0044070,1,0.242620154813009,0,4,regulation of anion transport,BP,
3968,GO:0044090,1,0.696012829206827,0,1,positive regulation of vacuole organization,BP,
3969,GO:0044091,1,0.734589394501328,0,1,membrane biogenesis,BP,
3990,GO:0044264,1,0.516768288390107,0,2,cellular polysaccharide metabolic process,BP,
4000,GO:0044291,1,0.394993526526019,0,3,cell-cell contact zone,CC,
4004,GO:0044309,1,0.284011168278666,0,4,neuron spine,CC,
4009,GO:0044331,1,0.539176843585691,0,2,cell-cell adhesion mediated by cadherin,BP,
4015,GO:0044351,1,0.624051270746175,0,1,macropinocytosis,BP,
4016,GO:0044364,1,0.685061814505026,0,1,disruption of cells of other organism,BP,
4017,GO:0044381,1,0.395311467339384,0,3,glucose import in response to insulin stimulus,BP,
4022,GO:0044406,1,0.707679132473116,0,1,adhesion of symbiont to host,BP,
4025,GO:0044420,1,0.337977722876629,0,3,extracellular matrix component,CC,
4030,GO:0044427,1,0.370022514905198,0,3,chromosomal part,CC,
4046,GO:0044449,1,0.0284474636235428,0,10,contractile fiber part,CC,
4047,GO:0044450,1,0.493997556399147,0,2,microtubule organizing center part,CC,
4049,GO:0044452,1,0.727559953538537,0,1,nucleolar part,CC,
4050,GO:0044454,1,0.734627459219659,0,1,nuclear chromosome part,CC,
4056,GO:0044539,1,0.634405611216108,0,1,long-chain fatty acid import,BP,
4057,GO:0044548,1,0.636323430837946,0,1,S100 protein binding,MF,
4058,GO:0044550,1,0.530687970511746,0,2,secondary metabolite biosynthetic process,BP,
4059,GO:0044557,1,0.720481830454823,0,1,relaxation of smooth muscle,BP,
4060,GO:0044650,1,0.707679132473116,0,1,adhesion of symbiont to host cell,BP,
4074,GO:0044729,1,0.725196311092909,0,1,hemi-methylated DNA-binding,MF,
4084,GO:0044773,1,0.32683251076091,0,3,mitotic DNA damage checkpoint,BP,
4085,GO:0044774,1,0.32683251076091,0,3,mitotic DNA integrity checkpoint,BP,
4087,GO:0044783,1,0.448535957280229,0,2,G1 DNA damage checkpoint,BP,
4089,GO:0044800,1,0.707679132473116,0,1,multi-organism membrane fusion,BP,
4092,GO:0044803,1,0.707679132473116,0,1,multi-organism membrane organization,BP,
4093,GO:0044818,1,0.730352294167363,0,1,mitotic G2/M transition checkpoint,BP,
4094,GO:0044819,1,0.448535957280229,0,2,mitotic G1/S transition checkpoint,BP,
4096,GO:0044843,1,0.0972141658790313,0,6,cell cycle G1/S phase transition,BP,
4097,GO:0044848,1,0.734655294999483,0,1,biological phase,BP,
4098,GO:0044851,1,0.734655294999483,0,1,hair cycle phase,BP,
4100,GO:0044872,1,0.656640353294477,0,1,lipoprotein localization,BP,
4104,GO:0045019,1,0.441601710452898,0,2,negative regulation of nitric oxide biosynthetic process,BP,
4105,GO:0045022,1,0.734550444064761,0,1,early endosome to late endosome transport,BP,
4106,GO:0045023,1,0.510752974134535,0,2,G0 to G1 transition,BP,
4107,GO:0045026,1,0.698707300486311,0,1,plasma membrane fusion,BP,
4108,GO:0045028,1,0.710841574163711,0,1,G-protein coupled purinergic nucleotide receptor activity,MF,
4109,GO:0045029,1,0.710841574163711,0,1,UDP-activated nucleotide receptor activity,MF,
4110,GO:0045054,1,0.719239884495386,0,1,constitutive secretory pathway,BP,
4112,GO:0045056,1,0.678660193884167,0,1,transcytosis,BP,
4117,GO:0045071,1,0.734576401742655,0,1,negative regulation of viral genome replication,BP,
4118,GO:0045072,1,0.730064105565976,0,1,regulation of interferon-gamma biosynthetic process,BP,
4119,GO:0045073,1,0.525154618129057,0,2,regulation of chemokine biosynthetic process,BP,
4120,GO:0045078,1,0.730064105565976,0,1,positive regulation of interferon-gamma biosynthetic process,BP,
4121,GO:0045080,1,0.525154618129057,0,2,positive regulation of chemokine biosynthetic process,BP,
4130,GO:0045117,1,0.687857981162908,0,1,azole transport,BP,
4134,GO:0045125,1,0.671454541303455,0,1,bioactive lipid receptor activity,MF,
4135,GO:0045136,1,0.734655294999483,0,1,development of secondary sexual characteristics,BP,
4140,GO:0045168,1,0.731051540942314,0,1,cell-cell signaling involved in cell fate commitment,BP,
4141,GO:0045171,1,0.481793963758607,0,2,intercellular bridge,CC,
4143,GO:0045178,1,0.353889962086667,0,3,basal part of cell,CC,
4146,GO:0045187,1,0.720481830454823,0,1,regulation of circadian sleep/wake cycle, sleep,BP,
4147,GO:0045188,1,0.720481830454823,0,1,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
4148,GO:0045190,1,0.67186132548751,0,1,isotype switching,BP,
4149,GO:0045191,1,0.67186132548751,0,1,regulation of isotype switching,BP,
4150,GO:0045197,1,0.539148185841117,0,2,establishment or maintenance of epithelial cell apical/basal polarity,BP,
4151,GO:0045198,1,0.539148185841117,0,2,establishment of epithelial cell apical/basal polarity,BP,
4153,GO:0045210,1,0.734657854922162,0,1,FasL biosynthetic process,BP,
4155,GO:0045214,1,0.26403839663005,0,4,sarcomere organization,BP,
4157,GO:0045217,1,0.706886301239446,0,1,cell-cell junction maintenance,BP,
4158,GO:0045218,1,0.706886301239446,0,1,zonula adherens maintenance,BP,
4160,GO:0045294,1,0.528169963642725,0,2,alpha-catenin binding,MF,
4163,GO:0045309,1,0.539137129467295,0,2,protein phosphorylated amino acid binding,MF,
4166,GO:0045334,1,0.5143666840257,0,2,clathrin-coated endocytic vesicle,CC,
4168,GO:0045349,1,0.654756153569277,0,1,interferon-alpha biosynthetic process,BP,
4169,GO:0045350,1,0.467902075476333,0,2,interferon-beta biosynthetic process,BP,
4170,GO:0045351,1,0.467902075476333,0,2,type I interferon biosynthetic process,BP,
4171,GO:0045354,1,0.654756153569277,0,1,regulation of interferon-alpha biosynthetic process,BP,
4172,GO:0045355,1,0.654756153569277,0,1,negative regulation of interferon-alpha biosynthetic process,BP,
4173,GO:0045357,1,0.467902075476333,0,2,regulation of interferon-beta biosynthetic process,BP,
4174,GO:0045358,1,0.654756153569277,0,1,negative regulation of interferon-beta biosynthetic process,BP,
4175,GO:0045359,1,0.71553036272411,0,1,positive regulation of interferon-beta biosynthetic process,BP,
4178,GO:0045402,1,0.730064105565976,0,1,regulation of interleukin-4 biosynthetic process,BP,
4179,GO:0045403,1,0.730064105565976,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
4180,GO:0045428,1,0.155059743150086,0,5,regulation of nitric oxide biosynthetic process,BP,
4181,GO:0045429,1,0.353830774522892,0,3,positive regulation of nitric oxide biosynthetic process,BP,
4187,GO:0045485,1,0.734591748630676,0,1,omega-6 fatty acid desaturase activity,MF,
4188,GO:0045494,1,0.734548276341575,0,1,photoreceptor cell maintenance,BP,
4195,GO:0045582,1,0.703491083600584,0,1,positive regulation of T cell differentiation,BP,
4213,GO:0045621,1,0.497289712214936,0,2,positive regulation of lymphocyte differentiation,BP,
4216,GO:0045634,1,0.734638208028596,0,1,regulation of melanocyte differentiation,BP,
4217,GO:0045636,1,0.734638208028596,0,1,positive regulation of melanocyte differentiation,BP,
4221,GO:0045646,1,0.730064105565976,0,1,regulation of erythrocyte differentiation,BP,
4241,GO:0045723,1,0.678874584138857,0,1,positive regulation of fatty acid biosynthetic process,BP,
4242,GO:0045725,1,0.721277899526339,0,1,positive regulation of glycogen biosynthetic process,BP,
4243,GO:0045727,1,0.71794240190076,0,1,positive regulation of translation,BP,
4246,GO:0045736,1,0.693238114134537,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
4247,GO:0045737,1,0.210904484307355,0,4,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
4248,GO:0045739,1,0.610551717868249,0,1,positive regulation of DNA repair,BP,
4250,GO:0045741,1,0.356717845346648,0,3,positive regulation of epidermal growth factor-activated receptor activity,BP,
4251,GO:0045742,1,0.172750872057431,0,5,positive regulation of epidermal growth factor receptor signaling pathway,BP,
4252,GO:0045744,1,0.521919952681309,0,2,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
4253,GO:0045745,1,0.685061814505026,0,1,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
4257,GO:0045766,1,0.274960414991668,0,4,positive regulation of angiogenesis,BP,
4259,GO:0045777,1,0.720481830454823,0,1,positive regulation of blood pressure,BP,
4266,GO:0045793,1,0.687857981162908,0,1,positive regulation of cell size,BP,
4267,GO:0045806,1,0.394866768801652,0,2,negative regulation of endocytosis,BP,
4268,GO:0045807,1,0.0811824574892184,0,7,positive regulation of endocytosis,BP,
4271,GO:0045823,1,0.328665039559409,0,3,positive regulation of heart contraction,BP,
4272,GO:0045824,1,0.480374539118214,0,2,negative regulation of innate immune response,BP,
4273,GO:0045830,1,0.67186132548751,0,1,positive regulation of isotype switching,BP,
4276,GO:0045835,1,0.734513896772137,0,1,negative regulation of meiotic nuclear division,BP,
4277,GO:0045836,1,0.539112223566813,0,2,positive regulation of meiotic nuclear division,BP,
4286,GO:0045861,1,0.100968301771564,0,6,negative regulation of proteolysis,BP,
4288,GO:0045879,1,0.734595256616651,0,1,negative regulation of smoothened signaling pathway,BP,
4291,GO:0045907,1,0.490037742395751,0,2,positive regulation of vasoconstriction,BP,
4292,GO:0045911,1,0.67186132548751,0,1,positive regulation of DNA recombination,BP,
4298,GO:0045923,1,0.678874584138857,0,1,positive regulation of fatty acid metabolic process,BP,
4304,GO:0045933,1,0.328665039559409,0,3,positive regulation of muscle contraction,BP,
4309,GO:0045939,1,0.382643336970993,0,3,negative regulation of steroid metabolic process,BP,
4315,GO:0045986,1,0.48949534172683,0,2,negative regulation of smooth muscle contraction,BP,
4316,GO:0045987,1,0.687857981162908,0,1,positive regulation of smooth muscle contraction,BP,
4318,GO:0045989,1,0.47899761864459,0,2,positive regulation of striated muscle contraction,BP,
4324,GO:0046039,1,0.734598124981224,0,1,GTP metabolic process,BP,
4325,GO:0046058,1,0.126516851576625,0,5,cAMP metabolic process,BP,
4327,GO:0046102,1,0.703491083600584,0,1,inosine metabolic process,BP,
4328,GO:0046110,1,0.734619092483416,0,1,xanthine metabolic process,BP,
4329,GO:0046113,1,0.734619092483416,0,1,nucleobase catabolic process,BP,
4330,GO:0046121,1,0.668032632215708,0,1,deoxyribonucleoside catabolic process,BP,
4331,GO:0046128,1,0.516257181557568,0,2,purine ribonucleoside metabolic process,BP,
4332,GO:0046130,1,0.703491083600584,0,1,purine ribonucleoside catabolic process,BP,
4334,GO:0046148,1,0.734655294999483,0,1,pigment biosynthetic process,BP,
4338,GO:0046209,1,0.155059743150086,0,5,nitric oxide metabolic process,BP,
4342,GO:0046324,1,0.208071299217913,0,5,regulation of glucose import,BP,
4343,GO:0046326,1,0.208071299217913,0,5,positive regulation of glucose import,BP,
4345,GO:0046329,1,0.721277899526339,0,1,negative regulation of JNK cascade,BP,
4347,GO:0046331,1,0.731051540942314,0,1,lateral inhibition,BP,
4349,GO:0046339,1,0.62828243039627,0,1,diacylglycerol metabolic process,BP,
4353,GO:0046386,1,0.668032632215708,0,1,deoxyribose phosphate catabolic process,BP,
4357,GO:0046415,1,0.703491083600584,0,1,urate metabolic process,BP,
4361,GO:0046449,1,0.734588622258976,0,1,creatinine metabolic process,BP,
4362,GO:0046456,1,0.208291182420284,0,4,icosanoid biosynthetic process,BP,
4363,GO:0046457,1,0.461029926266115,0,2,prostanoid biosynthetic process,BP,
4364,GO:0046460,1,0.425862541897857,0,2,neutral lipid biosynthetic process,BP,
4366,GO:0046463,1,0.425862541897857,0,2,acylglycerol biosynthetic process,BP,
4368,GO:0046466,1,0.440919064064122,0,2,membrane lipid catabolic process,BP,
4372,GO:0046475,1,0.602424533559327,0,1,glycerophospholipid catabolic process,BP,
4373,GO:0046477,1,0.651434792770337,0,1,glycosylceramide catabolic process,BP,
4374,GO:0046479,1,0.440919064064122,0,2,glycosphingolipid catabolic process,BP,
4380,GO:0046495,1,0.703491083600584,0,1,nicotinamide riboside metabolic process,BP,
4383,GO:0046514,1,0.440919064064122,0,2,ceramide catabolic process,BP,
4384,GO:0046523,1,0.727559953538537,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
4389,GO:0046541,1,0.610551717868249,0,1,saliva secretion,BP,
4390,GO:0046543,1,0.734655294999483,0,1,development of secondary female sexual characteristics,BP,
4393,GO:0046573,1,0.663248360975453,0,1,lactonohydrolase activity,MF,
4396,GO:0046580,1,0.734619771595464,0,1,negative regulation of Ras protein signal transduction,BP,
4397,GO:0046605,1,0.726840642387705,0,1,regulation of centrosome cycle,BP,
4401,GO:0046626,1,0.734654319492406,0,1,regulation of insulin receptor signaling pathway,BP,
4403,GO:0046631,1,0.513062322168484,0,2,alpha-beta T cell activation,BP,
4404,GO:0046632,1,0.513062322168484,0,2,alpha-beta T cell differentiation,BP,
4405,GO:0046634,1,0.703491083600584,0,1,regulation of alpha-beta T cell activation,BP,
4406,GO:0046635,1,0.703491083600584,0,1,positive regulation of alpha-beta T cell activation,BP,
4407,GO:0046637,1,0.703491083600584,0,1,regulation of alpha-beta T cell differentiation,BP,
4408,GO:0046638,1,0.703491083600584,0,1,positive regulation of alpha-beta T cell differentiation,BP,
4416,GO:0046685,1,0.693238114134537,0,1,response to arsenic-containing substance,BP,
4417,GO:0046686,1,0.318412544455344,0,3,response to cadmium ion,BP,
4420,GO:0046717,1,0.362560676294799,0,3,acid secretion,BP,
4421,GO:0046718,1,0.148178012485866,0,6,viral entry into host cell,BP,
4422,GO:0046777,1,0.192474155257484,0,5,protein autophosphorylation,BP,
4423,GO:0046785,1,0.449704456689423,0,2,microtubule polymerization,BP,
4425,GO:0046794,1,0.734621422421857,0,1,transport of virus,BP,
4427,GO:0046813,1,0.707679132473116,0,1,receptor-mediated virion attachment to host cell,BP,
4431,GO:0046825,1,0.432310550574597,0,2,regulation of protein export from nucleus,BP,
4432,GO:0046827,1,0.707679132473116,0,1,positive regulation of protein export from nucleus,BP,
4434,GO:0046835,1,0.516387479317128,0,2,carbohydrate phosphorylation,BP,
4435,GO:0046847,1,0.248164381407653,0,4,filopodium assembly,BP,
4445,GO:0046877,1,0.610551717868249,0,1,regulation of saliva secretion,BP,
4462,GO:0046912,1,0.703143825629313,0,1,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
4464,GO:0046915,1,0.328334362761306,0,3,transition metal ion transmembrane transporter activity,MF,
4467,GO:0046935,1,0.539137129467295,0,2,1-phosphatidylinositol-3-kinase regulator activity,MF,
4469,GO:0046942,1,0.0868645229275558,0,7,carboxylic acid transport,BP,
4470,GO:0046943,1,0.733899513955252,0,1,carboxylic acid transmembrane transporter activity,MF,
4471,GO:0046949,1,0.272723595217001,0,4,fatty-acyl-CoA biosynthetic process,BP,
4478,GO:0046997,1,0.731018562409083,0,1,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
4479,GO:0047015,1,0.6269280304009,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
4480,GO:0047035,1,0.636687019414012,0,1,testosterone dehydrogenase (NAD+) activity,MF,
4481,GO:0047045,1,0.636687019414012,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
4482,GO:0047117,1,0.734715871907028,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
4484,GO:0047442,1,0.675836959389896,0,1,17-alpha-hydroxyprogesterone aldolase activity,MF,
4485,GO:0047451,1,0.734715871907028,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
4486,GO:0047485,1,0.47544849558096,0,2,protein N-terminus binding,MF,
4487,GO:0047598,1,0.71385568806396,0,1,7-dehydrocholesterol reductase activity,MF,
4488,GO:0047676,1,0.734629515296733,0,1,arachidonate-CoA ligase activity,MF,
4489,GO:0047750,1,0.637466954542453,0,1,cholestenol delta-isomerase activity,MF,
4490,GO:0047760,1,0.703997935140284,0,1,butyrate-CoA ligase activity,MF,
4491,GO:0047860,1,0.643589205720551,0,1,diiodophenylpyruvate reductase activity,MF,
4493,GO:0048008,1,0.526602541954919,0,2,platelet-derived growth factor receptor signaling pathway,BP,
4494,GO:0048009,1,0.28191305005233,0,4,insulin-like growth factor receptor signaling pathway,BP,
4496,GO:0048011,1,0.730381896558346,0,1,neurotrophin TRK receptor signaling pathway,BP,
4497,GO:0048012,1,0.730381896558346,0,1,hepatocyte growth factor receptor signaling pathway,BP,
4504,GO:0048021,1,0.734655294999483,0,1,regulation of melanin biosynthetic process,BP,
4505,GO:0048022,1,0.734655294999483,0,1,negative regulation of melanin biosynthetic process,BP,
4506,GO:0048029,1,0.664661465181863,0,1,monosaccharide binding,MF,
4513,GO:0048070,1,0.734638208028596,0,1,regulation of developmental pigmentation,BP,
4514,GO:0048087,1,0.734638208028596,0,1,positive regulation of developmental pigmentation,BP,
4519,GO:0048147,1,0.631206911498226,0,1,negative regulation of fibroblast proliferation,BP,
4521,GO:0048156,1,0.636323430837946,0,1,tau protein binding,MF,
4528,GO:0048179,1,0.724071876739581,0,1,activin receptor complex,CC,
4532,GO:0048237,1,0.687857981162908,0,1,rough endoplasmic reticulum lumen,CC,
4533,GO:0048241,1,0.496169850027802,0,2,epinephrine transport,BP,
4534,GO:0048242,1,0.496169850027802,0,2,epinephrine secretion,BP,
4535,GO:0048243,1,0.496169850027802,0,2,norepinephrine secretion,BP,
4536,GO:0048244,1,0.664661465181863,0,1,phytanoyl-CoA dioxygenase activity,MF,
4538,GO:0048251,1,0.734688491282273,0,1,elastic fiber assembly,BP,
4540,GO:0048259,1,0.283223639914483,0,3,regulation of receptor-mediated endocytosis,BP,
4541,GO:0048260,1,0.719222945349914,0,1,positive regulation of receptor-mediated endocytosis,BP,
4542,GO:0048261,1,0.394866768801652,0,2,negative regulation of receptor-mediated endocytosis,BP,
4543,GO:0048262,1,0.724071876739581,0,1,determination of dorsal/ventral asymmetry,BP,
4544,GO:0048263,1,0.724071876739581,0,1,determination of dorsal identity,BP,
4549,GO:0048289,1,0.67186132548751,0,1,isotype switching to IgE isotypes,BP,
4550,GO:0048293,1,0.67186132548751,0,1,regulation of isotype switching to IgE isotypes,BP,
4551,GO:0048295,1,0.67186132548751,0,1,positive regulation of isotype switching to IgE isotypes,BP,
4553,GO:0048306,1,0.454816402608767,0,2,calcium-dependent protein binding,MF,
4559,GO:0048339,1,0.734655294999483,0,1,paraxial mesoderm development,BP,
4560,GO:0048340,1,0.734655294999483,0,1,paraxial mesoderm morphogenesis,BP,
4561,GO:0048341,1,0.734655294999483,0,1,paraxial mesoderm formation,BP,
4567,GO:0048407,1,0.721696904193942,0,1,platelet-derived growth factor binding,MF,
4580,GO:0048512,1,0.514210881806709,0,2,circadian behavior,BP,
4583,GO:0048515,1,0.497813076500956,0,2,spermatid differentiation,BP,
4586,GO:0048520,1,0.720739389914957,0,1,positive regulation of behavior,BP,
4587,GO:0048521,1,0.720481830454823,0,1,negative regulation of behavior,BP,
4591,GO:0048525,1,0.734576401742655,0,1,negative regulation of viral process,BP,
4592,GO:0048531,1,0.717192339181394,0,1,beta-1,3-galactosyltransferase activity,MF,
4593,GO:0048532,1,0.731051540942314,0,1,anatomical structure arrangement,BP,
4602,GO:0048557,1,0.610551717868249,0,1,embryonic digestive tract morphogenesis,BP,
4604,GO:0048563,1,0.734698187201066,0,1,post-embryonic animal organ morphogenesis,BP,
4606,GO:0048566,1,0.439421434200077,0,2,embryonic digestive tract development,BP,
4608,GO:0048569,1,0.734698187201066,0,1,post-embryonic animal organ development,BP,
4609,GO:0048570,1,0.734655294999483,0,1,notochord morphogenesis,BP,
4632,GO:0048642,1,0.636323430837946,0,1,negative regulation of skeletal muscle tissue development,BP,
4640,GO:0048662,1,0.460928071498204,0,2,negative regulation of smooth muscle cell proliferation,BP,
4642,GO:0048665,1,0.731051540942314,0,1,neuron fate specification,BP,
4650,GO:0048678,1,0.733958464826053,0,1,response to axon injury,BP,
4673,GO:0048752,1,0.610551717868249,0,1,semicircular canal morphogenesis,BP,
4680,GO:0048786,1,0.720481830454823,0,1,presynaptic active zone,CC,
4682,GO:0048799,1,0.728387748399053,0,1,animal organ maturation,BP,
4685,GO:0048808,1,0.610551717868249,0,1,male genitalia morphogenesis,BP,
4688,GO:0048814,1,0.734640725657069,0,1,regulation of dendrite morphogenesis,BP,
4689,GO:0048818,1,0.734655294999483,0,1,positive regulation of hair follicle maturation,BP,
4690,GO:0048819,1,0.734655294999483,0,1,regulation of hair follicle maturation,BP,
4691,GO:0048820,1,0.734655294999483,0,1,hair follicle maturation,BP,
4698,GO:0048850,1,0.734655294999483,0,1,hypophysis morphogenesis,BP,
4699,GO:0048852,1,0.734655294999483,0,1,diencephalon morphogenesis,BP,
4704,GO:0048861,1,0.734513896772137,0,1,leukemia inhibitory factor signaling pathway,BP,
4712,GO:0050000,1,0.668902320485507,0,1,chromosome localization,BP,
4713,GO:0050220,1,0.671129001439236,0,1,prostaglandin-E synthase activity,MF,
4714,GO:0050277,1,0.734423653901122,0,1,sedoheptulokinase activity,MF,
4715,GO:0050308,1,0.734590273582109,0,1,sugar-phosphatase activity,MF,
4716,GO:0050321,1,0.734617631152968,0,1,tau-protein kinase activity,MF,
4717,GO:0050431,1,0.724071876739581,0,1,transforming growth factor beta binding,MF,
4720,GO:0050508,1,0.734563521305442,0,1,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
4721,GO:0050543,1,0.634405611216108,0,1,icosatetraenoic acid binding,MF,
4722,GO:0050654,1,0.469006068069894,0,2,chondroitin sulfate proteoglycan metabolic process,BP,
4723,GO:0050655,1,0.692808616325038,0,1,dermatan sulfate proteoglycan metabolic process,BP,
4732,GO:0050674,1,0.610551717868249,0,1,urothelial cell proliferation,BP,
4733,GO:0050675,1,0.610551717868249,0,1,regulation of urothelial cell proliferation,BP,
4734,GO:0050677,1,0.610551717868249,0,1,positive regulation of urothelial cell proliferation,BP,
4738,GO:0050699,1,0.637935451872259,0,1,WW domain binding,MF,
4739,GO:0050701,1,0.323229372108408,0,3,interleukin-1 secretion,BP,
4740,GO:0050702,1,0.457863957762274,0,2,interleukin-1 beta secretion,BP,
4741,GO:0050704,1,0.323229372108408,0,3,regulation of interleukin-1 secretion,BP,
4742,GO:0050706,1,0.457863957762274,0,2,regulation of interleukin-1 beta secretion,BP,
4743,GO:0050707,1,0.323229372108408,0,3,regulation of cytokine secretion,BP,
4746,GO:0050710,1,0.707679132473116,0,1,negative regulation of cytokine secretion,BP,
4747,GO:0050711,1,0.707679132473116,0,1,negative regulation of interleukin-1 secretion,BP,
4749,GO:0050715,1,0.457863957762274,0,2,positive regulation of cytokine secretion,BP,
4750,GO:0050716,1,0.457863957762274,0,2,positive regulation of interleukin-1 secretion,BP,
4751,GO:0050718,1,0.457863957762274,0,2,positive regulation of interleukin-1 beta secretion,BP,
4756,GO:0050728,1,0.528717154773441,0,2,negative regulation of inflammatory response,BP,
4758,GO:0050730,1,0.00916932956583558,0,13,regulation of peptidyl-tyrosine phosphorylation,BP,
4759,GO:0050731,1,0.00916932956583558,0,13,positive regulation of peptidyl-tyrosine phosphorylation,BP,
4760,GO:0050755,1,0.525154618129057,0,2,chemokine metabolic process,BP,
4761,GO:0050764,1,0.213674968476913,0,4,regulation of phagocytosis,BP,
4762,GO:0050766,1,0.213674968476913,0,4,positive regulation of phagocytosis,BP,
4771,GO:0050777,1,0.480374539118214,0,2,negative regulation of immune response,BP,
4773,GO:0050786,1,0.636323430837946,0,1,RAGE receptor binding,MF,
4779,GO:0050795,1,0.518755912343801,0,2,regulation of behavior,BP,
4783,GO:0050802,1,0.514210881806709,0,2,circadian sleep/wake cycle, sleep,BP,
4786,GO:0050805,1,0.720481830454823,0,1,negative regulation of synaptic transmission,BP,
4791,GO:0050812,1,0.734076412283897,0,1,regulation of acyl-CoA biosynthetic process,BP,
4793,GO:0050818,1,0.256693797637455,0,4,regulation of coagulation,BP,
4794,GO:0050819,1,0.350478925022211,0,3,negative regulation of coagulation,BP,
4795,GO:0050821,1,0.220902945753129,0,4,protein stabilization,BP,
4796,GO:0050829,1,0.426854527304632,0,2,defense response to Gram-negative bacterium,BP,
4797,GO:0050830,1,0.685061814505026,0,1,defense response to Gram-positive bacterium,BP,
4798,GO:0050832,1,0.685061814505026,0,1,defense response to fungus,BP,
4800,GO:0050840,1,0.734619771595464,0,1,extracellular matrix binding,MF,
4805,GO:0050853,1,0.730381896558346,0,1,B cell receptor signaling pathway,BP,
4807,GO:0050864,1,0.332054355296759,0,3,regulation of B cell activation,BP,
4813,GO:0050871,1,0.332054355296759,0,3,positive regulation of B cell activation,BP,
4814,GO:0050872,1,0.610551717868249,0,1,white fat cell differentiation,BP,
4819,GO:0050880,1,0.0337337186438115,0,9,regulation of blood vessel size,BP,
4821,GO:0050885,1,0.266831222719284,0,4,neuromuscular process controlling balance,BP,
4823,GO:0050890,1,0.0841629528802614,0,7,cognition,BP,
4824,GO:0050891,1,0.379593401532809,0,3,multicellular organismal water homeostasis,BP,
4828,GO:0050905,1,0.191531753441792,0,5,neuromuscular process,BP,
4829,GO:0050906,1,0.720481830454823,0,1,detection of stimulus involved in sensory perception,BP,
4831,GO:0050919,1,0.734655294999483,0,1,negative chemotaxis,BP,
4839,GO:0050932,1,0.734638208028596,0,1,regulation of pigment cell differentiation,BP,
4840,GO:0050942,1,0.734638208028596,0,1,positive regulation of pigment cell differentiation,BP,
4841,GO:0050951,1,0.720481830454823,0,1,sensory perception of temperature stimulus,BP,
4844,GO:0050957,1,0.539178144265601,0,2,equilibrioception,BP,
4845,GO:0050961,1,0.720481830454823,0,1,detection of temperature stimulus involved in sensory perception,BP,
4846,GO:0050965,1,0.720481830454823,0,1,detection of temperature stimulus involved in sensory perception of pain,BP,
4849,GO:0050996,1,0.732887609658439,0,1,positive regulation of lipid catabolic process,BP,
4850,GO:0050997,1,0.420257328523098,0,2,quaternary ammonium group binding,MF,
4852,GO:0051000,1,0.721277899526339,0,1,positive regulation of nitric-oxide synthase activity,BP,
4853,GO:0051001,1,0.651434792770337,0,1,negative regulation of nitric-oxide synthase activity,BP,
4854,GO:0051004,1,0.602424533559327,0,1,regulation of lipoprotein lipase activity,BP,
4855,GO:0051005,1,0.602424533559327,0,1,negative regulation of lipoprotein lipase activity,BP,
4856,GO:0051011,1,0.706886301239446,0,1,microtubule minus-end binding,MF,
4858,GO:0051017,1,0.142210360258772,0,6,actin filament bundle assembly,BP,
4859,GO:0051018,1,0.707766673908358,0,1,protein kinase A binding,MF,
4863,GO:0051040,1,0.728387748399053,0,1,regulation of calcium-independent cell-cell adhesion,BP,
4864,GO:0051042,1,0.728387748399053,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
4872,GO:0051053,1,0.405568804265199,0,2,negative regulation of DNA metabolic process,BP,
4877,GO:0051058,1,0.734619771595464,0,1,negative regulation of small GTPase mediated signal transduction,BP,
4880,GO:0051092,1,0.213103926623685,0,4,positive regulation of NF-kappaB transcription factor activity,BP,
4887,GO:0051117,1,0.696012829206827,0,1,ATPase binding,MF,
4898,GO:0051151,1,0.526581145142827,0,2,negative regulation of smooth muscle cell differentiation,BP,
4902,GO:0051156,1,0.490058217144967,0,2,glucose 6-phosphate metabolic process,BP,
4903,GO:0051168,1,0.432310550574597,0,2,nuclear export,BP,
4911,GO:0051180,1,0.508942530562673,0,2,vitamin transport,BP,
4912,GO:0051181,1,0.733916729266681,0,1,cofactor transport,BP,
4914,GO:0051184,1,0.733916729266681,0,1,cofactor transporter activity,MF,
4926,GO:0051208,1,0.46415575177156,0,2,sequestering of calcium ion,BP,
4927,GO:0051209,1,0.46415575177156,0,2,release of sequestered calcium ion into cytosol,BP,
4928,GO:0051213,1,0.664661465181863,0,1,dioxygenase activity,MF,
4930,GO:0051219,1,0.539137129467295,0,2,phosphoprotein binding,MF,
4931,GO:0051220,1,0.721277899526339,0,1,cytoplasmic sequestering of protein,BP,
4935,GO:0051233,1,0.656640353294477,0,1,spindle midzone,CC,
4938,GO:0051238,1,0.46415575177156,0,2,sequestering of metal ion,BP,
4959,GO:0051276,1,0.179714291939976,0,5,chromosome organization,BP,
4960,GO:0051279,1,0.715718629020694,0,1,regulation of release of sequestered calcium ion into cytosol,BP,
4961,GO:0051280,1,0.715718629020694,0,1,negative regulation of release of sequestered calcium ion into cytosol,BP,
4962,GO:0051282,1,0.46415575177156,0,2,regulation of sequestering of calcium ion,BP,
4963,GO:0051283,1,0.46415575177156,0,2,negative regulation of sequestering of calcium ion,BP,
4964,GO:0051284,1,0.715718629020694,0,1,positive regulation of sequestering of calcium ion,BP,
4965,GO:0051287,1,0.237518666512138,0,4,NAD binding,MF,
4968,GO:0051293,1,0.610551717868249,0,1,establishment of spindle localization,BP,
4969,GO:0051294,1,0.610551717868249,0,1,establishment of spindle orientation,BP,
4970,GO:0051297,1,0.470347636274046,0,2,centrosome organization,BP,
4971,GO:0051298,1,0.726840642387705,0,1,centrosome duplication,BP,
4974,GO:0051303,1,0.668902320485507,0,1,establishment of chromosome localization,BP,
4975,GO:0051310,1,0.668902320485507,0,1,metaphase plate congression,BP,
4976,GO:0051321,1,0.11859326312275,0,6,meiotic cell cycle,BP,
4979,GO:0051340,1,0.678874584138857,0,1,regulation of ligase activity,BP,
4981,GO:0051342,1,0.678874584138857,0,1,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
4982,GO:0051344,1,0.678874584138857,0,1,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
4987,GO:0051352,1,0.678874584138857,0,1,negative regulation of ligase activity,BP,
4989,GO:0051354,1,0.651434792770337,0,1,negative regulation of oxidoreductase activity,BP,
4990,GO:0051373,1,0.734598335802591,0,1,FATZ binding,MF,
4991,GO:0051379,1,0.496169850027802,0,2,epinephrine binding,MF,
4993,GO:0051385,1,0.236820956938109,0,4,response to mineralocorticoid,BP,
4996,GO:0051412,1,0.494717868455972,0,2,response to corticosterone,BP,
4998,GO:0051428,1,0.598426664068228,0,1,peptide hormone receptor binding,MF,
5005,GO:0051445,1,0.172295841723332,0,5,regulation of meiotic cell cycle,BP,
5006,GO:0051446,1,0.539112223566813,0,2,positive regulation of meiotic cell cycle,BP,
5007,GO:0051447,1,0.321688345117573,0,3,negative regulation of meiotic cell cycle,BP,
5011,GO:0051482,1,0.687857981162908,0,1,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
5012,GO:0051489,1,0.364410750847098,0,3,regulation of filopodium assembly,BP,
5013,GO:0051491,1,0.538150499488845,0,2,positive regulation of filopodium assembly,BP,
5014,GO:0051492,1,0.267339795763795,0,4,regulation of stress fiber assembly,BP,
5018,GO:0051496,1,0.364974984478449,0,3,positive regulation of stress fiber assembly,BP,
5019,GO:0051531,1,0.734654319492406,0,1,NFAT protein import into nucleus,BP,
5021,GO:0051537,1,0.734619092483416,0,1,2 iron, 2 sulfur cluster binding,MF,
5024,GO:0051541,1,0.700866560072831,0,1,elastin metabolic process,BP,
5025,GO:0051542,1,0.700866560072831,0,1,elastin biosynthetic process,BP,
5026,GO:0051543,1,0.700866560072831,0,1,regulation of elastin biosynthetic process,BP,
5027,GO:0051545,1,0.700866560072831,0,1,negative regulation of elastin biosynthetic process,BP,
5028,GO:0051546,1,0.427263343796211,0,2,keratinocyte migration,BP,
5029,GO:0051547,1,0.427263343796211,0,2,regulation of keratinocyte migration,BP,
5030,GO:0051549,1,0.427263343796211,0,2,positive regulation of keratinocyte migration,BP,
5036,GO:0051592,1,0.24106729400681,0,4,response to calcium ion,BP,
5037,GO:0051597,1,0.636323430837946,0,1,response to methylmercury,BP,
5038,GO:0051601,1,0.696012829206827,0,1,exocyst localization,BP,
5044,GO:0051608,1,0.687857981162908,0,1,histamine transport,BP,
5045,GO:0051639,1,0.734619139408899,0,1,actin filament network formation,BP,
5052,GO:0051653,1,0.610551717868249,0,1,spindle localization,BP,
5054,GO:0051668,1,0.734589394501328,0,1,localization within membrane,BP,
5057,GO:0051694,1,0.646438464904563,0,1,pointed-end actin filament capping,BP,
5058,GO:0051695,1,0.734598335802591,0,1,actin filament uncapping,BP,
5063,GO:0051721,1,0.721277899526339,0,1,protein phosphatase 2A binding,MF,
5068,GO:0051771,1,0.687857981162908,0,1,negative regulation of nitric-oxide synthase biosynthetic process,BP,
5073,GO:0051797,1,0.480447540547715,0,2,regulation of hair follicle development,BP,
5074,GO:0051798,1,0.480447540547715,0,2,positive regulation of hair follicle development,BP,
5077,GO:0051875,1,0.357459678272068,0,3,pigment granule localization,BP,
5079,GO:0051884,1,0.734655294999483,0,1,regulation of timing of anagen,BP,
5080,GO:0051885,1,0.734655294999483,0,1,positive regulation of timing of anagen,BP,
5081,GO:0051893,1,0.522474176558044,0,2,regulation of focal adhesion assembly,BP,
5082,GO:0051894,1,0.522474176558044,0,2,positive regulation of focal adhesion assembly,BP,
5085,GO:0051899,1,0.501044338726434,0,2,membrane depolarization,BP,
5086,GO:0051904,1,0.357459678272068,0,3,pigment granule transport,BP,
5087,GO:0051905,1,0.357459678272068,0,3,establishment of pigment granule localization,BP,
5089,GO:0051926,1,0.715718629020694,0,1,negative regulation of calcium ion transport,BP,
5090,GO:0051928,1,0.489376058557407,0,2,positive regulation of calcium ion transport,BP,
5091,GO:0051930,1,0.335888515411797,0,3,regulation of sensory perception of pain,BP,
5092,GO:0051931,1,0.335888515411797,0,3,regulation of sensory perception,BP,
5093,GO:0051932,1,0.720481830454823,0,1,synaptic transmission, GABAergic,BP,
5096,GO:0051938,1,0.733899513955252,0,1,L-glutamate import,BP,
5099,GO:0051953,1,0.243505700099272,0,4,negative regulation of amine transport,BP,
5101,GO:0051955,1,0.720481830454823,0,1,regulation of amino acid transport,BP,
5102,GO:0051956,1,0.720481830454823,0,1,negative regulation of amino acid transport,BP,
5107,GO:0051964,1,0.734655294999483,0,1,negative regulation of synapse assembly,BP,
5109,GO:0051966,1,0.720481830454823,0,1,regulation of synaptic transmission, glutamatergic,BP,
5110,GO:0051967,1,0.720481830454823,0,1,negative regulation of synaptic transmission, glutamatergic,BP,
5111,GO:0051990,1,0.69967224305375,0,1,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
5116,GO:0052692,1,0.651434792770337,0,1,raffinose alpha-galactosidase activity,MF,
5123,GO:0055003,1,0.734619139408899,0,1,cardiac myofibril assembly,BP,
5144,GO:0055070,1,0.49194105018732,0,2,copper ion homeostasis,BP,
5147,GO:0055075,1,0.729209164791576,0,1,potassium ion homeostasis,BP,
5149,GO:0055078,1,0.362898355912859,0,3,sodium ion homeostasis,BP,
5156,GO:0055090,1,0.732887609658439,0,1,acylglycerol homeostasis,BP,
5159,GO:0055093,1,0.693238114134537,0,1,response to hyperoxia,BP,
5162,GO:0055102,1,0.602424533559327,0,1,lipase inhibitor activity,MF,
5166,GO:0055119,1,0.502690714461259,0,2,relaxation of cardiac muscle,BP,
5168,GO:0055131,1,0.729209164791576,0,1,C3HC4-type RING finger domain binding,MF,
5169,GO:0060019,1,0.447895486490401,0,2,radial glial cell differentiation,BP,
5171,GO:0060024,1,0.687857981162908,0,1,rhythmic synaptic transmission,BP,
5172,GO:0060026,1,0.734655294999483,0,1,convergent extension,BP,
5173,GO:0060027,1,0.734655294999483,0,1,convergent extension involved in gastrulation,BP,
5174,GO:0060028,1,0.734655294999483,0,1,convergent extension involved in axis elongation,BP,
5175,GO:0060029,1,0.734655294999483,0,1,convergent extension involved in organogenesis,BP,
5176,GO:0060031,1,0.734655294999483,0,1,mediolateral intercalation,BP,
5196,GO:0060067,1,0.734655294999483,0,1,cervix development,BP,
5201,GO:0060076,1,0.539146376398311,0,2,excitatory synapse,CC,
5204,GO:0060087,1,0.720481830454823,0,1,relaxation of vascular smooth muscle,BP,
5205,GO:0060088,1,0.734698187201066,0,1,auditory receptor cell stereocilium organization,BP,
5207,GO:0060090,1,0.33921488605848,0,3,binding, bridging,MF,
5209,GO:0060117,1,0.734698187201066,0,1,auditory receptor cell development,BP,
5210,GO:0060119,1,0.383153003632655,0,3,inner ear receptor cell development,BP,
5212,GO:0060122,1,0.383153003632655,0,3,inner ear receptor stereocilium organization,BP,
5213,GO:0060126,1,0.734501565602613,0,1,somatotropin secreting cell differentiation,BP,
5217,GO:0060136,1,0.734629515296733,0,1,embryonic process involved in female pregnancy,BP,
5218,GO:0060137,1,0.687857981162908,0,1,maternal process involved in parturition,BP,
5226,GO:0060178,1,0.696012829206827,0,1,regulation of exocyst localization,BP,
5227,GO:0060179,1,0.677828420297706,0,1,male mating behavior,BP,
5228,GO:0060191,1,0.252804119512933,0,3,regulation of lipase activity,BP,
5229,GO:0060192,1,0.602424533559327,0,1,negative regulation of lipase activity,BP,
5230,GO:0060193,1,0.421192418256224,0,2,positive regulation of lipase activity,BP,
5232,GO:0060205,1,0.0119205249740166,0,12,cytoplasmic vesicle lumen,CC,
5233,GO:0060215,1,0.730064105565976,0,1,primitive hemopoiesis,BP,
5234,GO:0060216,1,0.730064105565976,0,1,definitive hemopoiesis,BP,
5235,GO:0060228,1,0.602424533559327,0,1,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
5238,GO:0060236,1,0.668902320485507,0,1,regulation of mitotic spindle organization,BP,
5249,GO:0060281,1,0.598426664068228,0,1,regulation of oocyte development,BP,
5250,GO:0060283,1,0.598426664068228,0,1,negative regulation of oocyte development,BP,
5252,GO:0060291,1,0.636323430837946,0,1,long-term synaptic potentiation,BP,
5253,GO:0060292,1,0.720481830454823,0,1,long term synaptic depression,BP,
5254,GO:0060297,1,0.687857981162908,0,1,regulation of sarcomere organization,BP,
5255,GO:0060298,1,0.687857981162908,0,1,positive regulation of sarcomere organization,BP,
5256,GO:0060306,1,0.521389098206347,0,2,regulation of membrane repolarization,BP,
5257,GO:0060307,1,0.729209164791576,0,1,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
5258,GO:0060314,1,0.715718629020694,0,1,regulation of ryanodine-sensitive calcium-release channel activity,BP,
5259,GO:0060315,1,0.715718629020694,0,1,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
5261,GO:0060318,1,0.730064105565976,0,1,definitive erythrocyte differentiation,BP,
5262,GO:0060319,1,0.730064105565976,0,1,primitive erythrocyte differentiation,BP,
5265,GO:0060324,1,0.264018524949281,0,4,face development,BP,
5266,GO:0060325,1,0.360451138757792,0,3,face morphogenesis,BP,
5268,GO:0060333,1,0.412600751326425,0,2,interferon-gamma-mediated signaling pathway,BP,
5278,GO:0060351,1,0.598426664068228,0,1,cartilage development involved in endochondral bone morphogenesis,BP,
5281,GO:0060374,1,0.730064105565976,0,1,mast cell differentiation,BP,
5282,GO:0060375,1,0.730064105565976,0,1,regulation of mast cell differentiation,BP,
5283,GO:0060377,1,0.730064105565976,0,1,negative regulation of mast cell differentiation,BP,
5290,GO:0060396,1,0.539175557745488,0,2,growth hormone receptor signaling pathway,BP,
5291,GO:0060397,1,0.734588622258976,0,1,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
5292,GO:0060401,1,0.324132911257305,0,3,cytosolic calcium ion transport,BP,
5293,GO:0060402,1,0.46415575177156,0,2,calcium ion transport into cytosol,BP,
5296,GO:0060413,1,0.528109275263181,0,2,atrial septum morphogenesis,BP,
5298,GO:0060416,1,0.276475599798371,0,4,response to growth hormone,BP,
5305,GO:0060426,1,0.528884877237284,0,2,lung vasculature development,BP,
5308,GO:0060430,1,0.439421434200077,0,2,lung saccule development,BP,
5310,GO:0060432,1,0.610551717868249,0,1,lung pattern specification process,BP,
5312,GO:0060435,1,0.610551717868249,0,1,bronchiole development,BP,
5313,GO:0060436,1,0.610551717868249,0,1,bronchiole morphogenesis,BP,
5314,GO:0060437,1,0.610551717868249,0,1,lung growth,BP,
5323,GO:0060447,1,0.610551717868249,0,1,bud outgrowth involved in lung branching,BP,
5325,GO:0060452,1,0.47899761864459,0,2,positive regulation of cardiac muscle contraction,BP,
5327,GO:0060462,1,0.734513896772137,0,1,lung lobe development,BP,
5328,GO:0060463,1,0.734513896772137,0,1,lung lobe morphogenesis,BP,
5329,GO:0060479,1,0.610551717868249,0,1,lung cell differentiation,BP,
5332,GO:0060487,1,0.610551717868249,0,1,lung epithelial cell differentiation,BP,
5335,GO:0060495,1,0.610551717868249,0,1,cell-cell signaling involved in lung development,BP,
5336,GO:0060496,1,0.610551717868249,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
5340,GO:0060510,1,0.610551717868249,0,1,Type II pneumocyte differentiation,BP,
5350,GO:0060539,1,0.522158977923792,0,2,diaphragm development,BP,
5364,GO:0060574,1,0.693238114134537,0,1,intestinal epithelial cell maturation,BP,
5365,GO:0060575,1,0.693238114134537,0,1,intestinal epithelial cell differentiation,BP,
5366,GO:0060576,1,0.693238114134537,0,1,intestinal epithelial cell development,BP,
5367,GO:0060584,1,0.687857981162908,0,1,regulation of prostaglandin-endoperoxide synthase activity,BP,
5368,GO:0060585,1,0.687857981162908,0,1,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
5372,GO:0060594,1,0.610551717868249,0,1,mammary gland specification,BP,
5373,GO:0060595,1,0.610551717868249,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
5374,GO:0060599,1,0.734655294999483,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
5380,GO:0060615,1,0.610551717868249,0,1,mammary gland bud formation,BP,
5382,GO:0060638,1,0.310613062247484,0,3,mesenchymal-epithelial cell signaling,BP,
5383,GO:0060644,1,0.721277899526339,0,1,mammary gland epithelial cell differentiation,BP,
5384,GO:0060648,1,0.610551717868249,0,1,mammary gland bud morphogenesis,BP,
5385,GO:0060661,1,0.610551717868249,0,1,submandibular salivary gland formation,BP,
5386,GO:0060664,1,0.610551717868249,0,1,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
5387,GO:0060665,1,0.610551717868249,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
5388,GO:0060667,1,0.610551717868249,0,1,branch elongation involved in salivary gland morphogenesis,BP,
5400,GO:0060693,1,0.610551717868249,0,1,regulation of branching involved in salivary gland morphogenesis,BP,
5401,GO:0060696,1,0.420839809132828,0,2,regulation of phospholipid catabolic process,BP,
5402,GO:0060706,1,0.529280991493322,0,2,cell differentiation involved in embryonic placenta development,BP,
5403,GO:0060707,1,0.734513896772137,0,1,trophoblast giant cell differentiation,BP,
5404,GO:0060708,1,0.734513896772137,0,1,spongiotrophoblast differentiation,BP,
5405,GO:0060709,1,0.721277899526339,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
5408,GO:0060712,1,0.529280991493322,0,2,spongiotrophoblast layer development,BP,
5413,GO:0060744,1,0.734655294999483,0,1,mammary gland branching involved in thelarche,BP,
5415,GO:0060748,1,0.734501565602613,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
5416,GO:0060749,1,0.734417317850469,0,1,mammary gland alveolus development,BP,
5417,GO:0060750,1,0.734655294999483,0,1,epithelial cell proliferation involved in mammary gland duct elongation,BP,
5418,GO:0060751,1,0.734655294999483,0,1,branch elongation involved in mammary gland duct branching,BP,
5421,GO:0060761,1,0.458925695168661,0,2,negative regulation of response to cytokine stimulus,BP,
5422,GO:0060762,1,0.734655294999483,0,1,regulation of branching involved in mammary gland duct morphogenesis,BP,
5425,GO:0060775,1,0.734655294999483,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
5428,GO:0060804,1,0.728387748399053,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
5429,GO:0060809,1,0.734655294999483,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
5432,GO:0060831,1,0.734595256616651,0,1,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
5434,GO:0060839,1,0.528825341235236,0,2,endothelial cell fate commitment,BP,
5439,GO:0060844,1,0.731051540942314,0,1,arterial endothelial cell fate commitment,BP,
5440,GO:0060846,1,0.731051540942314,0,1,blood vessel endothelial cell fate commitment,BP,
5441,GO:0060847,1,0.731051540942314,0,1,endothelial cell fate specification,BP,
5442,GO:0060853,1,0.731051540942314,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
5444,GO:0060872,1,0.610551717868249,0,1,semicircular canal development,BP,
5445,GO:0060876,1,0.610551717868249,0,1,semicircular canal formation,BP,
5446,GO:0060879,1,0.610551717868249,0,1,semicircular canal fusion,BP,
5449,GO:0060900,1,0.528986947202499,0,2,embryonic camera-type eye formation,BP,
5450,GO:0060907,1,0.734655294999483,0,1,positive regulation of macrophage cytokine production,BP,
5451,GO:0060911,1,0.52457929510808,0,2,cardiac cell fate commitment,BP,
5453,GO:0060915,1,0.610551717868249,0,1,mesenchymal cell differentiation involved in lung development,BP,
5454,GO:0060923,1,0.52457929510808,0,2,cardiac muscle cell fate commitment,BP,
5458,GO:0060957,1,0.724071876739581,0,1,endocardial cell fate commitment,BP,
5469,GO:0060992,1,0.71444051523567,0,1,response to fungicide,BP,
5478,GO:0061014,1,0.734269630851481,0,1,positive regulation of mRNA catabolic process,BP,
5483,GO:0061029,1,0.720739389914957,0,1,eyelid development in camera-type eye,BP,
5484,GO:0061032,1,0.725196311092909,0,1,visceral serous pericardium development,BP,
5485,GO:0061033,1,0.610551717868249,0,1,secretion by lung epithelial cell involved in lung growth,BP,
5491,GO:0061045,1,0.256642651155294,0,4,negative regulation of wound healing,BP,
5494,GO:0061049,1,0.687857981162908,0,1,cell growth involved in cardiac muscle cell development,BP,
5495,GO:0061050,1,0.687857981162908,0,1,regulation of cell growth involved in cardiac muscle cell development,BP,
5496,GO:0061051,1,0.687857981162908,0,1,positive regulation of cell growth involved in cardiac muscle cell development,BP,
5498,GO:0061054,1,0.734501565602613,0,1,dermatome development,BP,
5501,GO:0061081,1,0.734655294999483,0,1,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
5502,GO:0061082,1,0.354997151842348,0,3,myeloid leukocyte cytokine production,BP,
5503,GO:0061097,1,0.117966582919429,0,6,regulation of protein tyrosine kinase activity,BP,
5504,GO:0061098,1,0.117966582919429,0,6,positive regulation of protein tyrosine kinase activity,BP,
5506,GO:0061107,1,0.698707300486311,0,1,seminal vesicle development,BP,
5507,GO:0061110,1,0.685061814505026,0,1,dense core granule biogenesis,BP,
5508,GO:0061115,1,0.610551717868249,0,1,lung proximal/distal axis specification,BP,
5510,GO:0061134,1,0.087173163303055,0,6,peptidase regulator activity,MF,
5511,GO:0061135,1,0.140812601355857,0,5,endopeptidase regulator activity,MF,
5514,GO:0061140,1,0.610551717868249,0,1,lung secretory cell differentiation,BP,
5515,GO:0061143,1,0.720739389914957,0,1,alveolar primary septum development,BP,
5523,GO:0061162,1,0.539148185841117,0,2,establishment of monopolar cell polarity,BP,
5525,GO:0061183,1,0.734501565602613,0,1,regulation of dermatome development,BP,
5526,GO:0061184,1,0.734501565602613,0,1,positive regulation of dermatome development,BP,
5527,GO:0061205,1,0.528875975840574,0,2,paramesonephric duct development,BP,
5534,GO:0061245,1,0.539148185841117,0,2,establishment or maintenance of bipolar cell polarity,BP,
5535,GO:0061298,1,0.677667252574895,0,1,retina vasculature development in camera-type eye,BP,
5536,GO:0061299,1,0.677667252574895,0,1,retina vasculature morphogenesis in camera-type eye,BP,
5537,GO:0061302,1,0.519722588512373,0,2,smooth muscle cell-matrix adhesion,BP,
5538,GO:0061303,1,0.462778721484723,0,2,cornea development in camera-type eye,BP,
5548,GO:0061339,1,0.539148185841117,0,2,establishment or maintenance of monopolar cell polarity,BP,
5549,GO:0061341,1,0.734655294999483,0,1,non-canonical Wnt signaling pathway involved in heart development,BP,
5550,GO:0061343,1,0.724071876739581,0,1,cell adhesion involved in heart morphogenesis,BP,
5551,GO:0061346,1,0.734655294999483,0,1,planar cell polarity pathway involved in heart morphogenesis,BP,
5552,GO:0061347,1,0.734655294999483,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
5553,GO:0061348,1,0.734655294999483,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
5554,GO:0061349,1,0.734655294999483,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
5555,GO:0061350,1,0.734655294999483,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
5557,GO:0061354,1,0.734655294999483,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
5558,GO:0061369,1,0.734501565602613,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
5559,GO:0061370,1,0.332906483743995,0,3,testosterone biosynthetic process,BP,
5561,GO:0061377,1,0.734417317850469,0,1,mammary gland lobule development,BP,
5567,GO:0061436,1,0.73224972901803,0,1,establishment of skin barrier,BP,
5572,GO:0061443,1,0.724071876739581,0,1,endocardial cushion cell differentiation,BP,
5573,GO:0061445,1,0.724071876739581,0,1,endocardial cushion cell fate commitment,BP,
5576,GO:0061462,1,0.734629141546962,0,1,protein localization to lysosome,BP,
5578,GO:0061525,1,0.734655294999483,0,1,hindgut development,BP,
5580,GO:0061572,1,0.142210360258772,0,6,actin filament bundle organization,BP,
5581,GO:0061614,1,0.525161162776296,0,2,pri-miRNA transcription from RNA polymerase II promoter,BP,
5582,GO:0061615,1,0.734590273582109,0,1,glycolytic process through fructose-6-phosphate,BP,
5583,GO:0061620,1,0.734590273582109,0,1,glycolytic process through glucose-6-phosphate,BP,
5584,GO:0061621,1,0.734590273582109,0,1,canonical glycolysis,BP,
5585,GO:0061624,1,0.703675733824822,0,1,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
5588,GO:0061640,1,0.734630587357061,0,1,cytoskeleton-dependent cytokinesis,BP,
5589,GO:0061642,1,0.734655294999483,0,1,chemoattraction of axon,BP,
5590,GO:0061643,1,0.734655294999483,0,1,chemorepulsion of axon,BP,
5593,GO:0061700,1,0.732887609658439,0,1,GATOR2 complex,CC,
5594,GO:0061702,1,0.402924638225269,0,2,inflammasome complex,CC,
5595,GO:0061718,1,0.734590273582109,0,1,glucose catabolic process to pyruvate,BP,
5596,GO:0061724,1,0.732887609658439,0,1,lipophagy,BP,
5597,GO:0061772,1,0.73224972901803,0,1,drug transport across blood-nerve barrier,BP,
5599,GO:0065005,1,0.602424533559327,0,1,protein-lipid complex assembly,BP,
5607,GO:0070050,1,0.734544012449274,0,1,neuron cellular homeostasis,BP,
5608,GO:0070053,1,0.712035988887385,0,1,thrombospondin receptor activity,MF,
5611,GO:0070064,1,0.734588622258976,0,1,proline-rich region binding,MF,
5612,GO:0070075,1,0.610551717868249,0,1,tear secretion,BP,
5613,GO:0070080,1,0.734598335802591,0,1,titin Z domain binding,MF,
5616,GO:0070099,1,0.687857981162908,0,1,regulation of chemokine-mediated signaling pathway,BP,
5617,GO:0070101,1,0.687857981162908,0,1,positive regulation of chemokine-mediated signaling pathway,BP,
5621,GO:0070141,1,0.721277899526339,0,1,response to UV-A,BP,
5624,GO:0070162,1,0.734687452370601,0,1,adiponectin secretion,BP,
5625,GO:0070163,1,0.734687452370601,0,1,regulation of adiponectin secretion,BP,
5626,GO:0070164,1,0.734687452370601,0,1,negative regulation of adiponectin secretion,BP,
5628,GO:0070168,1,0.707679132473116,0,1,negative regulation of biomineral tissue development,BP,
5630,GO:0070170,1,0.666510188931046,0,1,regulation of tooth mineralization,BP,
5631,GO:0070172,1,0.666510188931046,0,1,positive regulation of tooth mineralization,BP,
5632,GO:0070195,1,0.734588622258976,0,1,growth hormone receptor complex,CC,
5637,GO:0070230,1,0.734655294999483,0,1,positive regulation of lymphocyte apoptotic process,BP,
5641,GO:0070234,1,0.734655294999483,0,1,positive regulation of T cell apoptotic process,BP,
5647,GO:0070245,1,0.734655294999483,0,1,positive regulation of thymocyte apoptotic process,BP,
5649,GO:0070254,1,0.720481830454823,0,1,mucus secretion,BP,
5650,GO:0070255,1,0.720481830454823,0,1,regulation of mucus secretion,BP,
5651,GO:0070256,1,0.720481830454823,0,1,negative regulation of mucus secretion,BP,
5656,GO:0070278,1,0.700055882594153,0,1,extracellular matrix constituent secretion,BP,
5660,GO:0070296,1,0.46415575177156,0,2,sarcoplasmic reticulum calcium ion transport,BP,
5661,GO:0070301,1,0.701056391605478,0,1,cellular response to hydrogen peroxide,BP,
5663,GO:0070303,1,0.721277899526339,0,1,negative regulation of stress-activated protein kinase signaling cascade,BP,
5667,GO:0070316,1,0.510752974134535,0,2,regulation of G0 to G1 transition,BP,
5668,GO:0070317,1,0.730352294167363,0,1,negative regulation of G0 to G1 transition,BP,
5669,GO:0070318,1,0.700055882594153,0,1,positive regulation of G0 to G1 transition,BP,
5670,GO:0070328,1,0.732887609658439,0,1,triglyceride homeostasis,BP,
5671,GO:0070341,1,0.610551717868249,0,1,fat cell proliferation,BP,
5672,GO:0070343,1,0.610551717868249,0,1,white fat cell proliferation,BP,
5673,GO:0070344,1,0.610551717868249,0,1,regulation of fat cell proliferation,BP,
5674,GO:0070346,1,0.610551717868249,0,1,positive regulation of fat cell proliferation,BP,
5675,GO:0070350,1,0.610551717868249,0,1,regulation of white fat cell proliferation,BP,
5676,GO:0070352,1,0.610551717868249,0,1,positive regulation of white fat cell proliferation,BP,
5679,GO:0070373,1,0.734513896772137,0,1,negative regulation of ERK1 and ERK2 cascade,BP,
5682,GO:0070384,1,0.610551717868249,0,1,Harderian gland development,BP,
5685,GO:0070405,1,0.420257328523098,0,2,ammonium ion binding,MF,
5687,GO:0070444,1,0.734589394501328,0,1,oligodendrocyte progenitor proliferation,BP,
5688,GO:0070445,1,0.734589394501328,0,1,regulation of oligodendrocyte progenitor proliferation,BP,
5689,GO:0070471,1,0.680185229568388,0,1,uterine smooth muscle contraction,BP,
5690,GO:0070472,1,0.680185229568388,0,1,regulation of uterine smooth muscle contraction,BP,
5691,GO:0070473,1,0.680185229568388,0,1,negative regulation of uterine smooth muscle contraction,BP,
5695,GO:0070507,1,0.342488127188183,0,3,regulation of microtubule cytoskeleton organization,BP,
5696,GO:0070509,1,0.334211149834662,0,3,calcium ion import,BP,
5697,GO:0070513,1,0.654756153569277,0,1,death domain binding,MF,
5700,GO:0070528,1,0.529691406461447,0,2,protein kinase C signaling,BP,
5701,GO:0070538,1,0.634405611216108,0,1,oleic acid binding,MF,
5702,GO:0070542,1,0.116394985858962,0,6,response to fatty acid,BP,
5704,GO:0070557,1,0.693238114134537,0,1,PCNA-p21 complex,CC,
5706,GO:0070569,1,0.647073695085383,0,1,uridylyltransferase activity,MF,
5709,GO:0070613,1,0.339016595905006,0,3,regulation of protein processing,BP,
5710,GO:0070627,1,0.719222945349914,0,1,ferrous iron import,BP,
5711,GO:0070633,1,0.687857981162908,0,1,transepithelial transport,BP,
5712,GO:0070637,1,0.703491083600584,0,1,pyridine nucleoside metabolic process,BP,
5713,GO:0070638,1,0.703491083600584,0,1,pyridine nucleoside catabolic process,BP,
5718,GO:0070662,1,0.734638208028596,0,1,mast cell proliferation,BP,
5722,GO:0070666,1,0.734638208028596,0,1,regulation of mast cell proliferation,BP,
5723,GO:0070668,1,0.734638208028596,0,1,positive regulation of mast cell proliferation,BP,
5724,GO:0070670,1,0.539099455543588,0,2,response to interleukin-4,BP,
5725,GO:0070672,1,0.734629515296733,0,1,response to interleukin-15,BP,
5726,GO:0070673,1,0.380048973410466,0,3,response to interleukin-18,BP,
5729,GO:0070704,1,0.734591748630676,0,1,sterol desaturase activity,MF,
5730,GO:0070724,1,0.728387748399053,0,1,BMP receptor complex,CC,
5732,GO:0070728,1,0.732887609658439,0,1,leucine binding,MF,
5733,GO:0070742,1,0.53225021503749,0,2,C2H2 zinc finger domain binding,MF,
5734,GO:0070777,1,0.733899513955252,0,1,D-aspartate transport,BP,
5735,GO:0070779,1,0.733899513955252,0,1,D-aspartate import,BP,
5737,GO:0070821,1,0.507218047045254,0,2,tertiary granule membrane,CC,
5738,GO:0070822,1,0.734627459219659,0,1,Sin3-type complex,CC,
5739,GO:0070830,1,0.470566950363031,0,2,bicellular tight junction assembly,BP,
5742,GO:0070849,1,0.721277899526339,0,1,response to epidermal growth factor,BP,
5745,GO:0070857,1,0.71444051523567,0,1,regulation of bile acid biosynthetic process,BP,
5746,GO:0070859,1,0.71444051523567,0,1,positive regulation of bile acid biosynthetic process,BP,
5747,GO:0070873,1,0.721277899526339,0,1,regulation of glycogen metabolic process,BP,
5748,GO:0070875,1,0.721277899526339,0,1,positive regulation of glycogen metabolic process,BP,
5753,GO:0070901,1,0.6269280304009,0,1,mitochondrial tRNA methylation,BP,
5755,GO:0070915,1,0.671454541303455,0,1,lysophosphatidic acid receptor activity,MF,
5759,GO:0070936,1,0.654756153569277,0,1,protein K48-linked ubiquitination,BP,
5760,GO:0070970,1,0.703491083600584,0,1,interleukin-2 secretion,BP,
5761,GO:0070977,1,0.728387748399053,0,1,bone maturation,BP,
5763,GO:0070996,1,0.619801351202952,0,1,type 1 melanocortin receptor binding,MF,
5765,GO:0071062,1,0.734583532995424,0,1,alphav-beta3 integrin-vitronectin complex,CC,
5766,GO:0071071,1,0.31911599703309,0,3,regulation of phospholipid biosynthetic process,BP,
5767,GO:0071072,1,0.721696904193942,0,1,negative regulation of phospholipid biosynthetic process,BP,
5768,GO:0071073,1,0.634405611216108,0,1,positive regulation of phospholipid biosynthetic process,BP,
5769,GO:0071156,1,0.13618757657737,0,5,regulation of cell cycle arrest,BP,
5770,GO:0071157,1,0.420271091824188,0,2,negative regulation of cell cycle arrest,BP,
5771,GO:0071158,1,0.32683251076091,0,3,positive regulation of cell cycle arrest,BP,
5778,GO:0071230,1,0.537905564242702,0,2,cellular response to amino acid stimulus,BP,
5779,GO:0071233,1,0.732887609658439,0,1,cellular response to leucine,BP,
5780,GO:0071236,1,0.71444051523567,0,1,cellular response to antibiotic,BP,
5784,GO:0071265,1,0.727559953538537,0,1,L-methionine biosynthetic process,BP,
5785,GO:0071267,1,0.727559953538537,0,1,L-methionine salvage,BP,
5786,GO:0071276,1,0.514780501856006,0,2,cellular response to cadmium ion,BP,
5787,GO:0071277,1,0.504796924238897,0,2,cellular response to calcium ion,BP,
5789,GO:0071284,1,0.73224972901803,0,1,cellular response to lead ion,BP,
5794,GO:0071307,1,0.707679132473116,0,1,cellular response to vitamin K,BP,
5796,GO:0071312,1,0.510802649642662,0,2,cellular response to alkaloid,BP,
5797,GO:0071313,1,0.715718629020694,0,1,cellular response to caffeine,BP,
5803,GO:0071335,1,0.610551717868249,0,1,hair follicle cell proliferation,BP,
5804,GO:0071336,1,0.610551717868249,0,1,regulation of hair follicle cell proliferation,BP,
5805,GO:0071338,1,0.610551717868249,0,1,positive regulation of hair follicle cell proliferation,BP,
5809,GO:0071351,1,0.520022212716508,0,2,cellular response to interleukin-18,BP,
5810,GO:0071353,1,0.539099455543588,0,2,cellular response to interleukin-4,BP,
5814,GO:0071360,1,0.696012829206827,0,1,cellular response to exogenous dsRNA,BP,
5816,GO:0071364,1,0.721277899526339,0,1,cellular response to epidermal growth factor stimulus,BP,
5819,GO:0071373,1,0.71444051523567,0,1,cellular response to luteinizing hormone stimulus,BP,
5822,GO:0071378,1,0.384451302388202,0,3,cellular response to growth hormone stimulus,BP,
5823,GO:0071379,1,0.721277899526339,0,1,cellular response to prostaglandin stimulus,BP,
5824,GO:0071380,1,0.721277899526339,0,1,cellular response to prostaglandin E stimulus,BP,
5828,GO:0071389,1,0.687857981162908,0,1,cellular response to mineralocorticoid stimulus,BP,
5829,GO:0071394,1,0.734550444064761,0,1,cellular response to testosterone stimulus,BP,
5831,GO:0071398,1,0.26505018814256,0,4,cellular response to fatty acid,BP,
5833,GO:0071415,1,0.715718629020694,0,1,cellular response to purine-containing compound,BP,
5835,GO:0071425,1,0.374097710414338,0,3,hematopoietic stem cell proliferation,BP,
5836,GO:0071435,1,0.729209164791576,0,1,potassium ion export,BP,
5837,GO:0071436,1,0.60595713946183,0,1,sodium ion export,BP,
5838,GO:0071437,1,0.734619771595464,0,1,invadopodium,CC,
5839,GO:0071438,1,0.734619771595464,0,1,invadopodium membrane,CC,
5844,GO:0071466,1,0.323746084995579,0,3,cellular response to xenobiotic stimulus,BP,
5848,GO:0071482,1,0.373004511017025,0,3,cellular response to light stimulus,BP,
5849,GO:0071493,1,0.693238114134537,0,1,cellular response to UV-B,BP,
5852,GO:0071505,1,0.721696904193942,0,1,response to mycophenolic acid,BP,
5853,GO:0071506,1,0.721696904193942,0,1,cellular response to mycophenolic acid,BP,
5859,GO:0071553,1,0.710841574163711,0,1,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
5867,GO:0071622,1,0.5043167780991,0,2,regulation of granulocyte chemotaxis,BP,
5868,GO:0071624,1,0.687857981162908,0,1,positive regulation of granulocyte chemotaxis,BP,
5872,GO:0071688,1,0.734688491282273,0,1,striated muscle myosin thick filament assembly,BP,
5873,GO:0071695,1,0.534614034603587,0,2,anatomical structure maturation,BP,
5882,GO:0071709,1,0.734589394501328,0,1,membrane assembly,BP,
5883,GO:0071715,1,0.687857981162908,0,1,icosanoid transport,BP,
5886,GO:0071733,1,0.730064105565976,0,1,transcriptional activation by promoter-enhancer looping,BP,
5890,GO:0071782,1,0.734254180896456,0,1,endoplasmic reticulum tubular network,CC,
5891,GO:0071786,1,0.734254180896456,0,1,endoplasmic reticulum tubular network organization,BP,
5892,GO:0071800,1,0.734550444064761,0,1,podosome assembly,BP,
5893,GO:0071801,1,0.734550444064761,0,1,regulation of podosome assembly,BP,
5894,GO:0071803,1,0.734550444064761,0,1,positive regulation of podosome assembly,BP,
5899,GO:0071826,1,0.649356158897709,0,1,ribonucleoprotein complex subunit organization,BP,
5901,GO:0071830,1,0.602424533559327,0,1,triglyceride-rich lipoprotein particle clearance,BP,
5904,GO:0071850,1,0.448535957280229,0,2,mitotic cell cycle arrest,BP,
5905,GO:0071855,1,0.425675672414994,0,2,neuropeptide receptor binding,MF,
5906,GO:0071867,1,0.524301444379429,0,2,response to monoamine,BP,
5907,GO:0071868,1,0.524301444379429,0,2,cellular response to monoamine stimulus,BP,
5908,GO:0071869,1,0.524301444379429,0,2,response to catecholamine,BP,
5909,GO:0071870,1,0.524301444379429,0,2,cellular response to catecholamine stimulus,BP,
5910,GO:0071871,1,0.524301444379429,0,2,response to epinephrine,BP,
5911,GO:0071872,1,0.524301444379429,0,2,cellular response to epinephrine stimulus,BP,
5912,GO:0071875,1,0.339090043736765,0,3,adrenergic receptor signaling pathway,BP,
5913,GO:0071880,1,0.339090043736765,0,3,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
5914,GO:0071883,1,0.496169850027802,0,2,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
5916,GO:0071889,1,0.721277899526339,0,1,14-3-3 protein binding,MF,
5918,GO:0071897,1,0.236096944543374,0,4,DNA biosynthetic process,BP,
5924,GO:0071963,1,0.669065351404653,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
5925,GO:0071971,1,0.712035988887385,0,1,extracellular exosome assembly,BP,
5926,GO:0071985,1,0.719239884495386,0,1,multivesicular body sorting pathway,BP,
5939,GO:0072033,1,0.734501565602613,0,1,renal vesicle formation,BP,
5940,GO:0072034,1,0.734501565602613,0,1,renal vesicle induction,BP,
5984,GO:0072126,1,0.721696904193942,0,1,positive regulation of glomerular mesangial cell proliferation,BP,
5996,GO:0072160,1,0.734513896772137,0,1,nephron tubule epithelial cell differentiation,BP,
5998,GO:0072162,1,0.734501565602613,0,1,metanephric mesenchymal cell differentiation,BP,
6001,GO:0072166,1,0.725196311092909,0,1,posterior mesonephric tubule development,BP,
6005,GO:0072173,1,0.734501565602613,0,1,metanephric tubule morphogenesis,BP,
6006,GO:0072174,1,0.734501565602613,0,1,metanephric tubule formation,BP,
6011,GO:0072182,1,0.734513896772137,0,1,regulation of nephron tubule epithelial cell differentiation,BP,
6026,GO:0072209,1,0.721696904193942,0,1,metanephric mesangial cell differentiation,BP,
6031,GO:0072223,1,0.522854398184172,0,2,metanephric glomerular mesangium development,BP,
6032,GO:0072224,1,0.522854398184172,0,2,metanephric glomerulus development,BP,
6037,GO:0072239,1,0.522854398184172,0,2,metanephric glomerulus vasculature development,BP,
6039,GO:0072254,1,0.721696904193942,0,1,metanephric glomerular mesangial cell differentiation,BP,
6040,GO:0072255,1,0.721696904193942,0,1,metanephric glomerular mesangial cell development,BP,
6041,GO:0072257,1,0.734513896772137,0,1,metanephric nephron tubule epithelial cell differentiation,BP,
6042,GO:0072262,1,0.725196311092909,0,1,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
6047,GO:0072298,1,0.725196311092909,0,1,regulation of metanephric glomerulus development,BP,
6048,GO:0072299,1,0.725196311092909,0,1,negative regulation of metanephric glomerulus development,BP,
6049,GO:0072301,1,0.725196311092909,0,1,regulation of metanephric glomerular mesangial cell proliferation,BP,
6050,GO:0072302,1,0.725196311092909,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
6051,GO:0072307,1,0.734513896772137,0,1,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
6054,GO:0072320,1,0.683400968465533,0,1,volume-sensitive chloride channel activity,MF,
6059,GO:0072338,1,0.734588622258976,0,1,cellular lactam metabolic process,BP,
6061,GO:0072350,1,0.329577650941292,0,3,tricarboxylic acid metabolic process,BP,
6064,GO:0072376,1,0.504995568976659,0,2,protein activation cascade,BP,
6065,GO:0072378,1,0.708829925476856,0,1,blood coagulation, fibrin clot formation,BP,
6066,GO:0072395,1,0.448535957280229,0,2,signal transduction involved in cell cycle checkpoint,BP,
6067,GO:0072401,1,0.448535957280229,0,2,signal transduction involved in DNA integrity checkpoint,BP,
6068,GO:0072413,1,0.448535957280229,0,2,signal transduction involved in mitotic cell cycle checkpoint,BP,
6069,GO:0072422,1,0.448535957280229,0,2,signal transduction involved in DNA damage checkpoint,BP,
6070,GO:0072431,1,0.448535957280229,0,2,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
6075,GO:0072509,1,0.463171284536355,0,2,divalent inorganic cation transmembrane transporter activity,MF,
6076,GO:0072510,1,0.719222945349914,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
6078,GO:0072512,1,0.719222945349914,0,1,trivalent inorganic cation transport,BP,
6083,GO:0072525,1,0.463579231864392,0,2,pyridine-containing compound biosynthetic process,BP,
6084,GO:0072526,1,0.703491083600584,0,1,pyridine-containing compound catabolic process,BP,
6085,GO:0072557,1,0.646782454309935,0,1,IPAF inflammasome complex,CC,
6086,GO:0072558,1,0.624051270746175,0,1,NLRP1 inflammasome complex,CC,
6087,GO:0072559,1,0.402924638225269,0,2,NLRP3 inflammasome complex,CC,
6088,GO:0072562,1,0.375661679093502,0,3,blood microparticle,CC,
6089,GO:0072574,1,0.689178626063054,0,1,hepatocyte proliferation,BP,
6090,GO:0072575,1,0.689178626063054,0,1,epithelial cell proliferation involved in liver morphogenesis,BP,
6091,GO:0072576,1,0.689178626063054,0,1,liver morphogenesis,BP,
6092,GO:0072577,1,0.707679132473116,0,1,endothelial cell apoptotic process,BP,
6094,GO:0072584,1,0.656640353294477,0,1,caveolin-mediated endocytosis,BP,
6097,GO:0072595,1,0.721277899526339,0,1,maintenance of protein localization in organelle,BP,
6099,GO:0072604,1,0.440995605856633,0,2,interleukin-6 secretion,BP,
6100,GO:0072606,1,0.457863957762274,0,2,interleukin-8 secretion,BP,
6101,GO:0072608,1,0.624051270746175,0,1,interleukin-10 secretion,BP,
6103,GO:0072656,1,0.721277899526339,0,1,maintenance of protein location in mitochondrion,BP,
6106,GO:0072661,1,0.707679132473116,0,1,protein targeting to plasma membrane,BP,
6107,GO:0072665,1,0.734629141546962,0,1,protein localization to vacuole,BP,
6113,GO:0075733,1,0.734621422421857,0,1,intracellular transport of virus,BP,
6119,GO:0086001,1,0.535200859247393,0,2,cardiac muscle cell action potential,BP,
6120,GO:0086002,1,0.535200859247393,0,2,cardiac muscle cell action potential involved in contraction,BP,
6121,GO:0086003,1,0.392422155154263,0,3,cardiac muscle cell contraction,BP,
6122,GO:0086004,1,0.539154861265391,0,2,regulation of cardiac muscle cell contraction,BP,
6123,GO:0086005,1,0.535200859247393,0,2,ventricular cardiac muscle cell action potential,BP,
6124,GO:0086008,1,0.729209164791576,0,1,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
6125,GO:0086009,1,0.521389098206347,0,2,membrane repolarization,BP,
6126,GO:0086010,1,0.729209164791576,0,1,membrane depolarization during action potential,BP,
6127,GO:0086011,1,0.729209164791576,0,1,membrane repolarization during action potential,BP,
6128,GO:0086013,1,0.729209164791576,0,1,membrane repolarization during cardiac muscle cell action potential,BP,
6129,GO:0086019,1,0.715718629020694,0,1,cell-cell signaling involved in cardiac conduction,BP,
6130,GO:0086023,1,0.685061814505026,0,1,adrenergic receptor signaling pathway involved in heart process,BP,
6131,GO:0086029,1,0.715718629020694,0,1,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
6132,GO:0086030,1,0.685061814505026,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
6133,GO:0086036,1,0.60595713946183,0,1,regulation of cardiac muscle cell membrane potential,BP,
6134,GO:0086042,1,0.734631305001351,0,1,cardiac muscle cell-cardiac muscle cell adhesion,BP,
6135,GO:0086065,1,0.525275928952281,0,2,cell communication involved in cardiac conduction,BP,
6136,GO:0086068,1,0.715718629020694,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
6137,GO:0086069,1,0.734631305001351,0,1,bundle of His cell to Purkinje myocyte communication,BP,
6138,GO:0086073,1,0.734631305001351,0,1,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
6139,GO:0086080,1,0.734631305001351,0,1,protein binding involved in heterotypic cell-cell adhesion,MF,
6140,GO:0086083,1,0.734631305001351,0,1,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
6141,GO:0086091,1,0.535200859247393,0,2,regulation of heart rate by cardiac conduction,BP,
6142,GO:0086097,1,0.734598335802591,0,1,phospholipase C-activating angiotensin-activated signaling pathway,BP,
6143,GO:0086103,1,0.685061814505026,0,1,G-protein coupled receptor signaling pathway involved in heart process,BP,
6144,GO:0089711,1,0.733899513955252,0,1,L-glutamate transmembrane transport,BP,
6147,GO:0090003,1,0.284346611205607,0,4,regulation of establishment of protein localization to plasma membrane,BP,
6148,GO:0090004,1,0.388164970988262,0,3,positive regulation of establishment of protein localization to plasma membrane,BP,
6149,GO:0090005,1,0.734598124981224,0,1,negative regulation of establishment of protein localization to plasma membrane,BP,
6150,GO:0090009,1,0.734655294999483,0,1,primitive streak formation,BP,
6151,GO:0090022,1,0.5043167780991,0,2,regulation of neutrophil chemotaxis,BP,
6152,GO:0090023,1,0.687857981162908,0,1,positive regulation of neutrophil chemotaxis,BP,
6155,GO:0090032,1,0.521954174827692,0,2,negative regulation of steroid hormone biosynthetic process,BP,
6156,GO:0090036,1,0.734655294999483,0,1,regulation of protein kinase C signaling,BP,
6157,GO:0090037,1,0.734655294999483,0,1,positive regulation of protein kinase C signaling,BP,
6162,GO:0090075,1,0.361417907931172,0,3,relaxation of muscle,BP,
6169,GO:0090102,1,0.734655294999483,0,1,cochlea development,BP,
6170,GO:0090103,1,0.734655294999483,0,1,cochlea morphogenesis,BP,
6171,GO:0090109,1,0.522474176558044,0,2,regulation of cell-substrate junction assembly,BP,
6173,GO:0090131,1,0.660127822057299,0,1,mesenchyme migration,BP,
6177,GO:0090136,1,0.516816927682327,0,2,epithelial cell-cell adhesion,BP,
6178,GO:0090138,1,0.733958464826053,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
6180,GO:0090162,1,0.539148185841117,0,2,establishment of epithelial cell polarity,BP,
6183,GO:0090177,1,0.734655294999483,0,1,establishment of planar polarity involved in neural tube closure,BP,
6184,GO:0090178,1,0.734655294999483,0,1,regulation of establishment of planar polarity involved in neural tube closure,BP,
6185,GO:0090179,1,0.734655294999483,0,1,planar cell polarity pathway involved in neural tube closure,BP,
6196,GO:0090193,1,0.721696904193942,0,1,positive regulation of glomerulus development,BP,
6198,GO:0090195,1,0.624051270746175,0,1,chemokine secretion,BP,
6199,GO:0090196,1,0.624051270746175,0,1,regulation of chemokine secretion,BP,
6200,GO:0090197,1,0.624051270746175,0,1,positive regulation of chemokine secretion,BP,
6203,GO:0090201,1,0.467772416492944,0,2,negative regulation of release of cytochrome c from mitochondria,BP,
6204,GO:0090202,1,0.730064105565976,0,1,gene looping,BP,
6207,GO:0090208,1,0.678874584138857,0,1,positive regulation of triglyceride metabolic process,BP,
6209,GO:0090218,1,0.721696904193942,0,1,positive regulation of lipid kinase activity,BP,
6210,GO:0090224,1,0.668902320485507,0,1,regulation of spindle organization,BP,
6216,GO:0090279,1,0.516004098154942,0,2,regulation of calcium ion import,BP,
6217,GO:0090280,1,0.721696904193942,0,1,positive regulation of calcium ion import,BP,
6218,GO:0090281,1,0.715718629020694,0,1,negative regulation of calcium ion import,BP,
6223,GO:0090305,1,0.460926171262399,0,2,nucleic acid phosphodiester bond hydrolysis,BP,
6233,GO:0090399,1,0.693238114134537,0,1,replicative senescence,BP,
6234,GO:0090400,1,0.693238114134537,0,1,stress-induced premature senescence,BP,
6236,GO:0090484,1,0.637466954542453,0,1,drug transporter activity,MF,
6239,GO:0090501,1,0.460926171262399,0,2,RNA phosphodiester bond hydrolysis,BP,
6240,GO:0090502,1,0.734576401742655,0,1,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
6243,GO:0090526,1,0.732887609658439,0,1,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
6244,GO:0090533,1,0.60595713946183,0,1,cation-transporting ATPase complex,CC,
6245,GO:0090557,1,0.73224972901803,0,1,establishment of endothelial intestinal barrier,BP,
6248,GO:0090579,1,0.730064105565976,0,1,dsDNA loop formation,BP,
6250,GO:0090598,1,0.610551717868249,0,1,male anatomical structure morphogenesis,BP,
6254,GO:0090677,1,0.721696904193942,0,1,reversible differentiation,BP,
6255,GO:0090678,1,0.721696904193942,0,1,cell dedifferentiation involved in phenotypic switching,BP,
6258,GO:0097011,1,0.721277899526339,0,1,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
6259,GO:0097012,1,0.721277899526339,0,1,response to granulocyte macrophage colony-stimulating factor,BP,
6260,GO:0097017,1,0.707679132473116,0,1,renal protein absorption,BP,
6261,GO:0097018,1,0.707679132473116,0,1,renal albumin absorption,BP,
6263,GO:0097028,1,0.446284390931222,0,2,dendritic cell differentiation,BP,
6264,GO:0097038,1,0.734654319492406,0,1,perinuclear endoplasmic reticulum,CC,
6265,GO:0097048,1,0.707679132473116,0,1,dendritic cell apoptotic process,BP,
6267,GO:0097058,1,0.67186132548751,0,1,CRLF-CLCF1 complex,CC,
6268,GO:0097059,1,0.67186132548751,0,1,CNTFR-CLCF1 complex,CC,
6271,GO:0097062,1,0.734619771595464,0,1,dendritic spine maintenance,BP,
6272,GO:0097070,1,0.720739389914957,0,1,ductus arteriosus closure,BP,
6274,GO:0097089,1,0.664661465181863,0,1,methyl-branched fatty acid metabolic process,BP,
6275,GO:0097091,1,0.734589394501328,0,1,synaptic vesicle clustering,BP,
6277,GO:0097101,1,0.731051540942314,0,1,blood vessel endothelial cell fate specification,BP,
6278,GO:0097102,1,0.731051540942314,0,1,endothelial tip cell fate specification,BP,
6279,GO:0097104,1,0.734589394501328,0,1,postsynaptic membrane assembly,BP,
6280,GO:0097106,1,0.734589394501328,0,1,postsynaptic density organization,BP,
6281,GO:0097110,1,0.532586521869268,0,2,scaffold protein binding,MF,
6282,GO:0097118,1,0.734589394501328,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
6283,GO:0097119,1,0.734589394501328,0,1,postsynaptic density protein 95 clustering,BP,
6286,GO:0097153,1,0.402924638225269,0,2,cysteine-type endopeptidase activity involved in apoptotic process,MF,
6289,GO:0097169,1,0.402924638225269,0,2,AIM2 inflammasome complex,CC,
6291,GO:0097179,1,0.698707300486311,0,1,protease inhibitor complex,CC,
6292,GO:0097180,1,0.698707300486311,0,1,serine protease inhibitor complex,CC,
6293,GO:0097181,1,0.698707300486311,0,1,protein C inhibitor-coagulation factor V complex,CC,
6294,GO:0097182,1,0.698707300486311,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
6295,GO:0097183,1,0.698707300486311,0,1,protein C inhibitor-coagulation factor XI complex,CC,
6296,GO:0097186,1,0.7346518247608,0,1,amelogenesis,BP,
6301,GO:0097194,1,0.465913757298282,0,2,execution phase of apoptosis,BP,
6303,GO:0097200,1,0.646782454309935,0,1,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
6305,GO:0097205,1,0.268686108053417,0,4,renal filtration,BP,
6307,GO:0097241,1,0.707679132473116,0,1,hematopoietic stem cell migration to bone marrow,BP,
6308,GO:0097252,1,0.707679132473116,0,1,oligodendrocyte apoptotic process,BP,
6309,GO:0097278,1,0.719239884495386,0,1,complement-dependent cytotoxicity,BP,
6311,GO:0097286,1,0.719222945349914,0,1,iron ion import,BP,
6316,GO:0097325,1,0.734655294999483,0,1,melanocyte proliferation,BP,
6317,GO:0097338,1,0.734595256616651,0,1,response to clozapine,BP,
6318,GO:0097340,1,0.649356158897709,0,1,inhibition of cysteine-type endopeptidase activity,BP,
6319,GO:0097341,1,0.649356158897709,0,1,zymogen inhibition,BP,
6325,GO:0097421,1,0.496552578422917,0,2,liver regeneration,BP,
6326,GO:0097425,1,0.456602885212195,0,2,smooth endoplasmic reticulum part,CC,
6330,GO:0097459,1,0.719222945349914,0,1,iron ion import into cell,BP,
6331,GO:0097460,1,0.719222945349914,0,1,ferrous iron import into cell,BP,
6339,GO:0097531,1,0.685061814505026,0,1,mast cell migration,BP,
6340,GO:0097546,1,0.519400362978979,0,2,ciliary base,CC,
6341,GO:0097553,1,0.46415575177156,0,2,calcium ion transmembrane import into cytosol,BP,
6342,GO:0097581,1,0.669065351404653,0,1,lamellipodium organization,BP,
6343,GO:0097610,1,0.701056391605478,0,1,cell surface furrow,CC,
6344,GO:0097623,1,0.729209164791576,0,1,potassium ion export across plasma membrane,BP,
6349,GO:0097711,1,0.734617631152968,0,1,ciliary basal body docking,BP,
6351,GO:0097722,1,0.678874584138857,0,1,sperm motility,BP,
6355,GO:0097734,1,0.511590213238085,0,2,extracellular exosome biogenesis,BP,
6356,GO:0097746,1,0.0337337186438115,0,9,regulation of blood vessel diameter,BP,
6357,GO:0097755,1,0.430518635642279,0,2,positive regulation of blood vessel diameter,BP,
6358,GO:0097756,1,0.0783116174508035,0,7,negative regulation of blood vessel diameter,BP,
6360,GO:0098533,1,0.60595713946183,0,1,ATPase dependent transmembrane transport complex,CC,
6364,GO:0098563,1,0.677129625885184,0,1,intrinsic component of synaptic vesicle membrane,CC,
6369,GO:0098596,1,0.720739389914957,0,1,imitative learning,BP,
6370,GO:0098597,1,0.720739389914957,0,1,observational learning,BP,
6371,GO:0098598,1,0.720739389914957,0,1,learned vocalization behavior or vocal learning,BP,
6375,GO:0098631,1,0.528200173484652,0,2,protein binding involved in cell adhesion,MF,
6376,GO:0098632,1,0.528200173484652,0,2,protein binding involved in cell-cell adhesion,MF,
6377,GO:0098636,1,0.211214773844819,0,5,protein complex involved in cell adhesion,CC,
6378,GO:0098641,1,0.719693492985385,0,1,cadherin binding involved in cell-cell adhesion,MF,
6380,GO:0098656,1,0.157489168975936,0,5,anion transmembrane transport,BP,
6382,GO:0098659,1,0.719222945349914,0,1,inorganic cation import into cell,BP,
6384,GO:0098661,1,0.413435230092464,0,2,inorganic anion transmembrane transport,BP,
6386,GO:0098668,1,0.729209164791576,0,1,potassium ion export from cell,BP,
6397,GO:0098781,1,0.62828243039627,0,1,ncRNA transcription,BP,
6404,GO:0098801,1,0.183970270880518,0,5,regulation of renal system process,BP,
6409,GO:0098813,1,0.668902320485507,0,1,nuclear chromosome segregation,BP,
6411,GO:0098827,1,0.734254180896456,0,1,endoplasmic reticulum subcompartment,CC,
6414,GO:0098858,1,0.0500982968789977,0,9,actin-based cell projection,CC,
6415,GO:0098862,1,0.394625122759368,0,3,cluster of actin-based cell projections,CC,
6416,GO:0098868,1,0.598426664068228,0,1,bone growth,BP,
6419,GO:0098900,1,0.734631305001351,0,1,regulation of action potential,BP,
6420,GO:0098901,1,0.734631305001351,0,1,regulation of cardiac muscle cell action potential,BP,
6421,GO:0098911,1,0.734631305001351,0,1,regulation of ventricular cardiac muscle cell action potential,BP,
6422,GO:0098915,1,0.729209164791576,0,1,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
6424,GO:0098927,1,0.734550444064761,0,1,vesicle-mediated transport between endosomal compartments,BP,
6427,GO:0099023,1,0.696012829206827,0,1,tethering complex,CC,
6428,GO:0099024,1,0.497540454624916,0,2,plasma membrane invagination,BP,
6433,GO:0099084,1,0.734589394501328,0,1,postsynaptic specialization organization,BP,
6447,GO:0099587,1,0.719222945349914,0,1,inorganic ion import into cell,BP,
6449,GO:0099622,1,0.729209164791576,0,1,cardiac muscle cell membrane repolarization,BP,
6450,GO:0099623,1,0.729209164791576,0,1,regulation of cardiac muscle cell membrane repolarization,BP,
6451,GO:0099625,1,0.729209164791576,0,1,ventricular cardiac muscle cell membrane repolarization,BP,
6453,GO:0100002,1,0.721277899526339,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
6454,GO:0101002,1,0.239879125700958,0,4,ficolin-1-rich granule,CC,
6456,GO:0102007,1,0.663248360975453,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
6458,GO:0102132,1,0.734715871907028,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
6459,GO:0102336,1,0.730712451364202,0,1,3-oxo-arachidoyl-CoA synthase activity,MF,
6460,GO:0102337,1,0.730712451364202,0,1,3-oxo-cerotoyl-CoA synthase activity,MF,
6461,GO:0102338,1,0.730712451364202,0,1,3-oxo-lignoceronyl-CoA synthase activity,MF,
6462,GO:0102391,1,0.734629515296733,0,1,decanoate--CoA ligase activity,MF,
6466,GO:1900019,1,0.734655294999483,0,1,regulation of protein kinase C activity,BP,
6467,GO:1900020,1,0.734655294999483,0,1,positive regulation of protein kinase C activity,BP,
6470,GO:1900046,1,0.256693797637455,0,4,regulation of hemostasis,BP,
6471,GO:1900047,1,0.350478925022211,0,3,negative regulation of hemostasis,BP,
6472,GO:1900076,1,0.395311467339384,0,3,regulation of cellular response to insulin stimulus,BP,
6473,GO:1900078,1,0.395311467339384,0,3,positive regulation of cellular response to insulin stimulus,BP,
6474,GO:1900101,1,0.734654319492406,0,1,regulation of endoplasmic reticulum unfolded protein response,BP,
6475,GO:1900103,1,0.734654319492406,0,1,positive regulation of endoplasmic reticulum unfolded protein response,BP,
6478,GO:1900125,1,0.721696904193942,0,1,regulation of hyaluronan biosynthetic process,BP,
6479,GO:1900127,1,0.721696904193942,0,1,positive regulation of hyaluronan biosynthetic process,BP,
6480,GO:1900141,1,0.707679132473116,0,1,regulation of oligodendrocyte apoptotic process,BP,
6481,GO:1900142,1,0.707679132473116,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
6482,GO:1900165,1,0.707679132473116,0,1,negative regulation of interleukin-6 secretion,BP,
6486,GO:1900186,1,0.656640353294477,0,1,negative regulation of clathrin-dependent endocytosis,BP,
6487,GO:1900193,1,0.598426664068228,0,1,regulation of oocyte maturation,BP,
6488,GO:1900194,1,0.598426664068228,0,1,negative regulation of oocyte maturation,BP,
6489,GO:1900238,1,0.721696904193942,0,1,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
6490,GO:1900239,1,0.721696904193942,0,1,regulation of phenotypic switching,BP,
6491,GO:1900241,1,0.721696904193942,0,1,positive regulation of phenotypic switching,BP,
6492,GO:1900274,1,0.421192418256224,0,2,regulation of phospholipase C activity,BP,
6493,GO:1900371,1,0.18572194535739,0,4,regulation of purine nucleotide biosynthetic process,BP,
6494,GO:1900372,1,0.687857981162908,0,1,negative regulation of purine nucleotide biosynthetic process,BP,
6495,GO:1900373,1,0.27116363370479,0,3,positive regulation of purine nucleotide biosynthetic process,BP,
6496,GO:1900376,1,0.734655294999483,0,1,regulation of secondary metabolite biosynthetic process,BP,
6497,GO:1900377,1,0.734655294999483,0,1,negative regulation of secondary metabolite biosynthetic process,BP,
6499,GO:1900408,1,0.467772416492944,0,2,negative regulation of cellular response to oxidative stress,BP,
6500,GO:1900409,1,0.678874584138857,0,1,positive regulation of cellular response to oxidative stress,BP,
6501,GO:1900452,1,0.720481830454823,0,1,regulation of long term synaptic depression,BP,
6502,GO:1900453,1,0.720481830454823,0,1,negative regulation of long term synaptic depression,BP,
6506,GO:1900736,1,0.685061814505026,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
6507,GO:1900738,1,0.685061814505026,0,1,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
6510,GO:1900744,1,0.471351952923282,0,2,regulation of p38MAPK cascade,BP,
6511,GO:1900745,1,0.471351952923282,0,2,positive regulation of p38MAPK cascade,BP,
6512,GO:1900746,1,0.731051540942314,0,1,regulation of vascular endothelial growth factor signaling pathway,BP,
6513,GO:1900750,1,0.671129001439236,0,1,oligopeptide binding,MF,
6515,GO:1901016,1,0.525252294946068,0,2,regulation of potassium ion transmembrane transporter activity,BP,
6516,GO:1901017,1,0.525252294946068,0,2,negative regulation of potassium ion transmembrane transporter activity,BP,
6517,GO:1901018,1,0.734598335802591,0,1,positive regulation of potassium ion transmembrane transporter activity,BP,
6518,GO:1901019,1,0.355757459000654,0,3,regulation of calcium ion transmembrane transporter activity,BP,
6519,GO:1901020,1,0.715718629020694,0,1,negative regulation of calcium ion transmembrane transporter activity,BP,
6520,GO:1901021,1,0.678874584138857,0,1,positive regulation of calcium ion transmembrane transporter activity,BP,
6524,GO:1901033,1,0.678874584138857,0,1,positive regulation of response to reactive oxygen species,BP,
6525,GO:1901052,1,0.731018562409083,0,1,sarcosine metabolic process,BP,
6526,GO:1901053,1,0.731018562409083,0,1,sarcosine catabolic process,BP,
6527,GO:1901068,1,0.734598124981224,0,1,guanosine-containing compound metabolic process,BP,
6528,GO:1901077,1,0.502690714461259,0,2,regulation of relaxation of muscle,BP,
6529,GO:1901078,1,0.734583504697188,0,1,negative regulation of relaxation of muscle,BP,
6530,GO:1901079,1,0.685061814505026,0,1,positive regulation of relaxation of muscle,BP,
6536,GO:1901184,1,0.0845175850525205,0,7,regulation of ERBB signaling pathway,BP,
6537,GO:1901185,1,0.494873063993686,0,2,negative regulation of ERBB signaling pathway,BP,
6538,GO:1901186,1,0.172750872057431,0,5,positive regulation of ERBB signaling pathway,BP,
6547,GO:1901317,1,0.678874584138857,0,1,regulation of flagellated sperm motility,BP,
6548,GO:1901318,1,0.678874584138857,0,1,negative regulation of flagellated sperm motility,BP,
6549,GO:1901338,1,0.496169850027802,0,2,catecholamine binding,MF,
6556,GO:1901379,1,0.382278693217935,0,3,regulation of potassium ion transmembrane transport,BP,
6557,GO:1901380,1,0.382278693217935,0,3,negative regulation of potassium ion transmembrane transport,BP,
6558,GO:1901381,1,0.535176781371065,0,2,positive regulation of potassium ion transmembrane transport,BP,
6559,GO:1901385,1,0.734583504697188,0,1,regulation of voltage-gated calcium channel activity,BP,
6565,GO:1901550,1,0.682977610744016,0,1,regulation of endothelial cell development,BP,
6566,GO:1901552,1,0.682977610744016,0,1,positive regulation of endothelial cell development,BP,
6570,GO:1901568,1,0.137365523454399,0,5,fatty acid derivative metabolic process,BP,
6571,GO:1901570,1,0.208291182420284,0,4,fatty acid derivative biosynthetic process,BP,
6572,GO:1901571,1,0.687857981162908,0,1,fatty acid derivative transport,BP,
6577,GO:1901607,1,0.533454285322874,0,2,alpha-amino acid biosynthetic process,BP,
6581,GO:1901620,1,0.734595256616651,0,1,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
6582,GO:1901621,1,0.734595256616651,0,1,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
6583,GO:1901623,1,0.734655294999483,0,1,regulation of lymphocyte chemotaxis,BP,
6584,GO:1901626,1,0.734589394501328,0,1,regulation of postsynaptic membrane organization,BP,
6589,GO:1901657,1,0.223211154690738,0,4,glycosyl compound metabolic process,BP,
6590,GO:1901658,1,0.304886266898405,0,3,glycosyl compound catabolic process,BP,
6591,GO:1901668,1,0.678874584138857,0,1,regulation of superoxide dismutase activity,BP,
6592,GO:1901671,1,0.678874584138857,0,1,positive regulation of superoxide dismutase activity,BP,
6593,GO:1901674,1,0.734513896772137,0,1,regulation of histone H3-K27 acetylation,BP,
6594,GO:1901676,1,0.734513896772137,0,1,positive regulation of histone H3-K27 acetylation,BP,
6595,GO:1901678,1,0.733916729266681,0,1,iron coordination entity transport,BP,
6597,GO:1901685,1,0.61919681818651,0,1,glutathione derivative metabolic process,BP,
6598,GO:1901687,1,0.61919681818651,0,1,glutathione derivative biosynthetic process,BP,
6605,GO:1901724,1,0.721696904193942,0,1,positive regulation of cell proliferation involved in kidney development,BP,
6609,GO:1901841,1,0.734583504697188,0,1,regulation of high voltage-gated calcium channel activity,BP,
6615,GO:1901881,1,0.734598335802591,0,1,positive regulation of protein depolymerization,BP,
6616,GO:1901888,1,0.381845313709445,0,3,regulation of cell junction assembly,BP,
6617,GO:1901890,1,0.381845313709445,0,3,positive regulation of cell junction assembly,BP,
6618,GO:1901894,1,0.678874584138857,0,1,regulation of calcium-transporting ATPase activity,BP,
6619,GO:1901896,1,0.678874584138857,0,1,positive regulation of calcium-transporting ATPase activity,BP,
6620,GO:1901897,1,0.502690714461259,0,2,regulation of relaxation of cardiac muscle,BP,
6621,GO:1901898,1,0.734583504697188,0,1,negative regulation of relaxation of cardiac muscle,BP,
6622,GO:1901899,1,0.685061814505026,0,1,positive regulation of relaxation of cardiac muscle,BP,
6625,GO:1901976,1,0.721277899526339,0,1,regulation of cell cycle checkpoint,BP,
6627,GO:1901983,1,0.734513896772137,0,1,regulation of protein acetylation,BP,
6628,GO:1901985,1,0.734513896772137,0,1,positive regulation of protein acetylation,BP,
6634,GO:1902001,1,0.524036738085078,0,2,fatty acid transmembrane transport,BP,
6635,GO:1902010,1,0.732887609658439,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
6636,GO:1902033,1,0.734638208028596,0,1,regulation of hematopoietic stem cell proliferation,BP,
6637,GO:1902035,1,0.734638208028596,0,1,positive regulation of hematopoietic stem cell proliferation,BP,
6641,GO:1902074,1,0.687857981162908,0,1,response to salt,BP,
6647,GO:1902109,1,0.649356158897709,0,1,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
6650,GO:1902117,1,0.248743796993363,0,4,positive regulation of organelle assembly,BP,
6653,GO:1902175,1,0.467772416492944,0,2,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
6654,GO:1902176,1,0.467772416492944,0,2,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
6655,GO:1902221,1,0.629717088917049,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
6656,GO:1902222,1,0.629717088917049,0,1,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
6662,GO:1902275,1,0.734513896772137,0,1,regulation of chromatin organization,BP,
6663,GO:1902282,1,0.729209164791576,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
6665,GO:1902302,1,0.729209164791576,0,1,regulation of potassium ion export,BP,
6666,GO:1902303,1,0.729209164791576,0,1,negative regulation of potassium ion export,BP,
6667,GO:1902305,1,0.60595713946183,0,1,regulation of sodium ion transmembrane transport,BP,
6668,GO:1902307,1,0.60595713946183,0,1,positive regulation of sodium ion transmembrane transport,BP,
6669,GO:1902311,1,0.670477648906454,0,1,regulation of copper ion transmembrane transport,BP,
6675,GO:1902379,1,0.734655294999483,0,1,chemoattractant activity involved in axon guidance,MF,
6676,GO:1902400,1,0.448535957280229,0,2,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
6677,GO:1902402,1,0.448535957280229,0,2,signal transduction involved in mitotic DNA damage checkpoint,BP,
6678,GO:1902403,1,0.448535957280229,0,2,signal transduction involved in mitotic DNA integrity checkpoint,BP,
6682,GO:1902475,1,0.733899513955252,0,1,L-alpha-amino acid transmembrane transport,BP,
6683,GO:1902476,1,0.413435230092464,0,2,chloride transmembrane transport,BP,
6686,GO:1902524,1,0.654756153569277,0,1,positive regulation of protein K48-linked ubiquitination,BP,
6690,GO:1902547,1,0.731051540942314,0,1,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
6691,GO:1902554,1,0.22790047738758,0,4,serine/threonine protein kinase complex,CC,
6692,GO:1902555,1,0.6269280304009,0,1,endoribonuclease complex,CC,
6696,GO:1902581,1,0.734621422421857,0,1,multi-organism cellular localization,BP,
6698,GO:1902583,1,0.734621422421857,0,1,multi-organism intracellular transport,BP,
6701,GO:1902600,1,0.62028039706305,0,1,hydrogen ion transmembrane transport,BP,
6702,GO:1902612,1,0.717300502787745,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
6703,GO:1902613,1,0.717300502787745,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
6704,GO:1902622,1,0.5043167780991,0,2,regulation of neutrophil migration,BP,
6705,GO:1902624,1,0.687857981162908,0,1,positive regulation of neutrophil migration,BP,
6708,GO:1902656,1,0.46415575177156,0,2,calcium ion import into cytosol,BP,
6720,GO:1902806,1,0.196106882373205,0,4,regulation of cell cycle G1/S phase transition,BP,
6721,GO:1902807,1,0.448535957280229,0,2,negative regulation of cell cycle G1/S phase transition,BP,
6722,GO:1902850,1,0.668902320485507,0,1,microtubule cytoskeleton organization involved in mitosis,BP,
6726,GO:1902883,1,0.467772416492944,0,2,negative regulation of response to oxidative stress,BP,
6727,GO:1902884,1,0.678874584138857,0,1,positive regulation of response to oxidative stress,BP,
6728,GO:1902893,1,0.525161162776296,0,2,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6729,GO:1902894,1,0.721696904193942,0,1,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6730,GO:1902895,1,0.525161162776296,0,2,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
6731,GO:1902897,1,0.734589394501328,0,1,regulation of postsynaptic density protein 95 clustering,BP,
6734,GO:1902905,1,0.0752698774343812,0,7,positive regulation of supramolecular fiber organization,BP,
6735,GO:1902911,1,0.22790047738758,0,4,protein kinase complex,CC,
6736,GO:1902914,1,0.654756153569277,0,1,regulation of protein polyubiquitination,BP,
6737,GO:1902916,1,0.654756153569277,0,1,positive regulation of protein polyubiquitination,BP,
6741,GO:1902946,1,0.734550444064761,0,1,protein localization to early endosome,BP,
6742,GO:1902965,1,0.734550444064761,0,1,regulation of protein localization to early endosome,BP,
6743,GO:1902966,1,0.734550444064761,0,1,positive regulation of protein localization to early endosome,BP,
6746,GO:1903018,1,0.700866560072831,0,1,regulation of glycoprotein metabolic process,BP,
6747,GO:1903019,1,0.700866560072831,0,1,negative regulation of glycoprotein metabolic process,BP,
6748,GO:1903025,1,0.734513896772137,0,1,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
6750,GO:1903035,1,0.256642651155294,0,4,negative regulation of response to wounding,BP,
6755,GO:1903046,1,0.272807244947581,0,4,meiotic cell cycle process,BP,
6760,GO:1903076,1,0.284346611205607,0,4,regulation of protein localization to plasma membrane,BP,
6761,GO:1903077,1,0.734598124981224,0,1,negative regulation of protein localization to plasma membrane,BP,
6762,GO:1903078,1,0.388164970988262,0,3,positive regulation of protein localization to plasma membrane,BP,
6763,GO:1903115,1,0.539154861265391,0,2,regulation of actin filament-based movement,BP,
6765,GO:1903140,1,0.682977610744016,0,1,regulation of establishment of endothelial barrier,BP,
6766,GO:1903142,1,0.682977610744016,0,1,positive regulation of establishment of endothelial barrier,BP,
6768,GO:1903170,1,0.715718629020694,0,1,negative regulation of calcium ion transmembrane transport,BP,
6769,GO:1903173,1,0.676160423272601,0,1,fatty alcohol metabolic process,BP,
6770,GO:1903201,1,0.467772416492944,0,2,regulation of oxidative stress-induced cell death,BP,
6771,GO:1903202,1,0.467772416492944,0,2,negative regulation of oxidative stress-induced cell death,BP,
6773,GO:1903273,1,0.60595713946183,0,1,regulation of sodium ion export,BP,
6774,GO:1903275,1,0.60595713946183,0,1,positive regulation of sodium ion export,BP,
6775,GO:1903276,1,0.60595713946183,0,1,regulation of sodium ion export from cell,BP,
6776,GO:1903278,1,0.60595713946183,0,1,positive regulation of sodium ion export from cell,BP,
6782,GO:1903313,1,0.734269630851481,0,1,positive regulation of mRNA metabolic process,BP,
6783,GO:1903317,1,0.339016595905006,0,3,regulation of protein maturation,BP,
6784,GO:1903318,1,0.649356158897709,0,1,negative regulation of protein maturation,BP,
6788,GO:1903348,1,0.73224972901803,0,1,positive regulation of bicellular tight junction assembly,BP,
6791,GO:1903391,1,0.522474176558044,0,2,regulation of adherens junction organization,BP,
6792,GO:1903393,1,0.522474176558044,0,2,positive regulation of adherens junction organization,BP,
6793,GO:1903409,1,0.110892708442285,0,6,reactive oxygen species biosynthetic process,BP,
6794,GO:1903426,1,0.110892708442285,0,6,regulation of reactive oxygen species biosynthetic process,BP,
6795,GO:1903427,1,0.441601710452898,0,2,negative regulation of reactive oxygen species biosynthetic process,BP,
6796,GO:1903428,1,0.253677151851776,0,4,positive regulation of reactive oxygen species biosynthetic process,BP,
6797,GO:1903429,1,0.598426664068228,0,1,regulation of cell maturation,BP,
6798,GO:1903430,1,0.598426664068228,0,1,negative regulation of cell maturation,BP,
6799,GO:1903432,1,0.732887609658439,0,1,regulation of TORC1 signaling,BP,
6800,GO:1903433,1,0.719239884495386,0,1,regulation of constitutive secretory pathway,BP,
6801,GO:1903435,1,0.719239884495386,0,1,positive regulation of constitutive secretory pathway,BP,
6806,GO:1903510,1,0.173362226465898,0,5,mucopolysaccharide metabolic process,BP,
6807,GO:1903514,1,0.46415575177156,0,2,calcium ion transport from endoplasmic reticulum to cytosol,BP,
6812,GO:1903524,1,0.159897234141652,0,5,positive regulation of blood circulation,BP,
6817,GO:1903541,1,0.712035988887385,0,1,regulation of exosomal secretion,BP,
6818,GO:1903543,1,0.712035988887385,0,1,positive regulation of exosomal secretion,BP,
6819,GO:1903544,1,0.73224972901803,0,1,response to butyrate,BP,
6820,GO:1903545,1,0.73224972901803,0,1,cellular response to butyrate,BP,
6821,GO:1903551,1,0.712035988887385,0,1,regulation of extracellular exosome assembly,BP,
6822,GO:1903553,1,0.712035988887385,0,1,positive regulation of extracellular exosome assembly,BP,
6824,GO:1903556,1,0.707679132473116,0,1,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
6830,GO:1903610,1,0.678874584138857,0,1,regulation of calcium-dependent ATPase activity,BP,
6831,GO:1903611,1,0.678874584138857,0,1,negative regulation of calcium-dependent ATPase activity,BP,
6832,GO:1903624,1,0.678874584138857,0,1,regulation of DNA catabolic process,BP,
6833,GO:1903625,1,0.678874584138857,0,1,negative regulation of DNA catabolic process,BP,
6834,GO:1903627,1,0.678874584138857,0,1,regulation of dUTP diphosphatase activity,BP,
6835,GO:1903629,1,0.678874584138857,0,1,positive regulation of dUTP diphosphatase activity,BP,
6836,GO:1903630,1,0.678874584138857,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
6837,GO:1903631,1,0.678874584138857,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
6838,GO:1903633,1,0.678874584138857,0,1,regulation of leucine-tRNA ligase activity,BP,
6839,GO:1903634,1,0.678874584138857,0,1,negative regulation of leucine-tRNA ligase activity,BP,
6840,GO:1903649,1,0.734550444064761,0,1,regulation of cytoplasmic transport,BP,
6841,GO:1903651,1,0.734550444064761,0,1,positive regulation of cytoplasmic transport,BP,
6844,GO:1903672,1,0.536521345478187,0,2,positive regulation of sprouting angiogenesis,BP,
6849,GO:1903719,1,0.721277899526339,0,1,regulation of I-kappaB phosphorylation,BP,
6850,GO:1903721,1,0.721277899526339,0,1,positive regulation of I-kappaB phosphorylation,BP,
6851,GO:1903725,1,0.102163757521577,0,6,regulation of phospholipid metabolic process,BP,
6852,GO:1903726,1,0.434135608964736,0,2,negative regulation of phospholipid metabolic process,BP,
6853,GO:1903727,1,0.457242137499831,0,2,positive regulation of phospholipid metabolic process,BP,
6854,GO:1903729,1,0.284346611205607,0,4,regulation of plasma membrane organization,BP,
6857,GO:1903779,1,0.188962430149302,0,4,regulation of cardiac conduction,BP,
6858,GO:1903792,1,0.519144485214915,0,2,negative regulation of anion transport,BP,
6859,GO:1903793,1,0.687857981162908,0,1,positive regulation of anion transport,BP,
6862,GO:1903825,1,0.383857280602429,0,3,organic acid transmembrane transport,BP,
6866,GO:1903830,1,0.655347613928356,0,1,magnesium ion transmembrane transport,BP,
6867,GO:1903844,1,0.357172847313627,0,3,regulation of cellular response to transforming growth factor beta stimulus,BP,
6868,GO:1903845,1,0.680024981343857,0,1,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
6873,GO:1903901,1,0.734576401742655,0,1,negative regulation of viral life cycle,BP,
6875,GO:1903959,1,0.721277899526339,0,1,regulation of anion transmembrane transport,BP,
6876,GO:1903960,1,0.721277899526339,0,1,negative regulation of anion transmembrane transport,BP,
6881,GO:1904029,1,0.0935547196083433,0,6,regulation of cyclin-dependent protein kinase activity,BP,
6882,GO:1904030,1,0.693238114134537,0,1,negative regulation of cyclin-dependent protein kinase activity,BP,
6883,GO:1904031,1,0.145458278836077,0,5,positive regulation of cyclin-dependent protein kinase activity,BP,
6884,GO:1904035,1,0.707679132473116,0,1,regulation of epithelial cell apoptotic process,BP,
6885,GO:1904036,1,0.707679132473116,0,1,negative regulation of epithelial cell apoptotic process,BP,
6887,GO:1904063,1,0.382278693217935,0,3,negative regulation of cation transmembrane transport,BP,
6888,GO:1904064,1,0.218684188357222,0,4,positive regulation of cation transmembrane transport,BP,
6891,GO:1904251,1,0.71444051523567,0,1,regulation of bile acid metabolic process,BP,
6892,GO:1904253,1,0.71444051523567,0,1,positive regulation of bile acid metabolic process,BP,
6893,GO:1904262,1,0.732887609658439,0,1,negative regulation of TORC1 signaling,BP,
6894,GO:1904375,1,0.284346611205607,0,4,regulation of protein localization to cell periphery,BP,
6895,GO:1904376,1,0.734598124981224,0,1,negative regulation of protein localization to cell periphery,BP,
6896,GO:1904377,1,0.388164970988262,0,3,positive regulation of protein localization to cell periphery,BP,
6897,GO:1904385,1,0.734598335802591,0,1,cellular response to angiotensin,BP,
6898,GO:1904406,1,0.441601710452898,0,2,negative regulation of nitric oxide metabolic process,BP,
6899,GO:1904407,1,0.353830774522892,0,3,positive regulation of nitric oxide metabolic process,BP,
6900,GO:1904427,1,0.678874584138857,0,1,positive regulation of calcium ion transmembrane transport,BP,
6901,GO:1904502,1,0.732887609658439,0,1,regulation of lipophagy,BP,
6902,GO:1904504,1,0.732887609658439,0,1,positive regulation of lipophagy,BP,
6906,GO:1904645,1,0.646782454309935,0,1,response to beta-amyloid,BP,
6907,GO:1904646,1,0.646782454309935,0,1,cellular response to beta-amyloid,BP,
6914,GO:1904705,1,0.721696904193942,0,1,regulation of vascular smooth muscle cell proliferation,BP,
6915,GO:1904707,1,0.721696904193942,0,1,positive regulation of vascular smooth muscle cell proliferation,BP,
6916,GO:1904724,1,0.69967224305375,0,1,tertiary granule lumen,CC,
6917,GO:1904738,1,0.721696904193942,0,1,vascular associated smooth muscle cell migration,BP,
6921,GO:1904752,1,0.721696904193942,0,1,regulation of vascular associated smooth muscle cell migration,BP,
6922,GO:1904754,1,0.721696904193942,0,1,positive regulation of vascular associated smooth muscle cell migration,BP,
6923,GO:1904813,1,0.239879125700958,0,4,ficolin-1-rich granule lumen,CC,
6924,GO:1904833,1,0.678874584138857,0,1,positive regulation of removal of superoxide radicals,BP,
6929,GO:1904862,1,0.734655294999483,0,1,inhibitory synapse assembly,BP,
6937,GO:1904933,1,0.734655294999483,0,1,regulation of cell proliferation in midbrain,BP,
6938,GO:1904934,1,0.734655294999483,0,1,negative regulation of cell proliferation in midbrain,BP,
6939,GO:1904938,1,0.734655294999483,0,1,planar cell polarity pathway involved in axon guidance,BP,
6941,GO:1904949,1,0.60595713946183,0,1,ATPase complex,CC,
6946,GO:1904955,1,0.734655294999483,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
6947,GO:1905005,1,0.724071876739581,0,1,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
6948,GO:1905007,1,0.724071876739581,0,1,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
6950,GO:1905039,1,0.383857280602429,0,3,carboxylic acid transmembrane transport,BP,
6951,GO:1905063,1,0.721696904193942,0,1,regulation of vascular smooth muscle cell differentiation,BP,
6952,GO:1905064,1,0.721696904193942,0,1,negative regulation of vascular smooth muscle cell differentiation,BP,
6955,GO:1905174,1,0.721696904193942,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
6956,GO:1905176,1,0.721696904193942,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
6960,GO:1905269,1,0.734513896772137,0,1,positive regulation of chromatin organization,BP,
6967,GO:1905348,1,0.6269280304009,0,1,endonuclease complex,CC,
6973,GO:1905438,1,0.734655294999483,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
6978,GO:1905476,1,0.734598124981224,0,1,negative regulation of protein localization to membrane,BP,
6982,GO:1905666,1,0.734550444064761,0,1,regulation of protein localization to endosome,BP,
6983,GO:1905668,1,0.734550444064761,0,1,positive regulation of protein localization to endosome,BP,
6984,GO:1905709,1,0.649356158897709,0,1,negative regulation of membrane permeability,BP,
6986,GO:1905809,1,0.734655294999483,0,1,negative regulation of synapse organization,BP,
6988,GO:1905874,1,0.734589394501328,0,1,regulation of postsynaptic density organization,BP,
6989,GO:1905879,1,0.598426664068228,0,1,regulation of oogenesis,BP,
6990,GO:1905880,1,0.598426664068228,0,1,negative regulation of oogenesis,BP,
6993,GO:1905939,1,0.532154342469593,0,2,regulation of gonad development,BP,
6994,GO:1905940,1,0.532154342469593,0,2,negative regulation of gonad development,BP,
6995,GO:1905941,1,0.725196311092909,0,1,positive regulation of gonad development,BP,
7000,GO:1990001,1,0.649356158897709,0,1,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
7001,GO:1990089,1,0.721277899526339,0,1,response to nerve growth factor,BP,
7002,GO:1990090,1,0.721277899526339,0,1,cellular response to nerve growth factor stimulus,BP,
7007,GO:1990172,1,0.734656689076872,0,1,G-protein coupled receptor catabolic process,BP,
7008,GO:1990182,1,0.511590213238085,0,2,exosomal secretion,BP,
7011,GO:1990262,1,0.717300502787745,0,1,anti-Mullerian hormone signaling pathway,BP,
7013,GO:1990316,1,0.732887609658439,0,1,ATG1/ULK1 kinase complex,CC,
7015,GO:1990418,1,0.721277899526339,0,1,response to insulin-like growth factor stimulus,BP,
7016,GO:1990427,1,0.734698187201066,0,1,stereocilia tip-link density,CC,
7017,GO:1990430,1,0.734719033698558,0,1,extracellular matrix protein binding,MF,
7018,GO:1990435,1,0.734698187201066,0,1,upper tip-link density,CC,
7019,GO:1990459,1,0.719222945349914,0,1,transferrin receptor binding,MF,
7021,GO:1990542,1,0.727254309212684,0,1,mitochondrial transmembrane transport,BP,
7022,GO:1990578,1,0.734654319492406,0,1,perinuclear endoplasmic reticulum membrane,CC,
7023,GO:1990712,1,0.719222945349914,0,1,HFE-transferrin receptor complex,CC,
7026,GO:1990776,1,0.734598335802591,0,1,response to angiotensin,BP,
7027,GO:1990777,1,0.602424533559327,0,1,lipoprotein particle,CC,
7029,GO:1990782,1,0.278915684159176,0,4,protein tyrosine kinase binding,MF,
7030,GO:1990785,1,0.730352294167363,0,1,response to water-immersion restraint stress,BP,
7032,GO:1990841,1,0.730352294167363,0,1,promoter-specific chromatin binding,MF,
7033,GO:1990851,1,0.729015514498003,0,1,Wnt-Frizzled-LRP5/6 complex,CC,
7034,GO:1990874,1,0.721696904193942,0,1,vascular smooth muscle cell proliferation,BP,
7037,GO:1990936,1,0.721696904193942,0,1,vascular smooth muscle cell dedifferentiation,BP,
7043,GO:2000008,1,0.734598335802591,0,1,regulation of protein localization to cell surface,BP,
7044,GO:2000009,1,0.734598335802591,0,1,negative regulation of protein localization to cell surface,BP,
7045,GO:2000015,1,0.724071876739581,0,1,regulation of determination of dorsal identity,BP,
7046,GO:2000017,1,0.724071876739581,0,1,positive regulation of determination of dorsal identity,BP,
7047,GO:2000018,1,0.532154342469593,0,2,regulation of male gonad development,BP,
7048,GO:2000019,1,0.734501565602613,0,1,negative regulation of male gonad development,BP,
7049,GO:2000020,1,0.725196311092909,0,1,positive regulation of male gonad development,BP,
7050,GO:2000021,1,0.167246316624002,0,5,regulation of ion homeostasis,BP,
7054,GO:2000045,1,0.196106882373205,0,4,regulation of G1/S transition of mitotic cell cycle,BP,
7055,GO:2000047,1,0.734655294999483,0,1,regulation of cell-cell adhesion mediated by cadherin,BP,
7056,GO:2000049,1,0.734655294999483,0,1,positive regulation of cell-cell adhesion mediated by cadherin,BP,
7057,GO:2000050,1,0.734655294999483,0,1,regulation of non-canonical Wnt signaling pathway,BP,
7058,GO:2000052,1,0.734655294999483,0,1,positive regulation of non-canonical Wnt signaling pathway,BP,
7061,GO:2000064,1,0.382643336970993,0,3,regulation of cortisol biosynthetic process,BP,
7062,GO:2000065,1,0.521954174827692,0,2,negative regulation of cortisol biosynthetic process,BP,
7063,GO:2000066,1,0.734501565602613,0,1,positive regulation of cortisol biosynthetic process,BP,
7064,GO:2000097,1,0.708376329021044,0,1,regulation of smooth muscle cell-matrix adhesion,BP,
7068,GO:2000108,1,0.734655294999483,0,1,positive regulation of leukocyte apoptotic process,BP,
7072,GO:2000117,1,0.330242903962089,0,3,negative regulation of cysteine-type endopeptidase activity,BP,
7074,GO:2000134,1,0.448535957280229,0,2,negative regulation of G1/S transition of mitotic cell cycle,BP,
7084,GO:2000178,1,0.505768436916422,0,2,negative regulation of neural precursor cell proliferation,BP,
7087,GO:2000191,1,0.495579542709413,0,2,regulation of fatty acid transport,BP,
7088,GO:2000192,1,0.721277899526339,0,1,negative regulation of fatty acid transport,BP,
7089,GO:2000193,1,0.687857981162908,0,1,positive regulation of fatty acid transport,BP,
7090,GO:2000194,1,0.725196311092909,0,1,regulation of female gonad development,BP,
7091,GO:2000195,1,0.725196311092909,0,1,negative regulation of female gonad development,BP,
7093,GO:2000224,1,0.734501565602613,0,1,regulation of testosterone biosynthetic process,BP,
7094,GO:2000225,1,0.734501565602613,0,1,negative regulation of testosterone biosynthetic process,BP,
7100,GO:2000257,1,0.713203645219262,0,1,regulation of protein activation cascade,BP,
7103,GO:2000272,1,0.715718629020694,0,1,negative regulation of receptor activity,BP,
7104,GO:2000273,1,0.261257017244274,0,4,positive regulation of receptor activity,BP,
7105,GO:2000278,1,0.338447223980029,0,3,regulation of DNA biosynthetic process,BP,
7106,GO:2000279,1,0.678874584138857,0,1,negative regulation of DNA biosynthetic process,BP,
7107,GO:2000345,1,0.689178626063054,0,1,regulation of hepatocyte proliferation,BP,
7108,GO:2000346,1,0.689178626063054,0,1,negative regulation of hepatocyte proliferation,BP,
7109,GO:2000351,1,0.707679132473116,0,1,regulation of endothelial cell apoptotic process,BP,
7110,GO:2000352,1,0.707679132473116,0,1,negative regulation of endothelial cell apoptotic process,BP,
7111,GO:2000369,1,0.656640353294477,0,1,regulation of clathrin-dependent endocytosis,BP,
7113,GO:2000378,1,0.441601710452898,0,2,negative regulation of reactive oxygen species metabolic process,BP,
7114,GO:2000379,1,0.0543439552185502,0,8,positive regulation of reactive oxygen species metabolic process,BP,
7123,GO:2000425,1,0.67801637721819,0,1,regulation of apoptotic cell clearance,BP,
7124,GO:2000427,1,0.67801637721819,0,1,positive regulation of apoptotic cell clearance,BP,
7130,GO:2000479,1,0.518189790464599,0,2,regulation of cAMP-dependent protein kinase activity,BP,
7131,GO:2000480,1,0.707766673908358,0,1,negative regulation of cAMP-dependent protein kinase activity,BP,
7132,GO:2000482,1,0.457863957762274,0,2,regulation of interleukin-8 secretion,BP,
7133,GO:2000484,1,0.457863957762274,0,2,positive regulation of interleukin-8 secretion,BP,
7134,GO:2000505,1,0.731051540942314,0,1,regulation of energy homeostasis,BP,
7135,GO:2000508,1,0.707679132473116,0,1,regulation of dendritic cell chemotaxis,BP,
7136,GO:2000510,1,0.707679132473116,0,1,positive regulation of dendritic cell chemotaxis,BP,
7137,GO:2000532,1,0.707679132473116,0,1,regulation of renal albumin absorption,BP,
7138,GO:2000533,1,0.707679132473116,0,1,negative regulation of renal albumin absorption,BP,
7142,GO:2000573,1,0.721696904193942,0,1,positive regulation of DNA biosynthetic process,BP,
7143,GO:2000586,1,0.721696904193942,0,1,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
7144,GO:2000587,1,0.721696904193942,0,1,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
7145,GO:2000589,1,0.721696904193942,0,1,regulation of metanephric mesenchymal cell migration,BP,
7146,GO:2000591,1,0.721696904193942,0,1,positive regulation of metanephric mesenchymal cell migration,BP,
7150,GO:2000641,1,0.734550444064761,0,1,regulation of early endosome to late endosome transport,BP,
7151,GO:2000643,1,0.734550444064761,0,1,positive regulation of early endosome to late endosome transport,BP,
7153,GO:2000649,1,0.60595713946183,0,1,regulation of sodium ion transmembrane transporter activity,BP,
7155,GO:2000668,1,0.707679132473116,0,1,regulation of dendritic cell apoptotic process,BP,
7156,GO:2000669,1,0.707679132473116,0,1,negative regulation of dendritic cell apoptotic process,BP,
7161,GO:2000705,1,0.685061814505026,0,1,regulation of dense core granule biogenesis,BP,
7162,GO:2000707,1,0.685061814505026,0,1,positive regulation of dense core granule biogenesis,BP,
7168,GO:2000756,1,0.734513896772137,0,1,regulation of peptidyl-lysine acetylation,BP,
7169,GO:2000758,1,0.734513896772137,0,1,positive regulation of peptidyl-lysine acetylation,BP,
7170,GO:2000778,1,0.624051270746175,0,1,positive regulation of interleukin-6 secretion,BP,
7172,GO:2000786,1,0.696012829206827,0,1,positive regulation of autophagosome assembly,BP,
7174,GO:2000807,1,0.734589394501328,0,1,regulation of synaptic vesicle clustering,BP,
7175,GO:2000809,1,0.734589394501328,0,1,positive regulation of synaptic vesicle clustering,BP,
7176,GO:2000810,1,0.73224972901803,0,1,regulation of bicellular tight junction assembly,BP,
7193,GO:2001014,1,0.636323430837946,0,1,regulation of skeletal muscle cell differentiation,BP,
7194,GO:2001015,1,0.636323430837946,0,1,negative regulation of skeletal muscle cell differentiation,BP,
7200,GO:2001044,1,0.689178626063054,0,1,regulation of integrin-mediated signaling pathway,BP,
7201,GO:2001046,1,0.689178626063054,0,1,positive regulation of integrin-mediated signaling pathway,BP,
7205,GO:2001057,1,0.155059743150086,0,5,reactive nitrogen species metabolic process,BP,
7206,GO:2001074,1,0.725196311092909,0,1,regulation of metanephric ureteric bud development,BP,
7207,GO:2001076,1,0.725196311092909,0,1,positive regulation of metanephric ureteric bud development,BP,
7208,GO:2001135,1,0.734598335802591,0,1,regulation of endocytic recycling,BP,
7209,GO:2001137,1,0.734598335802591,0,1,positive regulation of endocytic recycling,BP,
7211,GO:2001179,1,0.624051270746175,0,1,regulation of interleukin-10 secretion,BP,
7212,GO:2001181,1,0.624051270746175,0,1,positive regulation of interleukin-10 secretion,BP,
7213,GO:2001198,1,0.631515652607527,0,1,regulation of dendritic cell differentiation,BP,
7214,GO:2001199,1,0.631515652607527,0,1,negative regulation of dendritic cell differentiation,BP,
7227,GO:2001243,1,0.467772416492944,0,2,negative regulation of intrinsic apoptotic signaling pathway,BP,
7229,GO:2001245,1,0.634405611216108,0,1,regulation of phosphatidylcholine biosynthetic process,BP,
7230,GO:2001252,1,0.734513896772137,0,1,positive regulation of chromosome organization,BP,
7231,GO:2001257,1,0.385110202759887,0,3,regulation of cation channel activity,BP,
7232,GO:2001258,1,0.715718629020694,0,1,negative regulation of cation channel activity,BP,
7233,GO:2001259,1,0.734598335802591,0,1,positive regulation of cation channel activity,BP,
7236,GO:2001273,1,0.395311467339384,0,3,regulation of glucose import in response to insulin stimulus,BP,
7237,GO:2001275,1,0.395311467339384,0,3,positive regulation of glucose import in response to insulin stimulus,BP,
7238,GO:2001286,1,0.656640353294477,0,1,regulation of caveolin-mediated endocytosis,BP,
7239,GO:2001287,1,0.656640353294477,0,1,negative regulation of caveolin-mediated endocytosis,BP,
